STUDYID|DOMAIN|USUBJID|QSSEQ|QSGRPID|QSSPID|QSTESTCD|QSTEST|QSCAT|QSSCAT|QSORRES|QSORRESU|QSSTRESC|QSSTRESN|QSSTRESU|QSSTAT|QSREASND|QSMETHOD|QSLOBXFL|QSBLFL|QSDRVFL|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|QSDTC|QSDY|QSTPT|QSTPTNUM|QSELTM|QSTPTREF|QSRFTDTC|QSEVLINT|QSEVINTX
TRIAL STUDY 134XCP|QS|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||U/KG|||FOZ_US|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|N|1||38||SCREENING|1971-12-16||||1962-09-18||1966-06-15|1962-10-01|
TRIAL STUDY 134XCP|QS|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2|||||LEC-5 STANDARD VERSION|||MONTHS|||BQ/UL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|NA|2||58||INDUCTION TREATMENT|1960-06-28||||1963-12-30||1971-09-29|1973-01-10|
TRIAL STUDY 134XCP|QS|28FBEC95-59B8-4821-BD7A-125E2C87D71C|3|||||PHQ-15|||PIXEL|||M/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|3||39||SCREENING|1968-07-06||||1961-06-04||1960-01-01|1961-06-06|
TRIAL STUDY 134XCP|QS|28FBEC95-59B8-4821-BD7A-125E2C87D71C|4|||||ADCS-ADL|||VIRTUAL PIXEL|||ML/MMHG/MIN/L|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|4||88||BASELINE|1970-02-22||||1962-06-20||1963-08-10|1970-01-03|
TRIAL STUDY 134XCP|QS|28FBEC95-59B8-4821-BD7A-125E2C87D71C|5|||||SWLS|||V/SEC|||BQ/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|Y|5||7||BLINDED TREATMENT|1960-03-09||||1973-02-16||1973-05-08|1973-04-09|
TRIAL STUDY 134XCP|QS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||10^3 COPIES/ML|||UMOL/DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|NA|1||38||SCREENING|1972-07-10||||1965-03-05||1966-10-18|1970-09-24|
TRIAL STUDY 134XCP|QS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2|||||CCQ 1 WEEK VERSION|||10^4/HPF|||IN|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|2||58||BASELINE|1969-07-28||||1968-07-17||1968-05-14|1963-04-03|
TRIAL STUDY 134XCP|QS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|3|||||BORG CR10|||MMHG*MIN/L|||CUP EQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|N|3||39||RUN-IN|1968-02-12||||1963-04-20||1968-02-01|1963-03-17|
TRIAL STUDY 134XCP|QS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||HPA|||MU/G|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|U|4||88||INDUCTION TREATMENT|1960-01-01||||1964-02-14||1965-10-10|1960-10-10|
TRIAL STUDY 134XCP|QS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|5|||||SDS|||WATT|||UG/KG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|5||7||FOLLOW-UP|1972-10-22||||1963-12-01||1971-11-25|1964-07-26|
TRIAL STUDY 134XCP|QS|1117C221-3530-45CB-82B2-B831C4DAD86B|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||APL U|||DMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|1||38||LONG-TERM FOLLOW-UP|1967-11-20||||1967-10-27||1961-03-15|1965-11-21|
TRIAL STUDY 134XCP|QS|1117C221-3530-45CB-82B2-B831C4DAD86B|2|||||FLU-IIQ ONCE DAILY|||PG/CELL|||VOXEL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|2||58||CONTINUATION TREATMENT|1973-08-03||||1967-09-01||1969-04-20|1966-12-31|
TRIAL STUDY 134XCP|QS|1117C221-3530-45CB-82B2-B831C4DAD86B|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||EVENTS|||FT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|NA|3||39||INDUCTION TREATMENT|1960-09-01||||1962-05-10||1967-04-30|1966-09-08|
TRIAL STUDY 134XCP|QS|1117C221-3530-45CB-82B2-B831C4DAD86B|4|||||PSQI|||L/S/KPA|||UL/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|Y|4||88||LONG-TERM FOLLOW-UP|1972-07-01||||1961-10-30||1973-03-27|1961-05-09|
TRIAL STUDY 134XCP|QS|1117C221-3530-45CB-82B2-B831C4DAD86B|5|||||SIQ|||FINGERTIP UNIT|||TRANSDUCING UNIT/ML|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|5||7||WASHOUT|1960-02-01||||1967-02-19||1968-04-24|1960-11-18|
TRIAL STUDY 134XCP|QS|3ACFF838-5B16-4898-9640-A60C85096F64|1|||||BEBQ RETROSPECTIVE|||UMOL/L/SEC|||MG/ML/DAY|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|1||38||OBSERVATION|1961-01-23||||1971-11-27||1960-06-17|1965-09-01|
TRIAL STUDY 134XCP|QS|3ACFF838-5B16-4898-9640-A60C85096F64|2|||||FKSI-DRS V4|||NMOL BCE/NMOL|||RATIO|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|NA|2||58||WASHOUT|1968-11-30||||1964-02-13||1961-11-08|1973-06-03|
TRIAL STUDY 134XCP|QS|3ACFF838-5B16-4898-9640-A60C85096F64|3|||||SF36 V1.0 STANDARD|||MG/MOL|||NG/DAY|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|3||39||CONTINUATION TREATMENT|1963-10-05||||1962-02-20||1971-12-30|1960-11-24|
TRIAL STUDY 134XCP|QS|3ACFF838-5B16-4898-9640-A60C85096F64|4|||||NPI|||UG/L FEU|||10^6 ORGANISMS/ML|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|4||88||SCREENING|1965-12-10||||1960-05-17||1973-04-01|1973-07-29|
TRIAL STUDY 134XCP|QS|3ACFF838-5B16-4898-9640-A60C85096F64|5|||||TSCC|||NMOL/L/H|||CM/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|NA|5||7||BLINDED TREATMENT|1964-10-05||||1963-03-12||1972-06-20|1966-03-02|
TRIAL STUDY 134XCP|QS|308F422A-B02B-4C76-86E7-834AAC127FE3|1|||||IBDQ|||PHERESIS UNIT|||UV2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|U|1||38||RUN-IN|1970-01-26||||1964-04-07||1968-10-07|1969-08-18|
TRIAL STUDY 134XCP|QS|308F422A-B02B-4C76-86E7-834AAC127FE3|2|||||PSQI|||10^4/L|||10^3 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|2||58||BASELINE|1965-08-08||||1968-03-15||1966-04-12|1964-02-04|
TRIAL STUDY 134XCP|QS|308F422A-B02B-4C76-86E7-834AAC127FE3|3|||||WHODAS 2.0 - 12-ITEM PROXY|||BREATHS/30S|||MMOL2/L2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|3||39||LONG-TERM FOLLOW-UP|1960-03-31||||1965-02-22||1970-09-02|1963-08-21|
TRIAL STUDY 134XCP|QS|308F422A-B02B-4C76-86E7-834AAC127FE3|4|||||MDQ-T|||UG/L/H|||U/KG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|NA|4||88||FOLLOW-UP|1964-06-04||||1970-07-13||1972-11-08|1961-06-23|
TRIAL STUDY 134XCP|QS|308F422A-B02B-4C76-86E7-834AAC127FE3|5|||||SF8 V1.0 STANDARD|||ML/MMHG/MIN/L|||UMOL/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|Y|5||7||INDUCTION TREATMENT|1967-10-17||||1971-09-18||1966-09-01|1964-11-18|
TRIAL STUDY 134XCP|QS|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1|||||ODI V2.1A|||OI50|||ML/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|1||38||SCREENING|1966-01-22||||1965-02-21||1966-04-27|1973-05-03|
TRIAL STUDY 134XCP|QS|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2|||||MSIS-29 V1|||CMOL|||MG/ML/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|Y|2||58||OPEN LABEL TREATMENT|1971-04-23||||1967-04-24||1961-01-06|1969-02-06|
TRIAL STUDY 134XCP|QS|34A3AA01-3595-42C2-95C3-44E3AF77B28D|3|||||IPAQ-LF PHONE VERSION|||VG/KG|||CIGAR|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|3||39||CONTINUATION TREATMENT|1964-07-11||||1966-02-06||1960-03-29|1960-03-09|
TRIAL STUDY 134XCP|QS|34A3AA01-3595-42C2-95C3-44E3AF77B28D|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||/SEC|||L/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|U|4||88||OBSERVATION|1968-08-13||||1972-10-13||1971-01-30|1960-09-12|
TRIAL STUDY 134XCP|QS|34A3AA01-3595-42C2-95C3-44E3AF77B28D|5|||||FACT-BRM V4|||ML/CAGE/DAY|||ML/M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|5||7||INDUCTION TREATMENT|1966-11-29||||1971-06-17||1971-04-27|1970-11-29|
TRIAL STUDY 134XCP|QS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1|||||FOSI|||DRINK|||EP U|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|NA|1||38||WASHOUT|1968-08-13||||1962-02-02||1969-10-12|1965-10-23|
TRIAL STUDY 134XCP|QS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2|||||OAB-Q|||BQ/MG|||ARBITRARY U|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|U|2||58||BASELINE|1969-07-11||||1970-12-18||1967-09-18|1973-03-18|
TRIAL STUDY 134XCP|QS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|3|||||ACQ|||LOG10 TCID 50/ML|||CD/M2|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|3||39||FOLLOW-UP|1967-06-25||||1963-05-22||1966-05-24|1969-08-15|
TRIAL STUDY 134XCP|QS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|4|||||SGRQ-C|||DIOPTER|||MIU/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|4||88||WASHOUT|1965-01-14||||1963-01-31||1965-11-28|1968-08-11|
TRIAL STUDY 134XCP|QS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|5|||||MDS-UPDRS|||MG/DOSE|||EIA UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|N|5||7||SCREENING|1966-05-15||||1972-05-06||1961-09-27|1961-08-03|
TRIAL STUDY 134XCP|QS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1|||||BPI|||CCID 50/DOSE|||STRIP|NOT DONE||LIKERT SCALE 7-POINT|U|U|U|1||38||BLINDED TREATMENT|1970-08-09||||1960-05-16||1968-10-15|1961-04-03|
TRIAL STUDY 134XCP|QS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2|||||FACIT-DYSPNEA SF|||BAU|||YEARS|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|2||58||FOLLOW-UP|1971-12-28||||1967-10-18||1962-04-26|1968-01-20|
TRIAL STUDY 134XCP|QS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|3|||||CDLQ|||WAFER|||PIXELS/IN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|Y|3||39||OBSERVATION|1964-08-05||||1960-01-21||1971-02-14|1966-05-24|
TRIAL STUDY 134XCP|QS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|4|||||SOWS SHORT|||POINT|||COAT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|4||88||BLINDED TREATMENT|1972-11-03||||1971-08-08||1968-02-13|1971-01-08|
TRIAL STUDY 134XCP|QS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|5|||||SIQR|||DRUM|||UEQ/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|5||7||BASELINE|1964-06-02||||1961-12-21||1961-03-19|1966-10-22|
TRIAL STUDY 134XCP|QS|ECA054C6-EA0F-4D7B-905C-849EA4592624|1|||||EPDS|||PMOL/L|||PIPE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|Y|1||38||WASHOUT|1973-09-01||||1966-05-08||1969-09-07|1971-07-19|
TRIAL STUDY 134XCP|QS|ECA054C6-EA0F-4D7B-905C-849EA4592624|2|||||HAMD 6 SELF-REPORT VERSION|||PIPE|||CCID 50/DOSE|NOT DONE||LIKERT SCALE 7-POINT|N|U|NA|2||58||BLINDED TREATMENT|1969-08-07||||1967-04-17||1962-08-18|1962-07-31|
TRIAL STUDY 134XCP|QS|ECA054C6-EA0F-4D7B-905C-849EA4592624|3|||||FLSI|||MG/G/MIN|||DPM/ML|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|3||39||RUN-IN|1960-07-29||||1971-12-13||1962-04-07|1961-01-25|
TRIAL STUDY 134XCP|QS|ECA054C6-EA0F-4D7B-905C-849EA4592624|4|||||UPS|||CCID 50/DOSE|||FEU|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|4||88||OPEN LABEL TREATMENT|1964-06-19||||1966-07-28||1962-10-10|1964-01-01|
TRIAL STUDY 134XCP|QS|ECA054C6-EA0F-4D7B-905C-849EA4592624|5|||||PSQI|||JOULE|||UMOL|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1966-11-27||||1960-09-03||1964-02-05|1970-03-06|
TRIAL STUDY 134XCP|QS|83823CA3-1C1D-455E-BE49-DC5E3651A939|1|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||UM/S|||MIU/L|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|N|1||38||OPEN LABEL TREATMENT|1962-04-14||||1971-01-09||1968-01-30|1966-12-01|
TRIAL STUDY 134XCP|QS|83823CA3-1C1D-455E-BE49-DC5E3651A939|2|||||OAB-Q SHORT FORM|||KM/H|||MMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|2||58||FOLLOW-UP|1969-06-26||||1967-02-19||1969-10-27|1963-08-13|
TRIAL STUDY 134XCP|QS|83823CA3-1C1D-455E-BE49-DC5E3651A939|3|||||VFQ-25 INTERVIEWER ADMINISTERED|||MG/ANIMAL|||HR/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|Y|3||39||CONTINUATION TREATMENT|1961-02-09||||1963-03-31||1972-05-17|1961-12-12|
TRIAL STUDY 134XCP|QS|83823CA3-1C1D-455E-BE49-DC5E3651A939|4|||||BEBQ RETROSPECTIVE|||MG/ML/MIN|||MCI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|4||88||INDUCTION TREATMENT|1967-02-20||||1964-01-05||1973-03-16|1973-02-28|
TRIAL STUDY 134XCP|QS|83823CA3-1C1D-455E-BE49-DC5E3651A939|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||/MBP|||10^9/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|N|5||7||INDUCTION TREATMENT|1961-10-13||||1971-03-21||1961-01-21|1964-01-15|
TRIAL STUDY 134XCP|QS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1|||||IBDQ|||UG/KG/DAY|||NMOL BCE/NMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|NA|1||38||OPEN LABEL TREATMENT|1967-05-25||||1969-11-03||1961-03-08|1970-01-14|
TRIAL STUDY 134XCP|QS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2|||||MSIS-29 V2|||10^7 PFU|||TRANSDUCING UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|U|2||58||LONG-TERM FOLLOW-UP|1972-08-24||||1971-02-23||1972-05-29|1964-09-07|
TRIAL STUDY 134XCP|QS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|3|||||IPAQ-SF PHONE VERSION|||IU|||CM H2O|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|U|3||39||BASELINE|1962-06-11||||1961-02-06||1960-05-09|1971-05-08|
TRIAL STUDY 134XCP|QS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||UMOL/MIN|||TCID 50/DOSE|NOT DONE||LIKERT SCALE 7-POINT|NA|N|Y|4||88||TREATMENT|1963-02-06||||1962-04-06||1970-11-23|1970-12-16|
TRIAL STUDY 134XCP|QS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|5|||||SMDDS V1.0|||G/M2|||MG2/DL2|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|5||7||BLINDED TREATMENT|1972-09-28||||1963-03-27||1969-10-13|1971-02-23|
TRIAL STUDY 134XCP|QS|9C24F018-315A-4B9C-B89B-F54CA26452E7|1|||||FACIT-F V4|||AMFI|||10^6 ORGANISMS/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|1||38||RUN-IN|1973-06-19||||1962-02-06||1965-07-20|1965-11-08|
TRIAL STUDY 134XCP|QS|9C24F018-315A-4B9C-B89B-F54CA26452E7|2|||||EPIC-CP|||U/M2|||/5X10^4 WBC|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|2||58||CONTINUATION TREATMENT|1967-05-05||||1967-03-05||1962-06-04|1962-01-05|
TRIAL STUDY 134XCP|QS|9C24F018-315A-4B9C-B89B-F54CA26452E7|3|||||MSQOL-54|||TSP EQ|||BQ/MG|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1963-02-02||||1969-04-05||1967-11-23|1973-01-26|
TRIAL STUDY 134XCP|QS|9C24F018-315A-4B9C-B89B-F54CA26452E7|4|||||OAB-Q SHORT FORM|||NG/MOL|||UMOL/L/MIN|NOT DONE||LIKERT SCALE 5-POINT|U|Y|U|4||88||SCREENING|1968-04-26||||1969-01-25||1965-07-21|1964-02-05|
TRIAL STUDY 134XCP|QS|9C24F018-315A-4B9C-B89B-F54CA26452E7|5|||||SF36 V2.0 ACUTE|||MET*MIN|||MASK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|U|5||7||TREATMENT|1973-08-08||||1967-02-12||1969-04-20|1969-12-12|
TRIAL STUDY 134XCP|QS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1|||||IBDQ|||USEC|||%/S|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|N|1||38||WASHOUT|1967-08-18||||1962-08-07||1970-09-10|1961-07-10|
TRIAL STUDY 134XCP|QS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2|||||IDS-SR|||COPIES/ML|||INHALATION|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|2||58||INDUCTION TREATMENT|1965-07-29||||1968-10-30||1968-11-28|1969-01-13|
TRIAL STUDY 134XCP|QS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|3|||||SF12 V2.0 STANDARD|||KG|||CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|NA|3||39||BASELINE|1961-08-27||||1972-11-05||1965-07-25|1969-03-03|
TRIAL STUDY 134XCP|QS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|4|||||SHORT-FORM MPQ-2|||FG|||10^3 CFU/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|4||88||OBSERVATION|1972-07-14||||1967-04-27||1968-10-30|1970-08-20|
TRIAL STUDY 134XCP|QS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|5|||||IPAQ-SF PHONE VERSION|||BU/ML|||MOSM/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|5||7||RUN-IN|1968-04-07||||1962-07-18||1962-04-12|1963-04-16|
TRIAL STUDY 134XCP|QS|8D48F229-F38B-4335-B8A7-0AA24C928707|1|||||SF36 V2.0 STANDARD|||EQ|||CCID 50/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|NA|1||38||CONTINUATION TREATMENT|1962-10-29||||1970-06-05||1969-08-18|1962-08-15|
TRIAL STUDY 134XCP|QS|8D48F229-F38B-4335-B8A7-0AA24C928707|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||G|||MV/SEC|NOT DONE||LIKERT SCALE 5-POINT|U|N|Y|2||58||BASELINE|1972-06-30||||1962-05-25||1967-09-24|1964-08-07|
TRIAL STUDY 134XCP|QS|8D48F229-F38B-4335-B8A7-0AA24C928707|3|||||PARTNER-DDS|||ML/MIN/1.73M2|||KAT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|N|3||39||FOLLOW-UP|1967-03-08||||1964-06-09||1971-01-16|1964-03-15|
TRIAL STUDY 134XCP|QS|8D48F229-F38B-4335-B8A7-0AA24C928707|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||UEQ|||L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|4||88||OBSERVATION|1962-08-04||||1960-07-15||1965-12-01|1972-04-25|
TRIAL STUDY 134XCP|QS|8D48F229-F38B-4335-B8A7-0AA24C928707|5|||||MADRS|||YEARS|||DEG|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|5||7||OPEN LABEL TREATMENT|1965-04-23||||1969-02-14||1963-11-20|1966-11-02|
TRIAL STUDY 134XCP|QS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1|||||PEDS-FACIT-F|||UEQ|||VIRTUAL PIXEL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|1||38||SCREENING|1968-03-27||||1960-01-13||1965-05-02|1972-01-05|
TRIAL STUDY 134XCP|QS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||MV2/HZ|||10^6/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|U|2||58||WASHOUT|1964-03-03||||1964-02-04||1967-08-26|1964-03-10|
TRIAL STUDY 134XCP|QS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|3|||||Q-LES-Q|||BQ/UL|||10^8/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|NA|3||39||LONG-TERM FOLLOW-UP|1972-05-07||||1960-07-10||1961-02-21|1969-05-03|
TRIAL STUDY 134XCP|QS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|4|||||IVIS|||10^3 CFU/ML|||G/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|4||88||LONG-TERM FOLLOW-UP|1962-01-29||||1965-10-09||1971-02-28|1964-08-22|
TRIAL STUDY 134XCP|QS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|5|||||SF12 V2.0 ACUTE|||APL U|||TABLET|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|5||7||INDUCTION TREATMENT|1963-12-12||||1968-07-25||1965-05-02|1966-05-28|
TRIAL STUDY 134XCP|QS|C882CB1F-C0DE-4BE5-B762-611333949C74|1|||||OCI|||10^4/L|||MEQ/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|N|1||38||TREATMENT|1966-11-22||||1971-07-24||1960-11-21|1970-07-16|
TRIAL STUDY 134XCP|QS|C882CB1F-C0DE-4BE5-B762-611333949C74|2|||||SF12 V1.0 ACUTE|||ARBITRARY U|||FMOL/L/SEC|NOT DONE||LIKERT SCALE 7-POINT|Y|N|N|2||58||OBSERVATION|1968-11-11||||1972-08-20||1968-06-18|1960-07-24|
TRIAL STUDY 134XCP|QS|C882CB1F-C0DE-4BE5-B762-611333949C74|3|||||SOBDA|||G/CAGE/DAY|||S*KPA|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|3||39||BLINDED TREATMENT|1968-03-10||||1962-08-10||1962-08-16|1971-11-23|
TRIAL STUDY 134XCP|QS|C882CB1F-C0DE-4BE5-B762-611333949C74|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||KALLIKREIN INHIBITOR UNIT|||BAG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|4||88||TREATMENT|1969-08-08||||1962-06-08||1962-08-09|1970-04-23|
TRIAL STUDY 134XCP|QS|C882CB1F-C0DE-4BE5-B762-611333949C74|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||OI50|||OHM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|N|5||7||OPEN LABEL TREATMENT|1960-10-22||||1967-01-27||1967-09-23|1965-10-24|
TRIAL STUDY 134XCP|QS|7F3C3801-607B-4141-AA83-383FDFFD7152|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||NG|||MG/M2|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|NA|1||38||FOLLOW-UP|1972-08-23||||1966-10-19||1962-07-24|1973-03-28|
TRIAL STUDY 134XCP|QS|7F3C3801-607B-4141-AA83-383FDFFD7152|2|||||PARTNER-DDS|||LOG10 COPIES/ML|||G/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|2||58||OPEN LABEL TREATMENT|1970-12-25||||1962-01-09||1962-02-28|1966-08-10|
TRIAL STUDY 134XCP|QS|7F3C3801-607B-4141-AA83-383FDFFD7152|3|||||Q-LES-Q|||MG/M2/MIN|||G/G|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|NA|3||39||SCREENING|1960-10-17||||1967-09-13||1966-03-07|1968-10-21|
TRIAL STUDY 134XCP|QS|7F3C3801-607B-4141-AA83-383FDFFD7152|4|||||NCCN-FACT FKSI-19 V2|||GENEQ/ML|||PL|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|4||88||FOLLOW-UP|1971-01-24||||1970-05-14||1961-10-02|1960-07-11|
TRIAL STUDY 134XCP|QS|7F3C3801-607B-4141-AA83-383FDFFD7152|5|||||IVIS|||AMU|||PG/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|5||7||OPEN LABEL TREATMENT|1973-05-12||||1967-10-13||1962-07-30|1962-08-06|
TRIAL STUDY 134XCP|QS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1|||||VFQ-25 INTERVIEWER ADMINISTERED|||%/S|||KG/CM|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|1||38||OPEN LABEL TREATMENT|1962-02-25||||1971-08-04||1963-08-24|1972-05-08|
TRIAL STUDY 134XCP|QS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2|||||DAD|||/MS|||ML/ANIMAL/WK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|2||58||INDUCTION TREATMENT|1969-03-31||||1960-11-20||1967-01-02|1965-10-06|
TRIAL STUDY 134XCP|QS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|3|||||FACT-LYM V4|||OZ|||LOG EID 50/DOSE|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|3||39||OPEN LABEL TREATMENT|1969-04-15||||1965-06-10||1969-06-21|1963-07-22|
TRIAL STUDY 134XCP|QS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|4|||||IPAQ-SF PHONE VERSION|||/2000 RBC|||U/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|4||88||RUN-IN|1971-03-28||||1963-06-02||1967-05-13|1960-08-27|
TRIAL STUDY 134XCP|QS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|5|||||COWS|||BEATS/MIN|||10^7 CFU|NOT DONE||LIKERT SCALE 3-POINT|U|U|U|5||7||LONG-TERM FOLLOW-UP|1968-10-27||||1961-08-24||1961-04-24|1965-03-29|
TRIAL STUDY 134XCP|QS|67025219-DBC0-4222-9D04-7F23EE3D5806|1|||||SOBDA|||%(V/V)|||GPL U|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|U|1||38||BLINDED TREATMENT|1960-07-28||||1971-07-18||1961-06-01|1962-01-17|
TRIAL STUDY 134XCP|QS|67025219-DBC0-4222-9D04-7F23EE3D5806|2|||||PSQI|||CI/KG|||ANTIBODY UNIT|NOT DONE||LIKERT SCALE 7-POINT|U|U|U|2||58||OPEN LABEL TREATMENT|1971-12-07||||1964-04-13||1965-03-18|1973-08-10|
TRIAL STUDY 134XCP|QS|67025219-DBC0-4222-9D04-7F23EE3D5806|3|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||MEQ/DAY|||POUCH|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|3||39||FOLLOW-UP|1966-10-20||||1969-05-30||1962-01-16|1961-11-18|
TRIAL STUDY 134XCP|QS|67025219-DBC0-4222-9D04-7F23EE3D5806|4|||||FBRSI|||U/KG|||PMOL/DL|NOT DONE||LIKERT SCALE 5-POINT|U|N|N|4||88||FOLLOW-UP|1963-11-20||||1962-11-02||1970-12-18|1962-08-02|
TRIAL STUDY 134XCP|QS|67025219-DBC0-4222-9D04-7F23EE3D5806|5|||||FACT/GOG-NTX V4|||BISCUIT|||M|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|5||7||CONTINUATION TREATMENT|1960-03-25||||1971-03-22||1968-12-26|1964-06-24|
TRIAL STUDY 134XCP|QS|A865B860-E5F2-423D-8110-58EBF7E470F3|1|||||CCQ 24 HOUR VERSION|||FRACTION OF 1|||V|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|N|1||38||RUN-IN|1960-02-08||||1963-10-25||1968-08-17|1965-02-03|
TRIAL STUDY 134XCP|QS|A865B860-E5F2-423D-8110-58EBF7E470F3|2|||||SDS|||LOG EID 50/DOSE|||NEBULE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|Y|2||58||RUN-IN|1964-10-09||||1970-01-05||1961-07-15|1970-11-16|
TRIAL STUDY 134XCP|QS|A865B860-E5F2-423D-8110-58EBF7E470F3|3|||||CDLQ|||POINT|||L/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|Y|3||39||INDUCTION TREATMENT|1960-07-13||||1964-01-25||1964-05-25|1961-01-10|
TRIAL STUDY 134XCP|QS|A865B860-E5F2-423D-8110-58EBF7E470F3|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||MMOL/DAY|||/100 WBC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|U|4||88||BASELINE|1966-05-22||||1973-02-20||1967-03-16|1961-08-23|
TRIAL STUDY 134XCP|QS|A865B860-E5F2-423D-8110-58EBF7E470F3|5|||||ADCS-ADL MCI|||KUSP|||DRUM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|5||7||OPEN LABEL TREATMENT|1960-12-29||||1968-10-30||1967-03-25|1966-10-21|
TRIAL STUDY 134XCP|QS|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1|||||PDDS|||UKAT/L|||G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|Y|1||38||SCREENING|1964-04-01||||1965-07-14||1963-01-07|1966-05-01|
TRIAL STUDY 134XCP|QS|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2|||||HADS|||DEG/S|||UV|NOT DONE||LIKERT SCALE 3-POINT|N|Y|NA|2||58||SCREENING|1966-04-12||||1966-11-27||1971-02-08|1963-10-19|
TRIAL STUDY 134XCP|QS|E78B2C0E-81D6-4898-B78A-FE136029AEA4|3|||||IVIS|||MOL/MOL|||MHZ|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|3||39||INDUCTION TREATMENT|1969-02-17||||1961-03-03||1960-10-03|1973-08-02|
TRIAL STUDY 134XCP|QS|E78B2C0E-81D6-4898-B78A-FE136029AEA4|4|||||UPS|||KM|||UU/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|NA|4||88||BLINDED TREATMENT|1966-11-04||||1964-05-13||1970-03-16|1961-07-25|
TRIAL STUDY 134XCP|QS|E78B2C0E-81D6-4898-B78A-FE136029AEA4|5|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||MM3/MM2/YEAR|||EJACULATE U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|NA|5||7||OBSERVATION|1973-06-02||||1968-12-12||1961-08-02|1969-07-21|
TRIAL STUDY 134XCP|QS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1|||||WHODAS 2.0 - 36-ITEM PROXY|||NL|||GAUSS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|1||38||OPEN LABEL TREATMENT|1961-09-28||||1963-11-27||1971-03-01|1961-09-30|
TRIAL STUDY 134XCP|QS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2|||||FAS-NACC UDS V3.0|||AFU|||MASK|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|2||58||TREATMENT|1972-01-04||||1970-12-09||1972-08-22|1963-08-03|
TRIAL STUDY 134XCP|QS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|3|||||WHODAS 2.0 - 12-ITEM PROXY|||MU/G|||KEV|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|U|3||39||LONG-TERM FOLLOW-UP|1966-06-14||||1973-02-11||1965-09-20|1960-05-05|
TRIAL STUDY 134XCP|QS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||CCID 50/ML|||10^4 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|Y|4||88||RUN-IN|1966-08-16||||1960-12-05||1968-10-11|1968-07-13|
TRIAL STUDY 134XCP|QS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|5|||||VFQ-25 INTERVIEWER ADMINISTERED|||U/L|||DRINK|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|Y|5||7||BASELINE|1968-02-22||||1967-10-12||1967-05-30|1961-03-28|
TRIAL STUDY 134XCP|QS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1|||||PARTNER-DDS|||LOG10 ELISA UNIT|||APL U/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|NA|1||38||RUN-IN|1972-11-04||||1970-06-02||1971-06-04|1972-01-11|
TRIAL STUDY 134XCP|QS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||ML/CAGE/DAY|||KG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|2||58||SCREENING|1966-12-26||||1963-01-28||1972-08-27|1972-01-04|
TRIAL STUDY 134XCP|QS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|3|||||SWLS|||NL|||ML/MIN/1.73M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|Y|3||39||TREATMENT|1961-07-15||||1972-05-25||1966-07-07|1966-04-27|
TRIAL STUDY 134XCP|QS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|4|||||NPS|||UU/L|||DAMOL/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|4||88||FOLLOW-UP|1960-08-27||||1961-12-14||1964-07-06|1967-10-12|
TRIAL STUDY 134XCP|QS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||KEV|||WEEKS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|N|5||7||FOLLOW-UP|1966-10-23||||1962-01-19||1967-04-01|1961-02-09|
TRIAL STUDY 134XCP|QS|55210E20-F6B9-446F-994D-2D9149E33BAF|1|||||ADCS-CGIC|||10^9 CFU/ML|||POINT|NOT DONE||LIKERT SCALE 7-POINT|U|N|Y|1||38||OPEN LABEL TREATMENT|1963-07-16||||1964-01-26||1969-12-27|1971-02-11|
TRIAL STUDY 134XCP|QS|55210E20-F6B9-446F-994D-2D9149E33BAF|2|||||SIQ-JR|||CCID 50/ML|||VG/DOSE|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|2||58||CONTINUATION TREATMENT|1961-09-09||||1968-06-08||1969-02-21|1960-06-15|
TRIAL STUDY 134XCP|QS|55210E20-F6B9-446F-994D-2D9149E33BAF|3|||||ACT|||LOG10 PFU/ML|||ANTI-XA IU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|3||39||CONTINUATION TREATMENT|1962-02-05||||1971-07-09||1968-01-19|1970-07-05|
TRIAL STUDY 134XCP|QS|55210E20-F6B9-446F-994D-2D9149E33BAF|4|||||FLSI|||10^8 PFU|||FL|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|4||88||TREATMENT|1970-12-08||||1968-05-11||1970-09-18|1963-01-26|
TRIAL STUDY 134XCP|QS|55210E20-F6B9-446F-994D-2D9149E33BAF|5|||||EORTC QLQ-C15-PAL V1.0|||STRIP|||G/DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|N|5||7||BLINDED TREATMENT|1971-08-08||||1964-09-03||1963-05-22|1970-05-18|
TRIAL STUDY 134XCP|QS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1|||||C-SSRS BASELINE|||HOURS|||CM H2O|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|1||38||BASELINE|1961-03-15||||1967-04-09||1965-02-14|1966-12-30|
TRIAL STUDY 134XCP|QS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2|||||UPS|||U/L|||ML/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|2||58||RUN-IN|1968-03-12||||1965-05-01||1966-05-09|1965-01-30|
TRIAL STUDY 134XCP|QS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|3|||||BIS-11|||MBP|||G/G/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|NA|3||39||FOLLOW-UP|1968-12-27||||1967-10-03||1972-05-05|1969-09-04|
TRIAL STUDY 134XCP|QS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|4|||||FACIT-FATIGUE 13-ITEM V4|||ANTI-XA IU|||HZ/S|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|U|4||88||WASHOUT|1971-04-07||||1968-10-28||1971-07-21|1963-04-21|
TRIAL STUDY 134XCP|QS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||MPA|||PMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|5||7||RUN-IN|1970-06-24||||1973-01-03||1965-01-22|1960-09-18|
TRIAL STUDY 134XCP|QS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1|||||ASEX-MALE|||10^6 U|||MMU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|NA|1||38||RUN-IN|1960-06-25||||1970-02-08||1973-07-07|1968-07-18|
TRIAL STUDY 134XCP|QS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2|||||Q-LES-Q-SF|||UG|||MEQ/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|N|2||58||FOLLOW-UP|1967-07-06||||1964-03-13||1960-12-15|1960-06-24|
TRIAL STUDY 134XCP|QS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|3|||||FKSI-DRS V4|||10^6/G|||SCOOPFUL|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|3||39||WASHOUT|1967-06-29||||1969-12-27||1970-01-09|1961-01-10|
TRIAL STUDY 134XCP|QS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|4|||||VFQ-25 SELF ADMINISTERED|||VIRTUAL PIXEL|||KG/L|NOT DONE||LIKERT SCALE 7-POINT|N|N|U|4||88||INDUCTION TREATMENT|1967-08-17||||1963-01-16||1965-08-03|1961-05-27|
TRIAL STUDY 134XCP|QS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|5|||||C-SSRS CHILDREN'S BASELINE|||UEQ/L|||G/DL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|5||7||FOLLOW-UP|1963-12-05||||1966-11-09||1960-08-02|1964-03-23|
TRIAL STUDY 134XCP|QS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||10^6 U|||AMOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|U|1||38||SCREENING|1964-08-21||||1967-05-26||1963-07-03|1973-03-30|
TRIAL STUDY 134XCP|QS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2|||||PHQ SCREENER VERSION|||MONTHS|||NEEDLE GAUGE|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|2||58||INDUCTION TREATMENT|1965-10-01||||1969-12-09||1970-02-14|1961-03-12|
TRIAL STUDY 134XCP|QS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||PPTR|||DROP|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|Y|3||39||OBSERVATION|1963-12-01||||1969-03-07||1966-08-16|1969-02-26|
TRIAL STUDY 134XCP|QS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|4|||||FACT-L V4|||DISK|||/MM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|4||88||CONTINUATION TREATMENT|1963-05-01||||1967-12-13||1968-08-14|1962-02-11|
TRIAL STUDY 134XCP|QS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|5|||||WHODAS 2.0 - 12-ITEM PROXY|||UMOL/L/SEC|||MG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1971-05-31||||1972-12-12||1972-06-12|1972-03-30|
TRIAL STUDY 134XCP|QS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1|||||FKSI-DRS V4|||U/CL|||PMOL/10^9 CELLS|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|U|1||38||INDUCTION TREATMENT|1966-09-10||||1960-12-15||1971-06-10|1963-12-19|
TRIAL STUDY 134XCP|QS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2|||||FSS|||ML/CM H2O|||PKAT/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|2||58||BASELINE|1961-10-25||||1962-09-06||1967-08-17|1973-02-16|
TRIAL STUDY 134XCP|QS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||GAUSS|||IU/G HB|NOT DONE||LIKERT SCALE 5-POINT|Y|N|NA|3||39||BASELINE|1966-08-10||||1970-05-07||1966-05-27|1969-03-20|
TRIAL STUDY 134XCP|QS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|4|||||EPIC-CP|||10^3 CFU/ML|||L/S|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|4||88||FOLLOW-UP|1971-08-30||||1968-08-19||1961-06-27|1961-04-19|
TRIAL STUDY 134XCP|QS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|5|||||HAQ-DI WITH VAS|||KEV|||U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|N|5||7||OBSERVATION|1962-03-21||||1963-07-05||1966-12-11|1973-02-09|
TRIAL STUDY 134XCP|QS|CAD0ED37-954A-4935-8A7E-589EC108E141|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||PIXELS/IN|||CD|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|1||38||BLINDED TREATMENT|1972-06-04||||1966-06-07||1961-10-22|1971-05-20|
TRIAL STUDY 134XCP|QS|CAD0ED37-954A-4935-8A7E-589EC108E141|2|||||ADCS-CGIC|||CP|||DDU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|N|2||58||BLINDED TREATMENT|1972-01-09||||1968-12-31||1966-11-12|1962-11-11|
TRIAL STUDY 134XCP|QS|CAD0ED37-954A-4935-8A7E-589EC108E141|3|||||IPAQ-LF SELF-ADMINISTERED VERSION|||MS/MMHG|||MET*H|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|3||39||FOLLOW-UP|1967-12-31||||1961-10-08||1962-08-09|1960-06-01|
TRIAL STUDY 134XCP|QS|CAD0ED37-954A-4935-8A7E-589EC108E141|4|||||AQLQ|||U/G/MIN|||ELISA UNIT|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|4||88||LONG-TERM FOLLOW-UP|1964-04-24||||1963-05-10||1970-01-06|1968-10-24|
TRIAL STUDY 134XCP|QS|CAD0ED37-954A-4935-8A7E-589EC108E141|5|||||MSWS-12|||UG/G/MIN|||PIXELS/CM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|5||7||OBSERVATION|1964-02-21||||1968-11-25||1962-03-17|1973-06-15|
TRIAL STUDY 134XCP|QS|BC9A31E2-100C-4AC3-8910-A04309854590|1|||||LEC-5 STANDARD VERSION|||SIEMENS|||NFIU|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|1||38||RUN-IN|1971-07-24||||1969-02-21||1968-12-08|1965-01-25|
TRIAL STUDY 134XCP|QS|BC9A31E2-100C-4AC3-8910-A04309854590|2|||||CHART-SF INTERVIEW VERSION|||CGY|||ML/S/M2|NOT DONE||LIKERT SCALE 5-POINT|U|N|U|2||58||TREATMENT|1969-09-17||||1964-09-14||1962-09-05|1969-06-23|
TRIAL STUDY 134XCP|QS|BC9A31E2-100C-4AC3-8910-A04309854590|3|||||EORTC QLQ-LC13|||GBQ|||UG/KG/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|N|3||39||BLINDED TREATMENT|1968-07-07||||1962-06-16||1969-12-05|1966-06-24|
TRIAL STUDY 134XCP|QS|BC9A31E2-100C-4AC3-8910-A04309854590|4|||||FACIT-DYSPNEA SF|||GPL U|||G/M2|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|N|4||88||BLINDED TREATMENT|1962-10-31||||1962-06-17||1970-01-22|1972-11-23|
TRIAL STUDY 134XCP|QS|BC9A31E2-100C-4AC3-8910-A04309854590|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||U/L|||/40 HPFS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|NA|5||7||BLINDED TREATMENT|1967-06-26||||1971-10-24||1964-12-03|1963-04-18|
TRIAL STUDY 134XCP|QS|13A424BB-CC85-41EC-BDED-165A29532DFF|1|||||MDS-UPDRS|||UEQ|||UG|NOT DONE||LIKERT SCALE 5-POINT|NA|N|N|1||38||BASELINE|1969-01-14||||1964-09-06||1965-03-11|1961-11-07|
TRIAL STUDY 134XCP|QS|13A424BB-CC85-41EC-BDED-165A29532DFF|2|||||WOMAC VA 3.1 INDEX|||ML/S|||LOG10 ELISA UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|2||58||INDUCTION TREATMENT|1963-11-19||||1964-10-21||1960-06-21|1969-02-20|
TRIAL STUDY 134XCP|QS|13A424BB-CC85-41EC-BDED-165A29532DFF|3|||||ASEX-MALE|||G/KG/DAY|||UV*SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|NA|3||39||OBSERVATION|1967-06-30||||1966-10-29||1973-07-19|1964-04-16|
TRIAL STUDY 134XCP|QS|13A424BB-CC85-41EC-BDED-165A29532DFF|4|||||WHODAS 2.0 - 36-ITEM PROXY|||NMOL/KG/DAY|||10^3 ORGANISMS/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|NA|4||88||FOLLOW-UP|1964-09-10||||1971-01-11||1970-07-22|1971-02-14|
TRIAL STUDY 134XCP|QS|13A424BB-CC85-41EC-BDED-165A29532DFF|5|||||NPS|||FEU|||ML/DL|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|5||7||BASELINE|1962-07-03||||1973-06-27||1969-12-17|1963-04-15|
TRIAL STUDY 134XCP|QS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1|||||QIDS-SR|||WEEKS|||MBQ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|NA|1||38||INDUCTION TREATMENT|1964-11-04||||1968-01-22||1970-03-19|1966-08-08|
TRIAL STUDY 134XCP|QS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||DIOPTER|||NEWTON|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|U|2||58||BLINDED TREATMENT|1967-07-01||||1967-03-05||1966-06-26|1964-05-05|
TRIAL STUDY 134XCP|QS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||G/G/DAY|||CI/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|3||39||CONTINUATION TREATMENT|1966-07-05||||1965-11-28||1972-10-23|1961-09-04|
TRIAL STUDY 134XCP|QS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|4|||||WPAI-GH V2.0|||LOG10 PFU/ML|||ABSORBANCE U|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|4||88||SCREENING|1964-04-09||||1966-03-18||1965-07-04|1966-09-27|
TRIAL STUDY 134XCP|QS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|5|||||PSQI|||10^9 ORGANISMS/ML|||10^7/L|NOT DONE||LIKERT SCALE 3-POINT|N|U|N|5||7||BASELINE|1971-06-29||||1966-07-26||1964-05-21|1970-03-05|
TRIAL STUDY 134XCP|QS|059FE504-DEE4-4E24-AA80-3C64264636BF|1|||||HAMD 6 SELF-REPORT VERSION|||CGY|||JOULE|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|NA|1||38||TREATMENT|1967-11-12||||1972-03-20||1971-06-27|1968-12-18|
TRIAL STUDY 134XCP|QS|059FE504-DEE4-4E24-AA80-3C64264636BF|2|||||ADCS-ADL|||ML/G/MIN|||CAL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|2||58||CONTINUATION TREATMENT|1962-07-04||||1973-01-12||1972-11-09|1966-04-30|
TRIAL STUDY 134XCP|QS|059FE504-DEE4-4E24-AA80-3C64264636BF|3|||||EPIC-CP|||SUPPOSITORY|||PMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|3||39||OPEN LABEL TREATMENT|1968-09-16||||1961-05-21||1965-01-23|1972-05-11|
TRIAL STUDY 134XCP|QS|059FE504-DEE4-4E24-AA80-3C64264636BF|4|||||FACT-COG V3|||CCID 50/ML|||USEC|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|4||88||SCREENING|1962-03-18||||1971-08-10||1963-02-03|1963-06-18|
TRIAL STUDY 134XCP|QS|059FE504-DEE4-4E24-AA80-3C64264636BF|5|||||IPAQ-LF SELF-ADMINISTERED VERSION|||G/CAGE/DAY|||/2500 WBC|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|5||7||FOLLOW-UP|1964-02-28||||1966-11-25||1972-10-02|1967-10-17|
TRIAL STUDY 134XCP|QS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1|||||TSQM V1.4|||UG/G/H|||APL U|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|1||38||LONG-TERM FOLLOW-UP|1972-08-13||||1962-06-02||1971-01-05|1967-10-22|
TRIAL STUDY 134XCP|QS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2|||||HAEM-A-QOL|||FMOL/L/SEC|||/CMH2O|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|2||58||WASHOUT|1967-03-20||||1963-04-13||1969-12-04|1961-12-07|
TRIAL STUDY 134XCP|QS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|3|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||IU/G HB|||G/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|N|3||39||SCREENING|1972-12-10||||1973-08-09||1964-04-27|1972-09-27|
TRIAL STUDY 134XCP|QS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|4|||||PCL-5|||10^3 COPIES/ML|||MG/M2/DAY|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|4||88||FOLLOW-UP|1964-09-10||||1970-03-04||1973-07-28|1967-07-17|
TRIAL STUDY 134XCP|QS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|5|||||EQ-5D-3L|||UG/KG/DAY|||CMH2O*S2/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|N|5||7||SCREENING|1972-04-28||||1969-04-30||1965-06-23|1964-04-11|
TRIAL STUDY 134XCP|QS|69BCF810-6748-43AA-BDFC-64EE1536CB47|1|||||EQ-5D-3L|||NEEDLE GAUGE|||TSP EQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|1||38||CONTINUATION TREATMENT|1963-11-25||||1960-11-22||1963-06-25|1967-03-03|
TRIAL STUDY 134XCP|QS|69BCF810-6748-43AA-BDFC-64EE1536CB47|2|||||FACT-LYM V4|||MGEQ|||U/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|2||58||BASELINE|1969-06-17||||1963-07-23||1966-02-17|1964-02-09|
TRIAL STUDY 134XCP|QS|69BCF810-6748-43AA-BDFC-64EE1536CB47|3|||||SDS|||ROENTGEN|||CMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|U|3||39||BLINDED TREATMENT|1964-01-04||||1966-07-29||1965-07-16|1973-03-30|
TRIAL STUDY 134XCP|QS|69BCF810-6748-43AA-BDFC-64EE1536CB47|4|||||HAQ-DI WITH VAS|||UL/ML|||UG/MOL|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|4||88||FOLLOW-UP|1972-01-05||||1960-01-23||1965-10-11|1963-04-30|
TRIAL STUDY 134XCP|QS|69BCF810-6748-43AA-BDFC-64EE1536CB47|5|||||NCCN-FACT FBRSI-24 V2|||NMOL|||PFU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|NA|5||7||TREATMENT|1964-11-22||||1965-07-14||1972-10-01|1967-07-12|
TRIAL STUDY 134XCP|QS|DCE71DE9-8DFB-4796-BC41-21930EC21925|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||BEATS/MIN|||U/KG/H|NOT DONE||LIKERT SCALE 7-POINT|N|Y|U|1||38||TREATMENT|1961-09-25||||1967-05-06||1963-02-06|1969-12-04|
TRIAL STUDY 134XCP|QS|DCE71DE9-8DFB-4796-BC41-21930EC21925|2|||||RPQ|||CM/S|||MOSM/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|2||58||OBSERVATION|1967-07-01||||1962-09-24||1969-09-06|1962-05-24|
TRIAL STUDY 134XCP|QS|DCE71DE9-8DFB-4796-BC41-21930EC21925|3|||||TSCC|||10^12 IU/L|||BOLUS|NOT DONE||LIKERT SCALE 3-POINT|N|N|N|3||39||RUN-IN|1961-12-09||||1968-05-13||1965-06-09|1967-12-14|
TRIAL STUDY 134XCP|QS|DCE71DE9-8DFB-4796-BC41-21930EC21925|4|||||ADCS-ADL|||CAPLET|||TORR|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|4||88||OPEN LABEL TREATMENT|1961-07-25||||1970-10-21||1968-09-01|1973-05-27|
TRIAL STUDY 134XCP|QS|DCE71DE9-8DFB-4796-BC41-21930EC21925|5|||||SDS|||PACK|||USP U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|5||7||LONG-TERM FOLLOW-UP|1963-05-09||||1971-08-15||1973-07-27|1962-08-27|
TRIAL STUDY 134XCP|QS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1|||||CCQ 1 WEEK VERSION|||MMU/ML|||ML/CAGE|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|1||38||OPEN LABEL TREATMENT|1966-04-29||||1965-04-20||1964-02-17|1967-05-24|
TRIAL STUDY 134XCP|QS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2|||||PEDS-FACIT-F|||PACKET|||UCI/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|2||58||CONTINUATION TREATMENT|1972-05-23||||1962-08-23||1968-05-14|1973-05-06|
TRIAL STUDY 134XCP|QS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|3|||||SIQR|||PIPE|||PG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|3||39||TREATMENT|1973-02-07||||1971-09-23||1964-01-23|1966-06-05|
TRIAL STUDY 134XCP|QS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|4|||||GAD-7|||U/MMOL|||MG/DOSE|NOT DONE||LIKERT SCALE 5-POINT|Y|N|NA|4||88||TREATMENT|1960-05-29||||1967-12-19||1963-12-05|1970-05-04|
TRIAL STUDY 134XCP|QS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|5|||||IPAQ-LF PHONE VERSION|||FT|||MET*H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|5||7||LONG-TERM FOLLOW-UP|1960-10-16||||1969-09-29||1964-08-25|1961-06-20|
TRIAL STUDY 134XCP|QS|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1|||||FLU-IIQ ONCE DAILY|||APPLICATION|||ANTIBODY UNIT|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|1||38||CONTINUATION TREATMENT|1967-02-02||||1972-08-17||1960-01-13|1971-11-05|
TRIAL STUDY 134XCP|QS|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||ML/M2/H|||HZ/S|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|N|2||58||BASELINE|1973-02-17||||1969-09-19||1963-12-25|1970-10-15|
TRIAL STUDY 134XCP|QS|97D06076-FE6B-4C77-BD5C-2E665F707C7A|3|||||NPI|||NL|||GLOBULE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|N|3||39||BLINDED TREATMENT|1969-10-26||||1961-12-22||1970-11-17|1968-11-27|
TRIAL STUDY 134XCP|QS|97D06076-FE6B-4C77-BD5C-2E665F707C7A|4|||||GAD-7|||U/CL|||M|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|NA|4||88||SCREENING|1967-12-07||||1968-01-03||1963-04-22|1961-04-09|
TRIAL STUDY 134XCP|QS|97D06076-FE6B-4C77-BD5C-2E665F707C7A|5|||||NCCN-FACT FHNSI-22 V2|||UL|||KPA|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|5||7||WASHOUT|1964-03-24||||1971-06-02||1960-12-09|1962-02-03|
TRIAL STUDY 134XCP|QS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1|||||ASEX-MALE|||DROP|||BQ|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|1||38||SCREENING|1969-08-19||||1964-04-30||1972-03-08|1969-02-11|
TRIAL STUDY 134XCP|QS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2|||||WPAI-GH V2.0|||NMOL BCE/L|||PIXEL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|N|2||58||BLINDED TREATMENT|1964-10-16||||1972-01-25||1965-03-04|1972-04-19|
TRIAL STUDY 134XCP|QS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|3|||||SF36 V2.0 STANDARD|||GTT|||WAFER|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|3||39||WASHOUT|1962-08-05||||1972-08-31||1973-07-17|1963-11-15|
TRIAL STUDY 134XCP|QS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|4|||||MRS|||NG/DAY|||RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|Y|4||88||BASELINE|1962-11-25||||1967-11-01||1961-02-12|1969-01-14|
TRIAL STUDY 134XCP|QS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|5|||||IVIS|||ML/CM|||10^5/HPF|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|Y|5||7||OBSERVATION|1970-08-03||||1969-02-01||1970-01-13|1967-07-09|
TRIAL STUDY 134XCP|QS|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1|||||COPD ASSESSMENT TEST|||G/ANIMAL/WK|||MG/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|1||38||TREATMENT|1960-04-07||||1961-06-20||1960-11-14|1967-02-01|
TRIAL STUDY 134XCP|QS|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||MESF|||MG/MOL|NOT DONE||LIKERT SCALE 3-POINT|N|Y|U|2||58||RUN-IN|1970-02-15||||1964-09-10||1971-07-25|1966-10-05|
TRIAL STUDY 134XCP|QS|D5A1EB38-77EA-49A5-84CA-740A83D258AF|3|||||PDQUALIF|||H*%|||ARBITRARY U|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|3||39||RUN-IN|1962-08-02||||1962-03-26||1967-12-23|1972-05-21|
TRIAL STUDY 134XCP|QS|D5A1EB38-77EA-49A5-84CA-740A83D258AF|4|||||MDS-UPDRS|||G|||AU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|4||88||TREATMENT|1962-07-13||||1965-09-25||1972-08-06|1960-08-21|
TRIAL STUDY 134XCP|QS|D5A1EB38-77EA-49A5-84CA-740A83D258AF|5|||||WOMAC VA 3.1 INDEX|||CARTRIDGE|||MMHG/L/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|Y|5||7||INDUCTION TREATMENT|1966-04-09||||1971-03-10||1973-07-23|1960-09-01|
TRIAL STUDY 134XCP|QS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1|||||SOAPP-R|||TROCHE|||KM/H|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|1||38||INDUCTION TREATMENT|1963-03-09||||1962-03-16||1972-11-12|1964-04-14|
TRIAL STUDY 134XCP|QS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2|||||IPAQ-LF PHONE VERSION|||10^3/HPF|||ABSORBANCE U/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|2||58||RUN-IN|1961-08-12||||1960-05-23||1965-01-02|1960-11-17|
TRIAL STUDY 134XCP|QS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|3|||||CES|||U/M2|||MMOL/G|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|3||39||OBSERVATION|1963-02-17||||1972-10-15||1963-12-09|1961-11-09|
TRIAL STUDY 134XCP|QS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|4|||||MDS-UPDRS|||/500 WBC|||UG/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|4||88||SCREENING|1965-09-02||||1971-08-14||1968-05-11|1973-04-08|
TRIAL STUDY 134XCP|QS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||FMOL/L/SEC|||MV2/HZ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|U|5||7||LONG-TERM FOLLOW-UP|1967-02-22||||1960-12-21||1960-06-30|1970-08-21|
TRIAL STUDY 134XCP|QS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1|||||EQ-5D-3L|||UL/ML|||PG/CELL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|1||38||TREATMENT|1967-01-22||||1972-04-25||1968-03-30|1969-10-13|
TRIAL STUDY 134XCP|QS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2|||||YMRS|||10^11/L|||/SEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|2||58||BASELINE|1969-06-05||||1971-09-02||1969-10-11|1965-02-27|
TRIAL STUDY 134XCP|QS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|3|||||SF8 V1.0 STANDARD|||TRANSDUCING UNIT|||NMOL/L|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|3||39||FOLLOW-UP|1962-01-16||||1966-12-28||1973-04-27|1964-04-28|
TRIAL STUDY 134XCP|QS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|4|||||PODCI - PEDIATRIC PARENT REPORTED|||HEP|||U/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|U|4||88||BASELINE|1972-02-21||||1960-10-09||1960-09-13|1965-01-25|
TRIAL STUDY 134XCP|QS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|5|||||DLQI|||MPH|||CI/UL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|NA|5||7||CONTINUATION TREATMENT|1969-07-24||||1966-01-18||1969-06-13|1970-10-21|
TRIAL STUDY 134XCP|QS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1|||||COWS|||10^3 ORGANISMS/ML|||KS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|1||38||WASHOUT|1965-09-15||||1970-03-26||1963-06-03|1966-08-23|
TRIAL STUDY 134XCP|QS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2|||||EXACT|||TRANSDUCING UNIT/ML|||NG/MOL|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|2||58||BLINDED TREATMENT|1972-01-17||||1963-03-23||1962-01-12|1969-12-08|
TRIAL STUDY 134XCP|QS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|3|||||NCCN-FACT FHNSI-22 V2|||MBP|||ANTI-XA IU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|3||39||SCREENING|1962-06-07||||1964-01-06||1963-04-12|1962-03-05|
TRIAL STUDY 134XCP|QS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|4|||||FACT-P V4|||CUP|||MOL/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|4||88||RUN-IN|1966-09-30||||1970-09-20||1960-05-26|1968-04-28|
TRIAL STUDY 134XCP|QS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|5|||||UPS|||10^7/L|||G/DAY|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|5||7||OPEN LABEL TREATMENT|1964-08-29||||1960-06-26||1966-11-08|1968-12-30|
TRIAL STUDY 134XCP|QS|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1|||||MSIS-29 V1|||DRINK|||NG/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|U|1||38||OPEN LABEL TREATMENT|1970-07-09||||1968-10-11||1966-08-02|1971-03-20|
TRIAL STUDY 134XCP|QS|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2|||||IPAQ-SF PHONE VERSION|||HOURS|||CI/MG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|N|2||58||LONG-TERM FOLLOW-UP|1962-11-27||||1965-12-31||1965-12-02|1962-12-14|
TRIAL STUDY 134XCP|QS|640DDEF5-748A-4F92-A13D-15D1C7CE0800|3|||||DRRI-2|||LINEAR FT*LB|||MBP|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|3||39||SCREENING|1960-10-26||||1961-06-01||1972-04-23|1973-02-26|
TRIAL STUDY 134XCP|QS|640DDEF5-748A-4F92-A13D-15D1C7CE0800|4|||||PARTNER-DDS|||UM2|||/MS|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|4||88||BASELINE|1966-12-23||||1970-06-16||1971-04-03|1972-10-17|
TRIAL STUDY 134XCP|QS|640DDEF5-748A-4F92-A13D-15D1C7CE0800|5|||||AUDIT-SR|||KM|||UG/L DDU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|5||7||SCREENING|1961-12-13||||1961-12-04||1963-10-16|1971-01-12|
TRIAL STUDY 134XCP|QS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1|||||SWLS|||BREATHS/MIN|||PPB|NOT DONE||LIKERT SCALE 7-POINT|N|U|Y|1||38||BASELINE|1972-08-07||||1972-03-16||1968-10-01|1967-05-13|
TRIAL STUDY 134XCP|QS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2|||||FACT/GOG-NTX V4|||TUBERCULIN UNIT/ML|||UL/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|2||58||INDUCTION TREATMENT|1964-07-05||||1973-07-15||1972-02-22|1963-05-08|
TRIAL STUDY 134XCP|QS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|3|||||SF36 V1.0 ACUTE|||CAPSULE|||IU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|3||39||TREATMENT|1965-11-17||||1967-05-09||1969-05-26|1965-05-13|
TRIAL STUDY 134XCP|QS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|4|||||FACT/GOG-NTX V4|||/KG|||U/G/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|Y|4||88||FOLLOW-UP|1970-08-23||||1966-12-23||1970-02-26|1961-10-16|
TRIAL STUDY 134XCP|QS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||/MBP|||UMOL/DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|N|5||7||TREATMENT|1970-06-20||||1969-03-10||1971-01-27|1968-04-25|
TRIAL STUDY 134XCP|QS|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1|||||NCCN-FACT FOSI-18 V2|||U/ANIMAL|||DAGU|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|1||38||OBSERVATION|1973-01-13||||1961-07-31||1965-01-26|1968-04-10|
TRIAL STUDY 134XCP|QS|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||10^6 U|||CMH2O*S/ML|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|2||58||INDUCTION TREATMENT|1973-07-30||||1971-01-23||1965-08-31|1966-11-21|
TRIAL STUDY 134XCP|QS|EBC7BF7B-18C6-463C-8500-027B2A6966DB|3|||||FKSI-15|||TABLET|||MCI/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|3||39||OBSERVATION|1960-10-28||||1969-07-14||1972-12-27|1963-04-17|
TRIAL STUDY 134XCP|QS|EBC7BF7B-18C6-463C-8500-027B2A6966DB|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||V/SEC|||DMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|4||88||OBSERVATION|1965-06-28||||1960-02-13||1968-11-08|1968-11-20|
TRIAL STUDY 134XCP|QS|EBC7BF7B-18C6-463C-8500-027B2A6966DB|5|||||NCCN-FACT FKSI-19 V2|||G/CM2|||MG/KG/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|U|5||7||SCREENING|1970-05-01||||1972-09-15||1967-03-19|1967-05-31|
TRIAL STUDY 134XCP|QS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1|||||NSCLC-SAQ V1.0|||LOG10 ELISA UNIT|||CI/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|1||38||LONG-TERM FOLLOW-UP|1964-11-24||||1967-04-07||1965-03-24|1971-11-06|
TRIAL STUDY 134XCP|QS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2|||||PDQUALIF|||/LSQN|||10^3 CFU/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|2||58||RUN-IN|1965-08-11||||1969-12-04||1965-05-22|1960-10-21|
TRIAL STUDY 134XCP|QS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|3|||||CES|||L/L|||L/S|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|N|3||39||FOLLOW-UP|1970-08-09||||1960-01-19||1960-12-09|1961-01-25|
TRIAL STUDY 134XCP|QS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|4|||||EORTC QLQ-LC13|||KM/H|||TRACE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|Y|4||88||CONTINUATION TREATMENT|1963-05-23||||1962-09-11||1973-01-02|1973-06-27|
TRIAL STUDY 134XCP|QS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|5|||||BPI|||OD UNIT|||MEQ/MMOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|5||7||BLINDED TREATMENT|1966-01-22||||1963-04-02||1961-11-30|1963-01-12|
TRIAL STUDY 134XCP|QS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1|||||BEBQ CONCURRENT|||PL|||WAFER|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|NA|1||38||BLINDED TREATMENT|1968-02-21||||1963-09-08||1969-08-21|1964-05-25|
TRIAL STUDY 134XCP|QS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||DRINK|||10^4/HPF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|N|2||58||OBSERVATION|1960-10-10||||1972-12-30||1967-10-30|1961-08-15|
TRIAL STUDY 134XCP|QS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|3|||||FACIT-F V4|||UKAT/10^12 RBC|||AMU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|NA|3||39||OBSERVATION|1973-07-27||||1966-03-31||1972-08-31|1967-02-05|
TRIAL STUDY 134XCP|QS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|4|||||BWCS|||SV|||UG/CM2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|Y|4||88||LONG-TERM FOLLOW-UP|1967-02-04||||1966-02-15||1964-01-02|1967-10-13|
TRIAL STUDY 134XCP|QS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|5|||||SGRQ PAST 3 MONTHS VERSION|||MEQ/DL|||MCI/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|5||7||BASELINE|1963-09-08||||1960-04-07||1973-04-15|1970-11-10|
TRIAL STUDY 134XCP|QS|74741526-F925-4AA5-9BE3-F3B3884BEE68|1|||||FACIT-F V4|||MSEC|||ML/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|1||38||BASELINE|1960-08-30||||1970-04-02||1965-07-27|1964-07-02|
TRIAL STUDY 134XCP|QS|74741526-F925-4AA5-9BE3-F3B3884BEE68|2|||||ASEX-MALE|||10^4 CFU|||UCI/KG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|2||58||OPEN LABEL TREATMENT|1965-11-30||||1966-05-12||1962-07-30|1969-04-18|
TRIAL STUDY 134XCP|QS|74741526-F925-4AA5-9BE3-F3B3884BEE68|3|||||C-SSRS SCREENING|||CI/L|||SEC|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|3||39||LONG-TERM FOLLOW-UP|1971-09-02||||1962-03-24||1973-07-07|1963-12-13|
TRIAL STUDY 134XCP|QS|74741526-F925-4AA5-9BE3-F3B3884BEE68|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||CS|||MG/CM2|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|4||88||RUN-IN|1962-03-02||||1969-11-19||1960-06-14|1961-12-02|
TRIAL STUDY 134XCP|QS|74741526-F925-4AA5-9BE3-F3B3884BEE68|5|||||WHODAS 2.0 - 36-ITEM PROXY|||IU/G|||U/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|Y|5||7||TREATMENT|1970-03-20||||1966-06-19||1962-03-04|1963-08-22|
TRIAL STUDY 134XCP|QS|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||LB|||EIA UNIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|1||38||OBSERVATION|1969-03-21||||1966-11-12||1960-07-15|1963-12-02|
TRIAL STUDY 134XCP|QS|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2|||||NCCN-FACT FKSI-19 V2|||/2000 RBC|||PIXELS/CM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|N|2||58||FOLLOW-UP|1963-12-22||||1960-07-13||1968-01-11|1961-08-29|
TRIAL STUDY 134XCP|QS|25088C28-0FA3-4005-90C3-CCF9C6FF5851|3|||||SF8 V1.0 STANDARD|||SV|||LOG10 ELISA UNIT/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|Y|3||39||BASELINE|1969-01-16||||1970-12-29||1963-05-19|1962-10-31|
TRIAL STUDY 134XCP|QS|25088C28-0FA3-4005-90C3-CCF9C6FF5851|4|||||MADRS|||JAR|||U/G/DAY|NOT DONE||LIKERT SCALE 3-POINT|N|N|Y|4||88||LONG-TERM FOLLOW-UP|1963-10-09||||1971-07-09||1964-02-11|1967-04-23|
TRIAL STUDY 134XCP|QS|25088C28-0FA3-4005-90C3-CCF9C6FF5851|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||VP/ML|||U/M2|NOT DONE||LIKERT SCALE 5-POINT|N|NA|U|5||7||INDUCTION TREATMENT|1962-10-08||||1963-11-26||1971-12-03|1963-08-28|
TRIAL STUDY 134XCP|QS|9BF13738-0A50-46E6-A3DA-AC956A361B97|1|||||NCCN-FACT FHNSI-22 V2|||APS U|||KIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|U|1||38||FOLLOW-UP|1971-01-10||||1969-03-30||1965-07-16|1968-02-08|
TRIAL STUDY 134XCP|QS|9BF13738-0A50-46E6-A3DA-AC956A361B97|2|||||FACT-BMT V4|||LOG10 TCID 50/UL|||/5X10^4 WBC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|NA|2||58||RUN-IN|1969-12-29||||1964-07-10||1966-09-22|1961-03-09|
TRIAL STUDY 134XCP|QS|9BF13738-0A50-46E6-A3DA-AC956A361B97|3|||||FACT-G V4|||MEQ/DL|||MOL/G|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|3||39||WASHOUT|1966-08-05||||1972-03-22||1969-10-09|1965-01-03|
TRIAL STUDY 134XCP|QS|9BF13738-0A50-46E6-A3DA-AC956A361B97|4|||||PROSQOLI|||MONTHS|||U/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|U|4||88||OBSERVATION|1960-05-22||||1963-07-25||1968-12-27|1971-07-08|
TRIAL STUDY 134XCP|QS|9BF13738-0A50-46E6-A3DA-AC956A361B97|5|||||C-SSRS SCREENING|||U/KG/H|||ENZYME U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|NA|5||7||WASHOUT|1972-08-29||||1972-05-25||1971-11-26|1972-04-04|
TRIAL STUDY 134XCP|QS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1|||||ADCS-CGIC|||MG/M2/MIN|||MU|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|NA|1||38||RUN-IN|1960-02-01||||1969-10-23||1962-09-12|1963-09-10|
TRIAL STUDY 134XCP|QS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2|||||BSI-18|||NGEQ/L|||ML/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|U|2||58||CONTINUATION TREATMENT|1971-02-26||||1965-12-13||1964-09-27|1965-09-14|
TRIAL STUDY 134XCP|QS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|3|||||FACT-G V4|||FMOL/L/SEC|||S/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|N|3||39||OBSERVATION|1967-04-07||||1964-03-31||1971-03-04|1964-08-25|
TRIAL STUDY 134XCP|QS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|4|||||C-SSRS ALREADY ENROLLED SUBJECTS|||10^3 CFU/ML|||P|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|4||88||LONG-TERM FOLLOW-UP|1970-09-19||||1964-05-24||1963-05-26|1960-02-18|
TRIAL STUDY 134XCP|QS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|5|||||SGRQ PAST 3 MONTHS VERSION|||UG/L DDU|||PPB|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|5||7||WASHOUT|1964-10-26||||1968-01-19||1966-02-15|1970-03-01|
TRIAL STUDY 134XCP|QS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||/2500 WBC|||ML/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|Y|1||38||TREATMENT|1962-04-12||||1965-03-06||1962-05-08|1970-07-06|
TRIAL STUDY 134XCP|QS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2|||||BEBQ RETROSPECTIVE|||L/S/KPA|||PHERESIS UNIT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|N|2||58||OBSERVATION|1967-04-16||||1965-12-02||1966-03-08|1964-06-20|
TRIAL STUDY 134XCP|QS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|3|||||RDQ|||LOG10 TCID 50/DOSE|||ML/100G/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|3||39||CONTINUATION TREATMENT|1960-12-30||||1966-02-23||1965-07-26|1965-07-09|
TRIAL STUDY 134XCP|QS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|4|||||SMDDS V1.0|||MBQ|||CI/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|NA|4||88||WASHOUT|1972-06-27||||1963-03-06||1968-12-10|1961-10-04|
TRIAL STUDY 134XCP|QS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|5|||||WPAI-SHP V2.0|||/VF|||CM2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|5||7||INDUCTION TREATMENT|1965-03-31||||1972-08-17||1965-02-03|1967-06-05|
TRIAL STUDY 134XCP|QS|5AEA7EE9-1095-4967-B833-7665B6A71B31|1|||||NSCLC-SAQ V1.0|||CD*S/M2|||ENZYME U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|Y|1||38||OBSERVATION|1961-02-25||||1962-10-20||1962-09-26|1962-07-12|
TRIAL STUDY 134XCP|QS|5AEA7EE9-1095-4967-B833-7665B6A71B31|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||KBQ|||KPA|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|2||58||CONTINUATION TREATMENT|1968-11-18||||1967-05-31||1964-03-11|1960-06-12|
TRIAL STUDY 134XCP|QS|5AEA7EE9-1095-4967-B833-7665B6A71B31|3|||||MDS-UPDRS|||BU/ML|||MONTHS|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|3||39||BASELINE|1963-10-24||||1966-04-15||1963-05-29|1966-02-02|
TRIAL STUDY 134XCP|QS|5AEA7EE9-1095-4967-B833-7665B6A71B31|4|||||IVIS|||DIOPTER|||MEQ/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|N|4||88||WASHOUT|1969-08-19||||1971-10-25||1961-06-28|1966-11-17|
TRIAL STUDY 134XCP|QS|5AEA7EE9-1095-4967-B833-7665B6A71B31|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||U.CARR|||MG/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|5||7||BASELINE|1969-03-26||||1968-12-23||1972-02-16|1963-05-25|
TRIAL STUDY 134XCP|QS|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1|||||VFQ-25 INTERVIEWER ADMINISTERED|||IU/DAY|||CI/UG|NOT DONE||LIKERT SCALE 5-POINT|NA|U|Y|1||38||SCREENING|1971-04-18||||1971-11-08||1963-03-04|1967-02-18|
TRIAL STUDY 134XCP|QS|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2|||||SHORT-FORM MPQ-2|||FINGERTIP UNIT|||PIPE|NOT DONE||LIKERT SCALE 5-POINT|U|Y|U|2||58||RUN-IN|1969-07-21||||1973-03-17||1962-07-04|1968-07-17|
TRIAL STUDY 134XCP|QS|241CD521-D0BD-40BB-ABA2-B8C8E500B491|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||MG/KG/H|||AMP|NOT DONE||LIKERT SCALE 5-POINT|NA|N|NA|3||39||LONG-TERM FOLLOW-UP|1972-05-24||||1972-09-18||1964-01-06|1966-04-22|
TRIAL STUDY 134XCP|QS|241CD521-D0BD-40BB-ABA2-B8C8E500B491|4|||||FACT-L V4|||LOG10 ELISA UNIT/DOSE|||NMOL/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|N|4||88||INDUCTION TREATMENT|1969-01-28||||1968-10-18||1962-09-06|1969-03-03|
TRIAL STUDY 134XCP|QS|241CD521-D0BD-40BB-ABA2-B8C8E500B491|5|||||NCCN-FACT FBRSI-24 V2|||DAGU|||ML/KG|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|5||7||RUN-IN|1961-07-21||||1966-04-12||1969-11-15|1967-11-04|
TRIAL STUDY 134XCP|QS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1|||||NPI|||LOZENGE|||NMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|NA|1||38||FOLLOW-UP|1970-09-12||||1967-04-25||1970-01-31|1968-07-05|
TRIAL STUDY 134XCP|QS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2|||||WHODAS 2.0 - 36-ITEM SELF|||MG/G/H|||U/G/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|Y|2||58||RUN-IN|1960-02-06||||1971-09-25||1970-05-02|1963-04-26|
TRIAL STUDY 134XCP|QS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|3|||||WLQ|||GRAIN|||U/M2/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|Y|3||39||LONG-TERM FOLLOW-UP|1963-06-07||||1973-04-29||1970-01-29|1972-03-09|
TRIAL STUDY 134XCP|QS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|4|||||MPAI-4|||DNA COPIES/ML|||NCI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|N|4||88||SCREENING|1970-01-17||||1962-08-04||1964-05-26|1965-08-03|
TRIAL STUDY 134XCP|QS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|5|||||ADAS-COG|||TUBE|||HZ/S|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|U|5||7||BLINDED TREATMENT|1962-09-13||||1964-08-16||1960-11-04|1960-10-02|
TRIAL STUDY 134XCP|QS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1|||||EXPANDED DRS-PI CAREGIVER VERSION|||MOSM/L|||MS2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|1||38||RUN-IN|1962-03-07||||1960-08-06||1965-02-13|1961-05-07|
TRIAL STUDY 134XCP|QS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2|||||SGRQ-C|||10^3/HPF|||GRAVITATIONAL UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|2||58||FOLLOW-UP|1963-04-17||||1967-11-04||1960-05-06|1963-03-05|
TRIAL STUDY 134XCP|QS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|3|||||MNSI|||UEQ/L|||MET*H|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|3||39||RUN-IN|1971-11-30||||1970-01-17||1961-09-04|1960-07-26|
TRIAL STUDY 134XCP|QS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|4|||||SOWS SHORT|||HOUNSFIELD UNIT|||NMOL/L/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|N|4||88||WASHOUT|1973-05-13||||1965-09-25||1960-05-28|1973-06-03|
TRIAL STUDY 134XCP|QS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|5|||||ACQ|||PIXELS/CM|||PATCH|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|5||7||BLINDED TREATMENT|1962-12-27||||1963-07-02||1973-01-31|1971-01-11|
TRIAL STUDY 134XCP|QS|FD609B1C-D1E7-4349-B036-DF0126D96A52|1|||||WLQ|||TSP|||10^9 CFU/G|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|1||38||CONTINUATION TREATMENT|1961-03-14||||1961-06-30||1960-11-04|1960-09-22|
TRIAL STUDY 134XCP|QS|FD609B1C-D1E7-4349-B036-DF0126D96A52|2|||||MMRC|||IU/KG/H|||G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|N|2||58||OPEN LABEL TREATMENT|1963-09-23||||1968-02-22||1971-04-02|1963-07-11|
TRIAL STUDY 134XCP|QS|FD609B1C-D1E7-4349-B036-DF0126D96A52|3|||||PGI|||BQ/ML|||ML/MIN/MMHG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|N|3||39||OBSERVATION|1966-08-08||||1966-01-02||1970-04-13|1961-11-06|
TRIAL STUDY 134XCP|QS|FD609B1C-D1E7-4349-B036-DF0126D96A52|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||BEAM BREAKS|||AMFI|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|4||88||RUN-IN|1971-03-22||||1969-04-25||1962-08-13|1967-03-27|
TRIAL STUDY 134XCP|QS|FD609B1C-D1E7-4349-B036-DF0126D96A52|5|||||SF36 V1.0 STANDARD|||UV*SEC|||GPS U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|N|5||7||LONG-TERM FOLLOW-UP|1964-03-13||||1970-07-11||1968-06-23|1963-12-21|
TRIAL STUDY 134XCP|QS|DEB0593B-E3FD-471C-A800-43058AC5FD86|1|||||COMM|||DAYS|||VP/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|1||38||WASHOUT|1966-11-15||||1960-06-25||1965-04-28|1964-08-13|
TRIAL STUDY 134XCP|QS|DEB0593B-E3FD-471C-A800-43058AC5FD86|2|||||FACT-B V4|||ML/ANIMAL/DAY|||MOL/MG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|2||58||FOLLOW-UP|1973-07-08||||1968-06-21||1963-10-14|1964-10-05|
TRIAL STUDY 134XCP|QS|DEB0593B-E3FD-471C-A800-43058AC5FD86|3|||||FIQR|||TAMPON|||MMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|N|3||39||TREATMENT|1963-06-22||||1962-08-21||1969-12-31|1966-01-22|
TRIAL STUDY 134XCP|QS|DEB0593B-E3FD-471C-A800-43058AC5FD86|4|||||EORTC QLQ-C30 V3.0|||CUP|||PMOL/DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|U|4||88||CONTINUATION TREATMENT|1969-12-13||||1972-12-27||1970-08-11|1971-07-28|
TRIAL STUDY 134XCP|QS|DEB0593B-E3FD-471C-A800-43058AC5FD86|5|||||SOAPP-R|||/MM|||MG/L|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|5||7||SCREENING|1967-04-04||||1971-08-07||1969-03-17|1960-04-22|
TRIAL STUDY 134XCP|QS|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1|||||ACQ|||MGEQ|||MPL U/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|1||38||SCREENING|1963-01-06||||1961-01-12||1968-03-02|1972-02-01|
TRIAL STUDY 134XCP|QS|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||L/H/M2|||COPIES/UG|NOT DONE||LIKERT SCALE 7-POINT|U|NA|NA|2||58||INDUCTION TREATMENT|1972-08-24||||1964-01-01||1968-07-31|1968-09-24|
TRIAL STUDY 134XCP|QS|596BD728-2487-44E4-AFB1-8A4331EEDDF6|3|||||NPS|||C|||OZ EQ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|Y|3||39||BASELINE|1964-03-21||||1960-10-11||1965-09-23|1964-10-29|
TRIAL STUDY 134XCP|QS|596BD728-2487-44E4-AFB1-8A4331EEDDF6|4|||||FACT-BL V4|||10^6 U|||OZ|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|U|4||88||OBSERVATION|1967-09-09||||1970-08-09||1963-09-07|1965-11-12|
TRIAL STUDY 134XCP|QS|596BD728-2487-44E4-AFB1-8A4331EEDDF6|5|||||PODCI - ADOLESCENT SELF REPORTED|||G/MOL|||RAD|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|5||7||INDUCTION TREATMENT|1961-07-24||||1973-03-08||1966-03-21|1973-09-07|
TRIAL STUDY 134XCP|QS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1|||||QIDS-SR|||10^9 ORGANISMS/ML|||FL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|1||38||BLINDED TREATMENT|1966-01-28||||1960-12-24||1962-09-16|1960-10-11|
TRIAL STUDY 134XCP|QS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2|||||HAMD 6 SELF-REPORT VERSION|||BISCUIT|||10^3 CFU|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|2||58||FOLLOW-UP|1960-11-09||||1961-10-01||1971-01-15|1963-03-21|
TRIAL STUDY 134XCP|QS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|3|||||MSIS-29 V1|||EU|||MMHG/L/MIN|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|U|3||39||BASELINE|1967-12-12||||1966-10-02||1971-01-08|1961-05-23|
TRIAL STUDY 134XCP|QS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|4|||||SF8 V1.0 ACUTE|||CL|||UG/KG/H|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|4||88||WASHOUT|1963-03-11||||1966-01-09||1963-01-06|1973-08-03|
TRIAL STUDY 134XCP|QS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|5|||||FBRSI|||MMOL/L|||MCI/L|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|U|5||7||OPEN LABEL TREATMENT|1963-10-30||||1969-03-07||1964-04-20|1964-03-03|
TRIAL STUDY 134XCP|QS|0365EB5F-7364-4B1F-8919-543D8D21B045|1|||||PCL-5|||MOL|||GBQ/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|1||38||TREATMENT|1971-04-06||||1970-06-22||1963-09-30|1963-04-14|
TRIAL STUDY 134XCP|QS|0365EB5F-7364-4B1F-8919-543D8D21B045|2|||||CCQ 24 HOUR VERSION|||PACKET|||MEQ/MMOL|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|2||58||LONG-TERM FOLLOW-UP|1962-01-13||||1964-08-09||1969-10-20|1962-06-03|
TRIAL STUDY 134XCP|QS|0365EB5F-7364-4B1F-8919-543D8D21B045|3|||||CES|||DRUM|||10^6 ORGANISMS|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|N|3||39||WASHOUT|1963-08-02||||1971-05-03||1971-01-30|1966-02-11|
TRIAL STUDY 134XCP|QS|0365EB5F-7364-4B1F-8919-543D8D21B045|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||APPLICATION|||U/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|4||88||BLINDED TREATMENT|1969-08-03||||1960-06-10||1968-06-10|1972-09-27|
TRIAL STUDY 134XCP|QS|0365EB5F-7364-4B1F-8919-543D8D21B045|5|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||U/MG|||G/ANIMAL/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|5||7||OPEN LABEL TREATMENT|1960-01-26||||1963-01-11||1967-09-08|1972-03-01|
TRIAL STUDY 134XCP|QS|364277A8-875C-4A6F-93C3-C913BB3C97CA|1|||||PHQ-9|||NG/DL|||U/CL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|1||38||OBSERVATION|1962-06-22||||1962-09-14||1966-02-01|1966-10-09|
TRIAL STUDY 134XCP|QS|364277A8-875C-4A6F-93C3-C913BB3C97CA|2|||||PSQI|||USP U|||FMOL/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|Y|2||58||CONTINUATION TREATMENT|1965-12-08||||1971-07-17||1964-01-13|1971-06-04|
TRIAL STUDY 134XCP|QS|364277A8-875C-4A6F-93C3-C913BB3C97CA|3|||||CCQ 24 HOUR VERSION|||IU/L|||NMOL BCE/NMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|NA|3||39||OPEN LABEL TREATMENT|1967-04-15||||1962-07-27||1967-05-30|1968-12-15|
TRIAL STUDY 134XCP|QS|364277A8-875C-4A6F-93C3-C913BB3C97CA|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||BEAM BREAKS|||NL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|4||88||CONTINUATION TREATMENT|1971-06-16||||1972-08-19||1969-07-16|1968-08-05|
TRIAL STUDY 134XCP|QS|364277A8-875C-4A6F-93C3-C913BB3C97CA|5|||||FOSI|||ENZYME U/L|||/500 WBC|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|Y|5||7||TREATMENT|1961-02-20||||1963-03-28||1966-06-24|1961-05-09|
TRIAL STUDY 134XCP|QS|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1|||||MFIS|||PMOL/10^10 CELLS|||MOSM|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|1||38||OPEN LABEL TREATMENT|1969-02-23||||1962-05-18||1968-12-04|1963-08-24|
TRIAL STUDY 134XCP|QS|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2|||||SGRQ PAST 4 WEEKS VERSION|||FRAMES/S|||MKAT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|NA|2||58||CONTINUATION TREATMENT|1971-12-29||||1962-06-06||1966-02-09|1967-04-06|
TRIAL STUDY 134XCP|QS|B824951F-58EE-4003-A2AD-A91AADBBAC0D|3|||||ANSD V1.0|||LOZENGE|||MG/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|NA|3||39||OBSERVATION|1964-08-12||||1961-05-29||1963-12-28|1963-05-29|
TRIAL STUDY 134XCP|QS|B824951F-58EE-4003-A2AD-A91AADBBAC0D|4|||||EORTC QLQ-LC13|||MG/L|||ML/100G/MIN|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|4||88||BLINDED TREATMENT|1971-04-03||||1966-08-22||1962-02-23|1971-05-13|
TRIAL STUDY 134XCP|QS|B824951F-58EE-4003-A2AD-A91AADBBAC0D|5|||||SF36 V2.0 STANDARD|||NMOL|||S^-1(%O2)^-1|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|Y|5||7||BLINDED TREATMENT|1967-11-11||||1961-04-16||1968-07-12|1964-09-12|
TRIAL STUDY 134XCP|QS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1|||||PSQI|||LX|||MM/2H|NOT DONE||LIKERT SCALE 3-POINT|Y|U|N|1||38||WASHOUT|1963-10-24||||1960-03-12||1969-12-04|1961-03-02|
TRIAL STUDY 134XCP|QS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2|||||AQLQ|||GBQ|||ML/ANIMAL|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|2||58||RUN-IN|1970-07-31||||1972-07-03||1963-08-10|1972-04-13|
TRIAL STUDY 134XCP|QS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|3|||||FPSR|||NMOL/G|||MMOL/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|3||39||BLINDED TREATMENT|1971-07-24||||1965-07-07||1973-08-15|1972-02-16|
TRIAL STUDY 134XCP|QS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|4|||||SIQ|||100 IU/ML|||CY/CM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|Y|4||88||CONTINUATION TREATMENT|1968-06-21||||1964-03-15||1962-11-15|1960-12-24|
TRIAL STUDY 134XCP|QS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|5|||||GAD-7 V2|||ABSORBANCE U/ML|||10^3 DNA COPIES/ML|NOT DONE||LIKERT SCALE 3-POINT|N|N|Y|5||7||RUN-IN|1967-05-18||||1963-04-26||1961-02-17|1970-02-10|
TRIAL STUDY 134XCP|QS|A108F408-906C-4320-965A-D5D295BC5C31|1|||||SF8 V1.0 STANDARD|||V/V|||/MM|NOT DONE||LIKERT SCALE 7-POINT|U|U|N|1||38||SCREENING|1971-06-21||||1965-03-11||1963-12-15|1969-12-31|
TRIAL STUDY 134XCP|QS|A108F408-906C-4320-965A-D5D295BC5C31|2|||||SF10 V1.0 CHILDREN ACUTE|||ML/BREATH|||NCI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|2||58||TREATMENT|1961-02-05||||1960-03-26||1964-08-12|1965-08-29|
TRIAL STUDY 134XCP|QS|A108F408-906C-4320-965A-D5D295BC5C31|3|||||WOMAC LK 3.1 INDEX|||10^12/L|||MET*H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|3||39||WASHOUT|1971-03-06||||1969-06-11||1969-04-02|1961-06-02|
TRIAL STUDY 134XCP|QS|A108F408-906C-4320-965A-D5D295BC5C31|4|||||FOSI|||/100 HPFS|||ML/DAY|NOT DONE||LIKERT SCALE 7-POINT|Y|N|NA|4||88||SCREENING|1967-12-23||||1962-12-27||1962-01-18|1966-01-22|
TRIAL STUDY 134XCP|QS|A108F408-906C-4320-965A-D5D295BC5C31|5|||||LEC-5 STANDARD VERSION|||ML/(MIN*100ML)|||GPELISA UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|5||7||SCREENING|1960-03-12||||1966-03-06||1965-04-24|1970-03-26|
TRIAL STUDY 134XCP|QS|8E627D27-4855-4E1B-B823-1E14368973AF|1|||||ADCS-ADL|||DPM/ML|||RING|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|1||38||FOLLOW-UP|1966-02-01||||1969-08-17||1972-02-08|1960-03-12|
TRIAL STUDY 134XCP|QS|8E627D27-4855-4E1B-B823-1E14368973AF|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||CI/KG|||YD|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|2||58||FOLLOW-UP|1964-08-03||||1963-12-19||1962-11-07|1967-08-28|
TRIAL STUDY 134XCP|QS|8E627D27-4855-4E1B-B823-1E14368973AF|3|||||BIS-11|||NKAT|||/H|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|3||39||FOLLOW-UP|1966-01-04||||1961-01-04||1968-01-16|1960-04-09|
TRIAL STUDY 134XCP|QS|8E627D27-4855-4E1B-B823-1E14368973AF|4|||||SGRQ-C|||UG/DAY|||RFU|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|4||88||OPEN LABEL TREATMENT|1970-12-02||||1972-07-16||1965-12-11|1960-11-18|
TRIAL STUDY 134XCP|QS|8E627D27-4855-4E1B-B823-1E14368973AF|5|||||WHODAS 2.0 - 36-ITEM SELF|||GENEQ|||FT3|NOT DONE||LIKERT SCALE 7-POINT|NA|U|U|5||7||OPEN LABEL TREATMENT|1969-12-31||||1972-11-17||1969-05-30|1970-05-06|
TRIAL STUDY 134XCP|QS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1|||||PODCI - ADOLESCENT SELF REPORTED|||/KG|||NL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|1||38||SCREENING|1964-07-24||||1971-01-14||1963-09-28|1963-12-17|
TRIAL STUDY 134XCP|QS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2|||||TSQM V1.4|||10^6 CFU/ML|||LOZENGE|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|2||58||INDUCTION TREATMENT|1961-07-02||||1961-06-08||1972-05-18|1968-06-09|
TRIAL STUDY 134XCP|QS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|3|||||FPSR|||UG/H|||NKAT/G HB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|3||39||OPEN LABEL TREATMENT|1968-03-13||||1963-12-19||1973-02-21|1961-12-21|
TRIAL STUDY 134XCP|QS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|4|||||FACIT-DYSPNEA 33 ITEM BANK|||CMOL|||HEP|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|4||88||RUN-IN|1970-03-06||||1965-10-19||1967-05-26|1970-12-13|
TRIAL STUDY 134XCP|QS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|5|||||VFQ-25 INTERVIEWER ADMINISTERED|||MMOL/L|||L/H/M2|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|5||7||CONTINUATION TREATMENT|1969-07-12||||1971-03-04||1973-07-24|1964-04-23|
TRIAL STUDY 134XCP|QS|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1|||||ADCS-ADL|||U/KG|||LOG10 PFU|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|1||38||RUN-IN|1961-04-16||||1964-10-18||1963-09-14|1969-08-04|
TRIAL STUDY 134XCP|QS|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2|||||BEBQ CONCURRENT|||AMOL|||KIU|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|2||58||TREATMENT|1966-03-31||||1960-12-19||1967-07-01|1971-10-01|
TRIAL STUDY 134XCP|QS|483D89E1-45FD-41D4-B9E0-22FFB41D323A|3|||||NCCN-FACT FBLSI-18 V2|||S*KPA|||COPIES/UL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|NA|3||39||RUN-IN|1967-04-14||||1972-01-08||1966-08-29|1963-03-31|
TRIAL STUDY 134XCP|QS|483D89E1-45FD-41D4-B9E0-22FFB41D323A|4|||||WHODAS 2.0 - 12-ITEM PROXY|||G/G/DAY|||CY/CM|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|4||88||BLINDED TREATMENT|1964-01-05||||1965-12-22||1965-07-19|1963-03-06|
TRIAL STUDY 134XCP|QS|483D89E1-45FD-41D4-B9E0-22FFB41D323A|5|||||MNSI|||USIEMENS|||10^6/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|Y|5||7||CONTINUATION TREATMENT|1972-06-20||||1970-05-15||1961-06-28|1971-12-29|
TRIAL STUDY 134XCP|QS|2CCBED9D-5F24-4ED8-B575-8523C820A227|1|||||PODCI - ADOLESCENT SELF REPORTED|||ANTI-XA IU/ML|||CIGARETTE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|1||38||CONTINUATION TREATMENT|1961-05-03||||1960-01-15||1963-06-18|1972-01-31|
TRIAL STUDY 134XCP|QS|2CCBED9D-5F24-4ED8-B575-8523C820A227|2|||||BLCS|||GLOBULE|||VG/KG|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|2||58||TREATMENT|1962-10-15||||1960-12-24||1960-07-15|1967-06-21|
TRIAL STUDY 134XCP|QS|2CCBED9D-5F24-4ED8-B575-8523C820A227|3|||||OCI|||VG/ML|||GENEQ/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|3||39||CONTINUATION TREATMENT|1971-11-29||||1962-12-15||1966-12-13|1960-06-20|
TRIAL STUDY 134XCP|QS|2CCBED9D-5F24-4ED8-B575-8523C820A227|4|||||COMM|||M/SEC|||L/H/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|4||88||WASHOUT|1968-02-11||||1966-04-22||1967-10-24|1960-07-25|
TRIAL STUDY 134XCP|QS|2CCBED9D-5F24-4ED8-B575-8523C820A227|5|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||U/10^12 RBC|||NEBULE|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|5||7||INDUCTION TREATMENT|1967-02-10||||1969-03-01||1971-04-27|1963-09-03|
TRIAL STUDY 134XCP|QS|F4D6A28D-569F-4639-ACE2-10EB517128B2|1|||||SDS|||VIRTUAL PIXEL|||MG/M2/MIN|NOT DONE||LIKERT SCALE 3-POINT|N|U|N|1||38||BLINDED TREATMENT|1965-12-14||||1971-04-26||1972-07-29|1961-08-16|
TRIAL STUDY 134XCP|QS|F4D6A28D-569F-4639-ACE2-10EB517128B2|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||PPB|||UG/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|Y|2||58||SCREENING|1961-06-27||||1971-09-04||1968-04-27|1965-02-03|
TRIAL STUDY 134XCP|QS|F4D6A28D-569F-4639-ACE2-10EB517128B2|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||MPH|||/MBP|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|3||39||BLINDED TREATMENT|1968-09-14||||1968-03-22||1966-01-22|1961-04-03|
TRIAL STUDY 134XCP|QS|F4D6A28D-569F-4639-ACE2-10EB517128B2|4|||||RAND-36 V1.0|||L/L|||ENZYME U/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|U|4||88||INDUCTION TREATMENT|1964-04-02||||1967-01-01||1963-08-09|1963-12-19|
TRIAL STUDY 134XCP|QS|F4D6A28D-569F-4639-ACE2-10EB517128B2|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||10^3/HPF|||UG/G/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|5||7||BASELINE|1967-08-24||||1961-08-19||1960-09-17|1964-06-10|
TRIAL STUDY 134XCP|QS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1|||||MMRC|||MBP|||LOG10 TCID 50/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|U|U|1||38||SCREENING|1971-06-26||||1960-05-09||1972-11-17|1971-10-23|
TRIAL STUDY 134XCP|QS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2|||||TSCC|||MM/MIN|||U/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|2||58||CONTINUATION TREATMENT|1971-08-19||||1967-11-17||1961-08-02|1969-10-28|
TRIAL STUDY 134XCP|QS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|3|||||FLU-IIQ ONCE DAILY|||UCI/L|||UU/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|3||39||WASHOUT|1961-08-13||||1966-06-11||1960-12-15|1966-01-10|
TRIAL STUDY 134XCP|QS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|4|||||PODCI - ADOLESCENT SELF REPORTED|||NMOL/KG/DAY|||U/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|4||88||RUN-IN|1968-04-26||||1967-12-16||1970-10-08|1963-06-29|
TRIAL STUDY 134XCP|QS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|5|||||MRS|||NMOL/L/H|||PG/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|U|5||7||OBSERVATION|1963-12-11||||1963-08-05||1960-10-22|1968-08-01|
TRIAL STUDY 134XCP|QS|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1|||||WLQ|||ENZYME U|||MCI|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|1||38||OPEN LABEL TREATMENT|1968-12-27||||1968-01-13||1970-02-09|1962-06-14|
TRIAL STUDY 134XCP|QS|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2|||||PODCI - ADOLESCENT PARENT REPORTED|||HOUNSFIELD UNIT|||MV|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|2||58||LONG-TERM FOLLOW-UP|1964-01-10||||1970-08-09||1965-01-26|1972-06-27|
TRIAL STUDY 134XCP|QS|415EF35E-6D99-48F8-80A1-89A4CDC621B8|3|||||Q-LES-Q|||BQ|||H/WK|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|3||39||RUN-IN|1962-04-21||||1966-08-07||1969-06-20|1960-02-21|
TRIAL STUDY 134XCP|QS|415EF35E-6D99-48F8-80A1-89A4CDC621B8|4|||||FACT-L V4|||PRESSOR UNITS|||JDF UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|NA|4||88||RUN-IN|1972-12-12||||1966-02-12||1963-06-04|1966-09-11|
TRIAL STUDY 134XCP|QS|415EF35E-6D99-48F8-80A1-89A4CDC621B8|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||ML/ANIMAL/DAY|||FOZ_US|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|N|5||7||BLINDED TREATMENT|1969-10-07||||1966-05-11||1966-10-07|1972-03-11|
TRIAL STUDY 134XCP|QS|AA0F6192-A377-43C6-8203-BDF7553AEA88|1|||||GOSE|||COPIES/UG|||U/CL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|NA|1||38||BASELINE|1966-08-12||||1963-12-14||1972-06-25|1963-03-16|
TRIAL STUDY 134XCP|QS|AA0F6192-A377-43C6-8203-BDF7553AEA88|2|||||HCS|||YD|||EU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|2||58||BASELINE|1967-05-05||||1973-02-19||1971-10-02|1960-05-27|
TRIAL STUDY 134XCP|QS|AA0F6192-A377-43C6-8203-BDF7553AEA88|3|||||EXACT|||CM/S|||MMHG|NOT DONE||LIKERT SCALE 5-POINT|U|NA|N|3||39||BASELINE|1971-05-26||||1960-04-10||1964-05-28|1966-06-29|
TRIAL STUDY 134XCP|QS|AA0F6192-A377-43C6-8203-BDF7553AEA88|4|||||SOAPP-R|||IN2|||EU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|4||88||OBSERVATION|1969-04-29||||1972-11-05||1961-08-30|1960-12-01|
TRIAL STUDY 134XCP|QS|AA0F6192-A377-43C6-8203-BDF7553AEA88|5|||||HAQ-DI WITHOUT VAS|||MET*H|||KEV|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|5||7||TREATMENT|1972-03-23||||1962-01-01||1962-10-24|1965-08-10|
TRIAL STUDY 134XCP|QS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1|||||FOSI|||GPL U/ML|||CI/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|1||38||OPEN LABEL TREATMENT|1961-12-08||||1968-02-28||1972-10-06|1962-07-12|
TRIAL STUDY 134XCP|QS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||U/KG/H|||AGU/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|2||58||CONTINUATION TREATMENT|1968-10-05||||1970-02-17||1970-11-26|1968-11-02|
TRIAL STUDY 134XCP|QS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|3|||||PSQI|||POUCH|||L/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|U|3||39||TREATMENT|1967-12-11||||1966-02-06||1971-06-30|1966-06-18|
TRIAL STUDY 134XCP|QS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||SV|||ML/G/H|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|4||88||RUN-IN|1966-07-01||||1970-04-19||1970-04-29|1962-04-09|
TRIAL STUDY 134XCP|QS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|5|||||IPAQ-LF PHONE VERSION|||10^6/EJACULATE U|||ML/G/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|U|5||7||CONTINUATION TREATMENT|1961-05-07||||1967-10-06||1965-09-10|1966-12-23|
TRIAL STUDY 134XCP|QS|A848B1B5-679F-4C45-AD73-6506604C835E|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||MG/DOSE|||DAGU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|Y|1||38||LONG-TERM FOLLOW-UP|1960-11-30||||1963-02-14||1961-02-16|1963-12-26|
TRIAL STUDY 134XCP|QS|A848B1B5-679F-4C45-AD73-6506604C835E|2|||||Q-LES-Q|||MOL/DAY|||UL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|2||58||INDUCTION TREATMENT|1969-07-02||||1969-12-01||1965-07-14|1966-03-07|
TRIAL STUDY 134XCP|QS|A848B1B5-679F-4C45-AD73-6506604C835E|3|||||ODI V2.1A|||L/H|||ML/SEC/1.73M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|U|3||39||INDUCTION TREATMENT|1962-07-20||||1971-12-16||1963-04-20|1960-04-10|
TRIAL STUDY 134XCP|QS|A848B1B5-679F-4C45-AD73-6506604C835E|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||L/S|||MV2/HZ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1970-10-10||||1960-03-28||1966-07-05|1968-11-07|
TRIAL STUDY 134XCP|QS|A848B1B5-679F-4C45-AD73-6506604C835E|5|||||IDS-SR|||FINGERTIP UNIT|||MEQ|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|5||7||INDUCTION TREATMENT|1963-12-12||||1966-01-08||1964-02-23|1963-06-02|
TRIAL STUDY 134XCP|QS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1|||||ACT|||ML/G/DAY|||ELISA UNIT/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|N|1||38||RUN-IN|1964-03-21||||1973-07-25||1972-08-18|1960-04-10|
TRIAL STUDY 134XCP|QS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2|||||PSQI|||CI/KG|||PNU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|Y|2||58||INDUCTION TREATMENT|1972-06-29||||1973-07-07||1966-02-21|1970-06-03|
TRIAL STUDY 134XCP|QS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|3|||||FACIT-DYSPNEA SF|||PG/CELL|||WEBER|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|N|3||39||SCREENING|1971-03-27||||1966-04-07||1960-06-27|1970-02-14|
TRIAL STUDY 134XCP|QS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|4|||||VFQ-25 INTERVIEWER ADMINISTERED|||PNU/ML|||FARAD|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|4||88||LONG-TERM FOLLOW-UP|1971-07-24||||1964-09-07||1969-08-14|1963-02-06|
TRIAL STUDY 134XCP|QS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|5|||||MDS-UPDRS|||UG/L|||H/WK|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1970-03-03||||1967-02-01||1971-09-24|1972-11-09|
TRIAL STUDY 134XCP|QS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1|||||ANSD V1.0|||MBQ/UL|||EP U|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|U|1||38||BASELINE|1962-03-11||||1971-01-09||1966-12-25|1966-07-13|
TRIAL STUDY 134XCP|QS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2|||||FOSI|||ML/KG|||UG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|2||58||SCREENING|1963-11-23||||1967-10-19||1968-12-09|1961-07-05|
TRIAL STUDY 134XCP|QS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|3|||||WHODAS 2.0 - 12-ITEM PROXY|||ML/KG/DAY|||GRAVITATIONAL UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|NA|3||39||SCREENING|1964-08-26||||1963-07-16||1971-09-26|1972-05-22|
TRIAL STUDY 134XCP|QS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|4|||||BEBQ CONCURRENT|||EU|||DRAM|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|4||88||OBSERVATION|1962-09-02||||1965-10-28||1969-07-06|1968-08-21|
TRIAL STUDY 134XCP|QS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|5|||||SHORT-FORM MPQ-2|||PKAT|||PT_US|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|5||7||TREATMENT|1968-03-27||||1961-08-30||1971-12-19|1972-07-02|
TRIAL STUDY 134XCP|QS|FC155F37-522F-4620-BBFF-4999D37C1379|1|||||SHORT-FORM MPQ-2|||M3|||TUBERCULIN UNIT/ML|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|1||38||TREATMENT|1963-10-04||||1970-03-02||1968-04-18|1961-12-23|
TRIAL STUDY 134XCP|QS|FC155F37-522F-4620-BBFF-4999D37C1379|2|||||TSQM V1.4|||MAMP|||CI/MG|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|NA|2||58||BASELINE|1972-01-06||||1968-07-25||1963-10-20|1961-11-19|
TRIAL STUDY 134XCP|QS|FC155F37-522F-4620-BBFF-4999D37C1379|3|||||FACIT-F V4|||NMOL BCE/NMOL|||VOXEL|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|3||39||OBSERVATION|1972-11-15||||1973-02-05||1960-09-14|1969-08-03|
TRIAL STUDY 134XCP|QS|FC155F37-522F-4620-BBFF-4999D37C1379|4|||||HAMD 6 SELF-REPORT VERSION|||ENZYME U/L|||DAYS/MONTH|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|NA|4||88||OPEN LABEL TREATMENT|1966-10-26||||1965-07-29||1960-08-10|1962-08-05|
TRIAL STUDY 134XCP|QS|FC155F37-522F-4620-BBFF-4999D37C1379|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||U/MG|||NMOL BCE/MMOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|NA|5||7||TREATMENT|1972-12-16||||1964-02-29||1960-10-13|1963-10-04|
TRIAL STUDY 134XCP|QS|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||IN|||P|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|1||38||BLINDED TREATMENT|1963-04-09||||1965-11-13||1968-05-18|1966-11-12|
TRIAL STUDY 134XCP|QS|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2|||||BIS-11|||CYLINDER|||LB|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|N|2||58||WASHOUT|1969-01-29||||1960-06-09||1960-08-18|1960-11-12|
TRIAL STUDY 134XCP|QS|20F817BC-4C89-4F6C-AA45-36CE786A73A8|3|||||NPI|||NGEQ/L|||RATIO|NOT DONE||LIKERT SCALE 7-POINT|N|Y|U|3||39||OBSERVATION|1960-07-08||||1964-03-09||1972-08-12|1968-08-04|
TRIAL STUDY 134XCP|QS|20F817BC-4C89-4F6C-AA45-36CE786A73A8|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||UCI/L|||IU/DL|NOT DONE||LIKERT SCALE 7-POINT|U|N|U|4||88||OBSERVATION|1970-09-28||||1962-11-14||1961-04-05|1961-06-01|
TRIAL STUDY 134XCP|QS|20F817BC-4C89-4F6C-AA45-36CE786A73A8|5|||||Q-LES-Q|||TORR|||AMP|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|5||7||WASHOUT|1960-01-31||||1967-08-15||1967-05-26|1971-05-20|
TRIAL STUDY 134XCP|QS|99058E64-9873-4CD5-BB31-28C08758A1B5|1|||||HAQ-DI WITHOUT VAS|||MMHG*MIN/L|||CS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|1||38||OBSERVATION|1965-10-06||||1965-12-14||1960-04-02|1970-12-29|
TRIAL STUDY 134XCP|QS|99058E64-9873-4CD5-BB31-28C08758A1B5|2|||||RDQ|||PMOL/L|||HOUNSFIELD UNIT|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|2||58||FOLLOW-UP|1966-11-25||||1967-02-12||1964-10-08|1971-08-01|
TRIAL STUDY 134XCP|QS|99058E64-9873-4CD5-BB31-28C08758A1B5|3|||||EPDS|||10^4/HPF|||MG/G/H|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|3||39||FOLLOW-UP|1972-02-20||||1967-05-11||1967-07-01|1970-01-18|
TRIAL STUDY 134XCP|QS|99058E64-9873-4CD5-BB31-28C08758A1B5|4|||||BPI|||GENEQ/ML|||KG/CM|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|4||88||FOLLOW-UP|1972-09-06||||1960-12-11||1964-12-03|1972-12-16|
TRIAL STUDY 134XCP|QS|99058E64-9873-4CD5-BB31-28C08758A1B5|5|||||ESS|||WEEKS|||ROENTGEN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|N|5||7||FOLLOW-UP|1969-05-18||||1972-10-16||1966-07-22|1969-06-09|
TRIAL STUDY 134XCP|QS|656B6693-1C1C-433B-84E3-77E89F0B543E|1|||||FACT-L V4|||GY|||ML/MIN/1.73M2|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|1||38||LONG-TERM FOLLOW-UP|1960-11-18||||1970-08-29||1966-06-16|1960-10-17|
TRIAL STUDY 134XCP|QS|656B6693-1C1C-433B-84E3-77E89F0B543E|2|||||MNSI|||10^9 ORGANISMS/G|||WEBER|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|2||58||BLINDED TREATMENT|1970-11-13||||1970-04-30||1972-12-19|1969-03-27|
TRIAL STUDY 134XCP|QS|656B6693-1C1C-433B-84E3-77E89F0B543E|3|||||NCCN-FACT FPSI-17 V2|||UMOL/KG/MIN|||BAU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|3||39||FOLLOW-UP|1972-02-04||||1966-06-01||1964-01-30|1971-07-01|
TRIAL STUDY 134XCP|QS|656B6693-1C1C-433B-84E3-77E89F0B543E|4|||||WPAI-SHP V2.0|||TITER|||UG/MOL|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|4||88||OPEN LABEL TREATMENT|1970-04-20||||1973-08-19||1962-02-04|1963-09-26|
TRIAL STUDY 134XCP|QS|656B6693-1C1C-433B-84E3-77E89F0B543E|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||MIN|||ML/CAGE|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|NA|5||7||SCREENING|1962-11-11||||1969-01-15||1973-02-16|1970-02-05|
TRIAL STUDY 134XCP|QS|43C443F9-AB0F-44BE-B28B-63A60EE09205|1|||||SF12 V1.0 ACUTE|||UM/DAY|||VOXEL|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|1||38||BASELINE|1967-02-17||||1963-06-09||1970-03-03|1964-08-23|
TRIAL STUDY 134XCP|QS|43C443F9-AB0F-44BE-B28B-63A60EE09205|2|||||UPDRS|||MG/ANIMAL|||10^10/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|NA|2||58||TREATMENT|1967-10-29||||1971-06-10||1964-03-30|1970-06-11|
TRIAL STUDY 134XCP|QS|43C443F9-AB0F-44BE-B28B-63A60EE09205|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||KEV|||NG/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|3||39||OPEN LABEL TREATMENT|1970-05-09||||1964-03-13||1968-03-11|1963-09-15|
TRIAL STUDY 134XCP|QS|43C443F9-AB0F-44BE-B28B-63A60EE09205|4|||||GAD-7 V2|||ML/CM H2O|||%(W/V)|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|NA|4||88||OPEN LABEL TREATMENT|1962-01-03||||1968-10-25||1964-11-21|1973-01-06|
TRIAL STUDY 134XCP|QS|43C443F9-AB0F-44BE-B28B-63A60EE09205|5|||||AQLQ|||UG/L DDU|||MEQ/MMOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|5||7||TREATMENT|1968-11-17||||1963-01-24||1963-05-14|1966-03-13|
TRIAL STUDY 134XCP|QS|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1|||||NCCN-FACT FKSI-19 V2|||ML/H|||/LPF|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|1||38||LONG-TERM FOLLOW-UP|1960-03-18||||1963-11-07||1969-07-17|1969-10-01|
TRIAL STUDY 134XCP|QS|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2|||||RDQ|||UG/DL|||U/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|NA|2||58||INDUCTION TREATMENT|1961-05-23||||1968-09-22||1973-02-21|1963-01-07|
TRIAL STUDY 134XCP|QS|37FF91B1-CE3C-4587-85CE-F76B880D40E7|3|||||MDS-UPDRS|||COPIES/UG|||M|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|N|3||39||FOLLOW-UP|1972-02-15||||1973-07-26||1963-03-17|1965-11-25|
TRIAL STUDY 134XCP|QS|37FF91B1-CE3C-4587-85CE-F76B880D40E7|4|||||FACT-C V4|||NCI|||10^6 ORGANISMS/MG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|4||88||OPEN LABEL TREATMENT|1973-09-03||||1965-02-04||1963-11-06|1970-02-04|
TRIAL STUDY 134XCP|QS|37FF91B1-CE3C-4587-85CE-F76B880D40E7|5|||||EORTC QLQ-CR29 V2.1|||NKAT/L|||MEQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|N|5||7||BLINDED TREATMENT|1961-01-22||||1965-08-26||1969-06-24|1970-04-09|
TRIAL STUDY 134XCP|QS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1|||||CDLQ|||JOULE|||10^9/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|U|1||38||OBSERVATION|1964-08-01||||1973-04-27||1965-02-22|1968-10-12|
TRIAL STUDY 134XCP|QS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2|||||YMRS|||SBE/ML|||FRACTION OF 1|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|2||58||RUN-IN|1965-07-25||||1963-10-13||1965-05-29|1971-01-18|
TRIAL STUDY 134XCP|QS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|3|||||EPIC-CP|||PKAT|||LM|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|N|3||39||OPEN LABEL TREATMENT|1961-12-19||||1960-12-13||1966-12-12|1961-07-19|
TRIAL STUDY 134XCP|QS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|4|||||AUDIT-C|||NKAT|||10^6 CFU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|Y|4||88||CONTINUATION TREATMENT|1961-05-03||||1970-05-30||1971-08-13|1968-06-14|
TRIAL STUDY 134XCP|QS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|5|||||FPSR|||ML/CAGE|||TRACE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|5||7||TREATMENT|1961-01-20||||1963-01-17||1970-04-03|1973-05-24|
TRIAL STUDY 134XCP|QS|49017491-2C28-4F86-BF72-CF83651052F6|1|||||WOMAC VA 3.1 INDEX|||TUBERCULIN UNIT|||EP U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|1||38||SCREENING|1973-03-01||||1967-06-28||1969-09-16|1972-01-10|
TRIAL STUDY 134XCP|QS|49017491-2C28-4F86-BF72-CF83651052F6|2|||||FKSI-15|||MG/L|||LOG10 TCID 50/UL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|2||58||CONTINUATION TREATMENT|1971-07-13||||1967-08-04||1961-03-02|1966-04-10|
TRIAL STUDY 134XCP|QS|49017491-2C28-4F86-BF72-CF83651052F6|3|||||BSFS|||TCID 50/DOSE|||STEPS|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|3||39||CONTINUATION TREATMENT|1973-09-04||||1966-08-29||1969-09-12|1966-01-11|
TRIAL STUDY 134XCP|QS|49017491-2C28-4F86-BF72-CF83651052F6|4|||||MNSI|||TSP|||IU|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|4||88||INDUCTION TREATMENT|1971-09-23||||1962-11-24||1971-02-25|1966-04-03|
TRIAL STUDY 134XCP|QS|49017491-2C28-4F86-BF72-CF83651052F6|5|||||FIQR|||APS U|||ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|Y|5||7||OBSERVATION|1965-02-15||||1963-01-20||1968-09-03|1964-10-31|
TRIAL STUDY 134XCP|QS|DAA65EE6-66ED-4354-935B-1347E1B572A5|1|||||IPAQ-SF SELF-ADMINISTERED VERSION|||10^12 IU/L|||FG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|Y|1||38||TREATMENT|1962-10-26||||1963-09-06||1967-01-31|1973-01-02|
TRIAL STUDY 134XCP|QS|DAA65EE6-66ED-4354-935B-1347E1B572A5|2|||||SOBDA|||CMH2O*S/ML|||CI/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|2||58||OBSERVATION|1966-06-04||||1961-11-07||1960-08-29|1971-10-16|
TRIAL STUDY 134XCP|QS|DAA65EE6-66ED-4354-935B-1347E1B572A5|3|||||GAD-7|||MILE|||KG/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|N|3||39||OPEN LABEL TREATMENT|1970-09-05||||1966-03-13||1969-03-07|1966-10-26|
TRIAL STUDY 134XCP|QS|DAA65EE6-66ED-4354-935B-1347E1B572A5|4|||||OAB-Q SHORT FORM|||UG/KG/H|||PNU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|4||88||BLINDED TREATMENT|1968-08-25||||1961-03-11||1963-02-24|1964-10-11|
TRIAL STUDY 134XCP|QS|DAA65EE6-66ED-4354-935B-1347E1B572A5|5|||||EPIC-26|||10^6 CFU/ML|||UG/CM2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|5||7||FOLLOW-UP|1968-11-15||||1962-08-26||1961-08-07|1970-12-14|
TRIAL STUDY 134XCP|QS|A440A3E5-F87D-4306-9195-3A842F0DDE33|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||NM|||UG/KG/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|Y|1||38||SCREENING|1967-02-28||||1973-06-23||1969-02-28|1966-07-05|
TRIAL STUDY 134XCP|QS|A440A3E5-F87D-4306-9195-3A842F0DDE33|2|||||FKSI-15|||MOL/MOL|||DEG/S|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|2||58||BLINDED TREATMENT|1961-12-17||||1965-07-02||1966-05-06|1965-12-04|
TRIAL STUDY 134XCP|QS|A440A3E5-F87D-4306-9195-3A842F0DDE33|3|||||VFQ-25 SELF ADMINISTERED|||VIAL|||NSEC|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|U|3||39||CONTINUATION TREATMENT|1961-04-06||||1970-08-20||1969-01-14|1970-07-12|
TRIAL STUDY 134XCP|QS|A440A3E5-F87D-4306-9195-3A842F0DDE33|4|||||ADHD-RS-IV HOME VERSION|||BE/ML|||MG/CM2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|4||88||RUN-IN|1963-06-24||||1963-01-31||1963-03-09|1968-03-13|
TRIAL STUDY 134XCP|QS|A440A3E5-F87D-4306-9195-3A842F0DDE33|5|||||HAEM-A-QOL|||V/V|||CS|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|5||7||OBSERVATION|1969-07-19||||1966-08-04||1969-05-01|1960-03-09|
TRIAL STUDY 134XCP|QS|48BBE085-BD68-451A-9700-6A1AB18D84EE|1|||||NCCN-FACT FOSI-18 V2|||PSEC|||COULOMB|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|1||38||WASHOUT|1973-03-26||||1965-05-21||1970-12-06|1969-07-24|
TRIAL STUDY 134XCP|QS|48BBE085-BD68-451A-9700-6A1AB18D84EE|2|||||ADHD-RS-IV HOME VERSION|||10^8 PFU|||BQ/KG|NOT DONE||LIKERT SCALE 5-POINT|U|NA|Y|2||58||OBSERVATION|1965-06-10||||1968-01-18||1960-04-01|1970-07-25|
TRIAL STUDY 134XCP|QS|48BBE085-BD68-451A-9700-6A1AB18D84EE|3|||||GAD-7 V2|||MG/DOSE|||MILE|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|3||39||OBSERVATION|1965-01-04||||1973-05-17||1961-09-26|1972-09-04|
TRIAL STUDY 134XCP|QS|48BBE085-BD68-451A-9700-6A1AB18D84EE|4|||||COMM|||MG/MOL|||DIOPTER|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|4||88||BLINDED TREATMENT|1970-09-23||||1962-03-18||1973-02-05|1960-08-07|
TRIAL STUDY 134XCP|QS|48BBE085-BD68-451A-9700-6A1AB18D84EE|5|||||FACT-C V4|||U/G/H|||10^7/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|NA|5||7||WASHOUT|1971-09-03||||1960-03-19||1971-10-10|1965-11-13|
TRIAL STUDY 134XCP|QS|F38055A2-11E2-437B-BD6A-662D81521F1D|1|||||NCCN-FACT FPSI-17 V2|||UCI/L|||DEG/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|Y|1||38||TREATMENT|1969-05-16||||1963-06-01||1970-04-13|1966-04-08|
TRIAL STUDY 134XCP|QS|F38055A2-11E2-437B-BD6A-662D81521F1D|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||TCID 50/DOSE|||CMH2O*S2/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|NA|2||58||OPEN LABEL TREATMENT|1962-09-18||||1967-08-27||1968-03-04|1964-07-29|
TRIAL STUDY 134XCP|QS|F38055A2-11E2-437B-BD6A-662D81521F1D|3|||||AQ20|||MG/DAY|||GPELISA UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|N|3||39||BASELINE|1972-07-17||||1968-07-04||1961-10-15|1973-02-27|
TRIAL STUDY 134XCP|QS|F38055A2-11E2-437B-BD6A-662D81521F1D|4|||||FIQR|||10^4/L|||BQ/UG|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|N|4||88||OBSERVATION|1967-04-29||||1972-03-28||1960-05-12|1969-07-02|
TRIAL STUDY 134XCP|QS|F38055A2-11E2-437B-BD6A-662D81521F1D|5|||||WOMAC NRS 3.1 INDEX|||HOUNSFIELD UNIT|||10^3 DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|5||7||WASHOUT|1964-09-06||||1971-11-09||1970-10-18|1965-01-29|
TRIAL STUDY 134XCP|QS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1|||||WPAI-SHP V2.0|||OI50|||MEQ/UG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|1||38||BASELINE|1970-09-12||||1960-07-09||1972-07-27|1969-04-21|
TRIAL STUDY 134XCP|QS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2|||||MNSI|||KPA/L/SEC|||PMOL/L/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|2||58||INDUCTION TREATMENT|1965-07-05||||1972-10-29||1966-11-05|1961-03-15|
TRIAL STUDY 134XCP|QS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|3|||||IVIS|||UG/ANIMAL|||DMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|3||39||LONG-TERM FOLLOW-UP|1963-04-28||||1971-01-27||1960-06-17|1968-11-26|
TRIAL STUDY 134XCP|QS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|4|||||HAQ-DI WITHOUT VAS|||ML/DAY|||MEQ/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|U|4||88||RUN-IN|1973-01-30||||1963-08-27||1961-06-01|1971-09-11|
TRIAL STUDY 134XCP|QS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|5|||||ACT|||V|||CP|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|5||7||SCREENING|1964-03-10||||1961-02-06||1971-10-14|1966-12-11|
TRIAL STUDY 134XCP|QS|22B0F097-D571-4E65-9B58-BEF2C3482F05|1|||||EPIC-CP|||STEPS/MIN|||BQ/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|1||38||FOLLOW-UP|1963-03-11||||1972-10-29||1960-10-25|1963-05-17|
TRIAL STUDY 134XCP|QS|22B0F097-D571-4E65-9B58-BEF2C3482F05|2|||||FBRSI|||U/CL|||MPL U|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|2||58||CONTINUATION TREATMENT|1968-12-06||||1972-12-23||1962-08-28|1967-02-01|
TRIAL STUDY 134XCP|QS|22B0F097-D571-4E65-9B58-BEF2C3482F05|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||DRINK|||10^7 PFU|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|Y|3||39||OBSERVATION|1968-06-06||||1963-08-09||1963-01-09|1969-06-09|
TRIAL STUDY 134XCP|QS|22B0F097-D571-4E65-9B58-BEF2C3482F05|4|||||FKSI-15|||VP/ML|||UU/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|NA|4||88||INDUCTION TREATMENT|1965-12-17||||1970-09-05||1961-03-02|1965-12-26|
TRIAL STUDY 134XCP|QS|22B0F097-D571-4E65-9B58-BEF2C3482F05|5|||||FAMS|||MG/KG|||PACK|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|Y|5||7||OBSERVATION|1973-09-07||||1967-01-08||1960-11-19|1973-05-29|
TRIAL STUDY 134XCP|QS|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1|||||BLCS|||G/CAGE/WK|||/10^5|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|1||38||TREATMENT|1969-08-08||||1970-05-09||1960-08-02|1964-09-14|
TRIAL STUDY 134XCP|QS|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2|||||CCQ 1 WEEK VERSION|||KEV|||DEG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|2||58||SCREENING|1972-09-02||||1967-07-04||1967-07-07|1964-06-23|
TRIAL STUDY 134XCP|QS|F56B6C70-0513-4032-A0BE-B961F6F2EF30|3|||||WOMAC LK 3.1 INDEX|||U/M2/DAY|||BOX|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|3||39||BASELINE|1965-08-16||||1962-04-09||1964-08-09|1965-09-12|
TRIAL STUDY 134XCP|QS|F56B6C70-0513-4032-A0BE-B961F6F2EF30|4|||||HAQ-DI WITH VAS|||BQ/UL|||ML*CMH2O|NOT DONE||LIKERT SCALE 5-POINT|U|U|N|4||88||BASELINE|1972-07-13||||1966-05-01||1966-01-09|1973-04-29|
TRIAL STUDY 134XCP|QS|F56B6C70-0513-4032-A0BE-B961F6F2EF30|5|||||VFQ-25 SELF ADMINISTERED|||PFU|||COPIES/UL|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|5||7||INDUCTION TREATMENT|1963-05-16||||1960-09-05||1963-05-22|1970-01-05|
TRIAL STUDY 134XCP|QS|8E385A66-25C9-417E-9298-FB87A73B661F|1|||||VFQ-25 INTERVIEWER ADMINISTERED|||ML/CM H2O|||LOG EID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|1||38||RUN-IN|1960-03-12||||1971-11-22||1971-06-03|1969-06-18|
TRIAL STUDY 134XCP|QS|8E385A66-25C9-417E-9298-FB87A73B661F|2|||||YMRS|||CYLINDER|||MCI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|2||58||LONG-TERM FOLLOW-UP|1968-05-19||||1961-09-25||1969-01-18|1966-06-28|
TRIAL STUDY 134XCP|QS|8E385A66-25C9-417E-9298-FB87A73B661F|3|||||FACT-LEU V4|||MV2/HZ|||PMOL/10^10 CELLS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|N|3||39||WASHOUT|1964-09-02||||1963-03-20||1961-12-15|1970-07-14|
TRIAL STUDY 134XCP|QS|8E385A66-25C9-417E-9298-FB87A73B661F|4|||||FPSR|||HEP|||M3|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|4||88||WASHOUT|1962-07-19||||1970-02-13||1968-08-12|1961-04-19|
TRIAL STUDY 134XCP|QS|8E385A66-25C9-417E-9298-FB87A73B661F|5|||||HAQ-DI WITH VAS|||MU|||LOG10 TCID 50/UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|N|5||7||RUN-IN|1960-11-27||||1970-05-27||1966-08-22|1972-04-29|
TRIAL STUDY 134XCP|QS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||EID 50/DOSE|||G/ANIMAL|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|1||38||WASHOUT|1965-06-11||||1973-06-08||1966-04-02|1967-04-25|
TRIAL STUDY 134XCP|QS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2|||||DLQI|||MCI/L|||G/M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|2||58||FOLLOW-UP|1964-04-14||||1967-02-13||1970-12-21|1965-10-09|
TRIAL STUDY 134XCP|QS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|3|||||ADCS-ADL MCI|||UL/DOSE|||MIU/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|Y|3||39||BASELINE|1969-02-23||||1964-03-27||1965-12-01|1971-07-14|
TRIAL STUDY 134XCP|QS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|4|||||GAD-7 V2|||JDF UNIT|||TUBERCULIN UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|Y|4||88||OBSERVATION|1960-09-14||||1972-11-06||1961-08-04|1966-10-25|
TRIAL STUDY 134XCP|QS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|5|||||MRS|||CG|||MMOL/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|5||7||OPEN LABEL TREATMENT|1968-07-12||||1966-05-22||1961-04-02|1971-03-25|
TRIAL STUDY 134XCP|QS|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1|||||ADCS-CGIC|||CCID 50/DOSE|||CMOL/L|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|1||38||INDUCTION TREATMENT|1961-04-13||||1967-04-30||1968-07-22|1960-05-19|
TRIAL STUDY 134XCP|QS|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2|||||EQ-5D-3L|||10^9/DOSE|||UMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|2||58||OPEN LABEL TREATMENT|1973-08-20||||1961-09-22||1970-07-28|1970-05-10|
TRIAL STUDY 134XCP|QS|D0AE2069-B430-4771-9A8C-0F5442DFCECE|3|||||FLU-IIQ ONCE DAILY|||M/SEC|||MM/SEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|NA|3||39||RUN-IN|1973-01-23||||1967-08-24||1972-08-26|1971-04-22|
TRIAL STUDY 134XCP|QS|D0AE2069-B430-4771-9A8C-0F5442DFCECE|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||MMOL/L|||UMOL/H/MMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|4||88||CONTINUATION TREATMENT|1963-11-30||||1960-03-29||1962-12-18|1969-03-03|
TRIAL STUDY 134XCP|QS|D0AE2069-B430-4771-9A8C-0F5442DFCECE|5|||||PODCI - PEDIATRIC PARENT REPORTED|||CAL|||ATM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|5||7||SCREENING|1960-10-27||||1967-04-03||1964-04-08|1964-01-11|
TRIAL STUDY 134XCP|QS|CF214007-AC24-4760-AEDE-F78CDE3D9351|1|||||WOMAC VA 3.1 INDEX|||PACK|||NMOL BCE/L|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|1||38||INDUCTION TREATMENT|1970-01-12||||1969-06-10||1960-05-11|1972-06-06|
TRIAL STUDY 134XCP|QS|CF214007-AC24-4760-AEDE-F78CDE3D9351|2|||||BPI|||GBQ|||FEU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|2||58||OPEN LABEL TREATMENT|1967-04-28||||1963-09-23||1963-01-10|1971-02-23|
TRIAL STUDY 134XCP|QS|CF214007-AC24-4760-AEDE-F78CDE3D9351|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||TITER|||NMOL/G|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|3||39||TREATMENT|1963-09-15||||1966-11-03||1961-05-13|1966-10-04|
TRIAL STUDY 134XCP|QS|CF214007-AC24-4760-AEDE-F78CDE3D9351|4|||||NCCN-FACT FPSI-17 V2|||HOURS|||UMOL/L/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|4||88||INDUCTION TREATMENT|1960-10-10||||1968-12-14||1961-02-23|1966-10-05|
TRIAL STUDY 134XCP|QS|CF214007-AC24-4760-AEDE-F78CDE3D9351|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||LOG10 CFU/ML|||OZ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|U|5||7||CONTINUATION TREATMENT|1973-05-07||||1971-12-18||1968-08-28|1970-04-12|
TRIAL STUDY 134XCP|QS|E996BE19-2824-49D3-944F-B777F3D8E746|1|||||SF36 V2.0 STANDARD|||GPL U|||ANTIBODY UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|1||38||BASELINE|1971-03-08||||1961-12-11||1961-12-07|1969-08-04|
TRIAL STUDY 134XCP|QS|E996BE19-2824-49D3-944F-B777F3D8E746|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MSEC|||TSP|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|2||58||BASELINE|1970-07-21||||1966-07-23||1964-03-26|1969-11-06|
TRIAL STUDY 134XCP|QS|E996BE19-2824-49D3-944F-B777F3D8E746|3|||||SOAPP-R|||ML/M2/MIN|||KM/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|3||39||LONG-TERM FOLLOW-UP|1968-08-11||||1964-06-02||1962-01-23|1971-08-12|
TRIAL STUDY 134XCP|QS|E996BE19-2824-49D3-944F-B777F3D8E746|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||MG/M2/MIN|||G/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|4||88||CONTINUATION TREATMENT|1964-03-01||||1968-05-05||1970-11-26|1966-11-20|
TRIAL STUDY 134XCP|QS|E996BE19-2824-49D3-944F-B777F3D8E746|5|||||ASEX-FEMALE|||AGU/ML|||/MONTH|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|5||7||LONG-TERM FOLLOW-UP|1970-07-09||||1970-04-24||1971-08-07|1972-12-14|
TRIAL STUDY 134XCP|QS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1|||||C-SSRS LIFETIME/RECENT VERSION|||SCOOPFUL|||IN2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|NA|1||38||OBSERVATION|1970-04-06||||1972-01-18||1972-01-23|1963-01-07|
TRIAL STUDY 134XCP|QS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2|||||FKSI-15|||PKAT|||LINEAR FT*LB|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|2||58||TREATMENT|1961-05-27||||1970-11-02||1964-07-14|1962-05-21|
TRIAL STUDY 134XCP|QS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|3|||||SGRQ-C|||/H|||ML/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|NA|3||39||OBSERVATION|1967-11-27||||1963-04-21||1965-03-29|1967-11-18|
TRIAL STUDY 134XCP|QS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|4|||||UPDRS|||ML/ANIMAL/DAY|||QUANTITY SUFFICIENT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|U|4||88||OBSERVATION|1961-09-04||||1964-02-25||1964-02-08|1960-12-16|
TRIAL STUDY 134XCP|QS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||K|||MOL/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|U|5||7||FOLLOW-UP|1962-08-19||||1966-08-26||1969-05-01|1964-03-29|
TRIAL STUDY 134XCP|QS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1|||||ACQ|||MU/G|||DB|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|1||38||OBSERVATION|1960-11-28||||1967-05-18||1960-12-21|1964-05-11|
TRIAL STUDY 134XCP|QS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2|||||Q-LES-Q-SF|||KCAL|||RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|2||58||WASHOUT|1964-11-03||||1962-06-09||1965-05-12|1966-07-12|
TRIAL STUDY 134XCP|QS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|3|||||ADCS-ADL SEVERE DEMENTIA|||MILE|||FMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|NA|3||39||LONG-TERM FOLLOW-UP|1964-04-18||||1968-10-04||1969-07-14|1963-04-22|
TRIAL STUDY 134XCP|QS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|4|||||COMM|||UG/M2/DAY|||UMOL/H/MMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|4||88||BLINDED TREATMENT|1963-05-27||||1968-08-15||1973-05-13|1962-12-10|
TRIAL STUDY 134XCP|QS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|5|||||SIQR|||UG/MIN|||EID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|5||7||TREATMENT|1972-10-27||||1971-09-02||1966-11-05|1972-10-02|
TRIAL STUDY 134XCP|QS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1|||||PEDS-FACIT-F|||ML/SEC/1.73M2|||KALLIKREIN INHIBITOR UNIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|N|1||38||BLINDED TREATMENT|1960-10-24||||1970-08-08||1965-01-27|1960-07-18|
TRIAL STUDY 134XCP|QS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||UKAT|||KAT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|2||58||SCREENING|1969-04-07||||1973-01-31||1963-03-10|1965-12-23|
TRIAL STUDY 134XCP|QS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|3|||||HCS|||CM|||EID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|3||39||OPEN LABEL TREATMENT|1963-02-19||||1971-09-12||1973-07-20|1963-01-12|
TRIAL STUDY 134XCP|QS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|4|||||ADCS-ADL|||G/CAGE/DAY|||UIU/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|N|4||88||INDUCTION TREATMENT|1964-03-14||||1965-11-24||1965-05-09|1965-06-07|
TRIAL STUDY 134XCP|QS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|5|||||GDS|||DNA COPIES/UG|||BAR|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|5||7||LONG-TERM FOLLOW-UP|1960-03-18||||1970-02-12||1965-10-13|1965-01-24|
TRIAL STUDY 134XCP|QS|1F75D53C-E8AA-45DA-8410-F00266080E80|1|||||CES|||ML/G/H|||/MS|NOT DONE||LIKERT SCALE 7-POINT|Y|U|U|1||38||SCREENING|1960-12-01||||1966-07-07||1962-09-03|1969-04-02|
TRIAL STUDY 134XCP|QS|1F75D53C-E8AA-45DA-8410-F00266080E80|2|||||ANSD V1.0|||NCI|||G/CAGE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|2||58||INDUCTION TREATMENT|1963-01-16||||1971-06-17||1970-03-23|1970-09-24|
TRIAL STUDY 134XCP|QS|1F75D53C-E8AA-45DA-8410-F00266080E80|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||UV|||PG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|3||39||LONG-TERM FOLLOW-UP|1966-04-22||||1972-06-11||1972-11-01|1960-08-06|
TRIAL STUDY 134XCP|QS|1F75D53C-E8AA-45DA-8410-F00266080E80|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||10^9 ORGANISMS/ML|||MEQ/UL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|4||88||BLINDED TREATMENT|1960-09-13||||1969-09-19||1967-01-11|1968-01-28|
TRIAL STUDY 134XCP|QS|1F75D53C-E8AA-45DA-8410-F00266080E80|5|||||PROSQOLI|||MM|||DRUM|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|Y|5||7||INDUCTION TREATMENT|1964-11-06||||1969-12-30||1971-12-20|1962-12-25|
TRIAL STUDY 134XCP|QS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1|||||PDQUALIF|||/MONTH|||GRAVITATIONAL UNIT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|1||38||RUN-IN|1960-07-22||||1961-04-26||1970-03-31|1969-11-28|
TRIAL STUDY 134XCP|QS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2|||||MSIS-29 V1|||NMOL/DAY|||10^9 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|2||58||OPEN LABEL TREATMENT|1971-09-23||||1969-07-08||1969-07-25|1963-12-12|
TRIAL STUDY 134XCP|QS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|3|||||WHODAS 2.0 - 36-ITEM SELF|||HZ|||KM/H|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|U|3||39||LONG-TERM FOLLOW-UP|1971-01-11||||1968-01-15||1960-03-01|1973-01-17|
TRIAL STUDY 134XCP|QS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|4|||||WLQ|||BAU|||LOG10 IU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|4||88||WASHOUT|1964-12-09||||1962-06-26||1972-12-05|1963-09-19|
TRIAL STUDY 134XCP|QS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|5|||||MRS|||EID 50/DOSE|||KN/CM2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|U|5||7||SCREENING|1961-07-05||||1973-01-21||1964-03-11|1973-03-14|
TRIAL STUDY 134XCP|QS|EE14E53E-19A8-4441-BF82-31444CBC8B49|1|||||SF8 V1.0 ACUTE|||DRAM|||MG/ML/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|1||38||BASELINE|1968-05-15||||1964-11-17||1971-07-07|1970-05-18|
TRIAL STUDY 134XCP|QS|EE14E53E-19A8-4441-BF82-31444CBC8B49|2|||||FACT/GOG-NTX V4|||BAU|||BQ/UL|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|2||58||RUN-IN|1973-06-30||||1963-10-06||1963-03-04|1972-11-02|
TRIAL STUDY 134XCP|QS|EE14E53E-19A8-4441-BF82-31444CBC8B49|3|||||GCGI|||GPELISA UNIT/ML|||ML/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|3||39||LONG-TERM FOLLOW-UP|1972-04-25||||1962-04-15||1973-03-02|1965-09-23|
TRIAL STUDY 134XCP|QS|EE14E53E-19A8-4441-BF82-31444CBC8B49|4|||||HCS|||10^9 CFU/ML|||PACKAGE|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|4||88||INDUCTION TREATMENT|1972-12-11||||1968-02-29||1963-09-21|1970-11-06|
TRIAL STUDY 134XCP|QS|EE14E53E-19A8-4441-BF82-31444CBC8B49|5|||||GOSE|||ML/M2/DAY|||U/M2/H|NOT DONE||LIKERT SCALE 7-POINT|N|NA|Y|5||7||TREATMENT|1963-04-04||||1965-11-23||1962-04-09|1965-09-26|
TRIAL STUDY 134XCP|QS|DAF741EF-DCCF-4E18-844B-05640A94C181|1|||||BSI-18|||UG/L FEU|||%(W/W)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|1||38||WASHOUT|1962-02-11||||1962-05-09||1972-11-24|1971-11-13|
TRIAL STUDY 134XCP|QS|DAF741EF-DCCF-4E18-844B-05640A94C181|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||NMOL/DAY|||KG/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|U|2||58||OBSERVATION|1961-08-25||||1973-06-03||1968-07-19|1967-09-02|
TRIAL STUDY 134XCP|QS|DAF741EF-DCCF-4E18-844B-05640A94C181|3|||||NCCN-FACT FHNSI-22 V2|||CYCLE/MIN|||DIOPTER|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|3||39||WASHOUT|1966-10-24||||1969-06-04||1962-11-23|1964-08-28|
TRIAL STUDY 134XCP|QS|DAF741EF-DCCF-4E18-844B-05640A94C181|4|||||MSQOL-54|||U/MG|||ML/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|Y|4||88||INDUCTION TREATMENT|1971-06-22||||1973-06-27||1966-05-17|1966-10-15|
TRIAL STUDY 134XCP|QS|DAF741EF-DCCF-4E18-844B-05640A94C181|5|||||MMRC|||CPM|||CD/M2|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|5||7||CONTINUATION TREATMENT|1972-10-09||||1969-04-02||1964-03-30|1963-01-09|
TRIAL STUDY 134XCP|QS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1|||||SOAPP-R|||DAGU|||VOXEL|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|1||38||INDUCTION TREATMENT|1972-07-04||||1963-09-23||1968-11-21|1972-03-12|
TRIAL STUDY 134XCP|QS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2|||||C-SSRS LIFETIME/RECENT VERSION|||PIPE|||SUPPOSITORY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|2||58||RUN-IN|1970-04-27||||1969-11-11||1961-05-03|1961-02-06|
TRIAL STUDY 134XCP|QS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|3|||||FACT-C V4|||MMOL/MOL|||CI/G|NOT DONE||LIKERT SCALE 7-POINT|N|Y|NA|3||39||RUN-IN|1969-06-21||||1968-01-26||1962-02-11|1964-11-19|
TRIAL STUDY 134XCP|QS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||CS|||10^3/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|U|4||88||SCREENING|1969-03-26||||1970-09-18||1972-09-28|1965-10-18|
TRIAL STUDY 134XCP|QS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|5|||||ADAS-COG|||M|||S*KPA|NOT DONE||LIKERT SCALE 7-POINT|U|Y|N|5||7||SCREENING|1969-04-03||||1963-02-22||1961-10-20|1961-10-27|
TRIAL STUDY 134XCP|QS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1|||||BPI|||/40 HPFS|||KG/MOL|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|N|1||38||FOLLOW-UP|1960-05-24||||1963-05-04||1970-05-09|1968-03-05|
TRIAL STUDY 134XCP|QS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||GRAVITATIONAL UNIT|||DAYS/MONTH|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|2||58||RUN-IN|1963-08-05||||1960-05-11||1968-12-31|1961-10-20|
TRIAL STUDY 134XCP|QS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|3|||||GCGI|||UMOL/KG/MIN|||HZ|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|3||39||TREATMENT|1963-06-03||||1961-05-26||1972-03-12|1970-12-22|
TRIAL STUDY 134XCP|QS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|4|||||EPIC-CP|||VIRTUAL PIXEL|||COPIES/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|4||88||LONG-TERM FOLLOW-UP|1969-08-10||||1970-04-23||1965-04-21|1969-07-30|
TRIAL STUDY 134XCP|QS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|5|||||IPAQ-LF SELF-ADMINISTERED VERSION|||LM|||PHERESIS UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|5||7||INDUCTION TREATMENT|1963-06-28||||1964-02-14||1968-11-22|1963-06-08|
TRIAL STUDY 134XCP|QS|CF3E1636-762F-4821-A44E-455F33F5E4CC|1|||||WHODAS 2.0 - 12-ITEM SELF|||CIGARETTE|||UMOL/L/SEC|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|1||38||RUN-IN|1969-08-28||||1969-09-27||1971-03-29|1961-06-30|
TRIAL STUDY 134XCP|QS|CF3E1636-762F-4821-A44E-455F33F5E4CC|2|||||FAS-NACC UDS V3.0|||ML/CM H2O|||STEPS/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|N|2||58||BASELINE|1960-09-05||||1962-02-18||1973-03-02|1962-12-21|
TRIAL STUDY 134XCP|QS|CF3E1636-762F-4821-A44E-455F33F5E4CC|3|||||WHODAS 2.0 - 36-ITEM SELF|||U/KG/H|||C|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|NA|3||39||OBSERVATION|1963-01-29||||1962-10-23||1961-05-20|1970-08-11|
TRIAL STUDY 134XCP|QS|CF3E1636-762F-4821-A44E-455F33F5E4CC|4|||||BLCS|||/10^4|||ML/BEAT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|Y|4||88||RUN-IN|1970-09-07||||1966-06-07||1968-08-07|1973-05-22|
TRIAL STUDY 134XCP|QS|CF3E1636-762F-4821-A44E-455F33F5E4CC|5|||||C-SSRS ALREADY ENROLLED SUBJECTS|||/100 HPFS|||DDU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|5||7||INDUCTION TREATMENT|1972-07-23||||1972-04-24||1961-01-21|1972-02-22|
TRIAL STUDY 134XCP|QS|3846A0A8-2D38-44C9-A579-84C66315C436|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||KAT|||FT|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|1||38||RUN-IN|1968-03-09||||1967-10-16||1968-01-05|1971-09-14|
TRIAL STUDY 134XCP|QS|3846A0A8-2D38-44C9-A579-84C66315C436|2|||||NPS|||MG/M2|||PMOL/10^10 CELLS|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|U|2||58||SCREENING|1963-09-07||||1972-05-16||1967-06-30|1971-04-25|
TRIAL STUDY 134XCP|QS|3846A0A8-2D38-44C9-A579-84C66315C436|3|||||MMRC|||LOG10 CCID 50/DOSE|||MANSON U/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|3||39||BASELINE|1963-12-29||||1964-06-23||1972-08-14|1973-07-01|
TRIAL STUDY 134XCP|QS|3846A0A8-2D38-44C9-A579-84C66315C436|4|||||PODCI - PEDIATRIC PARENT REPORTED|||G/G/DAY|||10^12 IU/L|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|4||88||CONTINUATION TREATMENT|1968-03-30||||1970-03-23||1962-02-14|1965-11-14|
TRIAL STUDY 134XCP|QS|3846A0A8-2D38-44C9-A579-84C66315C436|5|||||SF36 V2.0 STANDARD|||MOL|||/200 HPFS|NOT DONE||LIKERT SCALE 3-POINT|N|N|Y|5||7||OBSERVATION|1973-05-09||||1964-09-18||1967-12-05|1972-08-14|
TRIAL STUDY 134XCP|QS|75B429C2-E173-4F72-8D4A-76F62C97F006|1|||||FKSI-DRS V4|||G/M2|||SEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|1||38||TREATMENT|1963-07-19||||1961-03-25||1971-07-24|1972-05-21|
TRIAL STUDY 134XCP|QS|75B429C2-E173-4F72-8D4A-76F62C97F006|2|||||NPS|||ANTI-XA IU|||UMOL/L/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|2||58||INDUCTION TREATMENT|1970-01-23||||1972-11-04||1963-03-09|1961-12-06|
TRIAL STUDY 134XCP|QS|75B429C2-E173-4F72-8D4A-76F62C97F006|3|||||EPDS|||AMFI|||ML/100G/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|N|3||39||LONG-TERM FOLLOW-UP|1962-06-30||||1964-11-23||1969-11-10|1966-01-15|
TRIAL STUDY 134XCP|QS|75B429C2-E173-4F72-8D4A-76F62C97F006|4|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MM2|||UEQ|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|Y|4||88||LONG-TERM FOLLOW-UP|1970-01-27||||1963-08-19||1965-04-08|1969-08-30|
TRIAL STUDY 134XCP|QS|75B429C2-E173-4F72-8D4A-76F62C97F006|5|||||SF10 V1.0 CHILDREN ACUTE|||QUANTITY SUFFICIENT|||/100 WBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|5||7||BASELINE|1966-10-22||||1969-08-27||1966-06-03|1970-06-06|
TRIAL STUDY 134XCP|QS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1|||||ESS|||U/MMOL|||LOG10 IU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|1||38||FOLLOW-UP|1972-04-04||||1967-03-25||1970-07-18|1969-11-23|
TRIAL STUDY 134XCP|QS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2|||||BSI-18|||UU/L|||UMOL/L/H|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|2||58||INDUCTION TREATMENT|1971-11-12||||1961-12-17||1961-09-08|1972-04-08|
TRIAL STUDY 134XCP|QS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|3|||||SOAPP-R|||AU/ML|||/2000 RBC|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|3||39||CONTINUATION TREATMENT|1973-05-21||||1963-12-19||1960-05-05|1970-02-20|
TRIAL STUDY 134XCP|QS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|4|||||BORG CR10|||UMOL/H/MMOL|||MG/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|N|4||88||FOLLOW-UP|1969-10-06||||1964-09-13||1960-01-20|1966-01-28|
TRIAL STUDY 134XCP|QS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||MAMP|||10^6 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|U|5||7||BLINDED TREATMENT|1965-10-30||||1967-10-16||1971-08-11|1972-06-12|
TRIAL STUDY 134XCP|QS|8065F0B9-9183-43E4-998A-D2F096D87998|1|||||FLSI|||TUBERCULIN UNIT|||K|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|1||38||TREATMENT|1961-06-04||||1960-12-20||1970-08-02|1966-09-03|
TRIAL STUDY 134XCP|QS|8065F0B9-9183-43E4-998A-D2F096D87998|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||LM|||AFU|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|2||58||BASELINE|1970-03-15||||1960-10-24||1962-09-04|1969-06-10|
TRIAL STUDY 134XCP|QS|8065F0B9-9183-43E4-998A-D2F096D87998|3|||||MSWS-12|||NMOL/G|||U/M2|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|3||39||FOLLOW-UP|1960-11-01||||1967-02-24||1968-08-30|1962-01-18|
TRIAL STUDY 134XCP|QS|8065F0B9-9183-43E4-998A-D2F096D87998|4|||||ADCS-ADL|||MU/L|||RPM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|Y|4||88||BASELINE|1963-07-24||||1963-01-06||1961-09-01|1960-07-04|
TRIAL STUDY 134XCP|QS|8065F0B9-9183-43E4-998A-D2F096D87998|5|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||UG/G/DAY|||TSP EQ|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|5||7||CONTINUATION TREATMENT|1970-06-19||||1963-12-05||1960-11-01|1968-01-20|
TRIAL STUDY 134XCP|QS|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1|||||EORTC QLQ-LC13|||MG/ML/DAY|||ATM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|1||38||OPEN LABEL TREATMENT|1963-04-06||||1966-04-25||1961-12-04|1962-11-28|
TRIAL STUDY 134XCP|QS|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2|||||IPAQ-LF SELF-ADMINISTERED VERSION|||GPS U|||MG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|2||58||SCREENING|1971-02-22||||1973-07-26||1967-05-09|1961-02-08|
TRIAL STUDY 134XCP|QS|697EB3B7-5AD1-4D1D-BB53-BB0556915957|3|||||WHODAS 2.0 - 12-ITEM PROXY|||ECL UNIT|||PA|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|Y|3||39||CONTINUATION TREATMENT|1960-09-05||||1960-05-01||1970-06-11|1973-02-06|
TRIAL STUDY 134XCP|QS|697EB3B7-5AD1-4D1D-BB53-BB0556915957|4|||||AUDIT-C|||ENZYME U/G HB|||TRACE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|NA|4||88||WASHOUT|1961-06-06||||1968-06-24||1966-09-17|1964-06-08|
TRIAL STUDY 134XCP|QS|697EB3B7-5AD1-4D1D-BB53-BB0556915957|5|||||MSQOL-54|||MET|||HENRY|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|5||7||FOLLOW-UP|1965-08-17||||1972-04-11||1972-04-25|1965-06-21|
TRIAL STUDY 134XCP|QS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1|||||LEC-5 STANDARD VERSION|||S*KPA|||NG/MOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|1||38||TREATMENT|1965-04-27||||1962-04-23||1964-12-26|1969-05-01|
TRIAL STUDY 134XCP|QS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2|||||SOWS SHORT|||OD UNIT|||UU/DL|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1964-07-09||||1963-12-16||1972-07-14|1972-04-16|
TRIAL STUDY 134XCP|QS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|3|||||CCQ 1 WEEK VERSION|||G/KG/DAY|||MOSM|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|3||39||BASELINE|1972-07-03||||1964-04-24||1967-08-24|1972-01-19|
TRIAL STUDY 134XCP|QS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|4|||||NCCN-FACT FBRSI-24 V2|||NEBULE|||KG|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|4||88||LONG-TERM FOLLOW-UP|1970-12-16||||1962-08-22||1968-05-04|1973-03-22|
TRIAL STUDY 134XCP|QS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|5|||||EORTC QLQ-CR29 V2.1|||MEQ/UL|||STEPS/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|5||7||WASHOUT|1960-11-11||||1973-03-25||1970-08-19|1961-10-09|
TRIAL STUDY 134XCP|QS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1|||||NCCN-FACT FHNSI-22 V2|||APPLICATION|||M|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|N|1||38||OPEN LABEL TREATMENT|1963-09-03||||1973-01-31||1963-05-09|1962-09-18|
TRIAL STUDY 134XCP|QS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2|||||BSI-18|||MAC50|||KG/CM2|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|U|2||58||BASELINE|1969-11-04||||1972-06-22||1965-01-19|1969-08-18|
TRIAL STUDY 134XCP|QS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|3|||||SOWS SHORT|||/H|||BQ/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|3||39||BASELINE|1962-10-09||||1971-06-30||1966-12-31|1966-01-21|
TRIAL STUDY 134XCP|QS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|4|||||FKSI-15|||EQ|||/MM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|4||88||INDUCTION TREATMENT|1965-01-25||||1970-07-11||1969-09-27|1969-09-04|
TRIAL STUDY 134XCP|QS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|5|||||IBDQ|||U/KG|||ELISA UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|5||7||FOLLOW-UP|1965-06-29||||1963-08-14||1964-12-08|1963-01-29|
TRIAL STUDY 134XCP|QS|52EC57AA-56E4-47A8-AADA-36F62653B423|1|||||EXPANDED DRS-PI CAREGIVER VERSION|||UMOL/DL|||MDFI|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|1||38||RUN-IN|1968-04-19||||1967-05-05||1965-06-18|1963-09-02|
TRIAL STUDY 134XCP|QS|52EC57AA-56E4-47A8-AADA-36F62653B423|2|||||FACT-LYM V4|||MDFI|||10^6 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|NA|2||58||TREATMENT|1965-04-29||||1962-05-10||1967-03-11|1965-09-16|
TRIAL STUDY 134XCP|QS|52EC57AA-56E4-47A8-AADA-36F62653B423|3|||||GOSE|||HZ/S|||FOZ_BR|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|3||39||RUN-IN|1966-08-31||||1962-03-12||1963-12-06|1962-04-17|
TRIAL STUDY 134XCP|QS|52EC57AA-56E4-47A8-AADA-36F62653B423|4|||||GOSE|||MOL/MOL|||HOURS|NOT DONE||LIKERT SCALE 3-POINT|N|U|Y|4||88||LONG-TERM FOLLOW-UP|1966-03-13||||1961-03-04||1961-04-23|1967-06-19|
TRIAL STUDY 134XCP|QS|52EC57AA-56E4-47A8-AADA-36F62653B423|5|||||NCCN-FACT FOSI-18 V2|||WEBER|||SBE/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|5||7||LONG-TERM FOLLOW-UP|1968-08-25||||1964-10-30||1966-09-09|1968-03-06|
TRIAL STUDY 134XCP|QS|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1|||||EPIC-CP|||ML/M2|||MET|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|1||38||LONG-TERM FOLLOW-UP|1965-11-26||||1964-07-27||1967-11-17|1967-04-09|
TRIAL STUDY 134XCP|QS|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2|||||FBRSI|||G/DL|||KG/MOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|Y|2||58||OBSERVATION|1971-06-07||||1968-07-05||1965-02-23|1963-06-05|
TRIAL STUDY 134XCP|QS|F09C04A4-4F9E-4033-9115-81C6007DE8B4|3|||||FLU-IIQ ONCE DAILY|||DIP|||UG/G/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|U|3||39||LONG-TERM FOLLOW-UP|1972-07-13||||1965-12-24||1973-05-15|1961-07-23|
TRIAL STUDY 134XCP|QS|F09C04A4-4F9E-4033-9115-81C6007DE8B4|4|||||QIDS-SR|||TSP EQ|||FINGERTIP UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|4||88||RUN-IN|1968-09-06||||1967-12-01||1963-02-10|1960-05-10|
TRIAL STUDY 134XCP|QS|F09C04A4-4F9E-4033-9115-81C6007DE8B4|5|||||PCL-5|||BAU/ML|||LOG10 TCID 50/UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|5||7||TREATMENT|1964-04-23||||1962-12-10||1962-03-05|1966-10-06|
TRIAL STUDY 134XCP|QS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1|||||GCGI|||MANSON U/ML|||/7.5 ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|1||38||WASHOUT|1960-04-26||||1970-05-13||1972-10-21|1972-01-21|
TRIAL STUDY 134XCP|QS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2|||||EPDS|||CI/UG|||ENZYME U/G HB|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|2||58||FOLLOW-UP|1971-10-06||||1965-07-27||1962-04-04|1971-07-16|
TRIAL STUDY 134XCP|QS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|3|||||C-SSRS CHILDREN'S BASELINE|||10^6 DNA COPIES/ML|||PACK|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|3||39||TREATMENT|1964-04-18||||1965-11-17||1965-12-21|1960-01-19|
TRIAL STUDY 134XCP|QS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||KM|||SBE/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|4||88||OPEN LABEL TREATMENT|1969-12-07||||1966-04-12||1962-10-18|1973-07-13|
TRIAL STUDY 134XCP|QS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|5|||||PHQ-15|||CARTRIDGE|||S^-1(%O2)^-1|NOT DONE||LIKERT SCALE 3-POINT|U|Y|N|5||7||OPEN LABEL TREATMENT|1962-02-11||||1972-08-06||1968-08-14|1966-02-19|
TRIAL STUDY 134XCP|QS|4779A01C-1219-46AC-B0F7-71C9717A2B45|1|||||PSQI|||UL/KG/DAY|||10^9 ORGANISMS/MG|NOT DONE||LIKERT SCALE 7-POINT|U|Y|NA|1||38||LONG-TERM FOLLOW-UP|1964-08-13||||1967-09-28||1962-10-11|1960-12-11|
TRIAL STUDY 134XCP|QS|4779A01C-1219-46AC-B0F7-71C9717A2B45|2|||||BPI SHORT FORM|||H/WK|||MG/ML/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|2||58||OBSERVATION|1969-01-30||||1968-03-04||1966-04-26|1966-07-12|
TRIAL STUDY 134XCP|QS|4779A01C-1219-46AC-B0F7-71C9717A2B45|3|||||SF12 V1.0 STANDARD|||MG/KG/DAY|||MM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|U|3||39||CONTINUATION TREATMENT|1962-05-13||||1968-05-03||1961-09-30|1965-12-01|
TRIAL STUDY 134XCP|QS|4779A01C-1219-46AC-B0F7-71C9717A2B45|4|||||BARS|||PFU|||U/10^12 RBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|4||88||CONTINUATION TREATMENT|1963-06-03||||1969-06-27||1973-02-25|1971-10-03|
TRIAL STUDY 134XCP|QS|4779A01C-1219-46AC-B0F7-71C9717A2B45|5|||||EORTC QLQ-CR29 V2.1|||10^10/L|||M/SEC2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|5||7||OBSERVATION|1964-11-15||||1971-11-22||1970-04-07|1961-01-03|
TRIAL STUDY 134XCP|QS|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1|||||WOMAC LK 3.1 INDEX|||MU/L|||NMOL/L/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|1||38||LONG-TERM FOLLOW-UP|1964-08-15||||1970-01-03||1965-01-12|1972-03-15|
TRIAL STUDY 134XCP|QS|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2|||||FKSI-DRS V4|||NMOL/ML/MIN|||NG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|Y|2||58||CONTINUATION TREATMENT|1968-12-26||||1961-07-11||1969-10-16|1965-09-29|
TRIAL STUDY 134XCP|QS|5F5C5DED-7547-40D2-9B34-77B37CCD7732|3|||||MSIS-29 V1|||/2500 WBC|||U/DL|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|3||39||INDUCTION TREATMENT|1963-03-27||||1962-05-11||1968-01-27|1973-04-12|
TRIAL STUDY 134XCP|QS|5F5C5DED-7547-40D2-9B34-77B37CCD7732|4|||||FACT-COG V3|||MG/ML/DAY|||10^11/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|Y|4||88||SCREENING|1960-09-23||||1968-02-16||1970-10-23|1961-12-31|
TRIAL STUDY 134XCP|QS|5F5C5DED-7547-40D2-9B34-77B37CCD7732|5|||||PODCI - ADOLESCENT PARENT REPORTED|||KG|||MCI|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|5||7||CONTINUATION TREATMENT|1967-03-03||||1960-03-21||1964-09-13|1963-07-02|
TRIAL STUDY 134XCP|QS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1|||||SIQR|||G/CAGE/WK|||UKAT|NOT DONE||LIKERT SCALE 7-POINT|N|U|Y|1||38||INDUCTION TREATMENT|1972-02-26||||1961-09-14||1962-12-24|1964-07-14|
TRIAL STUDY 134XCP|QS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2|||||RPQ|||BISCUIT|||EP U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|2||58||OBSERVATION|1966-07-07||||1964-05-12||1962-05-06|1970-07-25|
TRIAL STUDY 134XCP|QS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|3|||||FACIT-DYSPNEA 33 ITEM BANK|||DEG/MM|||MG/KG/WEEK|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|3||39||OPEN LABEL TREATMENT|1960-01-05||||1972-08-27||1970-12-15|1965-11-04|
TRIAL STUDY 134XCP|QS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|4|||||C-SSRS ALREADY ENROLLED SUBJECTS|||/SEC|||MG/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|4||88||TREATMENT|1971-04-16||||1971-06-08||1968-08-04|1964-12-18|
TRIAL STUDY 134XCP|QS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|5|||||FIQR|||10^3 DNA COPIES/ML|||S^-1(%O2)^-1|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|5||7||INDUCTION TREATMENT|1968-07-31||||1964-05-30||1964-08-06|1964-10-18|
TRIAL STUDY 134XCP|QS|48348DF0-33DA-457F-86C6-797FF7B32857|1|||||PROSQOLI|||FARAD|||ML/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|1||38||WASHOUT|1968-01-23||||1962-12-14||1971-11-20|1962-11-10|
TRIAL STUDY 134XCP|QS|48348DF0-33DA-457F-86C6-797FF7B32857|2|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||MG/DAY|||UG/MOL|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|2||58||SCREENING|1969-11-17||||1970-10-23||1970-06-24|1962-11-12|
TRIAL STUDY 134XCP|QS|48348DF0-33DA-457F-86C6-797FF7B32857|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||MN|||NM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|Y|3||39||WASHOUT|1962-01-30||||1964-06-19||1970-09-02|1972-06-09|
TRIAL STUDY 134XCP|QS|48348DF0-33DA-457F-86C6-797FF7B32857|4|||||SHORT-FORM MPQ-2|||NMOL BCE/NMOL|||MILE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|4||88||BLINDED TREATMENT|1967-06-01||||1970-04-20||1968-08-11|1966-01-03|
TRIAL STUDY 134XCP|QS|48348DF0-33DA-457F-86C6-797FF7B32857|5|||||YMRS|||EVENTS|||MET|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|5||7||CONTINUATION TREATMENT|1963-10-20||||1972-03-24||1964-03-15|1960-06-06|
TRIAL STUDY 134XCP|QS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1|||||CDLQ|||ML/MIN/MMHG|||LOG10 TCID 50/UL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|1||38||TREATMENT|1971-11-30||||1972-12-24||1963-03-04|1964-02-13|
TRIAL STUDY 134XCP|QS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2|||||BEBQ CONCURRENT|||G/KG/DAY|||%(W/V)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|2||58||TREATMENT|1962-09-13||||1962-05-17||1969-01-28|1961-07-03|
TRIAL STUDY 134XCP|QS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|3|||||ASEX-FEMALE|||SFC/10^6 PBMC|||LOG10 PFU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|N|3||39||BLINDED TREATMENT|1963-01-10||||1970-09-14||1968-08-17|1972-08-30|
TRIAL STUDY 134XCP|QS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|4|||||WOMAC VA 3.1 INDEX|||10^3 CFU/ML|||KM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|4||88||CONTINUATION TREATMENT|1972-11-04||||1965-12-04||1971-05-13|1963-06-30|
TRIAL STUDY 134XCP|QS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|5|||||BSFS|||10^4 CFU|||V|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|5||7||OPEN LABEL TREATMENT|1972-09-19||||1967-03-18||1971-02-08|1960-10-18|
TRIAL STUDY 134XCP|QS|396CC122-5F23-418D-A75E-572ADF4FD6C1|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||APL U/ML|||DRINK|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|NA|1||38||INDUCTION TREATMENT|1972-04-29||||1960-06-19||1972-08-21|1966-05-27|
TRIAL STUDY 134XCP|QS|396CC122-5F23-418D-A75E-572ADF4FD6C1|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||U/G/DAY|||UMOL/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|2||58||BASELINE|1968-01-12||||1960-11-18||1964-02-28|1968-03-26|
TRIAL STUDY 134XCP|QS|396CC122-5F23-418D-A75E-572ADF4FD6C1|3|||||FLSI|||MAC50|||DRINK|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|3||39||TREATMENT|1968-08-17||||1966-05-18||1964-10-20|1972-04-12|
TRIAL STUDY 134XCP|QS|396CC122-5F23-418D-A75E-572ADF4FD6C1|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||WAFER|||MPH|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|4||88||BASELINE|1963-09-27||||1967-02-15||1971-03-25|1967-07-06|
TRIAL STUDY 134XCP|QS|396CC122-5F23-418D-A75E-572ADF4FD6C1|5|||||SOWS SHORT|||MET*H|||L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|NA|5||7||BASELINE|1964-07-10||||1967-08-06||1973-01-24|1967-06-11|
TRIAL STUDY 134XCP|QS|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1|||||FIQR|||G/KG|||ELISA UNIT|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|1||38||OPEN LABEL TREATMENT|1961-05-06||||1961-01-01||1966-04-11|1965-04-28|
TRIAL STUDY 134XCP|QS|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2|||||GCGI|||BOX|||COPIES/UG|NOT DONE||LIKERT SCALE 7-POINT|NA|U|NA|2||58||LONG-TERM FOLLOW-UP|1968-09-19||||1971-02-10||1960-07-08|1960-09-08|
TRIAL STUDY 134XCP|QS|9CF3CD51-5D5B-40E6-8F13-B314911BE461|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||ML/CAGE/WK|||IU/L|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|N|3||39||SCREENING|1972-01-05||||1970-01-19||1961-12-11|1973-05-27|
TRIAL STUDY 134XCP|QS|9CF3CD51-5D5B-40E6-8F13-B314911BE461|4|||||C-SSRS LIFETIME/RECENT VERSION|||ABSORBANCE U/MIN|||PG/DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|4||88||FOLLOW-UP|1971-05-03||||1968-08-01||1964-10-06|1960-12-29|
TRIAL STUDY 134XCP|QS|9CF3CD51-5D5B-40E6-8F13-B314911BE461|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||L/MIN|||10^6 COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|5||7||BLINDED TREATMENT|1969-07-08||||1973-07-01||1961-04-11|1969-10-03|
TRIAL STUDY 134XCP|QS|CB3B9054-5CDC-418D-8071-7429B1702587|1|||||FPSR|||MU/G|||HOURS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|Y|1||38||BLINDED TREATMENT|1972-10-08||||1966-09-01||1962-02-24|1966-12-06|
TRIAL STUDY 134XCP|QS|CB3B9054-5CDC-418D-8071-7429B1702587|2|||||FKSI-15|||CI/L|||CM/S|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|2||58||SCREENING|1961-05-11||||1964-08-30||1962-03-03|1971-05-03|
TRIAL STUDY 134XCP|QS|CB3B9054-5CDC-418D-8071-7429B1702587|3|||||MDQ-T|||CAN|||U/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|3||39||WASHOUT|1961-08-06||||1964-05-24||1963-02-03|1960-11-01|
TRIAL STUDY 134XCP|QS|CB3B9054-5CDC-418D-8071-7429B1702587|4|||||SF36 V2.0 STANDARD|||BAU/ML|||ML/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|4||88||FOLLOW-UP|1967-03-12||||1968-01-10||1965-01-15|1971-10-06|
TRIAL STUDY 134XCP|QS|CB3B9054-5CDC-418D-8071-7429B1702587|5|||||ASEX-FEMALE|||NMOL/KG/DAY|||CCID 50/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|5||7||CONTINUATION TREATMENT|1971-09-25||||1962-09-22||1964-04-24|1963-11-21|
TRIAL STUDY 134XCP|QS|1AC4DE34-3486-41FB-A979-8B368912F75A|1|||||MHIS-NACC|||/MM2|||IU/KG|NOT DONE||LIKERT SCALE 7-POINT|U|N|N|1||38||TREATMENT|1965-07-23||||1966-09-03||1968-09-08|1963-12-01|
TRIAL STUDY 134XCP|QS|1AC4DE34-3486-41FB-A979-8B368912F75A|2|||||FACT-P V4|||NMOL/L/MIN|||KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|2||58||OPEN LABEL TREATMENT|1968-01-14||||1960-01-02||1968-12-24|1960-09-24|
TRIAL STUDY 134XCP|QS|1AC4DE34-3486-41FB-A979-8B368912F75A|3|||||EPIC-26|||UG/ANIMAL|||/LPF|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|3||39||TREATMENT|1967-12-21||||1966-09-23||1962-05-30|1965-10-17|
TRIAL STUDY 134XCP|QS|1AC4DE34-3486-41FB-A979-8B368912F75A|4|||||FACT-B V4|||LINEAR FT*LB|||PKAT|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|4||88||OBSERVATION|1971-01-15||||1970-10-06||1973-02-06|1962-11-14|
TRIAL STUDY 134XCP|QS|1AC4DE34-3486-41FB-A979-8B368912F75A|5|||||FACT-BL V4|||KG|||/100 HPFS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|5||7||TREATMENT|1960-06-15||||1966-10-24||1969-01-01|1964-10-16|
TRIAL STUDY 134XCP|QS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||H*%|||DMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|Y|1||38||INDUCTION TREATMENT|1966-06-28||||1964-04-18||1973-02-02|1973-07-06|
TRIAL STUDY 134XCP|QS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2|||||BORG CR10|||MPA|||FMOL|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|2||58||INDUCTION TREATMENT|1962-03-02||||1969-07-02||1965-09-13|1968-07-06|
TRIAL STUDY 134XCP|QS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|3|||||FACT-LYM V4|||MOL|||MMOL/MIN/KPA|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|3||39||BASELINE|1962-12-23||||1961-08-03||1961-01-25|1967-11-13|
TRIAL STUDY 134XCP|QS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|4|||||WHODAS 2.0 - 36-ITEM PROXY|||CAPFUL|||10^9/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|4||88||SCREENING|1964-10-30||||1966-08-11||1973-05-12|1961-03-15|
TRIAL STUDY 134XCP|QS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|5|||||WOMAC NRS 3.1 INDEX|||CI/G|||LINEAR FT*LB|NOT DONE||LIKERT SCALE 7-POINT|U|Y|N|5||7||LONG-TERM FOLLOW-UP|1973-02-15||||1966-10-23||1972-06-08|1961-04-05|
TRIAL STUDY 134XCP|QS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1|||||ACT|||GBQ|||M3|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|1||38||RUN-IN|1964-05-15||||1970-05-28||1963-11-26|1963-12-22|
TRIAL STUDY 134XCP|QS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2|||||Q-LES-Q|||PA|||CY/CM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|N|2||58||BASELINE|1972-08-03||||1972-09-12||1962-02-13|1963-08-30|
TRIAL STUDY 134XCP|QS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|3|||||CHART-SF PAPER VERSION|||DPM/ML|||CARTRIDGE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|3||39||TREATMENT|1968-07-18||||1967-04-29||1973-01-18|1967-12-21|
TRIAL STUDY 134XCP|QS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|4|||||C-SSRS BASELINE/SCREENING VERSION|||KPA/L/SEC|||ML/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|4||88||OPEN LABEL TREATMENT|1960-10-31||||1967-05-11||1962-02-02|1971-09-01|
TRIAL STUDY 134XCP|QS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||U|||FARAD|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|5||7||SCREENING|1963-06-24||||1960-04-27||1970-08-05|1966-03-02|
TRIAL STUDY 134XCP|QS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||HZ/S|||BEL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|1||38||OPEN LABEL TREATMENT|1973-08-04||||1972-10-10||1967-06-07|1969-10-15|
TRIAL STUDY 134XCP|QS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2|||||PHQ-9|||/10^4|||MMOL/MIN/KPA|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|N|2||58||RUN-IN|1964-04-22||||1966-12-30||1964-12-14|1965-10-25|
TRIAL STUDY 134XCP|QS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|3|||||FIQR|||SCOOPFUL|||MMOL2/L2|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|3||39||WASHOUT|1970-10-18||||1966-08-06||1971-11-13|1965-09-01|
TRIAL STUDY 134XCP|QS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|4|||||ACT|||NG/L|||L/H|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|4||88||LONG-TERM FOLLOW-UP|1972-06-20||||1971-05-30||1967-01-31|1963-12-01|
TRIAL STUDY 134XCP|QS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|5|||||EXACT|||ML/MMHG/MIN/L|||DAYS/WK|NOT DONE||LIKERT SCALE 5-POINT|U|NA|N|5||7||INDUCTION TREATMENT|1970-08-25||||1963-04-17||1961-11-14|1969-04-26|
TRIAL STUDY 134XCP|QS|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1|||||FACT-TAXANE V4|||%|||U/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|1||38||OBSERVATION|1969-07-14||||1964-02-28||1960-05-03|1967-11-24|
TRIAL STUDY 134XCP|QS|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2|||||BEBQ RETROSPECTIVE|||STEPS|||AGU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|N|2||58||WASHOUT|1973-07-07||||1969-02-03||1961-10-28|1963-12-05|
TRIAL STUDY 134XCP|QS|0194CD2F-7ABE-4BEE-A6FC-61298880173D|3|||||GAD-7 V2|||PMOL/L/H|||ML/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|3||39||INDUCTION TREATMENT|1963-07-19||||1972-09-10||1967-05-22|1960-06-15|
TRIAL STUDY 134XCP|QS|0194CD2F-7ABE-4BEE-A6FC-61298880173D|4|||||ADCS-CGIC|||MEQ/DAY|||U/G HB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|4||88||CONTINUATION TREATMENT|1962-11-18||||1971-01-11||1972-11-13|1970-04-05|
TRIAL STUDY 134XCP|QS|0194CD2F-7ABE-4BEE-A6FC-61298880173D|5|||||WOMAC VA 3.1 INDEX|||MEQ/DAY|||10^9 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|U|5||7||LONG-TERM FOLLOW-UP|1961-10-26||||1963-09-20||1970-02-16|1961-04-20|
TRIAL STUDY 134XCP|QS|A6E531C7-1BC1-402E-9B2E-03B44313487B|1|||||COWS|||PIXEL|||AFU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|1||38||BLINDED TREATMENT|1963-02-06||||1961-01-06||1964-08-29|1966-11-17|
TRIAL STUDY 134XCP|QS|A6E531C7-1BC1-402E-9B2E-03B44313487B|2|||||SMDDS V1.0|||WAFER|||UMOL/L/H|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|U|2||58||CONTINUATION TREATMENT|1964-12-24||||1973-03-28||1964-10-06|1967-02-18|
TRIAL STUDY 134XCP|QS|A6E531C7-1BC1-402E-9B2E-03B44313487B|3|||||ADCS-CGIC|||G/CAGE/DAY|||UG/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|3||39||INDUCTION TREATMENT|1969-06-05||||1968-12-05||1971-01-22|1963-02-01|
TRIAL STUDY 134XCP|QS|A6E531C7-1BC1-402E-9B2E-03B44313487B|4|||||GMSS VERSION TYPE 1 DIABETES|||IU/L|||MMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|N|4||88||BLINDED TREATMENT|1968-02-12||||1961-08-26||1968-03-11|1965-12-27|
TRIAL STUDY 134XCP|QS|A6E531C7-1BC1-402E-9B2E-03B44313487B|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||UL/DOSE|||LOG10 IU/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|5||7||WASHOUT|1961-02-28||||1971-06-14||1970-06-13|1972-04-16|
TRIAL STUDY 134XCP|QS|47C0D833-BEAB-4BF2-B028-891808E729F1|1|||||FAQ-NACC VERSION|||WATT|||MPH|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|1||38||TREATMENT|1962-12-11||||1973-06-09||1972-05-07|1969-08-25|
TRIAL STUDY 134XCP|QS|47C0D833-BEAB-4BF2-B028-891808E729F1|2|||||PARENT-DDS|||10^6 ORGANISMS/ML|||1/(S*KPA)|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|N|2||58||BLINDED TREATMENT|1972-11-16||||1965-03-27||1962-01-29|1962-06-26|
TRIAL STUDY 134XCP|QS|47C0D833-BEAB-4BF2-B028-891808E729F1|3|||||C-SSRS ALREADY ENROLLED SUBJECTS|||VG/ML|||UCI/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|U|3||39||WASHOUT|1966-01-10||||1965-05-21||1965-10-15|1971-06-20|
TRIAL STUDY 134XCP|QS|47C0D833-BEAB-4BF2-B028-891808E729F1|4|||||COPD ASSESSMENT TEST|||UGEQ/L|||PG/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|4||88||BASELINE|1964-05-14||||1968-07-05||1970-01-16|1970-05-04|
TRIAL STUDY 134XCP|QS|47C0D833-BEAB-4BF2-B028-891808E729F1|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||P|||PNU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|5||7||FOLLOW-UP|1973-01-06||||1968-09-22||1966-05-29|1968-09-03|
TRIAL STUDY 134XCP|QS|BA1773BD-AA89-45FC-B7C6-C5267770B197|1|||||ADSD V1.0|||MU|||BISCUIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|1||38||TREATMENT|1961-08-27||||1968-07-14||1966-03-19|1968-09-12|
TRIAL STUDY 134XCP|QS|BA1773BD-AA89-45FC-B7C6-C5267770B197|2|||||MSIS-29 V1|||CI/KG|||10^6 DNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|2||58||OBSERVATION|1970-11-20||||1960-02-24||1972-08-06|1967-01-18|
TRIAL STUDY 134XCP|QS|BA1773BD-AA89-45FC-B7C6-C5267770B197|3|||||SF12 V2.0 ACUTE|||10^9 CFU|||KG|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|3||39||FOLLOW-UP|1966-07-19||||1963-02-17||1966-02-18|1962-05-31|
TRIAL STUDY 134XCP|QS|BA1773BD-AA89-45FC-B7C6-C5267770B197|4|||||CHART-SF INTERVIEW VERSION|||BQ/MG|||U/M2/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|4||88||BASELINE|1971-01-14||||1962-08-05||1962-07-03|1968-02-18|
TRIAL STUDY 134XCP|QS|BA1773BD-AA89-45FC-B7C6-C5267770B197|5|||||GCGI|||NEBULE|||BQ/MG|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|5||7||BASELINE|1964-07-30||||1961-10-27||1961-11-29|1973-02-10|
TRIAL STUDY 134XCP|QS|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1|||||GDS|||CARTRIDGE|||CM2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|1||38||WASHOUT|1968-04-27||||1968-05-13||1965-12-28|1969-05-07|
TRIAL STUDY 134XCP|QS|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2|||||COWS|||ML/MMHG/MIN/L|||FT|NOT DONE||LIKERT SCALE 5-POINT|U|N|U|2||58||SCREENING|1964-08-23||||1965-12-12||1961-04-23|1970-03-29|
TRIAL STUDY 134XCP|QS|03D3DDC6-03FA-469A-B8A4-D504919B68F1|3|||||EORTC QLQ-C30 V3.0|||FFU|||STEPS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|N|3||39||LONG-TERM FOLLOW-UP|1968-01-10||||1970-04-26||1965-01-05|1971-04-21|
TRIAL STUDY 134XCP|QS|03D3DDC6-03FA-469A-B8A4-D504919B68F1|4|||||ACT|||U/CL|||MMOL/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|4||88||SCREENING|1967-11-03||||1968-03-21||1962-11-06|1972-03-07|
TRIAL STUDY 134XCP|QS|03D3DDC6-03FA-469A-B8A4-D504919B68F1|5|||||OAB-Q SHORT FORM|||MEQ/G|||ML/M2/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|5||7||OBSERVATION|1972-04-03||||1965-10-31||1966-09-18|1960-09-05|
TRIAL STUDY 134XCP|QS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1|||||GAD-7 V2|||CFU/G|||10^9 CFU/G|NOT DONE||LIKERT SCALE 5-POINT|Y|U|N|1||38||SCREENING|1970-09-01||||1963-06-19||1972-10-13|1961-10-03|
TRIAL STUDY 134XCP|QS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2|||||ANSD V1.0|||FT2|||LOG10 CCID 50/DOSE|NOT DONE||LIKERT SCALE 7-POINT|NA|N|Y|2||58||CONTINUATION TREATMENT|1964-04-21||||1970-08-17||1973-07-30|1971-12-25|
TRIAL STUDY 134XCP|QS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||CPM|||CARTRIDGE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|3||39||INDUCTION TREATMENT|1962-04-04||||1967-11-25||1960-12-20|1968-05-04|
TRIAL STUDY 134XCP|QS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|4|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||F|||10^9 CFU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|4||88||BLINDED TREATMENT|1970-02-01||||1962-08-14||1966-05-25|1970-10-19|
TRIAL STUDY 134XCP|QS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|5|||||AUDIT-SR|||QUANTITY SUFFICIENT|||KAT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|5||7||CONTINUATION TREATMENT|1972-08-27||||1970-05-14||1962-06-17|1972-10-22|
TRIAL STUDY 134XCP|QS|1873D4CC-40B7-4303-9F07-8FE0E4595361|1|||||CES|||GRAIN|||PMOL/DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|1||38||TREATMENT|1962-02-14||||1966-07-06||1971-11-07|1971-02-27|
TRIAL STUDY 134XCP|QS|1873D4CC-40B7-4303-9F07-8FE0E4595361|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||10^12 IU/L|||CAPFUL|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|2||58||OBSERVATION|1965-05-29||||1971-12-30||1972-01-09|1960-08-03|
TRIAL STUDY 134XCP|QS|1873D4CC-40B7-4303-9F07-8FE0E4595361|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||LOG10 CFU/ML|||NMOL/L|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|NA|3||39||FOLLOW-UP|1969-02-16||||1969-08-13||1970-07-09|1967-08-31|
TRIAL STUDY 134XCP|QS|1873D4CC-40B7-4303-9F07-8FE0E4595361|4|||||IDS-SR|||MBP|||FFU|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|4||88||RUN-IN|1971-10-28||||1969-05-25||1962-12-26|1968-11-29|
TRIAL STUDY 134XCP|QS|1873D4CC-40B7-4303-9F07-8FE0E4595361|5|||||SOAPP-R|||BQ/MG|||U/MG|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|NA|5||7||OPEN LABEL TREATMENT|1965-10-15||||1963-09-10||1970-03-25|1970-04-14|
TRIAL STUDY 134XCP|QS|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1|||||IDS-SR|||G/L|||G/M2/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|N|U|1||38||LONG-TERM FOLLOW-UP|1971-12-20||||1964-08-10||1964-02-06|1963-04-26|
TRIAL STUDY 134XCP|QS|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2|||||SF10 V1.0 CHILDREN ACUTE|||COAT|||ML/M2/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|U|2||58||CONTINUATION TREATMENT|1968-02-02||||1965-04-24||1960-08-06|1972-10-20|
TRIAL STUDY 134XCP|QS|23E5569E-B324-4399-AC8A-5EC7C343C1D3|3|||||MMRC|||U/G/DAY|||LM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|3||39||FOLLOW-UP|1966-10-02||||1960-11-14||1960-01-31|1964-06-15|
TRIAL STUDY 134XCP|QS|23E5569E-B324-4399-AC8A-5EC7C343C1D3|4|||||FACT-LYM V4|||UMOL/MIN|||NMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|U|4||88||RUN-IN|1961-03-31||||1973-07-21||1970-03-23|1965-06-11|
TRIAL STUDY 134XCP|QS|23E5569E-B324-4399-AC8A-5EC7C343C1D3|5|||||PDQUALIF|||BLOCKS|||MMOL/G|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|U|5||7||INDUCTION TREATMENT|1967-04-02||||1961-09-13||1972-03-19|1972-09-16|
TRIAL STUDY 134XCP|QS|B349DD89-C41F-470E-8B54-B3589F0982FE|1|||||COMM|||UMOL/L/MIN|||BEATS/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|NA|1||38||TREATMENT|1967-02-17||||1962-02-21||1972-10-19|1971-12-02|
TRIAL STUDY 134XCP|QS|B349DD89-C41F-470E-8B54-B3589F0982FE|2|||||WOMAC LK 3.1 INDEX|||NMOL|||MMOL/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|N|2||58||INDUCTION TREATMENT|1962-09-29||||1963-08-31||1966-10-17|1970-08-14|
TRIAL STUDY 134XCP|QS|B349DD89-C41F-470E-8B54-B3589F0982FE|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||MV/SEC|||%(V/V)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|3||39||INDUCTION TREATMENT|1960-09-22||||1969-03-03||1960-12-07|1966-01-01|
TRIAL STUDY 134XCP|QS|B349DD89-C41F-470E-8B54-B3589F0982FE|4|||||C-SSRS SINCE LAST VISIT|||TESLA|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|4||88||BASELINE|1964-09-27||||1972-02-18||1969-11-26|1964-02-14|
TRIAL STUDY 134XCP|QS|B349DD89-C41F-470E-8B54-B3589F0982FE|5|||||COMM|||LOG10 TCID 50/ML|||UMOL/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|5||7||INDUCTION TREATMENT|1961-11-19||||1972-02-16||1961-09-03|1960-03-26|
TRIAL STUDY 134XCP|QS|415D178A-275A-440C-8617-154441A48F8D|1|||||WHODAS 2.0 - 36-ITEM SELF|||L/DAY|||WEBER|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|1||38||RUN-IN|1972-02-07||||1972-10-12||1968-11-17|1970-08-24|
TRIAL STUDY 134XCP|QS|415D178A-275A-440C-8617-154441A48F8D|2|||||SF12 V1.0 ACUTE|||10^6 ORGANISMS|||LOG10 TCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|2||58||LONG-TERM FOLLOW-UP|1969-10-27||||1965-11-04||1964-08-16|1963-06-16|
TRIAL STUDY 134XCP|QS|415D178A-275A-440C-8617-154441A48F8D|3|||||IPAQ-LF SELF-ADMINISTERED VERSION|||CM/S|||CAPLET|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|3||39||TREATMENT|1963-06-12||||1970-06-13||1966-03-29|1960-08-29|
TRIAL STUDY 134XCP|QS|415D178A-275A-440C-8617-154441A48F8D|4|||||ACQ|||UG/ANIMAL|||DNA COPIES/UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|4||88||LONG-TERM FOLLOW-UP|1969-07-09||||1969-08-03||1962-08-09|1971-03-30|
TRIAL STUDY 134XCP|QS|415D178A-275A-440C-8617-154441A48F8D|5|||||CDLQ|||KCAL|||MG/G/H|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|5||7||CONTINUATION TREATMENT|1971-05-15||||1960-11-21||1971-10-11|1964-06-23|
TRIAL STUDY 134XCP|QS|C23917E6-6CA5-4314-A59D-A0298483BF53|1|||||GDS SHORT FORM|||STEPS|||UG/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|N|1||38||OPEN LABEL TREATMENT|1968-11-12||||1970-09-11||1969-03-31|1971-06-02|
TRIAL STUDY 134XCP|QS|C23917E6-6CA5-4314-A59D-A0298483BF53|2|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||MV2/HZ|||KS|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|2||58||FOLLOW-UP|1962-01-23||||1960-09-06||1973-04-25|1960-08-11|
TRIAL STUDY 134XCP|QS|C23917E6-6CA5-4314-A59D-A0298483BF53|3|||||WPAI-SHP V2.0|||UG/L FEU|||HR/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|NA|3||39||SCREENING|1969-08-01||||1970-05-29||1967-06-22|1973-03-06|
TRIAL STUDY 134XCP|QS|C23917E6-6CA5-4314-A59D-A0298483BF53|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||QUANTITY SUFFICIENT|||10^9 ORGANISMS|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|4||88||RUN-IN|1960-11-02||||1971-03-11||1969-11-07|1966-06-04|
TRIAL STUDY 134XCP|QS|C23917E6-6CA5-4314-A59D-A0298483BF53|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||MMOL2/L2|||SEC|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|5||7||LONG-TERM FOLLOW-UP|1961-02-10||||1961-12-28||1965-07-30|1961-12-10|
TRIAL STUDY 134XCP|QS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1|||||QIDS-SR|||HZ|||MKAT|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|1||38||WASHOUT|1970-09-06||||1969-04-15||1972-10-18|1971-02-03|
TRIAL STUDY 134XCP|QS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2|||||PDDS|||U/G/H|||GMFI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|Y|2||58||LONG-TERM FOLLOW-UP|1968-03-05||||1966-01-20||1971-12-25|1973-01-12|
TRIAL STUDY 134XCP|QS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|3|||||WHODAS 2.0 - 36-ITEM PROXY|||KG/CM|||ML/S/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|3||39||INDUCTION TREATMENT|1969-05-06||||1967-08-05||1968-10-15|1963-08-18|
TRIAL STUDY 134XCP|QS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||USIEMENS|||UG/CM2|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|4||88||LONG-TERM FOLLOW-UP|1960-02-07||||1969-06-22||1963-07-03|1968-12-09|
TRIAL STUDY 134XCP|QS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|5|||||FACIT-DYSPNEA 33 ITEM BANK|||MG/KG/MIN|||PNU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|N|5||7||LONG-TERM FOLLOW-UP|1972-12-17||||1969-05-29||1966-06-04|1966-04-20|
TRIAL STUDY 134XCP|QS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1|||||GAD-7 V2|||PLUG|||ML/CM3/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|U|1||38||FOLLOW-UP|1962-09-09||||1966-05-24||1969-11-27|1967-03-01|
TRIAL STUDY 134XCP|QS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||UU/DL|||MG/KG/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|2||58||TREATMENT|1970-08-09||||1970-05-09||1969-07-06|1969-11-21|
TRIAL STUDY 134XCP|QS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|3|||||VFQ-25 INTERVIEWER ADMINISTERED|||IU/DAY|||EJACULATE U|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|3||39||WASHOUT|1973-02-27||||1960-05-17||1964-02-20|1969-02-07|
TRIAL STUDY 134XCP|QS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|4|||||BIS-11|||GAUSS|||UMOL|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|4||88||INDUCTION TREATMENT|1963-02-24||||1966-01-01||1969-08-03|1964-05-20|
TRIAL STUDY 134XCP|QS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|5|||||NCCN-FACT FPSI-17 V2|||DEG/MM|||FFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|5||7||FOLLOW-UP|1963-09-23||||1968-02-03||1967-07-26|1972-12-12|
TRIAL STUDY 134XCP|QS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1|||||NPI|||MU/G|||/HPF|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|1||38||TREATMENT|1965-02-07||||1971-08-25||1963-01-22|1965-06-07|
TRIAL STUDY 134XCP|QS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2|||||FACT-BMT V4|||DPM/ML|||IU/KG/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|N|2||58||TREATMENT|1969-12-19||||1960-07-17||1971-11-29|1973-06-22|
TRIAL STUDY 134XCP|QS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|3|||||ADCS-CGIC|||MNFI|||KAT|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|NA|3||39||LONG-TERM FOLLOW-UP|1972-06-26||||1965-11-16||1973-03-23|1962-05-09|
TRIAL STUDY 134XCP|QS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|4|||||WLQ|||KDA|||10^9 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|U|4||88||SCREENING|1966-08-22||||1971-10-15||1972-05-29|1970-11-22|
TRIAL STUDY 134XCP|QS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|5|||||BORG CR10|||BU/ML|||UMOL/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1966-04-09||||1969-03-16||1960-10-25|1962-09-12|
TRIAL STUDY 134XCP|QS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1|||||DLQI|||UG/G/MIN|||10^9/DOSE|NOT DONE||LIKERT SCALE 7-POINT|N|NA|Y|1||38||LONG-TERM FOLLOW-UP|1969-04-10||||1972-09-30||1962-04-08|1971-04-03|
TRIAL STUDY 134XCP|QS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||IU/KG/H|||MG/CM2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|NA|2||58||TREATMENT|1971-09-05||||1968-08-17||1973-03-27|1967-10-20|
TRIAL STUDY 134XCP|QS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|3|||||SF12 V2.0 STANDARD|||MDFI|||MG/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|3||39||OBSERVATION|1962-10-14||||1961-07-02||1971-02-10|1970-05-17|
TRIAL STUDY 134XCP|QS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|4|||||SF36 V1.0 ACUTE|||FT3|||KM/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|U|4||88||TREATMENT|1969-03-14||||1971-09-10||1960-11-07|1967-10-19|
TRIAL STUDY 134XCP|QS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|5|||||FIQR|||UG/DL|||PLUG|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|NA|5||7||FOLLOW-UP|1965-01-23||||1961-10-05||1968-11-16|1966-07-19|
TRIAL STUDY 134XCP|QS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1|||||BARS|||UG/DL|||SIEMENS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|1||38||TREATMENT|1969-09-14||||1972-02-12||1967-03-03|1960-08-17|
TRIAL STUDY 134XCP|QS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2|||||MNSI|||MMOL/MIN/KPA/L|||CARTRIDGE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|2||58||SCREENING|1967-10-01||||1970-02-04||1973-04-02|1963-06-25|
TRIAL STUDY 134XCP|QS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|3|||||SIQR|||NMOL BCE/L|||EIA UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|3||39||SCREENING|1966-07-30||||1966-08-27||1964-04-09|1968-09-02|
TRIAL STUDY 134XCP|QS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|4|||||WOMAC LK 3.1 INDEX|||DEG2|||UCI/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|4||88||OBSERVATION|1970-07-14||||1970-10-07||1969-09-20|1969-09-19|
TRIAL STUDY 134XCP|QS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|5|||||FACT-COG V3|||M/SEC2|||M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|5||7||OPEN LABEL TREATMENT|1961-04-13||||1967-12-24||1960-01-04|1969-01-26|
TRIAL STUDY 134XCP|QS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1|||||PHQ-2|||DL|||TBSP|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|NA|1||38||RUN-IN|1969-02-14||||1967-01-12||1960-02-03|1973-02-26|
TRIAL STUDY 134XCP|QS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2|||||PHQ-2|||MET*MIN|||KG/CM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|2||58||WASHOUT|1961-08-20||||1966-04-19||1966-08-18|1965-12-08|
TRIAL STUDY 134XCP|QS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||CMH2O*S2/ML|||MG/M2|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|3||39||BASELINE|1970-03-19||||1971-05-05||1965-05-07|1968-12-04|
TRIAL STUDY 134XCP|QS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|4|||||MADRS|||MMHG*MIN/L|||ML/BREATH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|NA|4||88||FOLLOW-UP|1972-08-29||||1960-10-28||1964-04-06|1968-02-25|
TRIAL STUDY 134XCP|QS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|5|||||FACT-L V4|||BEATS/MIN|||MOSM/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|5||7||BLINDED TREATMENT|1971-10-17||||1970-08-12||1971-07-19|1961-02-27|
TRIAL STUDY 134XCP|QS|EDB6B55B-7903-4F89-805C-32F067C2A230|1|||||WOMAC VA 3.1 INDEX|||MG/ML/DAY|||IU/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|1||38||INDUCTION TREATMENT|1964-08-24||||1972-09-23||1960-09-25|1972-03-29|
TRIAL STUDY 134XCP|QS|EDB6B55B-7903-4F89-805C-32F067C2A230|2|||||FACT-C V4|||FL|||10^7 TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|2||58||BLINDED TREATMENT|1962-05-13||||1973-04-29||1967-12-16|1963-03-12|
TRIAL STUDY 134XCP|QS|EDB6B55B-7903-4F89-805C-32F067C2A230|3|||||IPAQ-LF SELF-ADMINISTERED VERSION|||PRESSOR UNITS|||G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|3||39||OPEN LABEL TREATMENT|1960-12-12||||1964-12-17||1967-10-05|1968-03-15|
TRIAL STUDY 134XCP|QS|EDB6B55B-7903-4F89-805C-32F067C2A230|4|||||AQLQ|||TROCHE|||G/G/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|N|4||88||LONG-TERM FOLLOW-UP|1963-11-14||||1965-11-04||1968-03-30|1972-02-04|
TRIAL STUDY 134XCP|QS|EDB6B55B-7903-4F89-805C-32F067C2A230|5|||||Q-LES-Q-SF|||MU|||KIU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|5||7||BLINDED TREATMENT|1973-07-03||||1965-03-04||1970-06-30|1962-10-17|
TRIAL STUDY 134XCP|QS|8F6772DE-E4CA-4706-8754-740D3859ABDF|1|||||EORTC QLQ-C15-PAL V1.0|||NM|||MMOL/MIN/KPA/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|U|1||38||INDUCTION TREATMENT|1969-09-21||||1969-05-14||1965-11-27|1969-03-21|
TRIAL STUDY 134XCP|QS|8F6772DE-E4CA-4706-8754-740D3859ABDF|2|||||FACIT-FATIGUE 13-ITEM V4|||APS U|||MG/G/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|2||58||TREATMENT|1967-01-03||||1967-01-03||1961-12-10|1960-12-23|
TRIAL STUDY 134XCP|QS|8F6772DE-E4CA-4706-8754-740D3859ABDF|3|||||NPI|||STRIP|||DPM|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|3||39||SCREENING|1962-07-01||||1966-02-17||1960-12-14|1965-06-24|
TRIAL STUDY 134XCP|QS|8F6772DE-E4CA-4706-8754-740D3859ABDF|4|||||ESS|||L/KG|||MOSM/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|4||88||BLINDED TREATMENT|1965-04-14||||1962-08-28||1963-06-06|1972-07-28|
TRIAL STUDY 134XCP|QS|8F6772DE-E4CA-4706-8754-740D3859ABDF|5|||||PODCI - PEDIATRIC PARENT REPORTED|||10^6 RNA COPIES/ML|||KBQ|NOT DONE||LIKERT SCALE 3-POINT|U|U|NA|5||7||FOLLOW-UP|1969-03-04||||1969-10-10||1962-10-01|1965-06-17|
TRIAL STUDY 134XCP|QS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1|||||PDDS|||UG/G/MIN|||PFU/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|NA|1||38||RUN-IN|1969-01-21||||1969-01-30||1961-08-09|1969-11-26|
TRIAL STUDY 134XCP|QS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2|||||NCCN-FACT FBRSI-24 V2|||CARTRIDGE|||GPS U|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|Y|2||58||INDUCTION TREATMENT|1964-06-02||||1966-03-17||1962-10-22|1964-05-13|
TRIAL STUDY 134XCP|QS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||MEQ/G|||RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|3||39||LONG-TERM FOLLOW-UP|1968-04-16||||1964-08-02||1961-11-26|1969-09-11|
TRIAL STUDY 134XCP|QS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|4|||||HCS|||RFU|||L/MIN|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|4||88||OBSERVATION|1973-06-21||||1972-01-14||1963-03-27|1969-09-01|
TRIAL STUDY 134XCP|QS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|5|||||SDS|||%(W/V)|||RAD|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|5||7||OPEN LABEL TREATMENT|1962-04-04||||1964-02-13||1968-05-06|1973-05-03|
TRIAL STUDY 134XCP|QS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1|||||SGRQ-C|||NKAT/G HB|||ML/KG/H|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|1||38||RUN-IN|1966-06-06||||1967-03-25||1961-09-23|1962-02-21|
TRIAL STUDY 134XCP|QS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2|||||UPDRS|||M3|||ANTI-XA IU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|2||58||FOLLOW-UP|1960-06-24||||1961-11-18||1967-06-02|1962-08-30|
TRIAL STUDY 134XCP|QS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|3|||||SF36 V2.0 ACUTE|||MU/L|||LOG10 PFU|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|3||39||SCREENING|1973-04-01||||1972-02-04||1966-10-31|1960-01-19|
TRIAL STUDY 134XCP|QS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|4|||||SF10 V1.0 CHILDREN ACUTE|||FMOL/G|||CMHG|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|4||88||WASHOUT|1968-02-24||||1962-06-07||1966-12-06|1965-05-25|
TRIAL STUDY 134XCP|QS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|5|||||PDQUALIF|||CUP EQ|||U/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|5||7||TREATMENT|1961-12-09||||1965-09-29||1966-12-02|1972-06-17|
TRIAL STUDY 134XCP|QS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1|||||EQ-5D-5L|||ML/DAY|||ML|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|1||38||SCREENING|1968-06-22||||1962-02-28||1961-06-21|1967-08-05|
TRIAL STUDY 134XCP|QS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||MMHG/SEC|||F|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|2||58||TREATMENT|1968-10-13||||1961-05-18||1973-07-21|1969-10-06|
TRIAL STUDY 134XCP|QS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||KPA/L/SEC|||PIXELS/IN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|NA|3||39||BLINDED TREATMENT|1960-12-13||||1967-05-11||1964-08-09|1965-10-13|
TRIAL STUDY 134XCP|QS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||RAD|||10^7 TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|U|4||88||RUN-IN|1961-09-13||||1969-09-27||1971-06-22|1970-05-29|
TRIAL STUDY 134XCP|QS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|5|||||IPAQ-LF PHONE VERSION|||MMOL/MOL|||DNA COPIES/ML|NOT DONE||LIKERT SCALE 7-POINT|N|NA|Y|5||7||BASELINE|1972-03-23||||1967-11-23||1965-10-21|1960-11-12|
TRIAL STUDY 134XCP|QS|B3987A78-0D92-419D-A289-039C87C6C202|1|||||FACT-G V4|||RING|||MCI|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|1||38||FOLLOW-UP|1964-08-21||||1972-01-19||1971-05-05|1960-12-11|
TRIAL STUDY 134XCP|QS|B3987A78-0D92-419D-A289-039C87C6C202|2|||||FIQR|||10^3 ORGANISMS/ML|||DNA COPIES/UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|N|2||58||RUN-IN|1964-05-26||||1971-12-30||1960-10-25|1965-08-17|
TRIAL STUDY 134XCP|QS|B3987A78-0D92-419D-A289-039C87C6C202|3|||||TSCC|||DPM/100MG|||MONTHS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|3||39||TREATMENT|1963-07-27||||1961-03-08||1966-04-03|1963-09-13|
TRIAL STUDY 134XCP|QS|B3987A78-0D92-419D-A289-039C87C6C202|4|||||HAEM-A-QOL|||IN2|||IU/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|Y|4||88||SCREENING|1964-06-29||||1960-10-07||1971-01-02|1964-12-28|
TRIAL STUDY 134XCP|QS|B3987A78-0D92-419D-A289-039C87C6C202|5|||||C-SSRS ALREADY ENROLLED SUBJECTS|||UKAT|||GBQ/G|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|5||7||RUN-IN|1973-02-01||||1968-07-20||1971-03-20|1966-04-18|
TRIAL STUDY 134XCP|QS|2A0D27D8-EC46-4B40-B1BB-078268E03355|1|||||UPS|||MM/2H|||/500 WBC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|1||38||RUN-IN|1960-10-15||||1970-01-06||1972-12-25|1963-11-24|
TRIAL STUDY 134XCP|QS|2A0D27D8-EC46-4B40-B1BB-078268E03355|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||CYCLE/MIN|||%(W/V)|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|2||58||OBSERVATION|1973-05-09||||1962-05-10||1963-08-17|1963-03-17|
TRIAL STUDY 134XCP|QS|2A0D27D8-EC46-4B40-B1BB-078268E03355|3|||||WOMAC VA 3.1 INDEX|||PA|||CMOL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|3||39||OPEN LABEL TREATMENT|1970-06-04||||1963-01-30||1963-02-07|1961-05-29|
TRIAL STUDY 134XCP|QS|2A0D27D8-EC46-4B40-B1BB-078268E03355|4|||||ASEX-FEMALE|||% INHIBITION|||UG|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|4||88||SCREENING|1965-08-20||||1968-01-25||1963-02-10|1970-08-12|
TRIAL STUDY 134XCP|QS|2A0D27D8-EC46-4B40-B1BB-078268E03355|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||DRAM|||PIXEL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|N|5||7||SCREENING|1963-05-17||||1966-09-20||1968-03-04|1967-04-21|
TRIAL STUDY 134XCP|QS|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1|||||C-SSRS BASELINE|||CCID 50/DOSE|||KM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|1||38||BLINDED TREATMENT|1972-04-25||||1971-06-26||1964-07-25|1965-05-13|
TRIAL STUDY 134XCP|QS|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2|||||PDDS|||GPL U/ML|||NG/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|U|2||58||BLINDED TREATMENT|1960-07-27||||1971-03-11||1966-06-04|1967-07-03|
TRIAL STUDY 134XCP|QS|65EBB2AF-B97A-403A-9FB5-31C1559074C4|3|||||BLCS|||/MM2|||ANSON U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|3||39||BLINDED TREATMENT|1964-09-29||||1963-04-18||1968-08-02|1962-09-09|
TRIAL STUDY 134XCP|QS|65EBB2AF-B97A-403A-9FB5-31C1559074C4|4|||||C-SSRS LIFETIME/RECENT VERSION|||HENRY|||DPM/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|4||88||CONTINUATION TREATMENT|1961-08-23||||1964-07-13||1966-01-16|1960-10-30|
TRIAL STUDY 134XCP|QS|65EBB2AF-B97A-403A-9FB5-31C1559074C4|5|||||SHORT-FORM MPQ-2|||S*KPA|||FRACTION OF 1|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|5||7||WASHOUT|1960-07-06||||1964-08-31||1972-03-28|1960-10-06|
TRIAL STUDY 134XCP|QS|90892428-99C3-4E7D-B3A8-3C526812EDD2|1|||||FACT-B V4|||10^7 CFU|||MV*MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|1||38||OBSERVATION|1964-03-28||||1972-09-28||1964-07-05|1967-06-06|
TRIAL STUDY 134XCP|QS|90892428-99C3-4E7D-B3A8-3C526812EDD2|2|||||RPQ|||10^7 CFU/ML|||APL U/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|2||58||OBSERVATION|1969-12-18||||1968-07-17||1961-07-27|1966-05-17|
TRIAL STUDY 134XCP|QS|90892428-99C3-4E7D-B3A8-3C526812EDD2|3|||||FACT-HEP V4|||IMPLANT|||CARTRIDGE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|3||39||OPEN LABEL TREATMENT|1963-01-11||||1970-04-21||1970-11-05|1965-03-03|
TRIAL STUDY 134XCP|QS|90892428-99C3-4E7D-B3A8-3C526812EDD2|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||10^9/DOSE|||MESF|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|NA|4||88||WASHOUT|1972-03-11||||1969-12-14||1965-03-05|1962-01-16|
TRIAL STUDY 134XCP|QS|90892428-99C3-4E7D-B3A8-3C526812EDD2|5|||||PODCI - ADOLESCENT SELF REPORTED|||IU/DAY|||EJACULATE U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|5||7||SCREENING|1966-11-05||||1963-05-11||1962-11-08|1971-01-05|
TRIAL STUDY 134XCP|QS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1|||||SDS|||MMOL/DAY|||MBP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|Y|1||38||RUN-IN|1967-02-07||||1960-02-06||1965-09-21|1968-07-07|
TRIAL STUDY 134XCP|QS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2|||||FACT/GOG-NTX V4|||CI/UG|||AMPULE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|NA|2||58||WASHOUT|1963-04-16||||1965-03-29||1972-09-15|1970-03-01|
TRIAL STUDY 134XCP|QS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|3|||||PR|||CMHG|||GRAVITATIONAL UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|3||39||INDUCTION TREATMENT|1970-11-30||||1971-01-21||1965-06-25|1962-08-01|
TRIAL STUDY 134XCP|QS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|4|||||SOBDA|||ML/KG/MIN|||BQ|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|4||88||BASELINE|1968-09-10||||1969-09-30||1968-07-07|1962-04-30|
TRIAL STUDY 134XCP|QS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|5|||||SF36 V2.0 ACUTE|||MEQ/UL|||KHZ|NOT DONE||LIKERT SCALE 3-POINT|N|U|Y|5||7||INDUCTION TREATMENT|1965-10-25||||1967-03-24||1969-02-05|1961-04-23|
TRIAL STUDY 134XCP|QS|2B443EEA-B98B-47D9-8D27-801582804AB5|1|||||FACT-BMT V4|||/2500 WBC|||ML/ANIMAL/WK|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|NA|1||38||TREATMENT|1964-01-23||||1960-04-26||1971-12-12|1960-10-18|
TRIAL STUDY 134XCP|QS|2B443EEA-B98B-47D9-8D27-801582804AB5|2|||||NPS|||CL|||10^3/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|Y|2||58||SCREENING|1967-01-11||||1961-07-11||1964-08-07|1969-04-09|
TRIAL STUDY 134XCP|QS|2B443EEA-B98B-47D9-8D27-801582804AB5|3|||||DRRI-2|||UV|||UL|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|3||39||SCREENING|1970-12-26||||1973-06-13||1962-10-02|1965-12-30|
TRIAL STUDY 134XCP|QS|2B443EEA-B98B-47D9-8D27-801582804AB5|4|||||GOSE|||AG|||PM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|4||88||BASELINE|1962-05-28||||1970-06-17||1960-09-19|1969-01-26|
TRIAL STUDY 134XCP|QS|2B443EEA-B98B-47D9-8D27-801582804AB5|5|||||MSIS-29 V1|||FOZ_US|||10^6 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|NA|5||7||SCREENING|1973-09-02||||1968-09-26||1960-03-23|1966-06-11|
TRIAL STUDY 134XCP|QS|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1|||||ADCS-ADL MCI|||ML/MMHG/MIN/L|||UEQ/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|Y|1||38||FOLLOW-UP|1970-06-21||||1965-08-13||1973-01-28|1960-05-11|
TRIAL STUDY 134XCP|QS|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2|||||FACIT-F V4|||MMHG/SEC|||SBE/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|Y|2||58||FOLLOW-UP|1970-10-06||||1961-06-07||1969-02-07|1968-03-10|
TRIAL STUDY 134XCP|QS|0278D57A-30D6-4B7A-A45C-EB973F6686C6|3|||||EPIC-CP|||10^6/G|||ML/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|Y|3||39||FOLLOW-UP|1971-04-26||||1963-05-13||1971-03-25|1966-12-25|
TRIAL STUDY 134XCP|QS|0278D57A-30D6-4B7A-A45C-EB973F6686C6|4|||||MSIS-29 V1|||MPS U|||MPA|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|Y|4||88||RUN-IN|1960-11-27||||1970-04-07||1965-03-28|1971-10-13|
TRIAL STUDY 134XCP|QS|0278D57A-30D6-4B7A-A45C-EB973F6686C6|5|||||NPI|||LOZENGE|||NKAT/G HB|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|N|5||7||INDUCTION TREATMENT|1968-03-10||||1966-08-05||1960-03-01|1963-07-22|
TRIAL STUDY 134XCP|QS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1|||||FBRSI|||10^6 ORGANISMS|||% INHIBITION|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|1||38||INDUCTION TREATMENT|1971-03-19||||1966-08-19||1969-11-23|1962-04-01|
TRIAL STUDY 134XCP|QS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2|||||SOAPP-R|||GPS U|||LX|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|Y|2||58||SCREENING|1966-09-23||||1961-06-23||1965-04-27|1970-08-24|
TRIAL STUDY 134XCP|QS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|3|||||MRS|||100 IU/ML|||GBQ/G|NOT DONE||LIKERT SCALE 3-POINT|N|Y|Y|3||39||BLINDED TREATMENT|1972-09-19||||1961-03-09||1973-04-24|1961-03-08|
TRIAL STUDY 134XCP|QS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||MG/ANIMAL|||IU/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|Y|4||88||INDUCTION TREATMENT|1967-04-24||||1963-02-04||1960-07-24|1965-01-24|
TRIAL STUDY 134XCP|QS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|5|||||MDS-UPDRS|||%(W/W)|||DDU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|5||7||CONTINUATION TREATMENT|1967-09-18||||1964-01-27||1960-05-25|1966-11-23|
TRIAL STUDY 134XCP|QS|67D6A191-10C7-4414-BA63-DB7701998DF0|1|||||PHQ-2|||MNFI|||ENZYME U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|1||38||FOLLOW-UP|1970-11-11||||1971-03-20||1966-07-05|1965-04-27|
TRIAL STUDY 134XCP|QS|67D6A191-10C7-4414-BA63-DB7701998DF0|2|||||PSQI|||EJACULATE U|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|2||58||OBSERVATION|1965-02-03||||1968-04-24||1961-10-01|1971-06-20|
TRIAL STUDY 134XCP|QS|67D6A191-10C7-4414-BA63-DB7701998DF0|3|||||MSQOL-54|||U/G|||UM|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|3||39||CONTINUATION TREATMENT|1965-05-26||||1971-06-17||1960-11-21|1971-02-23|
TRIAL STUDY 134XCP|QS|67D6A191-10C7-4414-BA63-DB7701998DF0|4|||||FACT-BMT V4|||BEATS/MIN|||KBQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|4||88||OPEN LABEL TREATMENT|1961-04-06||||1967-09-19||1961-04-23|1964-07-20|
TRIAL STUDY 134XCP|QS|67D6A191-10C7-4414-BA63-DB7701998DF0|5|||||WPAI-SHP V2.0|||POUCH|||IN2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|5||7||LONG-TERM FOLLOW-UP|1966-12-10||||1962-12-14||1967-08-16|1971-12-17|
TRIAL STUDY 134XCP|QS|499B5A47-893A-40DE-9B64-60967378C81A|1|||||BPI SHORT FORM|||ML/100G/MIN|||MOSM/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|1||38||BLINDED TREATMENT|1973-02-27||||1971-01-11||1971-06-02|1972-04-08|
TRIAL STUDY 134XCP|QS|499B5A47-893A-40DE-9B64-60967378C81A|2|||||FLU-IIQ ONCE DAILY|||GBQ/G|||IU/MG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|U|2||58||SCREENING|1969-09-07||||1963-09-29||1965-07-16|1960-12-20|
TRIAL STUDY 134XCP|QS|499B5A47-893A-40DE-9B64-60967378C81A|3|||||FACT-P V4|||G/G/DAY|||FT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|3||39||BLINDED TREATMENT|1971-11-20||||1967-01-29||1966-11-06|1972-06-14|
TRIAL STUDY 134XCP|QS|499B5A47-893A-40DE-9B64-60967378C81A|4|||||FACT/GOG-NTX V4|||ML/KG/H|||CM/S|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|4||88||TREATMENT|1967-06-15||||1965-03-22||1969-06-03|1972-07-27|
TRIAL STUDY 134XCP|QS|499B5A47-893A-40DE-9B64-60967378C81A|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||CMH2O*S/ML|||ML/M2/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|Y|5||7||OBSERVATION|1970-12-07||||1965-05-23||1971-08-14|1969-04-16|
TRIAL STUDY 134XCP|QS|984103CA-F301-4510-A9DD-4916FA858EA2|1|||||NCCN-FACT FPSI-17 V2|||ENZYME U/L|||CIGAR|NOT DONE||LIKERT SCALE 3-POINT|N|Y|NA|1||38||BASELINE|1966-09-24||||1970-05-19||1971-05-21|1962-05-26|
TRIAL STUDY 134XCP|QS|984103CA-F301-4510-A9DD-4916FA858EA2|2|||||PCL-5|||UM/S|||PIXEL|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|Y|2||58||SCREENING|1964-12-11||||1962-01-10||1966-12-30|1966-12-27|
TRIAL STUDY 134XCP|QS|984103CA-F301-4510-A9DD-4916FA858EA2|3|||||COPD ASSESSMENT TEST|||CD|||BAU|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|3||39||CONTINUATION TREATMENT|1973-03-02||||1966-12-19||1970-09-14|1972-11-10|
TRIAL STUDY 134XCP|QS|984103CA-F301-4510-A9DD-4916FA858EA2|4|||||GDS SHORT FORM|||ABSORBANCE U|||FMOL/G|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|4||88||OPEN LABEL TREATMENT|1960-10-20||||1966-07-23||1960-03-20|1962-05-06|
TRIAL STUDY 134XCP|QS|984103CA-F301-4510-A9DD-4916FA858EA2|5|||||FPSR|||CYLINDER|||10^4 CFU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|5||7||TREATMENT|1973-08-14||||1968-07-06||1963-06-13|1967-07-10|
TRIAL STUDY 134XCP|QS|50E626B3-9133-4A50-8907-2388DAC22AD1|1|||||BPI SHORT FORM|||POUCH|||TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|Y|1||38||WASHOUT|1962-05-05||||1967-04-04||1973-01-18|1972-11-03|
TRIAL STUDY 134XCP|QS|50E626B3-9133-4A50-8907-2388DAC22AD1|2|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||CARTRIDGE|||KIT|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|2||58||TREATMENT|1962-04-15||||1972-12-19||1968-05-21|1963-09-20|
TRIAL STUDY 134XCP|QS|50E626B3-9133-4A50-8907-2388DAC22AD1|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||PMOL|||HOUNSFIELD UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|U|3||39||SCREENING|1963-05-04||||1968-12-07||1960-08-27|1971-06-27|
TRIAL STUDY 134XCP|QS|50E626B3-9133-4A50-8907-2388DAC22AD1|4|||||VFQ-25 SELF ADMINISTERED|||MG/MIN|||DRUM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|4||88||RUN-IN|1963-12-18||||1965-12-21||1970-05-10|1967-05-17|
TRIAL STUDY 134XCP|QS|50E626B3-9133-4A50-8907-2388DAC22AD1|5|||||FACT-TAXANE V4|||UV*SEC|||ML/KG/H|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|NA|5||7||TREATMENT|1967-07-31||||1960-04-27||1964-05-27|1962-01-27|
TRIAL STUDY 134XCP|QS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1|||||C-SSRS SCREENING|||CI/L|||10^3/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|U|1||38||OPEN LABEL TREATMENT|1964-01-09||||1968-06-05||1967-08-08|1967-10-23|
TRIAL STUDY 134XCP|QS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2|||||FLU-IIQ TWICE DAILY|||U/10^12 RBC|||MET*MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|N|2||58||LONG-TERM FOLLOW-UP|1968-11-30||||1967-12-11||1970-09-18|1962-12-26|
TRIAL STUDY 134XCP|QS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|3|||||SF36 V2.0 ACUTE|||F|||U/DL|NOT DONE||LIKERT SCALE 5-POINT|U|Y|N|3||39||BASELINE|1960-04-22||||1969-03-12||1962-02-20|1971-07-19|
TRIAL STUDY 134XCP|QS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|4|||||SDS|||ML/KG/MIN|||MG/G/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|4||88||RUN-IN|1961-01-01||||1962-04-28||1966-09-21|1971-02-28|
TRIAL STUDY 134XCP|QS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||FL|||UEQ/L|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|Y|5||7||FOLLOW-UP|1968-09-20||||1972-07-25||1965-04-14|1971-11-12|
TRIAL STUDY 134XCP|QS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1|||||ANSD V1.0|||U/KG/H|||CMH2O/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|1||38||OBSERVATION|1972-04-12||||1966-05-18||1967-07-06|1962-05-07|
TRIAL STUDY 134XCP|QS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2|||||MPAI-4|||PATCH|||OI50|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|2||58||INDUCTION TREATMENT|1960-04-24||||1964-06-27||1964-05-07|1969-01-18|
TRIAL STUDY 134XCP|QS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|3|||||SWLS|||TUBERCULIN UNIT/ML|||BISCUIT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|3||39||TREATMENT|1962-11-07||||1963-10-12||1972-12-17|1968-02-12|
TRIAL STUDY 134XCP|QS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|4|||||C-SSRS LIFETIME/RECENT VERSION|||10^6 IU/ML|||NMOL/ML/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|NA|4||88||RUN-IN|1966-03-05||||1960-05-11||1964-11-23|1965-09-09|
TRIAL STUDY 134XCP|QS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|5|||||EPIC-26|||G/ANIMAL/DAY|||10^6/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|U|5||7||SCREENING|1971-03-26||||1970-06-14||1966-03-16|1969-06-01|
TRIAL STUDY 134XCP|QS|F8F17A43-A74B-4570-8A06-D7657A4636B4|1|||||WHODAS 2.0 - 36-ITEM PROXY|||CAN|||AMFI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|1||38||INDUCTION TREATMENT|1966-02-19||||1964-01-13||1967-08-19|1970-09-15|
TRIAL STUDY 134XCP|QS|F8F17A43-A74B-4570-8A06-D7657A4636B4|2|||||FACT-L V4|||CCID 50/ML|||% INHIBITION|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|2||58||WASHOUT|1973-03-28||||1965-10-22||1961-07-12|1967-12-30|
TRIAL STUDY 134XCP|QS|F8F17A43-A74B-4570-8A06-D7657A4636B4|3|||||PI|||KV|||MG/MOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|N|3||39||OBSERVATION|1961-12-18||||1968-10-02||1964-06-25|1970-01-14|
TRIAL STUDY 134XCP|QS|F8F17A43-A74B-4570-8A06-D7657A4636B4|4|||||HAQ-DI WITH VAS|||MG2/DL2|||10^3 ORGANISMS/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|U|N|4||88||SCREENING|1969-10-22||||1965-09-04||1963-07-08|1965-01-07|
TRIAL STUDY 134XCP|QS|F8F17A43-A74B-4570-8A06-D7657A4636B4|5|||||C-SSRS CHILDREN'S BASELINE|||ABSORBANCE U|||BEL|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|5||7||FOLLOW-UP|1961-04-15||||1966-12-03||1973-09-03|1967-04-07|
TRIAL STUDY 134XCP|QS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1|||||ACQ|||MM/MIN|||L/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|1||38||RUN-IN|1961-05-24||||1963-02-27||1960-05-17|1966-10-03|
TRIAL STUDY 134XCP|QS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2|||||FACT-G V4|||TCID 50/DOSE|||S*KPA|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|2||58||LONG-TERM FOLLOW-UP|1963-04-01||||1963-09-08||1969-11-26|1970-02-12|
TRIAL STUDY 134XCP|QS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||FOZ_BR|||STEPS/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|3||39||RUN-IN|1967-02-23||||1968-08-04||1971-04-25|1960-09-10|
TRIAL STUDY 134XCP|QS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|4|||||SGRQ PAST 4 WEEKS VERSION|||FINGERTIP UNIT|||UL|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|NA|4||88||OBSERVATION|1968-12-30||||1969-02-03||1970-09-23|1972-05-04|
TRIAL STUDY 134XCP|QS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|5|||||VFQ-25 SELF ADMINISTERED|||MEQ/KG|||ELISA UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|5||7||LONG-TERM FOLLOW-UP|1960-01-22||||1965-06-07||1965-01-02|1968-10-20|
TRIAL STUDY 134XCP|QS|1177FD36-AAE8-4139-991A-A8C98B607565|1|||||PI|||JDF UNIT|||UMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|1||38||WASHOUT|1972-09-22||||1968-03-09||1965-11-23|1973-08-30|
TRIAL STUDY 134XCP|QS|1177FD36-AAE8-4139-991A-A8C98B607565|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||UCI/KG|||G/CM2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|2||58||RUN-IN|1967-12-24||||1963-04-18||1972-12-31|1966-06-11|
TRIAL STUDY 134XCP|QS|1177FD36-AAE8-4139-991A-A8C98B607565|3|||||EORTC QLQ-CR29 V2.1|||VIAL|||UG/KG/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|N|3||39||OPEN LABEL TREATMENT|1962-02-07||||1967-12-13||1970-03-15|1968-05-05|
TRIAL STUDY 134XCP|QS|1177FD36-AAE8-4139-991A-A8C98B607565|4|||||ADCS-ADL MCI|||ATM|||10^3 DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|NA|4||88||SCREENING|1967-11-05||||1963-06-07||1970-03-18|1967-04-20|
TRIAL STUDY 134XCP|QS|1177FD36-AAE8-4139-991A-A8C98B607565|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||PHERESIS UNIT|||MV2/HZ|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|5||7||RUN-IN|1972-08-08||||1967-01-25||1963-05-22|1973-04-15|
TRIAL STUDY 134XCP|QS|8C57F469-7CDF-493A-9839-C179D912A8A5|1|||||MDS-UPDRS|||VG/DOSE|||UM2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|1||38||BLINDED TREATMENT|1962-10-01||||1960-06-26||1969-10-21|1973-07-21|
TRIAL STUDY 134XCP|QS|8C57F469-7CDF-493A-9839-C179D912A8A5|2|||||CGI|||CY/CM|||MG/ML/DAY|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|2||58||CONTINUATION TREATMENT|1972-01-16||||1969-10-17||1966-12-12|1961-07-27|
TRIAL STUDY 134XCP|QS|8C57F469-7CDF-493A-9839-C179D912A8A5|3|||||UPS|||CMH2O*S2/ML|||DISK|NOT DONE||LIKERT SCALE 7-POINT|N|Y|NA|3||39||FOLLOW-UP|1963-04-26||||1970-07-17||1964-03-19|1967-11-04|
TRIAL STUDY 134XCP|QS|8C57F469-7CDF-493A-9839-C179D912A8A5|4|||||RDQ|||COPIES/UG|||HENRY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|NA|4||88||BLINDED TREATMENT|1962-03-01||||1967-05-02||1971-04-28|1962-05-10|
TRIAL STUDY 134XCP|QS|8C57F469-7CDF-493A-9839-C179D912A8A5|5|||||FLSI|||UIU/DL|||BAU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|5||7||OBSERVATION|1967-11-04||||1960-01-28||1966-01-05|1967-12-13|
TRIAL STUDY 134XCP|QS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1|||||WOMAC NRS 3.1 INDEX|||VP/DOSE|||/200 HPFS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|N|1||38||BASELINE|1965-09-09||||1964-01-03||1966-11-20|1972-03-27|
TRIAL STUDY 134XCP|QS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2|||||SF8 V1.0 STANDARD|||MMHG|||KAT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|N|2||58||WASHOUT|1972-11-25||||1960-07-14||1967-08-20|1965-07-22|
TRIAL STUDY 134XCP|QS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||GBQ|||UG/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|3||39||RUN-IN|1962-06-27||||1960-11-04||1963-11-16|1971-09-19|
TRIAL STUDY 134XCP|QS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|4|||||IBDQ|||APL U|||FT2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|U|4||88||BASELINE|1964-02-09||||1964-04-23||1970-10-31|1965-09-27|
TRIAL STUDY 134XCP|QS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|5|||||C-SSRS SINCE LAST VISIT|||MEQ/L|||WEBER|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|5||7||OBSERVATION|1969-03-25||||1971-09-26||1963-01-24|1969-06-20|
TRIAL STUDY 134XCP|QS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1|||||FACT/GOG-NTX V4|||DAGU/ML|||/MM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|NA|1||38||OPEN LABEL TREATMENT|1966-01-26||||1972-02-03||1965-04-15|1963-10-03|
TRIAL STUDY 134XCP|QS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2|||||SGRQ-C|||FT3|||MG/CM2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|Y|2||58||BLINDED TREATMENT|1965-05-01||||1960-12-29||1965-09-05|1973-02-05|
TRIAL STUDY 134XCP|QS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|3|||||PODCI - ADOLESCENT SELF REPORTED|||LM|||/MM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|3||39||BLINDED TREATMENT|1962-03-25||||1962-09-07||1960-05-13|1963-12-30|
TRIAL STUDY 134XCP|QS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|4|||||FOSI|||BEL|||CCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|4||88||LONG-TERM FOLLOW-UP|1963-08-13||||1965-11-13||1964-02-04|1967-05-18|
TRIAL STUDY 134XCP|QS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|5|||||DRRI-2|||PNU/ML|||/LPF|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|5||7||OBSERVATION|1970-04-08||||1960-11-29||1964-01-17|1968-05-25|
TRIAL STUDY 134XCP|QS|0AE36450-F37E-4F97-A250-79166011FCD7|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||CI/G|||/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|1||38||LONG-TERM FOLLOW-UP|1962-04-18||||1960-11-27||1964-09-24|1965-01-26|
TRIAL STUDY 134XCP|QS|0AE36450-F37E-4F97-A250-79166011FCD7|2|||||FPSR|||NMOL/L/MIN|||MM/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|2||58||OPEN LABEL TREATMENT|1964-03-24||||1962-01-26||1961-07-15|1961-11-20|
TRIAL STUDY 134XCP|QS|0AE36450-F37E-4F97-A250-79166011FCD7|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||EIA UNIT|||ARBITRARY U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|NA|3||39||FOLLOW-UP|1963-08-11||||1968-04-10||1960-03-06|1971-07-14|
TRIAL STUDY 134XCP|QS|0AE36450-F37E-4F97-A250-79166011FCD7|4|||||NCCN-FACT FHNSI-22 V2|||PELLET|||NKAT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|4||88||WASHOUT|1968-08-05||||1964-12-05||1967-09-10|1970-11-27|
TRIAL STUDY 134XCP|QS|0AE36450-F37E-4F97-A250-79166011FCD7|5|||||DRRI-2|||KAT|||10^3/HPF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|5||7||TREATMENT|1960-06-22||||1967-07-17||1964-07-12|1966-09-18|
TRIAL STUDY 134XCP|QS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1|||||OCI|||MS2|||MU/G|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|1||38||OPEN LABEL TREATMENT|1969-07-14||||1965-03-09||1969-04-23|1966-11-22|
TRIAL STUDY 134XCP|QS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2|||||NPI|||U/M2/MIN|||MMOL/S|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|NA|2||58||RUN-IN|1961-03-06||||1965-05-10||1969-03-08|1967-05-29|
TRIAL STUDY 134XCP|QS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|3|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||MM2|||LOG10 PFU|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|3||39||WASHOUT|1963-02-28||||1967-04-01||1971-01-18|1973-09-02|
TRIAL STUDY 134XCP|QS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|4|||||EXPANDED DRS-PI CAREGIVER VERSION|||YEARS|||BAU|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|N|4||88||OBSERVATION|1962-04-19||||1969-02-07||1970-04-05|1963-05-20|
TRIAL STUDY 134XCP|QS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|5|||||SOWS SUBJECTIVE|||ML/M2/MIN|||VP/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|5||7||OPEN LABEL TREATMENT|1972-12-16||||1966-08-04||1971-04-21|1973-08-05|
TRIAL STUDY 134XCP|QS|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1|||||SGRQ PAST 4 WEEKS VERSION|||MKAT|||UG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|1||38||SCREENING|1972-06-29||||1963-10-29||1963-02-10|1960-08-05|
TRIAL STUDY 134XCP|QS|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2|||||MSQOL-54|||LOG EID 50/DOSE|||UMOL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|2||58||OPEN LABEL TREATMENT|1970-12-16||||1962-11-15||1960-03-02|1971-02-02|
TRIAL STUDY 134XCP|QS|707FC46F-B8B1-456B-9E09-CABC86EA61D5|3|||||CDR|||MMOL/L|||MMAL|NOT DONE||LIKERT SCALE 7-POINT|N|NA|N|3||39||BASELINE|1960-10-21||||1961-06-16||1967-03-02|1962-01-09|
TRIAL STUDY 134XCP|QS|707FC46F-B8B1-456B-9E09-CABC86EA61D5|4|||||SIQR|||UG/M2/DAY|||KS|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|4||88||TREATMENT|1965-12-31||||1970-01-16||1971-09-13|1973-04-12|
TRIAL STUDY 134XCP|QS|707FC46F-B8B1-456B-9E09-CABC86EA61D5|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||10^6 RNA COPIES/ML|||NSEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|5||7||INDUCTION TREATMENT|1973-07-10||||1973-04-22||1971-07-15|1966-11-18|
TRIAL STUDY 134XCP|QS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1|||||IVIS|||/H|||IU/MG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|1||38||LONG-TERM FOLLOW-UP|1961-09-12||||1967-04-09||1968-06-28|1961-10-21|
TRIAL STUDY 134XCP|QS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2|||||NPS|||GENEQ/ML|||MEQ/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|2||58||BLINDED TREATMENT|1960-02-14||||1962-06-18||1964-10-26|1963-03-11|
TRIAL STUDY 134XCP|QS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|3|||||EXPANDED DRS-PI SURVIVOR VERSION|||MOL/MG|||CAPFUL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|3||39||CONTINUATION TREATMENT|1970-12-20||||1965-05-19||1972-04-08|1960-03-03|
TRIAL STUDY 134XCP|QS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|4|||||C-SSRS BASELINE|||SUPPOSITORY|||LOG10 CCID 50/DOSE|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|4||88||BASELINE|1967-04-20||||1962-02-25||1963-08-26|1961-02-27|
TRIAL STUDY 134XCP|QS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||MG/DL|||PACKET|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|5||7||RUN-IN|1973-05-27||||1963-06-25||1968-04-05|1969-12-12|
TRIAL STUDY 134XCP|QS|70196099-5D40-4048-AABF-EB40CE345328|1|||||MDQ-T|||MMAL|||AMOL|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|1||38||FOLLOW-UP|1968-12-23||||1964-11-27||1964-06-15|1966-08-12|
TRIAL STUDY 134XCP|QS|70196099-5D40-4048-AABF-EB40CE345328|2|||||BWCS|||SCOOPFUL|||WEEKS|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|U|2||58||BASELINE|1961-09-04||||1970-12-31||1970-10-09|1969-06-24|
TRIAL STUDY 134XCP|QS|70196099-5D40-4048-AABF-EB40CE345328|3|||||EPDS|||PIXELS/IN|||ML/(MIN*100ML)|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|3||39||CONTINUATION TREATMENT|1963-02-08||||1968-08-28||1969-05-24|1961-10-29|
TRIAL STUDY 134XCP|QS|70196099-5D40-4048-AABF-EB40CE345328|4|||||AQ20|||MJOULE/CM2|||ML/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|4||88||BLINDED TREATMENT|1966-11-22||||1966-05-31||1967-01-08|1962-11-25|
TRIAL STUDY 134XCP|QS|70196099-5D40-4048-AABF-EB40CE345328|5|||||GOSE|||GRAVITATIONAL UNIT|||COAT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|N|5||7||WASHOUT|1972-07-18||||1969-08-10||1971-09-02|1971-12-29|
TRIAL STUDY 134XCP|QS|F9D4C544-F217-4676-AC40-F71CC48045AF|1|||||SHORT-FORM MPQ-2|||10^9 ORGANISMS/G|||STEPS/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|1||38||INDUCTION TREATMENT|1965-11-12||||1970-06-06||1971-05-30|1965-04-21|
TRIAL STUDY 134XCP|QS|F9D4C544-F217-4676-AC40-F71CC48045AF|2|||||ASEX-FEMALE|||L/H|||UG/ML/H|NOT DONE||LIKERT SCALE 7-POINT|N|Y|NA|2||58||CONTINUATION TREATMENT|1967-07-20||||1965-11-12||1961-07-05|1968-05-07|
TRIAL STUDY 134XCP|QS|F9D4C544-F217-4676-AC40-F71CC48045AF|3|||||WOMAC LK 3.1 INDEX|||INHALATION|||ML/M2/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|3||39||BLINDED TREATMENT|1971-09-25||||1961-01-30||1967-09-28|1963-11-26|
TRIAL STUDY 134XCP|QS|F9D4C544-F217-4676-AC40-F71CC48045AF|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||CAPSULE|||/HPF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|4||88||LONG-TERM FOLLOW-UP|1965-06-15||||1970-12-29||1960-10-21|1969-01-03|
TRIAL STUDY 134XCP|QS|F9D4C544-F217-4676-AC40-F71CC48045AF|5|||||SIQ|||CMH2O*S2/ML|||MEQ/DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|NA|5||7||BLINDED TREATMENT|1961-11-20||||1961-04-16||1968-02-16|1967-01-30|
TRIAL STUDY 134XCP|QS|E6A42133-B082-4BD7-B840-A60E49E0562B|1|||||FAS-NACC UDS V3.0|||MBP|||L/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|NA|1||38||LONG-TERM FOLLOW-UP|1960-04-14||||1965-05-21||1967-02-14|1970-06-25|
TRIAL STUDY 134XCP|QS|E6A42133-B082-4BD7-B840-A60E49E0562B|2|||||EQ-5D-5L|||BAR|||AG|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|2||58||INDUCTION TREATMENT|1962-05-05||||1968-11-10||1960-05-23|1972-04-09|
TRIAL STUDY 134XCP|QS|E6A42133-B082-4BD7-B840-A60E49E0562B|3|||||DAD|||MN|||U/KG/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|Y|3||39||BLINDED TREATMENT|1972-04-25||||1961-10-11||1970-12-22|1961-06-19|
TRIAL STUDY 134XCP|QS|E6A42133-B082-4BD7-B840-A60E49E0562B|4|||||C-SSRS CHILDREN'S BASELINE|||NKAT/G HB|||UMOL/MG/MIN|NOT DONE||LIKERT SCALE 7-POINT|Y|U|Y|4||88||FOLLOW-UP|1968-10-20||||1970-06-15||1961-07-23|1971-01-08|
TRIAL STUDY 134XCP|QS|E6A42133-B082-4BD7-B840-A60E49E0562B|5|||||ADCS-ADL|||ENZYME U|||PACKAGE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|U|5||7||SCREENING|1965-09-01||||1961-03-22||1970-11-12|1961-03-30|
TRIAL STUDY 134XCP|QS|72C9FDBC-AA86-4001-9820-90AAF5422074|1|||||NCCN-FACT FBLSI-18 V2|||SFC/10^6 PBMC|||WEEKS|NOT DONE||LIKERT SCALE 5-POINT|N|Y|N|1||38||CONTINUATION TREATMENT|1966-10-24||||1967-03-19||1969-06-13|1972-05-02|
TRIAL STUDY 134XCP|QS|72C9FDBC-AA86-4001-9820-90AAF5422074|2|||||PCL-5|||LOG10 CCID 50/DOSE|||SQU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|Y|2||58||BLINDED TREATMENT|1963-03-18||||1961-08-23||1965-02-16|1963-08-31|
TRIAL STUDY 134XCP|QS|72C9FDBC-AA86-4001-9820-90AAF5422074|3|||||NCCN-FACT FPSI-17 V2|||MG/ML/DAY|||MBP|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|N|3||39||TREATMENT|1972-01-31||||1963-08-01||1963-06-12|1972-03-02|
TRIAL STUDY 134XCP|QS|72C9FDBC-AA86-4001-9820-90AAF5422074|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||ML/MMHG|||SUPPOSITORY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|4||88||WASHOUT|1961-06-09||||1972-07-19||1963-04-10|1966-04-17|
TRIAL STUDY 134XCP|QS|72C9FDBC-AA86-4001-9820-90AAF5422074|5|||||IPAQ-LF SELF-ADMINISTERED VERSION|||BAG|||ML/MIN/MMHG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|Y|5||7||BASELINE|1961-04-16||||1971-12-21||1973-05-01|1970-03-25|
TRIAL STUDY 134XCP|QS|186520B9-8AAD-4063-B48F-16040EF49944|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||UCI/KG|||GY/H|NOT DONE||LIKERT SCALE 5-POINT|Y|N|Y|1||38||TREATMENT|1968-11-06||||1967-01-13||1972-07-23|1969-07-15|
TRIAL STUDY 134XCP|QS|186520B9-8AAD-4063-B48F-16040EF49944|2|||||FACT-B V4|||COPIES/ML|||LOG10 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|2||58||CONTINUATION TREATMENT|1961-03-19||||1965-10-20||1967-07-17|1968-11-25|
TRIAL STUDY 134XCP|QS|186520B9-8AAD-4063-B48F-16040EF49944|3|||||COWS|||PG/DL|||NG/MOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|3||39||WASHOUT|1967-11-09||||1972-10-10||1962-01-23|1971-10-21|
TRIAL STUDY 134XCP|QS|186520B9-8AAD-4063-B48F-16040EF49944|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||OI50|||LOG10 PFU|NOT DONE||LIKERT SCALE 3-POINT|N|Y|Y|4||88||LONG-TERM FOLLOW-UP|1965-11-14||||1963-02-28||1967-02-25|1971-04-03|
TRIAL STUDY 134XCP|QS|186520B9-8AAD-4063-B48F-16040EF49944|5|||||SF12 V2.0 ACUTE|||UKAT/L|||UMOL/L/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|U|5||7||CONTINUATION TREATMENT|1967-01-16||||1967-10-24||1968-03-23|1971-08-18|
TRIAL STUDY 134XCP|QS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1|||||SIQ-JR|||DEG|||GBQ|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|1||38||BASELINE|1970-06-23||||1966-10-22||1960-07-21|1966-05-31|
TRIAL STUDY 134XCP|QS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2|||||GCGI|||L/DAY|||PPM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|NA|2||58||TREATMENT|1971-06-08||||1970-10-23||1961-04-16|1972-04-03|
TRIAL STUDY 134XCP|QS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|3|||||SMDDS V1.0|||VG/KG|||CMH2O/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|3||39||BASELINE|1971-10-27||||1962-06-09||1962-03-29|1970-04-24|
TRIAL STUDY 134XCP|QS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|4|||||ANSD V1.0|||S*KPA|||10^9 CFU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|4||88||LONG-TERM FOLLOW-UP|1962-08-15||||1960-08-08||1966-09-27|1964-07-07|
TRIAL STUDY 134XCP|QS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|5|||||FACT-B V4|||FT|||CMH2O/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|5||7||OPEN LABEL TREATMENT|1971-09-03||||1966-01-03||1963-03-22|1973-05-25|
TRIAL STUDY 134XCP|QS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||MMOL/MOL|||UG/H|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|1||38||SCREENING|1972-03-09||||1962-01-24||1969-06-16|1968-06-23|
TRIAL STUDY 134XCP|QS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2|||||MDS-UPDRS|||RPM|||10^5/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|N|2||58||OPEN LABEL TREATMENT|1969-12-26||||1964-01-11||1964-05-11|1964-08-04|
TRIAL STUDY 134XCP|QS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|3|||||ACQ|||ENZYME U/M2|||DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|3||39||WASHOUT|1963-05-17||||1969-07-21||1966-03-10|1969-08-26|
TRIAL STUDY 134XCP|QS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|4|||||HADS|||UG/L DDU|||10^4 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|N|4||88||OPEN LABEL TREATMENT|1965-10-03||||1970-09-30||1970-07-09|1962-05-21|
TRIAL STUDY 134XCP|QS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|5|||||ODI V2.1A|||CAN|||ML/KG/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|5||7||FOLLOW-UP|1971-11-26||||1960-12-05||1965-08-20|1972-07-27|
TRIAL STUDY 134XCP|QS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1|||||PROSQOLI|||QUANTITY SUFFICIENT|||MG/KG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|1||38||CONTINUATION TREATMENT|1966-03-07||||1973-06-10||1962-05-08|1964-08-16|
TRIAL STUDY 134XCP|QS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2|||||CHART-SF INTERVIEW VERSION|||FMOL|||PKAT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|U|2||58||TREATMENT|1967-02-24||||1964-08-04||1962-10-20|1973-05-29|
TRIAL STUDY 134XCP|QS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|3|||||FACIT-F V4|||IU/KG|||HZ/S|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1973-03-28||||1965-12-10||1972-08-11|1969-06-24|
TRIAL STUDY 134XCP|QS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|4|||||FAQ-NACC VERSION|||FT3|||WEBER|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|N|4||88||FOLLOW-UP|1966-03-17||||1963-02-19||1970-04-14|1965-02-08|
TRIAL STUDY 134XCP|QS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|5|||||WOMAC NRS 3.1 INDEX|||LB|||CPM|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|NA|5||7||TREATMENT|1973-03-09||||1961-11-27||1972-12-30|1971-01-18|
TRIAL STUDY 134XCP|QS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1|||||IPAQ-SF SELF-ADMINISTERED VERSION|||ML*CMH2O|||PELLET|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|1||38||TREATMENT|1968-05-06||||1962-04-16||1962-12-29|1961-06-07|
TRIAL STUDY 134XCP|QS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2|||||FLSI|||%(V/V)|||KG|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|Y|2||58||WASHOUT|1969-02-14||||1960-10-30||1968-12-29|1967-07-03|
TRIAL STUDY 134XCP|QS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|3|||||ADCS-ADL|||CMH2O*S/ML|||USEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|3||39||OPEN LABEL TREATMENT|1961-12-09||||1972-05-24||1966-02-12|1966-01-27|
TRIAL STUDY 134XCP|QS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|4|||||DAD|||CD/M2|||LOG10 TCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|4||88||TREATMENT|1973-02-22||||1964-05-17||1965-01-27|1966-07-25|
TRIAL STUDY 134XCP|QS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|5|||||SGRQ PAST 4 WEEKS VERSION|||CMH2O/ML|||MAC50|NOT DONE||LIKERT SCALE 5-POINT|N|N|Y|5||7||SCREENING|1963-06-27||||1970-06-23||1964-04-10|1973-08-07|
TRIAL STUDY 134XCP|QS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1|||||FOSI|||BQ/ML|||%(W/W)|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|U|1||38||TREATMENT|1963-08-26||||1971-08-21||1963-03-24|1961-09-14|
TRIAL STUDY 134XCP|QS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2|||||WLQ|||AFU|||KCAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|2||58||INDUCTION TREATMENT|1965-09-21||||1968-11-28||1962-01-03|1965-11-10|
TRIAL STUDY 134XCP|QS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|3|||||FACT-LEU V4|||ML/BREATH|||KBQ/UL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|N|3||39||INDUCTION TREATMENT|1973-06-06||||1964-09-04||1972-09-28|1963-07-19|
TRIAL STUDY 134XCP|QS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|4|||||OAB-Q SHORT FORM|||AG|||VG/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|U|4||88||TREATMENT|1971-10-10||||1968-09-17||1961-05-22|1972-12-08|
TRIAL STUDY 134XCP|QS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|5|||||SF12 V1.0 ACUTE|||MMOL|||CM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|5||7||CONTINUATION TREATMENT|1967-06-23||||1972-08-13||1966-12-19|1960-06-02|
TRIAL STUDY 134XCP|QS|460486B3-B7C8-4B54-848B-21BA899EAAD6|1|||||SWLS|||OHM|||10^4/HPF|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|N|1||38||RUN-IN|1972-06-11||||1969-12-26||1965-02-17|1964-09-03|
TRIAL STUDY 134XCP|QS|460486B3-B7C8-4B54-848B-21BA899EAAD6|2|||||T1-DDS|||ABSORBANCE U|||PMOL/10^9 CELLS|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|2||58||INDUCTION TREATMENT|1966-09-04||||1966-07-11||1965-04-12|1967-10-13|
TRIAL STUDY 134XCP|QS|460486B3-B7C8-4B54-848B-21BA899EAAD6|3|||||IPAQ-SF PHONE VERSION|||PPTR|||MEQ/MMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|3||39||SCREENING|1970-02-20||||1961-09-29||1973-08-12|1960-06-12|
TRIAL STUDY 134XCP|QS|460486B3-B7C8-4B54-848B-21BA899EAAD6|4|||||FACT/GOG-NTX V4|||UL/DOSE|||PFU|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|Y|4||88||TREATMENT|1966-03-15||||1967-12-21||1961-08-23|1969-05-20|
TRIAL STUDY 134XCP|QS|460486B3-B7C8-4B54-848B-21BA899EAAD6|5|||||GAD-7 V2|||MMOL/G|||TSP|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|5||7||LONG-TERM FOLLOW-UP|1971-08-24||||1968-03-28||1972-09-08|1968-12-24|
TRIAL STUDY 134XCP|QS|A068436F-E26E-44C5-8959-0BCBA28832D1|1|||||CDR|||MIN/DAY|||CAPFUL|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|1||38||SCREENING|1973-05-04||||1963-07-03||1973-08-11|1968-09-05|
TRIAL STUDY 134XCP|QS|A068436F-E26E-44C5-8959-0BCBA28832D1|2|||||EXPANDED DRS-PI SURVIVOR VERSION|||/4.0 ML|||U/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|N|2||58||CONTINUATION TREATMENT|1970-03-20||||1967-02-11||1972-08-17|1969-08-26|
TRIAL STUDY 134XCP|QS|A068436F-E26E-44C5-8959-0BCBA28832D1|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||TSP EQ|||ML*CMH2O|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|3||39||LONG-TERM FOLLOW-UP|1970-05-09||||1971-11-06||1960-05-06|1968-06-16|
TRIAL STUDY 134XCP|QS|A068436F-E26E-44C5-8959-0BCBA28832D1|4|||||AUDIT-SR|||MM/H|||DB|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|4||88||LONG-TERM FOLLOW-UP|1960-01-21||||1971-11-29||1966-11-06|1961-08-29|
TRIAL STUDY 134XCP|QS|A068436F-E26E-44C5-8959-0BCBA28832D1|5|||||EXPANDED DRS-PI CAREGIVER VERSION|||EVENTS|||/MM|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|NA|5||7||BASELINE|1960-10-03||||1965-06-27||1966-04-14|1960-03-07|
TRIAL STUDY 134XCP|QS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1|||||SDS|||KBQ/UL|||G/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|U|1||38||BASELINE|1960-01-15||||1973-04-11||1962-09-27|1969-02-02|
TRIAL STUDY 134XCP|QS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||/H|||CGY|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|2||58||OBSERVATION|1971-09-16||||1972-03-02||1965-03-12|1962-01-06|
TRIAL STUDY 134XCP|QS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|3|||||ADAS-COG|||FT2|||TITER|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|Y|3||39||CONTINUATION TREATMENT|1972-06-23||||1967-10-01||1963-04-16|1961-10-24|
TRIAL STUDY 134XCP|QS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|4|||||GOSE|||NGEQ/L|||LOG10 COPIES/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|4||88||FOLLOW-UP|1962-06-20||||1961-04-01||1967-02-17|1968-06-14|
TRIAL STUDY 134XCP|QS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|5|||||SF12 V2.0 ACUTE|||MIN/DAY|||PMOL/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|5||7||SCREENING|1971-12-06||||1960-06-10||1967-12-02|1967-12-26|
TRIAL STUDY 134XCP|QS|E065D436-92D2-453F-86A7-27F70FE1FD03|1|||||ACQ|||KPA/L/SEC|||IU|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|NA|1||38||WASHOUT|1967-01-26||||1961-04-08||1965-04-24|1971-06-29|
TRIAL STUDY 134XCP|QS|E065D436-92D2-453F-86A7-27F70FE1FD03|2|||||ADAS-COG|||UL/KG/DAY|||UMOL/L/MIN|NOT DONE||LIKERT SCALE 7-POINT|U|NA|N|2||58||OBSERVATION|1966-02-22||||1965-04-09||1973-03-03|1962-10-26|
TRIAL STUDY 134XCP|QS|E065D436-92D2-453F-86A7-27F70FE1FD03|3|||||NCCN-FACT FKSI-19 V2|||/LPF|||CI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|3||39||TREATMENT|1969-11-05||||1969-01-15||1966-01-12|1961-05-10|
TRIAL STUDY 134XCP|QS|E065D436-92D2-453F-86A7-27F70FE1FD03|4|||||SF36 V2.0 ACUTE|||ML/KG/MIN|||MN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|NA|4||88||BLINDED TREATMENT|1967-12-26||||1965-09-19||1970-10-06|1967-11-22|
TRIAL STUDY 134XCP|QS|E065D436-92D2-453F-86A7-27F70FE1FD03|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||PIXELS/CM|||CI/UL|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|5||7||TREATMENT|1963-03-05||||1960-02-27||1961-07-17|1961-10-14|
TRIAL STUDY 134XCP|QS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1|||||ADCS-CGIC|||CAL|||DNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|N|1||38||BLINDED TREATMENT|1960-08-20||||1964-08-31||1973-02-26|1960-02-17|
TRIAL STUDY 134XCP|QS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2|||||WHODAS 2.0 - 36-ITEM PROXY|||PG/DL|||10^7/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|2||58||OPEN LABEL TREATMENT|1966-06-18||||1972-01-06||1969-05-06|1969-12-30|
TRIAL STUDY 134XCP|QS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|3|||||FKSI-15|||U/KG/MIN|||10^12/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|3||39||WASHOUT|1970-01-19||||1960-11-09||1961-04-23|1965-05-14|
TRIAL STUDY 134XCP|QS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|4|||||BPI|||SYRINGE|||MV2/HZ|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|4||88||OPEN LABEL TREATMENT|1971-04-23||||1973-05-29||1966-09-19|1973-03-05|
TRIAL STUDY 134XCP|QS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|5|||||CES|||GY/H|||GBQ|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|5||7||LONG-TERM FOLLOW-UP|1972-03-12||||1973-04-27||1965-12-31|1967-05-01|
TRIAL STUDY 134XCP|QS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1|||||TSCYC|||LOG10 TCID 50/ML|||BOLUS|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|1||38||OBSERVATION|1972-05-24||||1967-03-12||1966-02-17|1965-11-30|
TRIAL STUDY 134XCP|QS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2|||||WOMAC LK 3.1 INDEX|||SHOCK WAVE|||MEQ/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|N|2||58||LONG-TERM FOLLOW-UP|1968-08-30||||1961-11-22||1972-11-24|1969-12-28|
TRIAL STUDY 134XCP|QS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|3|||||GMSS VERSION TYPE 1 DIABETES|||EID 50/DOSE|||G/ANIMAL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|3||39||INDUCTION TREATMENT|1962-06-20||||1963-07-22||1960-07-02|1966-12-31|
TRIAL STUDY 134XCP|QS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|4|||||PODCI - PEDIATRIC PARENT REPORTED|||HOURS|||PLUG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|N|4||88||SCREENING|1968-02-03||||1969-08-21||1960-09-24|1969-03-10|
TRIAL STUDY 134XCP|QS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||U/ML|||LOG10 CFU/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|5||7||BLINDED TREATMENT|1964-10-16||||1970-11-11||1969-06-05|1967-06-05|
TRIAL STUDY 134XCP|QS|D108D040-7177-4A14-8CA7-748D59DC5F8B|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||NMOL BCE/NMOL|||G/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|1||38||OPEN LABEL TREATMENT|1971-09-01||||1960-02-17||1968-05-21|1966-06-06|
TRIAL STUDY 134XCP|QS|D108D040-7177-4A14-8CA7-748D59DC5F8B|2|||||EPIC-CP|||ML/MIN/1.73M2|||NSEC|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|2||58||CONTINUATION TREATMENT|1969-05-07||||1960-10-06||1962-04-13|1968-03-08|
TRIAL STUDY 134XCP|QS|D108D040-7177-4A14-8CA7-748D59DC5F8B|3|||||FACT-LEU V4|||FMOL/L/SEC|||CM/S|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|3||39||TREATMENT|1962-08-07||||1961-10-24||1969-06-30|1969-09-05|
TRIAL STUDY 134XCP|QS|D108D040-7177-4A14-8CA7-748D59DC5F8B|4|||||MADRS|||NEWTON|||MG/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|4||88||LONG-TERM FOLLOW-UP|1968-04-22||||1969-04-25||1970-09-29|1962-09-14|
TRIAL STUDY 134XCP|QS|D108D040-7177-4A14-8CA7-748D59DC5F8B|5|||||NCCN-FACT FPSI-17 V2|||G/CAGE/DAY|||PMOL/10^10 CELLS|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|5||7||RUN-IN|1964-07-17||||1962-10-16||1961-03-01|1960-07-18|
TRIAL STUDY 134XCP|QS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1|||||FACIT-F V4|||BQ/UL|||10^7 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|U|1||38||OPEN LABEL TREATMENT|1968-06-01||||1970-02-27||1964-10-29|1961-04-20|
TRIAL STUDY 134XCP|QS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2|||||C-SSRS BASELINE|||PFU/ANIMAL|||ML/(MIN*100ML)|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|U|2||58||INDUCTION TREATMENT|1973-06-30||||1971-07-04||1968-11-18|1966-09-30|
TRIAL STUDY 134XCP|QS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|3|||||FSS|||LOG10 CCID 50/DOSE|||U/L|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|3||39||BLINDED TREATMENT|1961-06-05||||1973-05-04||1968-04-30|1966-04-04|
TRIAL STUDY 134XCP|QS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|4|||||UPS|||M|||PFU/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|4||88||BLINDED TREATMENT|1968-03-09||||1960-06-09||1971-04-03|1961-04-15|
TRIAL STUDY 134XCP|QS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|5|||||MSQOL-54|||NG/L|||LM|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1963-05-16||||1966-04-21||1973-03-31|1962-03-28|
TRIAL STUDY 134XCP|QS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1|||||ODI V2.1A|||MMOL/L|||MEQ/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|NA|1||38||CONTINUATION TREATMENT|1964-09-20||||1960-04-02||1971-07-01|1963-03-14|
TRIAL STUDY 134XCP|QS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2|||||CDLQ|||10^6 ORGANISMS|||PFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|U|2||58||BLINDED TREATMENT|1961-06-29||||1970-11-07||1966-10-07|1972-03-30|
TRIAL STUDY 134XCP|QS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|3|||||CDR|||MOL/MG|||ML/(MIN*100ML)|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|U|3||39||FOLLOW-UP|1969-02-16||||1962-06-05||1968-05-09|1961-10-21|
TRIAL STUDY 134XCP|QS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|4|||||FAMS|||WEEKS|||CYLINDER|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|4||88||OPEN LABEL TREATMENT|1972-02-15||||1960-01-31||1960-04-05|1969-07-18|
TRIAL STUDY 134XCP|QS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|5|||||UPS|||HOURS|||SCOOPFUL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|5||7||INDUCTION TREATMENT|1973-08-04||||1969-07-25||1961-10-18|1973-06-12|
TRIAL STUDY 134XCP|QS|580CCA66-3D51-4A5C-80E1-361A90369055|1|||||NCCN-FACT FBLSI-18 V2|||UGEQ|||KG/M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|N|1||38||RUN-IN|1972-08-14||||1961-06-09||1966-02-08|1972-09-09|
TRIAL STUDY 134XCP|QS|580CCA66-3D51-4A5C-80E1-361A90369055|2|||||HAQ-DI WITHOUT VAS|||CMHG|||TESLA|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|2||58||OBSERVATION|1969-09-10||||1968-09-11||1962-12-30|1963-03-09|
TRIAL STUDY 134XCP|QS|580CCA66-3D51-4A5C-80E1-361A90369055|3|||||BEBQ CONCURRENT|||F|||NMOL/L/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|N|3||39||TREATMENT|1962-12-10||||1965-07-14||1962-11-08|1964-05-24|
TRIAL STUDY 134XCP|QS|580CCA66-3D51-4A5C-80E1-361A90369055|4|||||IPAQ-LF SELF-ADMINISTERED VERSION|||MG/ML/DAY|||10^7 TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|4||88||SCREENING|1970-01-01||||1960-06-13||1972-08-22|1968-04-21|
TRIAL STUDY 134XCP|QS|580CCA66-3D51-4A5C-80E1-361A90369055|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||UKAT/10^12 RBC|||EIA UNIT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|5||7||TREATMENT|1972-08-16||||1973-02-02||1963-04-02|1967-03-01|
TRIAL STUDY 134XCP|QS|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1|||||MSIS-29 V2|||MMHG/SEC|||PIXELS/CM|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|1||38||TREATMENT|1960-02-06||||1972-01-24||1970-04-20|1966-05-10|
TRIAL STUDY 134XCP|QS|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2|||||PODCI - ADOLESCENT PARENT REPORTED|||LOG10 IU/ML|||NL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|Y|2||58||OBSERVATION|1965-01-18||||1970-11-06||1972-04-22|1961-09-08|
TRIAL STUDY 134XCP|QS|DAB276EB-3581-4C20-88AC-5A3D267E54D8|3|||||EQ-5D-3L|||CI/G|||MOSM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|3||39||BLINDED TREATMENT|1970-02-15||||1970-01-19||1966-06-15|1960-10-25|
TRIAL STUDY 134XCP|QS|DAB276EB-3581-4C20-88AC-5A3D267E54D8|4|||||WPAI-SHP V2.0|||10^3 CFU/ML|||GPELISA UNIT/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|4||88||BLINDED TREATMENT|1960-10-07||||1965-05-12||1966-04-13|1968-01-09|
TRIAL STUDY 134XCP|QS|DAB276EB-3581-4C20-88AC-5A3D267E54D8|5|||||NCCN-FACT FKSI-19 V2|||UG/M2|||UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|NA|5||7||OBSERVATION|1967-08-28||||1968-02-23||1970-01-21|1964-06-15|
TRIAL STUDY 134XCP|QS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1|||||WHODAS 2.0 - 12-ITEM PROXY|||MPA|||DYN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|1||38||OBSERVATION|1961-06-16||||1971-06-21||1970-09-09|1968-03-31|
TRIAL STUDY 134XCP|QS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2|||||ADCS-ADL MCI|||UG/L FEU|||MOSM|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|2||58||FOLLOW-UP|1967-09-27||||1960-06-26||1963-10-23|1966-05-21|
TRIAL STUDY 134XCP|QS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|3|||||SIQR|||AMP|||MJOULE/CM2|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|U|3||39||SCREENING|1961-09-08||||1961-11-10||1973-09-05|1967-03-12|
TRIAL STUDY 134XCP|QS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|4|||||PODCI - ADOLESCENT SELF REPORTED|||MG/DAY|||KG/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|4||88||SCREENING|1966-04-28||||1968-06-17||1961-04-07|1969-10-28|
TRIAL STUDY 134XCP|QS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|5|||||T1-DDS|||KG/CM2|||/4.0 ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|5||7||OBSERVATION|1963-01-12||||1966-10-29||1964-04-07|1968-02-28|
TRIAL STUDY 134XCP|QS|5B703A43-A280-4D6A-AC40-FF5187521DB2|1|||||FACT-BRM V4|||10^9/DOSE|||NEWTON|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|U|1||38||OBSERVATION|1961-09-22||||1968-03-31||1966-05-22|1970-04-01|
TRIAL STUDY 134XCP|QS|5B703A43-A280-4D6A-AC40-FF5187521DB2|2|||||FOSI|||MASK|||IU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|N|2||58||BASELINE|1968-09-10||||1961-03-06||1966-07-27|1972-12-15|
TRIAL STUDY 134XCP|QS|5B703A43-A280-4D6A-AC40-FF5187521DB2|3|||||YMRS|||% INHIBITION|||CL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|U|3||39||FOLLOW-UP|1966-10-07||||1970-07-25||1965-01-17|1970-03-06|
TRIAL STUDY 134XCP|QS|5B703A43-A280-4D6A-AC40-FF5187521DB2|4|||||Q-LES-Q-SF|||%/MIN|||10^5/HPF|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|4||88||BASELINE|1967-04-20||||1960-01-01||1971-11-07|1971-08-24|
TRIAL STUDY 134XCP|QS|5B703A43-A280-4D6A-AC40-FF5187521DB2|5|||||PHQ-2|||UG|||S^-1(%O2)^-1|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|5||7||RUN-IN|1963-07-02||||1966-11-27||1966-07-22|1964-07-17|
TRIAL STUDY 134XCP|QS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1|||||ADCS-ADL SEVERE DEMENTIA|||LOG10 TCID 50/ML|||PFU|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|1||38||FOLLOW-UP|1971-11-20||||1973-05-02||1966-11-19|1972-03-04|
TRIAL STUDY 134XCP|QS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||MCI/L|||BP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|2||58||OBSERVATION|1969-09-21||||1965-06-17||1967-04-25|1963-03-14|
TRIAL STUDY 134XCP|QS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|3|||||WHODAS 2.0 - 12-ITEM PROXY|||10^7 PFU|||UMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|3||39||INDUCTION TREATMENT|1973-08-07||||1962-02-09||1966-01-06|1962-01-23|
TRIAL STUDY 134XCP|QS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|4|||||PODCI - ADOLESCENT SELF REPORTED|||TBSP|||L/S|NOT DONE||LIKERT SCALE 3-POINT|NA|U|U|4||88||LONG-TERM FOLLOW-UP|1964-10-18||||1973-03-18||1971-07-20|1964-08-25|
TRIAL STUDY 134XCP|QS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|5|||||FACT-L V4|||TRACE|||OZ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|N|5||7||INDUCTION TREATMENT|1964-10-03||||1965-07-19||1973-03-06|1960-05-05|
TRIAL STUDY 134XCP|QS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1|||||COWS|||UMOL/MIN|||TITER|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|U|1||38||RUN-IN|1960-05-20||||1972-04-21||1972-06-26|1971-09-25|
TRIAL STUDY 134XCP|QS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2|||||TSQM V1.4|||NMOL/ML/MIN|||10^9 CFU/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|2||58||BASELINE|1966-05-05||||1961-10-01||1969-07-01|1969-11-28|
TRIAL STUDY 134XCP|QS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|3|||||BEBQ CONCURRENT|||PMOL|||10^4/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|3||39||RUN-IN|1962-06-28||||1961-03-27||1973-07-06|1968-10-02|
TRIAL STUDY 134XCP|QS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|4|||||MPAI-4|||PPTH|||G/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|4||88||WASHOUT|1970-05-01||||1970-10-25||1965-09-21|1966-10-12|
TRIAL STUDY 134XCP|QS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|5|||||PARTNER-DDS|||10^9/DOSE|||PG/CELL|NOT DONE||LIKERT SCALE 3-POINT|U|N|NA|5||7||OBSERVATION|1965-07-17||||1972-12-15||1962-10-31|1968-10-30|
TRIAL STUDY 134XCP|QS|51F3D3C1-3361-499F-B037-CCE8AB989989|1|||||TSCC|||MEQ/L|||NKAT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|1||38||INDUCTION TREATMENT|1961-11-27||||1969-08-24||1967-10-18|1971-01-05|
TRIAL STUDY 134XCP|QS|51F3D3C1-3361-499F-B037-CCE8AB989989|2|||||BWCS|||10^4 CFU|||NU/CL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|2||58||RUN-IN|1964-01-17||||1972-12-23||1960-12-08|1971-05-10|
TRIAL STUDY 134XCP|QS|51F3D3C1-3361-499F-B037-CCE8AB989989|3|||||HAMD 6 SELF-REPORT VERSION|||10^3 ORGANISMS/ML|||NMOL BCE/NMOL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|3||39||BASELINE|1961-02-07||||1961-10-19||1961-03-14|1967-07-17|
TRIAL STUDY 134XCP|QS|51F3D3C1-3361-499F-B037-CCE8AB989989|4|||||SF10 V1.0 CHILDREN STANDARD|||10^3 DNA COPIES/ML|||10^12 IU/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|Y|4||88||OPEN LABEL TREATMENT|1965-07-20||||1972-06-09||1972-12-16|1960-07-05|
TRIAL STUDY 134XCP|QS|51F3D3C1-3361-499F-B037-CCE8AB989989|5|||||SOWS SHORT|||KBQ|||/VF|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|N|5||7||RUN-IN|1960-07-19||||1966-04-19||1969-05-13|1965-03-14|
TRIAL STUDY 134XCP|QS|231D401F-CA93-49E0-AC5C-C7F636343D2F|1|||||SF12 V1.0 ACUTE|||PG/CELL|||L/KG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|1||38||BASELINE|1961-01-14||||1971-03-07||1960-07-18|1967-09-06|
TRIAL STUDY 134XCP|QS|231D401F-CA93-49E0-AC5C-C7F636343D2F|2|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||ML/S|||CUP EQ|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|U|2||58||BLINDED TREATMENT|1970-01-20||||1968-04-26||1961-12-29|1962-12-04|
TRIAL STUDY 134XCP|QS|231D401F-CA93-49E0-AC5C-C7F636343D2F|3|||||FACT-B V4|||U/G HB|||OD UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|N|3||39||TREATMENT|1964-12-30||||1971-08-28||1972-09-11|1960-07-14|
TRIAL STUDY 134XCP|QS|231D401F-CA93-49E0-AC5C-C7F636343D2F|4|||||BEBQ CONCURRENT|||FOZ_BR|||MPS U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|4||88||CONTINUATION TREATMENT|1973-06-28||||1972-09-03||1972-08-07|1969-02-13|
TRIAL STUDY 134XCP|QS|231D401F-CA93-49E0-AC5C-C7F636343D2F|5|||||NSCLC-SAQ V1.0|||CMH2O*S/ML|||/WK|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|5||7||CONTINUATION TREATMENT|1961-10-22||||1969-06-28||1966-07-14|1968-05-16|
TRIAL STUDY 134XCP|QS|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1|||||PSQI|||%/S|||PACK YEAR|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|1||38||BASELINE|1960-01-15||||1967-05-30||1961-07-26|1963-05-02|
TRIAL STUDY 134XCP|QS|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2|||||IPAQ-SF PHONE VERSION|||BQ/KG|||PT_BR|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|2||58||OBSERVATION|1961-07-21||||1962-09-12||1969-10-27|1966-11-26|
TRIAL STUDY 134XCP|QS|2704A3C0-3345-48E5-AC9B-C00EA51AB085|3|||||SWLS|||FIU|||10^4 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|Y|3||39||CONTINUATION TREATMENT|1963-08-12||||1960-03-17||1960-07-20|1971-08-06|
TRIAL STUDY 134XCP|QS|2704A3C0-3345-48E5-AC9B-C00EA51AB085|4|||||BPI|||LENS|||CI/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|4||88||WASHOUT|1965-10-28||||1962-02-09||1966-08-16|1970-07-19|
TRIAL STUDY 134XCP|QS|2704A3C0-3345-48E5-AC9B-C00EA51AB085|5|||||SF36 V1.0 STANDARD|||DRINK|||ML/KG/H|NOT DONE||LIKERT SCALE 7-POINT|N|NA|NA|5||7||BLINDED TREATMENT|1967-12-02||||1968-06-07||1968-07-08|1961-03-17|
TRIAL STUDY 134XCP|QS|2F636370-94FE-4BC0-9E16-DDD42D19A985|1|||||WHODAS 2.0 - 36-ITEM SELF|||ML/(MIN*100ML)|||MOSM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|N|1||38||WASHOUT|1961-09-10||||1963-07-19||1964-08-12|1972-11-23|
TRIAL STUDY 134XCP|QS|2F636370-94FE-4BC0-9E16-DDD42D19A985|2|||||ADSD V1.0|||DAYS/WK|||SHOCK WAVE|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|2||58||LONG-TERM FOLLOW-UP|1964-06-30||||1969-09-04||1961-11-13|1967-07-17|
TRIAL STUDY 134XCP|QS|2F636370-94FE-4BC0-9E16-DDD42D19A985|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||IU/DL|||UG/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|3||39||WASHOUT|1966-05-16||||1965-11-05||1960-02-18|1961-12-02|
TRIAL STUDY 134XCP|QS|2F636370-94FE-4BC0-9E16-DDD42D19A985|4|||||ASEX-FEMALE|||V|||FIU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|4||88||CONTINUATION TREATMENT|1966-07-30||||1964-02-17||1967-04-17|1970-02-11|
TRIAL STUDY 134XCP|QS|2F636370-94FE-4BC0-9E16-DDD42D19A985|5|||||WOMAC LK 3.1 INDEX|||/10^3|||NMOL BCE/MMOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|5||7||RUN-IN|1970-08-23||||1970-07-14||1973-07-31|1963-07-13|
TRIAL STUDY 134XCP|QS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1|||||WPAI-GH V2.0|||G|||TUBERCULIN UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|1||38||BASELINE|1963-09-08||||1973-01-14||1972-04-25|1971-06-25|
TRIAL STUDY 134XCP|QS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2|||||ADCS-ADL MCI|||/100 WBC|||M3|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|NA|2||58||OPEN LABEL TREATMENT|1972-11-02||||1972-03-14||1964-12-27|1963-10-29|
TRIAL STUDY 134XCP|QS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|3|||||C-SSRS CHILDREN'S BASELINE|||PMOL/10^10 CELLS|||MEQ/UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|U|3||39||CONTINUATION TREATMENT|1970-06-24||||1964-02-19||1973-06-09|1963-10-31|
TRIAL STUDY 134XCP|QS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|4|||||LEC-5 STANDARD VERSION|||BLOCKS|||ENZYME U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|4||88||TREATMENT|1965-10-21||||1964-03-15||1965-05-27|1967-12-01|
TRIAL STUDY 134XCP|QS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|5|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||MV/SEC|||LOG10 CFU/ML|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|5||7||TREATMENT|1973-01-11||||1964-01-31||1967-09-13|1969-11-18|
TRIAL STUDY 134XCP|QS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1|||||MDQ-T|||FT|||KPA|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|1||38||INDUCTION TREATMENT|1961-12-14||||1970-04-05||1969-05-15|1970-02-01|
TRIAL STUDY 134XCP|QS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2|||||PCL-5|||MN|||NG/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|2||58||TREATMENT|1971-11-05||||1962-03-05||1969-06-10|1965-07-26|
TRIAL STUDY 134XCP|QS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||EVENTS|||MG/KG/WEEK|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|3||39||RUN-IN|1970-03-15||||1961-01-22||1960-09-21|1964-12-18|
TRIAL STUDY 134XCP|QS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|4|||||EQ-5D-3L|||V/SEC|||M|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|4||88||WASHOUT|1961-01-13||||1960-05-18||1969-01-14|1971-03-08|
TRIAL STUDY 134XCP|QS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|5|||||MMRC|||G/M2/DAY|||MEQ/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|5||7||FOLLOW-UP|1965-11-27||||1970-02-12||1963-10-01|1968-05-16|
TRIAL STUDY 134XCP|QS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1|||||MNSI|||UU/DL|||ML/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|NA|1||38||BASELINE|1961-07-03||||1971-09-04||1971-04-30|1972-01-11|
TRIAL STUDY 134XCP|QS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2|||||SOBDA|||GY/H|||U.CARR|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|2||58||INDUCTION TREATMENT|1960-01-15||||1971-07-12||1972-03-25|1973-07-24|
TRIAL STUDY 134XCP|QS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|3|||||FIQR|||FEU|||/LSQN|NOT DONE||LIKERT SCALE 5-POINT|NA|N|N|3||39||RUN-IN|1968-10-20||||1960-10-14||1962-07-15|1969-11-12|
TRIAL STUDY 134XCP|QS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|4|||||BEBQ RETROSPECTIVE|||UV2|||BEATS/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|4||88||LONG-TERM FOLLOW-UP|1971-09-11||||1960-12-07||1960-10-27|1969-11-22|
TRIAL STUDY 134XCP|QS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|5|||||FACIT-FATIGUE 13-ITEM V4|||GY|||10^6 IU|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|5||7||FOLLOW-UP|1967-06-19||||1962-08-29||1968-03-26|1966-04-26|
TRIAL STUDY 134XCP|QS|A1FAB383-1757-4832-B888-90C133842EF8|1|||||EORTC QLQ-CR29 V2.1|||MU/L|||MS2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|1||38||RUN-IN|1966-03-16||||1972-10-01||1963-08-23|1973-02-16|
TRIAL STUDY 134XCP|QS|A1FAB383-1757-4832-B888-90C133842EF8|2|||||DRRI-2|||GY/H|||10^7/L|NOT DONE||LIKERT SCALE 3-POINT|NA|U|NA|2||58||FOLLOW-UP|1973-01-05||||1960-10-14||1965-12-08|1962-05-14|
TRIAL STUDY 134XCP|QS|A1FAB383-1757-4832-B888-90C133842EF8|3|||||UPDRS|||BAR|||MMOL/MOL|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|3||39||WASHOUT|1968-01-25||||1970-05-12||1961-10-03|1964-02-13|
TRIAL STUDY 134XCP|QS|A1FAB383-1757-4832-B888-90C133842EF8|4|||||FACT-COG V3|||IN2|||%/S|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|Y|4||88||BLINDED TREATMENT|1964-06-15||||1961-08-17||1970-05-29|1963-05-03|
TRIAL STUDY 134XCP|QS|A1FAB383-1757-4832-B888-90C133842EF8|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||KM/H|||AG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|N|5||7||LONG-TERM FOLLOW-UP|1962-05-25||||1973-08-21||1968-01-03|1969-06-23|
TRIAL STUDY 134XCP|QS|72AA1945-E676-4485-BD7F-6B969E314D83|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||EU|||10^8/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|NA|1||38||OPEN LABEL TREATMENT|1962-01-24||||1962-03-21||1972-03-02|1973-08-07|
TRIAL STUDY 134XCP|QS|72AA1945-E676-4485-BD7F-6B969E314D83|2|||||SOWS SUBJECTIVE|||DNA COPIES/UG|||RPM|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|U|2||58||BLINDED TREATMENT|1967-05-07||||1969-07-04||1969-03-15|1962-11-24|
TRIAL STUDY 134XCP|QS|72AA1945-E676-4485-BD7F-6B969E314D83|3|||||SGRQ-C|||BAR|||AG|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|3||39||LONG-TERM FOLLOW-UP|1968-03-29||||1971-10-19||1966-08-12|1972-03-03|
TRIAL STUDY 134XCP|QS|72AA1945-E676-4485-BD7F-6B969E314D83|4|||||MADRS|||GENEQ|||MCI/L|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|NA|4||88||WASHOUT|1966-10-05||||1969-11-08||1972-12-27|1960-05-21|
TRIAL STUDY 134XCP|QS|72AA1945-E676-4485-BD7F-6B969E314D83|5|||||C-SSRS CHILDREN'S BASELINE|||BQ/G|||/MM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|Y|5||7||LONG-TERM FOLLOW-UP|1972-05-16||||1969-11-09||1968-04-17|1972-06-20|
TRIAL STUDY 134XCP|QS|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1|||||GDS|||G/G|||C|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|Y|1||38||SCREENING|1973-05-17||||1970-09-22||1973-07-12|1968-10-10|
TRIAL STUDY 134XCP|QS|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2|||||FACT-BL V4|||KEV|||LOG10 TCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|Y|2||58||WASHOUT|1971-01-30||||1960-12-21||1972-03-08|1967-06-24|
TRIAL STUDY 134XCP|QS|B297C689-0D99-4E36-9F27-F93D4F43E2DD|3|||||PEDS-FACIT-F|||UEQ|||AU/ML|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|3||39||BLINDED TREATMENT|1960-06-01||||1964-01-02||1961-04-27|1969-04-04|
TRIAL STUDY 134XCP|QS|B297C689-0D99-4E36-9F27-F93D4F43E2DD|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||NMOL BCE/MMOL|||UG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|4||88||TREATMENT|1963-10-09||||1973-04-02||1964-03-21|1971-03-19|
TRIAL STUDY 134XCP|QS|B297C689-0D99-4E36-9F27-F93D4F43E2DD|5|||||NSCLC-SAQ V1.0|||GPELISA UNIT/ML|||KUSP|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|5||7||FOLLOW-UP|1967-01-17||||1966-12-04||1960-08-26|1971-12-02|
TRIAL STUDY 134XCP|QS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1|||||HAMD 6 SELF-REPORT VERSION|||MV|||TUBERCULIN UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|1||38||FOLLOW-UP|1966-11-08||||1972-09-16||1963-10-04|1970-07-05|
TRIAL STUDY 134XCP|QS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2|||||SF36 V2.0 ACUTE|||IU/MMOL|||V/V|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|2||58||INDUCTION TREATMENT|1961-01-24||||1972-04-16||1970-07-21|1971-12-11|
TRIAL STUDY 134XCP|QS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|3|||||ASEX-FEMALE|||EJACULATE U|||NMOL/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|N|3||39||BLINDED TREATMENT|1966-09-24||||1972-10-20||1972-05-07|1961-11-01|
TRIAL STUDY 134XCP|QS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|4|||||RAND-36 V1.0|||INHALATION|||UG/DL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|4||88||OPEN LABEL TREATMENT|1972-07-14||||1962-03-07||1964-08-17|1960-11-11|
TRIAL STUDY 134XCP|QS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|5|||||SF10 V1.0 CHILDREN STANDARD|||PUFF|||KPA/L/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|5||7||OPEN LABEL TREATMENT|1962-05-09||||1962-10-13||1962-04-05|1961-08-06|
TRIAL STUDY 134XCP|QS|3F18534E-367D-45C8-BB08-C82151A0CF00|1|||||SF12 V1.0 STANDARD|||PFU/DOSE|||UG/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|N|1||38||WASHOUT|1969-02-19||||1961-05-04||1965-10-27|1972-03-09|
TRIAL STUDY 134XCP|QS|3F18534E-367D-45C8-BB08-C82151A0CF00|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||UG/DAY|||G/G|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|2||58||OPEN LABEL TREATMENT|1962-03-15||||1960-02-24||1960-03-24|1973-05-12|
TRIAL STUDY 134XCP|QS|3F18534E-367D-45C8-BB08-C82151A0CF00|3|||||WPAI-GH V2.0|||DAGU/ML|||ML/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|U|3||39||CONTINUATION TREATMENT|1971-10-20||||1971-11-06||1970-08-05|1962-07-22|
TRIAL STUDY 134XCP|QS|3F18534E-367D-45C8-BB08-C82151A0CF00|4|||||ANSD V1.0|||COPIES/UL|||NL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|N|4||88||BASELINE|1967-11-17||||1963-02-14||1960-09-10|1966-01-17|
TRIAL STUDY 134XCP|QS|3F18534E-367D-45C8-BB08-C82151A0CF00|5|||||SF12 V2.0 STANDARD|||UG/L FEU|||NU/CL|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|5||7||LONG-TERM FOLLOW-UP|1962-06-30||||1963-10-20||1969-08-15|1960-12-28|
TRIAL STUDY 134XCP|QS|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1|||||SOWS SHORT|||MPL U/ML|||UMOL/L/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|1||38||OPEN LABEL TREATMENT|1971-09-24||||1964-07-15||1969-10-03|1962-04-30|
TRIAL STUDY 134XCP|QS|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||TESLA|||ML/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|2||58||LONG-TERM FOLLOW-UP|1964-06-30||||1971-12-18||1973-06-05|1965-06-30|
TRIAL STUDY 134XCP|QS|81C10FB0-3B47-46D8-B8B7-9C772246CA55|3|||||DAD|||MIN|||LOG10 TCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|Y|3||39||CONTINUATION TREATMENT|1960-01-16||||1965-05-31||1966-06-14|1973-05-31|
TRIAL STUDY 134XCP|QS|81C10FB0-3B47-46D8-B8B7-9C772246CA55|4|||||ESS|||M/SEC|||/4.0 ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|4||88||OBSERVATION|1966-03-12||||1971-12-05||1967-12-30|1962-08-12|
TRIAL STUDY 134XCP|QS|81C10FB0-3B47-46D8-B8B7-9C772246CA55|5|||||FSS|||UV2|||TUBERCULIN UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|5||7||SCREENING|1966-10-11||||1964-04-27||1973-03-16|1973-07-01|
TRIAL STUDY 134XCP|QS|67C99F41-D839-4B8E-9220-6EC161FCD457|1|||||IPAQ-LF PHONE VERSION|||UMOL/L/MIN|||PPB|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|1||38||WASHOUT|1968-10-27||||1962-08-07||1965-06-13|1965-02-03|
TRIAL STUDY 134XCP|QS|67C99F41-D839-4B8E-9220-6EC161FCD457|2|||||ADCS-CGIC|||MEQ/DAY|||G/CAGE/WK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|Y|2||58||INDUCTION TREATMENT|1961-10-15||||1969-01-31||1972-02-01|1965-05-20|
TRIAL STUDY 134XCP|QS|67C99F41-D839-4B8E-9220-6EC161FCD457|3|||||C-SSRS SCREENING|||KALLIKREIN INHIBITOR UNIT|||IU/G HB|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|3||39||BLINDED TREATMENT|1973-06-15||||1960-11-28||1967-11-11|1961-03-24|
TRIAL STUDY 134XCP|QS|67C99F41-D839-4B8E-9220-6EC161FCD457|4|||||FACT-LEU V4|||CUP EQ|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|4||88||RUN-IN|1965-10-13||||1973-07-28||1961-08-03|1965-08-11|
TRIAL STUDY 134XCP|QS|67C99F41-D839-4B8E-9220-6EC161FCD457|5|||||IPAQ-LF SELF-ADMINISTERED VERSION|||WATT|||MM/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|5||7||SCREENING|1971-11-16||||1966-01-27||1966-11-21|1963-11-22|
TRIAL STUDY 134XCP|QS|76B9C25F-B418-4979-9E18-4372C8AA700C|1|||||EQ-5D-3L|||SCOOPFUL|||MSEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|1||38||TREATMENT|1972-05-18||||1971-02-15||1961-11-22|1972-06-17|
TRIAL STUDY 134XCP|QS|76B9C25F-B418-4979-9E18-4372C8AA700C|2|||||GOSE|||KG|||BREATHS/30S|NOT DONE||LIKERT SCALE 7-POINT|N|Y|NA|2||58||FOLLOW-UP|1960-12-07||||1972-08-22||1967-08-23|1967-12-31|
TRIAL STUDY 134XCP|QS|76B9C25F-B418-4979-9E18-4372C8AA700C|3|||||FACT-LEU V4|||KHZ|||10^6 ORGANISMS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|3||39||OPEN LABEL TREATMENT|1961-09-19||||1970-12-18||1964-12-27|1969-05-31|
TRIAL STUDY 134XCP|QS|76B9C25F-B418-4979-9E18-4372C8AA700C|4|||||UPS|||MS/MMHG|||10^7 PFU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|4||88||OPEN LABEL TREATMENT|1966-08-23||||1972-05-17||1961-08-27|1966-03-08|
TRIAL STUDY 134XCP|QS|76B9C25F-B418-4979-9E18-4372C8AA700C|5|||||ACT|||TRANSDUCING UNIT/ML|||VIRTUAL PIXEL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|5||7||WASHOUT|1966-02-17||||1972-10-01||1964-01-10|1973-03-27|
TRIAL STUDY 134XCP|QS|9F622B53-71F8-4362-99A5-251993E3A946|1|||||EXPANDED DRS-PI SURVIVOR VERSION|||LENS|||U/G/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|1||38||TREATMENT|1972-06-24||||1960-06-12||1966-12-31|1963-06-30|
TRIAL STUDY 134XCP|QS|9F622B53-71F8-4362-99A5-251993E3A946|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||GPL U|||VG/KG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|N|2||58||BASELINE|1961-05-14||||1972-11-04||1964-12-24|1969-11-03|
TRIAL STUDY 134XCP|QS|9F622B53-71F8-4362-99A5-251993E3A946|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||YD|||MMOL/G|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|Y|3||39||OPEN LABEL TREATMENT|1973-05-11||||1962-08-03||1963-05-21|1966-08-28|
TRIAL STUDY 134XCP|QS|9F622B53-71F8-4362-99A5-251993E3A946|4|||||C-SSRS BASELINE/SCREENING VERSION|||RPM|||BAR|NOT DONE||LIKERT SCALE 7-POINT|NA|N|NA|4||88||BASELINE|1971-03-27||||1972-04-28||1963-08-19|1967-12-06|
TRIAL STUDY 134XCP|QS|9F622B53-71F8-4362-99A5-251993E3A946|5|||||SF8 V1.0 STANDARD|||BEATS/MIN|||CCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|5||7||RUN-IN|1963-01-03||||1960-10-01||1969-11-19|1964-01-12|
TRIAL STUDY 134XCP|QS|8F2DC6EB-0264-4112-B379-17896F4266E4|1|||||HADS|||MU/G|||CI/MG|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|NA|1||38||INDUCTION TREATMENT|1968-12-06||||1961-12-24||1971-11-30|1967-04-30|
TRIAL STUDY 134XCP|QS|8F2DC6EB-0264-4112-B379-17896F4266E4|2|||||UPDRS|||M/SEC2|||MG/M2|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|NA|2||58||RUN-IN|1972-03-31||||1968-04-24||1967-04-10|1964-02-13|
TRIAL STUDY 134XCP|QS|8F2DC6EB-0264-4112-B379-17896F4266E4|3|||||BLCS|||KG|||KAT|NOT DONE||LIKERT SCALE 7-POINT|U|Y|NA|3||39||SCREENING|1965-04-06||||1960-10-19||1964-02-05|1969-04-10|
TRIAL STUDY 134XCP|QS|8F2DC6EB-0264-4112-B379-17896F4266E4|4|||||MDS-UPDRS|||KS|||ML/CAGE/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|4||88||CONTINUATION TREATMENT|1972-08-24||||1972-02-12||1960-04-22|1969-10-21|
TRIAL STUDY 134XCP|QS|8F2DC6EB-0264-4112-B379-17896F4266E4|5|||||TSCYC|||GENEQ/ML|||UKAT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|U|5||7||OBSERVATION|1971-05-08||||1963-03-27||1960-02-06|1968-07-24|
TRIAL STUDY 134XCP|QS|448246D1-5625-4F69-B214-3A8848E86C28|1|||||SF8 V1.0 ACUTE|||PL|||ML*CMH2O|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|1||38||OBSERVATION|1964-08-27||||1963-09-27||1966-09-03|1970-01-10|
TRIAL STUDY 134XCP|QS|448246D1-5625-4F69-B214-3A8848E86C28|2|||||WLQ|||CMHG|||MNFI|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|2||58||BASELINE|1973-05-12||||1960-02-23||1963-08-11|1966-02-15|
TRIAL STUDY 134XCP|QS|448246D1-5625-4F69-B214-3A8848E86C28|3|||||CCQ 24 HOUR VERSION|||NKAT/L|||ABSORBANCE U/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|3||39||TREATMENT|1972-04-19||||1962-05-09||1969-07-16|1969-08-20|
TRIAL STUDY 134XCP|QS|448246D1-5625-4F69-B214-3A8848E86C28|4|||||CDR|||NMOL|||BAU|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|4||88||OBSERVATION|1972-06-25||||1965-02-07||1971-03-16|1965-04-16|
TRIAL STUDY 134XCP|QS|448246D1-5625-4F69-B214-3A8848E86C28|5|||||BIS-11|||M/SEC2|||BQ/UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|5||7||OPEN LABEL TREATMENT|1966-01-21||||1970-02-05||1971-05-03|1963-11-18|
TRIAL STUDY 134XCP|QS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1|||||FACT-BL V4|||G/MOL|||VP/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|1||38||RUN-IN|1962-12-12||||1971-11-09||1963-11-26|1970-08-07|
TRIAL STUDY 134XCP|QS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2|||||BIS-11|||VP/DOSE|||CG|NOT DONE||LIKERT SCALE 5-POINT|N|Y|U|2||58||BLINDED TREATMENT|1972-11-23||||1971-07-12||1970-01-09|1968-03-30|
TRIAL STUDY 134XCP|QS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|3|||||COWS|||DEG2|||CMH2O*S/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|3||39||RUN-IN|1968-07-09||||1963-02-26||1969-02-23|1968-02-03|
TRIAL STUDY 134XCP|QS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|4|||||TSCYC|||NSEC|||MG/KG/DOSE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|NA|4||88||RUN-IN|1970-07-23||||1965-07-16||1963-11-05|1969-12-14|
TRIAL STUDY 134XCP|QS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|5|||||WHODAS 2.0 - 36-ITEM SELF|||UG/H|||STEPS/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|5||7||LONG-TERM FOLLOW-UP|1967-12-01||||1971-01-10||1973-04-17|1966-08-23|
TRIAL STUDY 134XCP|QS|27DDBB16-ED11-45B6-987D-FB0D8223B993|1|||||FPSR|||UMOL/L/MIN|||ML/CAGE|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|1||38||FOLLOW-UP|1965-06-10||||1967-07-03||1972-04-13|1967-11-03|
TRIAL STUDY 134XCP|QS|27DDBB16-ED11-45B6-987D-FB0D8223B993|2|||||HAMD 6 SELF-REPORT VERSION|||MG/L FEU|||USIEMENS|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|2||58||RUN-IN|1971-12-14||||1962-03-08||1965-12-04|1962-09-17|
TRIAL STUDY 134XCP|QS|27DDBB16-ED11-45B6-987D-FB0D8223B993|3|||||SF36 V2.0 STANDARD|||NG/MOL|||KCAL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|Y|3||39||WASHOUT|1969-12-05||||1969-11-07||1970-11-24|1967-09-16|
TRIAL STUDY 134XCP|QS|27DDBB16-ED11-45B6-987D-FB0D8223B993|4|||||ACT|||ML/CAGE/WK|||KS|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|U|4||88||LONG-TERM FOLLOW-UP|1960-09-17||||1963-05-31||1972-10-22|1965-04-27|
TRIAL STUDY 134XCP|QS|27DDBB16-ED11-45B6-987D-FB0D8223B993|5|||||OCI|||SV|||U/10^12 RBC|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|5||7||OPEN LABEL TREATMENT|1973-07-22||||1961-10-10||1965-06-20|1972-05-09|
TRIAL STUDY 134XCP|QS|5545846C-F90F-4346-A075-05999641B872|1|||||ESS|||CI/G|||10^6/EJACULATE U|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|1||38||BASELINE|1965-05-26||||1963-01-28||1961-05-25|1962-11-21|
TRIAL STUDY 134XCP|QS|5545846C-F90F-4346-A075-05999641B872|2|||||GAD-7 V2|||U/MG|||MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|Y|2||58||FOLLOW-UP|1964-11-02||||1967-03-13||1967-07-11|1971-12-24|
TRIAL STUDY 134XCP|QS|5545846C-F90F-4346-A075-05999641B872|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||UG/ANIMAL|||NMOL/L|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|3||39||OBSERVATION|1970-09-03||||1966-02-13||1965-04-18|1964-04-07|
TRIAL STUDY 134XCP|QS|5545846C-F90F-4346-A075-05999641B872|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MOL/L|||HOURS|NOT DONE||LIKERT SCALE 7-POINT|N|U|Y|4||88||RUN-IN|1963-08-16||||1973-01-19||1964-01-30|1970-03-30|
TRIAL STUDY 134XCP|QS|5545846C-F90F-4346-A075-05999641B872|5|||||ACT|||10^9/DOSE|||MMHG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|5||7||WASHOUT|1970-01-22||||1962-06-29||1962-03-27|1966-09-19|
TRIAL STUDY 134XCP|QS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1|||||IBDQ|||UM/S|||HZ/S|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|1||38||OBSERVATION|1968-11-17||||1964-01-09||1965-08-02|1969-07-26|
TRIAL STUDY 134XCP|QS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2|||||YMRS|||STRIP|||UMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|Y|2||58||WASHOUT|1962-02-13||||1972-03-08||1972-12-29|1964-06-12|
TRIAL STUDY 134XCP|QS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|3|||||ADAS-COG|||WAFER|||DPM|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|3||39||BASELINE|1968-08-15||||1973-05-02||1972-04-25|1968-03-28|
TRIAL STUDY 134XCP|QS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|4|||||FBRSI|||UG/KG/MIN|||AMPULE|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|N|4||88||BASELINE|1960-01-22||||1969-05-02||1964-05-09|1969-03-12|
TRIAL STUDY 134XCP|QS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|5|||||BSFS|||MOSM|||LOG10 CFU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|5||7||SCREENING|1967-07-22||||1961-08-17||1968-11-05|1960-07-11|
TRIAL STUDY 134XCP|QS|111541DB-D863-4C68-9E62-B8741A62401C|1|||||CCQ 1 WEEK VERSION|||IN2|||CS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|N|1||38||LONG-TERM FOLLOW-UP|1966-06-01||||1961-11-16||1969-10-13|1966-04-11|
TRIAL STUDY 134XCP|QS|111541DB-D863-4C68-9E62-B8741A62401C|2|||||RDQ|||C|||/10^3|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|N|2||58||WASHOUT|1968-09-28||||1966-09-19||1966-08-02|1968-01-22|
TRIAL STUDY 134XCP|QS|111541DB-D863-4C68-9E62-B8741A62401C|3|||||PEDS-FACIT-F|||ML/M2/H|||G/CAGE/WK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|3||39||OBSERVATION|1968-09-16||||1969-12-28||1964-07-14|1969-05-08|
TRIAL STUDY 134XCP|QS|111541DB-D863-4C68-9E62-B8741A62401C|4|||||GAD-7 V2|||NMOL/G|||10^6 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|4||88||RUN-IN|1970-01-07||||1962-09-24||1967-08-09|1970-04-02|
TRIAL STUDY 134XCP|QS|111541DB-D863-4C68-9E62-B8741A62401C|5|||||VFQ-25 SELF ADMINISTERED|||NMOL|||CY/CM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|5||7||WASHOUT|1969-02-23||||1967-06-22||1967-03-04|1971-01-05|
TRIAL STUDY 134XCP|QS|5095C113-7278-4D41-B860-0DF6B9B98738|1|||||ACQ|||CI|||RAD|NOT DONE||LIKERT SCALE 7-POINT|U|NA|U|1||38||TREATMENT|1969-06-29||||1972-10-27||1962-01-23|1969-06-06|
TRIAL STUDY 134XCP|QS|5095C113-7278-4D41-B860-0DF6B9B98738|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||AMFI|||PFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|NA|2||58||OBSERVATION|1966-02-02||||1972-04-20||1970-04-27|1971-04-20|
TRIAL STUDY 134XCP|QS|5095C113-7278-4D41-B860-0DF6B9B98738|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||UEQ|||KV|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|3||39||SCREENING|1969-04-03||||1962-05-16||1971-05-05|1963-01-09|
TRIAL STUDY 134XCP|QS|5095C113-7278-4D41-B860-0DF6B9B98738|4|||||FACT-COG V3|||/KG|||MV*MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|N|4||88||RUN-IN|1964-02-14||||1968-12-09||1965-07-13|1962-08-31|
TRIAL STUDY 134XCP|QS|5095C113-7278-4D41-B860-0DF6B9B98738|5|||||HAQ-DI WITHOUT VAS|||% INHIBITION|||CM H2O|NOT DONE||LIKERT SCALE 7-POINT|N|Y|N|5||7||RUN-IN|1970-07-20||||1967-09-23||1963-10-27|1962-03-18|
TRIAL STUDY 134XCP|QS|61319D2E-A512-425F-9301-BAD27B5F5C9B|1|||||FOSI|||10^6 ORGANISMS/ML|||10^3/HPF|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|U|1||38||BASELINE|1960-02-02||||1962-06-01||1966-09-28|1965-09-08|
TRIAL STUDY 134XCP|QS|61319D2E-A512-425F-9301-BAD27B5F5C9B|2|||||PODCI - ADOLESCENT SELF REPORTED|||G/M2|||DIOPTER|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|2||58||BASELINE|1962-04-16||||1970-08-16||1963-05-21|1960-12-09|
TRIAL STUDY 134XCP|QS|61319D2E-A512-425F-9301-BAD27B5F5C9B|3|||||FIQR|||PFU/DOSE|||G/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|3||39||FOLLOW-UP|1969-05-29||||1961-07-25||1961-12-09|1969-11-09|
TRIAL STUDY 134XCP|QS|61319D2E-A512-425F-9301-BAD27B5F5C9B|4|||||IPAQ-LF PHONE VERSION|||SV|||CI/L|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|4||88||BASELINE|1960-09-29||||1964-08-04||1964-05-03|1968-12-31|
TRIAL STUDY 134XCP|QS|61319D2E-A512-425F-9301-BAD27B5F5C9B|5|||||EQ-5D-5L|||PMOL/L|||AMP|NOT DONE||LIKERT SCALE 5-POINT|N|N|Y|5||7||SCREENING|1962-04-17||||1966-11-06||1971-05-30|1962-04-21|
TRIAL STUDY 134XCP|QS|3B865A8F-949B-4B64-A818-85472EABB8FB|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||UV*SEC|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|1||38||RUN-IN|1973-07-05||||1969-06-21||1960-01-24|1970-08-21|
TRIAL STUDY 134XCP|QS|3B865A8F-949B-4B64-A818-85472EABB8FB|2|||||FACT-LEU V4|||MIN/DAY|||PIXELS/CM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|2||58||WASHOUT|1963-08-07||||1964-02-23||1969-03-01|1972-02-02|
TRIAL STUDY 134XCP|QS|3B865A8F-949B-4B64-A818-85472EABB8FB|3|||||IBDQ|||/100 WBC|||U/G/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|NA|3||39||BASELINE|1968-11-29||||1967-01-25||1970-04-05|1967-11-18|
TRIAL STUDY 134XCP|QS|3B865A8F-949B-4B64-A818-85472EABB8FB|4|||||FACT-TAXANE V4|||BREATHS/30S|||UGEQ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|Y|4||88||CONTINUATION TREATMENT|1965-04-09||||1969-03-09||1971-03-12|1967-03-09|
TRIAL STUDY 134XCP|QS|3B865A8F-949B-4B64-A818-85472EABB8FB|5|||||HAMD 6 SELF-REPORT VERSION|||DIP|||KG/MOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|U|5||7||WASHOUT|1962-03-11||||1966-08-03||1969-12-20|1973-06-03|
TRIAL STUDY 134XCP|QS|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1|||||SOWS SHORT|||DMOL|||MG2/DL2|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|U|1||38||FOLLOW-UP|1973-01-25||||1965-12-07||1965-10-07|1968-07-02|
TRIAL STUDY 134XCP|QS|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2|||||MSQOL-54|||KPA|||IU/G HB|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|2||58||TREATMENT|1964-07-05||||1972-04-10||1971-02-02|1967-10-14|
TRIAL STUDY 134XCP|QS|A6909912-22B9-4EE7-AEDF-F791F243A6B7|3|||||ADSD V1.0|||FG|||/2000 RBC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|3||39||OBSERVATION|1963-08-28||||1971-09-04||1969-04-11|1968-12-17|
TRIAL STUDY 134XCP|QS|A6909912-22B9-4EE7-AEDF-F791F243A6B7|4|||||ODI V2.1A|||CI/MG|||MHZ|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|4||88||WASHOUT|1969-05-31||||1970-04-23||1960-06-26|1971-01-16|
TRIAL STUDY 134XCP|QS|A6909912-22B9-4EE7-AEDF-F791F243A6B7|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||NMOL BCE/L|||DL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|5||7||INDUCTION TREATMENT|1970-09-12||||1961-09-21||1962-04-04|1965-09-11|
TRIAL STUDY 134XCP|QS|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1|||||PHQ-15|||NMOL/G|||MEQ/MMOL|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|1||38||BLINDED TREATMENT|1970-04-03||||1969-03-02||1970-02-09|1960-05-23|
TRIAL STUDY 134XCP|QS|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2|||||NPS|||CM2|||CAPSULE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|2||58||LONG-TERM FOLLOW-UP|1968-10-13||||1963-01-28||1965-05-30|1968-02-02|
TRIAL STUDY 134XCP|QS|83C8AAD3-B22D-42C6-870A-D069FAC601F3|3|||||FACIT-FATIGUE 13-ITEM V4|||/MBP|||10^7 CFU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|3||39||CONTINUATION TREATMENT|1962-06-26||||1967-07-29||1960-10-01|1973-03-16|
TRIAL STUDY 134XCP|QS|83C8AAD3-B22D-42C6-870A-D069FAC601F3|4|||||EPIC-CP|||KUSP|||M/SEC2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|Y|4||88||CONTINUATION TREATMENT|1965-10-15||||1963-09-19||1961-05-03|1967-01-06|
TRIAL STUDY 134XCP|QS|83C8AAD3-B22D-42C6-870A-D069FAC601F3|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||HOURS|||BOLUS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|NA|5||7||FOLLOW-UP|1972-01-05||||1965-11-01||1963-03-15|1973-05-16|
TRIAL STUDY 134XCP|QS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1|||||FAS-NACC UDS V3.0|||USEC|||/MM2|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|Y|1||38||WASHOUT|1966-04-23||||1969-06-18||1969-03-10|1961-07-08|
TRIAL STUDY 134XCP|QS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2|||||SIQR|||PMOL/L/H|||PM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|2||58||LONG-TERM FOLLOW-UP|1971-02-12||||1962-05-18||1961-03-17|1973-01-03|
TRIAL STUDY 134XCP|QS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||PIPE|||CI/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|NA|3||39||WASHOUT|1964-05-18||||1960-01-02||1966-08-24|1965-08-30|
TRIAL STUDY 134XCP|QS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|4|||||ADCS-ADL MCI|||UG/MOL|||MG/KG/WEEK|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|4||88||FOLLOW-UP|1971-02-23||||1960-03-28||1967-11-17|1968-11-18|
TRIAL STUDY 134XCP|QS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|5|||||SF12 V1.0 ACUTE|||MV2/HZ|||MOSM|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|5||7||BLINDED TREATMENT|1972-08-30||||1961-03-09||1964-09-08|1967-09-18|
TRIAL STUDY 134XCP|QS|937BF41A-157D-45F6-9797-2C5D19D100E6|1|||||CGI|||UG/KG/DAY|||OZ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|1||38||BASELINE|1973-07-14||||1962-11-17||1963-08-18|1971-04-03|
TRIAL STUDY 134XCP|QS|937BF41A-157D-45F6-9797-2C5D19D100E6|2|||||MPAI-4|||PPM|||DAYS|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|N|2||58||WASHOUT|1967-10-22||||1966-05-29||1962-07-11|1971-08-25|
TRIAL STUDY 134XCP|QS|937BF41A-157D-45F6-9797-2C5D19D100E6|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||IU/KG|||10^6 CFU/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|Y|3||39||BASELINE|1972-09-17||||1966-12-05||1965-06-02|1968-01-08|
TRIAL STUDY 134XCP|QS|937BF41A-157D-45F6-9797-2C5D19D100E6|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||DIP|||TSP EQ|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|4||88||INDUCTION TREATMENT|1960-01-18||||1960-07-23||1968-11-13|1969-05-30|
TRIAL STUDY 134XCP|QS|937BF41A-157D-45F6-9797-2C5D19D100E6|5|||||PDDS|||MET*MIN|||LOG EID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|5||7||RUN-IN|1971-09-02||||1961-03-15||1963-09-09|1963-12-16|
TRIAL STUDY 134XCP|QS|1BA56D89-E536-491E-AD6A-190A07331BEA|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||UG/H|||MOL/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|1||38||FOLLOW-UP|1965-10-30||||1971-02-10||1965-01-25|1969-12-18|
TRIAL STUDY 134XCP|QS|1BA56D89-E536-491E-AD6A-190A07331BEA|2|||||EORTC QLQ-C15-PAL V1.0|||FT2|||QUANTITY SUFFICIENT|NOT DONE||LIKERT SCALE 7-POINT|U|N|Y|2||58||BLINDED TREATMENT|1967-07-27||||1966-12-16||1961-07-02|1972-10-14|
TRIAL STUDY 134XCP|QS|1BA56D89-E536-491E-AD6A-190A07331BEA|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||MCI|||TESLA|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|NA|3||39||OPEN LABEL TREATMENT|1964-02-07||||1964-12-24||1966-08-04|1972-07-27|
TRIAL STUDY 134XCP|QS|1BA56D89-E536-491E-AD6A-190A07331BEA|4|||||C-SSRS SINCE LAST VISIT|||MCI/L|||MET*MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|4||88||RUN-IN|1966-11-11||||1969-04-27||1971-09-22|1968-04-16|
TRIAL STUDY 134XCP|QS|1BA56D89-E536-491E-AD6A-190A07331BEA|5|||||PI|||ATM|||BEL|NOT DONE||LIKERT SCALE 7-POINT|N|U|NA|5||7||FOLLOW-UP|1960-05-11||||1965-01-04||1969-06-19|1964-04-30|
TRIAL STUDY 134XCP|QS|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1|||||WOMAC LK 3.1 INDEX|||PMOL/10^9 CELLS|||UG/L DDU|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|1||38||LONG-TERM FOLLOW-UP|1966-09-04||||1961-03-15||1961-08-24|1965-08-06|
TRIAL STUDY 134XCP|QS|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||MET|||MBP|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|N|2||58||TREATMENT|1973-07-23||||1971-12-23||1964-03-31|1960-05-25|
TRIAL STUDY 134XCP|QS|BE208D93-7322-427F-A8E5-1DBE5040BE8F|3|||||T1-DDS|||PG|||ML/G/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|3||39||CONTINUATION TREATMENT|1963-05-24||||1966-06-17||1969-12-11|1964-03-23|
TRIAL STUDY 134XCP|QS|BE208D93-7322-427F-A8E5-1DBE5040BE8F|4|||||FACT-P V4|||IU/KG/H|||L/S/KPA|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|4||88||WASHOUT|1971-08-31||||1966-08-20||1961-02-05|1969-03-25|
TRIAL STUDY 134XCP|QS|BE208D93-7322-427F-A8E5-1DBE5040BE8F|5|||||LEC-5 STANDARD VERSION|||PT_US|||UU/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|Y|5||7||INDUCTION TREATMENT|1961-03-01||||1960-03-27||1970-05-31|1969-03-23|
TRIAL STUDY 134XCP|QS|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1|||||EPIC-CP|||HEP|||DRUM|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|1||38||SCREENING|1971-03-18||||1966-01-24||1965-02-02|1973-04-23|
TRIAL STUDY 134XCP|QS|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2|||||MSQOL-54|||PPB|||U/M2/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|2||58||CONTINUATION TREATMENT|1970-04-06||||1973-09-04||1967-06-19|1968-01-21|
TRIAL STUDY 134XCP|QS|A58C5E7B-21EC-4F59-BB74-3264AC945F61|3|||||HADS|||CUP|||GENEQ/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|3||39||TREATMENT|1967-04-15||||1964-03-29||1964-05-21|1964-03-19|
TRIAL STUDY 134XCP|QS|A58C5E7B-21EC-4F59-BB74-3264AC945F61|4|||||SF12 V2.0 ACUTE|||PLUG|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|4||88||WASHOUT|1960-06-27||||1964-07-20||1969-08-19|1966-11-03|
TRIAL STUDY 134XCP|QS|A58C5E7B-21EC-4F59-BB74-3264AC945F61|5|||||SOWS SUBJECTIVE|||ML/DOSE|||MG/G/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|NA|U|5||7||WASHOUT|1966-09-29||||1968-03-23||1972-05-30|1973-09-07|
TRIAL STUDY 134XCP|QS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1|||||DLQI|||ABSORBANCE U/ML|||10^9 CFU/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|N|1||38||BLINDED TREATMENT|1968-11-21||||1969-12-25||1968-07-14|1965-08-07|
TRIAL STUDY 134XCP|QS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2|||||FACT-BL V4|||IN|||SV|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|Y|2||58||OPEN LABEL TREATMENT|1968-01-20||||1965-10-18||1969-09-04|1969-11-28|
TRIAL STUDY 134XCP|QS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|3|||||FACT-TAXANE V4|||PFU/ANIMAL|||SYRINGE|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||CONTINUATION TREATMENT|1963-05-27||||1972-08-14||1960-07-30|1964-06-28|
TRIAL STUDY 134XCP|QS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||CD|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|4||88||OBSERVATION|1964-05-20||||1967-05-01||1963-02-22|1962-10-18|
TRIAL STUDY 134XCP|QS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|5|||||FAMS|||ML/KG|||UKAT|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|5||7||INDUCTION TREATMENT|1968-03-20||||1972-07-12||1967-09-24|1969-11-21|
TRIAL STUDY 134XCP|QS|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1|||||MSQOL-54|||L/S|||EVENTS|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|1||38||BASELINE|1963-07-13||||1960-03-25||1964-09-17|1968-11-24|
TRIAL STUDY 134XCP|QS|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2|||||TSCYC|||MG/KG|||MPH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|2||58||RUN-IN|1964-01-10||||1963-03-20||1965-01-09|1965-12-21|
TRIAL STUDY 134XCP|QS|434B4F6A-C436-4F92-8FA5-9C2F1964098A|3|||||ADHD-RS-IV HOME VERSION|||UG/MIN|||IU/DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|Y|3||39||BASELINE|1971-12-01||||1970-10-31||1962-06-30|1969-02-01|
TRIAL STUDY 134XCP|QS|434B4F6A-C436-4F92-8FA5-9C2F1964098A|4|||||C-SSRS BASELINE/SCREENING VERSION|||TSP|||ML/S/M2|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|4||88||FOLLOW-UP|1965-10-19||||1964-03-28||1970-04-25|1961-12-01|
TRIAL STUDY 134XCP|QS|434B4F6A-C436-4F92-8FA5-9C2F1964098A|5|||||FACT-LEU V4|||UG|||L/DAY|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|5||7||OBSERVATION|1961-06-19||||1966-04-01||1968-11-22|1961-08-25|
TRIAL STUDY 134XCP|QS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1|||||SF10 V1.0 CHILDREN ACUTE|||VIRTUAL PIXEL|||U/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|U|1||38||TREATMENT|1970-03-17||||1963-12-30||1969-10-08|1961-02-26|
TRIAL STUDY 134XCP|QS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2|||||SF12 V1.0 ACUTE|||MG/L|||10^6/EJACULATE U|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|2||58||LONG-TERM FOLLOW-UP|1964-09-10||||1963-11-26||1970-04-24|1967-03-05|
TRIAL STUDY 134XCP|QS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||MG/KG|||CI/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|3||39||WASHOUT|1964-04-28||||1970-11-16||1960-05-28|1973-05-13|
TRIAL STUDY 134XCP|QS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|4|||||FACT-BL V4|||G/CM2|||U/DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|4||88||OBSERVATION|1967-10-29||||1966-01-23||1969-08-04|1965-10-08|
TRIAL STUDY 134XCP|QS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|5|||||FACIT-DYSPNEA 33 ITEM BANK|||%/S|||10^6 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|5||7||INDUCTION TREATMENT|1971-11-11||||1968-01-14||1962-08-04|1971-03-23|
TRIAL STUDY 134XCP|QS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1|||||OCI|||CYCLE/MIN|||UM/S|NOT DONE||LIKERT SCALE 5-POINT|N|Y|Y|1||38||BASELINE|1964-03-29||||1969-11-29||1963-04-26|1960-11-23|
TRIAL STUDY 134XCP|QS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2|||||OCI|||BEATS/MIN|||COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|Y|2||58||INDUCTION TREATMENT|1973-06-27||||1961-10-28||1963-12-14|1970-04-20|
TRIAL STUDY 134XCP|QS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|3|||||C-SSRS BASELINE|||GPELISA UNIT/ML|||DPM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|U|3||39||LONG-TERM FOLLOW-UP|1971-03-12||||1968-10-31||1973-09-05|1961-09-15|
TRIAL STUDY 134XCP|QS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|4|||||GMSS VERSION TYPE 1 DIABETES|||/DAY|||/VF|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|4||88||BLINDED TREATMENT|1968-12-18||||1965-11-14||1973-06-27|1970-10-15|
TRIAL STUDY 134XCP|QS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|5|||||PODCI - ADOLESCENT SELF REPORTED|||DIP|||PMOL/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|Y|5||7||CONTINUATION TREATMENT|1966-04-05||||1964-11-06||1971-08-01|1966-02-15|
TRIAL STUDY 134XCP|QS|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1|||||PODCI - ADOLESCENT PARENT REPORTED|||GMFI|||TSP EQ|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|1||38||SCREENING|1961-10-17||||1973-04-23||1963-11-26|1960-03-23|
TRIAL STUDY 134XCP|QS|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2|||||DRRI-2|||10^6 COPIES/ML|||QUANTITY SUFFICIENT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|2||58||WASHOUT|1970-02-01||||1966-03-02||1968-01-19|1964-04-22|
TRIAL STUDY 134XCP|QS|73C4A4D7-2177-47F3-818A-C0774F5E4A08|3|||||BPI|||GLOBULE|||MM/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|Y|3||39||FOLLOW-UP|1960-10-12||||1966-06-01||1962-09-25|1972-06-16|
TRIAL STUDY 134XCP|QS|73C4A4D7-2177-47F3-818A-C0774F5E4A08|4|||||EXPANDED DRS-PI CAREGIVER VERSION|||GRAVITATIONAL UNIT|||ML/H|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|4||88||SCREENING|1971-04-18||||1972-05-18||1965-10-26|1967-09-01|
TRIAL STUDY 134XCP|QS|73C4A4D7-2177-47F3-818A-C0774F5E4A08|5|||||ADAS-COG|||G/DL|||TRANSDUCING UNIT/ML|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|5||7||INDUCTION TREATMENT|1965-03-08||||1965-08-16||1966-01-15|1973-05-14|
TRIAL STUDY 134XCP|QS|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1|||||WHODAS 2.0 - 36-ITEM SELF|||UV2|||UG/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|Y|1||38||WASHOUT|1960-09-12||||1964-01-06||1968-06-17|1964-04-04|
TRIAL STUDY 134XCP|QS|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2|||||SMDDS V1.0|||PFU/ANIMAL|||BQ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|2||58||OPEN LABEL TREATMENT|1970-08-04||||1961-06-01||1964-04-29|1972-10-01|
TRIAL STUDY 134XCP|QS|4E3929B3-63F2-4E89-8EB4-60991E7284E1|3|||||PHQ-15|||BREATHS/MIN|||RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|NA|3||39||CONTINUATION TREATMENT|1962-04-05||||1962-12-09||1962-03-08|1963-03-18|
TRIAL STUDY 134XCP|QS|4E3929B3-63F2-4E89-8EB4-60991E7284E1|4|||||NPS|||10^6 ORGANISMS/ML|||10^4 CFU|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|U|4||88||INDUCTION TREATMENT|1970-04-30||||1970-02-17||1969-03-31|1970-10-16|
TRIAL STUDY 134XCP|QS|4E3929B3-63F2-4E89-8EB4-60991E7284E1|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||DYN|||10^3 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|N|5||7||OPEN LABEL TREATMENT|1967-05-13||||1967-12-30||1969-10-05|1970-03-31|
TRIAL STUDY 134XCP|QS|F26E2F67-3F90-448C-92BB-AD60E71D5664|1|||||BSFS|||CFU/ML|||ML/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|1||38||BLINDED TREATMENT|1971-04-16||||1961-03-27||1966-02-23|1965-11-10|
TRIAL STUDY 134XCP|QS|F26E2F67-3F90-448C-92BB-AD60E71D5664|2|||||MNSI|||UG/ANIMAL|||CYCLE/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|2||58||RUN-IN|1964-12-17||||1962-03-28||1963-08-31|1966-10-02|
TRIAL STUDY 134XCP|QS|F26E2F67-3F90-448C-92BB-AD60E71D5664|3|||||FACT-COG V3|||MG/L|||/WK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|U|3||39||WASHOUT|1972-04-09||||1963-06-22||1962-05-18|1965-12-16|
TRIAL STUDY 134XCP|QS|F26E2F67-3F90-448C-92BB-AD60E71D5664|4|||||FACIT-FATIGUE 13-ITEM V4|||MESF|||ML/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|Y|4||88||RUN-IN|1962-03-24||||1970-12-26||1965-12-29|1960-08-17|
TRIAL STUDY 134XCP|QS|F26E2F67-3F90-448C-92BB-AD60E71D5664|5|||||ADCS-ADL|||QUANTITY SUFFICIENT|||KCAL/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|5||7||LONG-TERM FOLLOW-UP|1967-05-18||||1960-04-19||1969-11-01|1969-12-15|
TRIAL STUDY 134XCP|QS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1|||||SDS|||CAL|||NMOL BCE/L|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|1||38||BLINDED TREATMENT|1972-07-16||||1971-06-07||1965-12-27|1970-03-04|
TRIAL STUDY 134XCP|QS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2|||||NCCN-FACT FBRSI-24 V2|||CM/MIN|||KM/H|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|2||58||CONTINUATION TREATMENT|1968-08-23||||1963-06-21||1967-07-05|1963-02-18|
TRIAL STUDY 134XCP|QS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|3|||||NCCN-FACT FBLSI-18 V2|||U.CARR|||LENS|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|3||39||BASELINE|1970-05-18||||1966-02-23||1960-08-10|1968-02-13|
TRIAL STUDY 134XCP|QS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|4|||||PHQ-15|||JAR|||G/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|4||88||FOLLOW-UP|1971-09-13||||1963-05-08||1968-02-23|1963-04-09|
TRIAL STUDY 134XCP|QS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|5|||||LEC-5 STANDARD VERSION|||GLOBULE|||UL/ML|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|5||7||BLINDED TREATMENT|1963-02-19||||1972-06-26||1960-09-27|1971-03-06|
TRIAL STUDY 134XCP|QS|F2F1151C-F987-49CE-BC16-719DD339DBE7|1|||||AQ20|||ROENTGEN|||CMH2O*S2/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|NA|1||38||FOLLOW-UP|1964-01-03||||1961-02-08||1967-03-14|1961-03-11|
TRIAL STUDY 134XCP|QS|F2F1151C-F987-49CE-BC16-719DD339DBE7|2|||||IVIS|||MG/M2/H|||USIEMENS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|2||58||OBSERVATION|1964-01-30||||1967-01-22||1971-01-05|1968-01-23|
TRIAL STUDY 134XCP|QS|F2F1151C-F987-49CE-BC16-719DD339DBE7|3|||||IPAQ-LF PHONE VERSION|||/200 HPFS|||UU/DL|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|3||39||RUN-IN|1970-06-07||||1961-07-28||1964-09-04|1963-10-30|
TRIAL STUDY 134XCP|QS|F2F1151C-F987-49CE-BC16-719DD339DBE7|4|||||HAMD 6 SELF-REPORT VERSION|||AMFI|||VP/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|N|4||88||BLINDED TREATMENT|1967-01-23||||1964-08-18||1964-03-10|1969-07-26|
TRIAL STUDY 134XCP|QS|F2F1151C-F987-49CE-BC16-719DD339DBE7|5|||||SIQR|||MG/DAY|||MBQ/UL|NOT DONE||LIKERT SCALE 5-POINT|N|Y|U|5||7||TREATMENT|1972-12-29||||1962-04-19||1962-05-15|1961-11-24|
TRIAL STUDY 134XCP|QS|F88FCFA6-90D7-4033-86DF-223A63A6152D|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||SV|||UM/S|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|1||38||FOLLOW-UP|1969-03-22||||1963-03-19||1973-07-14|1966-07-30|
TRIAL STUDY 134XCP|QS|F88FCFA6-90D7-4033-86DF-223A63A6152D|2|||||PI|||UV2|||ML/CM H2O|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|NA|2||58||FOLLOW-UP|1967-03-29||||1969-06-06||1963-08-11|1968-01-05|
TRIAL STUDY 134XCP|QS|F88FCFA6-90D7-4033-86DF-223A63A6152D|3|||||CCQ 1 WEEK VERSION|||CD*S/M2|||SHOCK WAVE|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|3||39||OPEN LABEL TREATMENT|1963-08-18||||1960-07-14||1973-01-22|1971-06-24|
TRIAL STUDY 134XCP|QS|F88FCFA6-90D7-4033-86DF-223A63A6152D|4|||||PHQ-9|||MG/KG/DOSE|||PA|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|4||88||INDUCTION TREATMENT|1969-07-08||||1966-06-20||1967-07-31|1961-01-30|
TRIAL STUDY 134XCP|QS|F88FCFA6-90D7-4033-86DF-223A63A6152D|5|||||SF12 V1.0 ACUTE|||MET*H|||MG/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|5||7||INDUCTION TREATMENT|1960-02-26||||1973-01-29||1970-03-10|1972-04-29|
TRIAL STUDY 134XCP|QS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1|||||COWS|||TROCHE|||KIT|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|1||38||OPEN LABEL TREATMENT|1971-07-05||||1963-12-07||1970-11-15|1964-06-25|
TRIAL STUDY 134XCP|QS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2|||||C-SSRS ALREADY ENROLLED SUBJECTS|||CUP|||DNA COPIES/UG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|Y|2||58||OBSERVATION|1962-04-15||||1962-07-07||1971-12-01|1970-07-25|
TRIAL STUDY 134XCP|QS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|3|||||HAEM-A-QOL|||UMOL/L/MIN|||ML/M2/DAY|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|3||39||RUN-IN|1971-08-01||||1966-11-29||1965-10-30|1963-07-15|
TRIAL STUDY 134XCP|QS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|4|||||MSQOL-54|||UG/MIN|||MV|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|N|4||88||LONG-TERM FOLLOW-UP|1960-03-30||||1961-08-18||1961-03-25|1960-11-16|
TRIAL STUDY 134XCP|QS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|5|||||FAQ-NACC VERSION|||LOG10 PFU|||KM/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|N|5||7||RUN-IN|1973-04-21||||1965-12-20||1970-08-07|1969-09-27|
TRIAL STUDY 134XCP|QS|7D35B2F5-7334-448B-B4E1-14671B850B6A|1|||||SOBDA|||10^9 ORGANISMS|||10^6 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|Y|1||38||CONTINUATION TREATMENT|1967-03-14||||1966-04-14||1963-07-13|1961-04-09|
TRIAL STUDY 134XCP|QS|7D35B2F5-7334-448B-B4E1-14671B850B6A|2|||||SOAPP-R|||MIN/DAY|||10^7 CFU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|2||58||SCREENING|1961-10-18||||1961-01-19||1968-09-20|1967-08-31|
TRIAL STUDY 134XCP|QS|7D35B2F5-7334-448B-B4E1-14671B850B6A|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||CCID 50/DOSE|||ML/CM3/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|3||39||RUN-IN|1960-04-19||||1960-08-20||1970-11-05|1960-08-24|
TRIAL STUDY 134XCP|QS|7D35B2F5-7334-448B-B4E1-14671B850B6A|4|||||SOWS SHORT|||MG/M2|||DISK|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|4||88||BLINDED TREATMENT|1966-02-23||||1971-10-09||1967-03-06|1961-09-24|
TRIAL STUDY 134XCP|QS|7D35B2F5-7334-448B-B4E1-14671B850B6A|5|||||FIQR|||PPM|||USP U|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|5||7||OPEN LABEL TREATMENT|1972-01-29||||1973-01-18||1964-10-07|1972-12-22|
TRIAL STUDY 134XCP|QS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1|||||ADSD V1.0|||ML/H|||MPL U|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|1||38||INDUCTION TREATMENT|1962-02-12||||1973-05-31||1960-12-10|1967-08-02|
TRIAL STUDY 134XCP|QS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2|||||NCCN-FACT FBRSI-24 V2|||ML/DAY|||TITER|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|2||58||BLINDED TREATMENT|1960-01-08||||1970-02-27||1963-02-02|1962-06-28|
TRIAL STUDY 134XCP|QS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||S/H|||BE/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|3||39||OPEN LABEL TREATMENT|1970-08-10||||1970-02-15||1961-11-21|1971-05-08|
TRIAL STUDY 134XCP|QS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||DL|||CY/CM|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|Y|4||88||CONTINUATION TREATMENT|1964-06-04||||1968-01-30||1970-10-04|1973-07-06|
TRIAL STUDY 134XCP|QS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||V/V|||V/SEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|NA|5||7||BASELINE|1960-10-21||||1962-11-09||1960-08-18|1960-11-25|
TRIAL STUDY 134XCP|QS|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1|||||PHQ SCREENER VERSION|||MM|||LOZENGE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|1||38||RUN-IN|1960-09-29||||1970-10-05||1964-04-01|1971-01-29|
TRIAL STUDY 134XCP|QS|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2|||||SF12 V2.0 ACUTE|||10^8 PFU|||PT_BR|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|2||58||SCREENING|1964-08-18||||1960-05-14||1961-11-10|1968-01-17|
TRIAL STUDY 134XCP|QS|B09D371C-2E5C-4F84-986E-5A603C0C4A28|3|||||LEC-5 STANDARD VERSION|||CM/MIN|||CG|NOT DONE||LIKERT SCALE 7-POINT|N|NA|N|3||39||FOLLOW-UP|1968-09-04||||1969-09-22||1973-02-13|1965-03-28|
TRIAL STUDY 134XCP|QS|B09D371C-2E5C-4F84-986E-5A603C0C4A28|4|||||IPAQ-LF PHONE VERSION|||DRUM|||UG/G/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|U|Y|4||88||WASHOUT|1970-06-01||||1968-01-21||1963-09-04|1961-03-05|
TRIAL STUDY 134XCP|QS|B09D371C-2E5C-4F84-986E-5A603C0C4A28|5|||||FBRSI|||L/S/KPA|||100 IU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|Y|5||7||WASHOUT|1968-08-03||||1969-02-21||1970-02-05|1970-03-29|
TRIAL STUDY 134XCP|QS|11CB653E-F113-4639-B15C-B236A2F65F47|1|||||GAD-7|||CM H2O|||MMAL|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|1||38||OBSERVATION|1964-11-10||||1971-08-03||1962-12-22|1967-03-16|
TRIAL STUDY 134XCP|QS|11CB653E-F113-4639-B15C-B236A2F65F47|2|||||PGI|||/MONTH|||PNU/ML|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|N|2||58||OPEN LABEL TREATMENT|1969-04-07||||1973-03-19||1965-06-12|1965-04-02|
TRIAL STUDY 134XCP|QS|11CB653E-F113-4639-B15C-B236A2F65F47|3|||||RDQ|||U/KG/MIN|||DB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|3||39||OPEN LABEL TREATMENT|1972-08-05||||1967-03-06||1962-04-14|1970-03-06|
TRIAL STUDY 134XCP|QS|11CB653E-F113-4639-B15C-B236A2F65F47|4|||||ADHD-RS-IV HOME VERSION|||UMOL/DAY|||KUSP|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|4||88||LONG-TERM FOLLOW-UP|1960-02-15||||1962-03-20||1970-10-21|1964-06-16|
TRIAL STUDY 134XCP|QS|11CB653E-F113-4639-B15C-B236A2F65F47|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||UGEQ/L|||10^7 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|5||7||OBSERVATION|1962-05-29||||1966-11-24||1965-02-18|1969-12-06|
TRIAL STUDY 134XCP|QS|2AB992E7-55B7-4327-987C-47FD605B7D78|1|||||BLCS|||MSEC|||M3|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|Y|1||38||LONG-TERM FOLLOW-UP|1973-06-20||||1962-09-01||1963-03-31|1971-04-30|
TRIAL STUDY 134XCP|QS|2AB992E7-55B7-4327-987C-47FD605B7D78|2|||||CHART-SF INTERVIEW VERSION|||LOZENGE|||APS U|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|N|2||58||BASELINE|1964-08-20||||1971-03-01||1972-04-17|1972-12-17|
TRIAL STUDY 134XCP|QS|2AB992E7-55B7-4327-987C-47FD605B7D78|3|||||SF36 V2.0 STANDARD|||MMHG/L/MIN|||CCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|Y|3||39||OPEN LABEL TREATMENT|1969-05-20||||1965-12-31||1962-12-03|1969-04-01|
TRIAL STUDY 134XCP|QS|2AB992E7-55B7-4327-987C-47FD605B7D78|4|||||COMM|||MG/KG/DAY|||/2500 WBC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|4||88||FOLLOW-UP|1962-08-17||||1960-10-09||1972-02-04|1960-06-02|
TRIAL STUDY 134XCP|QS|2AB992E7-55B7-4327-987C-47FD605B7D78|5|||||FACT/GOG-NTX V4|||10^3 CFU/G|||NMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|NA|5||7||BLINDED TREATMENT|1962-06-11||||1968-03-08||1972-06-28|1967-01-15|
TRIAL STUDY 134XCP|QS|6AF1B0B0-9923-459A-8629-5E628400AD00|1|||||MSIS-29 V1|||SHOCK WAVE|||AU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|Y|1||38||BLINDED TREATMENT|1964-02-29||||1968-06-14||1971-05-04|1970-03-23|
TRIAL STUDY 134XCP|QS|6AF1B0B0-9923-459A-8629-5E628400AD00|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||DPM/ML|||NMOL/L/H|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|N|2||58||SCREENING|1965-10-05||||1969-03-10||1964-03-21|1971-09-28|
TRIAL STUDY 134XCP|QS|6AF1B0B0-9923-459A-8629-5E628400AD00|3|||||SF36 V1.0 STANDARD|||AMPULE|||MG/KG/DAY|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|3||39||TREATMENT|1966-06-25||||1973-05-25||1971-01-01|1962-11-08|
TRIAL STUDY 134XCP|QS|6AF1B0B0-9923-459A-8629-5E628400AD00|4|||||ADHD-RS-IV HOME VERSION|||ELISA UNIT/ML|||MEQ/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|N|4||88||SCREENING|1962-04-21||||1960-11-02||1969-08-23|1969-03-31|
TRIAL STUDY 134XCP|QS|6AF1B0B0-9923-459A-8629-5E628400AD00|5|||||SF10 V1.0 CHILDREN STANDARD|||BAR|||KA_U/DL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|Y|5||7||OBSERVATION|1960-11-03||||1969-05-29||1963-05-16|1967-11-07|
TRIAL STUDY 134XCP|QS|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1|||||IVIS|||PMOL/10^9 CELLS|||/500 WBC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|1||38||OBSERVATION|1972-12-31||||1968-09-25||1970-05-03|1967-11-17|
TRIAL STUDY 134XCP|QS|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2|||||EXPANDED DRS-PI SURVIVOR VERSION|||PUFF|||NSEC|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|2||58||WASHOUT|1963-04-20||||1971-06-30||1969-07-19|1967-05-31|
TRIAL STUDY 134XCP|QS|E1305E4E-DF64-4FD1-B0B2-131459AB629D|3|||||FIQR|||RAD|||10^6 CFU|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|3||39||INDUCTION TREATMENT|1965-11-17||||1963-10-29||1960-05-06|1972-08-18|
TRIAL STUDY 134XCP|QS|E1305E4E-DF64-4FD1-B0B2-131459AB629D|4|||||HADS|||L/KG|||FEU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|4||88||CONTINUATION TREATMENT|1963-08-28||||1967-01-04||1967-03-16|1963-02-13|
TRIAL STUDY 134XCP|QS|E1305E4E-DF64-4FD1-B0B2-131459AB629D|5|||||BORG CR10|||UG/M2|||10^4 CFU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|5||7||FOLLOW-UP|1965-09-15||||1966-07-20||1964-08-19|1969-12-08|
TRIAL STUDY 134XCP|QS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1|||||FACT-P V4|||UG/L/H|||ML/MMHG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|NA|1||38||CONTINUATION TREATMENT|1970-02-22||||1968-10-03||1966-12-15|1963-08-28|
TRIAL STUDY 134XCP|QS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2|||||PGI|||MMOL/S|||ANTI-XA IU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|2||58||SCREENING|1969-02-28||||1960-05-16||1972-10-02|1960-10-31|
TRIAL STUDY 134XCP|QS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|3|||||BPI|||UKAT/10^12 RBC|||S*KPA|NOT DONE||LIKERT SCALE 3-POINT|U|N|NA|3||39||CONTINUATION TREATMENT|1967-10-10||||1962-06-11||1960-05-30|1969-04-02|
TRIAL STUDY 134XCP|QS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|4|||||PODCI - PEDIATRIC PARENT REPORTED|||TITER|||10^6/HPF|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|4||88||BASELINE|1966-10-03||||1969-12-01||1965-05-15|1960-10-30|
TRIAL STUDY 134XCP|QS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|5|||||SIQ-JR|||U/CL|||KUSP|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|5||7||OPEN LABEL TREATMENT|1963-01-10||||1960-05-18||1965-07-17|1964-07-19|
TRIAL STUDY 134XCP|QS|0FD7F837-3D76-4A1C-B414-373B55A39506|1|||||PROSQOLI|||BU/ML|||MG/G/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|1||38||TREATMENT|1970-10-11||||1968-04-08||1968-12-15|1969-12-05|
TRIAL STUDY 134XCP|QS|0FD7F837-3D76-4A1C-B414-373B55A39506|2|||||PARTNER-DDS|||FEU|||PA|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|2||58||CONTINUATION TREATMENT|1963-03-21||||1966-04-13||1961-02-17|1960-06-22|
TRIAL STUDY 134XCP|QS|0FD7F837-3D76-4A1C-B414-373B55A39506|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||MS2|||MG/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|Y|3||39||FOLLOW-UP|1969-10-21||||1966-06-30||1971-04-15|1961-07-19|
TRIAL STUDY 134XCP|QS|0FD7F837-3D76-4A1C-B414-373B55A39506|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||/VF|||G/ANIMAL/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|N|4||88||SCREENING|1964-01-08||||1968-08-13||1968-02-06|1971-05-02|
TRIAL STUDY 134XCP|QS|0FD7F837-3D76-4A1C-B414-373B55A39506|5|||||MDS-UPDRS|||G/ANIMAL/WK|||RATIO|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|NA|5||7||LONG-TERM FOLLOW-UP|1965-05-11||||1964-05-28||1961-02-19|1965-11-20|
TRIAL STUDY 134XCP|QS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1|||||C-SSRS BASELINE/SCREENING VERSION|||10^3 COPIES/ML|||EP U|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|Y|1||38||CONTINUATION TREATMENT|1971-10-19||||1969-10-10||1966-05-10|1972-03-26|
TRIAL STUDY 134XCP|QS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2|||||ADCS-CGIC|||LOG10 TCID 50/UL|||HZ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|NA|2||58||BASELINE|1973-06-21||||1969-08-06||1964-08-26|1960-09-11|
TRIAL STUDY 134XCP|QS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|3|||||MMRC|||ML/DL|||MBP|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|Y|3||39||RUN-IN|1970-09-08||||1960-02-27||1961-11-18|1968-06-04|
TRIAL STUDY 134XCP|QS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|4|||||FACIT-DYSPNEA SF|||/MIN|||MMHG|NOT DONE||LIKERT SCALE 3-POINT|N|Y|U|4||88||LONG-TERM FOLLOW-UP|1961-01-24||||1966-11-13||1963-07-22|1964-01-17|
TRIAL STUDY 134XCP|QS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|5|||||EPIC-26|||U/MG|||ENZYME U/G HB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|N|5||7||BLINDED TREATMENT|1961-10-06||||1960-06-30||1961-02-17|1963-06-02|
TRIAL STUDY 134XCP|QS|92FB0125-67D2-41CC-9116-8C949F15614A|1|||||DAD|||LOG10 PFU/ML|||LM|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|1||38||LONG-TERM FOLLOW-UP|1969-09-22||||1960-03-10||1966-11-26|1962-03-14|
TRIAL STUDY 134XCP|QS|92FB0125-67D2-41CC-9116-8C949F15614A|2|||||FACIT-F V4|||FFU|||OSM|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|2||58||OPEN LABEL TREATMENT|1970-01-14||||1972-11-29||1972-04-26|1960-04-06|
TRIAL STUDY 134XCP|QS|92FB0125-67D2-41CC-9116-8C949F15614A|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||DNA COPIES/ML|||ML/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|3||39||BASELINE|1972-03-02||||1969-08-03||1965-05-17|1961-10-14|
TRIAL STUDY 134XCP|QS|92FB0125-67D2-41CC-9116-8C949F15614A|4|||||MRS|||IU/DL|||AMP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|NA|4||88||FOLLOW-UP|1968-09-24||||1962-01-16||1967-12-14|1967-12-07|
TRIAL STUDY 134XCP|QS|92FB0125-67D2-41CC-9116-8C949F15614A|5|||||FACT-C V4|||FMOL/G|||PLUG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|U|5||7||BLINDED TREATMENT|1963-05-22||||1971-03-19||1965-11-28|1964-02-21|
TRIAL STUDY 134XCP|QS|7042617F-0C29-4928-B3ED-9549A53BC195|1|||||C-SSRS SCREENING|||KEV|||NSEC|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|1||38||INDUCTION TREATMENT|1973-07-06||||1969-10-15||1972-02-11|1960-06-19|
TRIAL STUDY 134XCP|QS|7042617F-0C29-4928-B3ED-9549A53BC195|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||10^3 DNA COPIES/ML|||BQ|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|2||58||TREATMENT|1973-02-09||||1969-04-26||1967-12-20|1964-06-24|
TRIAL STUDY 134XCP|QS|7042617F-0C29-4928-B3ED-9549A53BC195|3|||||PARENT-DDS|||FRACTION OF 1|||UCI/L|NOT DONE||LIKERT SCALE 3-POINT|N|N|N|3||39||CONTINUATION TREATMENT|1964-10-12||||1969-10-14||1961-08-30|1972-10-14|
TRIAL STUDY 134XCP|QS|7042617F-0C29-4928-B3ED-9549A53BC195|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||MG/DAY|||LOG10 IU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|4||88||TREATMENT|1966-01-27||||1971-08-24||1960-07-14|1967-01-13|
TRIAL STUDY 134XCP|QS|7042617F-0C29-4928-B3ED-9549A53BC195|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||/VF|||KPA|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|5||7||LONG-TERM FOLLOW-UP|1972-05-25||||1968-07-31||1970-02-27|1969-03-10|
TRIAL STUDY 134XCP|QS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1|||||EQ-5D-3L|||MG/ANIMAL|||GY/H|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|NA|1||38||FOLLOW-UP|1973-05-18||||1964-02-10||1960-05-05|1962-04-20|
TRIAL STUDY 134XCP|QS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||NG/DL|||CI/UL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|2||58||SCREENING|1971-07-27||||1971-01-11||1968-04-18|1968-09-27|
TRIAL STUDY 134XCP|QS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||10^5/HPF|||KAT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|N|3||39||OBSERVATION|1972-03-02||||1970-06-13||1965-12-28|1964-06-14|
TRIAL STUDY 134XCP|QS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|4|||||FACIT-FATIGUE 13-ITEM V4|||/LSQN|||CMH2O*S2/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|Y|4||88||LONG-TERM FOLLOW-UP|1963-04-26||||1961-02-13||1967-09-22|1973-03-04|
TRIAL STUDY 134XCP|QS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|5|||||SF8 V1.0 STANDARD|||MOL/L|||CMH2O*S2/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|5||7||OBSERVATION|1972-02-12||||1964-05-30||1967-03-22|1964-05-10|
TRIAL STUDY 134XCP|QS|6633CC54-D711-4780-A833-A71756D8B234|1|||||MRS|||MOL|||G/ANIMAL/WK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|1||38||INDUCTION TREATMENT|1960-01-29||||1966-02-21||1972-05-28|1968-06-01|
TRIAL STUDY 134XCP|QS|6633CC54-D711-4780-A833-A71756D8B234|2|||||WOMAC NRS 3.1 INDEX|||UM/DAY|||10^6 ORGANISMS/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|2||58||WASHOUT|1971-06-12||||1971-08-29||1962-04-21|1969-11-27|
TRIAL STUDY 134XCP|QS|6633CC54-D711-4780-A833-A71756D8B234|3|||||BWCS|||UG/DL|||DPM/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|Y|3||39||BASELINE|1964-03-17||||1961-11-19||1970-11-14|1970-04-26|
TRIAL STUDY 134XCP|QS|6633CC54-D711-4780-A833-A71756D8B234|4|||||PCL-5|||10^9 ORGANISMS/G|||MONTHS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|4||88||INDUCTION TREATMENT|1962-02-05||||1960-12-15||1963-08-29|1973-08-24|
TRIAL STUDY 134XCP|QS|6633CC54-D711-4780-A833-A71756D8B234|5|||||TSQM V1.4|||MJOULE/CM2|||DNA COPIES/UG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|5||7||SCREENING|1963-10-21||||1961-03-02||1971-01-29|1965-04-27|
TRIAL STUDY 134XCP|QS|84C642FE-6D84-4525-AB1C-15FAF740D63B|1|||||SGRQ PAST 4 WEEKS VERSION|||HZ/S|||NMOL/MOL|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|1||38||INDUCTION TREATMENT|1964-04-02||||1971-12-14||1960-05-30|1971-08-30|
TRIAL STUDY 134XCP|QS|84C642FE-6D84-4525-AB1C-15FAF740D63B|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||ML/MMHG/MIN/L|||BEL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|N|2||58||OBSERVATION|1964-02-06||||1970-11-04||1973-08-19|1960-08-13|
TRIAL STUDY 134XCP|QS|84C642FE-6D84-4525-AB1C-15FAF740D63B|3|||||FACIT-F V4|||WEEKS|||G/CAGE/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|U|3||39||BASELINE|1964-05-08||||1960-09-19||1971-11-15|1971-05-04|
TRIAL STUDY 134XCP|QS|84C642FE-6D84-4525-AB1C-15FAF740D63B|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||UV*SEC|||POUCH|NOT DONE||LIKERT SCALE 5-POINT|Y|U|Y|4||88||LONG-TERM FOLLOW-UP|1970-11-25||||1970-08-21||1967-10-23|1969-04-17|
TRIAL STUDY 134XCP|QS|84C642FE-6D84-4525-AB1C-15FAF740D63B|5|||||TSQM V1.4|||KAT|||POUCH|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|5||7||BLINDED TREATMENT|1965-06-22||||1961-07-09||1967-09-06|1968-05-24|
TRIAL STUDY 134XCP|QS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1|||||SIQ|||UG/KG/H|||MG/G/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|NA|1||38||TREATMENT|1971-05-21||||1963-02-05||1970-09-22|1973-07-24|
TRIAL STUDY 134XCP|QS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2|||||MNSI|||MM/SEC|||MG/M2/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|2||58||RUN-IN|1970-04-13||||1969-12-06||1972-05-05|1964-12-29|
TRIAL STUDY 134XCP|QS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|3|||||MHIS-NACC|||DAYS/MONTH|||LOG10 CFU/G|NOT DONE||LIKERT SCALE 5-POINT|U|Y|U|3||39||SCREENING|1971-06-02||||1962-11-02||1961-01-16|1971-04-15|
TRIAL STUDY 134XCP|QS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|4|||||VFQ-25 INTERVIEWER ADMINISTERED|||CI/L|||ML/G/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|4||88||TREATMENT|1972-03-16||||1966-11-27||1972-04-24|1967-05-10|
TRIAL STUDY 134XCP|QS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||BISCUIT|||MG/G/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|5||7||RUN-IN|1968-04-14||||1964-09-19||1968-02-19|1968-10-22|
TRIAL STUDY 134XCP|QS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1|||||SOAPP-R|||DPM/0.5 ML|||NGEQ/L|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|1||38||WASHOUT|1968-06-07||||1963-11-14||1969-02-11|1962-05-15|
TRIAL STUDY 134XCP|QS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||ML/MMHG|||G/ANIMAL/WK|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|2||58||FOLLOW-UP|1965-02-21||||1962-03-03||1969-07-26|1966-12-15|
TRIAL STUDY 134XCP|QS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|3|||||SHORT-FORM MPQ-2|||YEARS|||HOUNSFIELD UNIT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|3||39||RUN-IN|1970-05-24||||1966-04-17||1969-12-09|1971-02-08|
TRIAL STUDY 134XCP|QS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|4|||||MFIS|||NU/CL|||OD UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|NA|4||88||INDUCTION TREATMENT|1968-09-30||||1968-06-11||1966-03-20|1967-10-06|
TRIAL STUDY 134XCP|QS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|5|||||SGRQ PAST 3 MONTHS VERSION|||U/G|||IMPLANT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|5||7||SCREENING|1967-05-10||||1966-03-15||1968-04-20|1971-01-12|
TRIAL STUDY 134XCP|QS|A0757669-2DF6-4E78-A021-9C777BEF5697|1|||||NCCN-FACT FOSI-18 V2|||PACKET|||ML/ANIMAL/WK|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|1||38||BASELINE|1972-08-24||||1965-02-25||1960-01-08|1964-03-30|
TRIAL STUDY 134XCP|QS|A0757669-2DF6-4E78-A021-9C777BEF5697|2|||||PI|||KIT|||PIPE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|2||58||WASHOUT|1960-07-09||||1961-11-13||1969-01-09|1972-11-04|
TRIAL STUDY 134XCP|QS|A0757669-2DF6-4E78-A021-9C777BEF5697|3|||||SF8 V1.0 ACUTE|||APS U|||NMOL BCE/MMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|3||39||OPEN LABEL TREATMENT|1972-05-14||||1960-11-22||1963-11-04|1969-03-12|
TRIAL STUDY 134XCP|QS|A0757669-2DF6-4E78-A021-9C777BEF5697|4|||||GCGI|||NCI|||HOURS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|4||88||INDUCTION TREATMENT|1971-03-21||||1970-02-27||1962-02-10|1962-07-21|
TRIAL STUDY 134XCP|QS|A0757669-2DF6-4E78-A021-9C777BEF5697|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||MG/H|||G/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|5||7||BASELINE|1966-08-24||||1968-04-18||1973-05-10|1962-06-05|
TRIAL STUDY 134XCP|QS|DAF7255A-888D-43D3-97B8-5E432938747F|1|||||EQ-5D-5L|||10^12 IU/L|||ML/MIN/1.73M2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|1||38||RUN-IN|1962-03-18||||1973-01-18||1966-11-03|1968-08-01|
TRIAL STUDY 134XCP|QS|DAF7255A-888D-43D3-97B8-5E432938747F|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||COULOMB|||GBQ|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|NA|2||58||CONTINUATION TREATMENT|1960-02-22||||1965-03-17||1967-05-15|1967-01-18|
TRIAL STUDY 134XCP|QS|DAF7255A-888D-43D3-97B8-5E432938747F|3|||||BPI|||U/G/MIN|||MG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|NA|3||39||BASELINE|1971-06-26||||1971-06-23||1963-12-25|1960-08-29|
TRIAL STUDY 134XCP|QS|DAF7255A-888D-43D3-97B8-5E432938747F|4|||||SWLS|||MPL U|||CG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|4||88||BASELINE|1964-08-01||||1963-12-15||1966-02-25|1964-02-14|
TRIAL STUDY 134XCP|QS|DAF7255A-888D-43D3-97B8-5E432938747F|5|||||SGRQ PAST 3 MONTHS VERSION|||1/(S*KPA)|||10^6 ORGANISMS/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|Y|5||7||INDUCTION TREATMENT|1973-02-08||||1962-08-30||1968-10-04|1971-01-01|
TRIAL STUDY 134XCP|QS|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1|||||SF10 V1.0 CHILDREN STANDARD|||USP U|||FT|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|1||38||SCREENING|1973-06-05||||1963-01-16||1969-01-19|1970-02-28|
TRIAL STUDY 134XCP|QS|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2|||||SF12 V2.0 STANDARD|||BU|||KBQ/UL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|2||58||CONTINUATION TREATMENT|1971-08-14||||1961-01-02||1966-02-14|1962-11-09|
TRIAL STUDY 134XCP|QS|51989FEC-B63E-4F58-B748-2FF5E73E5D14|3|||||AUDIT-SR|||S^-1(%O2)^-1|||UMOL/DL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|3||39||SCREENING|1965-07-27||||1970-01-20||1970-10-18|1962-05-19|
TRIAL STUDY 134XCP|QS|51989FEC-B63E-4F58-B748-2FF5E73E5D14|4|||||ANSD V1.0|||U/10^12 RBC|||FMOL/L/SEC|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|4||88||SCREENING|1960-09-29||||1961-10-25||1972-11-18|1963-07-06|
TRIAL STUDY 134XCP|QS|51989FEC-B63E-4F58-B748-2FF5E73E5D14|5|||||DRRI-2|||P|||BQ/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|Y|5||7||RUN-IN|1967-11-23||||1964-06-20||1971-08-14|1972-10-07|
TRIAL STUDY 134XCP|QS|776299DC-1CD5-448F-82C2-C1659CEE689D|1|||||CHART-SF INTERVIEW VERSION|||10^11/L|||VG/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|1||38||BLINDED TREATMENT|1969-07-22||||1966-08-08||1962-09-05|1961-04-25|
TRIAL STUDY 134XCP|QS|776299DC-1CD5-448F-82C2-C1659CEE689D|2|||||BEBQ RETROSPECTIVE|||10^5/L|||AMOL|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|2||58||CONTINUATION TREATMENT|1962-12-22||||1960-03-04||1961-10-09|1960-08-27|
TRIAL STUDY 134XCP|QS|776299DC-1CD5-448F-82C2-C1659CEE689D|3|||||C-SSRS CHILDREN'S BASELINE|||ML/CAGE/WK|||10^3 COPIES/ML|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|3||39||RUN-IN|1964-09-21||||1971-12-21||1961-06-09|1966-01-27|
TRIAL STUDY 134XCP|QS|776299DC-1CD5-448F-82C2-C1659CEE689D|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||UU/DL|||CAN|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|4||88||LONG-TERM FOLLOW-UP|1964-05-18||||1966-05-31||1970-02-26|1962-03-04|
TRIAL STUDY 134XCP|QS|776299DC-1CD5-448F-82C2-C1659CEE689D|5|||||NPI|||PMOL/L|||MM/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|Y|5||7||CONTINUATION TREATMENT|1961-01-23||||1969-02-17||1963-04-12|1961-03-16|
TRIAL STUDY 134XCP|QS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1|||||NCCN-FACT FOSI-18 V2|||ML*CMH2O|||NFIU|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|1||38||BASELINE|1964-09-17||||1961-04-19||1965-05-21|1969-11-14|
TRIAL STUDY 134XCP|QS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2|||||GDS|||SCM|||SCOOPFUL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|2||58||CONTINUATION TREATMENT|1970-07-20||||1964-06-05||1967-11-19|1967-07-14|
TRIAL STUDY 134XCP|QS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|3|||||GAD-7|||G/L|||CI|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|3||39||BLINDED TREATMENT|1972-08-06||||1961-06-10||1972-05-22|1973-05-27|
TRIAL STUDY 134XCP|QS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|4|||||SF12 V1.0 ACUTE|||10^3 CFU/ML|||CI/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|NA|4||88||LONG-TERM FOLLOW-UP|1970-02-09||||1971-02-03||1966-02-15|1965-01-14|
TRIAL STUDY 134XCP|QS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|5|||||MSIS-29 V1|||TSP EQ|||DEG/MM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|5||7||SCREENING|1962-07-14||||1971-12-11||1968-03-01|1972-10-11|
TRIAL STUDY 134XCP|QS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1|||||MADRS|||MOL/DAY|||MPL U/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|U|1||38||SCREENING|1964-09-02||||1972-01-15||1965-11-18|1963-12-11|
TRIAL STUDY 134XCP|QS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2|||||GAD-7|||NG|||KG/CM|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|NA|2||58||WASHOUT|1966-03-15||||1966-04-10||1972-07-11|1972-02-14|
TRIAL STUDY 134XCP|QS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|3|||||ADCS-ADL MCI|||FFU|||ML/S/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|U|3||39||BLINDED TREATMENT|1970-08-16||||1971-12-21||1971-12-25|1968-02-07|
TRIAL STUDY 134XCP|QS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|4|||||WHODAS 2.0 - 12-ITEM PROXY|||NFIU|||BEATS/MIN|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|4||88||RUN-IN|1965-10-07||||1962-11-01||1964-03-30|1967-09-01|
TRIAL STUDY 134XCP|QS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|5|||||BLCS|||CAL|||H/WK|NOT DONE||LIKERT SCALE 5-POINT|U|Y|U|5||7||FOLLOW-UP|1967-03-19||||1961-03-08||1968-11-07|1972-04-24|
TRIAL STUDY 134XCP|QS|054D4740-C675-4904-B912-B00A0B089F12|1|||||BEBQ CONCURRENT|||MG/DAY|||F|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|1||38||OPEN LABEL TREATMENT|1961-05-31||||1960-01-30||1972-11-18|1963-10-22|
TRIAL STUDY 134XCP|QS|054D4740-C675-4904-B912-B00A0B089F12|2|||||EPIC-26|||YEARS|||KM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|2||58||TREATMENT|1964-12-19||||1972-03-11||1968-07-06|1968-02-28|
TRIAL STUDY 134XCP|QS|054D4740-C675-4904-B912-B00A0B089F12|3|||||FACIT-F V4|||GPL U|||SFC/10^6 PBMC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|3||39||INDUCTION TREATMENT|1970-02-23||||1966-06-15||1964-07-12|1960-03-23|
TRIAL STUDY 134XCP|QS|054D4740-C675-4904-B912-B00A0B089F12|4|||||SGRQ PAST 3 MONTHS VERSION|||MMOL/KG|||10^9/L|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|4||88||OPEN LABEL TREATMENT|1960-12-10||||1962-06-11||1970-12-13|1964-12-10|
TRIAL STUDY 134XCP|QS|054D4740-C675-4904-B912-B00A0B089F12|5|||||LEC-5 STANDARD VERSION|||UM/S|||UEQ/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|5||7||OBSERVATION|1972-12-23||||1970-06-25||1967-06-19|1964-04-11|
TRIAL STUDY 134XCP|QS|9548556E-EECF-4460-A7DD-D93F853E9EA8|1|||||SOBDA|||G/MOL|||DEG2|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|NA|1||38||SCREENING|1972-02-13||||1965-08-03||1968-01-12|1972-08-17|
TRIAL STUDY 134XCP|QS|9548556E-EECF-4460-A7DD-D93F853E9EA8|2|||||TSCYC|||TESLA|||MPL U/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|2||58||BLINDED TREATMENT|1967-12-08||||1960-06-05||1971-09-21|1970-05-24|
TRIAL STUDY 134XCP|QS|9548556E-EECF-4460-A7DD-D93F853E9EA8|3|||||SMDDS V1.0|||CMOL/L|||SCOOPFUL|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|3||39||LONG-TERM FOLLOW-UP|1964-04-13||||1961-09-26||1965-02-14|1968-07-09|
TRIAL STUDY 134XCP|QS|9548556E-EECF-4460-A7DD-D93F853E9EA8|4|||||MSWS-12|||APL U|||CS|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|4||88||BLINDED TREATMENT|1973-07-09||||1970-06-23||1966-09-29|1963-03-28|
TRIAL STUDY 134XCP|QS|9548556E-EECF-4460-A7DD-D93F853E9EA8|5|||||IVIS|||10^9 CFU/G|||%(V/V)|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|5||7||BASELINE|1971-07-08||||1971-04-23||1971-12-25|1972-07-27|
TRIAL STUDY 134XCP|QS|0BCF6152-3718-402C-9333-A3EFBB3086FF|1|||||CHART-SF PAPER VERSION|||PL|||WATT|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|1||38||CONTINUATION TREATMENT|1961-01-31||||1972-05-08||1962-11-21|1970-04-16|
TRIAL STUDY 134XCP|QS|0BCF6152-3718-402C-9333-A3EFBB3086FF|2|||||PHQ-9|||UG/MOL|||MG/L FEU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|Y|2||58||TREATMENT|1967-06-06||||1963-06-07||1968-03-24|1973-02-20|
TRIAL STUDY 134XCP|QS|0BCF6152-3718-402C-9333-A3EFBB3086FF|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||CI/UG|||1/(S*KPA)|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|Y|3||39||BASELINE|1973-07-09||||1968-03-02||1962-09-16|1960-06-23|
TRIAL STUDY 134XCP|QS|0BCF6152-3718-402C-9333-A3EFBB3086FF|4|||||PODCI - ADOLESCENT SELF REPORTED|||10^9/L|||10^9 ORGANISMS/G|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|4||88||TREATMENT|1971-04-15||||1971-07-11||1973-03-18|1968-02-20|
TRIAL STUDY 134XCP|QS|0BCF6152-3718-402C-9333-A3EFBB3086FF|5|||||CES|||SIEMENS|||DEG|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|5||7||OBSERVATION|1969-01-22||||1967-02-21||1969-05-08|1968-11-18|
TRIAL STUDY 134XCP|QS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1|||||FACT-BMT V4|||ML/G/H|||DPM/100MG|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|1||38||BASELINE|1962-12-01||||1971-03-20||1967-10-04|1971-04-10|
TRIAL STUDY 134XCP|QS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2|||||BORG CR10|||UMOL/L/SEC|||U/G/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|2||58||FOLLOW-UP|1973-03-05||||1966-02-20||1972-07-26|1964-10-19|
TRIAL STUDY 134XCP|QS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|3|||||FACT-C V4|||MU/G|||OZ EQ|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|3||39||INDUCTION TREATMENT|1966-04-16||||1973-02-26||1964-11-17|1963-03-26|
TRIAL STUDY 134XCP|QS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|4|||||CDLQ|||ML/M2|||UM/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|4||88||WASHOUT|1963-11-24||||1968-05-07||1972-08-14|1964-07-07|
TRIAL STUDY 134XCP|QS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|5|||||MSWS-12|||MPL U|||MMOL2/L2|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|5||7||BLINDED TREATMENT|1967-10-11||||1969-05-29||1966-05-06|1968-01-20|
TRIAL STUDY 134XCP|QS|EED12AC0-1CBD-4D42-8786-91834AB33A46|1|||||MDQ-T|||CAL|||MG/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|Y|1||38||LONG-TERM FOLLOW-UP|1966-05-10||||1964-11-29||1965-07-27|1965-11-03|
TRIAL STUDY 134XCP|QS|EED12AC0-1CBD-4D42-8786-91834AB33A46|2|||||HAQ-DI WITHOUT VAS|||DEG/MM|||LM|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|U|2||58||BASELINE|1963-01-18||||1961-01-16||1963-03-26|1964-09-05|
TRIAL STUDY 134XCP|QS|EED12AC0-1CBD-4D42-8786-91834AB33A46|3|||||SF12 V1.0 ACUTE|||H/WK|||KHZ|NOT DONE||LIKERT SCALE 5-POINT|NA|N|NA|3||39||OBSERVATION|1966-12-08||||1971-07-13||1966-04-17|1972-12-19|
TRIAL STUDY 134XCP|QS|EED12AC0-1CBD-4D42-8786-91834AB33A46|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||MV2/HZ|||PFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|NA|4||88||OPEN LABEL TREATMENT|1960-05-08||||1966-06-14||1968-02-26|1965-08-07|
TRIAL STUDY 134XCP|QS|EED12AC0-1CBD-4D42-8786-91834AB33A46|5|||||WLQ|||U/ANIMAL|||PPTR|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|N|5||7||FOLLOW-UP|1971-06-27||||1970-05-21||1967-03-24|1973-03-07|
TRIAL STUDY 134XCP|QS|F30DC3E9-E919-4920-87FE-103CD85D89FA|1|||||FACIT-FATIGUE 13-ITEM V4|||MCI/L|||UG/ANIMAL|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|1||38||CONTINUATION TREATMENT|1960-06-04||||1973-07-12||1963-05-05|1973-03-20|
TRIAL STUDY 134XCP|QS|F30DC3E9-E919-4920-87FE-103CD85D89FA|2|||||SF36 V1.0 ACUTE|||ANTI-XA IU/ML|||G/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|N|2||58||CONTINUATION TREATMENT|1960-09-19||||1965-02-21||1963-09-01|1969-02-28|
TRIAL STUDY 134XCP|QS|F30DC3E9-E919-4920-87FE-103CD85D89FA|3|||||VFQ-25 INTERVIEWER ADMINISTERED|||ENZYME U|||BEL|NOT DONE||LIKERT SCALE 3-POINT|U|U|U|3||39||WASHOUT|1972-04-27||||1972-04-14||1966-11-08|1962-09-25|
TRIAL STUDY 134XCP|QS|F30DC3E9-E919-4920-87FE-103CD85D89FA|4|||||HCS|||MG2/DL2|||L/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|4||88||BLINDED TREATMENT|1966-05-04||||1960-05-06||1973-02-25|1963-12-25|
TRIAL STUDY 134XCP|QS|F30DC3E9-E919-4920-87FE-103CD85D89FA|5|||||SIQ|||PPTR|||UMOL/MG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|NA|5||7||CONTINUATION TREATMENT|1962-08-18||||1969-04-02||1963-02-28|1960-06-20|
TRIAL STUDY 134XCP|QS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1|||||C-SSRS CHILDREN'S BASELINE|||L/S|||UCI/KG|NOT DONE||LIKERT SCALE 5-POINT|N|N|Y|1||38||CONTINUATION TREATMENT|1973-04-03||||1965-08-16||1969-05-29|1969-12-16|
TRIAL STUDY 134XCP|QS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2|||||SWLS|||UGEQ/L|||UG/MOL|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|2||58||TREATMENT|1967-01-30||||1966-07-20||1964-03-04|1972-07-03|
TRIAL STUDY 134XCP|QS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|3|||||FACT-TAXANE V4|||OZ|||MMU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|3||39||FOLLOW-UP|1968-05-04||||1968-12-30||1960-08-11|1961-11-02|
TRIAL STUDY 134XCP|QS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|4|||||PGI|||CI/KG|||UEQ|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|NA|4||88||SCREENING|1966-02-21||||1969-07-13||1971-11-26|1969-05-10|
TRIAL STUDY 134XCP|QS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|5|||||SF12 V2.0 ACUTE|||BLOCKS|||ML/S|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|5||7||RUN-IN|1962-08-13||||1967-04-22||1970-12-06|1967-07-19|
TRIAL STUDY 134XCP|QS|729D254F-628C-4D35-8906-A1344833A610|1|||||SF36 V1.0 STANDARD|||MET*MIN|||LOG10 ELISA UNIT/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|NA|1||38||BASELINE|1969-02-06||||1971-06-25||1960-06-27|1967-12-07|
TRIAL STUDY 134XCP|QS|729D254F-628C-4D35-8906-A1344833A610|2|||||C-SSRS LIFETIME/RECENT VERSION|||10^3/L|||GBQ/UG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|2||58||LONG-TERM FOLLOW-UP|1963-02-09||||1961-12-07||1967-01-31|1971-09-16|
TRIAL STUDY 134XCP|QS|729D254F-628C-4D35-8906-A1344833A610|3|||||ODI V2.1A|||G/DL|||MS2|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|U|3||39||OBSERVATION|1966-04-26||||1966-01-27||1962-07-08|1972-08-29|
TRIAL STUDY 134XCP|QS|729D254F-628C-4D35-8906-A1344833A610|4|||||VFQ-25 SELF ADMINISTERED|||SYRINGE|||GY/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|4||88||FOLLOW-UP|1971-06-02||||1964-08-29||1967-03-07|1961-10-01|
TRIAL STUDY 134XCP|QS|729D254F-628C-4D35-8906-A1344833A610|5|||||Q-LES-Q|||KCAL/DAY|||NG/DL|NOT DONE||LIKERT SCALE 7-POINT|N|Y|Y|5||7||OPEN LABEL TREATMENT|1971-12-22||||1963-09-11||1964-04-02|1969-06-14|
TRIAL STUDY 134XCP|QS|A78936A2-B8B1-4D07-8679-E324F6447EFF|1|||||HAEM-A-QOL|||WAFER|||10^3/HPF|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|1||38||CONTINUATION TREATMENT|1970-06-23||||1961-10-15||1964-06-20|1969-12-20|
TRIAL STUDY 134XCP|QS|A78936A2-B8B1-4D07-8679-E324F6447EFF|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||10^6/G|||F|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|Y|2||58||TREATMENT|1969-10-13||||1962-08-22||1969-10-14|1963-01-08|
TRIAL STUDY 134XCP|QS|A78936A2-B8B1-4D07-8679-E324F6447EFF|3|||||SGRQ PAST 4 WEEKS VERSION|||MG/KG|||MOSM/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|N|3||39||OBSERVATION|1964-06-16||||1962-03-27||1965-07-19|1963-05-26|
TRIAL STUDY 134XCP|QS|A78936A2-B8B1-4D07-8679-E324F6447EFF|4|||||ACQ|||MG/M2|||/200 HPFS|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|4||88||CONTINUATION TREATMENT|1969-05-07||||1966-01-21||1968-10-02|1961-10-19|
TRIAL STUDY 134XCP|QS|A78936A2-B8B1-4D07-8679-E324F6447EFF|5|||||SF36 V2.0 STANDARD|||GTT|||CAN|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|N|5||7||OPEN LABEL TREATMENT|1965-07-30||||1968-12-29||1973-09-06|1968-09-22|
TRIAL STUDY 134XCP|QS|239B331A-08CD-41D9-BBB8-CE229480FC12|1|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||G|||MCI/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|N|1||38||LONG-TERM FOLLOW-UP|1970-08-11||||1966-06-12||1965-12-03|1962-01-10|
TRIAL STUDY 134XCP|QS|239B331A-08CD-41D9-BBB8-CE229480FC12|2|||||IPAQ-LF PHONE VERSION|||DEG/MM|||UG/DL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|Y|2||58||LONG-TERM FOLLOW-UP|1964-10-27||||1968-12-31||1963-08-15|1961-07-18|
TRIAL STUDY 134XCP|QS|239B331A-08CD-41D9-BBB8-CE229480FC12|3|||||WPAI-GH V2.0|||OD UNIT|||P|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|3||39||FOLLOW-UP|1962-05-21||||1960-03-16||1963-09-13|1962-03-13|
TRIAL STUDY 134XCP|QS|239B331A-08CD-41D9-BBB8-CE229480FC12|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||EIA UNIT|||10^6/HPF|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|4||88||WASHOUT|1971-11-23||||1964-04-11||1961-06-11|1963-10-28|
TRIAL STUDY 134XCP|QS|239B331A-08CD-41D9-BBB8-CE229480FC12|5|||||TSQM V1.4|||MG/KG/H|||GRAIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|N|5||7||CONTINUATION TREATMENT|1966-01-05||||1968-05-15||1969-12-27|1966-05-14|
TRIAL STUDY 134XCP|QS|958D39CD-D511-40C8-A0A6-8A138225470B|1|||||HCS|||10^3/L|||IU/G|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|1||38||INDUCTION TREATMENT|1963-01-03||||1960-05-01||1971-08-22|1964-08-13|
TRIAL STUDY 134XCP|QS|958D39CD-D511-40C8-A0A6-8A138225470B|2|||||SWLS|||NMOL/L/H|||MOL/MG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|NA|2||58||LONG-TERM FOLLOW-UP|1970-10-28||||1962-10-30||1961-08-26|1971-04-20|
TRIAL STUDY 134XCP|QS|958D39CD-D511-40C8-A0A6-8A138225470B|3|||||HAMD 6 SELF-REPORT VERSION|||MKAT|||FG|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|3||39||SCREENING|1962-07-21||||1963-05-03||1965-02-03|1963-12-28|
TRIAL STUDY 134XCP|QS|958D39CD-D511-40C8-A0A6-8A138225470B|4|||||ADCS-ADL MCI|||G/CAGE/DAY|||VIAL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|4||88||OPEN LABEL TREATMENT|1970-01-18||||1960-01-09||1967-11-18|1961-09-28|
TRIAL STUDY 134XCP|QS|958D39CD-D511-40C8-A0A6-8A138225470B|5|||||EQ-5D-5L|||CM H2O|||ML/BEAT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|NA|5||7||CONTINUATION TREATMENT|1973-07-28||||1972-06-27||1960-03-07|1960-06-24|
TRIAL STUDY 134XCP|QS|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1|||||SGRQ PAST 3 MONTHS VERSION|||10^6 CFU/ML|||G/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|N|U|1||38||FOLLOW-UP|1967-11-27||||1963-03-18||1963-02-28|1966-09-24|
TRIAL STUDY 134XCP|QS|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2|||||T1-DDS|||MG/M2|||ML/MIN/MMHG|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|2||58||FOLLOW-UP|1961-12-31||||1971-08-25||1968-08-17|1970-06-27|
TRIAL STUDY 134XCP|QS|5DA21FE5-E5B9-4461-9509-94AA264B59A8|3|||||HAEM-A-QOL|||UCI|||ML/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|Y|3||39||TREATMENT|1971-12-13||||1962-03-18||1971-11-02|1967-12-16|
TRIAL STUDY 134XCP|QS|5DA21FE5-E5B9-4461-9509-94AA264B59A8|4|||||GMSS VERSION TYPE 1 DIABETES|||NMOL/KG/DAY|||CGY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|N|4||88||RUN-IN|1970-04-05||||1967-06-05||1968-12-30|1969-09-12|
TRIAL STUDY 134XCP|QS|5DA21FE5-E5B9-4461-9509-94AA264B59A8|5|||||FACIT-DYSPNEA SF|||PFU/DOSE|||UMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|NA|5||7||OBSERVATION|1970-06-24||||1968-01-28||1961-08-11|1970-04-08|
TRIAL STUDY 134XCP|QS|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||TRANSDUCING UNIT|||% INHIBITION|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|1||38||BASELINE|1966-03-25||||1972-09-02||1968-08-25|1962-07-16|
TRIAL STUDY 134XCP|QS|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2|||||OAB-Q SHORT FORM|||MOL|||PFU/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|Y|2||58||WASHOUT|1961-06-16||||1966-04-26||1972-01-29|1968-04-17|
TRIAL STUDY 134XCP|QS|B125DCB9-1705-430B-9982-A20E7C4CA6A8|3|||||PODCI - PEDIATRIC PARENT REPORTED|||AMPULE|||UMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|N|3||39||FOLLOW-UP|1966-09-22||||1970-03-31||1968-05-11|1964-11-26|
TRIAL STUDY 134XCP|QS|B125DCB9-1705-430B-9982-A20E7C4CA6A8|4|||||C-SSRS ALREADY ENROLLED SUBJECTS|||UG|||POINT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|NA|4||88||RUN-IN|1973-04-03||||1961-04-13||1967-01-01|1970-03-19|
TRIAL STUDY 134XCP|QS|B125DCB9-1705-430B-9982-A20E7C4CA6A8|5|||||C-SSRS ALREADY ENROLLED SUBJECTS|||TORR|||10^6/EJACULATE U|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|5||7||WASHOUT|1963-06-08||||1960-08-16||1961-12-19|1969-02-03|
TRIAL STUDY 134XCP|QS|95C72325-301E-40D4-AA2D-49B80067FE23|1|||||ADCS-CGIC|||10^3 ORGANISMS/ML|||BEAM BREAKS|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|1||38||WASHOUT|1972-12-20||||1961-12-21||1962-08-19|1964-04-16|
TRIAL STUDY 134XCP|QS|95C72325-301E-40D4-AA2D-49B80067FE23|2|||||C-SSRS LIFETIME/RECENT VERSION|||V/SEC|||DPM/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|N|2||58||FOLLOW-UP|1963-09-02||||1970-03-28||1963-03-25|1971-08-15|
TRIAL STUDY 134XCP|QS|95C72325-301E-40D4-AA2D-49B80067FE23|3|||||FACT-TAXANE V4|||STEPS|||G/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|3||39||BASELINE|1963-05-17||||1968-04-07||1970-02-19|1969-12-12|
TRIAL STUDY 134XCP|QS|95C72325-301E-40D4-AA2D-49B80067FE23|4|||||SF12 V2.0 ACUTE|||GBQ|||MMOL/MIN/KPA/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|4||88||LONG-TERM FOLLOW-UP|1973-02-25||||1961-11-19||1965-12-15|1970-01-07|
TRIAL STUDY 134XCP|QS|95C72325-301E-40D4-AA2D-49B80067FE23|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||MMOL/DAY|||/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|U|5||7||OPEN LABEL TREATMENT|1970-07-03||||1972-01-23||1972-09-08|1960-05-21|
TRIAL STUDY 134XCP|QS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1|||||COMM|||DPM|||ML/S|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|Y|1||38||INDUCTION TREATMENT|1973-03-04||||1972-02-05||1968-06-21|1972-01-07|
TRIAL STUDY 134XCP|QS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2|||||SHORT-FORM MPQ-2|||CY/CM|||10^3 ORGANISMS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|2||58||WASHOUT|1973-03-19||||1960-04-29||1963-04-03|1971-04-02|
TRIAL STUDY 134XCP|QS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||NSEC|||CI/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|3||39||OPEN LABEL TREATMENT|1962-11-10||||1960-12-04||1970-09-07|1966-06-11|
TRIAL STUDY 134XCP|QS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||/KG|||PNU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|N|4||88||OBSERVATION|1963-12-18||||1960-04-16||1963-10-15|1973-08-22|
TRIAL STUDY 134XCP|QS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|5|||||ADSD V1.0|||DEG/MM|||MMOL/MIN/KPA|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|NA|5||7||OBSERVATION|1962-09-15||||1961-02-04||1973-07-23|1967-03-12|
TRIAL STUDY 134XCP|QS|7DF25CA4-0846-4180-9356-F53C704F0233|1|||||DAD|||TUBE|||LOG10 COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|N|1||38||SCREENING|1973-07-12||||1972-04-11||1962-07-12|1960-08-19|
TRIAL STUDY 134XCP|QS|7DF25CA4-0846-4180-9356-F53C704F0233|2|||||YMRS|||10^12 IU/L|||ML/S/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|U|2||58||LONG-TERM FOLLOW-UP|1960-02-22||||1966-08-10||1963-11-30|1967-07-31|
TRIAL STUDY 134XCP|QS|7DF25CA4-0846-4180-9356-F53C704F0233|3|||||EORTC QLQ-CR29 V2.1|||DEG|||SUPPOSITORY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|U|3||39||INDUCTION TREATMENT|1965-10-31||||1967-09-18||1963-09-21|1964-07-20|
TRIAL STUDY 134XCP|QS|7DF25CA4-0846-4180-9356-F53C704F0233|4|||||TSQM V1.4|||UG/DL|||IU/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|NA|4||88||LONG-TERM FOLLOW-UP|1960-03-24||||1966-07-22||1960-08-27|1973-08-29|
TRIAL STUDY 134XCP|QS|7DF25CA4-0846-4180-9356-F53C704F0233|5|||||EORTC QLQ-LC13|||CS|||EVENTS|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|5||7||LONG-TERM FOLLOW-UP|1973-02-18||||1969-03-29||1963-06-05|1962-12-13|
TRIAL STUDY 134XCP|QS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1|||||SOWS SHORT|||/100 WBC|||10^3 COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|NA|1||38||FOLLOW-UP|1962-09-17||||1963-07-31||1970-06-14|1970-01-09|
TRIAL STUDY 134XCP|QS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2|||||GOSE|||ATM|||KIT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|2||58||RUN-IN|1971-11-19||||1961-11-22||1968-07-22|1965-02-28|
TRIAL STUDY 134XCP|QS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|3|||||COWS|||CAN|||MEQ/MMOL|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||TREATMENT|1967-12-21||||1960-07-23||1960-03-11|1960-06-23|
TRIAL STUDY 134XCP|QS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||KV|||SIEMENS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|4||88||OPEN LABEL TREATMENT|1964-07-30||||1966-09-07||1965-04-14|1964-12-04|
TRIAL STUDY 134XCP|QS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|5|||||VFQ-25 SELF ADMINISTERED|||10^6 CFU/ML|||SEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|5||7||CONTINUATION TREATMENT|1967-09-12||||1965-09-24||1968-07-05|1970-05-13|
TRIAL STUDY 134XCP|QS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1|||||FACT-BL V4|||PG/DL|||MPS U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|1||38||WASHOUT|1966-10-30||||1964-10-01||1970-01-08|1961-03-28|
TRIAL STUDY 134XCP|QS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2|||||MSQOL-54|||10^5/L|||U/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|U|2||58||BLINDED TREATMENT|1965-10-29||||1962-10-29||1961-04-01|1964-11-13|
TRIAL STUDY 134XCP|QS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|3|||||Q-LES-Q|||ECL UNIT|||VIAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|Y|3||39||OBSERVATION|1969-03-15||||1966-01-20||1962-09-18|1966-10-31|
TRIAL STUDY 134XCP|QS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||UMOL/L/MIN|||ML/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|4||88||CONTINUATION TREATMENT|1963-03-24||||1960-05-27||1972-10-08|1961-02-02|
TRIAL STUDY 134XCP|QS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|5|||||PHQ-9|||ENZYME U/G HB|||10^6 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|5||7||BASELINE|1973-07-11||||1963-01-07||1960-12-10|1972-06-01|
TRIAL STUDY 134XCP|QS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||LOG EID 50/DOSE|||OI50|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|1||38||INDUCTION TREATMENT|1968-04-15||||1973-04-03||1972-09-23|1962-03-08|
TRIAL STUDY 134XCP|QS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2|||||SGRQ-C|||CFU/G|||PG/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|2||58||WASHOUT|1969-04-20||||1961-04-30||1964-12-11|1966-03-26|
TRIAL STUDY 134XCP|QS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|3|||||SOBDA|||PNU/ML|||AMPULE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|3||39||RUN-IN|1964-02-25||||1970-08-06||1971-06-18|1967-12-18|
TRIAL STUDY 134XCP|QS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|4|||||OAB-Q|||10^3 RNA COPIES/ML|||MS/MMHG|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|4||88||WASHOUT|1962-02-03||||1970-12-13||1966-09-23|1962-09-01|
TRIAL STUDY 134XCP|QS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|5|||||WOMAC NRS 3.1 INDEX|||MG/KG/WEEK|||K|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|5||7||BLINDED TREATMENT|1963-03-05||||1962-01-21||1960-02-12|1960-04-12|
TRIAL STUDY 134XCP|QS|2C15756E-1096-403B-989D-D2C3D31396A9|1|||||FACT-C V4|||MSEC|||IU/MG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|1||38||BLINDED TREATMENT|1967-03-02||||1961-04-10||1969-02-26|1973-06-04|
TRIAL STUDY 134XCP|QS|2C15756E-1096-403B-989D-D2C3D31396A9|2|||||ADAS-COG|||MM/MIN|||EID 50/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|N|2||58||FOLLOW-UP|1972-03-29||||1966-12-30||1964-02-17|1966-10-05|
TRIAL STUDY 134XCP|QS|2C15756E-1096-403B-989D-D2C3D31396A9|3|||||IPAQ-SF SELF-ADMINISTERED VERSION|||WEBER|||L/S|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|NA|3||39||OPEN LABEL TREATMENT|1964-11-11||||1973-09-05||1970-04-02|1965-03-31|
TRIAL STUDY 134XCP|QS|2C15756E-1096-403B-989D-D2C3D31396A9|4|||||ADHD-RS-IV HOME VERSION|||BQ|||F|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|4||88||OBSERVATION|1969-02-19||||1961-12-06||1970-02-06|1963-04-28|
TRIAL STUDY 134XCP|QS|2C15756E-1096-403B-989D-D2C3D31396A9|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||PL|||CG|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|U|5||7||WASHOUT|1969-02-17||||1964-11-14||1966-07-17|1962-06-10|
TRIAL STUDY 134XCP|QS|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1|||||IBDQ|||U/KG/MIN|||NCI|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|NA|1||38||OPEN LABEL TREATMENT|1961-10-22||||1971-06-26||1960-02-21|1964-06-26|
TRIAL STUDY 134XCP|QS|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2|||||GAD-7 V2|||MM/SEC|||UMOL/KG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|2||58||WASHOUT|1960-01-06||||1962-03-22||1969-07-18|1964-06-18|
TRIAL STUDY 134XCP|QS|CD103276-37FC-4E40-A0C8-8D1300D21AE1|3|||||COPD ASSESSMENT TEST|||ML/CAGE/WK|||L/MIN/M2|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|3||39||INDUCTION TREATMENT|1962-06-23||||1962-12-25||1966-06-07|1969-02-28|
TRIAL STUDY 134XCP|QS|CD103276-37FC-4E40-A0C8-8D1300D21AE1|4|||||IIEF|||PMOL|||FRAMES/S|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|U|4||88||WASHOUT|1964-01-03||||1969-07-31||1970-08-06|1962-09-18|
TRIAL STUDY 134XCP|QS|CD103276-37FC-4E40-A0C8-8D1300D21AE1|5|||||SF36 V1.0 ACUTE|||KG|||VIAL|NOT DONE||LIKERT SCALE 3-POINT|N|U|N|5||7||CONTINUATION TREATMENT|1973-07-14||||1965-04-19||1963-12-21|1968-11-19|
TRIAL STUDY 134XCP|QS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1|||||PDQUALIF|||FRAMES/S|||HEP|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|1||38||OBSERVATION|1961-04-29||||1965-05-24||1961-09-03|1963-02-27|
TRIAL STUDY 134XCP|QS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2|||||WHODAS 2.0 - 12-ITEM SELF|||G/M2/DAY|||/200 HPFS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|2||58||CONTINUATION TREATMENT|1967-04-24||||1960-03-22||1971-09-06|1965-03-26|
TRIAL STUDY 134XCP|QS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|3|||||PHQ-15|||10^6 RNA COPIES/ML|||SV|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|3||39||FOLLOW-UP|1963-02-08||||1963-01-18||1970-11-17|1966-02-14|
TRIAL STUDY 134XCP|QS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|4|||||FACT-LEU V4|||C|||PMOL/G|NOT DONE||LIKERT SCALE 3-POINT|U|N|NA|4||88||TREATMENT|1973-05-29||||1961-11-16||1965-07-12|1963-02-10|
TRIAL STUDY 134XCP|QS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|5|||||VFQ-25 INTERVIEWER ADMINISTERED|||KPA|||CI/MG|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|5||7||INDUCTION TREATMENT|1973-05-23||||1965-09-09||1964-11-01|1967-07-27|
TRIAL STUDY 134XCP|QS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1|||||IVIS|||UEQ/L|||UCI/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|1||38||RUN-IN|1963-12-19||||1964-07-23||1971-03-04|1966-08-03|
TRIAL STUDY 134XCP|QS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2|||||WPAI-GH V2.0|||KM/H|||IU/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|2||58||INDUCTION TREATMENT|1962-10-04||||1965-04-20||1961-01-14|1964-09-30|
TRIAL STUDY 134XCP|QS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|3|||||LEC-5 STANDARD VERSION|||/MIN|||10^7 TCID 50/DOSE|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|3||39||LONG-TERM FOLLOW-UP|1966-02-22||||1973-07-25||1967-08-06|1967-05-24|
TRIAL STUDY 134XCP|QS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|4|||||FACIT-DYSPNEA 33 ITEM BANK|||L/MIN|||G/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|4||88||WASHOUT|1966-10-21||||1972-07-21||1961-10-22|1972-09-26|
TRIAL STUDY 134XCP|QS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|5|||||FLU-IIQ TWICE DAILY|||KG/CM|||TABLET|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|5||7||INDUCTION TREATMENT|1961-05-16||||1963-08-13||1970-01-30|1968-02-01|
TRIAL STUDY 134XCP|QS|7B583F10-E460-4B25-8A6B-530A154442CD|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||UMOL/MG/MIN|||IU/L|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|1||38||LONG-TERM FOLLOW-UP|1966-07-29||||1960-02-03||1972-08-22|1971-09-13|
TRIAL STUDY 134XCP|QS|7B583F10-E460-4B25-8A6B-530A154442CD|2|||||WPAI-SHP V2.0|||GPELISA UNIT/ML|||M3|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|2||58||SCREENING|1967-09-03||||1971-08-04||1973-07-24|1966-02-07|
TRIAL STUDY 134XCP|QS|7B583F10-E460-4B25-8A6B-530A154442CD|3|||||GCGI|||BE/ML|||BQ/UG|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|3||39||RUN-IN|1971-06-30||||1973-03-25||1965-10-07|1972-11-01|
TRIAL STUDY 134XCP|QS|7B583F10-E460-4B25-8A6B-530A154442CD|4|||||WOMAC LK 3.1 INDEX|||CM/S|||S*KPA|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|N|4||88||BLINDED TREATMENT|1962-11-24||||1964-01-05||1970-07-05|1971-06-05|
TRIAL STUDY 134XCP|QS|7B583F10-E460-4B25-8A6B-530A154442CD|5|||||FBRSI|||LOG10 CFU/ML|||10^6 CFU/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|U|5||7||INDUCTION TREATMENT|1973-05-16||||1960-01-27||1969-11-04|1972-03-09|
TRIAL STUDY 134XCP|QS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1|||||EORTC QLQ-C30 V3.0|||BEATS/MIN|||/5X10^4 WBC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|1||38||TREATMENT|1963-05-04||||1967-08-14||1965-05-04|1962-12-06|
TRIAL STUDY 134XCP|QS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2|||||MDQ-T|||DEG2|||MG/KG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|U|2||58||BLINDED TREATMENT|1968-06-10||||1967-06-15||1968-12-08|1961-05-08|
TRIAL STUDY 134XCP|QS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||IU/G HB|||U/MG|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|3||39||CONTINUATION TREATMENT|1960-09-08||||1970-12-26||1964-11-19|1967-01-25|
TRIAL STUDY 134XCP|QS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|4|||||NCCN-FACT FPSI-17 V2|||BEAM BREAKS|||KALLIKREIN INHIBITOR UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|Y|4||88||WASHOUT|1970-08-28||||1968-08-27||1963-10-04|1973-05-30|
TRIAL STUDY 134XCP|QS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|5|||||MNSI|||TITER|||MPL U|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|5||7||INDUCTION TREATMENT|1969-03-06||||1964-10-10||1965-09-20|1970-06-14|
TRIAL STUDY 134XCP|QS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1|||||GCGI|||MESF|||G/L|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|1||38||BASELINE|1965-10-26||||1966-11-03||1968-03-18|1968-07-17|
TRIAL STUDY 134XCP|QS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2|||||PDQUALIF|||CI/UG|||MG/KG/WEEK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|NA|2||58||INDUCTION TREATMENT|1966-07-12||||1967-01-26||1961-12-11|1961-10-26|
TRIAL STUDY 134XCP|QS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|3|||||SF36 V1.0 ACUTE|||APPLICATION|||PM|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|3||39||BASELINE|1962-09-07||||1962-01-25||1964-10-27|1972-05-23|
TRIAL STUDY 134XCP|QS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||MG/KG/MIN|||GPS U|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|4||88||CONTINUATION TREATMENT|1962-03-04||||1973-04-19||1965-01-26|1962-02-09|
TRIAL STUDY 134XCP|QS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|5|||||ESS|||MU/L|||GRAIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|5||7||RUN-IN|1960-02-15||||1960-02-22||1967-02-11|1970-03-27|
TRIAL STUDY 134XCP|QS|51FE575E-2161-414B-B772-9F1888E7C5CC|1|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||ML/SEC/1.73M2|||NMOL/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|NA|1||38||CONTINUATION TREATMENT|1969-09-10||||1966-04-21||1965-05-02|1971-03-13|
TRIAL STUDY 134XCP|QS|51FE575E-2161-414B-B772-9F1888E7C5CC|2|||||PARENT-DDS|||TBSP|||CIGAR|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|2||58||OBSERVATION|1966-11-15||||1963-10-17||1961-11-19|1969-03-17|
TRIAL STUDY 134XCP|QS|51FE575E-2161-414B-B772-9F1888E7C5CC|3|||||WOMAC NRS 3.1 INDEX|||MMHG/L/MIN|||HEP|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|N|3||39||INDUCTION TREATMENT|1969-07-23||||1970-07-03||1966-08-01|1961-03-26|
TRIAL STUDY 134XCP|QS|51FE575E-2161-414B-B772-9F1888E7C5CC|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||BREATHS/MIN|||LOG10 PFU|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|Y|4||88||SCREENING|1968-02-04||||1968-11-22||1972-10-17|1967-12-08|
TRIAL STUDY 134XCP|QS|51FE575E-2161-414B-B772-9F1888E7C5CC|5|||||UPS|||SACHET|||ENZYME U/L|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|5||7||TREATMENT|1961-02-01||||1962-02-19||1970-05-20|1967-02-10|
TRIAL STUDY 134XCP|QS|991C72FC-777F-4CED-824B-A4DECA57BE99|1|||||SF12 V1.0 STANDARD|||DAGU/ML|||AMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|NA|1||38||RUN-IN|1969-06-03||||1960-10-21||1964-07-06|1962-02-16|
TRIAL STUDY 134XCP|QS|991C72FC-777F-4CED-824B-A4DECA57BE99|2|||||HADS|||CL|||/2000 RBC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|U|2||58||BLINDED TREATMENT|1968-05-12||||1964-01-30||1963-10-02|1966-12-24|
TRIAL STUDY 134XCP|QS|991C72FC-777F-4CED-824B-A4DECA57BE99|3|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||MG|||UM2|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|Y|3||39||SCREENING|1973-05-09||||1971-10-11||1970-04-26|1966-01-14|
TRIAL STUDY 134XCP|QS|991C72FC-777F-4CED-824B-A4DECA57BE99|4|||||IPAQ-LF PHONE VERSION|||MGEQ|||MDFI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|4||88||CONTINUATION TREATMENT|1960-04-25||||1962-08-14||1961-07-31|1966-08-28|
TRIAL STUDY 134XCP|QS|991C72FC-777F-4CED-824B-A4DECA57BE99|5|||||WHODAS 2.0 - 36-ITEM PROXY|||U/DL|||IMPLANT|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|5||7||TREATMENT|1962-05-18||||1972-05-11||1960-09-13|1973-07-20|
TRIAL STUDY 134XCP|QS|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1|||||OAB-Q SHORT FORM|||DAYS/MONTH|||COAT|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|1||38||LONG-TERM FOLLOW-UP|1972-12-28||||1963-09-13||1965-11-11|1971-02-16|
TRIAL STUDY 134XCP|QS|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2|||||SF10 V1.0 CHILDREN ACUTE|||KG|||G/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|U|2||58||BASELINE|1964-07-22||||1964-06-07||1963-06-25|1970-01-31|
TRIAL STUDY 134XCP|QS|FFECA538-8D16-421C-ACA2-4A769BC15D7D|3|||||ACQ|||LENS|||MBP|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|3||39||RUN-IN|1969-09-29||||1964-06-21||1972-06-29|1965-06-28|
TRIAL STUDY 134XCP|QS|FFECA538-8D16-421C-ACA2-4A769BC15D7D|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||DIOPTER|||ELISA UNIT|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|U|4||88||WASHOUT|1961-06-03||||1960-12-11||1967-08-28|1973-05-23|
TRIAL STUDY 134XCP|QS|FFECA538-8D16-421C-ACA2-4A769BC15D7D|5|||||SF36 V2.0 ACUTE|||IU/MMOL|||%(W/V)|NOT DONE||LIKERT SCALE 5-POINT|Y|U|N|5||7||RUN-IN|1964-11-06||||1966-03-15||1969-02-08|1965-07-25|
TRIAL STUDY 134XCP|QS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1|||||NCCN-FACT FHNSI-22 V2|||NMOL/L/MIN|||KM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|1||38||TREATMENT|1971-01-17||||1965-01-04||1962-08-17|1967-12-25|
TRIAL STUDY 134XCP|QS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2|||||BSI-18|||MG/MIN|||UG/G/DAY|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|2||58||OBSERVATION|1972-11-06||||1966-03-27||1964-10-02|1973-07-03|
TRIAL STUDY 134XCP|QS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|3|||||NCCN-FACT FHNSI-22 V2|||U/KG/MIN|||/4.0 ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|Y|3||39||TREATMENT|1965-04-26||||1964-08-13||1968-10-27|1970-03-07|
TRIAL STUDY 134XCP|QS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|4|||||EQ-5D-3L|||AMOL|||UG/ML/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|N|4||88||INDUCTION TREATMENT|1964-02-20||||1970-11-13||1963-10-14|1969-06-24|
TRIAL STUDY 134XCP|QS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|5|||||HAQ-DI WITH VAS|||ML/CM H2O|||BAR|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|U|5||7||BASELINE|1972-10-18||||1961-07-05||1963-03-24|1965-08-20|
TRIAL STUDY 134XCP|QS|54507F00-0C16-4F35-A762-104B47390283|1|||||ODI V2.1A|||CUP EQ|||/LSQN|NOT DONE||LIKERT SCALE 5-POINT|Y|N|NA|1||38||TREATMENT|1966-06-22||||1963-06-04||1961-08-19|1970-10-16|
TRIAL STUDY 134XCP|QS|54507F00-0C16-4F35-A762-104B47390283|2|||||EQ-5D-5L|||RING|||BEATS/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|N|2||58||OPEN LABEL TREATMENT|1972-09-13||||1963-07-08||1962-12-19|1961-01-12|
TRIAL STUDY 134XCP|QS|54507F00-0C16-4F35-A762-104B47390283|3|||||EORTC QLQ-CR29 V2.1|||10^6/L|||K|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|Y|3||39||LONG-TERM FOLLOW-UP|1971-09-25||||1971-09-12||1967-04-17|1973-02-07|
TRIAL STUDY 134XCP|QS|54507F00-0C16-4F35-A762-104B47390283|4|||||CCQ 24 HOUR VERSION|||HZ/S|||KBQ|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|4||88||WASHOUT|1972-11-05||||1965-06-27||1964-03-25|1968-07-04|
TRIAL STUDY 134XCP|QS|54507F00-0C16-4F35-A762-104B47390283|5|||||YMRS|||VIRTUAL PIXEL|||/VF|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|5||7||CONTINUATION TREATMENT|1967-02-10||||1972-09-17||1963-12-30|1964-10-05|
TRIAL STUDY 134XCP|QS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1|||||WHODAS 2.0 - 12-ITEM SELF|||/200 HPFS|||MGEQ|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|1||38||CONTINUATION TREATMENT|1970-12-12||||1969-01-08||1966-12-07|1971-08-17|
TRIAL STUDY 134XCP|QS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||ML|||PMOL/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|N|2||58||SCREENING|1965-04-12||||1971-07-10||1962-03-26|1966-04-21|
TRIAL STUDY 134XCP|QS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|3|||||CCQ 24 HOUR VERSION|||CL|||GPL U/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|U|3||39||OBSERVATION|1968-10-10||||1969-02-13||1963-09-24|1966-02-20|
TRIAL STUDY 134XCP|QS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|4|||||NCCN-FACT FOSI-18 V2|||EU|||MG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|4||88||LONG-TERM FOLLOW-UP|1963-08-26||||1963-09-16||1960-07-17|1965-11-06|
TRIAL STUDY 134XCP|QS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||AG|||UMOL/L/H|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|NA|5||7||OPEN LABEL TREATMENT|1967-10-13||||1969-12-15||1966-09-22|1967-04-14|
TRIAL STUDY 134XCP|QS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1|||||FACT-G V4|||KCAL|||BOWL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|1||38||LONG-TERM FOLLOW-UP|1966-09-20||||1961-03-05||1964-03-14|1964-12-29|
TRIAL STUDY 134XCP|QS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2|||||DAD|||UG|||/H|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|2||58||WASHOUT|1968-02-14||||1966-12-30||1972-07-18|1961-01-06|
TRIAL STUDY 134XCP|QS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|3|||||NCCN-FACT FHNSI-22 V2|||USIEMENS|||ENZYME U|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|3||39||BLINDED TREATMENT|1969-07-29||||1971-10-24||1971-02-04|1970-03-03|
TRIAL STUDY 134XCP|QS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|4|||||SIQ-JR|||MG/G/H|||PSEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|NA|4||88||SCREENING|1969-03-08||||1970-05-15||1961-06-25|1969-10-01|
TRIAL STUDY 134XCP|QS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|5|||||SIQR|||P|||IN2|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|5||7||FOLLOW-UP|1970-02-14||||1969-10-14||1962-05-24|1967-11-04|
TRIAL STUDY 134XCP|QS|CF8F9036-3380-4A0B-B17A-7EF814B02700|1|||||FLU-IIQ TWICE DAILY|||GRAVITATIONAL UNIT|||KBQ/UL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|N|1||38||BLINDED TREATMENT|1970-06-26||||1968-12-30||1969-09-12|1968-03-09|
TRIAL STUDY 134XCP|QS|CF8F9036-3380-4A0B-B17A-7EF814B02700|2|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||NMOL BCE/L|||BOWL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|N|2||58||OPEN LABEL TREATMENT|1967-09-17||||1963-05-22||1963-07-08|1963-04-18|
TRIAL STUDY 134XCP|QS|CF8F9036-3380-4A0B-B17A-7EF814B02700|3|||||SF12 V1.0 ACUTE|||OSM|||MG/G/H|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|3||39||OBSERVATION|1971-10-04||||1968-07-19||1964-05-28|1960-03-16|
TRIAL STUDY 134XCP|QS|CF8F9036-3380-4A0B-B17A-7EF814B02700|4|||||EPIC-26|||UKAT/10^12 RBC|||G/ANIMAL/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|N|4||88||OBSERVATION|1972-12-20||||1966-06-01||1970-12-20|1967-07-25|
TRIAL STUDY 134XCP|QS|CF8F9036-3380-4A0B-B17A-7EF814B02700|5|||||ADCS-ADL MCI|||FT|||GBQ/MG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|5||7||OBSERVATION|1962-10-20||||1964-11-18||1970-10-12|1965-09-18|
TRIAL STUDY 134XCP|QS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1|||||LEC-5 STANDARD VERSION|||PIPE|||ENZYME U/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|1||38||SCREENING|1965-08-13||||1968-06-15||1966-12-15|1961-04-12|
TRIAL STUDY 134XCP|QS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2|||||MSQOL-54|||U/KG/DAY|||MEQ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|2||58||INDUCTION TREATMENT|1965-11-10||||1970-08-16||1968-06-13|1969-10-05|
TRIAL STUDY 134XCP|QS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|3|||||ADSD V1.0|||GPL U/ML|||MG/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|3||39||OPEN LABEL TREATMENT|1970-11-10||||1960-05-15||1972-12-06|1968-08-03|
TRIAL STUDY 134XCP|QS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|4|||||ASEX-MALE|||MOSM|||APS U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|4||88||BASELINE|1969-03-22||||1962-08-24||1961-03-27|1972-03-04|
TRIAL STUDY 134XCP|QS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|5|||||ACT|||RATIO|||G/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|Y|5||7||BLINDED TREATMENT|1970-01-10||||1968-08-01||1973-04-30|1971-05-21|
TRIAL STUDY 134XCP|QS|58360390-F6AB-41D7-9A0D-1039E795403E|1|||||SDS|||TORR|||MMU/ML|NOT DONE||LIKERT SCALE 5-POINT|N|NA|U|1||38||INDUCTION TREATMENT|1968-11-20||||1962-08-21||1968-12-18|1970-12-30|
TRIAL STUDY 134XCP|QS|58360390-F6AB-41D7-9A0D-1039E795403E|2|||||FACT-P V4|||ML/ANIMAL|||U.CARR|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|2||58||SCREENING|1969-05-19||||1963-11-30||1972-07-22|1961-01-04|
TRIAL STUDY 134XCP|QS|58360390-F6AB-41D7-9A0D-1039E795403E|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||MV|||/100 HPFS|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|3||39||OBSERVATION|1964-10-03||||1967-09-17||1971-05-22|1960-06-16|
TRIAL STUDY 134XCP|QS|58360390-F6AB-41D7-9A0D-1039E795403E|4|||||PODCI - ADOLESCENT SELF REPORTED|||MM/2H|||GAUSS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|4||88||OPEN LABEL TREATMENT|1971-07-05||||1970-01-08||1970-12-19|1965-05-18|
TRIAL STUDY 134XCP|QS|58360390-F6AB-41D7-9A0D-1039E795403E|5|||||C-SSRS ALREADY ENROLLED SUBJECTS|||ML/CAGE|||MBP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|U|5||7||INDUCTION TREATMENT|1965-03-13||||1962-06-22||1972-10-25|1961-03-29|
TRIAL STUDY 134XCP|QS|61B02780-0C99-47F8-93B2-CA839876604E|1|||||MHIS-NACC|||CM2|||COULOMB|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|1||38||TREATMENT|1966-09-28||||1972-12-02||1965-09-30|1965-08-04|
TRIAL STUDY 134XCP|QS|61B02780-0C99-47F8-93B2-CA839876604E|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||BE/ML|||LOG10 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|2||58||BLINDED TREATMENT|1960-09-30||||1970-02-01||1965-02-18|1962-10-08|
TRIAL STUDY 134XCP|QS|61B02780-0C99-47F8-93B2-CA839876604E|3|||||PHQ-15|||YEARS|||STEPS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|3||39||OPEN LABEL TREATMENT|1965-02-13||||1966-04-07||1960-05-11|1964-06-21|
TRIAL STUDY 134XCP|QS|61B02780-0C99-47F8-93B2-CA839876604E|4|||||BSFS|||AMPULE|||APS U|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|4||88||FOLLOW-UP|1968-03-10||||1972-11-27||1962-05-11|1971-12-24|
TRIAL STUDY 134XCP|QS|61B02780-0C99-47F8-93B2-CA839876604E|5|||||FKSI-15|||GBQ/MG|||BAR|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|U|5||7||TREATMENT|1964-11-05||||1962-02-15||1972-07-31|1963-01-09|
TRIAL STUDY 134XCP|QS|1381458A-D702-467D-ADCA-984EE7BD894D|1|||||IDS-SR|||IU/G HB|||10^12/L|NOT DONE||LIKERT SCALE 5-POINT|U|Y|U|1||38||TREATMENT|1963-11-25||||1965-12-12||1966-01-16|1970-04-02|
TRIAL STUDY 134XCP|QS|1381458A-D702-467D-ADCA-984EE7BD894D|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||TSP|||PMOL/10^9 CELLS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|U|2||58||BASELINE|1963-06-14||||1973-03-06||1961-09-01|1962-10-20|
TRIAL STUDY 134XCP|QS|1381458A-D702-467D-ADCA-984EE7BD894D|3|||||FLSI|||10^9 ORGANISMS/G|||KIU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|U|3||39||OPEN LABEL TREATMENT|1960-08-29||||1966-12-10||1960-01-22|1970-01-21|
TRIAL STUDY 134XCP|QS|1381458A-D702-467D-ADCA-984EE7BD894D|4|||||WPAI-GH V2.0|||VG/DOSE|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|N|4||88||TREATMENT|1965-07-21||||1961-12-03||1962-03-14|1968-04-29|
TRIAL STUDY 134XCP|QS|1381458A-D702-467D-ADCA-984EE7BD894D|5|||||SF12 V2.0 STANDARD|||UU/DL|||SCM|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|5||7||WASHOUT|1971-08-17||||1963-06-26||1972-12-16|1961-07-15|
TRIAL STUDY 134XCP|QS|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1|||||SF12 V2.0 ACUTE|||10^6/G|||H*%|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|N|1||38||WASHOUT|1972-12-25||||1972-08-04||1972-03-19|1968-01-17|
TRIAL STUDY 134XCP|QS|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||VG/ML|||ELISA UNIT/DOSE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|2||58||WASHOUT|1961-06-29||||1962-01-15||1969-06-03|1960-06-04|
TRIAL STUDY 134XCP|QS|04211DA3-CFD5-4750-9D61-C91FF7BC338A|3|||||BORG CR10|||/DAY|||DYN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|Y|3||39||BLINDED TREATMENT|1967-12-09||||1967-02-19||1960-07-02|1966-05-30|
TRIAL STUDY 134XCP|QS|04211DA3-CFD5-4750-9D61-C91FF7BC338A|4|||||FACT-COG V3|||LX|||BQ/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|4||88||FOLLOW-UP|1967-07-27||||1972-08-02||1961-12-05|1972-08-16|
TRIAL STUDY 134XCP|QS|04211DA3-CFD5-4750-9D61-C91FF7BC338A|5|||||AUDIT-SR|||OZ EQ|||MEQ/UG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|5||7||RUN-IN|1971-05-05||||1969-01-18||1971-07-02|1962-02-21|
TRIAL STUDY 134XCP|QS|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||U/L|||CCID 50/DOSE|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|1||38||CONTINUATION TREATMENT|1960-10-31||||1960-07-02||1965-04-22|1971-01-12|
TRIAL STUDY 134XCP|QS|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2|||||SF12 V2.0 ACUTE|||UG/L|||MBP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|N|2||58||TREATMENT|1960-10-10||||1969-06-20||1967-06-29|1962-10-06|
TRIAL STUDY 134XCP|QS|EF707A48-6FAD-47C0-913A-5CBCACA539E0|3|||||PHQ-9|||UMOL/DL|||HENRY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|3||39||TREATMENT|1970-08-15||||1969-07-02||1968-10-10|1962-02-13|
TRIAL STUDY 134XCP|QS|EF707A48-6FAD-47C0-913A-5CBCACA539E0|4|||||OAB-Q|||M2|||PKAT/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|NA|4||88||BASELINE|1973-03-28||||1965-09-15||1962-02-12|1964-04-12|
TRIAL STUDY 134XCP|QS|EF707A48-6FAD-47C0-913A-5CBCACA539E0|5|||||PDQUALIF|||G/ANIMAL/DAY|||ELISA UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|5||7||OBSERVATION|1972-07-31||||1967-11-10||1961-07-03|1966-07-24|
TRIAL STUDY 134XCP|QS|C896767E-2418-4226-A8AE-D875DA40F9FB|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||HOURS|||DAYS|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|1||38||SCREENING|1970-11-13||||1973-03-20||1964-12-14|1963-08-09|
TRIAL STUDY 134XCP|QS|C896767E-2418-4226-A8AE-D875DA40F9FB|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||G/KG/DAY|||MM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|2||58||RUN-IN|1971-05-06||||1969-07-03||1965-11-04|1968-12-03|
TRIAL STUDY 134XCP|QS|C896767E-2418-4226-A8AE-D875DA40F9FB|3|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||UG/L FEU|||DDU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|3||39||LONG-TERM FOLLOW-UP|1962-07-29||||1968-06-07||1964-02-07|1961-12-23|
TRIAL STUDY 134XCP|QS|C896767E-2418-4226-A8AE-D875DA40F9FB|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||FT|||UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|4||88||FOLLOW-UP|1973-05-16||||1965-11-22||1971-04-26|1963-11-30|
TRIAL STUDY 134XCP|QS|C896767E-2418-4226-A8AE-D875DA40F9FB|5|||||ACQ|||MM/H|||FL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|N|5||7||TREATMENT|1970-05-12||||1969-10-27||1968-12-19|1964-12-16|
TRIAL STUDY 134XCP|QS|666BC019-B828-4DB4-BD2F-973BA689C9E7|1|||||WHODAS 2.0 - 36-ITEM PROXY|||10^10/L|||MOL/G|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|1||38||BLINDED TREATMENT|1972-06-29||||1971-02-03||1971-10-26|1965-05-03|
TRIAL STUDY 134XCP|QS|666BC019-B828-4DB4-BD2F-973BA689C9E7|2|||||ASEX-MALE|||%(W/W)|||UG/M2/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|N|2||58||TREATMENT|1967-10-02||||1962-04-28||1964-01-17|1967-09-15|
TRIAL STUDY 134XCP|QS|666BC019-B828-4DB4-BD2F-973BA689C9E7|3|||||ADCS-CGIC|||PACKAGE|||STEPS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|3||39||CONTINUATION TREATMENT|1972-06-23||||1961-09-04||1966-08-17|1972-08-15|
TRIAL STUDY 134XCP|QS|666BC019-B828-4DB4-BD2F-973BA689C9E7|4|||||PODCI - ADOLESCENT PARENT REPORTED|||MG/G/H|||CMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|4||88||FOLLOW-UP|1965-05-31||||1962-12-12||1964-03-26|1960-11-07|
TRIAL STUDY 134XCP|QS|666BC019-B828-4DB4-BD2F-973BA689C9E7|5|||||Q-LES-Q|||BOX|||G/G|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|Y|5||7||RUN-IN|1966-06-27||||1966-05-24||1969-10-13|1960-03-21|
TRIAL STUDY 134XCP|QS|91282D87-4943-4527-8F33-27A5C153951C|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||UCI/KG|||MMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|1||38||TREATMENT|1973-07-16||||1967-09-19||1967-12-01|1964-11-12|
TRIAL STUDY 134XCP|QS|91282D87-4943-4527-8F33-27A5C153951C|2|||||MDQ-T|||MESF|||USIEMENS|NOT DONE||LIKERT SCALE 7-POINT|U|NA|N|2||58||LONG-TERM FOLLOW-UP|1970-06-26||||1964-10-15||1973-01-16|1964-10-29|
TRIAL STUDY 134XCP|QS|91282D87-4943-4527-8F33-27A5C153951C|3|||||MNSI|||MMOL/MIN/KPA|||MOL/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|3||39||INDUCTION TREATMENT|1960-09-24||||1966-08-09||1968-05-12|1973-08-21|
TRIAL STUDY 134XCP|QS|91282D87-4943-4527-8F33-27A5C153951C|4|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||COULOMB|||ROENTGEN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|U|4||88||OPEN LABEL TREATMENT|1972-08-15||||1962-04-11||1968-08-06|1967-12-22|
TRIAL STUDY 134XCP|QS|91282D87-4943-4527-8F33-27A5C153951C|5|||||NCCN-FACT FBRSI-24 V2|||MM2|||FRACTION OF 1|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|Y|5||7||INDUCTION TREATMENT|1972-09-09||||1963-09-17||1960-12-01|1965-12-20|
TRIAL STUDY 134XCP|QS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1|||||EXPANDED DRS-PI CAREGIVER VERSION|||MG/ML/MIN|||INHALATION|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|1||38||TREATMENT|1960-09-13||||1961-06-14||1964-06-14|1960-01-11|
TRIAL STUDY 134XCP|QS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2|||||COMM|||WAFER|||PFU|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|2||58||BLINDED TREATMENT|1960-04-07||||1970-10-08||1962-03-15|1971-12-13|
TRIAL STUDY 134XCP|QS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||PFU/ML|||TRACE|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|Y|3||39||OPEN LABEL TREATMENT|1961-12-04||||1965-12-08||1962-06-09|1969-05-16|
TRIAL STUDY 134XCP|QS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||KBQ|||MV*MIN|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|4||88||SCREENING|1962-05-22||||1971-11-01||1965-04-26|1962-03-26|
TRIAL STUDY 134XCP|QS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||ML/100G/MIN|||UG/G/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|5||7||BLINDED TREATMENT|1970-08-07||||1965-03-04||1963-06-26|1960-04-25|
TRIAL STUDY 134XCP|QS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1|||||PHQ-2|||U/M2|||SYRINGE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|Y|1||38||RUN-IN|1969-06-02||||1965-09-07||1965-11-22|1969-02-08|
TRIAL STUDY 134XCP|QS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||POINT|||ML/MMHG/MIN/L|NOT DONE||LIKERT SCALE 3-POINT|U|NA|Y|2||58||INDUCTION TREATMENT|1964-12-29||||1970-06-10||1969-09-23|1963-08-21|
TRIAL STUDY 134XCP|QS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||MG/KG/DAY|||UG/DL|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|3||39||OBSERVATION|1968-03-19||||1965-09-25||1967-03-31|1971-05-11|
TRIAL STUDY 134XCP|QS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|4|||||EXPANDED DRS-PI CAREGIVER VERSION|||TRACE|||UL/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|4||88||TREATMENT|1964-01-27||||1962-03-23||1970-08-16|1965-07-21|
TRIAL STUDY 134XCP|QS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|5|||||WPAI-GH V2.0|||10^4/L|||VP/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|5||7||BASELINE|1963-03-18||||1961-09-18||1967-08-14|1968-09-09|
TRIAL STUDY 134XCP|QS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1|||||T1-DDS|||MBQ|||MJOULE/CM2|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|Y|1||38||FOLLOW-UP|1961-01-21||||1972-03-09||1964-01-27|1963-05-22|
TRIAL STUDY 134XCP|QS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||MG|||FEU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|U|2||58||LONG-TERM FOLLOW-UP|1970-04-26||||1966-03-22||1970-12-29|1965-05-22|
TRIAL STUDY 134XCP|QS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|3|||||FACIT-F V4|||M2|||BEATS/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|3||39||BLINDED TREATMENT|1962-05-17||||1970-03-12||1968-11-21|1968-09-25|
TRIAL STUDY 134XCP|QS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|4|||||FACIT-F V4|||U/ML|||MG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|4||88||CONTINUATION TREATMENT|1966-08-05||||1960-03-27||1972-02-25|1971-06-20|
TRIAL STUDY 134XCP|QS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|5|||||PEDS-FACIT-F|||PG/DL|||FOZ_BR|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|Y|5||7||TREATMENT|1966-12-08||||1965-08-26||1964-08-08|1973-09-01|
TRIAL STUDY 134XCP|QS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1|||||EPIC-26|||MV2/HZ|||PKAT/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|1||38||SCREENING|1963-03-20||||1966-10-11||1970-06-14|1965-05-31|
TRIAL STUDY 134XCP|QS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2|||||FSS|||G/DL|||UG/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|U|2||58||LONG-TERM FOLLOW-UP|1963-04-10||||1971-02-01||1961-07-12|1964-08-14|
TRIAL STUDY 134XCP|QS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|3|||||ADCS-ADL MCI|||BU|||/MS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|NA|3||39||CONTINUATION TREATMENT|1968-09-20||||1970-11-21||1969-07-28|1962-03-06|
TRIAL STUDY 134XCP|QS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|4|||||FSS|||FT2|||LOG10 CFU/ML|NOT DONE||LIKERT SCALE 7-POINT|U|NA|U|4||88||TREATMENT|1960-02-22||||1960-01-27||1972-05-05|1972-03-26|
TRIAL STUDY 134XCP|QS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|5|||||GOSE|||NMOL/L/MIN|||/SEC|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|5||7||OBSERVATION|1961-06-24||||1967-07-04||1964-07-03|1964-09-12|
TRIAL STUDY 134XCP|QS|0320460C-3770-486A-85EB-ECD133AE6EFA|1|||||FACT-HEP V4|||MG/DL|||UL/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|NA|1||38||RUN-IN|1971-09-30||||1964-01-23||1963-06-28|1966-06-26|
TRIAL STUDY 134XCP|QS|0320460C-3770-486A-85EB-ECD133AE6EFA|2|||||CGI|||MSEC|||TUBERCULIN UNIT|NOT DONE||LIKERT SCALE 3-POINT|N|U|Y|2||58||RUN-IN|1967-10-31||||1967-02-18||1971-02-26|1973-04-26|
TRIAL STUDY 134XCP|QS|0320460C-3770-486A-85EB-ECD133AE6EFA|3|||||BIS-11|||G/ANIMAL|||CI/L|NOT DONE||LIKERT SCALE 7-POINT|N|Y|N|3||39||LONG-TERM FOLLOW-UP|1969-12-08||||1965-10-20||1960-06-05|1970-02-22|
TRIAL STUDY 134XCP|QS|0320460C-3770-486A-85EB-ECD133AE6EFA|4|||||SGRQ-C|||G/L|||DEG2|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|4||88||LONG-TERM FOLLOW-UP|1966-12-06||||1964-06-05||1969-11-09|1961-01-26|
TRIAL STUDY 134XCP|QS|0320460C-3770-486A-85EB-ECD133AE6EFA|5|||||EQ-5D-3L|||BLOCKS|||MG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|5||7||FOLLOW-UP|1968-12-09||||1961-09-08||1967-12-14|1964-06-27|
TRIAL STUDY 134XCP|QS|810B0B08-9236-41EC-8879-924661FA224E|1|||||CCQ 24 HOUR VERSION|||KHZ|||FIU|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|NA|1||38||SCREENING|1963-06-06||||1963-07-29||1971-11-21|1970-09-30|
TRIAL STUDY 134XCP|QS|810B0B08-9236-41EC-8879-924661FA224E|2|||||PODCI - ADOLESCENT PARENT REPORTED|||MU/L|||MPL U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|U|2||58||BASELINE|1968-08-05||||1969-04-24||1968-08-20|1971-04-02|
TRIAL STUDY 134XCP|QS|810B0B08-9236-41EC-8879-924661FA224E|3|||||C-SSRS LIFETIME/RECENT VERSION|||1/(S*KPA)|||GENEQ/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|NA|3||39||SCREENING|1970-03-08||||1971-07-09||1971-03-24|1973-03-27|
TRIAL STUDY 134XCP|QS|810B0B08-9236-41EC-8879-924661FA224E|4|||||SMDDS V1.0|||UG/L FEU|||UG/CM2|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|4||88||OBSERVATION|1964-04-04||||1971-07-31||1969-02-26|1963-03-04|
TRIAL STUDY 134XCP|QS|810B0B08-9236-41EC-8879-924661FA224E|5|||||PHQ-15|||KUSP|||UCI|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|Y|5||7||WASHOUT|1963-07-02||||1964-11-10||1969-04-08|1961-03-07|
TRIAL STUDY 134XCP|QS|BA3B0D91-DC95-4916-8ACA-71451447BE81|1|||||COWS|||IU/DL|||POUCH|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|1||38||OBSERVATION|1966-03-31||||1963-10-18||1961-01-12|1961-04-19|
TRIAL STUDY 134XCP|QS|BA3B0D91-DC95-4916-8ACA-71451447BE81|2|||||SDS|||AMFI|||10^6 IU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|Y|2||58||OPEN LABEL TREATMENT|1964-08-02||||1972-03-11||1966-10-22|1970-07-06|
TRIAL STUDY 134XCP|QS|BA3B0D91-DC95-4916-8ACA-71451447BE81|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||U/KG/MIN|||MMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|3||39||SCREENING|1962-02-03||||1962-07-29||1968-06-28|1961-07-28|
TRIAL STUDY 134XCP|QS|BA3B0D91-DC95-4916-8ACA-71451447BE81|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||TRANSDUCING UNIT/ML|||APL U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|NA|4||88||BASELINE|1963-09-07||||1972-04-09||1968-10-02|1970-07-16|
TRIAL STUDY 134XCP|QS|BA3B0D91-DC95-4916-8ACA-71451447BE81|5|||||PHQ-2|||LOG10 ELISA UNIT|||/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|5||7||OBSERVATION|1964-04-28||||1971-01-17||1970-10-19|1972-07-13|
TRIAL STUDY 134XCP|QS|DE385129-5FB9-43C3-9FB1-005886674C9B|1|||||OAB-Q|||10^4/L|||KEV|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|1||38||CONTINUATION TREATMENT|1970-03-31||||1961-02-10||1967-01-01|1963-11-10|
TRIAL STUDY 134XCP|QS|DE385129-5FB9-43C3-9FB1-005886674C9B|2|||||FIQR|||U/ANIMAL|||MPA|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|2||58||WASHOUT|1962-08-14||||1960-03-25||1969-04-17|1968-04-04|
TRIAL STUDY 134XCP|QS|DE385129-5FB9-43C3-9FB1-005886674C9B|3|||||Q-LES-Q|||10^9 CFU/G|||/LPF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|3||39||WASHOUT|1964-03-04||||1964-07-14||1972-06-02|1968-06-21|
TRIAL STUDY 134XCP|QS|DE385129-5FB9-43C3-9FB1-005886674C9B|4|||||CES|||GAUSS|||NMOL/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|4||88||BASELINE|1961-04-02||||1972-02-13||1965-01-10|1962-06-28|
TRIAL STUDY 134XCP|QS|DE385129-5FB9-43C3-9FB1-005886674C9B|5|||||IDS-SR|||DAGU/ML|||TROCHE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|5||7||OPEN LABEL TREATMENT|1963-07-08||||1967-12-03||1963-08-12|1961-05-26|
TRIAL STUDY 134XCP|QS|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1|||||FACT-BMT V4|||U/G/H|||DNA COPIES/UG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|1||38||RUN-IN|1964-05-24||||1972-10-31||1962-03-07|1962-09-06|
TRIAL STUDY 134XCP|QS|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||MMOL/MOL|||DROP|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|2||58||RUN-IN|1961-11-12||||1967-02-15||1970-02-26|1966-10-01|
TRIAL STUDY 134XCP|QS|8AE8077F-A13C-4593-B012-213A5EBE0A1D|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||RATIO|||SPRAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|3||39||OPEN LABEL TREATMENT|1965-04-13||||1972-08-02||1968-07-15|1960-06-06|
TRIAL STUDY 134XCP|QS|8AE8077F-A13C-4593-B012-213A5EBE0A1D|4|||||WOMAC LK 3.1 INDEX|||P|||MU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|4||88||OPEN LABEL TREATMENT|1967-05-25||||1973-04-13||1965-10-26|1962-05-04|
TRIAL STUDY 134XCP|QS|8AE8077F-A13C-4593-B012-213A5EBE0A1D|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||EVENTS|||TUBE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|5||7||OPEN LABEL TREATMENT|1968-06-23||||1971-05-18||1967-02-20|1961-10-11|
TRIAL STUDY 134XCP|QS|72FCE18B-B3D6-45AC-993F-9883E4D11313|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||MEQ/UL|||KIT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|N|1||38||WASHOUT|1963-01-22||||1973-05-15||1961-11-16|1961-07-08|
TRIAL STUDY 134XCP|QS|72FCE18B-B3D6-45AC-993F-9883E4D11313|2|||||Q-LES-Q-SF|||U/G HB|||NMOL/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|2||58||OPEN LABEL TREATMENT|1971-06-05||||1969-01-26||1970-12-08|1971-07-20|
TRIAL STUDY 134XCP|QS|72FCE18B-B3D6-45AC-993F-9883E4D11313|3|||||NCCN-FACT FOSI-18 V2|||PIXELS/CM|||10^3 CFU/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|Y|3||39||TREATMENT|1963-06-01||||1971-08-18||1963-04-19|1970-02-02|
TRIAL STUDY 134XCP|QS|72FCE18B-B3D6-45AC-993F-9883E4D11313|4|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||FMOL|||KPA|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|4||88||CONTINUATION TREATMENT|1962-02-22||||1968-03-25||1972-11-01|1965-10-21|
TRIAL STUDY 134XCP|QS|72FCE18B-B3D6-45AC-993F-9883E4D11313|5|||||SF8 V1.0 ACUTE|||PL|||CAPFUL|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|5||7||FOLLOW-UP|1969-10-14||||1970-10-24||1965-09-28|1963-08-06|
TRIAL STUDY 134XCP|QS|1123F894-0821-41DF-9C28-ED6BC4A7098C|1|||||PDDS|||FOZ_US|||NMOL BCE/MMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|1||38||OBSERVATION|1965-07-21||||1967-08-31||1969-12-30|1966-09-20|
TRIAL STUDY 134XCP|QS|1123F894-0821-41DF-9C28-ED6BC4A7098C|2|||||MSIS-29 V2|||OZ|||RATIO|NOT DONE||LIKERT SCALE 3-POINT|N|NA|N|2||58||WASHOUT|1971-04-19||||1969-06-26||1970-02-26|1963-10-20|
TRIAL STUDY 134XCP|QS|1123F894-0821-41DF-9C28-ED6BC4A7098C|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||MG/ML/DAY|||MOL/MG|NOT DONE||LIKERT SCALE 5-POINT|N|N|Y|3||39||OBSERVATION|1971-08-08||||1970-11-24||1968-01-16|1973-08-31|
TRIAL STUDY 134XCP|QS|1123F894-0821-41DF-9C28-ED6BC4A7098C|4|||||MADRS|||SBE/ML|||MU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|NA|4||88||BLINDED TREATMENT|1970-10-15||||1961-05-19||1968-04-22|1965-01-23|
TRIAL STUDY 134XCP|QS|1123F894-0821-41DF-9C28-ED6BC4A7098C|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||PSI|||PACK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|5||7||OBSERVATION|1962-12-05||||1962-02-01||1971-10-01|1966-01-16|
TRIAL STUDY 134XCP|QS|42DD827A-E788-4E61-8E9F-421136A16166|1|||||IVIS|||UU/L|||U/MMOL|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|NA|1||38||BLINDED TREATMENT|1961-07-19||||1972-08-11||1972-11-27|1960-09-23|
TRIAL STUDY 134XCP|QS|42DD827A-E788-4E61-8E9F-421136A16166|2|||||BPI SHORT FORM|||USEC|||10^6 IU|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|2||58||RUN-IN|1966-09-30||||1960-11-20||1971-12-23|1966-12-05|
TRIAL STUDY 134XCP|QS|42DD827A-E788-4E61-8E9F-421136A16166|3|||||PSQI|||AMP|||KA_U/DL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|3||39||OPEN LABEL TREATMENT|1969-04-01||||1960-04-01||1967-02-13|1972-10-12|
TRIAL STUDY 134XCP|QS|42DD827A-E788-4E61-8E9F-421136A16166|4|||||SF12 V2.0 STANDARD|||1/(S*KPA)|||KG/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|N|4||88||FOLLOW-UP|1960-01-14||||1964-09-10||1966-05-24|1963-05-04|
TRIAL STUDY 134XCP|QS|42DD827A-E788-4E61-8E9F-421136A16166|5|||||UPDRS|||GPL U/ML|||UG/G/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|5||7||WASHOUT|1969-01-26||||1973-07-29||1961-05-19|1960-11-20|
TRIAL STUDY 134XCP|QS|CC1E2338-4454-4CBA-8848-0B994C459F05|1|||||MDS-UPDRS|||F|||U/G/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|Y|1||38||CONTINUATION TREATMENT|1971-10-07||||1960-02-02||1966-10-25|1962-04-26|
TRIAL STUDY 134XCP|QS|CC1E2338-4454-4CBA-8848-0B994C459F05|2|||||EPIC-CP|||G/DL|||GRAIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|N|2||58||TREATMENT|1969-07-28||||1963-05-07||1967-09-13|1966-10-31|
TRIAL STUDY 134XCP|QS|CC1E2338-4454-4CBA-8848-0B994C459F05|3|||||SOWS SHORT|||F|||HOURS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|3||39||OBSERVATION|1962-01-07||||1964-04-12||1966-12-03|1963-05-20|
TRIAL STUDY 134XCP|QS|CC1E2338-4454-4CBA-8848-0B994C459F05|4|||||FACT-BL V4|||MG/L FEU|||/MONTH|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|4||88||RUN-IN|1962-03-30||||1960-08-30||1966-07-12|1965-02-06|
TRIAL STUDY 134XCP|QS|CC1E2338-4454-4CBA-8848-0B994C459F05|5|||||ESS|||EP U|||STRIP|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|5||7||BASELINE|1971-05-06||||1969-03-16||1962-02-12|1967-12-06|
TRIAL STUDY 134XCP|QS|ED04E60D-256A-4DB9-9290-4EFD0602A130|1|||||PARTNER-DDS|||IU/MG|||/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|1||38||RUN-IN|1970-04-17||||1968-05-17||1960-10-31|1971-05-03|
TRIAL STUDY 134XCP|QS|ED04E60D-256A-4DB9-9290-4EFD0602A130|2|||||FLSI|||10^6 ORGANISMS/MG|||UKAT/10^12 RBC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|2||58||LONG-TERM FOLLOW-UP|1967-08-25||||1963-07-03||1964-01-26|1972-06-08|
TRIAL STUDY 134XCP|QS|ED04E60D-256A-4DB9-9290-4EFD0602A130|3|||||PEDS-FACIT-F|||/KG|||WATT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1960-07-30||||1963-10-15||1968-04-05|1972-10-19|
TRIAL STUDY 134XCP|QS|ED04E60D-256A-4DB9-9290-4EFD0602A130|4|||||Q-LES-Q|||NG/L|||LOG10 PFU/ML|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|4||88||INDUCTION TREATMENT|1964-05-06||||1969-07-25||1970-07-13|1961-02-09|
TRIAL STUDY 134XCP|QS|ED04E60D-256A-4DB9-9290-4EFD0602A130|5|||||SF36 V1.0 STANDARD|||UG/M2/H|||MU/G|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|5||7||SCREENING|1963-10-28||||1973-03-17||1960-05-13|1967-05-05|
TRIAL STUDY 134XCP|QS|C70F82F6-3280-429D-9657-CDFBA6B7F626|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||UL/KG/DAY|||GY|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|1||38||FOLLOW-UP|1962-01-01||||1965-04-28||1969-05-09|1973-06-04|
TRIAL STUDY 134XCP|QS|C70F82F6-3280-429D-9657-CDFBA6B7F626|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||TROCHE|||V/SEC|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|N|2||58||RUN-IN|1971-12-12||||1968-08-23||1960-11-01|1965-06-13|
TRIAL STUDY 134XCP|QS|C70F82F6-3280-429D-9657-CDFBA6B7F626|3|||||CHART-SF INTERVIEW VERSION|||KG/CM2|||U/MMOL|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|3||39||SCREENING|1972-08-04||||1971-01-31||1970-01-09|1963-04-04|
TRIAL STUDY 134XCP|QS|C70F82F6-3280-429D-9657-CDFBA6B7F626|4|||||HCS|||L/MIN|||%(V/V)|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|4||88||BASELINE|1966-06-05||||1965-06-10||1973-03-19|1971-11-02|
TRIAL STUDY 134XCP|QS|C70F82F6-3280-429D-9657-CDFBA6B7F626|5|||||GOSE|||MKAT|||PM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|NA|5||7||WASHOUT|1960-08-08||||1964-06-24||1961-03-30|1970-05-19|
TRIAL STUDY 134XCP|QS|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1|||||FKSI-15|||UG/KG/H|||MV*MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|1||38||OBSERVATION|1963-10-17||||1966-02-03||1962-10-23|1972-12-07|
TRIAL STUDY 134XCP|QS|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2|||||FACT-LYM V4|||UG/M2/MIN|||FT2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|2||58||TREATMENT|1964-04-29||||1970-08-01||1973-04-25|1969-12-04|
TRIAL STUDY 134XCP|QS|D735D137-2C27-4F27-BA18-9A0F7FF0B145|3|||||FACT-COG V3|||LOG10 PFU/ML|||UG/M2/H|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|3||39||BLINDED TREATMENT|1968-02-06||||1964-03-13||1964-12-26|1963-01-22|
TRIAL STUDY 134XCP|QS|D735D137-2C27-4F27-BA18-9A0F7FF0B145|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||WATT|||CP|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|NA|4||88||RUN-IN|1963-10-01||||1973-08-13||1972-07-12|1964-10-21|
TRIAL STUDY 134XCP|QS|D735D137-2C27-4F27-BA18-9A0F7FF0B145|5|||||WLQ|||SV|||U/M2/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|5||7||WASHOUT|1963-04-01||||1969-03-03||1965-09-30|1966-12-15|
TRIAL STUDY 134XCP|QS|B00194E0-0E85-46DD-86C3-CD9048535986|1|||||PR|||MG/DAY|||ANSON U|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|1||38||TREATMENT|1961-06-14||||1969-01-30||1971-10-21|1962-11-26|
TRIAL STUDY 134XCP|QS|B00194E0-0E85-46DD-86C3-CD9048535986|2|||||ADAS-COG|||PELLET|||ML/SEC/1.73M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|U|2||58||TREATMENT|1970-09-23||||1973-06-29||1970-06-29|1961-02-27|
TRIAL STUDY 134XCP|QS|B00194E0-0E85-46DD-86C3-CD9048535986|3|||||C-SSRS BASELINE/SCREENING VERSION|||VG/ML|||YD|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|3||39||BASELINE|1964-09-28||||1966-04-07||1972-11-13|1966-06-10|
TRIAL STUDY 134XCP|QS|B00194E0-0E85-46DD-86C3-CD9048535986|4|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||U/ANIMAL|||L/H/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|NA|4||88||OBSERVATION|1965-09-26||||1972-03-27||1965-12-25|1966-01-01|
TRIAL STUDY 134XCP|QS|B00194E0-0E85-46DD-86C3-CD9048535986|5|||||NCCN-FACT FPSI-17 V2|||ECL UNIT|||QUANTITY SUFFICIENT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|NA|5||7||OPEN LABEL TREATMENT|1966-03-11||||1972-09-24||1971-03-02|1963-05-24|
TRIAL STUDY 134XCP|QS|B4F372E9-C461-414A-95B4-93CA0221D396|1|||||FACT-BMT V4|||WEEKS|||10^6/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|N|1||38||BASELINE|1966-03-22||||1968-12-27||1967-01-24|1968-01-08|
TRIAL STUDY 134XCP|QS|B4F372E9-C461-414A-95B4-93CA0221D396|2|||||PR|||CI/KG|||U|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|2||58||TREATMENT|1971-05-24||||1966-04-20||1968-05-29|1965-09-04|
TRIAL STUDY 134XCP|QS|B4F372E9-C461-414A-95B4-93CA0221D396|3|||||SIQ-JR|||MG/M2|||UM/S|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|3||39||OBSERVATION|1966-07-21||||1972-08-11||1967-01-30|1973-03-21|
TRIAL STUDY 134XCP|QS|B4F372E9-C461-414A-95B4-93CA0221D396|4|||||BEBQ RETROSPECTIVE|||ML/DAY|||NKAT/L|NOT DONE||LIKERT SCALE 7-POINT|U|NA|U|4||88||BLINDED TREATMENT|1971-06-21||||1963-05-19||1965-12-06|1972-11-24|
TRIAL STUDY 134XCP|QS|B4F372E9-C461-414A-95B4-93CA0221D396|5|||||MSQOL-54|||MG/DL|||10^10/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|N|5||7||TREATMENT|1971-08-21||||1970-10-25||1965-09-07|1962-09-11|
TRIAL STUDY 134XCP|QS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1|||||EORTC QLQ-C15-PAL V1.0|||MG/M2|||%(W/V)|NOT DONE||LIKERT SCALE 3-POINT|NA|N|Y|1||38||INDUCTION TREATMENT|1973-07-29||||1973-05-08||1967-06-28|1972-06-18|
TRIAL STUDY 134XCP|QS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2|||||FACIT-F V4|||ML*CMH2O|||LOG10 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|2||58||OPEN LABEL TREATMENT|1961-06-13||||1970-05-28||1970-10-19|1966-08-31|
TRIAL STUDY 134XCP|QS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|3|||||HAMD 6 SELF-REPORT VERSION|||UGEQ/L|||ML/KG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|N|3||39||OPEN LABEL TREATMENT|1960-12-08||||1970-11-22||1971-12-07|1967-09-11|
TRIAL STUDY 134XCP|QS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|4|||||SF12 V1.0 ACUTE|||PATCH|||CI/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|4||88||FOLLOW-UP|1972-01-10||||1968-05-24||1970-11-08|1966-03-11|
TRIAL STUDY 134XCP|QS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|5|||||C-SSRS LIFETIME/RECENT VERSION|||UMOL/L/H|||CMOL/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|5||7||BASELINE|1963-10-20||||1965-01-20||1971-02-21|1972-09-08|
TRIAL STUDY 134XCP|QS|E43169E4-8B57-47D7-9C91-D42E40DD579B|1|||||OAB-Q|||CIGARETTE|||SV|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|1||38||FOLLOW-UP|1961-07-14||||1963-12-19||1960-04-07|1967-07-05|
TRIAL STUDY 134XCP|QS|E43169E4-8B57-47D7-9C91-D42E40DD579B|2|||||ADSD V1.0|||AU/ML|||ML/G/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|2||58||LONG-TERM FOLLOW-UP|1962-03-04||||1962-02-08||1970-10-16|1968-08-16|
TRIAL STUDY 134XCP|QS|E43169E4-8B57-47D7-9C91-D42E40DD579B|3|||||ADHD-RS-IV HOME VERSION|||/MM|||VIRTUAL PIXEL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|3||39||FOLLOW-UP|1969-04-24||||1961-02-22||1967-02-10|1964-03-30|
TRIAL STUDY 134XCP|QS|E43169E4-8B57-47D7-9C91-D42E40DD579B|4|||||ADHD-RS-IV HOME VERSION|||10^7/L|||GBQ/UG|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|N|4||88||WASHOUT|1972-05-16||||1966-12-11||1968-10-23|1968-03-27|
TRIAL STUDY 134XCP|QS|E43169E4-8B57-47D7-9C91-D42E40DD579B|5|||||PEDS-FACIT-F|||/2000 RBC|||NKAT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|5||7||INDUCTION TREATMENT|1968-03-20||||1963-01-23||1967-11-06|1969-01-26|
TRIAL STUDY 134XCP|QS|066393EE-D112-41DD-AF8F-65EF57A4415B|1|||||FACT-BL V4|||AMPULE|||/10^3|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|1||38||OBSERVATION|1965-02-25||||1962-11-17||1970-07-14|1962-02-03|
TRIAL STUDY 134XCP|QS|066393EE-D112-41DD-AF8F-65EF57A4415B|2|||||GDS SHORT FORM|||ML/G/DAY|||MV/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|NA|2||58||OBSERVATION|1968-11-03||||1962-01-23||1964-04-01|1972-07-19|
TRIAL STUDY 134XCP|QS|066393EE-D112-41DD-AF8F-65EF57A4415B|3|||||SIQ-JR|||MMHG/L/MIN|||MMOL/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|U|3||39||FOLLOW-UP|1968-02-13||||1967-08-09||1966-04-29|1961-07-28|
TRIAL STUDY 134XCP|QS|066393EE-D112-41DD-AF8F-65EF57A4415B|4|||||OAB-Q SHORT FORM|||COPIES/ML|||NG/MOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|4||88||OPEN LABEL TREATMENT|1963-10-05||||1971-11-11||1963-04-06|1971-08-14|
TRIAL STUDY 134XCP|QS|066393EE-D112-41DD-AF8F-65EF57A4415B|5|||||CDR|||MNFI|||K|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|N|5||7||WASHOUT|1970-01-01||||1972-04-08||1971-10-13|1963-05-11|
TRIAL STUDY 134XCP|QS|573C9228-D341-491C-9D66-0D0435E2C631|1|||||SOAPP-R|||GENEQ/ML|||JDF UNIT|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|1||38||BASELINE|1972-01-20||||1965-04-19||1970-11-18|1965-11-13|
TRIAL STUDY 134XCP|QS|573C9228-D341-491C-9D66-0D0435E2C631|2|||||SF10 V1.0 CHILDREN ACUTE|||PIXELS/IN|||SQU/ML|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|2||58||TREATMENT|1968-05-07||||1960-08-29||1970-01-24|1967-06-23|
TRIAL STUDY 134XCP|QS|573C9228-D341-491C-9D66-0D0435E2C631|3|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||ML/M2/DAY|||PMOL/L|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||LONG-TERM FOLLOW-UP|1963-11-26||||1969-03-18||1970-09-02|1966-03-13|
TRIAL STUDY 134XCP|QS|573C9228-D341-491C-9D66-0D0435E2C631|4|||||SF12 V2.0 STANDARD|||MN|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|4||88||WASHOUT|1969-10-26||||1965-07-02||1966-11-22|1969-01-18|
TRIAL STUDY 134XCP|QS|573C9228-D341-491C-9D66-0D0435E2C631|5|||||FACT-C V4|||MOL|||TSP EQ|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|5||7||SCREENING|1960-04-12||||1969-12-20||1972-01-26|1964-12-22|
TRIAL STUDY 134XCP|QS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1|||||EPIC-26|||RING|||10^9 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|N|1||38||LONG-TERM FOLLOW-UP|1966-09-28||||1960-06-12||1973-07-08|1968-01-31|
TRIAL STUDY 134XCP|QS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2|||||SIQ|||MEQ/UG|||UG/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|2||58||WASHOUT|1960-04-14||||1963-08-19||1963-06-10|1964-02-12|
TRIAL STUDY 134XCP|QS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|3|||||TSQM V1.4|||MOSM|||DIP|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|N|3||39||BLINDED TREATMENT|1960-05-25||||1969-07-05||1960-12-27|1965-05-20|
TRIAL STUDY 134XCP|QS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|4|||||C-SSRS SINCE LAST VISIT|||10^9 ORGANISMS/MG|||FMOL/G|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|4||88||RUN-IN|1972-05-22||||1964-03-13||1972-10-19|1963-05-12|
TRIAL STUDY 134XCP|QS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|5|||||GCGI|||UM/DAY|||NG|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|5||7||INDUCTION TREATMENT|1969-03-31||||1971-03-18||1971-07-07|1961-10-10|
TRIAL STUDY 134XCP|QS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1|||||SGRQ-C|||FG|||UG/L DDU|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|1||38||BLINDED TREATMENT|1966-05-11||||1972-08-30||1973-06-09|1963-10-25|
TRIAL STUDY 134XCP|QS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||G/MOL|||HOMEOPATHIC DILUTION|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|2||58||BASELINE|1960-03-10||||1965-09-04||1971-03-29|1968-06-22|
TRIAL STUDY 134XCP|QS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|3|||||FACT-LEU V4|||ARBITRARY U|||CD|NOT DONE||LIKERT SCALE 7-POINT|U|Y|N|3||39||RUN-IN|1970-08-07||||1970-01-13||1963-02-05|1967-09-24|
TRIAL STUDY 134XCP|QS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|4|||||MPAI-4|||CAN|||IU/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|4||88||TREATMENT|1964-03-28||||1966-02-25||1963-07-19|1970-11-22|
TRIAL STUDY 134XCP|QS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|5|||||PHQ SCREENER VERSION|||MM/H|||G/ANIMAL|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|U|5||7||BASELINE|1962-12-20||||1963-07-02||1973-04-19|1968-05-30|
TRIAL STUDY 134XCP|QS|61C75130-5C1A-4B8D-804C-92D3288B55D2|1|||||ACT|||GPELISA UNIT/ML|||ML/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|1||38||BASELINE|1966-04-19||||1966-04-01||1971-02-06|1968-12-11|
TRIAL STUDY 134XCP|QS|61C75130-5C1A-4B8D-804C-92D3288B55D2|2|||||EXPANDED DRS-PI CAREGIVER VERSION|||VG/KG|||MNFI|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|2||58||CONTINUATION TREATMENT|1971-08-19||||1960-11-08||1971-02-17|1963-05-08|
TRIAL STUDY 134XCP|QS|61C75130-5C1A-4B8D-804C-92D3288B55D2|3|||||SMDDS V1.0|||NMOL/G|||ECL UNIT|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|3||39||SCREENING|1971-09-18||||1961-01-04||1966-04-07|1960-03-07|
TRIAL STUDY 134XCP|QS|61C75130-5C1A-4B8D-804C-92D3288B55D2|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||PMOL/10^9 CELLS|||PLUG|NOT DONE||LIKERT SCALE 3-POINT|U|U|NA|4||88||RUN-IN|1969-06-27||||1964-01-19||1964-12-28|1973-08-01|
TRIAL STUDY 134XCP|QS|61C75130-5C1A-4B8D-804C-92D3288B55D2|5|||||IDS-SR|||U/KG/H|||PACK YEAR|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|5||7||INDUCTION TREATMENT|1966-07-02||||1961-07-08||1965-07-25|1970-04-24|
TRIAL STUDY 134XCP|QS|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1|||||SOWS SUBJECTIVE|||G/U|||PL|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|Y|1||38||OPEN LABEL TREATMENT|1966-08-25||||1962-03-06||1972-09-29|1967-11-01|
TRIAL STUDY 134XCP|QS|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||L/KG|||LOG10 ELISA UNIT/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|N|2||58||INDUCTION TREATMENT|1970-12-19||||1969-08-18||1968-06-19|1963-06-02|
TRIAL STUDY 134XCP|QS|90AFB57A-125C-4C08-AE92-061F66FC2DAC|3|||||NPS|||MV/SEC|||PIPE|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|3||39||INDUCTION TREATMENT|1960-09-21||||1972-09-25||1972-10-05|1968-04-15|
TRIAL STUDY 134XCP|QS|90AFB57A-125C-4C08-AE92-061F66FC2DAC|4|||||CCQ 1 WEEK VERSION|||ML/S/M2|||U/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|4||88||WASHOUT|1971-10-27||||1968-11-11||1964-12-09|1967-09-06|
TRIAL STUDY 134XCP|QS|90AFB57A-125C-4C08-AE92-061F66FC2DAC|5|||||COMM|||IU/L|||MMOL/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|N|5||7||WASHOUT|1971-03-05||||1965-01-25||1964-06-05|1966-12-29|
TRIAL STUDY 134XCP|QS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||10^3 DNA COPIES/ML|||DB|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|1||38||OPEN LABEL TREATMENT|1966-06-01||||1971-11-14||1960-08-04|1969-09-11|
TRIAL STUDY 134XCP|QS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2|||||IIEF|||MG/KG/WEEK|||NKAT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|NA|2||58||SCREENING|1968-10-13||||1961-12-22||1962-01-14|1961-03-01|
TRIAL STUDY 134XCP|QS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|3|||||PHQ SCREENER VERSION|||CAPFUL|||CD|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|3||39||INDUCTION TREATMENT|1962-07-16||||1965-11-02||1968-01-01|1970-05-23|
TRIAL STUDY 134XCP|QS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|4|||||MSQOL-54|||MOL/G|||JAR|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|4||88||BASELINE|1972-05-10||||1964-03-14||1964-08-20|1962-10-16|
TRIAL STUDY 134XCP|QS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|5|||||MDQ-T|||MM/MIN|||TSP|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|5||7||BLINDED TREATMENT|1967-09-26||||1971-04-14||1970-10-06|1971-02-26|
TRIAL STUDY 134XCP|QS|01A42FAE-1EE2-4203-A62E-E368F31434F7|1|||||CHART-SF PAPER VERSION|||MM/MIN|||10^7 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|N|1||38||OPEN LABEL TREATMENT|1973-01-28||||1973-01-18||1972-04-25|1962-06-21|
TRIAL STUDY 134XCP|QS|01A42FAE-1EE2-4203-A62E-E368F31434F7|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||KG/CM|||TORR|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|2||58||LONG-TERM FOLLOW-UP|1966-11-04||||1962-02-15||1970-05-18|1963-10-18|
TRIAL STUDY 134XCP|QS|01A42FAE-1EE2-4203-A62E-E368F31434F7|3|||||TSCYC|||CI/G|||G/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|NA|3||39||WASHOUT|1962-12-13||||1964-03-05||1971-04-09|1971-06-15|
TRIAL STUDY 134XCP|QS|01A42FAE-1EE2-4203-A62E-E368F31434F7|4|||||SF36 V1.0 ACUTE|||INHALATION|||MS2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|4||88||FOLLOW-UP|1964-05-09||||1965-11-23||1961-06-18|1967-02-24|
TRIAL STUDY 134XCP|QS|01A42FAE-1EE2-4203-A62E-E368F31434F7|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||ML/MIN/1.73M2|||UG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|Y|5||7||RUN-IN|1961-10-25||||1961-07-22||1969-03-27|1968-12-15|
TRIAL STUDY 134XCP|QS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1|||||PDDS|||U/G/MIN|||SIEMENS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|U|1||38||TREATMENT|1971-11-07||||1962-08-24||1962-11-21|1967-07-12|
TRIAL STUDY 134XCP|QS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2|||||COWS|||PATCH|||KG/CM2|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|N|2||58||INDUCTION TREATMENT|1965-09-30||||1963-11-22||1968-09-12|1964-02-01|
TRIAL STUDY 134XCP|QS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|3|||||HAEM-A-QOL|||DAGU/ML|||MG/KG|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|3||39||BLINDED TREATMENT|1970-09-25||||1965-10-02||1971-05-23|1971-06-27|
TRIAL STUDY 134XCP|QS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|4|||||FOSI|||ML/KG|||PG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|4||88||WASHOUT|1972-07-11||||1963-01-01||1971-03-13|1966-03-16|
TRIAL STUDY 134XCP|QS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||UG/ML/H|||BOTTLE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|5||7||BASELINE|1969-05-25||||1971-01-16||1963-04-21|1970-04-21|
TRIAL STUDY 134XCP|QS|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||CM/S|||MG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|1||38||RUN-IN|1967-08-17||||1961-10-09||1970-07-16|1961-09-13|
TRIAL STUDY 134XCP|QS|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2|||||WLQ|||KPA/L/SEC|||ENZYME U/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|NA|2||58||RUN-IN|1969-03-05||||1972-12-04||1961-03-17|1967-07-21|
TRIAL STUDY 134XCP|QS|92232C8B-0D28-4E2A-AA56-BA938429CCBF|3|||||GOSE|||FIU|||MG/ML/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|3||39||OBSERVATION|1965-11-16||||1973-07-17||1971-03-13|1961-07-20|
TRIAL STUDY 134XCP|QS|92232C8B-0D28-4E2A-AA56-BA938429CCBF|4|||||HAMD 6 SELF-REPORT VERSION|||LOG10 PFU|||/500 WBC|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|Y|4||88||BASELINE|1961-11-02||||1968-11-20||1965-06-25|1969-01-02|
TRIAL STUDY 134XCP|QS|92232C8B-0D28-4E2A-AA56-BA938429CCBF|5|||||FACIT-F V4|||JDF UNIT|||SCOOPFUL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|5||7||FOLLOW-UP|1964-05-10||||1969-04-23||1966-09-07|1963-05-19|
TRIAL STUDY 134XCP|QS|F4F12AAA-E825-45D7-B414-A06F2D20381A|1|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||UMOL/DL|||10^7 PFU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|1||38||BASELINE|1967-09-22||||1968-03-06||1969-01-21|1962-08-17|
TRIAL STUDY 134XCP|QS|F4F12AAA-E825-45D7-B414-A06F2D20381A|2|||||SF36 V1.0 ACUTE|||DRAM|||CIGAR|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|2||58||INDUCTION TREATMENT|1964-12-13||||1969-01-09||1964-12-08|1969-11-05|
TRIAL STUDY 134XCP|QS|F4F12AAA-E825-45D7-B414-A06F2D20381A|3|||||COPD ASSESSMENT TEST|||KM/H|||KUSP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|NA|3||39||OPEN LABEL TREATMENT|1967-04-19||||1969-10-13||1960-08-10|1969-02-09|
TRIAL STUDY 134XCP|QS|F4F12AAA-E825-45D7-B414-A06F2D20381A|4|||||SF8 V1.0 STANDARD|||JAR|||SPRAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|Y|4||88||OPEN LABEL TREATMENT|1967-08-10||||1963-09-21||1961-12-25|1961-07-27|
TRIAL STUDY 134XCP|QS|F4F12AAA-E825-45D7-B414-A06F2D20381A|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MEQ/UG|||ML/MIN/1.73M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|5||7||SCREENING|1964-06-17||||1964-05-25||1970-11-04|1961-05-06|
TRIAL STUDY 134XCP|QS|6CF611F2-686E-4AE9-B491-32157710F46D|1|||||SF36 V1.0 STANDARD|||UG/G/H|||UKAT/L|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|1||38||LONG-TERM FOLLOW-UP|1966-08-10||||1970-11-20||1960-10-02|1971-04-27|
TRIAL STUDY 134XCP|QS|6CF611F2-686E-4AE9-B491-32157710F46D|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||BOLUS|||NMOL/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|U|2||58||WASHOUT|1973-06-13||||1964-07-29||1965-12-20|1960-09-16|
TRIAL STUDY 134XCP|QS|6CF611F2-686E-4AE9-B491-32157710F46D|3|||||SMDDS V1.0|||DEG/MM|||NKAT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|3||39||BLINDED TREATMENT|1961-11-24||||1964-06-05||1973-01-31|1963-06-18|
TRIAL STUDY 134XCP|QS|6CF611F2-686E-4AE9-B491-32157710F46D|4|||||FACT-G V4|||IN2|||PACKET|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|N|4||88||BLINDED TREATMENT|1970-03-26||||1972-11-16||1971-05-24|1961-08-08|
TRIAL STUDY 134XCP|QS|6CF611F2-686E-4AE9-B491-32157710F46D|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||CAN|||UMOL/KG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|Y|5||7||FOLLOW-UP|1960-07-07||||1970-02-07||1965-08-10|1967-07-02|
TRIAL STUDY 134XCP|QS|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1|||||DRRI-2|||10^6/L|||/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|1||38||CONTINUATION TREATMENT|1963-10-31||||1968-04-22||1960-10-09|1964-10-08|
TRIAL STUDY 134XCP|QS|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2|||||CES|||COULOMB|||MIU/L|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|2||58||OBSERVATION|1971-03-02||||1963-02-18||1965-08-25|1961-09-11|
TRIAL STUDY 134XCP|QS|417DBC64-7BF9-4EB8-A14B-C5F63541F826|3|||||WHODAS 2.0 - 36-ITEM PROXY|||10^3 DNA COPIES/ML|||MG/DL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|NA|3||39||BLINDED TREATMENT|1967-04-06||||1963-06-10||1968-10-24|1968-05-23|
TRIAL STUDY 134XCP|QS|417DBC64-7BF9-4EB8-A14B-C5F63541F826|4|||||PODCI - PEDIATRIC PARENT REPORTED|||10^6/HPF|||MG/ML/MIN|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|4||88||OPEN LABEL TREATMENT|1965-04-08||||1970-06-16||1960-11-21|1964-04-03|
TRIAL STUDY 134XCP|QS|417DBC64-7BF9-4EB8-A14B-C5F63541F826|5|||||WHODAS 2.0 - 36-ITEM PROXY|||COPIES/ML|||BU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|NA|5||7||LONG-TERM FOLLOW-UP|1967-01-27||||1960-03-11||1972-05-02|1964-08-28|
TRIAL STUDY 134XCP|QS|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1|||||TSQM V1.4|||USP U|||LENS|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|NA|1||38||BLINDED TREATMENT|1964-04-07||||1965-11-19||1973-08-19|1971-02-02|
TRIAL STUDY 134XCP|QS|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2|||||MRS|||MCI/L|||10^5/HPF|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|2||58||BASELINE|1965-03-09||||1965-02-22||1969-07-28|1962-09-09|
TRIAL STUDY 134XCP|QS|C3EF644E-25DC-4E0D-9073-735AED77EFAF|3|||||FACT-COG V3|||FARAD|||CL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|NA|3||39||RUN-IN|1962-11-15||||1966-04-15||1964-07-05|1964-06-20|
TRIAL STUDY 134XCP|QS|C3EF644E-25DC-4E0D-9073-735AED77EFAF|4|||||AUDIT-C|||10^8/L|||GBQ/MG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|4||88||OPEN LABEL TREATMENT|1968-11-16||||1969-11-14||1966-08-25|1973-04-09|
TRIAL STUDY 134XCP|QS|C3EF644E-25DC-4E0D-9073-735AED77EFAF|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||VIAL|||MDFI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|U|5||7||WASHOUT|1966-04-18||||1962-03-22||1964-03-14|1968-01-20|
TRIAL STUDY 134XCP|QS|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1|||||TSCC|||MOL/L|||CI/G|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|1||38||FOLLOW-UP|1962-11-04||||1961-03-13||1966-12-28|1962-05-28|
TRIAL STUDY 134XCP|QS|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2|||||BSI-18|||LINEAR FT*LB|||S/H|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|NA|2||58||FOLLOW-UP|1970-07-24||||1973-05-11||1970-10-01|1962-07-01|
TRIAL STUDY 134XCP|QS|CAE5F41C-0560-4782-BA27-E314BF7E66B6|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||PELLET|||LOG10 PFU|NOT DONE||LIKERT SCALE 5-POINT|U|Y|U|3||39||CONTINUATION TREATMENT|1960-01-11||||1973-07-16||1964-10-23|1965-04-30|
TRIAL STUDY 134XCP|QS|CAE5F41C-0560-4782-BA27-E314BF7E66B6|4|||||FLU-IIQ TWICE DAILY|||U/KG/DAY|||UG/KG/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|4||88||OBSERVATION|1972-02-29||||1972-07-02||1966-07-19|1965-05-30|
TRIAL STUDY 134XCP|QS|CAE5F41C-0560-4782-BA27-E314BF7E66B6|5|||||DAD|||U/ML|||10^9 ORGANISMS/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1965-06-06||||1966-04-25||1966-12-26|1967-10-31|
TRIAL STUDY 134XCP|QS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1|||||DLQI|||ML/MIN/MMHG|||MM2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|Y|1||38||CONTINUATION TREATMENT|1961-10-26||||1962-12-08||1961-07-30|1966-10-27|
TRIAL STUDY 134XCP|QS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||MEQ/DL|||10^6 ORGANISMS/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|N|N|2||58||OPEN LABEL TREATMENT|1968-03-02||||1965-09-08||1966-02-04|1969-01-10|
TRIAL STUDY 134XCP|QS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|3|||||MNSI|||HENRY|||ML*CMH2O|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|3||39||INDUCTION TREATMENT|1965-07-04||||1962-07-08||1966-11-27|1961-05-11|
TRIAL STUDY 134XCP|QS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|4|||||NCCN-FACT FBRSI-24 V2|||10^6 ORGANISMS/G|||PNU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|4||88||WASHOUT|1965-07-27||||1963-04-29||1968-08-12|1972-04-17|
TRIAL STUDY 134XCP|QS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|5|||||PDQUALIF|||/SEC|||10^9 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|5||7||INDUCTION TREATMENT|1969-04-02||||1968-11-08||1968-05-22|1972-01-08|
TRIAL STUDY 134XCP|QS|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1|||||MSIS-29 V1|||G/M2/DAY|||ML/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|1||38||BLINDED TREATMENT|1969-01-14||||1971-10-10||1970-09-08|1971-07-10|
TRIAL STUDY 134XCP|QS|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2|||||FKSI-DRS V4|||NU/CL|||/MM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|N|2||58||SCREENING|1963-10-26||||1972-09-21||1973-06-06|1961-06-16|
TRIAL STUDY 134XCP|QS|F34E7DCC-8637-463D-88E6-28AEBF495E9B|3|||||C-SSRS LIFETIME/RECENT VERSION|||CI/MG|||ENZYME U/M2|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||FOLLOW-UP|1972-07-03||||1963-11-07||1965-07-21|1973-08-22|
TRIAL STUDY 134XCP|QS|F34E7DCC-8637-463D-88E6-28AEBF495E9B|4|||||MSIS-29 V2|||KAT|||LOG10 IU/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|4||88||OBSERVATION|1962-08-17||||1971-02-02||1970-11-09|1963-11-09|
TRIAL STUDY 134XCP|QS|F34E7DCC-8637-463D-88E6-28AEBF495E9B|5|||||FSS|||IN|||KA_U/DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|N|5||7||CONTINUATION TREATMENT|1967-10-13||||1969-10-24||1971-03-03|1960-10-06|
TRIAL STUDY 134XCP|QS|69530FE0-6896-4585-8B20-29AE90DB91F5|1|||||SOAPP-R|||10^3/HPF|||TRANSDUCING UNIT|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|1||38||CONTINUATION TREATMENT|1965-06-29||||1966-03-17||1962-08-02|1966-04-27|
TRIAL STUDY 134XCP|QS|69530FE0-6896-4585-8B20-29AE90DB91F5|2|||||PCL-5|||MMHG|||ML/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|2||58||BLINDED TREATMENT|1967-03-28||||1960-03-27||1964-01-20|1964-11-28|
TRIAL STUDY 134XCP|QS|69530FE0-6896-4585-8B20-29AE90DB91F5|3|||||ADCS-ADL MCI|||IU/KG|||L/S/KPA|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|N|3||39||WASHOUT|1963-07-31||||1969-05-04||1969-10-20|1971-10-18|
TRIAL STUDY 134XCP|QS|69530FE0-6896-4585-8B20-29AE90DB91F5|4|||||BEBQ CONCURRENT|||NG/MOL|||DAYS/WK|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|4||88||BASELINE|1963-11-10||||1968-01-27||1972-05-27|1960-09-27|
TRIAL STUDY 134XCP|QS|69530FE0-6896-4585-8B20-29AE90DB91F5|5|||||NSCLC-SAQ V1.0|||MG/DL|||NGEQ/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|Y|5||7||BASELINE|1967-04-21||||1967-09-21||1969-05-03|1961-06-26|
TRIAL STUDY 134XCP|QS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1|||||MNSI|||CI/UL|||KCAL/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|U|1||38||TREATMENT|1967-04-18||||1961-12-24||1964-02-09|1970-07-21|
TRIAL STUDY 134XCP|QS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2|||||FACT-G V4|||V|||MOL/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|NA|2||58||BLINDED TREATMENT|1962-03-01||||1969-06-15||1968-04-08|1963-12-07|
TRIAL STUDY 134XCP|QS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|3|||||PSQI|||BU/ML|||UG/L DDU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|U|3||39||FOLLOW-UP|1965-07-21||||1962-09-04||1965-07-04|1964-12-20|
TRIAL STUDY 134XCP|QS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|4|||||FBRSI|||RATIO|||DDU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|Y|4||88||FOLLOW-UP|1968-08-23||||1967-12-25||1969-08-16|1964-01-14|
TRIAL STUDY 134XCP|QS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|5|||||BSFS|||FEU|||TABLET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|N|5||7||SCREENING|1966-12-05||||1970-10-15||1966-08-09|1961-04-28|
TRIAL STUDY 134XCP|QS|F1EF928C-B819-4620-8991-ABDC4E182217|1|||||SGRQ PAST 3 MONTHS VERSION|||ML/MIN/1.73M2|||ELISA UNIT/DOSE|NOT DONE||LIKERT SCALE 5-POINT|Y|U|Y|1||38||BLINDED TREATMENT|1962-04-16||||1963-01-31||1968-03-30|1964-04-17|
TRIAL STUDY 134XCP|QS|F1EF928C-B819-4620-8991-ABDC4E182217|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||G/CAGE/DAY|||/10^4|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|2||58||CONTINUATION TREATMENT|1963-02-25||||1972-09-03||1960-05-12|1961-10-12|
TRIAL STUDY 134XCP|QS|F1EF928C-B819-4620-8991-ABDC4E182217|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||G/KG|||NSEC|NOT DONE||LIKERT SCALE 3-POINT|N|Y|Y|3||39||INDUCTION TREATMENT|1961-11-23||||1966-08-21||1963-11-08|1972-01-24|
TRIAL STUDY 134XCP|QS|F1EF928C-B819-4620-8991-ABDC4E182217|4|||||BLCS|||TAMPON|||VG/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|4||88||INDUCTION TREATMENT|1967-05-10||||1963-01-25||1970-10-17|1963-06-26|
TRIAL STUDY 134XCP|QS|F1EF928C-B819-4620-8991-ABDC4E182217|5|||||ADHD-RS-IV HOME VERSION|||LOG10 PFU/ML|||/MONTH|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|5||7||WASHOUT|1965-12-20||||1964-07-10||1969-01-31|1966-05-28|
TRIAL STUDY 134XCP|QS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1|||||BSI-18|||CMHG|||ML/S/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|1||38||LONG-TERM FOLLOW-UP|1960-04-03||||1971-06-05||1960-06-10|1960-05-03|
TRIAL STUDY 134XCP|QS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||HEP|||VG/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|2||58||INDUCTION TREATMENT|1963-04-26||||1967-06-06||1966-08-29|1965-03-04|
TRIAL STUDY 134XCP|QS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|3|||||NCCN-FACT FBRSI-24 V2|||G/G|||HPA|NOT DONE||LIKERT SCALE 7-POINT|N|NA|N|3||39||OBSERVATION|1966-09-29||||1964-03-21||1962-01-01|1970-11-18|
TRIAL STUDY 134XCP|QS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|4|||||PARTNER-DDS|||VP/DOSE|||MMOL/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|4||88||CONTINUATION TREATMENT|1973-06-13||||1971-07-16||1967-08-12|1971-02-07|
TRIAL STUDY 134XCP|QS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|5|||||SIQ|||UMOL/MG/MIN|||TRANSDUCING UNIT/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|5||7||INDUCTION TREATMENT|1962-11-22||||1966-02-04||1971-01-28|1972-05-22|
TRIAL STUDY 134XCP|QS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1|||||COPD ASSESSMENT TEST|||CI/MG|||ML/ANIMAL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|NA|1||38||BASELINE|1961-04-16||||1962-10-22||1962-02-25|1970-10-09|
TRIAL STUDY 134XCP|QS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2|||||BEBQ RETROSPECTIVE|||M/SEC|||S^-1(%O2)^-1|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|U|2||58||BLINDED TREATMENT|1968-12-26||||1972-03-27||1968-01-27|1961-07-23|
TRIAL STUDY 134XCP|QS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|3|||||EXPANDED DRS-PI SURVIVOR VERSION|||LENS|||FOZ_US|NOT DONE||LIKERT SCALE 7-POINT|N|N|NA|3||39||OPEN LABEL TREATMENT|1960-11-01||||1963-10-28||1971-02-10|1968-02-13|
TRIAL STUDY 134XCP|QS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||10^8 PFU|||KG/L|NOT DONE||LIKERT SCALE 3-POINT|U|Y|N|4||88||CONTINUATION TREATMENT|1970-07-25||||1969-06-23||1969-11-13|1961-07-07|
TRIAL STUDY 134XCP|QS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|5|||||MHIS-NACC|||NL|||LOZENGE|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|Y|5||7||BLINDED TREATMENT|1968-07-20||||1968-10-28||1967-02-13|1960-09-15|
TRIAL STUDY 134XCP|QS|27D5690D-BCB3-4FEC-988C-666C29D5239A|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||UM/S|||PKAT/L|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|1||38||WASHOUT|1966-03-14||||1964-05-01||1969-11-20|1962-08-25|
TRIAL STUDY 134XCP|QS|27D5690D-BCB3-4FEC-988C-666C29D5239A|2|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||UG/L/H|||BQ/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|N|2||58||OBSERVATION|1971-05-07||||1967-05-04||1961-01-19|1966-02-14|
TRIAL STUDY 134XCP|QS|27D5690D-BCB3-4FEC-988C-666C29D5239A|3|||||HAQ-DI WITHOUT VAS|||DROP|||NSEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|3||39||TREATMENT|1962-01-29||||1965-12-14||1972-07-08|1972-03-22|
TRIAL STUDY 134XCP|QS|27D5690D-BCB3-4FEC-988C-666C29D5239A|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MONTHS|||IU/MG|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|4||88||BLINDED TREATMENT|1963-02-22||||1963-08-29||1972-01-10|1968-03-04|
TRIAL STUDY 134XCP|QS|27D5690D-BCB3-4FEC-988C-666C29D5239A|5|||||SF36 V2.0 ACUTE|||BAU|||U/KG/DAY|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|NA|5||7||TREATMENT|1968-02-11||||1961-04-22||1972-11-12|1972-12-25|
TRIAL STUDY 134XCP|QS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||DPM/ML|||DDU|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|1||38||LONG-TERM FOLLOW-UP|1971-05-25||||1973-05-27||1964-09-22|1970-04-06|
TRIAL STUDY 134XCP|QS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2|||||NCCN-FACT FOSI-18 V2|||UMOL/L/H|||BEL|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|2||58||RUN-IN|1966-10-28||||1960-09-08||1967-09-07|1966-07-06|
TRIAL STUDY 134XCP|QS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|3|||||ACT|||TSP EQ|||PPTH|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|N|3||39||WASHOUT|1966-10-13||||1966-01-26||1968-12-08|1967-07-18|
TRIAL STUDY 134XCP|QS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|4|||||FACT-TAXANE V4|||POINT|||UCI/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|NA|4||88||CONTINUATION TREATMENT|1960-07-03||||1964-09-29||1971-12-16|1962-05-18|
TRIAL STUDY 134XCP|QS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|5|||||CES|||10^9/G|||CMH2O*S2/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|NA|5||7||RUN-IN|1961-05-12||||1961-10-27||1960-08-25|1961-08-21|
TRIAL STUDY 134XCP|QS|8E25F21F-A565-40CB-B0D7-6CC496171293|1|||||GCGI|||10^3 RNA COPIES/ML|||MPL U|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|Y|1||38||SCREENING|1972-01-18||||1968-05-10||1969-03-27|1961-04-10|
TRIAL STUDY 134XCP|QS|8E25F21F-A565-40CB-B0D7-6CC496171293|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||PT_BR|||PMOL/10^9 CELLS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|N|2||58||INDUCTION TREATMENT|1971-03-08||||1963-05-03||1968-05-16|1963-10-11|
TRIAL STUDY 134XCP|QS|8E25F21F-A565-40CB-B0D7-6CC496171293|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||PMOL/10^10 CELLS|||FT2|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|3||39||SCREENING|1970-06-14||||1961-03-30||1966-06-12|1961-05-14|
TRIAL STUDY 134XCP|QS|8E25F21F-A565-40CB-B0D7-6CC496171293|4|||||IVIS|||VG/DOSE|||U.CARR|NOT DONE||LIKERT SCALE 7-POINT|N|Y|U|4||88||BLINDED TREATMENT|1970-10-10||||1970-05-11||1969-08-23|1960-10-22|
TRIAL STUDY 134XCP|QS|8E25F21F-A565-40CB-B0D7-6CC496171293|5|||||DAD|||M/SEC|||SV|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|NA|5||7||TREATMENT|1965-01-23||||1964-04-28||1965-05-24|1973-05-28|
TRIAL STUDY 134XCP|QS|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||10^7 PFU|||PIXELS/CM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|U|1||38||WASHOUT|1965-01-19||||1971-12-02||1965-11-13|1968-04-19|
TRIAL STUDY 134XCP|QS|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2|||||BSFS|||MM/SEC|||PA|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|U|2||58||BLINDED TREATMENT|1972-02-14||||1967-05-29||1966-01-25|1968-11-05|
TRIAL STUDY 134XCP|QS|8CDD2247-485D-495C-9186-FF4CA3FFC32E|3|||||OAB-Q|||/40 HPFS|||GRAIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|3||39||RUN-IN|1972-10-09||||1962-12-09||1965-05-14|1967-04-06|
TRIAL STUDY 134XCP|QS|8CDD2247-485D-495C-9186-FF4CA3FFC32E|4|||||COWS|||CM/MIN|||COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|4||88||WASHOUT|1965-05-07||||1968-10-05||1968-11-18|1970-03-28|
TRIAL STUDY 134XCP|QS|8CDD2247-485D-495C-9186-FF4CA3FFC32E|5|||||BARS|||ANSON U|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|5||7||BLINDED TREATMENT|1966-01-24||||1966-10-22||1972-09-08|1963-11-29|
TRIAL STUDY 134XCP|QS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1|||||GAD-7|||MMHG*MIN/L|||ML/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|1||38||FOLLOW-UP|1966-02-02||||1965-05-15||1971-09-25|1970-12-12|
TRIAL STUDY 134XCP|QS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2|||||AUDIT-C|||U/MG|||MV|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|2||58||BLINDED TREATMENT|1972-01-14||||1971-01-03||1966-09-07|1963-02-14|
TRIAL STUDY 134XCP|QS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|3|||||PDDS|||%/MIN|||CARTRIDGE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|3||39||OPEN LABEL TREATMENT|1966-10-18||||1970-01-30||1961-06-28|1972-02-20|
TRIAL STUDY 134XCP|QS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|4|||||OCI|||ML/BREATH|||APL U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|4||88||CONTINUATION TREATMENT|1970-06-08||||1968-09-17||1965-07-07|1970-05-19|
TRIAL STUDY 134XCP|QS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|5|||||C-SSRS CHILDREN'S BASELINE|||/MS|||PMOL/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|5||7||CONTINUATION TREATMENT|1969-02-01||||1970-10-17||1965-05-25|1969-07-15|
TRIAL STUDY 134XCP|QS|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1|||||SOWS SHORT|||10^9 ORGANISMS|||CCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|NA|1||38||FOLLOW-UP|1973-02-14||||1966-04-02||1960-12-12|1961-03-07|
TRIAL STUDY 134XCP|QS|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2|||||ADCS-CGIC|||U/CL|||G/M2/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|2||58||RUN-IN|1971-08-28||||1969-03-13||1965-05-10|1971-03-20|
TRIAL STUDY 134XCP|QS|C004A8EB-220F-4FC5-A150-B5159DCA84D9|3|||||MNSI|||GPL U|||CARTRIDGE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|N|3||39||INDUCTION TREATMENT|1971-05-18||||1965-07-01||1967-05-07|1966-09-26|
TRIAL STUDY 134XCP|QS|C004A8EB-220F-4FC5-A150-B5159DCA84D9|4|||||FKSI-15|||HZ|||U/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|4||88||BLINDED TREATMENT|1970-10-11||||1961-05-15||1968-03-03|1962-02-12|
TRIAL STUDY 134XCP|QS|C004A8EB-220F-4FC5-A150-B5159DCA84D9|5|||||RDQ|||G/DL|||G/ANIMAL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|U|5||7||OBSERVATION|1961-07-19||||1963-06-14||1965-08-20|1971-01-19|
TRIAL STUDY 134XCP|QS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1|||||SF8 V1.0 STANDARD|||CI/UG|||LOG EID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|U|1||38||SCREENING|1969-04-08||||1970-05-23||1967-06-12|1973-08-09|
TRIAL STUDY 134XCP|QS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2|||||MRS|||DAGU/ML|||LOG10 ELISA UNIT/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|2||58||FOLLOW-UP|1967-05-18||||1972-12-18||1968-10-26|1969-08-01|
TRIAL STUDY 134XCP|QS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|3|||||WOMAC LK 3.1 INDEX|||MOSM/KG|||L/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|3||39||OPEN LABEL TREATMENT|1962-07-23||||1967-09-30||1973-05-10|1967-10-24|
TRIAL STUDY 134XCP|QS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|4|||||CES|||ML/CM|||UKAT/10^12 RBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|4||88||FOLLOW-UP|1971-02-02||||1967-10-08||1964-04-16|1966-08-17|
TRIAL STUDY 134XCP|QS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|5|||||CDR|||HENRY|||MU|NOT DONE||LIKERT SCALE 7-POINT|N|U|U|5||7||BLINDED TREATMENT|1970-10-07||||1970-04-29||1960-10-08|1973-09-07|
TRIAL STUDY 134XCP|QS|AE127EDD-D708-4B1A-95F7-176A541A9584|1|||||FACT-P V4|||PRESSOR UNITS|||NMOL/ML/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|NA|1||38||OPEN LABEL TREATMENT|1971-05-11||||1972-09-20||1967-11-18|1962-10-11|
TRIAL STUDY 134XCP|QS|AE127EDD-D708-4B1A-95F7-176A541A9584|2|||||FACT-P V4|||GTT|||STEPS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|2||58||FOLLOW-UP|1962-08-16||||1966-06-28||1966-09-06|1965-08-28|
TRIAL STUDY 134XCP|QS|AE127EDD-D708-4B1A-95F7-176A541A9584|3|||||BORG CR10|||ML/KG|||10^6 IU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|3||39||RUN-IN|1962-02-15||||1970-10-17||1960-04-22|1962-09-28|
TRIAL STUDY 134XCP|QS|AE127EDD-D708-4B1A-95F7-176A541A9584|4|||||BEBQ CONCURRENT|||IU|||10^3/HPF|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|4||88||TREATMENT|1971-12-03||||1965-09-02||1966-01-19|1969-10-24|
TRIAL STUDY 134XCP|QS|AE127EDD-D708-4B1A-95F7-176A541A9584|5|||||PSQI|||MG/MIN|||V/V|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|Y|5||7||BASELINE|1971-07-20||||1967-11-08||1971-03-30|1966-12-15|
TRIAL STUDY 134XCP|QS|F642D4A0-A67F-4A10-BB21-E4644E963D45|1|||||T1-DDS|||U/CL|||/MONTH|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|1||38||WASHOUT|1964-09-26||||1962-11-01||1961-08-24|1973-01-04|
TRIAL STUDY 134XCP|QS|F642D4A0-A67F-4A10-BB21-E4644E963D45|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||TESLA|||P|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|2||58||OPEN LABEL TREATMENT|1966-11-01||||1971-05-01||1966-05-07|1963-10-22|
TRIAL STUDY 134XCP|QS|F642D4A0-A67F-4A10-BB21-E4644E963D45|3|||||HAEM-A-QOL|||MG/M2/MIN|||/MS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|N|3||39||OPEN LABEL TREATMENT|1962-11-28||||1963-09-21||1966-10-03|1961-07-01|
TRIAL STUDY 134XCP|QS|F642D4A0-A67F-4A10-BB21-E4644E963D45|4|||||CCQ 1 WEEK VERSION|||G|||FT3|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|N|4||88||WASHOUT|1962-01-28||||1963-10-21||1965-04-14|1969-03-23|
TRIAL STUDY 134XCP|QS|F642D4A0-A67F-4A10-BB21-E4644E963D45|5|||||CES|||GPS U|||TUBERCULIN UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|NA|5||7||OPEN LABEL TREATMENT|1964-03-15||||1973-09-06||1969-06-04|1970-07-14|
TRIAL STUDY 134XCP|QS|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1|||||ADHD-RS-IV HOME VERSION|||BOLUS|||SIEMENS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|1||38||OBSERVATION|1967-06-12||||1968-05-14||1965-02-01|1973-04-28|
TRIAL STUDY 134XCP|QS|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2|||||DLQI|||IMPLANT|||PLUG|NOT DONE||LIKERT SCALE 7-POINT|N|U|U|2||58||TREATMENT|1960-01-06||||1967-04-27||1967-01-13|1973-01-10|
TRIAL STUDY 134XCP|QS|933A6DFF-D519-46F4-AB52-78E6A898E4A1|3|||||ODI V2.1A|||ENZYME U|||MPS U|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|3||39||OBSERVATION|1965-12-09||||1964-01-18||1968-08-25|1964-01-02|
TRIAL STUDY 134XCP|QS|933A6DFF-D519-46F4-AB52-78E6A898E4A1|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||UG/L/H|||%(V/V)|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|4||88||BASELINE|1967-02-14||||1966-06-30||1966-03-20|1965-10-25|
TRIAL STUDY 134XCP|QS|933A6DFF-D519-46F4-AB52-78E6A898E4A1|5|||||ADCS-ADL|||NMOL/ML/MIN|||U/M2/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|5||7||LONG-TERM FOLLOW-UP|1965-01-21||||1963-02-23||1960-12-18|1965-10-16|
TRIAL STUDY 134XCP|QS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1|||||RPQ|||IMPLANT|||MDFI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|1||38||BLINDED TREATMENT|1967-02-28||||1962-01-01||1960-02-20|1969-08-09|
TRIAL STUDY 134XCP|QS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2|||||BPI SHORT FORM|||NEWTON|||BREATHS/30S|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|2||58||OBSERVATION|1961-01-17||||1964-09-19||1971-12-23|1972-05-16|
TRIAL STUDY 134XCP|QS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|3|||||MRS|||UMOL/KG/MIN|||MG/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|NA|3||39||INDUCTION TREATMENT|1965-12-07||||1970-07-03||1963-07-13|1964-09-05|
TRIAL STUDY 134XCP|QS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|4|||||PGI|||APL U|||G/DL|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|4||88||RUN-IN|1960-08-26||||1963-12-23||1966-08-29|1964-04-28|
TRIAL STUDY 134XCP|QS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|5|||||MSWS-12|||KG/L|||MG/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|5||7||LONG-TERM FOLLOW-UP|1970-01-09||||1967-09-08||1960-03-03|1964-01-02|
TRIAL STUDY 134XCP|QS|38E177D4-1A58-4E78-90B7-85F76BF66826|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||UG/KG|||/10^3|NOT DONE||LIKERT SCALE 7-POINT|Y|N|N|1||38||CONTINUATION TREATMENT|1968-05-22||||1971-12-11||1972-10-16|1970-12-31|
TRIAL STUDY 134XCP|QS|38E177D4-1A58-4E78-90B7-85F76BF66826|2|||||C-SSRS SCREENING|||PIXEL|||L/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|NA|2||58||OPEN LABEL TREATMENT|1961-11-08||||1960-01-31||1970-05-19|1965-01-25|
TRIAL STUDY 134XCP|QS|38E177D4-1A58-4E78-90B7-85F76BF66826|3|||||VFQ-25 SELF ADMINISTERED|||MG2/DL2|||/500 WBC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|3||39||LONG-TERM FOLLOW-UP|1962-08-22||||1969-11-13||1966-01-23|1963-12-21|
TRIAL STUDY 134XCP|QS|38E177D4-1A58-4E78-90B7-85F76BF66826|4|||||MSIS-29 V2|||10^3 ORGANISMS/ML|||FMOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|4||88||LONG-TERM FOLLOW-UP|1966-03-09||||1960-07-27||1968-02-03|1961-10-09|
TRIAL STUDY 134XCP|QS|38E177D4-1A58-4E78-90B7-85F76BF66826|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||UG/ANIMAL|||MIN*MG/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|5||7||BLINDED TREATMENT|1960-12-22||||1963-04-29||1970-04-08|1961-01-30|
TRIAL STUDY 134XCP|QS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1|||||ASEX-FEMALE|||UEQ/L|||KALLIKREIN INHIBITOR UNIT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|Y|1||38||CONTINUATION TREATMENT|1962-03-18||||1961-08-22||1963-08-25|1970-12-19|
TRIAL STUDY 134XCP|QS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2|||||IIEF|||WEEKS|||PFU/ANIMAL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|Y|2||58||OBSERVATION|1964-01-14||||1965-08-21||1967-09-29|1971-03-31|
TRIAL STUDY 134XCP|QS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|3|||||ADCS-ADL SEVERE DEMENTIA|||ML/KG/MIN|||GPELISA UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|Y|3||39||BASELINE|1961-07-28||||1972-02-05||1965-05-05|1968-03-13|
TRIAL STUDY 134XCP|QS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|4|||||ADAS-COG|||DEG2|||10^6 CFU/G|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|4||88||BLINDED TREATMENT|1969-07-29||||1966-01-22||1969-02-26|1972-09-26|
TRIAL STUDY 134XCP|QS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|5|||||HCS|||STEPS|||HR/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|Y|5||7||WASHOUT|1972-08-24||||1971-08-15||1963-12-25|1969-12-13|
TRIAL STUDY 134XCP|QS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1|||||FACT/GOG-NTX V4|||CYCLE/MIN|||L/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|NA|1||38||WASHOUT|1972-12-17||||1968-12-30||1964-03-02|1970-10-10|
TRIAL STUDY 134XCP|QS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2|||||FAQ-NACC VERSION|||IN2|||10^9 ORGANISMS/ML|NOT DONE||LIKERT SCALE 7-POINT|N|NA|Y|2||58||OBSERVATION|1960-10-28||||1967-06-09||1961-05-11|1963-07-16|
TRIAL STUDY 134XCP|QS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|3|||||NCCN-FACT FOSI-18 V2|||ML/M2/DAY|||NMOL/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|U|3||39||INDUCTION TREATMENT|1960-07-02||||1962-03-04||1973-03-14|1960-03-24|
TRIAL STUDY 134XCP|QS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|4|||||C-SSRS CHILDREN'S BASELINE|||H*%|||/KG|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|4||88||CONTINUATION TREATMENT|1971-08-22||||1961-10-24||1960-03-29|1973-04-16|
TRIAL STUDY 134XCP|QS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|5|||||FLSI|||10^10/L|||CAPSULE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|5||7||BASELINE|1973-02-09||||1964-03-03||1968-09-01|1973-06-01|
TRIAL STUDY 134XCP|QS|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1|||||EQ-5D-3L|||GLOBULE|||PSEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|N|1||38||INDUCTION TREATMENT|1964-04-06||||1967-08-31||1964-07-07|1962-03-10|
TRIAL STUDY 134XCP|QS|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2|||||EXACT|||ML/CAGE/DAY|||BOLUS|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|2||58||WASHOUT|1961-01-28||||1970-06-01||1971-07-10|1960-04-30|
TRIAL STUDY 134XCP|QS|50CFC814-7135-4356-BAC2-3F975B9F6AE3|3|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||MM/2H|||M2|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|3||39||LONG-TERM FOLLOW-UP|1960-01-08||||1971-08-25||1966-05-22|1967-11-19|
TRIAL STUDY 134XCP|QS|50CFC814-7135-4356-BAC2-3F975B9F6AE3|4|||||WOMAC VA 3.1 INDEX|||GPL U|||MM/SEC|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|4||88||OBSERVATION|1966-09-28||||1962-03-07||1964-03-24|1968-09-02|
TRIAL STUDY 134XCP|QS|50CFC814-7135-4356-BAC2-3F975B9F6AE3|5|||||FKSI-DRS V4|||VIRTUAL PIXEL|||DPM|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|N|5||7||OPEN LABEL TREATMENT|1968-12-05||||1968-12-08||1969-06-23|1968-08-20|
TRIAL STUDY 134XCP|QS|8A639816-D878-4FD7-AF28-CF9EA2236462|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||G/G|||ML/CM3/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|1||38||OPEN LABEL TREATMENT|1972-08-22||||1970-03-26||1971-10-09|1972-02-16|
TRIAL STUDY 134XCP|QS|8A639816-D878-4FD7-AF28-CF9EA2236462|2|||||TSQM V1.4|||EVENTS|||ML/MMHG/MIN/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|U|2||58||OPEN LABEL TREATMENT|1966-03-10||||1965-09-20||1961-03-16|1962-07-07|
TRIAL STUDY 134XCP|QS|8A639816-D878-4FD7-AF28-CF9EA2236462|3|||||C-SSRS SINCE LAST VISIT|||OZ|||U/M2/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|NA|3||39||TREATMENT|1960-07-08||||1972-04-07||1966-12-15|1966-07-09|
TRIAL STUDY 134XCP|QS|8A639816-D878-4FD7-AF28-CF9EA2236462|4|||||ACQ|||CPM|||MG/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|NA|4||88||INDUCTION TREATMENT|1972-07-19||||1961-01-08||1967-05-10|1966-04-20|
TRIAL STUDY 134XCP|QS|8A639816-D878-4FD7-AF28-CF9EA2236462|5|||||NCCN-FACT FHNSI-22 V2|||/2500 WBC|||CMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|5||7||INDUCTION TREATMENT|1964-05-15||||1972-01-06||1962-08-24|1962-05-21|
TRIAL STUDY 134XCP|QS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1|||||SWLS|||CMHG|||TRANSDUCING UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|1||38||SCREENING|1968-07-09||||1962-07-06||1973-08-31|1960-07-17|
TRIAL STUDY 134XCP|QS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2|||||WHODAS 2.0 - 36-ITEM SELF|||UCI/L|||MEQ/L|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|2||58||TREATMENT|1971-07-25||||1960-02-29||1960-04-18|1964-12-26|
TRIAL STUDY 134XCP|QS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|3|||||EPIC-26|||MEQ/DL|||ML/G/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|NA|3||39||CONTINUATION TREATMENT|1972-11-09||||1966-09-20||1968-12-17|1973-05-05|
TRIAL STUDY 134XCP|QS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|4|||||WHODAS 2.0 - 12-ITEM SELF|||MEQ/UL|||LENS|NOT DONE||LIKERT SCALE 5-POINT|N|U|Y|4||88||TREATMENT|1972-11-28||||1969-06-24||1964-01-25|1963-11-23|
TRIAL STUDY 134XCP|QS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|5|||||TSQM V1.4|||10^7 PFU|||MG/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|5||7||LONG-TERM FOLLOW-UP|1966-12-13||||1971-08-17||1972-05-03|1961-06-27|
TRIAL STUDY 134XCP|QS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1|||||GCGI|||MMHG/SEC|||VP/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|1||38||WASHOUT|1960-07-16||||1964-01-08||1968-11-09|1970-03-15|
TRIAL STUDY 134XCP|QS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||MOL/MG|||NMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|2||58||FOLLOW-UP|1967-08-12||||1964-11-25||1962-08-25|1960-07-21|
TRIAL STUDY 134XCP|QS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|3|||||UPDRS|||FARAD|||MEQ/G|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|U|3||39||WASHOUT|1963-01-11||||1970-01-10||1972-04-17|1969-09-22|
TRIAL STUDY 134XCP|QS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|4|||||PHQ SCREENER VERSION|||CUP|||V/V|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|U|4||88||OBSERVATION|1963-04-20||||1961-10-02||1970-05-04|1969-07-31|
TRIAL STUDY 134XCP|QS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|5|||||C-SSRS SINCE LAST VISIT|||MN|||PG/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|Y|5||7||INDUCTION TREATMENT|1971-09-15||||1965-12-28||1966-12-22|1971-11-16|
TRIAL STUDY 134XCP|QS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1|||||PEDS-FACIT-F|||COULOMB|||UM/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|1||38||WASHOUT|1973-02-20||||1965-11-16||1966-04-14|1961-01-21|
TRIAL STUDY 134XCP|QS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2|||||DRRI-2|||HOURS|||UIU/DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|Y|2||58||BASELINE|1970-01-08||||1960-10-22||1969-03-28|1965-01-15|
TRIAL STUDY 134XCP|QS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|3|||||SOWS SUBJECTIVE|||NMOL BCE/NMOL|||MJOULE/CM2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|3||39||CONTINUATION TREATMENT|1961-05-26||||1961-03-28||1966-08-04|1966-10-04|
TRIAL STUDY 134XCP|QS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|4|||||C-SSRS BASELINE|||G/KG|||ML/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|U|4||88||INDUCTION TREATMENT|1961-06-01||||1964-12-06||1965-10-09|1973-08-09|
TRIAL STUDY 134XCP|QS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|5|||||SF12 V1.0 ACUTE|||CG|||COPIES/UG|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|5||7||OBSERVATION|1968-01-12||||1968-02-10||1965-02-18|1962-08-05|
TRIAL STUDY 134XCP|QS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||CGY|||AMU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|N|1||38||OBSERVATION|1970-06-17||||1968-08-15||1961-07-23|1970-06-20|
TRIAL STUDY 134XCP|QS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2|||||YMRS|||PMOL/G|||LOG10 ELISA UNIT/DOSE|NOT DONE||LIKERT SCALE 7-POINT|U|N|Y|2||58||OPEN LABEL TREATMENT|1965-03-21||||1960-08-27||1963-06-25|1967-08-30|
TRIAL STUDY 134XCP|QS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|3|||||BPI SHORT FORM|||10^9/L|||CFU/G|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|3||39||FOLLOW-UP|1967-08-29||||1965-12-13||1965-05-28|1962-04-22|
TRIAL STUDY 134XCP|QS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||LOG10 CCID 50/DOSE|||U/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|4||88||FOLLOW-UP|1966-08-12||||1968-11-24||1964-10-19|1973-07-21|
TRIAL STUDY 134XCP|QS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|5|||||ADCS-ADL MCI|||MOL/MOL|||/MBP|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|N|5||7||RUN-IN|1963-11-23||||1962-02-26||1967-02-05|1962-05-04|
TRIAL STUDY 134XCP|QS|30419F44-B519-488C-A505-F23D88A46024|1|||||COWS|||ECL UNIT|||ML/SEC/1.73M2|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|1||38||BASELINE|1967-09-07||||1966-05-20||1965-09-03|1961-11-15|
TRIAL STUDY 134XCP|QS|30419F44-B519-488C-A505-F23D88A46024|2|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MPA|||10^9 CFU/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|2||58||FOLLOW-UP|1969-10-29||||1971-05-20||1967-07-16|1965-05-03|
TRIAL STUDY 134XCP|QS|30419F44-B519-488C-A505-F23D88A46024|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||LOG10 CCID 50/DOSE|||MPA|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|3||39||RUN-IN|1969-09-25||||1970-01-01||1968-11-09|1970-08-10|
TRIAL STUDY 134XCP|QS|30419F44-B519-488C-A505-F23D88A46024|4|||||HAQ-DI WITHOUT VAS|||DAYS/WK|||MMAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|4||88||SCREENING|1966-09-17||||1967-06-16||1962-07-21|1960-03-21|
TRIAL STUDY 134XCP|QS|30419F44-B519-488C-A505-F23D88A46024|5|||||WHODAS 2.0 - 36-ITEM SELF|||U/M2/H|||MG/ML/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|5||7||SCREENING|1960-09-20||||1961-12-11||1972-03-22|1961-10-16|
TRIAL STUDY 134XCP|QS|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1|||||YMRS|||BEATS/MIN|||NMOL|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|1||38||INDUCTION TREATMENT|1963-06-24||||1960-08-14||1961-01-22|1966-04-23|
TRIAL STUDY 134XCP|QS|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2|||||PHQ-2|||MILE|||MKAT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|NA|2||58||TREATMENT|1961-05-18||||1970-06-19||1970-06-02|1963-08-08|
TRIAL STUDY 134XCP|QS|2AF06F66-5E51-4AC9-AF62-A34329724F7D|3|||||FIQR|||PMOL|||DRAM|NOT DONE||LIKERT SCALE 3-POINT|NA|U|N|3||39||BASELINE|1968-06-23||||1963-06-10||1963-01-15|1961-06-28|
TRIAL STUDY 134XCP|QS|2AF06F66-5E51-4AC9-AF62-A34329724F7D|4|||||FACT-BL V4|||LOG10 PFU|||CG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|4||88||OPEN LABEL TREATMENT|1968-01-08||||1968-05-11||1973-05-08|1968-03-29|
TRIAL STUDY 134XCP|QS|2AF06F66-5E51-4AC9-AF62-A34329724F7D|5|||||TSCYC|||UG/MOL|||ML/CAGE/WK|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|5||7||TREATMENT|1965-12-17||||1972-01-28||1960-07-23|1971-01-05|
TRIAL STUDY 134XCP|QS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1|||||SF10 V1.0 CHILDREN ACUTE|||CYCLE/MIN|||AMOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|Y|1||38||WASHOUT|1971-11-30||||1962-01-25||1961-04-15|1968-07-27|
TRIAL STUDY 134XCP|QS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2|||||TSCYC|||U/KG|||UMOL/H/MMOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|N|2||58||FOLLOW-UP|1966-04-19||||1964-11-30||1969-05-23|1962-11-17|
TRIAL STUDY 134XCP|QS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||S^-1(%O2)^-1|||MG/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|U|3||39||LONG-TERM FOLLOW-UP|1971-02-04||||1961-05-28||1961-01-01|1966-04-07|
TRIAL STUDY 134XCP|QS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|4|||||HAEM-A-QOL|||UIU/L|||LOG10 ELISA UNIT/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|NA|4||88||INDUCTION TREATMENT|1971-12-29||||1973-02-19||1967-10-08|1970-07-03|
TRIAL STUDY 134XCP|QS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||MG/DAY|||MASK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|U|5||7||SCREENING|1970-01-14||||1961-07-06||1960-07-27|1960-12-14|
TRIAL STUDY 134XCP|QS|94F4C997-3114-4444-BF89-E762226AAC89|1|||||FACT-BMT V4|||GBQ/G|||VOXEL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|N|1||38||INDUCTION TREATMENT|1962-06-20||||1961-05-30||1965-02-13|1964-01-27|
TRIAL STUDY 134XCP|QS|94F4C997-3114-4444-BF89-E762226AAC89|2|||||WOMAC LK 3.1 INDEX|||SHOCK WAVE|||DISK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|2||58||WASHOUT|1963-03-21||||1962-06-29||1960-05-28|1961-02-04|
TRIAL STUDY 134XCP|QS|94F4C997-3114-4444-BF89-E762226AAC89|3|||||BEBQ CONCURRENT|||U/M2/H|||AMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|NA|3||39||OBSERVATION|1969-09-08||||1968-10-20||1964-01-24|1971-08-15|
TRIAL STUDY 134XCP|QS|94F4C997-3114-4444-BF89-E762226AAC89|4|||||WPAI-GH V2.0|||KCAL|||ELISA UNIT/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|4||88||CONTINUATION TREATMENT|1962-03-12||||1960-07-08||1972-09-14|1960-12-24|
TRIAL STUDY 134XCP|QS|94F4C997-3114-4444-BF89-E762226AAC89|5|||||ADCS-ADL|||IU/G|||MPL U/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|N|5||7||BLINDED TREATMENT|1971-04-07||||1965-07-31||1962-05-17|1973-06-15|
TRIAL STUDY 134XCP|QS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1|||||EORTC QLQ-LC13|||MET*MIN|||UG/G/MIN|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|1||38||RUN-IN|1968-08-21||||1970-04-18||1973-03-25|1967-06-14|
TRIAL STUDY 134XCP|QS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2|||||ACT|||PMOL/L/H|||CI|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|2||58||WASHOUT|1962-06-08||||1960-03-15||1969-03-27|1972-10-09|
TRIAL STUDY 134XCP|QS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|3|||||UPS|||UG/L/H|||ML/MMHG/MIN/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|3||39||OPEN LABEL TREATMENT|1962-08-20||||1961-06-24||1968-12-26|1971-03-23|
TRIAL STUDY 134XCP|QS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||UMOL/DL|||SBE/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|4||88||INDUCTION TREATMENT|1962-07-26||||1965-02-01||1963-10-15|1963-11-27|
TRIAL STUDY 134XCP|QS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|5|||||IPAQ-SF PHONE VERSION|||DPM/0.5 ML|||UG/G/MIN|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|NA|5||7||RUN-IN|1969-06-08||||1962-06-24||1965-02-24|1962-01-31|
TRIAL STUDY 134XCP|QS|D20DE6F0-DA30-4453-8F80-61093BF046A6|1|||||EQ-5D-3L|||IU/MG|||PFU/DOSE|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|1||38||OBSERVATION|1970-03-07||||1961-12-10||1970-08-24|1969-03-17|
TRIAL STUDY 134XCP|QS|D20DE6F0-DA30-4453-8F80-61093BF046A6|2|||||EQ-5D-3L|||IU/L|||% INHIBITION|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|2||58||LONG-TERM FOLLOW-UP|1964-02-26||||1973-02-13||1968-10-06|1961-04-19|
TRIAL STUDY 134XCP|QS|D20DE6F0-DA30-4453-8F80-61093BF046A6|3|||||C-SSRS CHILDREN'S BASELINE|||NKAT/L|||/LPF|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|Y|3||39||BASELINE|1969-12-24||||1971-07-26||1972-05-16|1962-01-10|
TRIAL STUDY 134XCP|QS|D20DE6F0-DA30-4453-8F80-61093BF046A6|4|||||SOBDA|||PMOL/L/H|||GENEQ|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|4||88||TREATMENT|1969-08-31||||1966-05-17||1963-08-16|1966-09-18|
TRIAL STUDY 134XCP|QS|D20DE6F0-DA30-4453-8F80-61093BF046A6|5|||||HAEM-A-QOL|||10^9 ORGANISMS/G|||NKAT/G HB|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|5||7||OPEN LABEL TREATMENT|1966-06-09||||1968-03-15||1971-02-16|1964-11-17|
TRIAL STUDY 134XCP|QS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1|||||WHODAS 2.0 - 12-ITEM SELF|||10^9 ORGANISMS/G|||U/G/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|1||38||TREATMENT|1967-10-28||||1965-02-17||1968-01-05|1969-01-07|
TRIAL STUDY 134XCP|QS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MMOL/MOL|||IN|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|2||58||SCREENING|1961-10-20||||1972-06-29||1973-03-25|1962-03-31|
TRIAL STUDY 134XCP|QS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||LOG10 TCID 50/ML|||ML/M2/H|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|3||39||BASELINE|1971-02-08||||1966-01-01||1969-02-02|1962-08-03|
TRIAL STUDY 134XCP|QS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|4|||||DRRI-2|||10^6 CFU/G|||ML/G/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|4||88||OPEN LABEL TREATMENT|1961-05-24||||1960-10-15||1964-07-22|1962-05-07|
TRIAL STUDY 134XCP|QS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||ML/CAGE/DAY|||MG/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|U|5||7||RUN-IN|1970-04-17||||1963-05-29||1963-08-31|1964-01-26|
TRIAL STUDY 134XCP|QS|F20939CF-C668-4514-A2CF-63723560FA46|1|||||FPSR|||FMOL|||L/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|N|1||38||OPEN LABEL TREATMENT|1960-03-03||||1966-10-15||1961-01-26|1963-01-07|
TRIAL STUDY 134XCP|QS|F20939CF-C668-4514-A2CF-63723560FA46|2|||||MSWS-12|||DAYS|||VIRTUAL PIXEL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|N|2||58||WASHOUT|1969-05-06||||1969-03-12||1970-04-05|1966-04-06|
TRIAL STUDY 134XCP|QS|F20939CF-C668-4514-A2CF-63723560FA46|3|||||CDR|||UMOL|||BEATS/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|Y|Y|3||39||OBSERVATION|1968-11-19||||1961-05-14||1960-10-24|1969-09-16|
TRIAL STUDY 134XCP|QS|F20939CF-C668-4514-A2CF-63723560FA46|4|||||FACT-COG V3|||EID 50/ML|||INHALATION|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|4||88||BASELINE|1967-01-14||||1973-01-15||1963-05-15|1971-05-31|
TRIAL STUDY 134XCP|QS|F20939CF-C668-4514-A2CF-63723560FA46|5|||||ADAS-COG|||MU|||OD UNIT|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|5||7||OBSERVATION|1966-10-20||||1965-12-08||1962-02-14|1960-07-16|
TRIAL STUDY 134XCP|QS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1|||||CHART-SF PAPER VERSION|||CONTAINER|||CAPLET|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|1||38||BASELINE|1962-10-24||||1968-01-21||1971-09-18|1961-10-04|
TRIAL STUDY 134XCP|QS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||IN2|||MET*H|NOT DONE||LIKERT SCALE 3-POINT|U|Y|N|2||58||INDUCTION TREATMENT|1972-06-03||||1961-05-26||1971-07-28|1960-01-20|
TRIAL STUDY 134XCP|QS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|3|||||TSCC|||ECL UNIT|||GENEQ/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|U|3||39||SCREENING|1971-12-14||||1972-12-30||1965-07-22|1960-05-02|
TRIAL STUDY 134XCP|QS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|4|||||IBDQ|||UM/S|||10^8/L|NOT DONE||LIKERT SCALE 3-POINT|U|Y|U|4||88||WASHOUT|1960-04-14||||1971-07-26||1971-07-22|1963-03-15|
TRIAL STUDY 134XCP|QS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||KPA|||BEL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|5||7||OBSERVATION|1964-05-04||||1972-07-17||1973-07-24|1963-01-16|
TRIAL STUDY 134XCP|QS|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1|||||FLSI|||OHM|||UMOL/L/H|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|1||38||OBSERVATION|1968-09-14||||1960-05-03||1966-01-23|1963-02-12|
TRIAL STUDY 134XCP|QS|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2|||||SMDDS V1.0|||NMOL/L|||POINT|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|NA|2||58||BASELINE|1962-07-22||||1962-01-05||1968-05-31|1967-04-28|
TRIAL STUDY 134XCP|QS|9A60A414-54A0-4A7F-84EE-FCB8246D2477|3|||||EPIC-CP|||QUANTITY SUFFICIENT|||UGEQ/L|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|N|3||39||SCREENING|1968-03-26||||1969-09-12||1967-02-01|1966-06-07|
TRIAL STUDY 134XCP|QS|9A60A414-54A0-4A7F-84EE-FCB8246D2477|4|||||FACIT-DYSPNEA SF|||MU/L|||10^6 ORGANISMS/G|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|U|4||88||LONG-TERM FOLLOW-UP|1973-04-18||||1965-03-16||1964-12-11|1965-03-05|
TRIAL STUDY 134XCP|QS|9A60A414-54A0-4A7F-84EE-FCB8246D2477|5|||||NCCN-FACT FBRSI-24 V2|||U/10^12 RBC|||10^7 PFU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|5||7||LONG-TERM FOLLOW-UP|1960-01-12||||1967-10-22||1961-07-23|1961-06-26|
TRIAL STUDY 134XCP|QS|8D546F1C-E719-4C03-A66A-9916EFF2A144|1|||||COPD ASSESSMENT TEST|||/200 HPFS|||G/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|1||38||RUN-IN|1965-09-05||||1960-11-09||1969-05-25|1972-02-16|
TRIAL STUDY 134XCP|QS|8D546F1C-E719-4C03-A66A-9916EFF2A144|2|||||FACT-BL V4|||MMOL|||UMOL/L/SEC|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|2||58||OBSERVATION|1966-05-19||||1967-12-11||1968-05-29|1963-08-09|
TRIAL STUDY 134XCP|QS|8D546F1C-E719-4C03-A66A-9916EFF2A144|3|||||FIQR|||ABSORBANCE U/MIN|||ML/KG|NOT DONE||LIKERT SCALE 7-POINT|NA|N|NA|3||39||INDUCTION TREATMENT|1968-08-11||||1969-06-22||1970-10-30|1964-01-16|
TRIAL STUDY 134XCP|QS|8D546F1C-E719-4C03-A66A-9916EFF2A144|4|||||PODCI - PEDIATRIC PARENT REPORTED|||PMOL/DAY|||GBQ/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|4||88||LONG-TERM FOLLOW-UP|1967-07-22||||1971-10-15||1966-04-25|1968-09-03|
TRIAL STUDY 134XCP|QS|8D546F1C-E719-4C03-A66A-9916EFF2A144|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||PT_BR|||AMPULE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|5||7||LONG-TERM FOLLOW-UP|1967-12-01||||1972-10-17||1973-08-21|1961-02-11|
TRIAL STUDY 134XCP|QS|B998085D-F227-46C8-B2D8-37E97BA799D2|1|||||PARTNER-DDS|||INHALATION|||UCI/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1971-10-10||||1968-04-24||1964-09-25|1966-04-11|
TRIAL STUDY 134XCP|QS|B998085D-F227-46C8-B2D8-37E97BA799D2|2|||||BLCS|||CUP|||MEQ/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|U|2||58||FOLLOW-UP|1969-03-13||||1963-11-13||1967-03-29|1970-04-14|
TRIAL STUDY 134XCP|QS|B998085D-F227-46C8-B2D8-37E97BA799D2|3|||||GDS|||PPB|||GBQ/UG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|NA|3||39||RUN-IN|1963-08-25||||1966-09-17||1963-10-10|1963-09-03|
TRIAL STUDY 134XCP|QS|B998085D-F227-46C8-B2D8-37E97BA799D2|4|||||EQ-5D-3L|||PSI|||UU/DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|4||88||BASELINE|1971-10-10||||1968-03-03||1972-05-14|1961-08-01|
TRIAL STUDY 134XCP|QS|B998085D-F227-46C8-B2D8-37E97BA799D2|5|||||ODI V2.1A|||COPIES/UG|||MBQ/UL|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|5||7||OPEN LABEL TREATMENT|1960-08-18||||1962-12-08||1971-05-04|1968-11-06|
TRIAL STUDY 134XCP|QS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1|||||FACT-BL V4|||MG/L FEU|||UG/MIN|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|1||38||LONG-TERM FOLLOW-UP|1964-09-01||||1962-04-12||1960-04-22|1971-10-31|
TRIAL STUDY 134XCP|QS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2|||||PROSQOLI|||UG/MOL|||TESLA|NOT DONE||LIKERT SCALE 5-POINT|N|Y|Y|2||58||RUN-IN|1967-08-08||||1971-04-21||1970-03-14|1972-09-21|
TRIAL STUDY 134XCP|QS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|3|||||SOWS SHORT|||HZ|||ML/MMHG/MIN/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|3||39||INDUCTION TREATMENT|1967-04-16||||1963-09-12||1966-02-22|1960-10-22|
TRIAL STUDY 134XCP|QS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|4|||||WOMAC LK 3.1 INDEX|||10^3/HPF|||EID 50/DOSE|NOT DONE||LIKERT SCALE 5-POINT|U|N|NA|4||88||BASELINE|1970-08-04||||1972-09-28||1960-11-14|1962-08-09|
TRIAL STUDY 134XCP|QS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|5|||||FACT-L V4|||UMOL/L|||UG/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|N|5||7||FOLLOW-UP|1968-10-27||||1972-03-07||1962-05-24|1968-05-19|
TRIAL STUDY 134XCP|QS|537CE647-EA58-430C-B37B-F56BF20B5AF0|1|||||SF12 V1.0 STANDARD|||10^6 CFU|||FL|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|1||38||BLINDED TREATMENT|1966-07-20||||1969-06-28||1961-07-19|1961-09-14|
TRIAL STUDY 134XCP|QS|537CE647-EA58-430C-B37B-F56BF20B5AF0|2|||||TSCC|||10^9 ORGANISMS|||WEBER|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|U|2||58||RUN-IN|1961-05-09||||1960-04-25||1969-08-07|1971-08-07|
TRIAL STUDY 134XCP|QS|537CE647-EA58-430C-B37B-F56BF20B5AF0|3|||||ADHD-RS-IV HOME VERSION|||TBSP|||KBQ|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|3||39||SCREENING|1966-04-23||||1972-08-31||1966-12-12|1960-01-02|
TRIAL STUDY 134XCP|QS|537CE647-EA58-430C-B37B-F56BF20B5AF0|4|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||MPS U|||F|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|Y|4||88||BASELINE|1968-06-21||||1966-10-31||1966-10-04|1970-05-01|
TRIAL STUDY 134XCP|QS|537CE647-EA58-430C-B37B-F56BF20B5AF0|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||G/CM2|||TRANSDUCING UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|5||7||BLINDED TREATMENT|1971-10-28||||1972-06-15||1960-06-01|1966-06-15|
TRIAL STUDY 134XCP|QS|3464201C-9704-40B6-B3B3-2BADE02BD58F|1|||||BSFS|||MG|||USEC|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|1||38||OPEN LABEL TREATMENT|1973-09-05||||1966-01-15||1969-01-10|1966-01-06|
TRIAL STUDY 134XCP|QS|3464201C-9704-40B6-B3B3-2BADE02BD58F|2|||||HAEM-A-QOL|||VOXEL|||MG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|2||58||FOLLOW-UP|1967-02-14||||1967-02-05||1963-04-21|1967-11-12|
TRIAL STUDY 134XCP|QS|3464201C-9704-40B6-B3B3-2BADE02BD58F|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||KS|||UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|N|3||39||OBSERVATION|1960-05-06||||1969-01-28||1966-06-23|1970-04-30|
TRIAL STUDY 134XCP|QS|3464201C-9704-40B6-B3B3-2BADE02BD58F|4|||||IPAQ-SF PHONE VERSION|||DYN|||MM/SEC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|U|4||88||BLINDED TREATMENT|1960-10-13||||1972-12-06||1967-12-02|1963-01-09|
TRIAL STUDY 134XCP|QS|3464201C-9704-40B6-B3B3-2BADE02BD58F|5|||||BSFS|||M2|||U/CL|NOT DONE||LIKERT SCALE 5-POINT|U|U|N|5||7||INDUCTION TREATMENT|1960-09-01||||1970-10-21||1969-10-12|1967-10-07|
TRIAL STUDY 134XCP|QS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1|||||FAQ-NACC VERSION|||APPLICATION|||VG/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|1||38||OBSERVATION|1965-02-04||||1961-05-10||1965-05-28|1961-02-02|
TRIAL STUDY 134XCP|QS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2|||||SF12 V1.0 ACUTE|||MG/KG|||G/U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|Y|2||58||LONG-TERM FOLLOW-UP|1971-01-13||||1970-02-11||1960-11-25|1971-05-28|
TRIAL STUDY 134XCP|QS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|3|||||TSQM V1.4|||L/DAY|||ML/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|NA|3||39||OPEN LABEL TREATMENT|1972-02-05||||1973-08-03||1963-07-21|1962-03-02|
TRIAL STUDY 134XCP|QS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|4|||||NCCN-FACT FBLSI-18 V2|||MMU/ML|||MMOL/MIN/KPA|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|Y|4||88||LONG-TERM FOLLOW-UP|1965-08-10||||1963-07-24||1968-07-28|1961-03-02|
TRIAL STUDY 134XCP|QS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||MMOL/MIN/KPA/L|||FT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|N|5||7||BLINDED TREATMENT|1969-08-22||||1963-01-18||1960-03-15|1961-09-28|
TRIAL STUDY 134XCP|QS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1|||||ADCS-ADL MCI|||U|||PACK|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|1||38||LONG-TERM FOLLOW-UP|1960-09-10||||1970-04-18||1963-03-26|1970-10-26|
TRIAL STUDY 134XCP|QS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||BQ/KG|||UG/H|NOT DONE||LIKERT SCALE 3-POINT|U|NA|Y|2||58||SCREENING|1971-09-03||||1960-12-10||1964-10-02|1972-11-16|
TRIAL STUDY 134XCP|QS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|3|||||WPAI-SHP V2.0|||MET*H|||SCM|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|3||39||FOLLOW-UP|1961-09-02||||1970-04-25||1962-03-06|1969-03-11|
TRIAL STUDY 134XCP|QS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|4|||||C-SSRS SCREENING|||UOSM|||CG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|U|4||88||OPEN LABEL TREATMENT|1965-12-03||||1960-12-09||1970-04-25|1973-06-29|
TRIAL STUDY 134XCP|QS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||/LSQN|||10^6 U|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|5||7||LONG-TERM FOLLOW-UP|1971-11-05||||1971-10-13||1966-10-16|1964-08-01|
TRIAL STUDY 134XCP|QS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1|||||ADSD V1.0|||VG/ML|||10^6/EJACULATE U|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|Y|1||38||INDUCTION TREATMENT|1971-05-25||||1961-11-26||1962-11-16|1962-04-23|
TRIAL STUDY 134XCP|QS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||FT3|||10^3 RNA COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|2||58||WASHOUT|1963-04-21||||1962-02-22||1960-08-07|1968-09-09|
TRIAL STUDY 134XCP|QS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|3|||||MHIS-NACC|||TCID 50/DOSE|||PSI|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|3||39||RUN-IN|1971-03-13||||1960-07-21||1972-03-19|1972-04-26|
TRIAL STUDY 134XCP|QS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|4|||||NCCN-FACT FPSI-17 V2|||CMOL|||10^6 ORGANISMS/G|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|4||88||OPEN LABEL TREATMENT|1960-11-05||||1973-06-18||1969-02-13|1972-06-29|
TRIAL STUDY 134XCP|QS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|5|||||ADCS-ADL|||10^9 ORGANISMS/MG|||ML/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|N|5||7||SCREENING|1963-09-06||||1965-05-17||1972-03-10|1962-12-31|
TRIAL STUDY 134XCP|QS|11A6144A-895B-4143-85D2-69952C6D452C|1|||||FKSI-DRS V4|||WAFER|||RFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|NA|1||38||RUN-IN|1969-05-15||||1968-04-19||1968-12-13|1971-03-29|
TRIAL STUDY 134XCP|QS|11A6144A-895B-4143-85D2-69952C6D452C|2|||||C-SSRS CHILDREN'S BASELINE|||%(W/W)|||MMOL/G|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|N|2||58||LONG-TERM FOLLOW-UP|1972-06-24||||1963-01-19||1968-12-01|1971-09-17|
TRIAL STUDY 134XCP|QS|11A6144A-895B-4143-85D2-69952C6D452C|3|||||EPIC-26|||TBSP|||PKAT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|3||39||TREATMENT|1967-07-07||||1966-07-26||1971-09-20|1967-04-23|
TRIAL STUDY 134XCP|QS|11A6144A-895B-4143-85D2-69952C6D452C|4|||||MDQ-T|||KAT|||CI/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|4||88||OPEN LABEL TREATMENT|1963-06-22||||1965-03-18||1967-04-16|1972-07-25|
TRIAL STUDY 134XCP|QS|11A6144A-895B-4143-85D2-69952C6D452C|5|||||SIQR|||UG/L FEU|||M3|NOT DONE||LIKERT SCALE 5-POINT|U|U|N|5||7||INDUCTION TREATMENT|1973-01-01||||1962-06-29||1963-07-11|1967-01-09|
TRIAL STUDY 134XCP|QS|8958D35E-F685-4542-AE01-625133F1EF7D|1|||||ADCS-ADL SEVERE DEMENTIA|||UMOL/L/H|||/H|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1966-08-28||||1960-12-05||1965-03-22|1972-04-05|
TRIAL STUDY 134XCP|QS|8958D35E-F685-4542-AE01-625133F1EF7D|2|||||WPAI-SHP V2.0|||PMOL/10^10 CELLS|||10^9 CFU/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|Y|2||58||OPEN LABEL TREATMENT|1973-06-06||||1971-04-09||1968-09-24|1962-01-05|
TRIAL STUDY 134XCP|QS|8958D35E-F685-4542-AE01-625133F1EF7D|3|||||C-SSRS BASELINE|||MAMP|||CUP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|3||39||OBSERVATION|1962-06-06||||1966-06-20||1968-06-24|1967-09-11|
TRIAL STUDY 134XCP|QS|8958D35E-F685-4542-AE01-625133F1EF7D|4|||||IPAQ-LF PHONE VERSION|||ML/MMHG|||L/MIN/M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|U|4||88||OPEN LABEL TREATMENT|1966-04-27||||1971-12-24||1973-02-06|1973-07-11|
TRIAL STUDY 134XCP|QS|8958D35E-F685-4542-AE01-625133F1EF7D|5|||||PR|||GAUSS|||ANSON U|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|N|5||7||INDUCTION TREATMENT|1969-02-09||||1973-02-08||1970-10-21|1970-01-04|
TRIAL STUDY 134XCP|QS|00982640-C826-4CD4-B927-A311227E63CC|1|||||SIQ|||PACKET|||CM2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|N|1||38||FOLLOW-UP|1961-03-31||||1966-11-07||1961-08-22|1967-10-06|
TRIAL STUDY 134XCP|QS|00982640-C826-4CD4-B927-A311227E63CC|2|||||FKSI-DRS V4|||LOG10 TCID 50/DOSE|||10^8/L|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|U|2||58||FOLLOW-UP|1960-06-27||||1965-10-09||1965-07-22|1963-06-10|
TRIAL STUDY 134XCP|QS|00982640-C826-4CD4-B927-A311227E63CC|3|||||WHODAS 2.0 - 36-ITEM PROXY|||KBQ|||VG/DOSE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|NA|3||39||WASHOUT|1970-12-10||||1972-09-06||1971-03-08|1963-07-30|
TRIAL STUDY 134XCP|QS|00982640-C826-4CD4-B927-A311227E63CC|4|||||UPDRS|||MMHG*MIN/L|||UV*SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|NA|4||88||LONG-TERM FOLLOW-UP|1972-12-29||||1961-12-22||1968-02-17|1970-07-04|
TRIAL STUDY 134XCP|QS|00982640-C826-4CD4-B927-A311227E63CC|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||/H|||MG2/DL2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|NA|5||7||RUN-IN|1969-05-13||||1968-04-29||1966-02-26|1968-09-17|
TRIAL STUDY 134XCP|QS|C213CAA8-2FAC-402C-A19E-11A60708A71A|1|||||SIQR|||MDFI|||UMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|1||38||TREATMENT|1967-12-24||||1973-01-23||1964-06-11|1966-09-08|
TRIAL STUDY 134XCP|QS|C213CAA8-2FAC-402C-A19E-11A60708A71A|2|||||FACT-P V4|||BEATS/MIN|||MPL U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|2||58||OPEN LABEL TREATMENT|1971-07-27||||1961-09-05||1966-10-16|1967-10-12|
TRIAL STUDY 134XCP|QS|C213CAA8-2FAC-402C-A19E-11A60708A71A|3|||||FOSI|||KG/MOL|||FFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|3||39||SCREENING|1971-01-28||||1969-07-24||1960-12-21|1971-10-07|
TRIAL STUDY 134XCP|QS|C213CAA8-2FAC-402C-A19E-11A60708A71A|4|||||COWS|||MEQ/G|||10^12 IU/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|4||88||LONG-TERM FOLLOW-UP|1969-05-28||||1970-08-07||1962-03-05|1969-05-11|
TRIAL STUDY 134XCP|QS|C213CAA8-2FAC-402C-A19E-11A60708A71A|5|||||MPAI-4|||CI/G|||MMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|5||7||INDUCTION TREATMENT|1969-08-05||||1972-07-17||1971-07-08|1966-07-22|
TRIAL STUDY 134XCP|QS|F0559682-CD36-4ED0-8082-A54D40305512|1|||||PDDS|||MEQ|||MM/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|1||38||OBSERVATION|1961-02-12||||1965-12-04||1962-05-17|1967-07-07|
TRIAL STUDY 134XCP|QS|F0559682-CD36-4ED0-8082-A54D40305512|2|||||C-SSRS BASELINE|||OZ|||UG/ML/H|NOT DONE||LIKERT SCALE 3-POINT|N|N|Y|2||58||WASHOUT|1973-08-21||||1960-05-25||1964-02-25|1971-02-15|
TRIAL STUDY 134XCP|QS|F0559682-CD36-4ED0-8082-A54D40305512|3|||||SF36 V1.0 STANDARD|||ML/(MIN*100ML)|||ML/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|3||39||RUN-IN|1971-02-27||||1965-03-30||1964-04-04|1962-02-21|
TRIAL STUDY 134XCP|QS|F0559682-CD36-4ED0-8082-A54D40305512|4|||||MMRC|||FMOL|||DMOL|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|4||88||TREATMENT|1964-11-12||||1962-05-23||1971-03-05|1972-04-29|
TRIAL STUDY 134XCP|QS|F0559682-CD36-4ED0-8082-A54D40305512|5|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||UL/KG/DAY|||UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|Y|5||7||BASELINE|1970-11-14||||1969-02-09||1967-04-07|1961-08-07|
TRIAL STUDY 134XCP|QS|C004A4D5-DBD0-4967-9597-8C1653AB8298|1|||||SF36 V1.0 STANDARD|||CD|||HR/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|Y|1||38||OPEN LABEL TREATMENT|1967-05-16||||1963-01-25||1961-02-17|1966-07-04|
TRIAL STUDY 134XCP|QS|C004A4D5-DBD0-4967-9597-8C1653AB8298|2|||||FACIT-F V4|||PMOL/DAY|||PMOL/10^10 CELLS|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|2||58||LONG-TERM FOLLOW-UP|1966-07-17||||1965-11-25||1964-03-12|1973-01-11|
TRIAL STUDY 134XCP|QS|C004A4D5-DBD0-4967-9597-8C1653AB8298|3|||||FACT-BMT V4|||GBQ/UG|||MEQ/MMOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|Y|3||39||BLINDED TREATMENT|1969-04-11||||1962-11-22||1972-02-07|1964-06-05|
TRIAL STUDY 134XCP|QS|C004A4D5-DBD0-4967-9597-8C1653AB8298|4|||||NCCN-FACT FBRSI-24 V2|||ML/S|||M/SEC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|U|4||88||RUN-IN|1966-09-10||||1960-12-06||1963-05-08|1972-09-05|
TRIAL STUDY 134XCP|QS|C004A4D5-DBD0-4967-9597-8C1653AB8298|5|||||BORG CR10|||U/KG|||CI/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|5||7||OPEN LABEL TREATMENT|1961-07-19||||1972-03-06||1963-05-24|1967-01-30|
TRIAL STUDY 134XCP|QS|ABB838A1-2387-471E-8F50-1F48205BC8EE|1|||||ESS|||KA_U/DL|||OHM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|1||38||OPEN LABEL TREATMENT|1962-06-06||||1962-05-06||1968-09-06|1972-09-26|
TRIAL STUDY 134XCP|QS|ABB838A1-2387-471E-8F50-1F48205BC8EE|2|||||NPI|||%/MIN|||MN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|Y|2||58||BASELINE|1964-12-11||||1968-05-17||1964-08-11|1961-06-16|
TRIAL STUDY 134XCP|QS|ABB838A1-2387-471E-8F50-1F48205BC8EE|3|||||FACT-BMT V4|||CM/MIN|||MMU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|3||39||FOLLOW-UP|1972-04-16||||1971-12-18||1965-02-03|1961-01-27|
TRIAL STUDY 134XCP|QS|ABB838A1-2387-471E-8F50-1F48205BC8EE|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||10^6 DNA COPIES/ML|||CI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|4||88||LONG-TERM FOLLOW-UP|1962-07-05||||1960-07-01||1969-03-29|1960-03-15|
TRIAL STUDY 134XCP|QS|ABB838A1-2387-471E-8F50-1F48205BC8EE|5|||||SF10 V1.0 CHILDREN ACUTE|||ENZYME U/G HB|||HPA|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|NA|5||7||TREATMENT|1972-06-26||||1969-11-03||1970-12-09|1971-07-20|
TRIAL STUDY 134XCP|QS|88126417-8564-4659-AA60-63642067113D|1|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MMOL/DAY|||DEG2|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|1||38||CONTINUATION TREATMENT|1964-07-21||||1968-07-04||1963-01-24|1964-02-12|
TRIAL STUDY 134XCP|QS|88126417-8564-4659-AA60-63642067113D|2|||||OAB-Q|||G/KG/DAY|||UMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|Y|2||58||BASELINE|1966-03-07||||1968-04-25||1972-02-07|1960-04-27|
TRIAL STUDY 134XCP|QS|88126417-8564-4659-AA60-63642067113D|3|||||ADCS-ADL|||/200 HPFS|||MG2/DL2|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|3||39||INDUCTION TREATMENT|1960-01-16||||1961-05-07||1968-10-26|1971-11-14|
TRIAL STUDY 134XCP|QS|88126417-8564-4659-AA60-63642067113D|4|||||SIQ|||SIEMENS|||MG/H|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|4||88||RUN-IN|1961-01-27||||1967-04-06||1967-12-10|1970-06-27|
TRIAL STUDY 134XCP|QS|88126417-8564-4659-AA60-63642067113D|5|||||DAD|||LOG10 CFU/G|||ML/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|5||7||OBSERVATION|1967-08-09||||1970-07-07||1960-03-02|1970-09-12|
TRIAL STUDY 134XCP|QS|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1|||||FAS-NACC UDS V3.0|||BAR|||OI50|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|NA|1||38||CONTINUATION TREATMENT|1963-11-04||||1965-03-15||1962-10-30|1965-11-30|
TRIAL STUDY 134XCP|QS|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2|||||EORTC QLQ-LC13|||UV2|||LX|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|2||58||SCREENING|1967-04-03||||1971-05-30||1973-01-07|1960-06-15|
TRIAL STUDY 134XCP|QS|6ADA444E-F1B4-4E59-9F2D-26DC78845397|3|||||SGRQ PAST 3 MONTHS VERSION|||USIEMENS|||10^12 IU/L|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|3||39||WASHOUT|1963-01-22||||1964-09-30||1970-11-04|1970-01-13|
TRIAL STUDY 134XCP|QS|6ADA444E-F1B4-4E59-9F2D-26DC78845397|4|||||HAQ-DI WITH VAS|||10^6 RNA COPIES/ML|||AMPULE|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|4||88||OPEN LABEL TREATMENT|1963-11-09||||1967-11-24||1971-04-28|1961-12-05|
TRIAL STUDY 134XCP|QS|6ADA444E-F1B4-4E59-9F2D-26DC78845397|5|||||PEDS-FACIT-F|||/40 HPFS|||100 IU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|NA|5||7||OBSERVATION|1967-05-11||||1972-05-03||1968-02-21|1973-03-10|
TRIAL STUDY 134XCP|QS|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||G/DL|||MEQ/MMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1962-01-03||||1964-04-21||1960-06-03|1966-03-07|
TRIAL STUDY 134XCP|QS|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2|||||SIQR|||KPA|||DPM/0.5 ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|N|2||58||INDUCTION TREATMENT|1969-01-06||||1967-09-03||1969-04-14|1964-03-02|
TRIAL STUDY 134XCP|QS|85060A90-92F7-4440-AD1C-62A70C2FD5CB|3|||||NCCN-FACT FPSI-17 V2|||/7.5 ML|||DPM/0.5 ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|3||39||CONTINUATION TREATMENT|1963-02-28||||1971-10-05||1969-10-21|1960-06-03|
TRIAL STUDY 134XCP|QS|85060A90-92F7-4440-AD1C-62A70C2FD5CB|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||PFU|||UL/DOSE|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|4||88||CONTINUATION TREATMENT|1972-05-26||||1968-11-04||1962-12-01|1971-08-21|
TRIAL STUDY 134XCP|QS|85060A90-92F7-4440-AD1C-62A70C2FD5CB|5|||||PHQ SCREENER VERSION|||DRUM|||MMOL/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|Y|5||7||SCREENING|1967-03-08||||1960-06-30||1970-01-17|1970-02-09|
TRIAL STUDY 134XCP|QS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1|||||EORTC QLQ-C30 V3.0|||ML/KG/MIN|||USIEMENS|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|Y|1||38||BLINDED TREATMENT|1962-06-27||||1969-03-29||1960-02-22|1972-02-28|
TRIAL STUDY 134XCP|QS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2|||||ADCS-CGIC|||HENRY|||M|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|Y|2||58||BASELINE|1970-06-19||||1960-07-01||1966-10-09|1960-03-09|
TRIAL STUDY 134XCP|QS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|3|||||AQ20|||KG/CM|||CI/KG|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|3||39||BASELINE|1963-02-26||||1962-01-24||1965-05-24|1962-12-05|
TRIAL STUDY 134XCP|QS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|4|||||Q-LES-Q|||HOMEOPATHIC DILUTION|||MG/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|4||88||BASELINE|1960-03-07||||1969-09-06||1967-10-04|1961-05-08|
TRIAL STUDY 134XCP|QS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|5|||||VFQ-25 INTERVIEWER ADMINISTERED|||IU/MMOL|||10^6/L|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|5||7||WASHOUT|1964-11-22||||1966-03-05||1960-07-03|1970-09-11|
TRIAL STUDY 134XCP|QS|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||FOZ_BR|||10^3/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1971-09-18||||1963-05-12||1973-01-14|1960-01-18|
TRIAL STUDY 134XCP|QS|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2|||||SF36 V1.0 ACUTE|||10^9 CFU|||FFU|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|U|2||58||FOLLOW-UP|1960-10-14||||1970-08-28||1960-04-02|1969-08-15|
TRIAL STUDY 134XCP|QS|170052E6-031C-48EF-9CE4-CA84ED6B77FF|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||CD*S/M2|||MBQ|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|3||39||RUN-IN|1965-12-01||||1970-03-26||1964-08-27|1967-10-30|
TRIAL STUDY 134XCP|QS|170052E6-031C-48EF-9CE4-CA84ED6B77FF|4|||||HAMD 6 SELF-REPORT VERSION|||/10^4|||MM/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|4||88||CONTINUATION TREATMENT|1961-08-02||||1966-05-06||1971-01-02|1970-06-06|
TRIAL STUDY 134XCP|QS|170052E6-031C-48EF-9CE4-CA84ED6B77FF|5|||||SF36 V2.0 ACUTE|||EU|||AMU|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|Y|5||7||TREATMENT|1967-02-26||||1967-01-04||1964-09-20|1972-12-29|
TRIAL STUDY 134XCP|QS|D3F628DE-8358-4C2C-B474-763E48719E5E|1|||||FAS-NACC UDS V3.0|||GENEQ/ML|||BAU/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|NA|1||38||OBSERVATION|1971-10-26||||1963-03-28||1971-03-16|1968-12-18|
TRIAL STUDY 134XCP|QS|D3F628DE-8358-4C2C-B474-763E48719E5E|2|||||WPAI-SHP V2.0|||M3|||U/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|2||58||LONG-TERM FOLLOW-UP|1968-04-30||||1961-11-04||1970-12-23|1964-01-03|
TRIAL STUDY 134XCP|QS|D3F628DE-8358-4C2C-B474-763E48719E5E|3|||||IPAQ-SF SELF-ADMINISTERED VERSION|||VG/DOSE|||OHM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|3||39||TREATMENT|1972-07-23||||1965-06-05||1962-02-07|1969-02-01|
TRIAL STUDY 134XCP|QS|D3F628DE-8358-4C2C-B474-763E48719E5E|4|||||NCCN-FACT FHNSI-22 V2|||IU/G|||10^3 DNA COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|4||88||CONTINUATION TREATMENT|1970-01-27||||1973-06-06||1971-11-30|1969-11-26|
TRIAL STUDY 134XCP|QS|D3F628DE-8358-4C2C-B474-763E48719E5E|5|||||ADHD-RS-IV HOME VERSION|||TUBERCULIN UNIT|||PM|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|N|5||7||CONTINUATION TREATMENT|1970-04-17||||1962-08-15||1972-06-30|1965-04-25|
TRIAL STUDY 134XCP|QS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1|||||EPIC-26|||MM/MIN|||ML/G/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|1||38||INDUCTION TREATMENT|1964-12-13||||1966-03-14||1969-07-15|1966-03-31|
TRIAL STUDY 134XCP|QS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||PPB|||CYLINDER|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|2||58||FOLLOW-UP|1962-06-23||||1962-03-09||1966-07-04|1962-03-01|
TRIAL STUDY 134XCP|QS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|3|||||IPAQ-SF PHONE VERSION|||PKAT|||U/G|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|3||39||RUN-IN|1970-06-30||||1966-06-30||1961-05-25|1963-01-25|
TRIAL STUDY 134XCP|QS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||MAC50|||KS|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|4||88||OBSERVATION|1962-07-20||||1971-03-10||1972-08-13|1966-06-12|
TRIAL STUDY 134XCP|QS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|5|||||YMRS|||10^9/L|||MG/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|5||7||WASHOUT|1960-12-21||||1960-10-30||1967-08-21|1967-01-28|
TRIAL STUDY 134XCP|QS|4395486D-C521-4478-9442-68CF0344C6FB|1|||||FACIT-FATIGUE 13-ITEM V4|||CAPLET|||MOL/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|1||38||FOLLOW-UP|1968-03-26||||1967-08-01||1967-04-07|1961-03-26|
TRIAL STUDY 134XCP|QS|4395486D-C521-4478-9442-68CF0344C6FB|2|||||C-SSRS LIFETIME/RECENT VERSION|||BEATS/MIN|||LOG10 TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|2||58||OPEN LABEL TREATMENT|1960-06-24||||1960-04-16||1971-11-17|1965-07-04|
TRIAL STUDY 134XCP|QS|4395486D-C521-4478-9442-68CF0344C6FB|3|||||EPIC-26|||NFIU|||MM/SEC|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|3||39||LONG-TERM FOLLOW-UP|1968-11-23||||1971-03-09||1967-01-29|1968-02-18|
TRIAL STUDY 134XCP|QS|4395486D-C521-4478-9442-68CF0344C6FB|4|||||PODCI - ADOLESCENT PARENT REPORTED|||COULOMB|||DAGU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|4||88||BASELINE|1971-05-23||||1967-06-24||1966-05-09|1961-11-26|
TRIAL STUDY 134XCP|QS|4395486D-C521-4478-9442-68CF0344C6FB|5|||||GAD-7 V2|||U/G/MIN|||MEQ/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|NA|5||7||WASHOUT|1970-10-26||||1961-12-19||1970-03-08|1962-01-29|
TRIAL STUDY 134XCP|QS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1|||||FLU-IIQ TWICE DAILY|||ECL UNIT|||KG/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|1||38||OPEN LABEL TREATMENT|1972-08-23||||1972-07-24||1966-07-28|1964-04-25|
TRIAL STUDY 134XCP|QS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2|||||SGRQ-C|||WAFER|||/H|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|U|2||58||OBSERVATION|1962-08-18||||1960-07-16||1965-11-19|1972-09-28|
TRIAL STUDY 134XCP|QS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|3|||||WOMAC LK 3.1 INDEX|||CI/UG|||KIU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|3||39||OBSERVATION|1972-02-02||||1968-06-08||1972-07-31|1964-12-26|
TRIAL STUDY 134XCP|QS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|4|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||UMOL/H/MMOL|||/2500 WBC|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|NA|4||88||SCREENING|1965-02-13||||1973-08-02||1969-11-10|1971-11-21|
TRIAL STUDY 134XCP|QS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|5|||||DRRI-2|||K|||PNU/ML|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|5||7||RUN-IN|1973-07-04||||1969-12-04||1964-03-06|1971-10-05|
TRIAL STUDY 134XCP|QS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1|||||CCQ 24 HOUR VERSION|||MJOULE/CM2|||GAUSS|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|1||38||BLINDED TREATMENT|1973-05-30||||1965-09-24||1966-03-06|1962-10-20|
TRIAL STUDY 134XCP|QS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2|||||ADCS-ADL MCI|||UGEQ/L|||DPM/MG|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|Y|2||58||WASHOUT|1970-07-06||||1966-09-05||1970-03-28|1968-11-05|
TRIAL STUDY 134XCP|QS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|3|||||COWS|||10^4/L|||GTT|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|3||39||OPEN LABEL TREATMENT|1971-07-25||||1963-05-05||1968-01-02|1965-08-13|
TRIAL STUDY 134XCP|QS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|4|||||CHART-SF PAPER VERSION|||10^11/L|||10^3 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|N|4||88||WASHOUT|1963-12-05||||1971-06-06||1969-08-12|1972-10-27|
TRIAL STUDY 134XCP|QS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|5|||||RAND-36 V1.0|||/H|||CI/UG|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|5||7||FOLLOW-UP|1960-07-13||||1970-09-11||1961-02-25|1973-07-26|
TRIAL STUDY 134XCP|QS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||U/M2/DAY|||GBQ/UG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|Y|1||38||RUN-IN|1967-09-24||||1968-01-27||1968-12-09|1961-03-20|
TRIAL STUDY 134XCP|QS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2|||||NSCLC-SAQ V1.0|||QUANTITY SUFFICIENT|||PNU/ML|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|2||58||RUN-IN|1969-07-27||||1965-02-13||1967-07-09|1972-02-09|
TRIAL STUDY 134XCP|QS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||MEQ/UG|||L/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|3||39||FOLLOW-UP|1961-04-23||||1965-01-25||1963-09-04|1960-01-06|
TRIAL STUDY 134XCP|QS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|4|||||C-SSRS ALREADY ENROLLED SUBJECTS|||MSEC|||10^3/HPF|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|4||88||TREATMENT|1965-06-21||||1965-09-06||1969-10-22|1962-08-01|
TRIAL STUDY 134XCP|QS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|5|||||PARENT-DDS|||BE/ML|||NG/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|5||7||BLINDED TREATMENT|1970-04-03||||1966-03-02||1973-07-23|1973-07-14|
TRIAL STUDY 134XCP|QS|19394300-46A6-484F-AE02-50BDD39096E3|1|||||FACT-TAXANE V4|||KG/L|||MILE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|1||38||SCREENING|1969-12-27||||1961-09-24||1967-03-29|1972-10-15|
TRIAL STUDY 134XCP|QS|19394300-46A6-484F-AE02-50BDD39096E3|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||APS U|||ML/MIN/1.73M2|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|Y|2||58||TREATMENT|1967-02-04||||1964-06-27||1960-11-24|1963-05-19|
TRIAL STUDY 134XCP|QS|19394300-46A6-484F-AE02-50BDD39096E3|3|||||AUDIT-C|||DMOL|||CAN|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|3||39||OPEN LABEL TREATMENT|1965-11-27||||1967-12-17||1966-02-07|1962-08-26|
TRIAL STUDY 134XCP|QS|19394300-46A6-484F-AE02-50BDD39096E3|4|||||PHQ-15|||MG/KG/MIN|||G/G/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|4||88||WASHOUT|1967-06-07||||1966-08-22||1961-02-18|1967-04-07|
TRIAL STUDY 134XCP|QS|19394300-46A6-484F-AE02-50BDD39096E3|5|||||PSQI|||NG|||10^10/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|5||7||TREATMENT|1969-05-19||||1970-11-26||1971-03-14|1972-05-31|
TRIAL STUDY 134XCP|QS|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1|||||SMDDS V1.0|||FFU|||IU/MMOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|NA|1||38||OBSERVATION|1962-02-07||||1963-12-15||1967-12-02|1970-04-30|
TRIAL STUDY 134XCP|QS|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2|||||ADAS-COG|||ML/G/H|||SYRINGE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|2||58||WASHOUT|1969-05-02||||1967-03-01||1969-02-02|1971-07-19|
TRIAL STUDY 134XCP|QS|8C89BD60-3504-4F8B-8F33-7F0C949DB407|3|||||FSS|||ML/DOSE|||CFU/G|NOT DONE||LIKERT SCALE 3-POINT|N|U|Y|3||39||SCREENING|1960-05-29||||1971-10-19||1968-09-13|1970-11-14|
TRIAL STUDY 134XCP|QS|8C89BD60-3504-4F8B-8F33-7F0C949DB407|4|||||AQLQ|||VIRTUAL PIXEL|||DEG2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|4||88||INDUCTION TREATMENT|1966-09-15||||1971-08-09||1969-12-12|1973-03-28|
TRIAL STUDY 134XCP|QS|8C89BD60-3504-4F8B-8F33-7F0C949DB407|5|||||FBRSI|||CI/UL|||CAPFUL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|5||7||SCREENING|1961-07-31||||1973-06-08||1960-12-07|1967-04-01|
TRIAL STUDY 134XCP|QS|4746A481-011E-4376-9D2F-5E57F560A6DE|1|||||C-SSRS SINCE LAST VISIT|||MMHG|||PMOL/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|1||38||LONG-TERM FOLLOW-UP|1968-01-26||||1971-11-24||1965-05-30|1960-11-18|
TRIAL STUDY 134XCP|QS|4746A481-011E-4376-9D2F-5E57F560A6DE|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||LOG10 ELISA UNIT/DOSE|||NU/CL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|NA|2||58||INDUCTION TREATMENT|1968-04-15||||1970-04-01||1967-05-02|1968-07-17|
TRIAL STUDY 134XCP|QS|4746A481-011E-4376-9D2F-5E57F560A6DE|3|||||WHODAS 2.0 - 36-ITEM SELF|||BAU|||/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|NA|3||39||BLINDED TREATMENT|1968-02-14||||1961-12-31||1961-11-16|1972-01-05|
TRIAL STUDY 134XCP|QS|4746A481-011E-4376-9D2F-5E57F560A6DE|4|||||ADCS-CGIC|||LOG10 CCID 50/DOSE|||DB|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|N|4||88||INDUCTION TREATMENT|1960-11-30||||1964-10-31||1961-01-07|1963-05-31|
TRIAL STUDY 134XCP|QS|4746A481-011E-4376-9D2F-5E57F560A6DE|5|||||FACT-COG V3|||L/MIN|||MCI|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|5||7||INDUCTION TREATMENT|1967-03-12||||1970-01-12||1962-12-10|1965-01-11|
TRIAL STUDY 134XCP|QS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1|||||VFQ-25 SELF ADMINISTERED|||UM|||ML/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|NA|1||38||BASELINE|1961-02-06||||1972-07-16||1967-06-22|1968-06-03|
TRIAL STUDY 134XCP|QS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2|||||BSFS|||MMOL|||CM H2O|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|NA|2||58||FOLLOW-UP|1970-08-09||||1962-02-17||1966-10-07|1968-08-25|
TRIAL STUDY 134XCP|QS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|3|||||PGI|||IU/DL|||G/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|3||39||LONG-TERM FOLLOW-UP|1967-08-21||||1963-02-28||1966-12-09|1969-02-17|
TRIAL STUDY 134XCP|QS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|4|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||10^3 DNA COPIES/ML|||TABLET|NOT DONE||LIKERT SCALE 5-POINT|N|U|Y|4||88||CONTINUATION TREATMENT|1972-01-28||||1962-09-29||1966-11-05|1967-02-23|
TRIAL STUDY 134XCP|QS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|5|||||C-SSRS LIFETIME/RECENT VERSION|||UKAT/L|||HZ/S|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|5||7||RUN-IN|1961-07-12||||1972-11-11||1969-11-25|1961-09-13|
TRIAL STUDY 134XCP|QS|04F5220E-7A8C-4982-9379-496306612E33|1|||||AUDIT-SR|||VIAL|||/MBP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|1||38||SCREENING|1960-03-04||||1964-11-11||1963-02-10|1969-01-28|
TRIAL STUDY 134XCP|QS|04F5220E-7A8C-4982-9379-496306612E33|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||DAGU/ML|||RPM|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|2||58||CONTINUATION TREATMENT|1963-06-05||||1960-02-15||1973-07-14|1970-04-25|
TRIAL STUDY 134XCP|QS|04F5220E-7A8C-4982-9379-496306612E33|3|||||SF12 V2.0 STANDARD|||MILE|||HOURS|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|U|3||39||OPEN LABEL TREATMENT|1960-03-21||||1970-08-26||1968-08-06|1961-10-11|
TRIAL STUDY 134XCP|QS|04F5220E-7A8C-4982-9379-496306612E33|4|||||EORTC QLQ-CR29 V2.1|||GRAIN|||BQ/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|4||88||INDUCTION TREATMENT|1971-06-14||||1964-06-20||1965-12-10|1964-07-18|
TRIAL STUDY 134XCP|QS|04F5220E-7A8C-4982-9379-496306612E33|5|||||PARENT-DDS|||NMOL|||BAG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|5||7||RUN-IN|1971-05-20||||1973-01-24||1970-10-01|1962-09-27|
TRIAL STUDY 134XCP|QS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1|||||PCL-5|||/MM2|||UV*SEC|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|1||38||OBSERVATION|1970-06-18||||1963-10-18||1969-10-18|1962-11-05|
TRIAL STUDY 134XCP|QS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2|||||ASEX-MALE|||TROCHE|||BU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|2||58||BASELINE|1970-06-02||||1972-02-10||1973-05-06|1966-12-16|
TRIAL STUDY 134XCP|QS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|3|||||SGRQ-C|||MG/L FEU|||BQ/KG|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|3||39||OPEN LABEL TREATMENT|1961-01-28||||1970-08-26||1972-05-24|1969-10-16|
TRIAL STUDY 134XCP|QS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|4|||||PROSQOLI|||L/L|||PATCH|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|4||88||FOLLOW-UP|1965-05-17||||1971-11-06||1960-02-19|1968-05-16|
TRIAL STUDY 134XCP|QS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|5|||||SDS|||10^9/G|||KIU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|5||7||WASHOUT|1968-01-27||||1965-06-10||1971-08-20|1963-07-13|
TRIAL STUDY 134XCP|QS|73BDFAA2-6260-4E1D-8039-7523F0C52873|1|||||IPAQ-LF PHONE VERSION|||KS|||FINGERTIP UNIT|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|1||38||FOLLOW-UP|1964-09-23||||1963-03-13||1964-09-12|1965-01-13|
TRIAL STUDY 134XCP|QS|73BDFAA2-6260-4E1D-8039-7523F0C52873|2|||||WHODAS 2.0 - 12-ITEM SELF|||MPL U/ML|||NGEQ/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|N|2||58||FOLLOW-UP|1971-05-17||||1961-04-03||1967-08-12|1966-09-04|
TRIAL STUDY 134XCP|QS|73BDFAA2-6260-4E1D-8039-7523F0C52873|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||UL/DOSE|||L/S/KPA|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|3||39||TREATMENT|1968-05-11||||1965-05-10||1968-03-24|1965-11-07|
TRIAL STUDY 134XCP|QS|73BDFAA2-6260-4E1D-8039-7523F0C52873|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||MMOL/MIN/KPA/L|||GRAVITATIONAL UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|4||88||SCREENING|1972-09-10||||1962-11-30||1963-09-29|1973-01-27|
TRIAL STUDY 134XCP|QS|73BDFAA2-6260-4E1D-8039-7523F0C52873|5|||||FACT-TAXANE V4|||ANTI-XA IU/ML|||UG/MIN|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|5||7||TREATMENT|1967-09-24||||1965-05-14||1972-11-21|1960-01-19|
TRIAL STUDY 134XCP|QS|147C2E77-A2C5-4219-9BB5-D209813E563B|1|||||FACT-HEP V4|||SQU/ML|||ML/MIN|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|Y|1||38||OBSERVATION|1970-10-14||||1968-01-16||1969-10-30|1965-10-09|
TRIAL STUDY 134XCP|QS|147C2E77-A2C5-4219-9BB5-D209813E563B|2|||||NCCN-FACT FHNSI-22 V2|||KAT|||L/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|N|2||58||FOLLOW-UP|1968-11-18||||1964-09-29||1961-10-14|1971-08-20|
TRIAL STUDY 134XCP|QS|147C2E77-A2C5-4219-9BB5-D209813E563B|3|||||PCL-5|||ROENTGEN|||/WK|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|Y|3||39||BLINDED TREATMENT|1963-02-26||||1971-02-17||1961-03-07|1973-02-16|
TRIAL STUDY 134XCP|QS|147C2E77-A2C5-4219-9BB5-D209813E563B|4|||||SF36 V2.0 STANDARD|||DRUM|||MBQ|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|N|4||88||FOLLOW-UP|1962-10-16||||1970-12-10||1960-10-18|1961-04-14|
TRIAL STUDY 134XCP|QS|147C2E77-A2C5-4219-9BB5-D209813E563B|5|||||Q-LES-Q-SF|||CM H2O|||CD/M2|NOT DONE||LIKERT SCALE 3-POINT|N|NA|Y|5||7||BASELINE|1969-10-09||||1964-12-17||1971-07-04|1972-01-09|
TRIAL STUDY 134XCP|QS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||/CMH2O|||10^9 CFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|1||38||WASHOUT|1963-12-29||||1971-04-12||1969-10-23|1965-06-13|
TRIAL STUDY 134XCP|QS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2|||||COPD ASSESSMENT TEST|||PFU/ML|||UG/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|2||58||BLINDED TREATMENT|1968-09-17||||1970-05-14||1962-02-18|1965-01-14|
TRIAL STUDY 134XCP|QS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||10^3/L|||H/WK|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|NA|3||39||OPEN LABEL TREATMENT|1964-09-27||||1965-02-15||1961-09-05|1967-11-01|
TRIAL STUDY 134XCP|QS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|4|||||GMSS VERSION TYPE 1 DIABETES|||%|||STEPS/MIN|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|4||88||TREATMENT|1962-10-01||||1972-11-21||1961-04-11|1968-09-08|
TRIAL STUDY 134XCP|QS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|5|||||C-SSRS BASELINE/SCREENING VERSION|||IU/MG|||/CMH2O|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|5||7||OPEN LABEL TREATMENT|1964-02-17||||1971-03-10||1968-09-06|1971-04-08|
TRIAL STUDY 134XCP|QS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||PMOL/DL|||LINEAR FT*LB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|NA|1||38||WASHOUT|1964-07-12||||1963-05-22||1962-03-30|1968-05-25|
TRIAL STUDY 134XCP|QS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||MJOULE/CM2|||/MM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|NA|2||58||BLINDED TREATMENT|1966-12-18||||1960-12-21||1971-04-29|1970-04-09|
TRIAL STUDY 134XCP|QS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|3|||||SF36 V2.0 STANDARD|||G/KG|||NMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|3||39||BLINDED TREATMENT|1973-03-12||||1970-01-05||1961-10-26|1971-03-25|
TRIAL STUDY 134XCP|QS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|4|||||PODCI - PEDIATRIC PARENT REPORTED|||PA|||GY/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|4||88||TREATMENT|1964-09-12||||1969-12-31||1968-05-05|1972-07-07|
TRIAL STUDY 134XCP|QS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|5|||||PHQ-9|||DB|||MG/L FEU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|5||7||OBSERVATION|1966-08-07||||1972-06-10||1973-08-13|1967-01-16|
TRIAL STUDY 134XCP|QS|25E17A89-8A2F-4870-B076-1D32634F5620|1|||||CDLQ|||10^9 ORGANISMS/MG|||SV|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|1||38||CONTINUATION TREATMENT|1966-01-04||||1966-12-10||1971-12-18|1960-07-14|
TRIAL STUDY 134XCP|QS|25E17A89-8A2F-4870-B076-1D32634F5620|2|||||YMRS|||/100 HPFS|||NMOL/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|2||58||OPEN LABEL TREATMENT|1963-07-17||||1966-08-14||1961-01-20|1970-05-08|
TRIAL STUDY 134XCP|QS|25E17A89-8A2F-4870-B076-1D32634F5620|3|||||CDR|||PNU/ML|||MG/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|3||39||WASHOUT|1965-10-15||||1961-06-16||1962-07-31|1970-11-15|
TRIAL STUDY 134XCP|QS|25E17A89-8A2F-4870-B076-1D32634F5620|4|||||GDS SHORT FORM|||L/S|||/5X10^4 WBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|Y|4||88||INDUCTION TREATMENT|1961-04-15||||1973-04-29||1971-08-24|1970-01-13|
TRIAL STUDY 134XCP|QS|25E17A89-8A2F-4870-B076-1D32634F5620|5|||||IDS-SR|||DEG/MM|||10^6 ORGANISMS/ML|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1970-08-28||||1967-11-19||1964-02-23|1963-06-02|
TRIAL STUDY 134XCP|QS|B7B67C06-0802-4E69-A5A1-469213BE7E48|1|||||SOBDA|||H*%|||BISCUIT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|1||38||CONTINUATION TREATMENT|1968-10-16||||1964-12-25||1962-02-04|1962-09-11|
TRIAL STUDY 134XCP|QS|B7B67C06-0802-4E69-A5A1-469213BE7E48|2|||||CDR|||ML*CMH2O|||G/ANIMAL/WK|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|2||58||WASHOUT|1971-06-29||||1969-04-11||1969-09-18|1963-06-11|
TRIAL STUDY 134XCP|QS|B7B67C06-0802-4E69-A5A1-469213BE7E48|3|||||PEDS-FACIT-F|||GPL U/ML|||RPM|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||BASELINE|1962-06-25||||1963-10-10||1962-12-13|1972-06-16|
TRIAL STUDY 134XCP|QS|B7B67C06-0802-4E69-A5A1-469213BE7E48|4|||||LEC-5 STANDARD VERSION|||PRESSOR UNITS|||ELISA UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|4||88||BLINDED TREATMENT|1960-09-29||||1971-12-19||1964-07-15|1961-01-31|
TRIAL STUDY 134XCP|QS|B7B67C06-0802-4E69-A5A1-469213BE7E48|5|||||IIEF|||/MONTH|||UG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|5||7||OBSERVATION|1965-03-14||||1971-12-16||1971-06-29|1964-08-30|
TRIAL STUDY 134XCP|QS|626E3EA7-423B-434F-89E4-CA076A39B8DB|1|||||FOSI|||MG/KG/DAY|||MBQ|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|1||38||CONTINUATION TREATMENT|1968-06-21||||1973-02-11||1972-04-03|1968-06-24|
TRIAL STUDY 134XCP|QS|626E3EA7-423B-434F-89E4-CA076A39B8DB|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||CG|||BP|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|2||58||WASHOUT|1972-02-28||||1969-06-25||1961-05-25|1965-11-25|
TRIAL STUDY 134XCP|QS|626E3EA7-423B-434F-89E4-CA076A39B8DB|3|||||SF8 V1.0 ACUTE|||MEQ/MMOL|||MJOULE/CM2|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|3||39||SCREENING|1970-08-02||||1966-02-15||1971-06-28|1969-11-14|
TRIAL STUDY 134XCP|QS|626E3EA7-423B-434F-89E4-CA076A39B8DB|4|||||CHART-SF INTERVIEW VERSION|||LOG10 TCID 50/UL|||CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|Y|4||88||RUN-IN|1962-09-22||||1970-07-04||1964-09-27|1966-04-17|
TRIAL STUDY 134XCP|QS|626E3EA7-423B-434F-89E4-CA076A39B8DB|5|||||FIQR|||LB|||PIXELS/CM|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|N|5||7||FOLLOW-UP|1968-01-11||||1972-11-10||1966-02-23|1960-02-12|
TRIAL STUDY 134XCP|QS|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1|||||BORG CR10|||PIXEL|||ML/CM3/MIN|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|1||38||OBSERVATION|1963-04-28||||1962-03-21||1970-08-26|1962-11-27|
TRIAL STUDY 134XCP|QS|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2|||||PHQ SCREENER VERSION|||MMOL|||/500 WBC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|U|2||58||TREATMENT|1970-06-25||||1963-07-02||1969-02-15|1965-07-02|
TRIAL STUDY 134XCP|QS|98ED3A38-1E74-470E-BF45-0D1E905BEF36|3|||||PHQ-2|||TROCHE|||GY/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|3||39||LONG-TERM FOLLOW-UP|1968-01-19||||1961-11-11||1968-07-14|1972-08-24|
TRIAL STUDY 134XCP|QS|98ED3A38-1E74-470E-BF45-0D1E905BEF36|4|||||LEC-5 STANDARD VERSION|||CS|||MMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|N|4||88||RUN-IN|1970-07-07||||1968-06-26||1967-07-02|1968-12-26|
TRIAL STUDY 134XCP|QS|98ED3A38-1E74-470E-BF45-0D1E905BEF36|5|||||SMDDS V1.0|||L/MIN|||GENEQ/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|5||7||BASELINE|1963-12-25||||1967-08-20||1960-11-08|1967-12-27|
TRIAL STUDY 134XCP|QS|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1|||||FACT-G V4|||LOG10 COPIES/ML|||MOL/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|1||38||CONTINUATION TREATMENT|1964-10-15||||1966-11-02||1971-07-02|1960-04-23|
TRIAL STUDY 134XCP|QS|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2|||||SF12 V2.0 ACUTE|||BP|||MEQ/UG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|N|2||58||FOLLOW-UP|1969-02-22||||1972-10-26||1971-08-14|1962-07-28|
TRIAL STUDY 134XCP|QS|99DF7819-987E-4E55-89FD-FF49E7C02A5A|3|||||BEBQ RETROSPECTIVE|||10^3/L|||MG/M2/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|N|3||39||BLINDED TREATMENT|1972-12-19||||1972-06-05||1963-07-28|1963-08-12|
TRIAL STUDY 134XCP|QS|99DF7819-987E-4E55-89FD-FF49E7C02A5A|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||ML/CM|||DRINK|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|4||88||OBSERVATION|1972-10-20||||1965-12-12||1967-12-25|1966-08-14|
TRIAL STUDY 134XCP|QS|99DF7819-987E-4E55-89FD-FF49E7C02A5A|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||LOG10 ELISA UNIT|||CMH2O*S/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|NA|5||7||SCREENING|1964-08-27||||1971-02-21||1970-03-17|1962-02-09|
TRIAL STUDY 134XCP|QS|05481BE7-9309-4356-B46E-9C2525D2C54E|1|||||SOBDA|||UKAT/10^12 RBC|||TESLA|NOT DONE||LIKERT SCALE 7-POINT|Y|U|Y|1||38||FOLLOW-UP|1966-07-13||||1965-12-29||1967-12-23|1966-11-27|
TRIAL STUDY 134XCP|QS|05481BE7-9309-4356-B46E-9C2525D2C54E|2|||||WOMAC VA 3.1 INDEX|||UOSM|||UV|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|2||58||INDUCTION TREATMENT|1972-09-23||||1968-08-04||1965-06-07|1962-09-14|
TRIAL STUDY 134XCP|QS|05481BE7-9309-4356-B46E-9C2525D2C54E|3|||||SF8 V1.0 STANDARD|||MG/KG/MIN|||10^3 CFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|3||39||RUN-IN|1969-02-28||||1965-02-01||1963-02-13|1972-12-05|
TRIAL STUDY 134XCP|QS|05481BE7-9309-4356-B46E-9C2525D2C54E|4|||||PDQUALIF|||UMOL/L/H|||DPM/100MG|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|NA|4||88||INDUCTION TREATMENT|1964-09-02||||1960-11-12||1968-11-07|1970-06-03|
TRIAL STUDY 134XCP|QS|05481BE7-9309-4356-B46E-9C2525D2C54E|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||EID 50/DOSE|||10^9 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|5||7||WASHOUT|1969-11-07||||1966-12-03||1966-10-27|1962-05-11|
TRIAL STUDY 134XCP|QS|2F49D512-0A23-4D2D-959B-A1756991E817|1|||||FIQR|||MEQ/DAY|||G/M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|1||38||INDUCTION TREATMENT|1972-06-23||||1973-01-25||1963-01-08|1968-02-22|
TRIAL STUDY 134XCP|QS|2F49D512-0A23-4D2D-959B-A1756991E817|2|||||AQLQ|||MCI|||UMOL/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|2||58||LONG-TERM FOLLOW-UP|1963-03-27||||1972-10-18||1961-01-28|1968-11-04|
TRIAL STUDY 134XCP|QS|2F49D512-0A23-4D2D-959B-A1756991E817|3|||||FAMS|||ML/MMHG|||GRAVITATIONAL UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|Y|3||39||BLINDED TREATMENT|1964-05-26||||1964-12-31||1960-11-02|1962-11-01|
TRIAL STUDY 134XCP|QS|2F49D512-0A23-4D2D-959B-A1756991E817|4|||||EORTC QLQ-C30 V3.0|||MU|||S^-1(%O2)^-1|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|U|4||88||TREATMENT|1964-09-10||||1960-03-07||1970-07-13|1968-11-01|
TRIAL STUDY 134XCP|QS|2F49D512-0A23-4D2D-959B-A1756991E817|5|||||PROSQOLI|||KCAL|||UM2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|5||7||OBSERVATION|1968-07-28||||1965-11-02||1971-01-30|1962-09-25|
TRIAL STUDY 134XCP|QS|E884C56C-1612-49CC-A594-B65E7B354842|1|||||PCL-5|||MG/M2|||UL|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|1||38||OBSERVATION|1960-08-13||||1972-12-06||1960-01-31|1971-01-04|
TRIAL STUDY 134XCP|QS|E884C56C-1612-49CC-A594-B65E7B354842|2|||||TSCC|||MEQ/UL|||10^6/G|NOT DONE||LIKERT SCALE 3-POINT|NA|N|U|2||58||SCREENING|1971-12-18||||1972-07-09||1964-02-15|1971-07-02|
TRIAL STUDY 134XCP|QS|E884C56C-1612-49CC-A594-B65E7B354842|3|||||FACT-C V4|||NG/MOL|||OZ|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|3||39||CONTINUATION TREATMENT|1964-04-16||||1965-02-19||1969-05-19|1967-05-20|
TRIAL STUDY 134XCP|QS|E884C56C-1612-49CC-A594-B65E7B354842|4|||||BSI-18|||CD*S/M2|||AFU|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|NA|4||88||RUN-IN|1966-09-15||||1966-08-25||1961-11-19|1973-05-05|
TRIAL STUDY 134XCP|QS|E884C56C-1612-49CC-A594-B65E7B354842|5|||||MNSI|||G/CM2|||GMFI|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|Y|5||7||WASHOUT|1970-05-29||||1971-02-11||1966-05-04|1968-11-20|
TRIAL STUDY 134XCP|QS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1|||||MFIS|||APL U/ML|||LOG10 PFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|1||38||LONG-TERM FOLLOW-UP|1961-09-05||||1965-12-26||1960-05-10|1962-09-30|
TRIAL STUDY 134XCP|QS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2|||||FACT-TAXANE V4|||IU/MMOL|||MG/MIN|NOT DONE||LIKERT SCALE 7-POINT|U|U|U|2||58||RUN-IN|1961-08-06||||1973-04-02||1968-02-15|1969-10-10|
TRIAL STUDY 134XCP|QS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|3|||||WHODAS 2.0 - 12-ITEM SELF|||PG/L|||/MONTH|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|NA|3||39||OBSERVATION|1963-09-22||||1972-11-04||1961-11-03|1972-08-23|
TRIAL STUDY 134XCP|QS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|4|||||RAND-36 V1.0|||ML/DAY|||FL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|4||88||INDUCTION TREATMENT|1963-06-13||||1969-09-20||1963-10-24|1969-06-29|
TRIAL STUDY 134XCP|QS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|5|||||FACT-C V4|||%|||VP/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|5||7||BASELINE|1962-03-05||||1963-12-20||1965-03-12|1968-02-26|
TRIAL STUDY 134XCP|QS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1|||||BPI SHORT FORM|||EP U|||U/G HB|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|1||38||OBSERVATION|1966-07-22||||1963-06-01||1960-10-29|1961-04-25|
TRIAL STUDY 134XCP|QS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2|||||IBDQ|||%/S|||DRINK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|2||58||INDUCTION TREATMENT|1968-03-02||||1971-03-21||1960-11-25|1960-07-27|
TRIAL STUDY 134XCP|QS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|3|||||TSCC|||FT|||KG/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|Y|3||39||TREATMENT|1961-07-05||||1966-02-26||1969-04-19|1962-11-06|
TRIAL STUDY 134XCP|QS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|4|||||PHQ SCREENER VERSION|||ANTIBODY UNIT|||MET*MIN|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|4||88||OBSERVATION|1968-05-26||||1969-11-28||1971-02-25|1968-04-20|
TRIAL STUDY 134XCP|QS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|5|||||HAQ-DI WITH VAS|||NM|||10^6 IU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|5||7||CONTINUATION TREATMENT|1967-11-04||||1970-09-30||1968-08-21|1963-04-16|
TRIAL STUDY 134XCP|QS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1|||||WHODAS 2.0 - 12-ITEM PROXY|||SBE/ML|||10^7 CFU/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|1||38||OPEN LABEL TREATMENT|1965-02-02||||1965-06-23||1968-03-21|1961-07-09|
TRIAL STUDY 134XCP|QS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2|||||SF8 V1.0 STANDARD|||BQ/UG|||MOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|2||58||BASELINE|1968-11-14||||1963-04-29||1962-10-25|1961-11-10|
TRIAL STUDY 134XCP|QS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|3|||||SF36 V2.0 STANDARD|||PKAT|||KPA/L/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|3||39||INDUCTION TREATMENT|1966-10-18||||1972-05-08||1961-02-11|1964-12-25|
TRIAL STUDY 134XCP|QS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|4|||||IPAQ-SF SELF-ADMINISTERED VERSION|||MEQ/G|||L/L|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|4||88||OPEN LABEL TREATMENT|1963-12-21||||1961-06-28||1963-11-12|1966-12-06|
TRIAL STUDY 134XCP|QS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|5|||||MDS-UPDRS|||MMOL/MIN/KPA/L|||TRANSDUCING UNIT/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|5||7||SCREENING|1961-03-11||||1968-10-02||1962-11-11|1968-03-10|
TRIAL STUDY 134XCP|QS|0B140787-9458-4F66-B7E9-1FAFF239085E|1|||||NCCN-FACT FHNSI-22 V2|||GY/MIN|||BQ/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|N|1||38||INDUCTION TREATMENT|1969-07-22||||1970-05-31||1963-03-11|1965-03-10|
TRIAL STUDY 134XCP|QS|0B140787-9458-4F66-B7E9-1FAFF239085E|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||MMOL/KG|||JAR|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|Y|2||58||FOLLOW-UP|1964-07-01||||1972-07-30||1962-03-18|1967-05-24|
TRIAL STUDY 134XCP|QS|0B140787-9458-4F66-B7E9-1FAFF239085E|3|||||FLU-IIQ ONCE DAILY|||MS2|||UGEQ/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|3||39||TREATMENT|1969-06-23||||1973-04-24||1961-10-08|1972-06-21|
TRIAL STUDY 134XCP|QS|0B140787-9458-4F66-B7E9-1FAFF239085E|4|||||PDDS|||ML/G/DAY|||DRUM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|N|4||88||BLINDED TREATMENT|1971-02-22||||1965-12-31||1961-09-08|1964-02-16|
TRIAL STUDY 134XCP|QS|0B140787-9458-4F66-B7E9-1FAFF239085E|5|||||MSQOL-54|||ML/KG/H|||AG|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|5||7||BASELINE|1966-05-05||||1964-06-16||1963-06-11|1965-05-18|
TRIAL STUDY 134XCP|QS|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1|||||PODCI - PEDIATRIC PARENT REPORTED|||PIXELS/IN|||L|NOT DONE||LIKERT SCALE 7-POINT|NA|U|NA|1||38||BLINDED TREATMENT|1962-05-06||||1972-04-07||1965-12-30|1963-08-13|
TRIAL STUDY 134XCP|QS|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2|||||SF12 V1.0 ACUTE|||AMOL|||ARBITRARY U|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|U|2||58||CONTINUATION TREATMENT|1962-03-11||||1967-07-14||1971-04-05|1972-10-22|
TRIAL STUDY 134XCP|QS|FB91BADF-308B-4F6A-90D0-032E93E20C4A|3|||||MSIS-29 V2|||PIXEL|||MMAL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|3||39||BASELINE|1967-02-08||||1965-06-27||1963-04-30|1968-03-04|
TRIAL STUDY 134XCP|QS|FB91BADF-308B-4F6A-90D0-032E93E20C4A|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||APL U/ML|||MPA|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|4||88||INDUCTION TREATMENT|1973-08-22||||1965-07-31||1964-10-05|1966-09-11|
TRIAL STUDY 134XCP|QS|FB91BADF-308B-4F6A-90D0-032E93E20C4A|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||NMOL BCE/L|||ML/CM3/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|5||7||SCREENING|1960-07-22||||1972-08-23||1964-12-05|1962-04-11|
TRIAL STUDY 134XCP|QS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1|||||CES|||MG/M2/H|||FMOL/G|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|U|1||38||INDUCTION TREATMENT|1970-07-12||||1969-07-03||1968-10-13|1963-05-25|
TRIAL STUDY 134XCP|QS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||U/ML|||PT_US|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|2||58||BASELINE|1970-12-15||||1972-04-27||1966-12-17|1973-04-20|
TRIAL STUDY 134XCP|QS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|3|||||ESS|||CI/L|||BREATHS/MIN|NOT DONE||LIKERT SCALE 7-POINT|N|U|NA|3||39||FOLLOW-UP|1972-07-13||||1960-03-02||1966-01-14|1964-04-06|
TRIAL STUDY 134XCP|QS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|4|||||PDDS|||TSP|||1/(S*KPA)|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|4||88||OPEN LABEL TREATMENT|1965-04-11||||1969-02-10||1968-12-23|1968-11-28|
TRIAL STUDY 134XCP|QS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|5|||||PARTNER-DDS|||UIU/DL|||10^3/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|5||7||BLINDED TREATMENT|1964-05-05||||1962-02-25||1965-04-08|1961-01-13|
TRIAL STUDY 134XCP|QS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1|||||IPAQ-SF SELF-ADMINISTERED VERSION|||KUSP|||IU/KG|NOT DONE||LIKERT SCALE 7-POINT|N|N|U|1||38||BLINDED TREATMENT|1968-04-17||||1962-02-15||1965-04-03|1966-07-31|
TRIAL STUDY 134XCP|QS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2|||||SF10 V1.0 CHILDREN ACUTE|||GMFI|||UM|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|2||58||FOLLOW-UP|1971-09-22||||1969-10-28||1970-08-24|1960-10-04|
TRIAL STUDY 134XCP|QS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|3|||||GDS SHORT FORM|||MOL/MOL|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|3||39||CONTINUATION TREATMENT|1964-08-30||||1962-06-12||1963-10-13|1968-05-12|
TRIAL STUDY 134XCP|QS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|4|||||FKSI-15|||IU/ML|||NEEDLE GAUGE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|4||88||SCREENING|1970-05-02||||1963-07-01||1973-01-13|1964-09-20|
TRIAL STUDY 134XCP|QS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||ELISA UNIT/DOSE|||CIGAR|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|5||7||BLINDED TREATMENT|1963-06-23||||1964-07-05||1971-03-23|1971-07-28|
TRIAL STUDY 134XCP|QS|3B583022-3A2C-4387-80A5-035E3FD111BD|1|||||ADAS-COG|||MMU/ML|||CM|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|1||38||TREATMENT|1965-02-24||||1971-03-11||1971-02-07|1966-10-31|
TRIAL STUDY 134XCP|QS|3B583022-3A2C-4387-80A5-035E3FD111BD|2|||||BIS-11|||MMOL/MOL|||BLOCKS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|Y|2||58||LONG-TERM FOLLOW-UP|1960-11-10||||1973-01-10||1971-06-04|1963-06-01|
TRIAL STUDY 134XCP|QS|3B583022-3A2C-4387-80A5-035E3FD111BD|3|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||G/KG|||LOG10 PFU/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|3||39||SCREENING|1964-07-05||||1969-03-16||1969-11-12|1972-04-20|
TRIAL STUDY 134XCP|QS|3B583022-3A2C-4387-80A5-035E3FD111BD|4|||||SF10 V1.0 CHILDREN ACUTE|||UG/M2/MIN|||PMOL/10^9 CELLS|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|Y|4||88||OBSERVATION|1967-10-31||||1964-10-31||1970-09-24|1973-04-24|
TRIAL STUDY 134XCP|QS|3B583022-3A2C-4387-80A5-035E3FD111BD|5|||||SOAPP-R|||KG/M2|||MPA|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|5||7||INDUCTION TREATMENT|1960-10-01||||1971-07-11||1973-05-01|1962-09-22|
TRIAL STUDY 134XCP|QS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||MIN*MG/ML|||MG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|1||38||CONTINUATION TREATMENT|1966-01-27||||1968-01-31||1963-08-24|1970-07-07|
TRIAL STUDY 134XCP|QS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2|||||C-SSRS CHILDREN'S BASELINE|||MG/H|||ML/G/MIN|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|N|2||58||FOLLOW-UP|1969-08-27||||1962-06-20||1965-02-28|1963-06-27|
TRIAL STUDY 134XCP|QS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|3|||||IIEF|||MG/H|||CI/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|Y|3||39||RUN-IN|1960-02-22||||1969-05-06||1966-12-19|1964-07-26|
TRIAL STUDY 134XCP|QS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|4|||||PCL-5|||ELISA UNIT/ML|||KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|4||88||WASHOUT|1961-02-24||||1973-05-10||1972-03-20|1971-11-05|
TRIAL STUDY 134XCP|QS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|5|||||FIQR|||/100 HPFS|||GENEQ/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|5||7||OBSERVATION|1965-02-13||||1964-12-25||1971-07-18|1964-04-17|
TRIAL STUDY 134XCP|QS|B5370AC4-3185-48DC-B1BC-A00AE8496783|1|||||FPSR|||BEATS/MIN|||ML/S/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|U|1||38||OBSERVATION|1965-12-04||||1963-11-18||1962-02-10|1971-09-07|
TRIAL STUDY 134XCP|QS|B5370AC4-3185-48DC-B1BC-A00AE8496783|2|||||COWS|||DRAM|||10^5/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|2||58||FOLLOW-UP|1963-08-26||||1967-03-27||1960-11-26|1962-12-04|
TRIAL STUDY 134XCP|QS|B5370AC4-3185-48DC-B1BC-A00AE8496783|3|||||FKSI-DRS V4|||PACKAGE|||UEQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|N|3||39||OBSERVATION|1962-08-04||||1969-11-27||1960-06-04|1965-08-04|
TRIAL STUDY 134XCP|QS|B5370AC4-3185-48DC-B1BC-A00AE8496783|4|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||UOSM|||MG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|Y|4||88||INDUCTION TREATMENT|1972-10-21||||1969-10-14||1966-08-03|1969-04-18|
TRIAL STUDY 134XCP|QS|B5370AC4-3185-48DC-B1BC-A00AE8496783|5|||||HAQ-DI WITH VAS|||NMOL BCE/MMOL|||NMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|5||7||INDUCTION TREATMENT|1968-10-04||||1966-01-15||1964-01-11|1966-07-05|
TRIAL STUDY 134XCP|QS|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||U/10^12 RBC|||10^6/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|1||38||CONTINUATION TREATMENT|1966-02-13||||1961-07-12||1969-10-09|1971-10-04|
TRIAL STUDY 134XCP|QS|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2|||||FACIT-FATIGUE 13-ITEM V4|||ML/MIN|||MHZ|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|2||58||WASHOUT|1971-04-14||||1972-09-26||1968-10-30|1961-06-10|
TRIAL STUDY 134XCP|QS|1112A903-1F2A-4583-BB9A-41DD206D5B4A|3|||||FACIT-F V4|||NG/DL|||KM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|N|3||39||OBSERVATION|1969-11-09||||1964-05-29||1962-04-09|1970-03-17|
TRIAL STUDY 134XCP|QS|1112A903-1F2A-4583-BB9A-41DD206D5B4A|4|||||IBDQ|||GY|||KEV|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|4||88||FOLLOW-UP|1971-05-04||||1962-04-21||1964-09-05|1962-10-17|
TRIAL STUDY 134XCP|QS|1112A903-1F2A-4583-BB9A-41DD206D5B4A|5|||||SF12 V2.0 ACUTE|||MEQ/UL|||KS|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|5||7||INDUCTION TREATMENT|1964-04-06||||1971-07-05||1960-01-28|1969-10-17|
TRIAL STUDY 134XCP|QS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1|||||FACT-P V4|||BQ/ML|||MEQ/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|1||38||LONG-TERM FOLLOW-UP|1972-06-01||||1961-11-06||1964-03-23|1960-03-14|
TRIAL STUDY 134XCP|QS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2|||||WPAI-SHP V2.0|||DEG|||UG/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|2||58||SCREENING|1968-08-11||||1969-11-03||1968-12-02|1963-10-28|
TRIAL STUDY 134XCP|QS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|3|||||CCQ 1 WEEK VERSION|||ML/CAGE|||MG2/DL2|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||FOLLOW-UP|1961-08-10||||1965-12-15||1965-08-04|1972-04-13|
TRIAL STUDY 134XCP|QS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|4|||||IDS-SR|||WAFER|||OI50|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|Y|4||88||OBSERVATION|1970-02-17||||1970-12-22||1961-11-14|1969-11-04|
TRIAL STUDY 134XCP|QS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|5|||||BLCS|||%/MIN|||U/KG/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|5||7||LONG-TERM FOLLOW-UP|1960-01-15||||1972-07-19||1972-04-14|1966-02-21|
TRIAL STUDY 134XCP|QS|D09F047E-E380-453B-875D-FF3C8C5EA839|1|||||FLSI|||DPM|||M|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|NA|1||38||FOLLOW-UP|1972-08-17||||1972-12-11||1968-09-23|1968-11-06|
TRIAL STUDY 134XCP|QS|D09F047E-E380-453B-875D-FF3C8C5EA839|2|||||DAD|||BOTTLE|||G/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|U|2||58||WASHOUT|1965-11-07||||1971-04-19||1968-06-03|1972-06-24|
TRIAL STUDY 134XCP|QS|D09F047E-E380-453B-875D-FF3C8C5EA839|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||SQU/ML|||GPL U/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|NA|3||39||BASELINE|1963-01-06||||1961-03-20||1965-11-30|1964-10-18|
TRIAL STUDY 134XCP|QS|D09F047E-E380-453B-875D-FF3C8C5EA839|4|||||ADHD-RS-IV HOME VERSION|||/40 HPFS|||KG/M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|4||88||SCREENING|1973-01-12||||1962-06-26||1968-07-06|1973-01-21|
TRIAL STUDY 134XCP|QS|D09F047E-E380-453B-875D-FF3C8C5EA839|5|||||ACT|||CI|||10^12/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|U|5||7||WASHOUT|1963-07-25||||1973-02-08||1970-09-21|1965-08-01|
TRIAL STUDY 134XCP|QS|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1|||||WPAI-SHP V2.0|||MPL U/ML|||/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|NA|1||38||BLINDED TREATMENT|1966-11-26||||1967-07-09||1965-02-28|1960-05-21|
TRIAL STUDY 134XCP|QS|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2|||||BLCS|||MM/MIN|||CMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|2||58||TREATMENT|1972-05-05||||1964-03-12||1964-11-06|1961-07-23|
TRIAL STUDY 134XCP|QS|E1B16559-B9CA-4B14-A77A-4AD546EF5262|3|||||MADRS|||10^4 CFU/ML|||G/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|3||39||CONTINUATION TREATMENT|1967-08-17||||1962-06-23||1970-02-12|1961-08-10|
TRIAL STUDY 134XCP|QS|E1B16559-B9CA-4B14-A77A-4AD546EF5262|4|||||MRS|||MG/KG/H|||KG/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|U|4||88||BLINDED TREATMENT|1965-07-15||||1970-01-06||1972-11-11|1968-07-11|
TRIAL STUDY 134XCP|QS|E1B16559-B9CA-4B14-A77A-4AD546EF5262|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||FOZ_BR|||/2500 WBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|5||7||BLINDED TREATMENT|1963-03-07||||1962-12-13||1971-12-01|1968-10-06|
TRIAL STUDY 134XCP|QS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1|||||EXACT|||PHERESIS UNIT|||1/(S*KPA)|NOT DONE||LIKERT SCALE 3-POINT|NA|U|N|1||38||INDUCTION TREATMENT|1963-03-14||||1971-12-24||1961-07-04|1972-01-10|
TRIAL STUDY 134XCP|QS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2|||||MPAI-4|||LOG10 PFU/ML|||FINGERTIP UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|2||58||BLINDED TREATMENT|1966-04-28||||1967-03-25||1971-03-27|1966-05-07|
TRIAL STUDY 134XCP|QS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|3|||||BORG CR10|||KBQ/UL|||WEBER|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|3||39||BLINDED TREATMENT|1965-11-20||||1964-01-26||1962-10-17|1961-10-21|
TRIAL STUDY 134XCP|QS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|4|||||FLU-IIQ TWICE DAILY|||UMOL/L/SEC|||10^12 IU/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|NA|4||88||INDUCTION TREATMENT|1973-07-26||||1964-07-13||1967-10-07|1973-06-13|
TRIAL STUDY 134XCP|QS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||FIU|||KM/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|U|5||7||BASELINE|1965-03-22||||1960-07-08||1961-06-25|1965-09-07|
TRIAL STUDY 134XCP|QS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1|||||FLU-IIQ TWICE DAILY|||MMOL/S|||EP U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|1||38||RUN-IN|1972-12-29||||1962-11-13||1961-08-09|1960-02-06|
TRIAL STUDY 134XCP|QS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2|||||GCGI|||NMOL|||CM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|N|2||58||TREATMENT|1960-10-08||||1968-03-13||1972-09-17|1972-01-30|
TRIAL STUDY 134XCP|QS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|3|||||MHIS-NACC|||DAYS/WK|||UG/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|3||39||LONG-TERM FOLLOW-UP|1964-01-25||||1963-07-19||1960-03-31|1964-01-28|
TRIAL STUDY 134XCP|QS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|4|||||GAD-7 V2|||UG/M2|||POUCH|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|4||88||CONTINUATION TREATMENT|1960-08-23||||1972-05-05||1969-01-05|1960-02-25|
TRIAL STUDY 134XCP|QS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|5|||||SF12 V2.0 ACUTE|||TAMPON|||UOSM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|5||7||BLINDED TREATMENT|1962-07-13||||1969-07-18||1965-05-15|1967-07-17|
TRIAL STUDY 134XCP|QS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1|||||RPQ|||PMOL/G|||/VF|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|NA|1||38||WASHOUT|1964-04-30||||1960-06-24||1963-01-26|1969-11-04|
TRIAL STUDY 134XCP|QS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2|||||COMM|||MV*MIN|||JDF UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|NA|2||58||INDUCTION TREATMENT|1963-04-11||||1961-09-17||1960-12-07|1960-08-30|
TRIAL STUDY 134XCP|QS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|3|||||WLQ|||KCAL/DAY|||MG/KG/MIN|NOT DONE||LIKERT SCALE 5-POINT|NA|N|N|3||39||BLINDED TREATMENT|1967-09-24||||1964-12-30||1964-04-07|1971-05-27|
TRIAL STUDY 134XCP|QS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|4|||||TSCC|||10^6/L|||KDA|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|4||88||BASELINE|1962-01-13||||1968-01-20||1966-03-29|1961-11-07|
TRIAL STUDY 134XCP|QS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|5|||||FACT-G V4|||IU/MG|||SPRAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|5||7||INDUCTION TREATMENT|1972-03-02||||1969-10-20||1964-03-07|1964-02-01|
TRIAL STUDY 134XCP|QS|44199000-F1B7-4187-9E5A-AA5F69E831C3|1|||||PDQUALIF|||ROENTGEN|||KM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|NA|1||38||SCREENING|1963-08-10||||1960-04-11||1969-07-07|1972-08-23|
TRIAL STUDY 134XCP|QS|44199000-F1B7-4187-9E5A-AA5F69E831C3|2|||||GDS SHORT FORM|||BOLUS|||DEG/S|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|2||58||BLINDED TREATMENT|1966-12-18||||1967-07-19||1972-04-23|1972-09-06|
TRIAL STUDY 134XCP|QS|44199000-F1B7-4187-9E5A-AA5F69E831C3|3|||||WPAI-GH V2.0|||10^7 CFU|||MJOULE/CM2|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|N|3||39||RUN-IN|1960-11-27||||1966-02-01||1971-11-11|1961-11-07|
TRIAL STUDY 134XCP|QS|44199000-F1B7-4187-9E5A-AA5F69E831C3|4|||||FACT-L V4|||PMOL/L/H|||U/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|4||88||FOLLOW-UP|1962-04-12||||1973-04-19||1973-01-04|1960-07-17|
TRIAL STUDY 134XCP|QS|44199000-F1B7-4187-9E5A-AA5F69E831C3|5|||||RDQ|||CM|||HZ/S|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|5||7||OPEN LABEL TREATMENT|1969-08-18||||1960-12-06||1967-11-28|1961-04-23|
TRIAL STUDY 134XCP|QS|1D487F49-92DB-4132-BD95-1B8797594DE7|1|||||WHODAS 2.0 - 12-ITEM PROXY|||BOWL|||BQ/MG|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|1||38||TREATMENT|1964-11-21||||1963-10-24||1963-11-10|1973-05-23|
TRIAL STUDY 134XCP|QS|1D487F49-92DB-4132-BD95-1B8797594DE7|2|||||BORG CR10|||MMOL/MIN/KPA|||GY|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|2||58||SCREENING|1961-02-08||||1962-08-10||1968-02-23|1973-04-26|
TRIAL STUDY 134XCP|QS|1D487F49-92DB-4132-BD95-1B8797594DE7|3|||||SHORT-FORM MPQ-2|||FG|||FT3|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|N|3||39||RUN-IN|1963-09-19||||1966-11-02||1965-09-22|1969-08-10|
TRIAL STUDY 134XCP|QS|1D487F49-92DB-4132-BD95-1B8797594DE7|4|||||HCS|||NSEC|||10^6/HPF|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|4||88||RUN-IN|1966-09-20||||1966-07-25||1972-11-15|1967-05-29|
TRIAL STUDY 134XCP|QS|1D487F49-92DB-4132-BD95-1B8797594DE7|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||%|||SUPPOSITORY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|Y|5||7||BLINDED TREATMENT|1972-08-17||||1965-05-26||1969-11-27|1971-12-17|
TRIAL STUDY 134XCP|QS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1|||||ADCS-ADL|||LOG10 TCID 50/UL|||V/V|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|1||38||LONG-TERM FOLLOW-UP|1966-10-21||||1963-03-10||1971-10-05|1961-08-05|
TRIAL STUDY 134XCP|QS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2|||||ADCS-ADL|||CP|||PNU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|2||58||LONG-TERM FOLLOW-UP|1969-09-27||||1961-05-31||1965-06-24|1967-04-26|
TRIAL STUDY 134XCP|QS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|3|||||SF10 V1.0 CHILDREN ACUTE|||MKAT|||ML/CM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|U|3||39||SCREENING|1961-10-26||||1967-03-16||1963-10-08|1967-07-25|
TRIAL STUDY 134XCP|QS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|4|||||TSCYC|||10^3/L|||DIP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|NA|4||88||WASHOUT|1967-04-02||||1970-07-15||1971-11-18|1970-09-13|
TRIAL STUDY 134XCP|QS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|5|||||WOMAC VA 3.1 INDEX|||EJACULATE U|||UG/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|Y|Y|5||7||BASELINE|1961-10-05||||1961-03-13||1967-06-22|1964-10-01|
TRIAL STUDY 134XCP|QS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1|||||FACT/GOG-NTX V4|||GBQ/G|||GY/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|NA|1||38||INDUCTION TREATMENT|1963-12-14||||1969-07-29||1966-11-04|1971-08-10|
TRIAL STUDY 134XCP|QS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2|||||FACT-BRM V4|||MEQ|||10^3 ORGANISMS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|N|2||58||SCREENING|1969-09-25||||1973-06-06||1970-04-28|1966-08-17|
TRIAL STUDY 134XCP|QS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|3|||||VFQ-25 INTERVIEWER ADMINISTERED|||NMOL/ML/MIN|||ROENTGEN|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|Y|3||39||BASELINE|1971-02-19||||1963-07-21||1964-11-14|1972-12-30|
TRIAL STUDY 134XCP|QS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|4|||||WOMAC NRS 3.1 INDEX|||NG|||DB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|4||88||RUN-IN|1968-03-25||||1969-03-24||1965-03-10|1965-01-17|
TRIAL STUDY 134XCP|QS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|5|||||MPAI-4|||CCID 50/DOSE|||10^10/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|U|5||7||SCREENING|1967-05-16||||1967-04-02||1968-06-15|1963-10-04|
TRIAL STUDY 134XCP|QS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1|||||HAEM-A-QOL|||FT|||MKAT|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|1||38||INDUCTION TREATMENT|1967-09-08||||1971-11-30||1968-10-25|1969-12-13|
TRIAL STUDY 134XCP|QS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2|||||SF10 V1.0 CHILDREN STANDARD|||10^8 PFU|||LOG10 IU/ML|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|2||58||CONTINUATION TREATMENT|1966-05-06||||1973-06-23||1968-03-25|1971-04-17|
TRIAL STUDY 134XCP|QS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|3|||||EXACT|||10^3 CFU/ML|||PMOL/10^9 CELLS|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|NA|3||39||WASHOUT|1966-09-30||||1960-03-01||1973-01-02|1961-06-25|
TRIAL STUDY 134XCP|QS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||DIOPTER|||MMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|4||88||FOLLOW-UP|1968-01-02||||1971-08-06||1972-06-12|1972-04-24|
TRIAL STUDY 134XCP|QS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|5|||||PEDS-FACIT-F|||ML/KG/H|||U/10^12 RBC|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|U|5||7||WASHOUT|1961-04-25||||1962-09-12||1960-02-29|1967-07-30|
TRIAL STUDY 134XCP|QS|33233744-4E16-437D-852B-B5F2CCC94B1A|1|||||GCGI|||10^3 CFU/G|||UG|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|NA|1||38||INDUCTION TREATMENT|1962-09-06||||1964-02-04||1961-01-19|1965-05-10|
TRIAL STUDY 134XCP|QS|33233744-4E16-437D-852B-B5F2CCC94B1A|2|||||SIQ-JR|||S*KPA|||FRACTION OF 1|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|2||58||WASHOUT|1970-02-04||||1968-02-20||1963-09-05|1962-08-14|
TRIAL STUDY 134XCP|QS|33233744-4E16-437D-852B-B5F2CCC94B1A|3|||||MMRC|||MEQ/G|||GRAIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|3||39||SCREENING|1961-03-24||||1968-12-14||1964-12-02|1970-06-02|
TRIAL STUDY 134XCP|QS|33233744-4E16-437D-852B-B5F2CCC94B1A|4|||||RDQ|||UEQ/L|||COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|4||88||BASELINE|1968-04-23||||1966-10-24||1969-01-08|1960-06-12|
TRIAL STUDY 134XCP|QS|33233744-4E16-437D-852B-B5F2CCC94B1A|5|||||WPAI-GH V2.0|||MEQ/MMOL|||10^6 ORGANISMS|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|5||7||TREATMENT|1967-05-12||||1962-09-19||1972-11-19|1964-12-30|
TRIAL STUDY 134XCP|QS|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1|||||HAQ-DI WITHOUT VAS|||IU/L|||LOG10 TCID 50/UL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|N|1||38||SCREENING|1969-05-22||||1960-02-09||1961-05-26|1962-10-13|
TRIAL STUDY 134XCP|QS|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||CAN|||%|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|Y|2||58||INDUCTION TREATMENT|1967-12-23||||1963-05-03||1971-08-26|1970-05-14|
TRIAL STUDY 134XCP|QS|B27DC754-F6E2-41E3-9804-0F92AE0006B4|3|||||SGRQ PAST 4 WEEKS VERSION|||PKAT|||UL/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|3||39||SCREENING|1970-04-13||||1971-12-25||1965-03-21|1972-03-27|
TRIAL STUDY 134XCP|QS|B27DC754-F6E2-41E3-9804-0F92AE0006B4|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||GPS U|||10^9 ORGANISMS/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|4||88||TREATMENT|1967-11-12||||1960-07-24||1973-07-06|1971-12-11|
TRIAL STUDY 134XCP|QS|B27DC754-F6E2-41E3-9804-0F92AE0006B4|5|||||FKSI-15|||L|||ML/CAGE/WK|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|5||7||BASELINE|1968-07-23||||1966-06-11||1968-10-30|1964-06-03|
TRIAL STUDY 134XCP|QS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1|||||FACT-BRM V4|||POINT|||DAYS/MONTH|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|1||38||OPEN LABEL TREATMENT|1971-08-13||||1965-05-16||1964-02-04|1969-12-06|
TRIAL STUDY 134XCP|QS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||ML/S|||FT3|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|N|2||58||OPEN LABEL TREATMENT|1970-01-08||||1963-02-10||1968-09-08|1965-09-12|
TRIAL STUDY 134XCP|QS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|3|||||FACT-P V4|||G|||PIXELS/CM|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|3||39||SCREENING|1961-10-07||||1966-05-09||1967-12-08|1961-01-21|
TRIAL STUDY 134XCP|QS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|4|||||UPS|||DMOL|||FFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|NA|4||88||SCREENING|1961-01-09||||1963-05-12||1964-08-07|1973-08-20|
TRIAL STUDY 134XCP|QS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|5|||||C-SSRS LIFETIME/RECENT VERSION|||K|||BQ/KG|NOT DONE||LIKERT SCALE 3-POINT|N|N|U|5||7||BLINDED TREATMENT|1966-05-18||||1968-08-10||1962-01-03|1965-05-31|
TRIAL STUDY 134XCP|QS|BDE843D8-2F69-4542-BC47-D52302FD4898|1|||||OCI|||MMOL/DAY|||APL U|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|U|1||38||WASHOUT|1968-05-22||||1966-01-14||1971-01-04|1965-05-18|
TRIAL STUDY 134XCP|QS|BDE843D8-2F69-4542-BC47-D52302FD4898|2|||||SIQ|||MG/DAY|||CMOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|2||58||INDUCTION TREATMENT|1970-04-11||||1969-01-05||1964-07-16|1963-11-02|
TRIAL STUDY 134XCP|QS|BDE843D8-2F69-4542-BC47-D52302FD4898|3|||||FPSR|||UG/KG|||ENZYME U/G HB|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|3||39||WASHOUT|1964-11-01||||1969-02-11||1970-08-25|1961-05-21|
TRIAL STUDY 134XCP|QS|BDE843D8-2F69-4542-BC47-D52302FD4898|4|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||NKAT/G HB|||MPH|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|U|4||88||WASHOUT|1960-04-03||||1961-05-13||1973-01-22|1962-11-15|
TRIAL STUDY 134XCP|QS|BDE843D8-2F69-4542-BC47-D52302FD4898|5|||||GMSS VERSION TYPE 1 DIABETES|||KG/MOL|||HENRY|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|U|5||7||LONG-TERM FOLLOW-UP|1967-04-02||||1969-07-12||1966-03-19|1961-08-29|
TRIAL STUDY 134XCP|QS|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||10^9/DOSE|||10^11/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|1||38||SCREENING|1962-11-05||||1969-03-12||1968-09-16|1970-12-15|
TRIAL STUDY 134XCP|QS|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||NMOL|||IN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|N|2||58||OBSERVATION|1971-01-11||||1970-02-26||1962-02-24|1962-05-18|
TRIAL STUDY 134XCP|QS|A8C8CB0C-C575-414C-BF1C-846361DB03BC|3|||||ADCS-ADL MCI|||CMH2O*S2/ML|||ANSON U|NOT DONE||LIKERT SCALE 5-POINT|N|Y|N|3||39||LONG-TERM FOLLOW-UP|1965-12-15||||1972-03-15||1969-04-14|1965-05-21|
TRIAL STUDY 134XCP|QS|A8C8CB0C-C575-414C-BF1C-846361DB03BC|4|||||ADCS-ADL SEVERE DEMENTIA|||MIU/L|||G/ANIMAL/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|4||88||INDUCTION TREATMENT|1963-11-29||||1964-03-13||1960-08-02|1972-10-29|
TRIAL STUDY 134XCP|QS|A8C8CB0C-C575-414C-BF1C-846361DB03BC|5|||||T1-DDS|||UKAT/L|||ROENTGEN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|5||7||BASELINE|1967-09-21||||1961-12-31||1964-12-23|1966-07-23|
TRIAL STUDY 134XCP|QS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1|||||Q-LES-Q|||DAYS/MONTH|||NGEQ/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|Y|1||38||OBSERVATION|1964-10-14||||1970-03-16||1960-11-18|1970-06-12|
TRIAL STUDY 134XCP|QS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2|||||FACT-TAXANE V4|||MCI|||BOWL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|2||58||CONTINUATION TREATMENT|1973-03-17||||1963-12-08||1971-01-01|1968-04-10|
TRIAL STUDY 134XCP|QS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|3|||||TSCYC|||G/DAY|||UG/KG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|N|3||39||SCREENING|1971-02-20||||1967-12-04||1971-03-22|1962-09-19|
TRIAL STUDY 134XCP|QS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|4|||||PHQ-2|||MOSM/L|||MM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|4||88||INDUCTION TREATMENT|1970-12-08||||1971-03-14||1960-04-30|1960-06-10|
TRIAL STUDY 134XCP|QS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|5|||||PGI|||MOL/G|||10^7/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1966-06-20||||1962-05-03||1973-08-04|1964-11-22|
TRIAL STUDY 134XCP|QS|86198851-0F45-45E0-A0CE-C50FEC078456|1|||||SGRQ-C|||10^9/L|||ML/BREATH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|U|1||38||OPEN LABEL TREATMENT|1964-04-27||||1962-11-29||1973-03-22|1967-06-17|
TRIAL STUDY 134XCP|QS|86198851-0F45-45E0-A0CE-C50FEC078456|2|||||PDDS|||LOG10 CFU/ML|||MMOL/MIN/KPA|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|N|2||58||WASHOUT|1969-07-24||||1967-04-04||1967-12-12|1962-04-15|
TRIAL STUDY 134XCP|QS|86198851-0F45-45E0-A0CE-C50FEC078456|3|||||PHQ SCREENER VERSION|||GTT|||ML/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|NA|3||39||TREATMENT|1966-03-04||||1965-07-31||1972-08-08|1964-12-10|
TRIAL STUDY 134XCP|QS|86198851-0F45-45E0-A0CE-C50FEC078456|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||U/G HB|||MEQ/UL|NOT DONE||LIKERT SCALE 5-POINT|NA|U|Y|4||88||LONG-TERM FOLLOW-UP|1968-10-16||||1964-09-26||1968-05-22|1967-07-08|
TRIAL STUDY 134XCP|QS|86198851-0F45-45E0-A0CE-C50FEC078456|5|||||GAD-7 V2|||NG|||PHERESIS UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|5||7||LONG-TERM FOLLOW-UP|1970-06-22||||1970-11-01||1973-08-16|1964-05-05|
TRIAL STUDY 134XCP|QS|9CD28016-BED9-4159-9C1B-60821D74615B|1|||||OAB-Q|||CFU/G|||CD/M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|NA|1||38||INDUCTION TREATMENT|1965-10-28||||1967-07-27||1963-03-13|1973-03-06|
TRIAL STUDY 134XCP|QS|9CD28016-BED9-4159-9C1B-60821D74615B|2|||||Q-LES-Q|||MU|||PUFF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|2||58||BASELINE|1962-10-28||||1969-08-09||1967-09-18|1961-08-20|
TRIAL STUDY 134XCP|QS|9CD28016-BED9-4159-9C1B-60821D74615B|3|||||SWLS|||L/MIN/M2|||S*KPA|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|3||39||OBSERVATION|1960-09-07||||1972-11-16||1964-06-01|1961-09-15|
TRIAL STUDY 134XCP|QS|9CD28016-BED9-4159-9C1B-60821D74615B|4|||||SIQ-JR|||ML/DOSE|||CI/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|4||88||FOLLOW-UP|1963-07-21||||1966-11-11||1963-10-12|1963-05-12|
TRIAL STUDY 134XCP|QS|9CD28016-BED9-4159-9C1B-60821D74615B|5|||||EORTC QLQ-C30 V3.0|||USEC|||CMH2O*S2/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|5||7||SCREENING|1968-12-09||||1962-02-16||1970-02-21|1961-03-19|
TRIAL STUDY 134XCP|QS|BE578D25-C23E-416F-8A57-C901F7B58596|1|||||IPAQ-SF PHONE VERSION|||GY|||M2|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|1||38||INDUCTION TREATMENT|1971-08-02||||1962-12-06||1970-08-17|1962-06-22|
TRIAL STUDY 134XCP|QS|BE578D25-C23E-416F-8A57-C901F7B58596|2|||||ASEX-MALE|||UKAT/L|||1/(S*KPA)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|2||58||LONG-TERM FOLLOW-UP|1969-11-24||||1972-12-09||1972-06-14|1969-08-03|
TRIAL STUDY 134XCP|QS|BE578D25-C23E-416F-8A57-C901F7B58596|3|||||DRRI-2|||ECL UNIT|||CI/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|3||39||RUN-IN|1973-07-21||||1972-05-30||1969-05-11|1963-12-12|
TRIAL STUDY 134XCP|QS|BE578D25-C23E-416F-8A57-C901F7B58596|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||MEQ/G|||GLOBULE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|4||88||OPEN LABEL TREATMENT|1966-06-14||||1970-01-22||1972-05-30|1960-05-06|
TRIAL STUDY 134XCP|QS|BE578D25-C23E-416F-8A57-C901F7B58596|5|||||EPIC-CP|||KV|||L/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|5||7||FOLLOW-UP|1961-08-13||||1961-02-24||1960-05-21|1962-03-06|
TRIAL STUDY 134XCP|QS|A60D5FE6-26BA-487D-98E0-5F464305924C|1|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||GPL U|||10^3 COPIES/ML|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|1||38||LONG-TERM FOLLOW-UP|1960-01-04||||1960-06-15||1969-07-20|1968-04-16|
TRIAL STUDY 134XCP|QS|A60D5FE6-26BA-487D-98E0-5F464305924C|2|||||HAQ-DI WITHOUT VAS|||MS2|||/2500 WBC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|2||58||TREATMENT|1964-02-06||||1970-08-28||1967-05-16|1966-05-31|
TRIAL STUDY 134XCP|QS|A60D5FE6-26BA-487D-98E0-5F464305924C|3|||||RAND-36 V1.0|||VP/ML|||MEQ/L|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|3||39||INDUCTION TREATMENT|1967-08-21||||1967-12-31||1967-04-05|1972-02-13|
TRIAL STUDY 134XCP|QS|A60D5FE6-26BA-487D-98E0-5F464305924C|4|||||FACIT-FATIGUE 13-ITEM V4|||VOXEL|||%(V/V)|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|U|4||88||FOLLOW-UP|1965-11-16||||1963-07-10||1967-08-14|1971-04-17|
TRIAL STUDY 134XCP|QS|A60D5FE6-26BA-487D-98E0-5F464305924C|5|||||NCCN-FACT FBRSI-24 V2|||DPM/ML|||GY/MIN|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|N|5||7||INDUCTION TREATMENT|1968-07-17||||1963-07-25||1960-07-15|1968-01-30|
TRIAL STUDY 134XCP|QS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1|||||IBDQ|||G/CAGE/WK|||MPH|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|1||38||OPEN LABEL TREATMENT|1967-11-27||||1963-01-04||1967-07-25|1964-05-22|
TRIAL STUDY 134XCP|QS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2|||||EORTC QLQ-LC13|||F|||U/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|NA|2||58||INDUCTION TREATMENT|1972-03-12||||1972-11-09||1973-08-10|1969-03-26|
TRIAL STUDY 134XCP|QS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|3|||||FACT-TAXANE V4|||MM2|||TITER|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|3||39||FOLLOW-UP|1962-08-07||||1966-07-17||1963-10-03|1972-07-02|
TRIAL STUDY 134XCP|QS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|4|||||ACQ|||/4.0 ML|||MBQ/UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|U|4||88||WASHOUT|1968-04-23||||1967-11-19||1972-08-25|1971-12-22|
TRIAL STUDY 134XCP|QS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||10^12 IU/L|||KA_U/DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|5||7||BLINDED TREATMENT|1969-10-25||||1966-02-10||1960-05-23|1965-02-28|
TRIAL STUDY 134XCP|QS|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||KHZ|||DPM/MG|NOT DONE||LIKERT SCALE 7-POINT|N|Y|Y|1||38||SCREENING|1967-10-25||||1965-07-05||1968-06-26|1970-02-04|
TRIAL STUDY 134XCP|QS|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||10^6/L|||CIGARETTE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|2||58||OPEN LABEL TREATMENT|1963-09-23||||1970-03-30||1966-02-10|1967-07-03|
TRIAL STUDY 134XCP|QS|89739AE0-A8B9-44DE-970E-9D679ED58C4F|3|||||SOWS SHORT|||MM/H|||UG/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|3||39||OBSERVATION|1965-05-05||||1960-08-14||1964-05-08|1966-11-20|
TRIAL STUDY 134XCP|QS|89739AE0-A8B9-44DE-970E-9D679ED58C4F|4|||||SF12 V1.0 STANDARD|||LX|||GMFI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|Y|4||88||FOLLOW-UP|1965-01-06||||1960-06-24||1966-01-03|1965-06-09|
TRIAL STUDY 134XCP|QS|89739AE0-A8B9-44DE-970E-9D679ED58C4F|5|||||WHODAS 2.0 - 12-ITEM PROXY|||LOG10 CFU/G|||MIN*MG/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|5||7||LONG-TERM FOLLOW-UP|1960-09-20||||1964-09-17||1971-04-22|1973-02-10|
TRIAL STUDY 134XCP|QS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1|||||SF36 V2.0 ACUTE|||KG/CM|||M2|NOT DONE||LIKERT SCALE 5-POINT|NA|U|U|1||38||CONTINUATION TREATMENT|1964-02-06||||1961-07-05||1970-03-20|1966-07-03|
TRIAL STUDY 134XCP|QS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||BOX|||PA|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|2||58||WASHOUT|1969-10-11||||1970-05-02||1964-04-27|1971-02-19|
TRIAL STUDY 134XCP|QS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|3|||||HAMD 6 SELF-REPORT VERSION|||UG/KG/MIN|||KG/M2|NOT DONE||LIKERT SCALE 3-POINT|N|N|N|3||39||SCREENING|1965-09-01||||1972-07-16||1972-02-29|1964-11-01|
TRIAL STUDY 134XCP|QS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|4|||||SIQ|||IU/KG|||UG/L/H|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|4||88||BASELINE|1970-08-07||||1971-02-01||1967-02-04|1966-04-10|
TRIAL STUDY 134XCP|QS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|5|||||GDS|||MG/M2/MIN|||MV/SEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|5||7||INDUCTION TREATMENT|1964-08-20||||1970-07-25||1967-01-29|1972-06-14|
TRIAL STUDY 134XCP|QS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1|||||SF10 V1.0 CHILDREN ACUTE|||U/KG/H|||MOSM/KG|NOT DONE||LIKERT SCALE 3-POINT|NA|N|Y|1||38||INDUCTION TREATMENT|1962-01-26||||1970-09-08||1967-03-05|1967-11-03|
TRIAL STUDY 134XCP|QS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2|||||EPDS|||MV/SEC|||IU/DL|NOT DONE||LIKERT SCALE 7-POINT|U|NA|U|2||58||TREATMENT|1963-10-05||||1970-12-30||1967-08-31|1972-11-13|
TRIAL STUDY 134XCP|QS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|3|||||CCQ 1 WEEK VERSION|||NG|||IN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|Y|3||39||TREATMENT|1972-03-29||||1961-01-27||1963-01-18|1963-06-03|
TRIAL STUDY 134XCP|QS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|4|||||TSCYC|||U/M2/DAY|||APL U/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|Y|4||88||INDUCTION TREATMENT|1962-07-22||||1970-12-31||1961-11-21|1970-05-29|
TRIAL STUDY 134XCP|QS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|5|||||ADCS-ADL MCI|||FT2|||ELISA UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|5||7||LONG-TERM FOLLOW-UP|1962-12-02||||1965-05-14||1964-09-08|1960-10-08|
TRIAL STUDY 134XCP|QS|CED88848-769E-41C1-9ACD-99E45766D27B|1|||||SOAPP-R|||10^6 RNA COPIES/ML|||10^3 COPIES/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|1||38||CONTINUATION TREATMENT|1970-01-24||||1968-08-30||1966-11-16|1960-08-17|
TRIAL STUDY 134XCP|QS|CED88848-769E-41C1-9ACD-99E45766D27B|2|||||SWLS|||10^7 TCID 50/DOSE|||DRUM|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|Y|2||58||CONTINUATION TREATMENT|1971-08-11||||1964-06-23||1972-05-13|1964-08-29|
TRIAL STUDY 134XCP|QS|CED88848-769E-41C1-9ACD-99E45766D27B|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||RPM|||APPLICATION|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|3||39||WASHOUT|1967-06-08||||1967-05-05||1970-09-16|1961-03-09|
TRIAL STUDY 134XCP|QS|CED88848-769E-41C1-9ACD-99E45766D27B|4|||||LEC-5 STANDARD VERSION|||CI|||PLUG|NOT DONE||LIKERT SCALE 5-POINT|Y|U|N|4||88||TREATMENT|1966-09-12||||1972-06-10||1960-02-14|1961-05-10|
TRIAL STUDY 134XCP|QS|CED88848-769E-41C1-9ACD-99E45766D27B|5|||||QIDS-SR|||10^8 PFU|||LOG10 PFU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|Y|5||7||CONTINUATION TREATMENT|1967-09-09||||1960-03-20||1961-04-26|1970-10-22|
TRIAL STUDY 134XCP|QS|E7958F8B-D987-4929-993A-8960EB30A309|1|||||BEBQ RETROSPECTIVE|||MOL/MOL|||OZ|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|1||38||RUN-IN|1967-04-02||||1969-06-13||1965-12-30|1967-02-22|
TRIAL STUDY 134XCP|QS|E7958F8B-D987-4929-993A-8960EB30A309|2|||||FACT/GOG-NTX V4|||MANSON U/ML|||10^4 CFU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|2||58||SCREENING|1968-05-09||||1971-09-06||1966-10-21|1960-08-16|
TRIAL STUDY 134XCP|QS|E7958F8B-D987-4929-993A-8960EB30A309|3|||||NCCN-FACT FKSI-19 V2|||MG/DL|||G/DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|3||39||FOLLOW-UP|1967-05-22||||1967-08-05||1961-05-13|1961-02-10|
TRIAL STUDY 134XCP|QS|E7958F8B-D987-4929-993A-8960EB30A309|4|||||PR|||10^12/L|||BEAM BREAKS|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|4||88||OBSERVATION|1962-10-08||||1962-07-15||1971-11-18|1964-04-16|
TRIAL STUDY 134XCP|QS|E7958F8B-D987-4929-993A-8960EB30A309|5|||||FACT-B V4|||CI/G|||10^4 CFU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|5||7||CONTINUATION TREATMENT|1967-10-08||||1962-09-15||1970-05-31|1973-06-29|
TRIAL STUDY 134XCP|QS|A633D973-B611-4014-A43E-C8C2D21DBFC2|1|||||ADCS-ADL MCI|||ROENTGEN|||CONTAINER|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|U|1||38||RUN-IN|1965-03-02||||1963-07-18||1969-04-25|1967-10-21|
TRIAL STUDY 134XCP|QS|A633D973-B611-4014-A43E-C8C2D21DBFC2|2|||||SF8 V1.0 ACUTE|||BQ/G|||TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1960-01-08||||1966-09-05||1960-04-10|1965-08-20|
TRIAL STUDY 134XCP|QS|A633D973-B611-4014-A43E-C8C2D21DBFC2|3|||||EQ-5D-5L|||UIU/L|||PMOL/10^9 CELLS|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|3||39||BASELINE|1964-05-21||||1964-08-26||1972-04-07|1972-10-19|
TRIAL STUDY 134XCP|QS|A633D973-B611-4014-A43E-C8C2D21DBFC2|4|||||Q-LES-Q|||MM/MIN|||MDFI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|4||88||OPEN LABEL TREATMENT|1961-04-16||||1970-06-21||1965-01-14|1973-03-16|
TRIAL STUDY 134XCP|QS|A633D973-B611-4014-A43E-C8C2D21DBFC2|5|||||BARS|||STEPS|||LOG EID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|5||7||OBSERVATION|1964-09-24||||1961-01-27||1960-07-09|1965-03-23|
TRIAL STUDY 134XCP|QS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1|||||MPAI-4|||MG/KG/DAY|||ML/MMHG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|N|1||38||LONG-TERM FOLLOW-UP|1960-08-26||||1967-04-28||1968-10-02|1966-02-23|
TRIAL STUDY 134XCP|QS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||PT_US|||PG/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|U|2||58||RUN-IN|1969-01-08||||1970-09-02||1962-04-17|1962-10-14|
TRIAL STUDY 134XCP|QS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|3|||||IVIS|||KG/M2|||NG/MOL|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|3||39||BASELINE|1962-08-17||||1967-12-01||1969-02-24|1966-06-05|
TRIAL STUDY 134XCP|QS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|4|||||EPIC-CP|||MU|||10^7 CFU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|4||88||BASELINE|1966-04-02||||1969-04-24||1964-02-02|1969-11-29|
TRIAL STUDY 134XCP|QS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|5|||||MHIS-NACC|||ML/(MIN*100ML)|||FRAMES/S|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|5||7||OPEN LABEL TREATMENT|1972-05-10||||1973-02-02||1970-05-20|1967-06-23|
TRIAL STUDY 134XCP|QS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1|||||CES|||DAYS/MONTH|||CARTRIDGE|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|1||38||INDUCTION TREATMENT|1961-07-21||||1964-06-12||1969-08-28|1970-07-22|
TRIAL STUDY 134XCP|QS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2|||||SF36 V2.0 STANDARD|||PFU|||L/H/M2|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|2||58||RUN-IN|1967-01-07||||1960-02-29||1969-03-18|1973-09-07|
TRIAL STUDY 134XCP|QS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|3|||||PHQ-9|||PSI|||ML/S/M2|NOT DONE||LIKERT SCALE 5-POINT|U|N|U|3||39||WASHOUT|1961-12-18||||1967-12-01||1970-02-12|1965-08-28|
TRIAL STUDY 134XCP|QS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|4|||||ADCS-CGIC|||UKAT/10^12 RBC|||MANSON U/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|4||88||RUN-IN|1972-04-22||||1965-09-06||1964-09-22|1968-04-16|
TRIAL STUDY 134XCP|QS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|5|||||PDQUALIF|||UM2|||CM|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|5||7||FOLLOW-UP|1962-11-04||||1961-07-04||1969-07-23|1965-08-13|
TRIAL STUDY 134XCP|QS|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1|||||FKSI-DRS V4|||10^8/L|||K|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|1||38||TREATMENT|1970-10-06||||1969-09-15||1963-05-04|1973-01-09|
TRIAL STUDY 134XCP|QS|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2|||||CDR|||BREATHS/30S|||GRAIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|NA|2||58||WASHOUT|1962-05-22||||1972-10-31||1966-12-05|1968-06-30|
TRIAL STUDY 134XCP|QS|264AA652-A25E-43CE-A54F-6FEB54AB62F3|3|||||GDS|||VIAL|||/HPF|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|3||39||LONG-TERM FOLLOW-UP|1963-07-01||||1971-03-29||1961-04-03|1962-07-24|
TRIAL STUDY 134XCP|QS|264AA652-A25E-43CE-A54F-6FEB54AB62F3|4|||||BPI|||MEQ/DL|||MG/KG/MIN|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|4||88||OPEN LABEL TREATMENT|1971-04-13||||1965-08-23||1969-07-24|1970-08-23|
TRIAL STUDY 134XCP|QS|264AA652-A25E-43CE-A54F-6FEB54AB62F3|5|||||SDS|||U/G/DAY|||CCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|5||7||OPEN LABEL TREATMENT|1963-03-14||||1965-04-05||1972-06-21|1970-06-22|
TRIAL STUDY 134XCP|QS|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1|||||FACT-LEU V4|||MJOULE/CM2|||UG/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|1||38||WASHOUT|1961-02-02||||1973-09-06||1963-08-28|1965-12-30|
TRIAL STUDY 134XCP|QS|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2|||||NCCN-FACT FBRSI-24 V2|||ANSON U|||GBQ/UG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|NA|2||58||LONG-TERM FOLLOW-UP|1967-03-31||||1963-01-24||1965-12-17|1963-07-29|
TRIAL STUDY 134XCP|QS|4DE042DC-2F1E-425C-BA36-F64A3493CE76|3|||||NSCLC-SAQ V1.0|||ENZYME U/L|||ML/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|3||39||FOLLOW-UP|1970-10-08||||1964-12-20||1969-07-31|1971-07-02|
TRIAL STUDY 134XCP|QS|4DE042DC-2F1E-425C-BA36-F64A3493CE76|4|||||HAQ-DI WITH VAS|||10^3/HPF|||MN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|4||88||BASELINE|1964-03-10||||1968-04-21||1965-08-23|1964-09-03|
TRIAL STUDY 134XCP|QS|4DE042DC-2F1E-425C-BA36-F64A3493CE76|5|||||C-SSRS SCREENING|||10^5/L|||DEG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|5||7||BLINDED TREATMENT|1961-11-17||||1967-06-20||1969-11-27|1971-01-27|
TRIAL STUDY 134XCP|QS|872942E9-A575-4929-9B21-D30DE51B367B|1|||||GAD-7|||UMOL|||/100 WBC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|1||38||INDUCTION TREATMENT|1964-10-14||||1964-07-07||1968-11-26|1964-11-15|
TRIAL STUDY 134XCP|QS|872942E9-A575-4929-9B21-D30DE51B367B|2|||||PHQ SCREENER VERSION|||MMHG*MIN/L|||IU/MG|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|2||58||BASELINE|1973-07-27||||1972-03-26||1960-12-20|1970-09-30|
TRIAL STUDY 134XCP|QS|872942E9-A575-4929-9B21-D30DE51B367B|3|||||FPSR|||CI/L|||MMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|3||39||INDUCTION TREATMENT|1972-05-07||||1971-01-29||1967-11-29|1963-04-24|
TRIAL STUDY 134XCP|QS|872942E9-A575-4929-9B21-D30DE51B367B|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||G/G/DAY|||TUBERCULIN UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|NA|4||88||INDUCTION TREATMENT|1961-12-05||||1970-09-05||1961-11-26|1969-02-14|
TRIAL STUDY 134XCP|QS|872942E9-A575-4929-9B21-D30DE51B367B|5|||||RDQ|||G|||PKAT|NOT DONE||LIKERT SCALE 5-POINT|NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1972-01-15||||1965-02-28||1971-12-16|1967-12-04|
TRIAL STUDY 134XCP|QS|628822F3-4983-44F8-B98D-7A35AAFF2962|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||PG/CELL|||MU/G|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|1||38||CONTINUATION TREATMENT|1967-07-18||||1965-04-20||1961-08-10|1966-03-02|
TRIAL STUDY 134XCP|QS|628822F3-4983-44F8-B98D-7A35AAFF2962|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||G/CM2|||UOSM|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|2||58||RUN-IN|1962-08-30||||1961-05-06||1965-01-18|1970-02-15|
TRIAL STUDY 134XCP|QS|628822F3-4983-44F8-B98D-7A35AAFF2962|3|||||SIQ|||GPELISA UNIT/ML|||KAT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1971-10-02||||1972-07-25||1969-09-04|1969-09-15|
TRIAL STUDY 134XCP|QS|628822F3-4983-44F8-B98D-7A35AAFF2962|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||UG/DL|||AMP|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|4||88||OPEN LABEL TREATMENT|1970-08-06||||1963-05-14||1967-08-24|1965-08-30|
TRIAL STUDY 134XCP|QS|628822F3-4983-44F8-B98D-7A35AAFF2962|5|||||CDLQ|||MOSM/KG|||ABSORBANCE U/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|NA|5||7||OBSERVATION|1963-10-15||||1964-06-05||1971-06-11|1968-10-02|
TRIAL STUDY 134XCP|QS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||MG/MIN|||PM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|U|1||38||INDUCTION TREATMENT|1961-12-02||||1970-05-27||1962-03-07|1971-10-06|
TRIAL STUDY 134XCP|QS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2|||||C-SSRS CHILDREN'S BASELINE|||PSI|||BU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|U|2||58||FOLLOW-UP|1963-08-03||||1968-01-22||1963-01-19|1971-01-11|
TRIAL STUDY 134XCP|QS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|3|||||BIS-11|||PACK|||TRANSDUCING UNIT/ML|NOT DONE||LIKERT SCALE 3-POINT|U|N|NA|3||39||INDUCTION TREATMENT|1972-03-07||||1961-10-22||1965-11-25|1960-12-22|
TRIAL STUDY 134XCP|QS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|4|||||CCQ 24 HOUR VERSION|||UG/MIN|||BQ/G|NOT DONE||LIKERT SCALE 3-POINT|N|N|U|4||88||FOLLOW-UP|1966-02-09||||1961-09-21||1971-07-11|1968-06-05|
TRIAL STUDY 134XCP|QS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|5|||||AUDIT-SR|||10^4/HPF|||STRIP|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|5||7||SCREENING|1965-11-17||||1966-11-16||1968-11-20|1965-11-26|
TRIAL STUDY 134XCP|QS|6045DFAB-0734-4E6D-A492-34BD613EC783|1|||||PDQUALIF|||EQ|||MMHG*MIN/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|NA|1||38||OBSERVATION|1968-10-21||||1961-10-15||1968-09-18|1965-04-18|
TRIAL STUDY 134XCP|QS|6045DFAB-0734-4E6D-A492-34BD613EC783|2|||||GDS|||PNU/ML|||MG/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|2||58||FOLLOW-UP|1971-01-04||||1968-12-12||1966-04-15|1961-07-27|
TRIAL STUDY 134XCP|QS|6045DFAB-0734-4E6D-A492-34BD613EC783|3|||||BWCS|||/HPF|||KCAL/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|3||39||CONTINUATION TREATMENT|1961-12-08||||1964-01-25||1971-10-28|1972-09-22|
TRIAL STUDY 134XCP|QS|6045DFAB-0734-4E6D-A492-34BD613EC783|4|||||TSCC|||SHOCK WAVE|||ANTI-XA IU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|4||88||OPEN LABEL TREATMENT|1962-09-19||||1967-01-10||1970-10-02|1963-03-29|
TRIAL STUDY 134XCP|QS|6045DFAB-0734-4E6D-A492-34BD613EC783|5|||||SOBDA|||PT_BR|||MASK|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|5||7||RUN-IN|1968-04-02||||1964-06-07||1966-09-19|1969-02-13|
TRIAL STUDY 134XCP|QS|482F0519-E738-46DE-A5C4-4AC76B6E7011|1|||||BORG CR10|||MG2/DL2|||U/DL|NOT DONE||LIKERT SCALE 5-POINT|U|NA|N|1||38||INDUCTION TREATMENT|1968-07-01||||1961-11-18||1960-08-02|1971-04-01|
TRIAL STUDY 134XCP|QS|482F0519-E738-46DE-A5C4-4AC76B6E7011|2|||||ASEX-FEMALE|||MMOL/S|||MMOL/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|2||58||SCREENING|1972-05-17||||1960-03-23||1964-10-13|1962-05-02|
TRIAL STUDY 134XCP|QS|482F0519-E738-46DE-A5C4-4AC76B6E7011|3|||||PDDS|||ML/KG|||UGEQ|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|3||39||CONTINUATION TREATMENT|1968-04-05||||1969-08-26||1971-11-25|1966-11-24|
TRIAL STUDY 134XCP|QS|482F0519-E738-46DE-A5C4-4AC76B6E7011|4|||||EPIC-26|||BOTTLE|||NKAT/G HB|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|N|4||88||INDUCTION TREATMENT|1970-11-04||||1969-01-31||1961-08-03|1970-01-11|
TRIAL STUDY 134XCP|QS|482F0519-E738-46DE-A5C4-4AC76B6E7011|5|||||FACIT-DYSPNEA 33 ITEM BANK|||UU/L|||NKAT/G HB|NOT DONE||LIKERT SCALE 5-POINT|N|Y|U|5||7||WASHOUT|1968-05-22||||1960-11-25||1972-03-30|1964-11-01|
TRIAL STUDY 134XCP|QS|DFDD42F5-749C-4AF0-8351-780DB9614F61|1|||||CGI|||VIRTUAL PIXEL|||MG/G/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|1||38||WASHOUT|1961-01-05||||1966-03-29||1969-04-16|1972-07-30|
TRIAL STUDY 134XCP|QS|DFDD42F5-749C-4AF0-8351-780DB9614F61|2|||||FACIT-DYSPNEA 33 ITEM BANK|||MM2|||POINT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|2||58||BLINDED TREATMENT|1969-01-22||||1971-11-27||1964-04-11|1970-02-07|
TRIAL STUDY 134XCP|QS|DFDD42F5-749C-4AF0-8351-780DB9614F61|3|||||SWLS|||UV*SEC|||ANTI-XA IU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|3||39||OPEN LABEL TREATMENT|1965-06-19||||1961-10-17||1968-11-18|1964-05-16|
TRIAL STUDY 134XCP|QS|DFDD42F5-749C-4AF0-8351-780DB9614F61|4|||||SDS|||UG/CM2|||PA|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|4||88||WASHOUT|1961-07-21||||1971-04-30||1965-06-27|1972-12-16|
TRIAL STUDY 134XCP|QS|DFDD42F5-749C-4AF0-8351-780DB9614F61|5|||||PDDS|||ROENTGEN|||10^9 ORGANISMS/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|5||7||CONTINUATION TREATMENT|1969-07-09||||1969-05-20||1971-05-03|1969-10-20|
TRIAL STUDY 134XCP|QS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1|||||SF36 V1.0 STANDARD|||MG/H|||BOWL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|NA|1||38||BASELINE|1966-06-23||||1966-03-05||1969-10-12|1970-06-27|
TRIAL STUDY 134XCP|QS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2|||||FACT-HEP V4|||ML/MMHG|||MANSON U/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|2||58||FOLLOW-UP|1967-06-18||||1966-12-14||1972-04-03|1969-04-29|
TRIAL STUDY 134XCP|QS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|3|||||IDS-SR|||10^9/L|||MEQ/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|3||39||TREATMENT|1961-02-23||||1960-04-07||1966-10-22|1961-06-27|
TRIAL STUDY 134XCP|QS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|4|||||GDS SHORT FORM|||/DAY|||U/CL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|4||88||TREATMENT|1967-07-29||||1962-01-05||1961-10-31|1963-05-28|
TRIAL STUDY 134XCP|QS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||JOULE|||%/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|U|5||7||CONTINUATION TREATMENT|1971-04-15||||1970-01-02||1970-01-30|1971-09-28|
TRIAL STUDY 134XCP|QS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1|||||Q-LES-Q-SF|||HEP|||/40 HPFS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|1||38||WASHOUT|1971-07-09||||1960-06-26||1963-03-31|1972-11-01|
TRIAL STUDY 134XCP|QS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2|||||TSQM V1.4|||GENEQ/ML|||ML/KG/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|2||58||TREATMENT|1971-08-12||||1969-03-10||1962-01-14|1970-02-12|
TRIAL STUDY 134XCP|QS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|3|||||EXPANDED DRS-PI SURVIVOR VERSION|||BU|||ML/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|3||39||OPEN LABEL TREATMENT|1968-11-24||||1968-03-20||1966-01-15|1970-01-22|
TRIAL STUDY 134XCP|QS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|4|||||PSQI|||UL|||NFIU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|4||88||FOLLOW-UP|1969-01-04||||1961-01-08||1964-08-22|1965-02-06|
TRIAL STUDY 134XCP|QS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||MG/M2/MIN|||ANTIBODY UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|N|5||7||WASHOUT|1963-09-01||||1962-03-19||1971-10-07|1966-03-05|
TRIAL STUDY 134XCP|QS|E0434C66-0F59-476F-9913-55766C4AED1B|1|||||GAD-7 V2|||KIU|||MMHG*MIN/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|1||38||OBSERVATION|1963-05-28||||1967-06-15||1968-01-18|1966-01-25|
TRIAL STUDY 134XCP|QS|E0434C66-0F59-476F-9913-55766C4AED1B|2|||||CES|||FL|||MOL/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|2||58||WASHOUT|1965-06-24||||1964-01-02||1966-06-22|1965-05-27|
TRIAL STUDY 134XCP|QS|E0434C66-0F59-476F-9913-55766C4AED1B|3|||||ADCS-ADL SEVERE DEMENTIA|||APL U/ML|||MS/MMHG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|U|3||39||OBSERVATION|1967-04-25||||1963-12-17||1960-02-28|1971-09-25|
TRIAL STUDY 134XCP|QS|E0434C66-0F59-476F-9913-55766C4AED1B|4|||||C-SSRS SINCE LAST VISIT|||PPB|||M|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|N|4||88||WASHOUT|1970-12-22||||1963-05-28||1969-03-12|1961-10-08|
TRIAL STUDY 134XCP|QS|E0434C66-0F59-476F-9913-55766C4AED1B|5|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||KDA|||ML/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|5||7||OBSERVATION|1964-03-14||||1970-05-08||1968-01-20|1971-03-21|
TRIAL STUDY 134XCP|QS|60B57F98-61FF-4322-8084-7A536964F60A|1|||||MSQOL-54|||MEQ/DAY|||ANTI-XA IU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|1||38||SCREENING|1968-04-02||||1968-06-14||1967-06-14|1970-08-08|
TRIAL STUDY 134XCP|QS|60B57F98-61FF-4322-8084-7A536964F60A|2|||||PDDS|||/500 WBC|||ML/DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|2||58||TREATMENT|1972-10-16||||1969-10-27||1968-03-30|1969-08-08|
TRIAL STUDY 134XCP|QS|60B57F98-61FF-4322-8084-7A536964F60A|3|||||MRS|||AFU|||10^3 DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|3||39||BASELINE|1963-04-29||||1972-07-07||1971-06-25|1971-09-05|
TRIAL STUDY 134XCP|QS|60B57F98-61FF-4322-8084-7A536964F60A|4|||||MFIS|||CG|||10^6 IU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|N|4||88||OBSERVATION|1972-09-29||||1967-03-25||1971-03-26|1960-03-02|
TRIAL STUDY 134XCP|QS|60B57F98-61FF-4322-8084-7A536964F60A|5|||||PEDS-FACIT-F|||ML/S/M2|||PPB|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|U|5||7||RUN-IN|1970-04-18||||1966-05-21||1972-06-09|1971-06-26|
TRIAL STUDY 134XCP|QS|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1|||||FOSI|||CD|||MET*MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|1||38||CONTINUATION TREATMENT|1969-03-28||||1967-01-14||1963-09-07|1963-06-09|
TRIAL STUDY 134XCP|QS|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||NMOL/L/H|||ML/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|2||58||OPEN LABEL TREATMENT|1973-04-17||||1968-01-06||1965-01-12|1971-07-29|
TRIAL STUDY 134XCP|QS|C79CA198-24E2-4A76-8C32-F3AA973EA41E|3|||||WHODAS 2.0 - 12-ITEM SELF|||SACHET|||ML/M2/DAY|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|3||39||RUN-IN|1961-01-01||||1968-09-12||1968-10-16|1965-12-20|
TRIAL STUDY 134XCP|QS|C79CA198-24E2-4A76-8C32-F3AA973EA41E|4|||||NCCN-FACT FBRSI-24 V2|||BU|||IU/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|4||88||WASHOUT|1970-08-30||||1972-01-14||1963-05-24|1965-05-12|
TRIAL STUDY 134XCP|QS|C79CA198-24E2-4A76-8C32-F3AA973EA41E|5|||||SF12 V1.0 STANDARD|||FT2|||MG/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|NA|5||7||BASELINE|1963-01-04||||1969-01-10||1960-09-02|1967-06-18|
TRIAL STUDY 134XCP|QS|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||UL/ML|||/LSQN|NOT DONE||LIKERT SCALE 5-POINT|Y|U|N|1||38||BASELINE|1962-08-04||||1964-04-17||1964-04-02|1961-06-21|
TRIAL STUDY 134XCP|QS|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2|||||BEBQ CONCURRENT|||PPTR|||ML/ANIMAL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|2||58||BLINDED TREATMENT|1967-04-01||||1966-07-22||1962-07-03|1965-03-06|
TRIAL STUDY 134XCP|QS|D250194D-9BBD-40D3-A13B-BBCEB53DB450|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||MIN*MG/ML|||MMOL/S|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|3||39||SCREENING|1964-08-07||||1967-11-19||1973-05-15|1969-04-10|
TRIAL STUDY 134XCP|QS|D250194D-9BBD-40D3-A13B-BBCEB53DB450|4|||||SIQ|||MG/KG/DAY|||MG/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|U|4||88||LONG-TERM FOLLOW-UP|1962-11-01||||1967-06-10||1967-03-28|1970-03-22|
TRIAL STUDY 134XCP|QS|D250194D-9BBD-40D3-A13B-BBCEB53DB450|5|||||BORG CR10|||ARBITRARY U|||MMHG|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|U|5||7||BLINDED TREATMENT|1962-12-25||||1969-07-05||1967-10-27|1961-02-04|
TRIAL STUDY 134XCP|QS|369AE0AF-8693-4363-9A6E-CD30567BD614|1|||||PR|||10^12 IU/L|||UMOL/L/H|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|1||38||TREATMENT|1962-03-20||||1971-11-12||1963-11-07|1971-03-28|
TRIAL STUDY 134XCP|QS|369AE0AF-8693-4363-9A6E-CD30567BD614|2|||||BWCS|||CI|||CM|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|2||58||OPEN LABEL TREATMENT|1969-04-21||||1965-01-29||1968-12-13|1967-08-20|
TRIAL STUDY 134XCP|QS|369AE0AF-8693-4363-9A6E-CD30567BD614|3|||||BPI SHORT FORM|||U|||CL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|3||39||OPEN LABEL TREATMENT|1965-08-30||||1972-11-27||1970-10-18|1972-05-31|
TRIAL STUDY 134XCP|QS|369AE0AF-8693-4363-9A6E-CD30567BD614|4|||||ESS|||CFU/ML|||EU|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|4||88||INDUCTION TREATMENT|1963-06-14||||1961-10-06||1966-03-02|1973-03-10|
TRIAL STUDY 134XCP|QS|369AE0AF-8693-4363-9A6E-CD30567BD614|5|||||SF10 V1.0 CHILDREN STANDARD|||MMOL/MOL|||G/U|NOT DONE||LIKERT SCALE 5-POINT|U|Y|N|5||7||OBSERVATION|1969-08-08||||1965-11-18||1963-05-10|1965-12-01|
TRIAL STUDY 134XCP|QS|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1|||||FAS-NACC UDS V3.0|||MOSM/KG|||U/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|U|1||38||BASELINE|1961-04-15||||1967-07-31||1970-06-14|1965-03-18|
TRIAL STUDY 134XCP|QS|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||KM/H|||UIU/DL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|2||58||CONTINUATION TREATMENT|1966-02-17||||1964-01-14||1960-04-23|1967-05-12|
TRIAL STUDY 134XCP|QS|4497DB94-5B91-4169-9D73-73EE5C1D9B76|3|||||NCCN-FACT FOSI-18 V2|||10^6 U|||TUBERCULIN UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|NA|3||39||SCREENING|1967-07-07||||1962-10-11||1967-10-13|1963-07-02|
TRIAL STUDY 134XCP|QS|4497DB94-5B91-4169-9D73-73EE5C1D9B76|4|||||PHQ-15|||MIN/DAY|||NG/DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|4||88||LONG-TERM FOLLOW-UP|1972-09-09||||1968-07-08||1965-08-31|1960-01-27|
TRIAL STUDY 134XCP|QS|4497DB94-5B91-4169-9D73-73EE5C1D9B76|5|||||C-SSRS BASELINE|||ENZYME U/G HB|||UG/G/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|Y|5||7||BASELINE|1963-06-23||||1970-05-12||1971-01-01|1972-09-16|
TRIAL STUDY 134XCP|QS|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1|||||FACT-G V4|||MSEC|||ML/DOSE|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|1||38||BLINDED TREATMENT|1965-08-18||||1961-05-30||1970-11-26|1970-10-18|
TRIAL STUDY 134XCP|QS|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2|||||EPDS|||UCI/KG|||L/S|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|2||58||BLINDED TREATMENT|1966-09-15||||1970-07-07||1960-05-13|1962-11-26|
TRIAL STUDY 134XCP|QS|487D7E2D-6E7E-4A5E-ADC7-72B888746263|3|||||AQLQ|||FARAD|||10^7/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|3||39||OPEN LABEL TREATMENT|1966-08-07||||1961-07-25||1965-04-24|1970-04-06|
TRIAL STUDY 134XCP|QS|487D7E2D-6E7E-4A5E-ADC7-72B888746263|4|||||IDS-SR|||/10^4|||BQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|NA|4||88||FOLLOW-UP|1973-08-01||||1969-08-07||1961-03-08|1967-07-25|
TRIAL STUDY 134XCP|QS|487D7E2D-6E7E-4A5E-ADC7-72B888746263|5|||||FACIT-FATIGUE 13-ITEM V4|||HOMEOPATHIC DILUTION|||U/G/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|Y|5||7||WASHOUT|1963-08-19||||1966-02-03||1963-09-01|1973-01-31|
TRIAL STUDY 134XCP|QS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1|||||HAQ-DI WITH VAS|||ENZYME U|||10^7 PFU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|1||38||OBSERVATION|1965-05-04||||1970-02-08||1973-06-30|1966-11-14|
TRIAL STUDY 134XCP|QS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||TROCHE|||IN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|N|2||58||CONTINUATION TREATMENT|1968-03-22||||1961-11-16||1967-03-28|1961-02-27|
TRIAL STUDY 134XCP|QS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|3|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||MMOL/L|||BQ/KG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|U|3||39||WASHOUT|1965-09-01||||1970-11-01||1969-07-09|1961-03-20|
TRIAL STUDY 134XCP|QS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|4|||||T1-DDS|||STEPS|||CM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|4||88||OBSERVATION|1964-11-05||||1962-12-09||1965-11-24|1971-01-03|
TRIAL STUDY 134XCP|QS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|5|||||HAMD 6 SELF-REPORT VERSION|||NU/CL|||UG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|5||7||TREATMENT|1961-08-20||||1973-09-02||1967-04-22|1966-01-22|
TRIAL STUDY 134XCP|QS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1|||||MSQOL-54|||CFU/G|||UEQ|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|1||38||OBSERVATION|1973-08-11||||1965-10-25||1963-12-21|1968-07-18|
TRIAL STUDY 134XCP|QS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2|||||PR|||L/DAY|||DRUM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|2||58||RUN-IN|1965-02-10||||1964-04-10||1962-03-28|1969-07-24|
TRIAL STUDY 134XCP|QS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|3|||||MDS-UPDRS|||GENEQ|||10^6 IU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|NA|3||39||INDUCTION TREATMENT|1963-05-02||||1971-01-31||1961-06-24|1960-11-23|
TRIAL STUDY 134XCP|QS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|4|||||SF12 V1.0 ACUTE|||UMOL/L/MIN|||DAYS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|U|4||88||LONG-TERM FOLLOW-UP|1966-08-26||||1963-11-16||1967-12-10|1962-04-26|
TRIAL STUDY 134XCP|QS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||SIEMENS|||TRANSDUCING UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|5||7||SCREENING|1963-04-01||||1967-11-28||1963-06-26|1970-09-18|
TRIAL STUDY 134XCP|QS|8BF6E538-2F39-48E4-B115-AE1693843BBC|1|||||SF12 V2.0 STANDARD|||SHOCK WAVE|||G/M2/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|1||38||WASHOUT|1960-04-07||||1964-01-21||1966-11-01|1972-12-03|
TRIAL STUDY 134XCP|QS|8BF6E538-2F39-48E4-B115-AE1693843BBC|2|||||SOAPP-R|||DDU|||MG/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|N|2||58||OBSERVATION|1961-01-17||||1968-07-01||1968-09-06|1968-12-16|
TRIAL STUDY 134XCP|QS|8BF6E538-2F39-48E4-B115-AE1693843BBC|3|||||ASEX-MALE|||10^8 PFU|||MG/ML/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|3||39||RUN-IN|1968-02-15||||1967-09-04||1963-01-09|1968-02-02|
TRIAL STUDY 134XCP|QS|8BF6E538-2F39-48E4-B115-AE1693843BBC|4|||||PI|||CAL|||MMOL/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|U|4||88||TREATMENT|1971-12-18||||1968-09-05||1964-08-20|1967-10-08|
TRIAL STUDY 134XCP|QS|8BF6E538-2F39-48E4-B115-AE1693843BBC|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||MV2/HZ|||UG/G/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|Y|5||7||TREATMENT|1967-02-01||||1966-09-14||1970-02-10|1965-11-21|
TRIAL STUDY 134XCP|QS|57F001BC-36EB-44AF-9487-373FA31B7311|1|||||EPIC-CP|||DRUM|||AMPULE|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|1||38||LONG-TERM FOLLOW-UP|1962-07-25||||1966-12-20||1965-03-01|1962-09-06|
TRIAL STUDY 134XCP|QS|57F001BC-36EB-44AF-9487-373FA31B7311|2|||||IBDQ|||/MBP|||UG/M2/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|2||58||BASELINE|1968-04-08||||1967-01-30||1963-03-10|1961-02-17|
TRIAL STUDY 134XCP|QS|57F001BC-36EB-44AF-9487-373FA31B7311|3|||||HAEM-A-QOL|||G/CM2|||G/ANIMAL/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1962-11-14||||1965-07-13||1963-07-22|1970-04-12|
TRIAL STUDY 134XCP|QS|57F001BC-36EB-44AF-9487-373FA31B7311|4|||||FBRSI|||U/M2/H|||UL/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|4||88||RUN-IN|1966-09-10||||1965-06-29||1969-03-09|1964-11-14|
TRIAL STUDY 134XCP|QS|57F001BC-36EB-44AF-9487-373FA31B7311|5|||||HAMD 6 SELF-REPORT VERSION|||MMHG/SEC|||L/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|5||7||BASELINE|1973-03-17||||1963-02-24||1969-08-03|1962-07-02|
TRIAL STUDY 134XCP|QS|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1|||||GOSE|||SQU/ML|||UG/L/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|1||38||INDUCTION TREATMENT|1973-01-25||||1970-07-20||1964-06-07|1967-11-07|
TRIAL STUDY 134XCP|QS|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2|||||COWS|||MMOL2/L2|||/MS|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|2||58||WASHOUT|1969-03-15||||1961-05-09||1964-06-07|1973-01-12|
TRIAL STUDY 134XCP|QS|3FBDC961-EB02-4B28-8672-2A0A0A33529E|3|||||WHODAS 2.0 - 36-ITEM PROXY|||10^12 IU/L|||G/MOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|3||39||WASHOUT|1960-10-08||||1967-04-24||1963-10-31|1963-05-21|
TRIAL STUDY 134XCP|QS|3FBDC961-EB02-4B28-8672-2A0A0A33529E|4|||||GOSE|||TCID 50/DOSE|||NEEDLE GAUGE|NOT DONE||LIKERT SCALE 5-POINT|Y|N|NA|4||88||LONG-TERM FOLLOW-UP|1972-08-19||||1965-08-19||1961-06-29|1961-02-03|
TRIAL STUDY 134XCP|QS|3FBDC961-EB02-4B28-8672-2A0A0A33529E|5|||||ACT|||LOG10 ELISA UNIT|||ML/CAGE/WK|NOT DONE||LIKERT SCALE 5-POINT|Y|N|U|5||7||OPEN LABEL TREATMENT|1968-05-17||||1971-04-01||1965-06-19|1972-01-09|
TRIAL STUDY 134XCP|QS|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1|||||FACT-LYM V4|||OHM|||RATIO|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|1||38||SCREENING|1967-08-14||||1964-01-30||1961-11-16|1963-05-04|
TRIAL STUDY 134XCP|QS|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2|||||GDS SHORT FORM|||UMOL/MOL|||PLUG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|2||58||OPEN LABEL TREATMENT|1973-01-29||||1960-02-02||1971-03-20|1972-03-25|
TRIAL STUDY 134XCP|QS|1B524FC4-365B-4A16-A4D7-ED818C6E6086|3|||||IIEF|||CAL|||VP/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|NA|3||39||BASELINE|1966-03-31||||1973-07-17||1965-08-14|1961-02-24|
TRIAL STUDY 134XCP|QS|1B524FC4-365B-4A16-A4D7-ED818C6E6086|4|||||C-SSRS BASELINE/SCREENING VERSION|||LOG10 CCID 50/DOSE|||UL/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|4||88||INDUCTION TREATMENT|1971-12-29||||1972-04-29||1972-04-03|1965-10-11|
TRIAL STUDY 134XCP|QS|1B524FC4-365B-4A16-A4D7-ED818C6E6086|5|||||GOSE|||10^9 ORGANISMS/ML|||PFU/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|5||7||SCREENING|1961-01-11||||1970-07-29||1973-08-21|1968-02-28|
TRIAL STUDY 134XCP|QS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1|||||BLCS|||/LPF|||AMP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|N|1||38||OPEN LABEL TREATMENT|1960-03-18||||1970-07-03||1966-07-21|1960-10-23|
TRIAL STUDY 134XCP|QS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2|||||MDQ-T|||PMOL/10^10 CELLS|||UG/CM2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|Y|2||58||WASHOUT|1968-08-22||||1966-05-16||1968-10-22|1969-04-23|
TRIAL STUDY 134XCP|QS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|3|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||10^6 ORGANISMS/G|||GBQ/UG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|3||39||BASELINE|1961-05-09||||1962-01-21||1970-06-24|1963-06-04|
TRIAL STUDY 134XCP|QS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|4|||||COPD ASSESSMENT TEST|||U/G|||KIT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|N|4||88||OPEN LABEL TREATMENT|1971-01-30||||1968-06-07||1961-02-17|1970-01-26|
TRIAL STUDY 134XCP|QS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||/40 HPFS|||NMOL BCE/L|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|U|5||7||LONG-TERM FOLLOW-UP|1961-04-26||||1962-08-21||1966-01-18|1963-01-30|
TRIAL STUDY 134XCP|QS|27671577-2C6D-429F-BED9-0EDAB15CCB33|1|||||PODCI - ADOLESCENT SELF REPORTED|||KM|||G/ANIMAL/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|1||38||WASHOUT|1972-02-07||||1960-11-30||1968-10-02|1966-11-14|
TRIAL STUDY 134XCP|QS|27671577-2C6D-429F-BED9-0EDAB15CCB33|2|||||TSCC|||U/M2/DAY|||MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|2||58||FOLLOW-UP|1972-06-19||||1969-05-23||1967-04-14|1963-04-23|
TRIAL STUDY 134XCP|QS|27671577-2C6D-429F-BED9-0EDAB15CCB33|3|||||FAQ-NACC VERSION|||MG/MIN|||M/SEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|Y|3||39||FOLLOW-UP|1971-02-03||||1973-07-06||1965-05-03|1970-02-16|
TRIAL STUDY 134XCP|QS|27671577-2C6D-429F-BED9-0EDAB15CCB33|4|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||CYLINDER|||APL U/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|Y|4||88||TREATMENT|1962-06-23||||1967-03-22||1961-10-31|1967-11-14|
TRIAL STUDY 134XCP|QS|27671577-2C6D-429F-BED9-0EDAB15CCB33|5|||||ASEX-MALE|||TRANSDUCING UNIT|||U/MG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|5||7||TREATMENT|1963-04-11||||1965-05-23||1960-03-04|1973-04-04|
TRIAL STUDY 134XCP|QS|CD69750D-957B-405C-A397-AFA331D30535|1|||||SIQ|||MET*H|||PT_US|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|U|1||38||TREATMENT|1970-10-10||||1973-06-11||1967-05-12|1966-02-09|
TRIAL STUDY 134XCP|QS|CD69750D-957B-405C-A397-AFA331D30535|2|||||RPQ|||MBP|||DYN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|2||58||RUN-IN|1969-04-16||||1966-11-21||1966-08-23|1962-09-02|
TRIAL STUDY 134XCP|QS|CD69750D-957B-405C-A397-AFA331D30535|3|||||OCI|||EID 50/DOSE|||PMOL/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|3||39||OBSERVATION|1960-04-20||||1970-07-04||1969-03-07|1965-01-01|
TRIAL STUDY 134XCP|QS|CD69750D-957B-405C-A397-AFA331D30535|4|||||GOSE|||BQ/L|||NMOL BCE/MMOL|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1962-06-30||||1970-10-07||1960-10-28|1960-01-25|
TRIAL STUDY 134XCP|QS|CD69750D-957B-405C-A397-AFA331D30535|5|||||NPS|||MG2/DL2|||H*%|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|5||7||WASHOUT|1970-05-24||||1968-04-08||1960-01-13|1960-08-27|
TRIAL STUDY 134XCP|QS|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1|||||FBRSI|||PG/L|||ML/CAGE/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|U|1||38||WASHOUT|1962-03-03||||1971-10-10||1972-06-13|1960-11-09|
TRIAL STUDY 134XCP|QS|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||MU|||UEQ|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|N|2||58||CONTINUATION TREATMENT|1971-05-24||||1970-12-21||1970-09-26|1973-02-18|
TRIAL STUDY 134XCP|QS|5BFDDFC2-7D15-4B01-8140-62376D160EF0|3|||||NCCN-FACT FBLSI-18 V2|||MOL|||TRANSDUCING UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|3||39||OPEN LABEL TREATMENT|1970-08-28||||1965-01-18||1967-07-06|1966-04-25|
TRIAL STUDY 134XCP|QS|5BFDDFC2-7D15-4B01-8140-62376D160EF0|4|||||NPS|||/100 HPFS|||L/S|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|Y|4||88||LONG-TERM FOLLOW-UP|1966-10-09||||1963-05-21||1973-05-29|1972-07-19|
TRIAL STUDY 134XCP|QS|5BFDDFC2-7D15-4B01-8140-62376D160EF0|5|||||WLQ|||IU/G|||G/M2|NOT DONE||LIKERT SCALE 7-POINT|Y|N|N|5||7||OBSERVATION|1970-03-27||||1964-09-02||1965-11-03|1966-10-18|
TRIAL STUDY 134XCP|QS|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1|||||PHQ-2|||UM/DAY|||TUBERCULIN UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|1||38||RUN-IN|1967-03-18||||1962-11-13||1966-08-28|1965-04-24|
TRIAL STUDY 134XCP|QS|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2|||||HCS|||ML/ANIMAL|||DDU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|Y|2||58||WASHOUT|1964-11-17||||1961-09-04||1970-11-09|1963-01-06|
TRIAL STUDY 134XCP|QS|DEA8E573-2709-41F9-AB0D-8C39F5169B48|3|||||GCGI|||ECL UNIT|||PIXEL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|U|3||39||TREATMENT|1961-08-03||||1965-04-13||1967-05-23|1967-01-30|
TRIAL STUDY 134XCP|QS|DEA8E573-2709-41F9-AB0D-8C39F5169B48|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||BP|||POUCH|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|4||88||WASHOUT|1961-10-08||||1968-01-20||1969-06-20|1965-11-25|
TRIAL STUDY 134XCP|QS|DEA8E573-2709-41F9-AB0D-8C39F5169B48|5|||||RDQ|||U/DL|||DYN|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|Y|5||7||TREATMENT|1965-07-07||||1971-10-12||1973-06-03|1972-04-02|
TRIAL STUDY 134XCP|QS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1|||||WHODAS 2.0 - 12-ITEM SELF|||UIU/L|||CM H2O|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|1||38||SCREENING|1972-05-21||||1961-03-01||1964-06-21|1969-07-08|
TRIAL STUDY 134XCP|QS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2|||||EORTC QLQ-CR29 V2.1|||ELISA UNIT/ML|||FMOL/L/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|2||58||WASHOUT|1963-08-28||||1968-04-01||1972-11-12|1962-12-04|
TRIAL STUDY 134XCP|QS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|3|||||HCS|||10^6 CFU|||MEQ/MMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|3||39||WASHOUT|1963-01-05||||1964-12-26||1969-04-16|1963-03-16|
TRIAL STUDY 134XCP|QS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|4|||||WHODAS 2.0 - 36-ITEM PROXY|||10^12 IU/L|||MIN*MG/ML|NOT DONE||LIKERT SCALE 7-POINT|N|Y|U|4||88||LONG-TERM FOLLOW-UP|1972-04-16||||1962-06-13||1960-10-07|1963-11-29|
TRIAL STUDY 134XCP|QS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|5|||||FOSI|||MEQ/UG|||10^12/L|NOT DONE||LIKERT SCALE 7-POINT|Y|N|NA|5||7||BLINDED TREATMENT|1971-07-06||||1970-12-29||1962-07-28|1965-06-26|
TRIAL STUDY 134XCP|QS|77CF8795-CFF5-40C6-A811-624972806A38|1|||||FACT-HEP V4|||G/ANIMAL/WK|||UM/S|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|1||38||RUN-IN|1972-11-18||||1969-02-23||1960-01-07|1970-04-12|
TRIAL STUDY 134XCP|QS|77CF8795-CFF5-40C6-A811-624972806A38|2|||||PGI|||ANTI-XA IU|||S/H|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|Y|2||58||BLINDED TREATMENT|1970-06-26||||1971-07-02||1964-11-17|1972-07-04|
TRIAL STUDY 134XCP|QS|77CF8795-CFF5-40C6-A811-624972806A38|3|||||FACT-BRM V4|||VP/ML|||CMH2O*S/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|3||39||OPEN LABEL TREATMENT|1968-05-16||||1964-10-14||1968-02-04|1970-10-05|
TRIAL STUDY 134XCP|QS|77CF8795-CFF5-40C6-A811-624972806A38|4|||||SF8 V1.0 ACUTE|||MG/DOSE|||10^5/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|N|4||88||SCREENING|1962-06-02||||1972-03-06||1960-12-17|1971-04-24|
TRIAL STUDY 134XCP|QS|77CF8795-CFF5-40C6-A811-624972806A38|5|||||AQ20|||JOULE|||F|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|N|5||7||INDUCTION TREATMENT|1965-07-24||||1961-10-17||1973-01-06|1965-07-15|
TRIAL STUDY 134XCP|QS|D43B827C-D393-41D4-81C5-AACB1A7673A1|1|||||WHODAS 2.0 - 36-ITEM PROXY|||IU/MMOL|||PMOL/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1965-01-04||||1962-11-02||1970-10-23|1963-10-15|
TRIAL STUDY 134XCP|QS|D43B827C-D393-41D4-81C5-AACB1A7673A1|2|||||FACT-LEU V4|||PIXEL|||COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|Y|2||58||INDUCTION TREATMENT|1960-07-02||||1973-05-10||1966-10-17|1972-04-10|
TRIAL STUDY 134XCP|QS|D43B827C-D393-41D4-81C5-AACB1A7673A1|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||KUSP|||FT2|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|3||39||CONTINUATION TREATMENT|1970-12-22||||1973-02-03||1972-11-17|1972-07-22|
TRIAL STUDY 134XCP|QS|D43B827C-D393-41D4-81C5-AACB1A7673A1|4|||||PODCI - ADOLESCENT SELF REPORTED|||NU/CL|||BEATS/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|N|4||88||FOLLOW-UP|1968-06-30||||1967-04-23||1971-04-06|1961-04-26|
TRIAL STUDY 134XCP|QS|D43B827C-D393-41D4-81C5-AACB1A7673A1|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||ANTI-XA IU|||G/CM2|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|5||7||BASELINE|1960-04-16||||1964-06-08||1970-09-08|1965-04-12|
TRIAL STUDY 134XCP|QS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1|||||IIEF|||CI/KG|||NG/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|N|1||38||FOLLOW-UP|1963-11-04||||1969-06-18||1960-02-20|1963-01-18|
TRIAL STUDY 134XCP|QS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2|||||ACQ|||KIT|||MMOL/MIN/KPA|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|2||58||RUN-IN|1964-06-20||||1966-05-23||1961-02-02|1960-11-03|
TRIAL STUDY 134XCP|QS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|3|||||GCGI|||PELLET|||HPA|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|N|3||39||LONG-TERM FOLLOW-UP|1972-02-17||||1962-05-15||1960-06-28|1963-08-26|
TRIAL STUDY 134XCP|QS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|4|||||WHODAS 2.0 - 36-ITEM PROXY|||FT|||IN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|4||88||CONTINUATION TREATMENT|1961-01-01||||1960-11-20||1960-06-22|1963-03-09|
TRIAL STUDY 134XCP|QS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|5|||||EPIC-26|||PIPE|||UG/G/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|U|5||7||FOLLOW-UP|1973-01-20||||1960-04-26||1973-01-10|1965-05-12|
TRIAL STUDY 134XCP|QS|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1|||||C-SSRS SCREENING|||UCI/KG|||JDF UNIT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|1||38||WASHOUT|1971-07-27||||1960-02-24||1971-07-28|1960-09-01|
TRIAL STUDY 134XCP|QS|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||10^3 ORGANISMS/ML|||JOULE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|NA|2||58||WASHOUT|1967-03-25||||1963-10-23||1965-06-28|1963-03-07|
TRIAL STUDY 134XCP|QS|0671FB62-42B8-4882-93ED-0E11CFE07DE9|3|||||FACIT-DYSPNEA SF|||BQ/UG|||NG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|U|3||39||RUN-IN|1966-03-03||||1969-12-01||1961-09-24|1968-01-25|
TRIAL STUDY 134XCP|QS|0671FB62-42B8-4882-93ED-0E11CFE07DE9|4|||||EQ-5D-5L|||KALLIKREIN INHIBITOR UNIT|||/10^4|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|N|4||88||INDUCTION TREATMENT|1969-05-25||||1962-08-01||1972-06-12|1963-08-25|
TRIAL STUDY 134XCP|QS|0671FB62-42B8-4882-93ED-0E11CFE07DE9|5|||||PHQ-2|||C|||CAN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|Y|5||7||BLINDED TREATMENT|1967-06-11||||1961-12-11||1960-01-26|1965-11-25|
TRIAL STUDY 134XCP|QS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1|||||HAEM-A-QOL|||10^6 CFU/G|||UKAT/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|1||38||BLINDED TREATMENT|1968-02-08||||1961-02-06||1973-01-20|1962-07-07|
TRIAL STUDY 134XCP|QS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2|||||FBRSI|||MPL U|||UMOL/H/MMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|2||58||CONTINUATION TREATMENT|1968-07-22||||1966-03-29||1967-06-09|1968-12-08|
TRIAL STUDY 134XCP|QS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|3|||||EORTC QLQ-LC13|||/SEC|||NG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|NA|3||39||RUN-IN|1965-08-22||||1968-01-03||1972-05-10|1970-09-04|
TRIAL STUDY 134XCP|QS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|4|||||SGRQ-C|||MOSM/KG|||L/H/M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|4||88||FOLLOW-UP|1965-11-15||||1970-01-31||1965-02-24|1966-10-06|
TRIAL STUDY 134XCP|QS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||PFU|||HZ|NOT DONE||LIKERT SCALE 7-POINT|N|N|U|5||7||SCREENING|1970-10-13||||1963-09-18||1972-02-16|1960-04-21|
TRIAL STUDY 134XCP|QS|E9161164-3B91-4855-AFBA-12C6BD93F95F|1|||||Q-LES-Q|||/100 WBC|||LOG10 CCID 50/DOSE|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|1||38||INDUCTION TREATMENT|1972-06-08||||1966-12-08||1971-07-10|1961-01-22|
TRIAL STUDY 134XCP|QS|E9161164-3B91-4855-AFBA-12C6BD93F95F|2|||||WOMAC VA 3.1 INDEX|||ML/(MIN*100ML)|||INHALATION|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|Y|2||58||OBSERVATION|1967-12-23||||1969-12-14||1962-05-16|1971-06-13|
TRIAL STUDY 134XCP|QS|E9161164-3B91-4855-AFBA-12C6BD93F95F|3|||||PHQ-15|||10^3 ORGANISMS/ML|||USP U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|3||39||LONG-TERM FOLLOW-UP|1969-03-10||||1965-03-04||1966-07-22|1963-11-01|
TRIAL STUDY 134XCP|QS|E9161164-3B91-4855-AFBA-12C6BD93F95F|4|||||FLU-IIQ ONCE DAILY|||FRACTION OF 1|||MEQ/G|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|4||88||FOLLOW-UP|1968-10-29||||1968-09-27||1967-03-11|1962-06-27|
TRIAL STUDY 134XCP|QS|E9161164-3B91-4855-AFBA-12C6BD93F95F|5|||||C-SSRS ALREADY ENROLLED SUBJECTS|||G/KG|||NSEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|5||7||LONG-TERM FOLLOW-UP|1960-04-23||||1966-10-22||1967-10-31|1972-05-01|
TRIAL STUDY 134XCP|QS|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1|||||CES|||MG/M2/H|||G/CAGE/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|1||38||RUN-IN|1970-04-05||||1972-10-25||1972-01-01|1966-09-02|
TRIAL STUDY 134XCP|QS|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2|||||FACT-G V4|||NG/L|||EP U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|U|2||58||WASHOUT|1964-09-12||||1960-07-10||1969-01-30|1969-08-14|
TRIAL STUDY 134XCP|QS|FBB66C13-05F5-4337-B34A-9900EB5F50F3|3|||||FACT-P V4|||BAU|||ML*CMH2O|NOT DONE||LIKERT SCALE 5-POINT|Y|U|N|3||39||INDUCTION TREATMENT|1968-01-26||||1970-02-05||1971-12-10|1971-08-28|
TRIAL STUDY 134XCP|QS|FBB66C13-05F5-4337-B34A-9900EB5F50F3|4|||||RDQ|||FOZ_US|||UMOL/H/MMOL|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|4||88||BASELINE|1971-08-24||||1968-02-28||1967-03-26|1971-07-02|
TRIAL STUDY 134XCP|QS|FBB66C13-05F5-4337-B34A-9900EB5F50F3|5|||||EXPANDED DRS-PI CAREGIVER VERSION|||10^6 U|||JDF UNIT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|N|5||7||RUN-IN|1968-12-10||||1969-07-15||1970-01-08|1965-06-16|
TRIAL STUDY 134XCP|QS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1|||||WPAI-GH V2.0|||CI/KG|||ML/SEC/1.73M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|1||38||FOLLOW-UP|1972-08-08||||1973-06-29||1973-05-16|1968-04-20|
TRIAL STUDY 134XCP|QS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2|||||FACT-BMT V4|||OD UNIT|||UU/DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|2||58||WASHOUT|1964-02-11||||1964-05-28||1971-01-23|1963-02-03|
TRIAL STUDY 134XCP|QS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|3|||||ACT|||% INHIBITION|||JAR|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|3||39||BASELINE|1968-04-26||||1960-04-08||1961-05-02|1964-11-09|
TRIAL STUDY 134XCP|QS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||SEC|||10^3 CFU/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|4||88||OPEN LABEL TREATMENT|1964-10-11||||1966-06-04||1967-06-16|1971-03-28|
TRIAL STUDY 134XCP|QS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|5|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||FMOL/L|||ML/MMHG|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|5||7||SCREENING|1964-11-27||||1964-08-17||1964-06-26|1970-05-02|
TRIAL STUDY 134XCP|QS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1|||||PI|||KIU|||SEC|NOT DONE||LIKERT SCALE 5-POINT|U|N|NA|1||38||RUN-IN|1970-11-06||||1966-11-18||1961-09-08|1968-04-18|
TRIAL STUDY 134XCP|QS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2|||||AQLQ|||CM|||ML/CAGE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|2||58||INDUCTION TREATMENT|1968-07-26||||1961-07-06||1967-02-24|1973-08-22|
TRIAL STUDY 134XCP|QS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|3|||||EPIC-26|||MG/L FEU|||CFU/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|3||39||OBSERVATION|1961-09-28||||1960-05-20||1963-06-25|1970-04-24|
TRIAL STUDY 134XCP|QS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|4|||||EPIC-26|||WATT|||CAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|4||88||OPEN LABEL TREATMENT|1962-08-16||||1969-03-09||1967-10-06|1965-07-28|
TRIAL STUDY 134XCP|QS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|5|||||SGRQ PAST 4 WEEKS VERSION|||NEEDLE GAUGE|||UL/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|Y|5||7||RUN-IN|1962-07-20||||1961-05-16||1962-09-21|1973-07-17|
TRIAL STUDY 134XCP|QS|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||FEU|||UMOL/L/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|1||38||RUN-IN|1972-03-09||||1964-09-23||1963-05-21|1961-08-16|
TRIAL STUDY 134XCP|QS|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2|||||IPAQ-LF PHONE VERSION|||/10^4|||LENS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|U|2||58||CONTINUATION TREATMENT|1970-02-02||||1960-01-03||1969-01-03|1970-01-15|
TRIAL STUDY 134XCP|QS|21223189-5527-4B3F-AFD5-21F77AC0DEBE|3|||||NCCN-FACT FBLSI-18 V2|||NSEC|||MCI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|N|3||39||OPEN LABEL TREATMENT|1964-04-21||||1970-09-01||1964-12-30|1968-05-31|
TRIAL STUDY 134XCP|QS|21223189-5527-4B3F-AFD5-21F77AC0DEBE|4|||||AUDIT-SR|||MOL/MOL|||L/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|N|4||88||OPEN LABEL TREATMENT|1967-07-20||||1962-09-04||1965-10-26|1972-03-19|
TRIAL STUDY 134XCP|QS|21223189-5527-4B3F-AFD5-21F77AC0DEBE|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||PUFF|||CFU/G|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|5||7||BASELINE|1970-12-28||||1961-08-20||1969-11-29|1960-05-15|
TRIAL STUDY 134XCP|QS|CA6ECC17-3E3B-435C-A485-8612C267E52B|1|||||FKSI-DRS V4|||MV2/HZ|||LOZENGE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|1||38||BASELINE|1968-03-18||||1971-06-03||1968-12-02|1965-04-27|
TRIAL STUDY 134XCP|QS|CA6ECC17-3E3B-435C-A485-8612C267E52B|2|||||SF10 V1.0 CHILDREN STANDARD|||10^3 COPIES/ML|||MPL U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|N|2||58||CONTINUATION TREATMENT|1969-10-01||||1965-04-05||1962-04-29|1960-02-03|
TRIAL STUDY 134XCP|QS|CA6ECC17-3E3B-435C-A485-8612C267E52B|3|||||FLU-IIQ TWICE DAILY|||RATIO|||MEQ/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|3||39||WASHOUT|1965-06-18||||1971-07-05||1965-04-06|1961-02-07|
TRIAL STUDY 134XCP|QS|CA6ECC17-3E3B-435C-A485-8612C267E52B|4|||||CGI|||U/DL|||U/10^12 RBC|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|U|4||88||WASHOUT|1969-12-04||||1960-07-10||1961-01-13|1961-08-11|
TRIAL STUDY 134XCP|QS|CA6ECC17-3E3B-435C-A485-8612C267E52B|5|||||IDS-SR|||IU/L|||ML/MIN/MMHG|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|5||7||TREATMENT|1963-06-23||||1972-07-08||1960-12-25|1969-11-10|
TRIAL STUDY 134XCP|QS|BCB41507-87B3-4773-B1E5-AE039853DED0|1|||||PARENT-DDS|||ML/DL|||L/H/M2|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|N|1||38||RUN-IN|1964-08-22||||1963-08-03||1962-04-23|1963-12-27|
TRIAL STUDY 134XCP|QS|BCB41507-87B3-4773-B1E5-AE039853DED0|2|||||BSI-18|||FEU|||MG/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|Y|2||58||BASELINE|1970-06-11||||1960-09-05||1963-12-23|1968-12-31|
TRIAL STUDY 134XCP|QS|BCB41507-87B3-4773-B1E5-AE039853DED0|3|||||HCS|||LOG10 TCID 50/DOSE|||10^6 ORGANISMS|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|3||39||TREATMENT|1968-10-18||||1960-09-28||1966-03-04|1960-08-04|
TRIAL STUDY 134XCP|QS|BCB41507-87B3-4773-B1E5-AE039853DED0|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||BAG|||UG/M2/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|4||88||RUN-IN|1962-04-15||||1969-05-05||1963-05-14|1966-11-14|
TRIAL STUDY 134XCP|QS|BCB41507-87B3-4773-B1E5-AE039853DED0|5|||||IVIS|||U/G|||DPM/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|5||7||FOLLOW-UP|1963-05-01||||1970-09-06||1963-12-20|1971-01-27|
TRIAL STUDY 134XCP|QS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1|||||HCS|||JAR|||KEV|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|1||38||CONTINUATION TREATMENT|1966-06-22||||1972-11-09||1962-03-06|1973-08-16|
TRIAL STUDY 134XCP|QS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2|||||GAD-7 V2|||ML/H|||BREATHS/30S|NOT DONE||LIKERT SCALE 7-POINT|N|Y|N|2||58||LONG-TERM FOLLOW-UP|1967-07-04||||1964-09-30||1965-07-23|1965-01-14|
TRIAL STUDY 134XCP|QS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|3|||||CHART-SF INTERVIEW VERSION|||NCI|||BU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|3||39||BASELINE|1969-10-05||||1971-04-15||1962-06-17|1963-04-04|
TRIAL STUDY 134XCP|QS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||UG/ANIMAL|||EIA UNIT|NOT DONE||LIKERT SCALE 3-POINT|U|NA|N|4||88||BLINDED TREATMENT|1972-06-02||||1963-06-03||1969-02-13|1969-11-12|
TRIAL STUDY 134XCP|QS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|5|||||SF36 V1.0 ACUTE|||PPTR|||/HPF|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|5||7||OBSERVATION|1962-02-27||||1967-01-18||1960-03-30|1972-10-27|
TRIAL STUDY 134XCP|QS|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1|||||FACT-P V4|||KUSP|||PPTH|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|1||38||TREATMENT|1960-03-03||||1969-01-04||1960-12-25|1964-10-07|
TRIAL STUDY 134XCP|QS|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2|||||ANSD V1.0|||BP|||ML/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|2||58||TREATMENT|1969-01-05||||1966-12-28||1962-08-18|1965-02-22|
TRIAL STUDY 134XCP|QS|EC726B09-0B0F-4933-94F4-8941DF68EDE6|3|||||C-SSRS SCREENING|||FL|||MG/G/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|Y|3||39||TREATMENT|1971-02-02||||1970-01-13||1972-02-01|1971-11-02|
TRIAL STUDY 134XCP|QS|EC726B09-0B0F-4933-94F4-8941DF68EDE6|4|||||UPS|||MOL/L|||MASK|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|4||88||BLINDED TREATMENT|1962-12-10||||1961-05-15||1963-04-24|1970-03-15|
TRIAL STUDY 134XCP|QS|EC726B09-0B0F-4933-94F4-8941DF68EDE6|5|||||PI|||ROENTGEN|||MU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|5||7||CONTINUATION TREATMENT|1970-11-29||||1967-01-14||1968-05-11|1965-04-21|
TRIAL STUDY 134XCP|QS|9F703096-9152-422E-AEAB-AD22F00863ED|1|||||GAD-7|||UCI/L|||MG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|NA|1||38||LONG-TERM FOLLOW-UP|1967-06-29||||1961-08-17||1969-04-06|1969-05-08|
TRIAL STUDY 134XCP|QS|9F703096-9152-422E-AEAB-AD22F00863ED|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||KG/MOL|||USP U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|2||58||INDUCTION TREATMENT|1966-11-01||||1961-12-15||1971-08-02|1966-10-04|
TRIAL STUDY 134XCP|QS|9F703096-9152-422E-AEAB-AD22F00863ED|3|||||AQLQ|||U/G/DAY|||U/M2/H|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|3||39||OBSERVATION|1967-06-06||||1965-05-02||1964-02-10|1967-01-31|
TRIAL STUDY 134XCP|QS|9F703096-9152-422E-AEAB-AD22F00863ED|4|||||MFIS|||V/SEC|||GLOBULE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|4||88||FOLLOW-UP|1967-07-26||||1969-09-07||1965-10-22|1973-07-02|
TRIAL STUDY 134XCP|QS|9F703096-9152-422E-AEAB-AD22F00863ED|5|||||PROSQOLI|||MG/CM2|||KCAL/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|Y|5||7||BASELINE|1966-02-02||||1960-03-24||1970-03-24|1967-05-27|
TRIAL STUDY 134XCP|QS|57455593-8872-4B17-8B3F-8A02FE855290|1|||||EXACT|||AGU/ML|||GY/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|1||38||INDUCTION TREATMENT|1971-08-07||||1969-02-21||1971-11-26|1967-02-05|
TRIAL STUDY 134XCP|QS|57455593-8872-4B17-8B3F-8A02FE855290|2|||||PHQ SCREENER VERSION|||U/ML|||G/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|2||58||SCREENING|1970-03-24||||1962-09-16||1969-05-07|1960-12-12|
TRIAL STUDY 134XCP|QS|57455593-8872-4B17-8B3F-8A02FE855290|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||MM/H|||OSM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|3||39||LONG-TERM FOLLOW-UP|1960-07-02||||1961-09-26||1960-12-26|1965-02-13|
TRIAL STUDY 134XCP|QS|57455593-8872-4B17-8B3F-8A02FE855290|4|||||UPDRS|||/200 HPFS|||10^6 CFU|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|4||88||BLINDED TREATMENT|1962-03-22||||1966-06-13||1963-02-24|1968-06-18|
TRIAL STUDY 134XCP|QS|57455593-8872-4B17-8B3F-8A02FE855290|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||MN|||UG/G/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|5||7||OPEN LABEL TREATMENT|1961-08-11||||1962-11-21||1966-08-02|1970-05-06|
TRIAL STUDY 134XCP|QS|97F58005-7367-49DC-967B-FAD681B55DF8|1|||||FACIT-FATIGUE 13-ITEM V4|||UG/KG/H|||FT2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|1||38||OBSERVATION|1970-08-29||||1964-11-28||1960-01-14|1965-05-22|
TRIAL STUDY 134XCP|QS|97F58005-7367-49DC-967B-FAD681B55DF8|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||ML/MMHG/MIN/L|||UCI|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|Y|2||58||CONTINUATION TREATMENT|1965-05-06||||1971-12-29||1964-06-21|1971-06-22|
TRIAL STUDY 134XCP|QS|97F58005-7367-49DC-967B-FAD681B55DF8|3|||||GDS|||FG|||UKAT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|U|3||39||FOLLOW-UP|1971-07-18||||1971-01-03||1965-10-07|1973-02-14|
TRIAL STUDY 134XCP|QS|97F58005-7367-49DC-967B-FAD681B55DF8|4|||||EPIC-26|||MG/ML/MIN|||10^9/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|U|4||88||RUN-IN|1966-12-16||||1962-04-07||1972-05-19|1963-03-29|
TRIAL STUDY 134XCP|QS|97F58005-7367-49DC-967B-FAD681B55DF8|5|||||COWS|||PATCH|||EJACULATE U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|NA|5||7||OPEN LABEL TREATMENT|1967-08-08||||1971-04-10||1965-12-23|1971-06-04|
TRIAL STUDY 134XCP|QS|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1|||||PODCI - PEDIATRIC PARENT REPORTED|||PG/L|||UKAT|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|N|1||38||FOLLOW-UP|1960-04-01||||1961-03-18||1971-02-17|1963-05-22|
TRIAL STUDY 134XCP|QS|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2|||||SGRQ PAST 4 WEEKS VERSION|||ML/M2/H|||MG/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|2||58||TREATMENT|1961-07-21||||1964-12-28||1963-06-20|1968-09-06|
TRIAL STUDY 134XCP|QS|83AC0828-3C22-4F7C-9D22-F044BB5B630D|3|||||COWS|||BAU|||MG/KG/H|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|Y|3||39||SCREENING|1964-07-26||||1973-04-13||1960-07-22|1960-03-20|
TRIAL STUDY 134XCP|QS|83AC0828-3C22-4F7C-9D22-F044BB5B630D|4|||||MPAI-4|||MNFI|||/200 HPFS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|N|4||88||TREATMENT|1966-06-15||||1969-03-16||1960-03-17|1966-01-26|
TRIAL STUDY 134XCP|QS|83AC0828-3C22-4F7C-9D22-F044BB5B630D|5|||||WLQ|||UKAT/L|||OD UNIT|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|5||7||WASHOUT|1968-03-14||||1973-07-16||1970-05-05|1961-02-07|
TRIAL STUDY 134XCP|QS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||DAMOL/L|||GRAVITATIONAL UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|N|1||38||TREATMENT|1971-03-05||||1963-01-23||1963-06-06|1960-11-02|
TRIAL STUDY 134XCP|QS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2|||||Q-LES-Q-SF|||DEG2|||MG/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|2||58||BASELINE|1970-09-21||||1972-05-21||1965-07-31|1970-02-19|
TRIAL STUDY 134XCP|QS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|3|||||DAD|||10^6 IU/ML|||TROCHE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|3||39||SCREENING|1971-06-12||||1968-01-08||1962-12-16|1965-05-25|
TRIAL STUDY 134XCP|QS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|4|||||AQ20|||LOG10 ELISA UNIT|||GENEQ|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|4||88||BLINDED TREATMENT|1962-09-16||||1963-11-03||1962-04-26|1970-11-01|
TRIAL STUDY 134XCP|QS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|5|||||PDQUALIF|||LOG10 CFU/G|||FEU|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|5||7||OBSERVATION|1963-10-10||||1963-12-19||1968-05-29|1968-03-21|
TRIAL STUDY 134XCP|QS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1|||||FACT-L V4|||BAR|||10^7 PFU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|NA|1||38||WASHOUT|1969-04-12||||1968-07-07||1962-05-04|1961-11-10|
TRIAL STUDY 134XCP|QS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||DB|||/MM|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|NA|2||58||BLINDED TREATMENT|1960-09-10||||1960-09-12||1963-09-30|1965-01-25|
TRIAL STUDY 134XCP|QS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||CI/UL|||MOL/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|NA|3||39||OPEN LABEL TREATMENT|1971-04-09||||1972-06-05||1964-07-14|1965-09-15|
TRIAL STUDY 134XCP|QS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||M/SEC|||UGEQ/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|4||88||FOLLOW-UP|1965-11-13||||1964-11-25||1972-10-08|1969-01-26|
TRIAL STUDY 134XCP|QS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|5|||||DAD|||UGEQ|||G/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|N|5||7||CONTINUATION TREATMENT|1966-05-28||||1970-08-28||1968-09-18|1964-05-14|
TRIAL STUDY 134XCP|QS|B386B813-1175-4421-9C86-F9AB597877FA|1|||||FACIT-DYSPNEA 33 ITEM BANK|||MMOL/MIN/KPA/L|||KALLIKREIN INHIBITOR UNIT|NOT DONE||LIKERT SCALE 7-POINT|N|N|U|1||38||FOLLOW-UP|1972-04-21||||1962-06-02||1963-09-28|1971-07-12|
TRIAL STUDY 134XCP|QS|B386B813-1175-4421-9C86-F9AB597877FA|2|||||SF12 V1.0 STANDARD|||MMHG/SEC|||TUBERCULIN UNIT|NOT DONE||LIKERT SCALE 7-POINT|NA|U|U|2||58||FOLLOW-UP|1961-02-17||||1962-01-27||1971-10-02|1964-06-05|
TRIAL STUDY 134XCP|QS|B386B813-1175-4421-9C86-F9AB597877FA|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||MEQ/DAY|||MOL/L|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|U|3||39||BASELINE|1966-05-06||||1970-12-22||1965-05-02|1968-06-20|
TRIAL STUDY 134XCP|QS|B386B813-1175-4421-9C86-F9AB597877FA|4|||||SDS|||ML/KG/H|||10^6 CFU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|4||88||INDUCTION TREATMENT|1973-03-09||||1971-01-26||1960-12-15|1961-11-02|
TRIAL STUDY 134XCP|QS|B386B813-1175-4421-9C86-F9AB597877FA|5|||||COPD ASSESSMENT TEST|||STRIP|||PHERESIS UNIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|5||7||INDUCTION TREATMENT|1970-05-07||||1966-08-18||1972-12-30|1966-06-24|
TRIAL STUDY 134XCP|QS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1|||||CHART-SF INTERVIEW VERSION|||VG/KG|||MG/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|N|1||38||LONG-TERM FOLLOW-UP|1969-01-16||||1971-11-16||1967-12-25|1965-05-30|
TRIAL STUDY 134XCP|QS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2|||||SMDDS V1.0|||NSEC|||CMHG|NOT DONE||LIKERT SCALE 5-POINT|U|Y|Y|2||58||BASELINE|1968-02-25||||1964-10-28||1968-12-18|1963-07-31|
TRIAL STUDY 134XCP|QS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||10^6 RNA COPIES/ML|||ML/KG/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|3||39||RUN-IN|1962-05-04||||1961-06-24||1961-06-19|1961-12-08|
TRIAL STUDY 134XCP|QS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|4|||||ADAS-COG|||NG/DL|||NG/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|Y|4||88||OBSERVATION|1965-02-28||||1964-07-08||1968-11-24|1967-08-28|
TRIAL STUDY 134XCP|QS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|5|||||SF12 V1.0 STANDARD|||ML|||MG/DOSE|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|5||7||FOLLOW-UP|1960-05-30||||1962-08-11||1964-08-31|1973-02-22|
TRIAL STUDY 134XCP|QS|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1|||||BWCS|||PM|||UKAT/10^12 RBC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|U|1||38||TREATMENT|1969-06-14||||1970-01-03||1971-03-13|1964-09-07|
TRIAL STUDY 134XCP|QS|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2|||||HAQ-DI WITH VAS|||SEC|||U/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|NA|2||58||FOLLOW-UP|1965-04-16||||1970-01-13||1960-02-28|1965-10-28|
TRIAL STUDY 134XCP|QS|7B33775D-1DFF-49A6-820E-7981F5C16AFF|3|||||ODI V2.1A|||MILE|||UM/DAY|NOT DONE||LIKERT SCALE 5-POINT|N|NA|U|3||39||SCREENING|1961-05-05||||1969-06-16||1964-11-14|1970-05-17|
TRIAL STUDY 134XCP|QS|7B33775D-1DFF-49A6-820E-7981F5C16AFF|4|||||C-SSRS LIFETIME/RECENT VERSION|||CMHG|||NG/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|U|4||88||SCREENING|1972-08-05||||1972-05-09||1962-07-19|1971-06-27|
TRIAL STUDY 134XCP|QS|7B33775D-1DFF-49A6-820E-7981F5C16AFF|5|||||PHQ-15|||ABSORBANCE U|||NKAT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|NA|5||7||TREATMENT|1972-06-12||||1967-01-30||1968-11-20|1969-10-24|
TRIAL STUDY 134XCP|QS|DC48DD03-B87E-422D-A2EE-D87342260E19|1|||||FACIT-DYSPNEA SF|||/2500 WBC|||ECL UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|Y|1||38||CONTINUATION TREATMENT|1961-11-30||||1962-11-15||1969-08-10|1969-01-17|
TRIAL STUDY 134XCP|QS|DC48DD03-B87E-422D-A2EE-D87342260E19|2|||||SWLS|||/100 WBC|||DIOPTER|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|2||58||TREATMENT|1968-12-26||||1965-10-29||1963-07-08|1969-04-03|
TRIAL STUDY 134XCP|QS|DC48DD03-B87E-422D-A2EE-D87342260E19|3|||||YMRS|||DAGU|||10^7 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|NA|3||39||OBSERVATION|1966-11-18||||1970-11-25||1961-12-28|1970-12-17|
TRIAL STUDY 134XCP|QS|DC48DD03-B87E-422D-A2EE-D87342260E19|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||MMAL|||COPIES/UG|NOT DONE||LIKERT SCALE 3-POINT|U|NA|Y|4||88||CONTINUATION TREATMENT|1964-06-23||||1969-09-03||1960-01-15|1971-11-02|
TRIAL STUDY 134XCP|QS|DC48DD03-B87E-422D-A2EE-D87342260E19|5|||||ODI V2.1A|||DRINK|||CM H2O|NOT DONE||LIKERT SCALE 3-POINT|N|U|N|5||7||WASHOUT|1968-10-09||||1963-02-15||1969-07-20|1966-11-04|
TRIAL STUDY 134XCP|QS|2E084441-61A3-4B8B-9050-A5D7B38CA978|1|||||EORTC QLQ-CR29 V2.1|||WAFER|||TBSP|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|Y|1||38||INDUCTION TREATMENT|1971-06-27||||1967-03-15||1968-06-30|1973-07-19|
TRIAL STUDY 134XCP|QS|2E084441-61A3-4B8B-9050-A5D7B38CA978|2|||||NPI|||KBQ/UL|||UG/L FEU|NOT DONE||LIKERT SCALE 5-POINT|Y|N|U|2||58||INDUCTION TREATMENT|1967-12-21||||1968-03-30||1970-09-16|1961-05-25|
TRIAL STUDY 134XCP|QS|2E084441-61A3-4B8B-9050-A5D7B38CA978|3|||||DRRI-2|||FMOL/L/SEC|||FIU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|N|3||39||CONTINUATION TREATMENT|1966-01-08||||1965-08-03||1965-01-03|1960-10-11|
TRIAL STUDY 134XCP|QS|2E084441-61A3-4B8B-9050-A5D7B38CA978|4|||||BIS-11|||APPLICATION|||NG/DL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|NA|4||88||LONG-TERM FOLLOW-UP|1963-05-27||||1962-12-22||1969-09-01|1971-08-11|
TRIAL STUDY 134XCP|QS|2E084441-61A3-4B8B-9050-A5D7B38CA978|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||CMHG|||S^-1(%O2)^-1|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|NA|5||7||RUN-IN|1967-01-29||||1963-02-13||1968-05-30|1968-05-02|
TRIAL STUDY 134XCP|QS|601D563B-AA21-4859-A87E-B2068C1E3F53|1|||||FACT-HEP V4|||CI/MG|||WATT|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|1||38||OBSERVATION|1969-07-11||||1970-12-04||1962-05-29|1965-04-02|
TRIAL STUDY 134XCP|QS|601D563B-AA21-4859-A87E-B2068C1E3F53|2|||||CCQ 1 WEEK VERSION|||ML/100G/MIN|||ABSORBANCE U/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|2||58||BLINDED TREATMENT|1971-01-31||||1972-08-04||1971-06-15|1960-01-29|
TRIAL STUDY 134XCP|QS|601D563B-AA21-4859-A87E-B2068C1E3F53|3|||||YMRS|||KDA|||SEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|3||39||RUN-IN|1960-10-17||||1965-08-07||1960-09-27|1965-08-31|
TRIAL STUDY 134XCP|QS|601D563B-AA21-4859-A87E-B2068C1E3F53|4|||||ADHD-RS-IV HOME VERSION|||FIU|||/MS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|4||88||BASELINE|1963-09-07||||1960-06-09||1965-12-23|1960-09-07|
TRIAL STUDY 134XCP|QS|601D563B-AA21-4859-A87E-B2068C1E3F53|5|||||YMRS|||ANTI-XA IU|||NL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|N|5||7||WASHOUT|1964-12-04||||1965-10-13||1964-01-26|1963-08-09|
TRIAL STUDY 134XCP|QS|D8FE5979-24C7-478F-8612-0102F28F5ADE|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||MG/ML/DAY|||CI/UG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|1||38||WASHOUT|1970-11-12||||1969-08-08||1968-01-09|1971-06-23|
TRIAL STUDY 134XCP|QS|D8FE5979-24C7-478F-8612-0102F28F5ADE|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||FL|||/DAY|NOT DONE||LIKERT SCALE 7-POINT|NA|U|U|2||58||BLINDED TREATMENT|1970-02-13||||1960-03-16||1964-09-22|1972-07-19|
TRIAL STUDY 134XCP|QS|D8FE5979-24C7-478F-8612-0102F28F5ADE|3|||||IDS-SR|||10^7 CFU|||MMOL/MIN/KPA/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|3||39||INDUCTION TREATMENT|1968-12-23||||1960-07-12||1961-05-04|1966-04-03|
TRIAL STUDY 134XCP|QS|D8FE5979-24C7-478F-8612-0102F28F5ADE|4|||||WPAI-GH V2.0|||10^6/HPF|||MEQ/UL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|4||88||OPEN LABEL TREATMENT|1964-06-21||||1967-03-13||1962-08-19|1969-08-20|
TRIAL STUDY 134XCP|QS|D8FE5979-24C7-478F-8612-0102F28F5ADE|5|||||MHIS-NACC|||/SEC|||10^7/L|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|5||7||FOLLOW-UP|1967-02-18||||1972-04-23||1961-12-12|1969-05-10|
TRIAL STUDY 134XCP|QS|D275315F-D3C5-4260-8BD6-37DDB67262B0|1|||||HAQ-DI WITH VAS|||10^6/HPF|||G/G/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|1||38||BLINDED TREATMENT|1964-07-27||||1963-08-29||1963-02-07|1968-10-05|
TRIAL STUDY 134XCP|QS|D275315F-D3C5-4260-8BD6-37DDB67262B0|2|||||C-SSRS CHILDREN'S BASELINE|||BLOCKS|||S/H|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|2||58||FOLLOW-UP|1970-10-11||||1961-04-30||1964-06-19|1963-11-13|
TRIAL STUDY 134XCP|QS|D275315F-D3C5-4260-8BD6-37DDB67262B0|3|||||HADS|||/500 WBC|||ML/MMHG/MIN/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|3||39||BASELINE|1967-09-12||||1973-03-04||1970-02-04|1971-09-26|
TRIAL STUDY 134XCP|QS|D275315F-D3C5-4260-8BD6-37DDB67262B0|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||FT2|||MV|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|4||88||FOLLOW-UP|1968-07-03||||1967-06-27||1971-06-23|1961-04-17|
TRIAL STUDY 134XCP|QS|D275315F-D3C5-4260-8BD6-37DDB67262B0|5|||||PODCI - ADOLESCENT SELF REPORTED|||MPA|||PUFF|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|5||7||TREATMENT|1967-05-19||||1969-07-01||1960-10-17|1967-06-19|
TRIAL STUDY 134XCP|QS|34127CD2-378B-4335-AD4B-F305D0A21AF4|1|||||FAS-NACC UDS V3.0|||L/H/M2|||JDF UNIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|1||38||LONG-TERM FOLLOW-UP|1968-06-28||||1964-03-13||1960-10-24|1962-01-24|
TRIAL STUDY 134XCP|QS|34127CD2-378B-4335-AD4B-F305D0A21AF4|2|||||MPAI-4|||PFU/ML|||BQ/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|N|2||58||OPEN LABEL TREATMENT|1960-07-05||||1961-01-15||1972-11-22|1970-02-20|
TRIAL STUDY 134XCP|QS|34127CD2-378B-4335-AD4B-F305D0A21AF4|3|||||T1-DDS|||NKAT/G HB|||/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|3||39||CONTINUATION TREATMENT|1964-12-05||||1972-03-10||1973-07-22|1960-03-08|
TRIAL STUDY 134XCP|QS|34127CD2-378B-4335-AD4B-F305D0A21AF4|4|||||CES|||BOTTLE|||V|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|Y|4||88||CONTINUATION TREATMENT|1970-08-24||||1966-08-31||1973-03-05|1960-10-21|
TRIAL STUDY 134XCP|QS|34127CD2-378B-4335-AD4B-F305D0A21AF4|5|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||CI/L|||MANSON U/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|Y|5||7||RUN-IN|1965-10-25||||1973-01-21||1969-07-05|1962-08-07|
TRIAL STUDY 134XCP|QS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1|||||GAD-7|||HEP|||10^12 IU/L|NOT DONE||LIKERT SCALE 3-POINT|NA|U|NA|1||38||RUN-IN|1963-02-03||||1965-03-02||1967-10-14|1972-05-02|
TRIAL STUDY 134XCP|QS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2|||||ADCS-CGIC|||DAGU/ML|||DAGU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|2||58||INDUCTION TREATMENT|1961-04-20||||1972-10-06||1963-02-13|1969-08-07|
TRIAL STUDY 134XCP|QS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||%|||CL|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|U|3||39||SCREENING|1972-10-25||||1970-07-30||1964-12-08|1962-08-23|
TRIAL STUDY 134XCP|QS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|4|||||PODCI - ADOLESCENT SELF REPORTED|||FEU|||UMOL/DL|NOT DONE||LIKERT SCALE 7-POINT|U|NA|NA|4||88||BASELINE|1960-05-15||||1972-09-19||1969-10-25|1961-08-09|
TRIAL STUDY 134XCP|QS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|5|||||SF8 V1.0 ACUTE|||ML/G/MIN|||MMHG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|5||7||RUN-IN|1969-06-25||||1962-07-04||1969-06-28|1964-02-28|
TRIAL STUDY 134XCP|QS|6EE04A90-681B-439E-9783-04B40A4AF240|1|||||HAMD 6 SELF-REPORT VERSION|||10^6 ORGANISMS|||/10^5|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|U|1||38||RUN-IN|1962-01-18||||1965-05-22||1962-04-13|1965-10-13|
TRIAL STUDY 134XCP|QS|6EE04A90-681B-439E-9783-04B40A4AF240|2|||||SIQR|||UMOL/L|||ML/(MIN*100ML)|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|2||58||WASHOUT|1966-02-01||||1966-10-07||1964-12-19|1968-11-29|
TRIAL STUDY 134XCP|QS|6EE04A90-681B-439E-9783-04B40A4AF240|3|||||PDQUALIF|||APPLICATION|||/10^4|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|Y|3||39||INDUCTION TREATMENT|1962-09-26||||1961-11-12||1964-05-12|1962-09-17|
TRIAL STUDY 134XCP|QS|6EE04A90-681B-439E-9783-04B40A4AF240|4|||||SIQR|||ENZYME U/G HB|||KCAL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|NA|4||88||SCREENING|1961-03-14||||1973-07-22||1967-06-21|1968-09-04|
TRIAL STUDY 134XCP|QS|6EE04A90-681B-439E-9783-04B40A4AF240|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||RATIO|||POINT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|5||7||FOLLOW-UP|1963-12-15||||1960-07-29||1971-02-21|1965-09-06|
TRIAL STUDY 134XCP|QS|A5C0B034-1226-40EE-87E3-D46A7342B550|1|||||FLU-IIQ TWICE DAILY|||AMOL|||CI/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|N|1||38||RUN-IN|1965-11-08||||1966-07-11||1972-05-11|1965-05-18|
TRIAL STUDY 134XCP|QS|A5C0B034-1226-40EE-87E3-D46A7342B550|2|||||FLU-IIQ ONCE DAILY|||MOL/MG|||SV|NOT DONE||LIKERT SCALE 7-POINT|U|NA|N|2||58||CONTINUATION TREATMENT|1966-03-21||||1967-12-11||1967-02-04|1968-01-01|
TRIAL STUDY 134XCP|QS|A5C0B034-1226-40EE-87E3-D46A7342B550|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||UEQ/L|||PMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|U|3||39||SCREENING|1962-03-18||||1961-08-07||1969-03-15|1971-06-05|
TRIAL STUDY 134XCP|QS|A5C0B034-1226-40EE-87E3-D46A7342B550|4|||||RAND-36 V1.0|||UCI/L|||VP/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|NA|4||88||BLINDED TREATMENT|1967-08-24||||1967-10-09||1967-05-13|1972-02-11|
TRIAL STUDY 134XCP|QS|A5C0B034-1226-40EE-87E3-D46A7342B550|5|||||EXACT|||LENS|||L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|5||7||RUN-IN|1973-07-27||||1963-07-19||1970-05-13|1973-09-01|
TRIAL STUDY 134XCP|QS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1|||||ADSD V1.0|||PIXELS/IN|||KM/H|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|1||38||FOLLOW-UP|1969-01-26||||1970-04-27||1964-04-14|1973-04-10|
TRIAL STUDY 134XCP|QS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2|||||WPAI-SHP V2.0|||KA_U/DL|||DNA COPIES/UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|N|2||58||OBSERVATION|1973-03-03||||1972-12-08||1960-09-06|1968-07-18|
TRIAL STUDY 134XCP|QS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|3|||||WHODAS 2.0 - 12-ITEM SELF|||IU/KG/H|||ML/DL|NOT DONE||LIKERT SCALE 5-POINT|Y|U|NA|3||39||INDUCTION TREATMENT|1968-09-26||||1971-01-05||1971-10-24|1960-07-17|
TRIAL STUDY 134XCP|QS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|4|||||SDS|||10^6 CFU|||CY/CM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|4||88||OPEN LABEL TREATMENT|1968-08-29||||1964-01-05||1967-04-21|1961-10-17|
TRIAL STUDY 134XCP|QS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||MONTHS|||PT_US|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|5||7||LONG-TERM FOLLOW-UP|1961-12-29||||1972-08-19||1963-09-16|1968-11-02|
TRIAL STUDY 134XCP|QS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1|||||FKSI-DRS V4|||MM/SEC|||MS2|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|N|1||38||BLINDED TREATMENT|1965-07-02||||1966-11-22||1968-10-30|1962-04-24|
TRIAL STUDY 134XCP|QS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2|||||NCCN-FACT FHNSI-22 V2|||MM|||MET*MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|NA|2||58||LONG-TERM FOLLOW-UP|1963-01-24||||1965-11-09||1969-12-23|1968-12-24|
TRIAL STUDY 134XCP|QS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||ML/100G/MIN|||MG/H|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|3||39||WASHOUT|1970-11-26||||1963-04-06||1966-10-17|1969-05-08|
TRIAL STUDY 134XCP|QS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|4|||||ADSD V1.0|||UMOL/L/SEC|||PT_US|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|4||88||RUN-IN|1970-07-27||||1965-05-28||1970-10-10|1968-04-03|
TRIAL STUDY 134XCP|QS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|5|||||MADRS|||KCAL/DAY|||/H|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|N|5||7||LONG-TERM FOLLOW-UP|1963-06-18||||1971-09-24||1969-07-02|1964-02-09|
TRIAL STUDY 134XCP|QS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||K|||IU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|1||38||CONTINUATION TREATMENT|1972-04-01||||1967-07-04||1969-05-21|1963-09-17|
TRIAL STUDY 134XCP|QS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2|||||NPS|||H/WK|||IU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|2||58||BASELINE|1960-05-10||||1961-08-16||1960-11-11|1964-04-01|
TRIAL STUDY 134XCP|QS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|3|||||BWCS|||S/H|||FMOL/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|U|3||39||OBSERVATION|1966-04-27||||1961-09-26||1973-06-16|1960-11-03|
TRIAL STUDY 134XCP|QS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|4|||||WHODAS 2.0 - 12-ITEM PROXY|||10^4 CFU|||UG/L DDU|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|4||88||CONTINUATION TREATMENT|1971-05-25||||1968-08-10||1967-07-07|1966-03-03|
TRIAL STUDY 134XCP|QS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|5|||||FAS-NACC UDS V3.0|||10^7 TCID 50/DOSE|||G/ANIMAL/WK|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|5||7||LONG-TERM FOLLOW-UP|1965-04-10||||1972-06-08||1972-04-02|1962-04-17|
TRIAL STUDY 134XCP|QS|D58A8C37-6659-4B00-8BED-256E8754F93C|1|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||MMHG*MIN/L|||PA|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|1||38||RUN-IN|1972-03-04||||1963-03-07||1965-07-26|1962-01-20|
TRIAL STUDY 134XCP|QS|D58A8C37-6659-4B00-8BED-256E8754F93C|2|||||PSQI|||SCOOPFUL|||U/M2/DAY|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|2||58||TREATMENT|1962-07-25||||1966-08-18||1968-07-11|1966-01-03|
TRIAL STUDY 134XCP|QS|D58A8C37-6659-4B00-8BED-256E8754F93C|3|||||ANSD V1.0|||MIN*MG/ML|||ML/(MIN*100ML)|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|3||39||FOLLOW-UP|1970-03-26||||1963-03-09||1964-02-24|1971-04-09|
TRIAL STUDY 134XCP|QS|D58A8C37-6659-4B00-8BED-256E8754F93C|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||ANSON U|||APL U/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|4||88||BASELINE|1967-02-13||||1967-05-28||1971-05-15|1970-05-10|
TRIAL STUDY 134XCP|QS|D58A8C37-6659-4B00-8BED-256E8754F93C|5|||||BPI|||EIA UNIT|||TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|5||7||OPEN LABEL TREATMENT|1970-03-05||||1973-08-15||1971-08-18|1973-06-26|
TRIAL STUDY 134XCP|QS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||TSP EQ|||WATT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|Y|1||38||OPEN LABEL TREATMENT|1967-11-27||||1965-10-29||1962-08-20|1969-12-31|
TRIAL STUDY 134XCP|QS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2|||||Q-LES-Q|||MMOL/G|||TUBERCULIN UNIT|NOT DONE||LIKERT SCALE 5-POINT|U|N|Y|2||58||BLINDED TREATMENT|1964-03-24||||1965-01-22||1964-01-16|1972-10-18|
TRIAL STUDY 134XCP|QS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|3|||||ESS|||%(V/V)|||/MS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|Y|3||39||BLINDED TREATMENT|1960-05-24||||1971-08-18||1963-01-13|1963-06-01|
TRIAL STUDY 134XCP|QS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|4|||||BORG CR10|||UL/KG/DAY|||ML/CM|NOT DONE||LIKERT SCALE 7-POINT|U|Y|N|4||88||BLINDED TREATMENT|1968-05-27||||1970-10-31||1971-12-12|1970-04-25|
TRIAL STUDY 134XCP|QS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|5|||||CHART-SF PAPER VERSION|||CFU/ML|||CYCLE/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|Y|5||7||CONTINUATION TREATMENT|1972-07-26||||1968-02-16||1967-06-04|1969-12-31|
TRIAL STUDY 134XCP|QS|5440F45F-C220-46E7-8354-6AF34A003E5E|1|||||WPAI-GH V2.0|||/100 WBC|||ANTIBODY UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|1||38||INDUCTION TREATMENT|1967-05-12||||1960-09-25||1972-06-23|1962-07-03|
TRIAL STUDY 134XCP|QS|5440F45F-C220-46E7-8354-6AF34A003E5E|2|||||PHQ-9|||MOL/L|||MEQ/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|2||58||INDUCTION TREATMENT|1966-12-31||||1970-10-30||1966-01-02|1969-09-24|
TRIAL STUDY 134XCP|QS|5440F45F-C220-46E7-8354-6AF34A003E5E|3|||||WLQ|||ML/MIN/1.73M2|||KBQ/UL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|3||39||CONTINUATION TREATMENT|1966-09-29||||1960-03-01||1970-01-11|1966-03-10|
TRIAL STUDY 134XCP|QS|5440F45F-C220-46E7-8354-6AF34A003E5E|4|||||ODI V2.1A|||10^9 ORGANISMS/ML|||CPM|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|4||88||WASHOUT|1971-11-21||||1969-08-27||1963-08-28|1972-12-24|
TRIAL STUDY 134XCP|QS|5440F45F-C220-46E7-8354-6AF34A003E5E|5|||||UPS|||SIEMENS|||HEP|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|5||7||RUN-IN|1973-05-03||||1965-12-09||1966-07-19|1970-03-29|
TRIAL STUDY 134XCP|QS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1|||||FACT-L V4|||MM/2H|||BQ/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|1||38||SCREENING|1961-06-30||||1964-10-17||1968-11-05|1973-01-25|
TRIAL STUDY 134XCP|QS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2|||||COWS|||HPA|||ENZYME U|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|2||58||LONG-TERM FOLLOW-UP|1969-09-22||||1969-08-20||1963-06-12|1966-10-23|
TRIAL STUDY 134XCP|QS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|3|||||NCCN-FACT FPSI-17 V2|||GPS U|||KPA/L/SEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|NA|3||39||TREATMENT|1969-10-26||||1973-07-09||1968-08-13|1965-10-16|
TRIAL STUDY 134XCP|QS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|4|||||SMDDS V1.0|||10^4 CFU|||UV2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|N|4||88||TREATMENT|1970-07-24||||1967-04-20||1968-03-01|1965-11-09|
TRIAL STUDY 134XCP|QS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|5|||||FACT-B V4|||U/M2/MIN|||KG/MOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|5||7||BLINDED TREATMENT|1966-07-18||||1967-04-18||1962-11-03|1963-12-27|
TRIAL STUDY 134XCP|QS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1|||||FLSI|||10^3 CFU/ML|||UU/L|NOT DONE||LIKERT SCALE 3-POINT|N|Y|NA|1||38||INDUCTION TREATMENT|1970-07-13||||1973-07-14||1969-03-27|1970-08-09|
TRIAL STUDY 134XCP|QS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2|||||FACT-C V4|||ELISA UNIT/DOSE|||MG/KG/H|NOT DONE||LIKERT SCALE 7-POINT|NA|N|Y|2||58||OBSERVATION|1972-03-25||||1969-08-06||1970-01-11|1971-04-08|
TRIAL STUDY 134XCP|QS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|3|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||BQ/UG|||/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|Y|3||39||CONTINUATION TREATMENT|1966-01-16||||1969-02-11||1970-10-07|1971-05-27|
TRIAL STUDY 134XCP|QS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||PL|||MG/KG|NOT DONE||LIKERT SCALE 5-POINT|U|N|NA|4||88||BASELINE|1966-12-04||||1960-08-10||1960-02-02|1971-09-19|
TRIAL STUDY 134XCP|QS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|5|||||SF12 V2.0 ACUTE|||CYLINDER|||COPIES/UL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|U|5||7||FOLLOW-UP|1968-03-17||||1966-01-05||1965-11-09|1969-03-04|
TRIAL STUDY 134XCP|QS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||/200 HPFS|||S^-1(%O2)^-1|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|1||38||FOLLOW-UP|1966-10-08||||1961-03-15||1960-07-03|1969-03-11|
TRIAL STUDY 134XCP|QS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2|||||BPI SHORT FORM|||10^7/L|||UG/KG/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|Y|2||58||OBSERVATION|1973-05-13||||1969-09-07||1965-06-12|1970-04-27|
TRIAL STUDY 134XCP|QS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|3|||||PODCI - ADOLESCENT SELF REPORTED|||S*KPA|||U/CL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|NA|3||39||BASELINE|1970-06-19||||1961-04-28||1972-11-09|1965-07-22|
TRIAL STUDY 134XCP|QS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|4|||||PR|||PMOL|||STRIP|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|4||88||WASHOUT|1968-12-29||||1970-09-26||1966-09-07|1960-03-20|
TRIAL STUDY 134XCP|QS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|5|||||FACIT-FATIGUE 13-ITEM V4|||GY/MIN|||RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|U|5||7||CONTINUATION TREATMENT|1968-08-13||||1972-10-23||1971-09-29|1963-07-23|
TRIAL STUDY 134XCP|QS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1|||||FACT-C V4|||PKAT/L|||TESLA|NOT DONE||LIKERT SCALE 5-POINT|N|Y|U|1||38||LONG-TERM FOLLOW-UP|1970-04-03||||1968-01-27||1968-05-26|1962-12-09|
TRIAL STUDY 134XCP|QS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2|||||ACQ|||CAPLET|||VP/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|N|2||58||TREATMENT|1960-07-21||||1966-09-30||1967-02-15|1971-10-06|
TRIAL STUDY 134XCP|QS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|3|||||FACT-BRM V4|||CI/L|||10^3 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|3||39||LONG-TERM FOLLOW-UP|1973-08-21||||1964-04-23||1969-04-21|1965-10-03|
TRIAL STUDY 134XCP|QS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|4|||||SF12 V2.0 STANDARD|||UG/KG/H|||MM/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|4||88||OBSERVATION|1969-05-31||||1964-01-01||1965-11-02|1972-11-12|
TRIAL STUDY 134XCP|QS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|5|||||IIEF|||MANSON U/ML|||SCOOPFUL|NOT DONE||LIKERT SCALE 3-POINT|U|U|NA|5||7||BASELINE|1961-10-13||||1972-01-03||1969-06-06|1962-04-15|
TRIAL STUDY 134XCP|QS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1|||||UPS|||FARAD|||L/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|N|1||38||TREATMENT|1966-07-25||||1960-05-12||1964-01-11|1960-03-12|
TRIAL STUDY 134XCP|QS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2|||||BSI-18|||10^6 RNA COPIES/ML|||MM/2H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|NA|2||58||WASHOUT|1962-11-02||||1962-02-12||1972-11-06|1965-05-31|
TRIAL STUDY 134XCP|QS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||PMOL/G|||MMOL/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|3||39||OBSERVATION|1967-02-13||||1961-06-09||1966-06-10|1964-07-26|
TRIAL STUDY 134XCP|QS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|4|||||MSIS-29 V1|||NEBULE|||10^3/HPF|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|NA|4||88||FOLLOW-UP|1965-04-26||||1966-10-27||1972-05-22|1969-11-06|
TRIAL STUDY 134XCP|QS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|5|||||VFQ-25 SELF ADMINISTERED|||CCID 50/ML|||TUBE|NOT DONE||LIKERT SCALE 7-POINT|U|U|N|5||7||FOLLOW-UP|1965-03-09||||1971-05-05||1964-02-21|1970-02-22|
TRIAL STUDY 134XCP|QS|1E9C7E41-8565-4C60-9EEB-814914081596|1|||||FPSR|||ML/S/M2|||SIEMENS|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|1||38||SCREENING|1965-03-20||||1973-04-08||1970-02-22|1971-03-19|
TRIAL STUDY 134XCP|QS|1E9C7E41-8565-4C60-9EEB-814914081596|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||M3|||UG/M2/DAY|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|2||58||SCREENING|1965-03-01||||1961-03-18||1973-04-06|1969-08-13|
TRIAL STUDY 134XCP|QS|1E9C7E41-8565-4C60-9EEB-814914081596|3|||||MNSI|||10^3 CFU/ML|||KALLIKREIN INHIBITOR UNIT|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|3||39||SCREENING|1968-07-31||||1970-01-19||1967-11-26|1973-05-30|
TRIAL STUDY 134XCP|QS|1E9C7E41-8565-4C60-9EEB-814914081596|4|||||FAMS|||MJOULE/CM2|||C|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|4||88||TREATMENT|1969-03-20||||1973-04-06||1968-07-27|1969-10-14|
TRIAL STUDY 134XCP|QS|1E9C7E41-8565-4C60-9EEB-814914081596|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||DAMOL/L|||FARAD|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|NA|5||7||RUN-IN|1969-11-07||||1967-05-04||1964-07-05|1963-06-27|
TRIAL STUDY 134XCP|QS|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1|||||CDR|||%(V/V)|||10^9 CFU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|1||38||BASELINE|1968-02-08||||1965-08-09||1970-08-29|1970-07-09|
TRIAL STUDY 134XCP|QS|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||CAN|||UCI|NOT DONE||LIKERT SCALE 7-POINT|N|NA|N|2||58||BASELINE|1964-04-03||||1969-11-23||1973-06-11|1960-07-02|
TRIAL STUDY 134XCP|QS|D7A008CF-5990-4D74-934A-A4DD3180EBD4|3|||||CDR|||EID 50/DOSE|||PMOL/10^9 CELLS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|3||39||WASHOUT|1969-02-04||||1968-11-15||1964-07-08|1971-09-10|
TRIAL STUDY 134XCP|QS|D7A008CF-5990-4D74-934A-A4DD3180EBD4|4|||||ADSD V1.0|||/VF|||/LSQN|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|NA|4||88||WASHOUT|1964-02-27||||1967-11-09||1973-04-14|1971-09-08|
TRIAL STUDY 134XCP|QS|D7A008CF-5990-4D74-934A-A4DD3180EBD4|5|||||IIEF|||UL|||V/SEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|U|5||7||LONG-TERM FOLLOW-UP|1971-03-21||||1969-01-09||1967-05-14|1964-07-22|
TRIAL STUDY 134XCP|QS|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1|||||WOMAC VA 3.1 INDEX|||ML/CAGE|||FG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|N|1||38||INDUCTION TREATMENT|1964-02-28||||1972-09-16||1969-07-06|1971-04-09|
TRIAL STUDY 134XCP|QS|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2|||||IPAQ-LF SELF-ADMINISTERED VERSION|||AU/ML|||BU/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|2||58||OPEN LABEL TREATMENT|1964-02-20||||1970-09-08||1973-04-05|1968-09-14|
TRIAL STUDY 134XCP|QS|C168FA23-40EE-46D8-9A56-8B80490A0EFB|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||MG/M2|||EVENTS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|U|3||39||SCREENING|1961-06-17||||1961-03-29||1972-09-25|1963-09-26|
TRIAL STUDY 134XCP|QS|C168FA23-40EE-46D8-9A56-8B80490A0EFB|4|||||FLU-IIQ TWICE DAILY|||L/MIN|||U/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|4||88||RUN-IN|1961-03-31||||1964-04-07||1961-11-11|1972-01-12|
TRIAL STUDY 134XCP|QS|C168FA23-40EE-46D8-9A56-8B80490A0EFB|5|||||LEC-5 STANDARD VERSION|||ABSORBANCE U/ML|||NCI|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|5||7||BLINDED TREATMENT|1965-03-11||||1961-10-14||1961-12-03|1962-02-21|
TRIAL STUDY 134XCP|QS|215E4E69-70C3-493C-9D67-F717363E8138|1|||||SF8 V1.0 STANDARD|||UG/DAY|||MG/G/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|1||38||BASELINE|1963-11-19||||1972-10-17||1968-04-29|1964-11-30|
TRIAL STUDY 134XCP|QS|215E4E69-70C3-493C-9D67-F717363E8138|2|||||HAMD 6 SELF-REPORT VERSION|||INHALATION|||PRESSOR UNITS|NOT DONE||LIKERT SCALE 5-POINT|U|NA|NA|2||58||TREATMENT|1973-05-18||||1969-05-08||1968-01-30|1960-01-04|
TRIAL STUDY 134XCP|QS|215E4E69-70C3-493C-9D67-F717363E8138|3|||||CHART-SF INTERVIEW VERSION|||ML/KG|||PSEC|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|3||39||TREATMENT|1971-05-04||||1963-11-12||1967-02-03|1962-04-06|
TRIAL STUDY 134XCP|QS|215E4E69-70C3-493C-9D67-F717363E8138|4|||||FACIT-DYSPNEA 33 ITEM BANK|||LENS|||10^6 ORGANISMS/MG|NOT DONE||LIKERT SCALE 7-POINT|N|Y|Y|4||88||INDUCTION TREATMENT|1970-12-02||||1966-09-12||1971-02-13|1969-07-05|
TRIAL STUDY 134XCP|QS|215E4E69-70C3-493C-9D67-F717363E8138|5|||||PARENT-DDS|||CYCLE/MIN|||ABSORBANCE U/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|5||7||INDUCTION TREATMENT|1965-12-09||||1960-11-26||1971-10-03|1962-04-21|
TRIAL STUDY 134XCP|QS|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||MMOL/MOL|||KPA|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|1||38||OBSERVATION|1967-10-21||||1962-07-26||1960-07-29|1964-09-15|
TRIAL STUDY 134XCP|QS|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2|||||ASEX-MALE|||H/WK|||KPA|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|Y|2||58||BLINDED TREATMENT|1964-12-10||||1967-08-19||1962-03-14|1964-02-16|
TRIAL STUDY 134XCP|QS|962CD4CA-AF22-42FB-ADB5-85F76850CA81|3|||||COWS|||EVENTS|||CIGAR|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|3||39||FOLLOW-UP|1960-12-01||||1962-06-29||1969-03-10|1960-12-04|
TRIAL STUDY 134XCP|QS|962CD4CA-AF22-42FB-ADB5-85F76850CA81|4|||||FKSI-15|||MV*MIN|||U/10^12 RBC|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|4||88||INDUCTION TREATMENT|1960-06-07||||1970-04-29||1973-09-03|1961-02-27|
TRIAL STUDY 134XCP|QS|962CD4CA-AF22-42FB-ADB5-85F76850CA81|5|||||MADRS|||ML/M2|||TSP EQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|N|5||7||RUN-IN|1968-06-18||||1970-04-17||1962-06-04|1968-03-31|
TRIAL STUDY 134XCP|QS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1|||||C-SSRS SCREENING|||CP|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|1||38||LONG-TERM FOLLOW-UP|1968-11-10||||1961-05-04||1970-03-17|1973-01-30|
TRIAL STUDY 134XCP|QS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2|||||ESS|||/CMH2O|||NMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|2||58||FOLLOW-UP|1966-11-01||||1962-07-23||1970-10-07|1967-09-29|
TRIAL STUDY 134XCP|QS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|3|||||HADS|||PG/CELL|||NEBULE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|3||39||WASHOUT|1961-09-05||||1962-01-14||1963-02-20|1966-08-28|
TRIAL STUDY 134XCP|QS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|4|||||WHODAS 2.0 - 36-ITEM SELF|||JAR|||KHZ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|U|4||88||CONTINUATION TREATMENT|1964-12-14||||1968-09-04||1960-01-21|1968-03-04|
TRIAL STUDY 134XCP|QS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|5|||||SGRQ PAST 3 MONTHS VERSION|||MBP|||LOG10 ELISA UNIT/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|5||7||TREATMENT|1972-08-20||||1961-03-14||1967-10-28|1969-11-11|
TRIAL STUDY 134XCP|QS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1|||||C-SSRS BASELINE|||PMOL/DL|||ML/(MIN*100ML)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|1||38||FOLLOW-UP|1969-03-27||||1963-11-09||1972-03-09|1962-04-19|
TRIAL STUDY 134XCP|QS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2|||||FACT-HEP V4|||VG/KG|||WAFER|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|Y|2||58||FOLLOW-UP|1973-02-18||||1973-05-06||1970-09-02|1973-08-16|
TRIAL STUDY 134XCP|QS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|3|||||ODI V2.1A|||MMOL/KG|||10^3/HPF|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|U|3||39||RUN-IN|1968-04-10||||1969-12-21||1962-12-07|1967-04-25|
TRIAL STUDY 134XCP|QS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|4|||||BARS|||DAYS|||UM|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|N|4||88||OPEN LABEL TREATMENT|1960-06-03||||1971-01-08||1968-04-16|1971-07-25|
TRIAL STUDY 134XCP|QS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||L/S|||KV|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|U|5||7||FOLLOW-UP|1968-05-03||||1963-10-31||1967-01-21|1973-04-04|
TRIAL STUDY 134XCP|QS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MMOL|||MG/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|NA|1||38||RUN-IN|1970-02-06||||1963-08-09||1964-08-04|1968-03-16|
TRIAL STUDY 134XCP|QS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2|||||BPI|||ML*CMH2O|||WEEKS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|Y|2||58||OPEN LABEL TREATMENT|1968-06-18||||1973-06-24||1960-09-02|1968-03-20|
TRIAL STUDY 134XCP|QS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|3|||||SF8 V1.0 ACUTE|||FIU|||GENEQ|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|3||39||FOLLOW-UP|1971-01-31||||1970-08-07||1965-01-13|1965-11-18|
TRIAL STUDY 134XCP|QS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|4|||||TSQM V1.4|||AG|||MEQ/ML|NOT DONE||LIKERT SCALE 7-POINT|U|NA|NA|4||88||INDUCTION TREATMENT|1971-05-18||||1961-09-25||1963-06-12|1965-12-03|
TRIAL STUDY 134XCP|QS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|5|||||Q-LES-Q|||CM/MIN|||MOSM|NOT DONE||LIKERT SCALE 7-POINT|NA|N|NA|5||7||OPEN LABEL TREATMENT|1961-12-23||||1965-03-02||1967-02-13|1968-11-08|
TRIAL STUDY 134XCP|QS|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1|||||ADSD V1.0|||GAUSS|||MG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|NA|1||38||OPEN LABEL TREATMENT|1962-07-21||||1971-04-09||1964-08-04|1969-09-18|
TRIAL STUDY 134XCP|QS|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2|||||PARENT-DDS|||LOG10 CFU/ML|||MMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|NA|2||58||LONG-TERM FOLLOW-UP|1972-07-25||||1970-12-04||1968-01-06|1966-02-23|
TRIAL STUDY 134XCP|QS|4A5A02C2-F875-4146-B58D-9E0E4F00527D|3|||||FACT-LYM V4|||FRAMES/S|||/VF|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|U|3||39||BLINDED TREATMENT|1970-07-08||||1960-07-12||1971-06-06|1971-09-03|
TRIAL STUDY 134XCP|QS|4A5A02C2-F875-4146-B58D-9E0E4F00527D|4|||||HCS|||SUPPOSITORY|||JOULE|NOT DONE||LIKERT SCALE 7-POINT|U|N|N|4||88||LONG-TERM FOLLOW-UP|1971-12-11||||1972-12-20||1972-07-09|1968-08-02|
TRIAL STUDY 134XCP|QS|4A5A02C2-F875-4146-B58D-9E0E4F00527D|5|||||IIEF|||APS U|||MMHG/L/MIN|NOT DONE||LIKERT SCALE 3-POINT|N|N|U|5||7||BASELINE|1970-01-27||||1963-01-24||1965-03-21|1969-05-10|
TRIAL STUDY 134XCP|QS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1|||||WOMAC VA 3.1 INDEX|||VG/DOSE|||FL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|Y|1||38||TREATMENT|1961-12-04||||1971-06-14||1970-02-26|1973-08-14|
TRIAL STUDY 134XCP|QS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2|||||EORTC QLQ-C30 V3.0|||MU|||OZ EQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|Y|2||58||SCREENING|1970-01-26||||1964-11-02||1967-06-06|1963-02-25|
TRIAL STUDY 134XCP|QS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|3|||||AQLQ|||10^4 CFU/ML|||PMOL/10^9 CELLS|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|Y|3||39||OBSERVATION|1961-12-02||||1964-03-26||1966-08-06|1971-05-09|
TRIAL STUDY 134XCP|QS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|4|||||FACIT-DYSPNEA SF|||10^9 ORGANISMS/ML|||COULOMB|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|N|4||88||OPEN LABEL TREATMENT|1961-01-07||||1967-09-24||1968-04-28|1968-11-04|
TRIAL STUDY 134XCP|QS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|5|||||PDDS|||10^9 ORGANISMS/G|||BEAM BREAKS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|5||7||SCREENING|1968-12-28||||1960-08-05||1968-05-16|1972-07-28|
TRIAL STUDY 134XCP|QS|859D9297-58D0-4740-899D-E7BEC931D419|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||10^6 ORGANISMS/G|||CI/UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|1||38||RUN-IN|1973-08-23||||1964-07-03||1967-12-03|1968-10-26|
TRIAL STUDY 134XCP|QS|859D9297-58D0-4740-899D-E7BEC931D419|2|||||SOAPP-R|||MASK|||ML/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|2||58||LONG-TERM FOLLOW-UP|1965-01-19||||1960-03-29||1965-05-25|1970-08-11|
TRIAL STUDY 134XCP|QS|859D9297-58D0-4740-899D-E7BEC931D419|3|||||TSQM V1.4|||LOG10 IU/ML|||ML/G/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|N|3||39||OBSERVATION|1970-11-26||||1968-03-16||1968-07-24|1966-02-20|
TRIAL STUDY 134XCP|QS|859D9297-58D0-4740-899D-E7BEC931D419|4|||||Q-LES-Q-SF|||BOTTLE|||CMH2O*S/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|N|Y|4||88||TREATMENT|1967-11-02||||1967-07-25||1970-05-12|1968-08-29|
TRIAL STUDY 134XCP|QS|859D9297-58D0-4740-899D-E7BEC931D419|5|||||SF8 V1.0 ACUTE|||UG/KG/MIN|||APL U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|5||7||FOLLOW-UP|1972-01-24||||1969-12-30||1963-06-15|1973-04-12|
TRIAL STUDY 134XCP|QS|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1|||||MNSI|||LOG10 PFU/ML|||UM2|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|1||38||BASELINE|1966-04-01||||1960-07-09||1964-05-13|1970-03-27|
TRIAL STUDY 134XCP|QS|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2|||||NPS|||FL|||UG/ANIMAL|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|2||58||OBSERVATION|1965-04-15||||1970-05-02||1973-01-24|1970-06-27|
TRIAL STUDY 134XCP|QS|A1E34C29-91C2-4C2B-942E-84CD6A10A056|3|||||SHORT-FORM MPQ-2|||UL|||MM/2H|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|3||39||RUN-IN|1969-07-11||||1963-02-10||1969-12-30|1966-10-07|
TRIAL STUDY 134XCP|QS|A1E34C29-91C2-4C2B-942E-84CD6A10A056|4|||||OCI|||KM|||MG/CM2|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|4||88||WASHOUT|1969-11-11||||1972-12-26||1969-10-23|1972-05-28|
TRIAL STUDY 134XCP|QS|A1E34C29-91C2-4C2B-942E-84CD6A10A056|5|||||CGI|||MEQ/MMOL|||UMOL/L/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|5||7||LONG-TERM FOLLOW-UP|1962-11-04||||1961-09-12||1962-05-31|1967-05-17|
TRIAL STUDY 134XCP|QS|4E5FF284-E15A-421D-BC13-94655EEFE540|1|||||EXPANDED DRS-PI SURVIVOR VERSION|||/MBP|||CI/G|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|Y|1||38||TREATMENT|1963-08-27||||1970-09-09||1965-08-23|1973-06-11|
TRIAL STUDY 134XCP|QS|4E5FF284-E15A-421D-BC13-94655EEFE540|2|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||OZ EQ|||G/CAGE|NOT DONE||LIKERT SCALE 7-POINT|U|N|N|2||58||OBSERVATION|1963-06-02||||1970-02-17||1971-04-03|1965-08-27|
TRIAL STUDY 134XCP|QS|4E5FF284-E15A-421D-BC13-94655EEFE540|3|||||NPS|||MOL|||UG/MIN|NOT DONE||LIKERT SCALE 7-POINT|N|U|NA|3||39||INDUCTION TREATMENT|1965-08-03||||1961-10-03||1962-07-25|1962-09-19|
TRIAL STUDY 134XCP|QS|4E5FF284-E15A-421D-BC13-94655EEFE540|4|||||SF12 V1.0 ACUTE|||MOL/ML|||UCI|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|NA|4||88||BASELINE|1963-08-17||||1967-11-11||1970-08-22|1967-04-09|
TRIAL STUDY 134XCP|QS|4E5FF284-E15A-421D-BC13-94655EEFE540|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||UU/DL|||YD|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|U|5||7||RUN-IN|1969-07-13||||1967-07-29||1962-02-05|1966-10-14|
TRIAL STUDY 134XCP|QS|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1|||||SF12 V1.0 STANDARD|||MGEQ|||H*%|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|1||38||SCREENING|1963-02-19||||1965-01-07||1969-06-22|1972-09-12|
TRIAL STUDY 134XCP|QS|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2|||||BIS-11|||SHOCK WAVE|||OZ|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|2||58||CONTINUATION TREATMENT|1960-03-07||||1968-06-12||1965-07-27|1966-12-23|
TRIAL STUDY 134XCP|QS|30BAB760-662A-41DF-9599-CBE0BC3A57D9|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||CD*S/M2|||MGEQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|U|3||39||INDUCTION TREATMENT|1963-11-23||||1973-02-25||1969-10-24|1964-03-28|
TRIAL STUDY 134XCP|QS|30BAB760-662A-41DF-9599-CBE0BC3A57D9|4|||||MMRC|||10^12 IU/L|||EP U|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|4||88||BLINDED TREATMENT|1961-04-22||||1968-02-04||1967-01-06|1965-02-28|
TRIAL STUDY 134XCP|QS|30BAB760-662A-41DF-9599-CBE0BC3A57D9|5|||||WPAI-SHP V2.0|||UCI|||CAN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|5||7||INDUCTION TREATMENT|1961-06-29||||1965-08-06||1960-02-10|1965-12-31|
TRIAL STUDY 134XCP|QS|8747C2AB-18EB-430B-8E89-CF9183DBF322|1|||||GDS|||MAMP|||MV*MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|N|1||38||TREATMENT|1969-06-18||||1964-04-22||1964-01-11|1973-05-24|
TRIAL STUDY 134XCP|QS|8747C2AB-18EB-430B-8E89-CF9183DBF322|2|||||FAS-NACC UDS V3.0|||CI/MG|||MM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|2||58||OBSERVATION|1969-11-20||||1965-12-15||1969-06-22|1969-09-11|
TRIAL STUDY 134XCP|QS|8747C2AB-18EB-430B-8E89-CF9183DBF322|3|||||MSWS-12|||10^6 CFU/ML|||OD UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|3||39||BASELINE|1964-01-07||||1971-11-30||1972-09-04|1966-07-12|
TRIAL STUDY 134XCP|QS|8747C2AB-18EB-430B-8E89-CF9183DBF322|4|||||CDR|||UGEQ|||MDFI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|4||88||LONG-TERM FOLLOW-UP|1961-06-15||||1971-11-11||1963-05-02|1965-09-25|
TRIAL STUDY 134XCP|QS|8747C2AB-18EB-430B-8E89-CF9183DBF322|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||UGEQ|||%(W/V)|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|5||7||INDUCTION TREATMENT|1969-07-19||||1967-04-24||1967-01-11|1969-02-09|
TRIAL STUDY 134XCP|QS|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1|||||EORTC QLQ-C30 V3.0|||EU|||UG/L/H|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|1||38||WASHOUT|1969-01-05||||1961-05-16||1962-12-07|1970-11-01|
TRIAL STUDY 134XCP|QS|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||GMFI|||GY/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|2||58||WASHOUT|1971-08-10||||1970-11-06||1970-05-03|1961-01-14|
TRIAL STUDY 134XCP|QS|5A0FF15D-E779-47BA-8D3C-247A0FA57854|3|||||OCI|||EIA UNIT|||ML/SEC/1.73M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|Y|3||39||SCREENING|1967-12-22||||1970-09-13||1973-02-21|1966-02-15|
TRIAL STUDY 134XCP|QS|5A0FF15D-E779-47BA-8D3C-247A0FA57854|4|||||GAD-7 V2|||LOG EID 50/DOSE|||LB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|4||88||SCREENING|1962-04-09||||1965-12-30||1965-12-28|1970-12-14|
TRIAL STUDY 134XCP|QS|5A0FF15D-E779-47BA-8D3C-247A0FA57854|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||BREATHS/MIN|||CIGARETTE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|5||7||OPEN LABEL TREATMENT|1971-06-02||||1961-09-16||1965-06-06|1965-02-13|
TRIAL STUDY 134XCP|QS|73260E60-6ADB-44DA-9A45-776B91F8B453|1|||||MSIS-29 V1|||MV/SEC|||U/MG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|1||38||CONTINUATION TREATMENT|1965-06-18||||1966-01-16||1972-04-14|1960-05-27|
TRIAL STUDY 134XCP|QS|73260E60-6ADB-44DA-9A45-776B91F8B453|2|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||UGEQ|||MU/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|2||58||RUN-IN|1970-10-16||||1960-07-19||1962-04-15|1963-02-02|
TRIAL STUDY 134XCP|QS|73260E60-6ADB-44DA-9A45-776B91F8B453|3|||||Q-LES-Q|||DB|||U/G/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|3||39||RUN-IN|1964-12-08||||1971-01-13||1964-07-01|1966-12-27|
TRIAL STUDY 134XCP|QS|73260E60-6ADB-44DA-9A45-776B91F8B453|4|||||PARTNER-DDS|||IU|||10^7 TCID 50/DOSE|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|4||88||BLINDED TREATMENT|1970-03-22||||1967-11-18||1970-06-22|1971-06-15|
TRIAL STUDY 134XCP|QS|73260E60-6ADB-44DA-9A45-776B91F8B453|5|||||EORTC QLQ-C30 V3.0|||ML/CM H2O|||MG/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|N|5||7||FOLLOW-UP|1964-11-11||||1968-11-12||1969-07-31|1966-08-22|
TRIAL STUDY 134XCP|QS|7B64252E-9A08-4177-BFA9-45B0C0E53097|1|||||OAB-Q SHORT FORM|||VP/ML|||10^6/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|N|1||38||FOLLOW-UP|1968-05-23||||1962-07-11||1963-02-16|1972-03-04|
TRIAL STUDY 134XCP|QS|7B64252E-9A08-4177-BFA9-45B0C0E53097|2|||||FACT-B V4|||ELISA UNIT|||LOG EID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|2||58||SCREENING|1970-01-28||||1967-05-04||1967-05-22|1964-05-14|
TRIAL STUDY 134XCP|QS|7B64252E-9A08-4177-BFA9-45B0C0E53097|3|||||FACIT-DYSPNEA SF|||M/SEC2|||UMOL/L/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|U|3||39||INDUCTION TREATMENT|1973-07-17||||1969-04-22||1961-04-28|1970-04-27|
TRIAL STUDY 134XCP|QS|7B64252E-9A08-4177-BFA9-45B0C0E53097|4|||||SOWS SUBJECTIVE|||NG/DL|||/100 WBC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|4||88||OBSERVATION|1962-02-14||||1971-08-13||1961-05-01|1964-09-02|
TRIAL STUDY 134XCP|QS|7B64252E-9A08-4177-BFA9-45B0C0E53097|5|||||UPDRS|||10^9/L|||MMOL/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|5||7||CONTINUATION TREATMENT|1960-08-24||||1960-02-09||1963-09-24|1964-11-05|
TRIAL STUDY 134XCP|QS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||UG/KG|||NG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|1||38||RUN-IN|1968-01-12||||1966-03-24||1963-02-28|1971-12-23|
TRIAL STUDY 134XCP|QS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2|||||VFQ-25 INTERVIEWER ADMINISTERED|||STRIP|||OD UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|2||58||CONTINUATION TREATMENT|1965-05-19||||1963-12-02||1966-06-20|1962-07-13|
TRIAL STUDY 134XCP|QS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|3|||||HAEM-A-QOL|||MMOL/DAY|||/5X10^4 WBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|3||39||LONG-TERM FOLLOW-UP|1967-09-06||||1962-04-22||1964-11-08|1961-07-12|
TRIAL STUDY 134XCP|QS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|4|||||ANSD V1.0|||MIN/DAY|||MCI/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|N|4||88||BASELINE|1960-12-22||||1972-05-27||1966-10-10|1971-08-14|
TRIAL STUDY 134XCP|QS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|5|||||EQ-5D-3L|||CM/S|||AMP|NOT DONE||LIKERT SCALE 3-POINT|N|NA|Y|5||7||RUN-IN|1971-05-02||||1963-05-16||1972-07-01|1966-02-11|
TRIAL STUDY 134XCP|QS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1|||||PODCI - PEDIATRIC PARENT REPORTED|||10^9 ORGANISMS/ML|||MMHG/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|NA|1||38||OBSERVATION|1964-09-23||||1970-08-21||1969-03-01|1966-01-05|
TRIAL STUDY 134XCP|QS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2|||||NCCN-FACT FHNSI-22 V2|||DPM/100MG|||UG/G/DAY|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|2||58||INDUCTION TREATMENT|1966-11-12||||1969-08-30||1967-09-17|1970-07-29|
TRIAL STUDY 134XCP|QS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|3|||||FACT-LEU V4|||MBP|||BAU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|3||39||LONG-TERM FOLLOW-UP|1966-07-18||||1963-07-08||1967-02-05|1966-09-20|
TRIAL STUDY 134XCP|QS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|4|||||EQ-5D-3L|||DMOL|||10^3 COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|NA|4||88||CONTINUATION TREATMENT|1969-06-08||||1960-08-28||1967-11-12|1960-11-26|
TRIAL STUDY 134XCP|QS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|5|||||PCL-5|||MG/ML/MIN|||CIGARETTE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|N|5||7||INDUCTION TREATMENT|1960-10-08||||1969-03-20||1970-03-07|1966-08-14|
TRIAL STUDY 134XCP|QS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1|||||FACT-G V4|||M|||HOMEOPATHIC DILUTION|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|1||38||LONG-TERM FOLLOW-UP|1973-05-31||||1964-03-16||1963-12-28|1961-03-16|
TRIAL STUDY 134XCP|QS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2|||||FIQR|||GPS U|||BOLUS|NOT DONE||LIKERT SCALE 7-POINT|N|NA|NA|2||58||WASHOUT|1966-04-05||||1966-10-18||1964-01-31|1965-03-20|
TRIAL STUDY 134XCP|QS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|3|||||NCCN-FACT FOSI-18 V2|||IU/MMOL|||MG/M2/DAY|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|N|3||39||FOLLOW-UP|1964-01-06||||1972-12-16||1968-05-12|1964-10-25|
TRIAL STUDY 134XCP|QS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||10^3 ORGANISMS/G|||IU/KG/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|4||88||CONTINUATION TREATMENT|1970-06-23||||1962-05-15||1964-10-07|1970-03-02|
TRIAL STUDY 134XCP|QS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|5|||||MDQ-T|||APL U|||UOSM|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|5||7||CONTINUATION TREATMENT|1967-09-26||||1963-01-05||1961-10-09|1970-11-24|
TRIAL STUDY 134XCP|QS|1B0EE182-6729-4333-BB9B-5561CAB31D26|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||ROENTGEN|||CFU/ML|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|1||38||TREATMENT|1968-08-09||||1963-08-26||1963-10-30|1962-11-11|
TRIAL STUDY 134XCP|QS|1B0EE182-6729-4333-BB9B-5561CAB31D26|2|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||CI/MG|||10^9/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|2||58||BASELINE|1971-06-11||||1973-07-11||1970-10-02|1969-12-16|
TRIAL STUDY 134XCP|QS|1B0EE182-6729-4333-BB9B-5561CAB31D26|3|||||SF12 V2.0 ACUTE|||PPTR|||COPIES/UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|3||39||OPEN LABEL TREATMENT|1964-06-03||||1971-12-07||1966-06-24|1961-12-18|
TRIAL STUDY 134XCP|QS|1B0EE182-6729-4333-BB9B-5561CAB31D26|4|||||GOSE|||PELLET|||MN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|NA|4||88||RUN-IN|1962-07-25||||1962-03-24||1963-08-14|1960-03-12|
TRIAL STUDY 134XCP|QS|1B0EE182-6729-4333-BB9B-5561CAB31D26|5|||||FACT-LEU V4|||PG|||UG/KG/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1973-07-06||||1966-11-02||1962-02-19|1972-06-22|
TRIAL STUDY 134XCP|QS|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1|||||SF8 V1.0 ACUTE|||DIP|||MMU/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|U|1||38||TREATMENT|1961-03-24||||1964-01-26||1968-02-15|1967-07-31|
TRIAL STUDY 134XCP|QS|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2|||||AUDIT-C|||U/CL|||UL/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|2||58||LONG-TERM FOLLOW-UP|1973-05-03||||1964-04-07||1968-04-04|1965-09-15|
TRIAL STUDY 134XCP|QS|1F3AD620-4B16-4EFF-8F5A-45105841BE02|3|||||BSI-18|||BISCUIT|||NFIU|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|3||39||INDUCTION TREATMENT|1971-02-25||||1970-01-10||1961-03-28|1966-04-18|
TRIAL STUDY 134XCP|QS|1F3AD620-4B16-4EFF-8F5A-45105841BE02|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||PMOL|||CYLINDER|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|4||88||OBSERVATION|1967-03-31||||1960-06-27||1971-12-21|1967-11-06|
TRIAL STUDY 134XCP|QS|1F3AD620-4B16-4EFF-8F5A-45105841BE02|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||ENZYME U/M2|||PACKET|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|N|5||7||TREATMENT|1962-01-25||||1964-10-24||1963-08-04|1962-05-14|
TRIAL STUDY 134XCP|QS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1|||||SOBDA|||GPL U/ML|||10^6 U|NOT DONE||LIKERT SCALE 3-POINT|NA|N|U|1||38||BLINDED TREATMENT|1970-10-11||||1961-12-26||1962-09-03|1968-01-31|
TRIAL STUDY 134XCP|QS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||MG/MOL|||10^9 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|NA|2||58||SCREENING|1963-07-01||||1971-11-23||1963-07-10|1961-11-04|
TRIAL STUDY 134XCP|QS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|3|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||ML/(MIN*100ML)|||UL/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|3||39||LONG-TERM FOLLOW-UP|1965-07-07||||1963-12-30||1960-06-09|1964-05-31|
TRIAL STUDY 134XCP|QS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|4|||||HAMD 6 SELF-REPORT VERSION|||TABLET|||NMOL/ML/MIN|NOT DONE||LIKERT SCALE 7-POINT|NA|U|NA|4||88||SCREENING|1961-11-22||||1965-06-30||1970-08-24|1964-03-08|
TRIAL STUDY 134XCP|QS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|5|||||WHODAS 2.0 - 36-ITEM SELF|||/MONTH|||CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|5||7||BASELINE|1967-01-07||||1966-06-23||1960-10-07|1960-10-28|
TRIAL STUDY 134XCP|QS|152147B0-6EAD-4124-8E1A-BD7707850B60|1|||||RDQ|||10^3 COPIES/ML|||10^11/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|1||38||BLINDED TREATMENT|1967-09-16||||1968-06-01||1960-05-23|1966-01-04|
TRIAL STUDY 134XCP|QS|152147B0-6EAD-4124-8E1A-BD7707850B60|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||MBQ/UL|||EP U|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|2||58||RUN-IN|1963-08-05||||1964-08-14||1969-07-06|1968-04-28|
TRIAL STUDY 134XCP|QS|152147B0-6EAD-4124-8E1A-BD7707850B60|3|||||DRRI-2|||CAPFUL|||CAN|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|3||39||OBSERVATION|1962-02-03||||1971-08-08||1971-02-24|1963-06-26|
TRIAL STUDY 134XCP|QS|152147B0-6EAD-4124-8E1A-BD7707850B60|4|||||FACIT-FATIGUE 13-ITEM V4|||UMOL/H/MMOL|||10^3 CFU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|U|4||88||RUN-IN|1968-12-03||||1966-10-31||1972-08-21|1963-04-05|
TRIAL STUDY 134XCP|QS|152147B0-6EAD-4124-8E1A-BD7707850B60|5|||||SOWS SUBJECTIVE|||APL U/ML|||TBSP|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|5||7||WASHOUT|1965-07-18||||1971-03-09||1971-10-13|1969-04-28|
TRIAL STUDY 134XCP|QS|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1|||||SF10 V1.0 CHILDREN ACUTE|||IU/DL|||PSI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|1||38||BLINDED TREATMENT|1965-05-26||||1967-11-13||1969-12-27|1961-12-10|
TRIAL STUDY 134XCP|QS|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2|||||PODCI - ADOLESCENT SELF REPORTED|||NMOL/KG/DAY|||DRUM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|Y|2||58||BASELINE|1968-11-04||||1963-10-08||1964-02-05|1966-11-07|
TRIAL STUDY 134XCP|QS|3CCF019C-5663-4670-B2D1-EC01D6B58D06|3|||||ACT|||MBQ/UL|||U/M2/H|NOT DONE||LIKERT SCALE 7-POINT|U|N|N|3||39||RUN-IN|1967-12-01||||1968-08-28||1968-01-24|1971-03-16|
TRIAL STUDY 134XCP|QS|3CCF019C-5663-4670-B2D1-EC01D6B58D06|4|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||TITER|||SCM|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|4||88||SCREENING|1968-04-01||||1962-12-08||1973-05-22|1968-02-26|
TRIAL STUDY 134XCP|QS|3CCF019C-5663-4670-B2D1-EC01D6B58D06|5|||||AUDIT-C|||10^9 CFU/ML|||HZ|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|Y|5||7||OBSERVATION|1968-11-18||||1964-02-02||1961-10-11|1967-10-22|
TRIAL STUDY 134XCP|QS|6599D082-A8A0-412D-BBDF-CD786C581905|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||HOMEOPATHIC DILUTION|||LOG10 IU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|U|1||38||OPEN LABEL TREATMENT|1973-07-24||||1970-10-28||1970-10-02|1971-04-29|
TRIAL STUDY 134XCP|QS|6599D082-A8A0-412D-BBDF-CD786C581905|2|||||BSFS|||UGEQ|||G/CAGE/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|2||58||FOLLOW-UP|1965-07-29||||1971-09-22||1967-08-22|1969-07-12|
TRIAL STUDY 134XCP|QS|6599D082-A8A0-412D-BBDF-CD786C581905|3|||||C-SSRS BASELINE|||RING|||MPA|NOT DONE||LIKERT SCALE 3-POINT|N|Y|Y|3||39||SCREENING|1971-02-08||||1963-04-23||1969-09-21|1962-09-21|
TRIAL STUDY 134XCP|QS|6599D082-A8A0-412D-BBDF-CD786C581905|4|||||EORTC QLQ-LC13|||M3|||NMOL BCE/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|4||88||LONG-TERM FOLLOW-UP|1963-06-16||||1960-01-29||1967-02-24|1965-08-07|
TRIAL STUDY 134XCP|QS|6599D082-A8A0-412D-BBDF-CD786C581905|5|||||MADRS|||UG/DOSE|||MBQ|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|N|5||7||WASHOUT|1963-06-22||||1966-10-11||1968-01-11|1972-05-04|
TRIAL STUDY 134XCP|QS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1|||||SF8 V1.0 STANDARD|||LOG10 IU/ML|||JAR|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|1||38||OBSERVATION|1973-02-17||||1962-08-10||1964-08-03|1960-04-20|
TRIAL STUDY 134XCP|QS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||ML/MIN/1.73M2|||ML/CM3/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|NA|2||58||FOLLOW-UP|1972-12-08||||1966-02-18||1961-07-22|1968-05-20|
TRIAL STUDY 134XCP|QS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|3|||||ADCS-CGIC|||10^6/HPF|||ML/MMHG/MIN/L|NOT DONE||LIKERT SCALE 3-POINT|Y|U|N|3||39||OBSERVATION|1964-07-11||||1971-08-24||1960-09-04|1973-05-06|
TRIAL STUDY 134XCP|QS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||BEATS/MIN|||CM/S|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|4||88||RUN-IN|1970-04-20||||1967-04-19||1963-08-14|1964-06-28|
TRIAL STUDY 134XCP|QS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|5|||||WOMAC NRS 3.1 INDEX|||IMPLANT|||%(W/W)|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|Y|5||7||LONG-TERM FOLLOW-UP|1969-04-30||||1965-06-06||1961-03-15|1963-07-18|
TRIAL STUDY 134XCP|QS|AAC3113C-793D-43F4-87E9-111246E03003|1|||||Q-LES-Q-SF|||MG/DAY|||10^3 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|Y|1||38||BASELINE|1971-11-27||||1968-07-26||1963-02-05|1972-03-25|
TRIAL STUDY 134XCP|QS|AAC3113C-793D-43F4-87E9-111246E03003|2|||||DRRI-2|||MONTHS|||IU/KG/H|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|Y|2||58||FOLLOW-UP|1972-04-03||||1964-07-21||1965-12-07|1960-02-09|
TRIAL STUDY 134XCP|QS|AAC3113C-793D-43F4-87E9-111246E03003|3|||||FIQR|||MG/KG/H|||MOL/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|3||39||LONG-TERM FOLLOW-UP|1965-12-17||||1972-09-02||1961-12-26|1973-02-05|
TRIAL STUDY 134XCP|QS|AAC3113C-793D-43F4-87E9-111246E03003|4|||||HAQ-DI WITH VAS|||DPM|||ML/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|NA|4||88||RUN-IN|1968-09-09||||1963-04-15||1968-12-21|1961-03-18|
TRIAL STUDY 134XCP|QS|AAC3113C-793D-43F4-87E9-111246E03003|5|||||FACT-LEU V4|||IU/DL|||HOMEOPATHIC DILUTION|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|U|5||7||CONTINUATION TREATMENT|1964-04-14||||1960-09-30||1965-08-31|1965-11-10|
TRIAL STUDY 134XCP|QS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1|||||COWS|||MBQ|||ML/CM3/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|Y|1||38||TREATMENT|1967-10-09||||1969-07-24||1970-03-01|1964-05-16|
TRIAL STUDY 134XCP|QS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2|||||EXACT|||/WK|||SACHET|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|Y|2||58||CONTINUATION TREATMENT|1969-08-10||||1960-01-28||1973-03-01|1961-08-11|
TRIAL STUDY 134XCP|QS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|3|||||MADRS|||PELLET|||VG/ML|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|3||39||FOLLOW-UP|1970-04-27||||1973-02-24||1969-10-07|1972-01-17|
TRIAL STUDY 134XCP|QS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|4|||||FACT-G V4|||10^6/HPF|||SACHET|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|4||88||INDUCTION TREATMENT|1971-08-23||||1973-05-03||1971-03-28|1971-10-29|
TRIAL STUDY 134XCP|QS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|5|||||ADSD V1.0|||U/DL|||10^6 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|U|5||7||OBSERVATION|1973-05-05||||1969-01-15||1960-01-14|1964-10-27|
TRIAL STUDY 134XCP|QS|941A9CF9-872C-42CF-A409-129BE5A88520|1|||||MFIS|||H/WK|||PMOL/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|Y|1||38||LONG-TERM FOLLOW-UP|1961-03-06||||1973-08-20||1961-09-02|1963-05-14|
TRIAL STUDY 134XCP|QS|941A9CF9-872C-42CF-A409-129BE5A88520|2|||||FACT-L V4|||U/M2/MIN|||AMFI|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|2||58||RUN-IN|1961-03-03||||1970-10-23||1964-01-03|1967-01-03|
TRIAL STUDY 134XCP|QS|941A9CF9-872C-42CF-A409-129BE5A88520|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||CM/S|||CMHG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|Y|3||39||LONG-TERM FOLLOW-UP|1960-06-12||||1967-01-12||1968-02-04|1972-10-12|
TRIAL STUDY 134XCP|QS|941A9CF9-872C-42CF-A409-129BE5A88520|4|||||FAQ-NACC VERSION|||PG|||MMOL/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|U|4||88||OPEN LABEL TREATMENT|1970-04-28||||1961-05-06||1969-09-04|1960-04-24|
TRIAL STUDY 134XCP|QS|941A9CF9-872C-42CF-A409-129BE5A88520|5|||||MSQOL-54|||PNU/ML|||LOG10 TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|5||7||TREATMENT|1960-08-07||||1968-11-12||1968-05-31|1973-04-26|
TRIAL STUDY 134XCP|QS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||DAYS/MONTH|||MBQ/UL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|NA|1||38||CONTINUATION TREATMENT|1965-05-10||||1971-10-27||1960-11-30|1962-05-15|
TRIAL STUDY 134XCP|QS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2|||||GCGI|||EJACULATE U|||MG/M2|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|2||58||BASELINE|1965-02-17||||1964-10-22||1971-04-06|1967-02-21|
TRIAL STUDY 134XCP|QS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|3|||||IIEF|||/2000 RBC|||UMOL/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|NA|3||39||FOLLOW-UP|1963-10-24||||1972-08-19||1969-07-13|1964-11-18|
TRIAL STUDY 134XCP|QS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|4|||||PI|||U/DL|||CMH2O/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|NA|4||88||OBSERVATION|1969-07-01||||1965-04-19||1960-02-07|1972-04-24|
TRIAL STUDY 134XCP|QS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|5|||||BIS-11|||ML/DL|||/VF|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|Y|5||7||TREATMENT|1962-07-16||||1964-11-09||1970-06-30|1966-08-23|
TRIAL STUDY 134XCP|QS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1|||||FACT-BRM V4|||DAYS/WK|||DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|1||38||OBSERVATION|1967-10-14||||1961-11-03||1960-09-13|1966-03-20|
TRIAL STUDY 134XCP|QS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2|||||FKSI-15|||MAC50|||MMOL/MOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|2||58||WASHOUT|1973-08-24||||1961-08-04||1968-01-25|1966-12-10|
TRIAL STUDY 134XCP|QS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|3|||||HAQ-DI WITHOUT VAS|||PMOL/DL|||WEEKS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|U|3||39||BASELINE|1965-09-28||||1960-12-14||1967-05-01|1972-12-15|
TRIAL STUDY 134XCP|QS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|4|||||FACIT-DYSPNEA SF|||10^7 PFU|||GPELISA UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|U|4||88||BLINDED TREATMENT|1971-02-25||||1967-02-10||1971-06-21|1971-06-30|
TRIAL STUDY 134XCP|QS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||CYLINDER|||MMOL2/L2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|5||7||WASHOUT|1970-04-28||||1963-03-16||1971-06-25|1960-08-22|
TRIAL STUDY 134XCP|QS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1|||||NPI|||10^9 ORGANISMS/ML|||MPL U/ML|NOT DONE||LIKERT SCALE 5-POINT|U|NA|N|1||38||SCREENING|1965-09-16||||1972-07-19||1969-12-27|1968-02-17|
TRIAL STUDY 134XCP|QS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||BAR|||%|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|NA|2||58||BLINDED TREATMENT|1972-03-19||||1970-06-18||1968-01-04|1973-08-14|
TRIAL STUDY 134XCP|QS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|3|||||GAD-7|||COULOMB|||SBE/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|NA|3||39||OPEN LABEL TREATMENT|1961-11-07||||1964-05-05||1964-08-25|1960-01-23|
TRIAL STUDY 134XCP|QS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|4|||||PODCI - PEDIATRIC PARENT REPORTED|||CAPFUL|||UG/M2/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|Y|4||88||WASHOUT|1971-10-27||||1960-11-20||1971-10-29|1960-07-14|
TRIAL STUDY 134XCP|QS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|5|||||SF12 V1.0 ACUTE|||BEL|||MOL/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|N|5||7||RUN-IN|1970-03-13||||1962-11-16||1960-03-25|1964-01-02|
TRIAL STUDY 134XCP|QS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1|||||IIEF|||PMOL/G|||PACK|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|1||38||LONG-TERM FOLLOW-UP|1964-04-10||||1968-08-21||1965-10-28|1963-06-13|
TRIAL STUDY 134XCP|QS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2|||||FACT-HEP V4|||ECL UNIT|||ML/(MIN*100ML)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|N|2||58||RUN-IN|1970-11-18||||1972-04-20||1973-04-26|1965-06-27|
TRIAL STUDY 134XCP|QS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|3|||||SOWS SUBJECTIVE|||NG|||AMFI|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|Y|3||39||CONTINUATION TREATMENT|1965-07-24||||1960-07-07||1972-03-17|1965-07-02|
TRIAL STUDY 134XCP|QS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|4|||||SMDDS V1.0|||MU|||U|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|4||88||WASHOUT|1964-12-23||||1971-06-18||1971-07-19|1964-03-23|
TRIAL STUDY 134XCP|QS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|5|||||ADSD V1.0|||MM3/MM2/YEAR|||PA|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|NA|5||7||BLINDED TREATMENT|1961-04-07||||1967-06-13||1966-11-29|1965-06-05|
TRIAL STUDY 134XCP|QS|A4A5E66A-E65C-4234-8858-E69D04AB1593|1|||||VFQ-25 SELF ADMINISTERED|||10^3 RNA COPIES/ML|||MESF|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|N|1||38||TREATMENT|1963-07-07||||1965-01-19||1968-11-17|1963-06-27|
TRIAL STUDY 134XCP|QS|A4A5E66A-E65C-4234-8858-E69D04AB1593|2|||||NCCN-FACT FPSI-17 V2|||10^3 RNA COPIES/ML|||PMOL/10^10 CELLS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|2||58||BLINDED TREATMENT|1961-06-22||||1964-06-06||1965-06-25|1973-04-22|
TRIAL STUDY 134XCP|QS|A4A5E66A-E65C-4234-8858-E69D04AB1593|3|||||PODCI - ADOLESCENT SELF REPORTED|||ML/ANIMAL|||MANSON U/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|NA|3||39||BLINDED TREATMENT|1966-02-08||||1965-10-14||1971-12-04|1967-05-14|
TRIAL STUDY 134XCP|QS|A4A5E66A-E65C-4234-8858-E69D04AB1593|4|||||IPAQ-LF PHONE VERSION|||AFU|||PG/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|Y|4||88||BLINDED TREATMENT|1962-12-01||||1963-06-08||1967-11-04|1960-03-28|
TRIAL STUDY 134XCP|QS|A4A5E66A-E65C-4234-8858-E69D04AB1593|5|||||OAB-Q SHORT FORM|||CMH2O*S2/ML|||UG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|N|5||7||CONTINUATION TREATMENT|1973-08-09||||1965-03-07||1973-08-26|1963-11-06|
TRIAL STUDY 134XCP|QS|0EA46DA5-4291-4585-9745-08BFA60BED3F|1|||||SIQ|||U/MG|||UM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|Y|1||38||WASHOUT|1966-05-08||||1963-11-30||1964-04-21|1962-04-13|
TRIAL STUDY 134XCP|QS|0EA46DA5-4291-4585-9745-08BFA60BED3F|2|||||FLU-IIQ ONCE DAILY|||CP|||HENRY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|NA|2||58||SCREENING|1967-06-03||||1965-09-02||1968-05-15|1963-10-20|
TRIAL STUDY 134XCP|QS|0EA46DA5-4291-4585-9745-08BFA60BED3F|3|||||ADCS-CGIC|||QUANTITY SUFFICIENT|||KG/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|Y|3||39||WASHOUT|1965-08-27||||1972-02-22||1969-07-31|1968-12-20|
TRIAL STUDY 134XCP|QS|0EA46DA5-4291-4585-9745-08BFA60BED3F|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||MASK|||LOG10 TCID 50/DOSE|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|4||88||BASELINE|1969-06-03||||1965-01-08||1965-01-14|1965-02-07|
TRIAL STUDY 134XCP|QS|0EA46DA5-4291-4585-9745-08BFA60BED3F|5|||||FLU-IIQ ONCE DAILY|||10^8 PFU|||MV|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|N|5||7||OBSERVATION|1965-09-23||||1964-08-09||1965-05-26|1968-05-13|
TRIAL STUDY 134XCP|QS|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1|||||SOWS SUBJECTIVE|||PKAT/L|||CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|1||38||LONG-TERM FOLLOW-UP|1969-12-21||||1965-02-08||1973-01-25|1970-08-14|
TRIAL STUDY 134XCP|QS|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2|||||HADS|||MG/CM2|||CG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|2||58||SCREENING|1961-10-26||||1963-03-05||1970-04-06|1968-11-24|
TRIAL STUDY 134XCP|QS|F54E494F-7EC2-41E7-A969-DF7151EA08E9|3|||||WOMAC VA 3.1 INDEX|||CUP EQ|||UG/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|N|3||39||OBSERVATION|1972-03-19||||1972-04-19||1971-11-19|1972-07-26|
TRIAL STUDY 134XCP|QS|F54E494F-7EC2-41E7-A969-DF7151EA08E9|4|||||FACT-B V4|||CI/ML|||AGU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|4||88||BLINDED TREATMENT|1964-10-31||||1968-05-14||1963-04-05|1972-11-04|
TRIAL STUDY 134XCP|QS|F54E494F-7EC2-41E7-A969-DF7151EA08E9|5|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||UM2|||10^6/HPF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|5||7||BASELINE|1968-06-18||||1971-08-11||1971-08-19|1969-04-24|
TRIAL STUDY 134XCP|QS|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1|||||EORTC QLQ-CR29 V2.1|||DPM/ML|||10^3 CFU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|1||38||BASELINE|1966-04-14||||1967-12-03||1966-08-25|1963-10-25|
TRIAL STUDY 134XCP|QS|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2|||||CHART-SF INTERVIEW VERSION|||ML/MIN/1.73M2|||CM/S|NOT DONE||LIKERT SCALE 3-POINT|NA|U|U|2||58||TREATMENT|1970-05-14||||1960-05-05||1960-09-23|1961-02-21|
TRIAL STUDY 134XCP|QS|3C4215F7-A7FA-4177-8B84-FD26FEB43039|3|||||COMM|||SHOCK WAVE|||G/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|3||39||WASHOUT|1962-07-05||||1963-10-18||1966-11-27|1962-11-11|
TRIAL STUDY 134XCP|QS|3C4215F7-A7FA-4177-8B84-FD26FEB43039|4|||||MMRC|||BU/ML|||ML/CM H2O|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|4||88||WASHOUT|1965-04-13||||1970-01-27||1960-09-22|1972-09-01|
TRIAL STUDY 134XCP|QS|3C4215F7-A7FA-4177-8B84-FD26FEB43039|5|||||BLCS|||KPA/L/SEC|||TITER|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|N|5||7||OBSERVATION|1964-05-13||||1969-04-14||1972-12-07|1969-05-16|
TRIAL STUDY 134XCP|QS|797C71A3-375E-466E-BDA8-A2828C9C45BB|1|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||SPRAY|||NKAT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|1||38||BLINDED TREATMENT|1962-06-01||||1965-02-14||1968-05-28|1969-01-06|
TRIAL STUDY 134XCP|QS|797C71A3-375E-466E-BDA8-A2828C9C45BB|2|||||GOSE|||PFU/ML|||G/CAGE/WK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|2||58||INDUCTION TREATMENT|1972-07-21||||1965-11-24||1973-01-02|1971-11-24|
TRIAL STUDY 134XCP|QS|797C71A3-375E-466E-BDA8-A2828C9C45BB|3|||||GAD-7 V2|||SBE/ML|||FARAD|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|3||39||WASHOUT|1961-12-12||||1960-10-25||1973-02-22|1967-02-07|
TRIAL STUDY 134XCP|QS|797C71A3-375E-466E-BDA8-A2828C9C45BB|4|||||FACT-G V4|||STRIP|||IU/G|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|4||88||FOLLOW-UP|1969-01-13||||1970-05-05||1966-07-06|1970-09-24|
TRIAL STUDY 134XCP|QS|797C71A3-375E-466E-BDA8-A2828C9C45BB|5|||||COMM|||TRANSDUCING UNIT|||AMFI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|5||7||CONTINUATION TREATMENT|1970-09-23||||1960-10-15||1961-05-26|1967-11-09|
TRIAL STUDY 134XCP|QS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||PM|||G/CAGE/WK|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|1||38||LONG-TERM FOLLOW-UP|1963-10-12||||1966-05-18||1970-07-23|1965-09-10|
TRIAL STUDY 134XCP|QS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||V/V|||MONTHS|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|U|2||58||SCREENING|1963-10-04||||1965-02-01||1970-04-28|1966-03-24|
TRIAL STUDY 134XCP|QS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|3|||||ADHD-RS-IV HOME VERSION|||M2|||CAL|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|3||39||INDUCTION TREATMENT|1972-05-31||||1964-10-28||1970-09-02|1970-03-12|
TRIAL STUDY 134XCP|QS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||UKAT/10^12 RBC|||LENS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|4||88||BASELINE|1971-06-29||||1967-05-15||1969-07-18|1972-10-29|
TRIAL STUDY 134XCP|QS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|5|||||C-SSRS ALREADY ENROLLED SUBJECTS|||NMOL/L/H|||UG/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|U|5||7||WASHOUT|1960-07-27||||1960-11-04||1973-05-22|1963-03-19|
TRIAL STUDY 134XCP|QS|5617A5B9-AEE0-4118-9113-3755ED8E961A|1|||||FAQ-NACC VERSION|||F|||UKAT/10^12 RBC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|1||38||OPEN LABEL TREATMENT|1971-01-25||||1969-10-04||1966-06-10|1967-05-15|
TRIAL STUDY 134XCP|QS|5617A5B9-AEE0-4118-9113-3755ED8E961A|2|||||ADCS-ADL SEVERE DEMENTIA|||UCI/L|||G/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|2||58||BASELINE|1962-03-17||||1960-06-02||1971-05-17|1964-12-10|
TRIAL STUDY 134XCP|QS|5617A5B9-AEE0-4118-9113-3755ED8E961A|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||MMOL/MIN/KPA|||MMHG|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|3||39||BLINDED TREATMENT|1967-05-26||||1963-02-17||1961-09-09|1970-05-09|
TRIAL STUDY 134XCP|QS|5617A5B9-AEE0-4118-9113-3755ED8E961A|4|||||BLCS|||IU/G HB|||TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|4||88||BASELINE|1969-11-26||||1962-02-14||1969-02-16|1971-08-27|
TRIAL STUDY 134XCP|QS|5617A5B9-AEE0-4118-9113-3755ED8E961A|5|||||SF10 V1.0 CHILDREN STANDARD|||KIT|||NEWTON|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|5||7||OBSERVATION|1969-06-06||||1971-12-21||1968-07-23|1966-11-11|
TRIAL STUDY 134XCP|QS|7ECE0F95-910A-4FB3-9435-73805E498415|1|||||SGRQ-C|||10^4/L|||10^9 CFU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|1||38||SCREENING|1971-12-29||||1964-08-31||1961-08-18|1972-11-18|
TRIAL STUDY 134XCP|QS|7ECE0F95-910A-4FB3-9435-73805E498415|2|||||SHORT-FORM MPQ-2|||UG/L/H|||/MBP|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|U|2||58||INDUCTION TREATMENT|1960-05-08||||1970-06-15||1967-01-22|1968-05-24|
TRIAL STUDY 134XCP|QS|7ECE0F95-910A-4FB3-9435-73805E498415|3|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||KS|||ML*CMH2O|NOT DONE||LIKERT SCALE 7-POINT|U|Y|NA|3||39||BASELINE|1968-10-23||||1962-08-21||1962-03-08|1970-02-07|
TRIAL STUDY 134XCP|QS|7ECE0F95-910A-4FB3-9435-73805E498415|4|||||EORTC QLQ-C15-PAL V1.0|||MEQ/UG|||UG/ANIMAL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|4||88||BLINDED TREATMENT|1968-09-24||||1973-07-13||1968-01-09|1963-02-08|
TRIAL STUDY 134XCP|QS|7ECE0F95-910A-4FB3-9435-73805E498415|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||IMPLANT|||UM/S|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|5||7||BLINDED TREATMENT|1969-12-01||||1964-11-20||1967-09-26|1967-02-25|
TRIAL STUDY 134XCP|QS|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1|||||SWLS|||EID 50/DOSE|||CL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|1||38||LONG-TERM FOLLOW-UP|1973-03-07||||1969-01-05||1962-07-16|1970-11-04|
TRIAL STUDY 134XCP|QS|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||L/DAY|||IU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|2||58||LONG-TERM FOLLOW-UP|1962-01-20||||1965-08-24||1961-09-04|1962-12-19|
TRIAL STUDY 134XCP|QS|83EDB0FE-728D-453F-8DB2-7D44202EEB43|3|||||RAND-36 V1.0|||COAT|||PACK YEAR|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|3||39||WASHOUT|1973-03-11||||1960-10-13||1960-10-28|1965-10-06|
TRIAL STUDY 134XCP|QS|83EDB0FE-728D-453F-8DB2-7D44202EEB43|4|||||EORTC QLQ-CR29 V2.1|||MEQ/G|||/MM|NOT DONE||LIKERT SCALE 3-POINT|N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1962-02-01||||1966-02-25||1965-01-29|1970-07-15|
TRIAL STUDY 134XCP|QS|83EDB0FE-728D-453F-8DB2-7D44202EEB43|5|||||FBRSI|||JDF UNIT|||ML*CMH2O|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|Y|5||7||OBSERVATION|1966-07-26||||1973-03-06||1964-06-08|1972-06-16|
TRIAL STUDY 134XCP|QS|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1|||||SF12 V2.0 ACUTE|||MM2|||CFU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|NA|1||38||CONTINUATION TREATMENT|1972-11-05||||1963-09-10||1964-08-18|1968-01-26|
TRIAL STUDY 134XCP|QS|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||PSEC|||10^7 TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|2||58||FOLLOW-UP|1960-09-18||||1965-12-05||1969-08-15|1966-06-01|
TRIAL STUDY 134XCP|QS|35589D89-B019-4C5E-8A4B-BFA58E894A9C|3|||||AUDIT-C|||UU/DL|||MG/ANIMAL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|N|3||39||OBSERVATION|1964-01-29||||1968-02-11||1963-08-24|1965-04-07|
TRIAL STUDY 134XCP|QS|35589D89-B019-4C5E-8A4B-BFA58E894A9C|4|||||BSFS|||DISK|||10^4 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|Y|4||88||SCREENING|1970-11-05||||1963-09-06||1971-07-31|1971-04-22|
TRIAL STUDY 134XCP|QS|35589D89-B019-4C5E-8A4B-BFA58E894A9C|5|||||MNSI|||BEAM BREAKS|||ML/MMHG/MIN/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|N|5||7||LONG-TERM FOLLOW-UP|1960-08-15||||1961-09-03||1972-02-22|1973-04-18|
TRIAL STUDY 134XCP|QS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1|||||IIEF|||CUP|||KPA|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|Y|1||38||BASELINE|1967-08-10||||1962-02-16||1966-07-26|1972-05-31|
TRIAL STUDY 134XCP|QS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2|||||FACT-BMT V4|||MM3/MM2/YEAR|||U/10^12 RBC|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|U|2||58||TREATMENT|1965-12-28||||1963-02-14||1960-07-01|1972-03-26|
TRIAL STUDY 134XCP|QS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|3|||||ANSD V1.0|||MEQ/ML|||CAL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|Y|3||39||SCREENING|1973-07-06||||1969-08-07||1960-06-30|1962-10-18|
TRIAL STUDY 134XCP|QS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||DEG/MM|||%|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|4||88||SCREENING|1964-12-04||||1965-07-24||1969-09-17|1964-05-16|
TRIAL STUDY 134XCP|QS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|5|||||MMRC|||G/KG|||UGEQ/L|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|U|5||7||OBSERVATION|1966-06-27||||1967-11-17||1968-02-23|1963-07-17|
TRIAL STUDY 134XCP|QS|21934F6E-8333-413B-931C-DF115519F394|1|||||YMRS|||MM/2H|||VIRTUAL PIXEL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|1||38||SCREENING|1960-06-01||||1972-04-28||1971-10-11|1960-12-23|
TRIAL STUDY 134XCP|QS|21934F6E-8333-413B-931C-DF115519F394|2|||||HADS|||ML/DOSE|||LOG10 ELISA UNIT/DOSE|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|2||58||OPEN LABEL TREATMENT|1972-02-09||||1969-03-23||1966-12-05|1966-05-04|
TRIAL STUDY 134XCP|QS|21934F6E-8333-413B-931C-DF115519F394|3|||||WOMAC NRS 3.1 INDEX|||UG/L|||10^3 CFU/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|3||39||RUN-IN|1968-03-13||||1966-03-10||1967-02-20|1965-01-18|
TRIAL STUDY 134XCP|QS|21934F6E-8333-413B-931C-DF115519F394|4|||||OCI|||UG/M2/H|||SYRINGE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|4||88||OPEN LABEL TREATMENT|1972-01-29||||1973-03-29||1965-11-21|1967-04-05|
TRIAL STUDY 134XCP|QS|21934F6E-8333-413B-931C-DF115519F394|5|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||U/M2/DAY|||TRANSDUCING UNIT/ML|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|5||7||WASHOUT|1966-09-12||||1964-12-21||1969-09-26|1973-01-30|
TRIAL STUDY 134XCP|QS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||UG/ANIMAL|||CM H2O|NOT DONE||LIKERT SCALE 5-POINT|Y|N|U|1||38||WASHOUT|1960-05-09||||1971-07-15||1965-08-07|1963-07-06|
TRIAL STUDY 134XCP|QS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2|||||WHODAS 2.0 - 36-ITEM SELF|||MOL|||MPL U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|2||58||SCREENING|1962-10-11||||1962-08-08||1965-05-08|1960-04-23|
TRIAL STUDY 134XCP|QS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|3|||||BIS-11|||UG|||CYCLE/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|NA|3||39||BASELINE|1961-05-27||||1963-10-02||1972-06-30|1967-10-25|
TRIAL STUDY 134XCP|QS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|4|||||EXPANDED DRS-PI CAREGIVER VERSION|||MOSM/L|||MV|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|4||88||LONG-TERM FOLLOW-UP|1970-10-30||||1969-12-25||1964-12-22|1963-09-08|
TRIAL STUDY 134XCP|QS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|5|||||UPS|||MOL|||DEG|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|5||7||OPEN LABEL TREATMENT|1968-03-11||||1964-05-21||1971-05-25|1965-01-20|
TRIAL STUDY 134XCP|QS|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1|||||MMRC|||MS/MMHG|||CFU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|N|1||38||FOLLOW-UP|1964-06-15||||1961-11-19||1967-04-08|1972-08-29|
TRIAL STUDY 134XCP|QS|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2|||||SF12 V1.0 STANDARD|||CMHG|||UG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|2||58||FOLLOW-UP|1970-02-23||||1967-01-17||1973-04-20|1968-10-13|
TRIAL STUDY 134XCP|QS|E31F3DEB-BCA2-4660-935D-BAEBC4238866|3|||||GDS SHORT FORM|||L/MIN|||PPTR|NOT DONE||LIKERT SCALE 3-POINT|Y|U|N|3||39||OBSERVATION|1971-11-26||||1966-02-10||1961-06-15|1960-10-11|
TRIAL STUDY 134XCP|QS|E31F3DEB-BCA2-4660-935D-BAEBC4238866|4|||||ASEX-FEMALE|||HR/DAY|||PG|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|4||88||WASHOUT|1960-06-05||||1963-05-22||1970-07-15|1965-06-12|
TRIAL STUDY 134XCP|QS|E31F3DEB-BCA2-4660-935D-BAEBC4238866|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||INHALATION|||EQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|N|5||7||LONG-TERM FOLLOW-UP|1964-07-05||||1967-06-03||1960-07-19|1961-07-12|
TRIAL STUDY 134XCP|QS|8310989D-82CC-456C-965A-E38AC9EA073F|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||10^4/L|||10^3 ORGANISMS/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|NA|1||38||BASELINE|1973-05-12||||1973-02-24||1964-07-30|1969-03-07|
TRIAL STUDY 134XCP|QS|8310989D-82CC-456C-965A-E38AC9EA073F|2|||||SF8 V1.0 STANDARD|||EVENTS|||UMOL/L/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|Y|2||58||RUN-IN|1968-06-29||||1969-09-17||1971-04-10|1963-07-13|
TRIAL STUDY 134XCP|QS|8310989D-82CC-456C-965A-E38AC9EA073F|3|||||SOWS SHORT|||10^6 IU|||SFC/10^6 PBMC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|3||39||RUN-IN|1967-09-17||||1964-05-20||1967-07-23|1972-02-18|
TRIAL STUDY 134XCP|QS|8310989D-82CC-456C-965A-E38AC9EA073F|4|||||SF12 V2.0 STANDARD|||EQ|||U/G/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|4||88||TREATMENT|1961-01-05||||1960-10-26||1971-11-18|1963-11-27|
TRIAL STUDY 134XCP|QS|8310989D-82CC-456C-965A-E38AC9EA073F|5|||||EQ-5D-5L|||G/ANIMAL|||SCM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|5||7||BLINDED TREATMENT|1973-04-17||||1970-12-01||1972-04-16|1969-08-04|
TRIAL STUDY 134XCP|QS|826D8DC2-E407-481C-93D8-5169DBDF99C4|1|||||FACT-BRM V4|||FOZ_US|||RFU|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|N|1||38||CONTINUATION TREATMENT|1973-03-19||||1971-05-05||1961-10-07|1968-08-02|
TRIAL STUDY 134XCP|QS|826D8DC2-E407-481C-93D8-5169DBDF99C4|2|||||PARENT-DDS|||UMOL/MIN|||/WK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|2||58||INDUCTION TREATMENT|1966-08-03||||1968-11-01||1971-08-23|1972-09-04|
TRIAL STUDY 134XCP|QS|826D8DC2-E407-481C-93D8-5169DBDF99C4|3|||||FACT-BMT V4|||SCOOPFUL|||YD|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|U|3||39||WASHOUT|1964-08-25||||1966-05-23||1969-06-24|1972-05-03|
TRIAL STUDY 134XCP|QS|826D8DC2-E407-481C-93D8-5169DBDF99C4|4|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||M2|||PMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|Y|4||88||TREATMENT|1969-03-07||||1963-03-04||1968-01-30|1960-09-15|
TRIAL STUDY 134XCP|QS|826D8DC2-E407-481C-93D8-5169DBDF99C4|5|||||EORTC QLQ-C30 V3.0|||UM2|||VIAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|5||7||RUN-IN|1966-12-27||||1961-01-19||1960-05-01|1964-05-28|
TRIAL STUDY 134XCP|QS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1|||||CCQ 1 WEEK VERSION|||CIGARETTE|||BISCUIT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|1||38||TREATMENT|1969-12-06||||1967-08-15||1973-08-15|1961-08-12|
TRIAL STUDY 134XCP|QS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2|||||HAQ-DI WITHOUT VAS|||MKAT|||PG/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|2||58||INDUCTION TREATMENT|1964-05-25||||1966-11-18||1972-01-30|1962-09-01|
TRIAL STUDY 134XCP|QS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|3|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||MEQ/L|||BQ/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|Y|3||39||BASELINE|1963-03-22||||1966-10-25||1967-04-25|1967-06-26|
TRIAL STUDY 134XCP|QS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|4|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||NMOL/L/H|||G/DAY|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|4||88||OBSERVATION|1965-01-17||||1965-11-26||1966-08-06|1962-10-04|
TRIAL STUDY 134XCP|QS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|5|||||SHORT-FORM MPQ-2|||MOL|||MG/KG/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|5||7||BASELINE|1967-05-27||||1963-12-20||1968-11-07|1960-12-25|
TRIAL STUDY 134XCP|QS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1|||||FACT-BMT V4|||ML/CM|||CI|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|N|1||38||BASELINE|1966-04-24||||1971-07-03||1960-01-19|1968-10-31|
TRIAL STUDY 134XCP|QS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2|||||Q-LES-Q-SF|||FARAD|||CI/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|N|2||58||TREATMENT|1966-07-26||||1972-09-06||1964-05-14|1962-02-24|
TRIAL STUDY 134XCP|QS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|3|||||IDS-SR|||ML/M2/H|||10^9 CFU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|3||39||BASELINE|1966-02-28||||1967-11-17||1963-07-18|1962-04-06|
TRIAL STUDY 134XCP|QS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|4|||||CHART-SF INTERVIEW VERSION|||10^9 ORGANISMS/G|||UG/CM2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|Y|4||88||OPEN LABEL TREATMENT|1964-04-29||||1965-08-21||1966-09-16|1970-07-10|
TRIAL STUDY 134XCP|QS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|5|||||C-SSRS SINCE LAST VISIT|||ML/DOSE|||IMPLANT|NOT DONE||LIKERT SCALE 3-POINT|NA|N|Y|5||7||LONG-TERM FOLLOW-UP|1966-10-22||||1964-10-02||1972-06-16|1961-04-11|
TRIAL STUDY 134XCP|QS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||MG/L FEU|||KBQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|1||38||BLINDED TREATMENT|1965-04-18||||1964-02-26||1962-02-05|1960-06-29|
TRIAL STUDY 134XCP|QS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2|||||ASEX-FEMALE|||USIEMENS|||UG/DAY|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|2||58||INDUCTION TREATMENT|1960-12-10||||1969-05-13||1972-04-19|1962-03-23|
TRIAL STUDY 134XCP|QS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|3|||||SMDDS V1.0|||MU/L|||DAYS/WK|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|U|3||39||BLINDED TREATMENT|1962-08-28||||1970-08-20||1970-10-09|1964-10-03|
TRIAL STUDY 134XCP|QS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|4|||||OAB-Q|||G|||RAD|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|4||88||FOLLOW-UP|1960-07-11||||1973-07-12||1973-07-06|1965-01-29|
TRIAL STUDY 134XCP|QS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|5|||||SOWS SUBJECTIVE|||10^3 RNA COPIES/ML|||10^12 IU/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|N|5||7||LONG-TERM FOLLOW-UP|1970-07-19||||1972-03-30||1965-03-09|1968-08-28|
TRIAL STUDY 134XCP|QS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1|||||AUDIT-SR|||IU/G HB|||FT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|Y|1||38||LONG-TERM FOLLOW-UP|1972-02-24||||1970-07-15||1966-12-31|1968-07-17|
TRIAL STUDY 134XCP|QS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2|||||ACQ|||TBSP|||CI/G|NOT DONE||LIKERT SCALE 5-POINT|N|NA|N|2||58||FOLLOW-UP|1961-04-17||||1962-11-09||1972-12-18|1960-08-12|
TRIAL STUDY 134XCP|QS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|3|||||BEBQ CONCURRENT|||UMOL/L|||10^7 PFU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|NA|3||39||CONTINUATION TREATMENT|1968-10-20||||1960-08-15||1972-11-03|1969-12-19|
TRIAL STUDY 134XCP|QS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|4|||||FACT-BL V4|||KPA|||U/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|U|4||88||BLINDED TREATMENT|1970-04-26||||1969-07-29||1967-11-21|1972-05-29|
TRIAL STUDY 134XCP|QS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|5|||||FACIT-F V4|||MONTHS|||MG/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|5||7||LONG-TERM FOLLOW-UP|1968-01-16||||1970-05-01||1969-07-06|1971-01-21|
TRIAL STUDY 134XCP|QS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1|||||SGRQ PAST 4 WEEKS VERSION|||BQ/KG|||DEG/S|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|1||38||INDUCTION TREATMENT|1972-06-06||||1973-05-21||1972-08-11|1968-03-09|
TRIAL STUDY 134XCP|QS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2|||||IPAQ-SF PHONE VERSION|||ML/CM H2O|||LB|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|Y|2||58||BASELINE|1966-12-20||||1971-04-17||1960-06-11|1960-05-07|
TRIAL STUDY 134XCP|QS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|3|||||C-SSRS CHILDREN'S BASELINE|||BQ/KG|||UG/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|Y|3||39||RUN-IN|1968-08-25||||1972-10-30||1961-08-22|1969-02-14|
TRIAL STUDY 134XCP|QS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|4|||||AQLQ|||UG/M2/MIN|||MG/KG/WEEK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|4||88||BASELINE|1968-12-17||||1973-06-28||1960-06-03|1964-05-05|
TRIAL STUDY 134XCP|QS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||PRESSOR UNITS|||ML/ANIMAL/WK|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|5||7||FOLLOW-UP|1972-12-17||||1973-03-22||1964-11-05|1970-03-10|
TRIAL STUDY 134XCP|QS|B396F12E-7BF5-47CC-AFD1-1B679066B106|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||UMOL/L/SEC|||CI/KG|NOT DONE||LIKERT SCALE 7-POINT|NA|U|NA|1||38||BLINDED TREATMENT|1962-07-17||||1965-07-22||1971-08-22|1972-09-04|
TRIAL STUDY 134XCP|QS|B396F12E-7BF5-47CC-AFD1-1B679066B106|2|||||WPAI-GH V2.0|||ML/CAGE|||/MONTH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|2||58||BLINDED TREATMENT|1972-11-15||||1960-08-23||1971-12-11|1963-05-21|
TRIAL STUDY 134XCP|QS|B396F12E-7BF5-47CC-AFD1-1B679066B106|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||LB|||PACKAGE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|3||39||SCREENING|1965-03-15||||1973-09-05||1965-01-17|1968-11-09|
TRIAL STUDY 134XCP|QS|B396F12E-7BF5-47CC-AFD1-1B679066B106|4|||||SF8 V1.0 ACUTE|||UM/DAY|||MOL|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|NA|4||88||BLINDED TREATMENT|1963-12-11||||1967-07-25||1962-11-01|1971-07-29|
TRIAL STUDY 134XCP|QS|B396F12E-7BF5-47CC-AFD1-1B679066B106|5|||||HAEM-A-QOL|||NMOL/L/H|||DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1968-01-30||||1965-12-20||1973-05-01|1971-05-01|
TRIAL STUDY 134XCP|QS|2936B26A-9A8D-4C28-90A7-6131837F255F|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||FMOL/L/SEC|||PRESSOR UNITS|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|1||38||TREATMENT|1969-02-05||||1970-08-07||1969-02-28|1971-09-21|
TRIAL STUDY 134XCP|QS|2936B26A-9A8D-4C28-90A7-6131837F255F|2|||||MSQOL-54|||LOG10 TCID 50/UL|||PMOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|2||58||BLINDED TREATMENT|1970-02-27||||1964-04-01||1961-06-24|1972-09-04|
TRIAL STUDY 134XCP|QS|2936B26A-9A8D-4C28-90A7-6131837F255F|3|||||DLQI|||GBQ/MG|||L/S/KPA|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|3||39||LONG-TERM FOLLOW-UP|1972-09-14||||1972-11-02||1971-02-26|1965-11-22|
TRIAL STUDY 134XCP|QS|2936B26A-9A8D-4C28-90A7-6131837F255F|4|||||TSQM V1.4|||LOG10 CFU/ML|||BQ/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|4||88||BASELINE|1960-09-13||||1960-01-16||1968-01-07|1963-08-03|
TRIAL STUDY 134XCP|QS|2936B26A-9A8D-4C28-90A7-6131837F255F|5|||||SGRQ PAST 4 WEEKS VERSION|||VP/ML|||KPA|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|NA|5||7||INDUCTION TREATMENT|1964-04-29||||1964-07-29||1960-08-08|1961-04-16|
TRIAL STUDY 134XCP|QS|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||MEQ/G|||BEATS/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|NA|1||38||RUN-IN|1969-01-22||||1964-12-08||1965-08-09|1960-04-02|
TRIAL STUDY 134XCP|QS|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||10^6/L|||PT_BR|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|2||58||WASHOUT|1973-01-06||||1963-07-22||1971-11-03|1970-12-08|
TRIAL STUDY 134XCP|QS|901A91DC-9EF3-4A20-A35D-9C426A5C640B|3|||||FACIT-DYSPNEA 33 ITEM BANK|||MG/ANIMAL|||MG/KG|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|3||39||CONTINUATION TREATMENT|1968-04-22||||1973-07-24||1968-06-01|1962-10-23|
TRIAL STUDY 134XCP|QS|901A91DC-9EF3-4A20-A35D-9C426A5C640B|4|||||CDLQ|||/HPF|||ML*CMH2O|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|4||88||WASHOUT|1970-08-05||||1965-07-06||1967-01-29|1962-04-16|
TRIAL STUDY 134XCP|QS|901A91DC-9EF3-4A20-A35D-9C426A5C640B|5|||||SF10 V1.0 CHILDREN STANDARD|||PG/CELL|||MEQ/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|5||7||FOLLOW-UP|1964-02-15||||1971-07-09||1971-02-28|1961-09-24|
TRIAL STUDY 134XCP|QS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||MOL/MOL|||JDF UNIT|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|NA|1||38||SCREENING|1965-09-09||||1971-10-23||1972-05-11|1963-06-24|
TRIAL STUDY 134XCP|QS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2|||||UPDRS|||CM|||ML/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|2||58||RUN-IN|1965-09-28||||1964-05-21||1960-12-09|1960-02-24|
TRIAL STUDY 134XCP|QS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|3|||||C-SSRS CHILDREN'S BASELINE|||10^5/HPF|||/CMH2O|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|3||39||FOLLOW-UP|1969-10-29||||1966-04-15||1966-11-25|1972-01-15|
TRIAL STUDY 134XCP|QS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|4|||||HAEM-A-QOL|||CI/ML|||NEEDLE GAUGE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|4||88||WASHOUT|1967-05-29||||1967-03-29||1966-10-15|1967-11-03|
TRIAL STUDY 134XCP|QS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|5|||||DAD|||ML/KG/MIN|||UMOL/KG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|N|5||7||CONTINUATION TREATMENT|1968-09-27||||1969-03-13||1961-09-11|1966-05-16|
TRIAL STUDY 134XCP|QS|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1|||||FKSI-15|||PFU/DOSE|||10^7 CFU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|1||38||BLINDED TREATMENT|1972-04-30||||1971-06-13||1970-08-27|1964-08-05|
TRIAL STUDY 134XCP|QS|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||IU/G HB|||G/CAGE/WK|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|2||58||TREATMENT|1972-02-12||||1965-06-15||1969-03-15|1962-11-28|
TRIAL STUDY 134XCP|QS|5A7F2C89-5398-4119-8EA0-B432FF8942A4|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||G/CAGE/WK|||G/CAGE/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|Y|3||39||BASELINE|1965-02-13||||1970-01-17||1966-09-21|1961-02-19|
TRIAL STUDY 134XCP|QS|5A7F2C89-5398-4119-8EA0-B432FF8942A4|4|||||T1-DDS|||LOG10 CFU/G|||FARAD|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|4||88||OBSERVATION|1962-04-15||||1970-02-28||1968-03-22|1966-08-24|
TRIAL STUDY 134XCP|QS|5A7F2C89-5398-4119-8EA0-B432FF8942A4|5|||||PDDS|||GBQ/MG|||KG/MOL|NOT DONE||LIKERT SCALE 5-POINT|Y|N|Y|5||7||SCREENING|1962-06-20||||1968-04-05||1964-09-06|1971-01-27|
TRIAL STUDY 134XCP|QS|898FB78B-63D1-4ECE-B6B8-34750E958D93|1|||||UPS|||GPELISA UNIT/ML|||FINGERTIP UNIT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|NA|1||38||RUN-IN|1969-02-01||||1966-02-09||1961-02-23|1964-05-26|
TRIAL STUDY 134XCP|QS|898FB78B-63D1-4ECE-B6B8-34750E958D93|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||BOTTLE|||ML/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|2||58||TREATMENT|1968-01-10||||1966-06-01||1972-07-05|1968-06-30|
TRIAL STUDY 134XCP|QS|898FB78B-63D1-4ECE-B6B8-34750E958D93|3|||||FPSR|||10^6 ORGANISMS|||UMOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|N|3||39||INDUCTION TREATMENT|1968-05-02||||1963-09-21||1960-03-03|1964-07-11|
TRIAL STUDY 134XCP|QS|898FB78B-63D1-4ECE-B6B8-34750E958D93|4|||||C-SSRS BASELINE|||ARBITRARY U|||TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|N|4||88||WASHOUT|1973-01-19||||1961-03-06||1963-07-20|1970-10-25|
TRIAL STUDY 134XCP|QS|898FB78B-63D1-4ECE-B6B8-34750E958D93|5|||||NCCN-FACT FKSI-19 V2|||L/L|||ML/KG/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|N|5||7||TREATMENT|1960-05-28||||1969-11-18||1970-10-30|1963-01-17|
TRIAL STUDY 134XCP|QS|AF1E7141-5390-4928-9F49-94E1C7464A63|1|||||BPI|||PRESSOR UNITS|||AFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|1||38||CONTINUATION TREATMENT|1973-05-08||||1963-12-04||1972-08-16|1971-07-22|
TRIAL STUDY 134XCP|QS|AF1E7141-5390-4928-9F49-94E1C7464A63|2|||||PEDS-FACIT-F|||GBQ/MG|||NL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|U|2||58||LONG-TERM FOLLOW-UP|1969-06-17||||1964-06-19||1967-03-07|1964-08-22|
TRIAL STUDY 134XCP|QS|AF1E7141-5390-4928-9F49-94E1C7464A63|3|||||Q-LES-Q-SF|||/2500 WBC|||KDA|NOT DONE||LIKERT SCALE 7-POINT|NA|N|Y|3||39||RUN-IN|1969-09-02||||1967-02-13||1969-08-17|1965-10-13|
TRIAL STUDY 134XCP|QS|AF1E7141-5390-4928-9F49-94E1C7464A63|4|||||FOSI|||MG/MOL|||FT3|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|4||88||CONTINUATION TREATMENT|1971-10-23||||1971-02-26||1973-03-07|1971-10-05|
TRIAL STUDY 134XCP|QS|AF1E7141-5390-4928-9F49-94E1C7464A63|5|||||FACT-C V4|||10^3 ORGANISMS|||LINEAR FT*LB|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|5||7||BLINDED TREATMENT|1963-09-03||||1965-03-31||1972-03-30|1971-08-22|
TRIAL STUDY 134XCP|QS|2188CADE-EE6F-4F14-8049-5EDD72020185|1|||||SF8 V1.0 ACUTE|||U/MG|||CYLINDER|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|U|1||38||TREATMENT|1972-01-11||||1960-12-15||1967-02-04|1972-11-03|
TRIAL STUDY 134XCP|QS|2188CADE-EE6F-4F14-8049-5EDD72020185|2|||||IDS-SR|||FT3|||UG/MIN|NOT DONE||LIKERT SCALE 7-POINT|N|Y|NA|2||58||INDUCTION TREATMENT|1964-10-26||||1966-12-16||1969-04-10|1963-02-13|
TRIAL STUDY 134XCP|QS|2188CADE-EE6F-4F14-8049-5EDD72020185|3|||||PARTNER-DDS|||OHM|||MG/KG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|3||39||OPEN LABEL TREATMENT|1972-10-28||||1963-09-22||1968-07-11|1967-09-24|
TRIAL STUDY 134XCP|QS|2188CADE-EE6F-4F14-8049-5EDD72020185|4|||||PHQ-9|||PIXEL|||G/ANIMAL/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|Y|4||88||WASHOUT|1967-05-17||||1966-09-05||1966-12-16|1967-07-28|
TRIAL STUDY 134XCP|QS|2188CADE-EE6F-4F14-8049-5EDD72020185|5|||||SGRQ PAST 4 WEEKS VERSION|||NMOL/G|||ABSORBANCE U/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|5||7||RUN-IN|1973-08-01||||1960-09-23||1973-07-26|1960-01-18|
TRIAL STUDY 134XCP|QS|DFF30783-4496-4134-8201-67C727683A7D|1|||||NPS|||UG/DL|||10^9 ORGANISMS/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|1||38||BLINDED TREATMENT|1969-06-12||||1964-07-21||1973-01-24|1965-08-14|
TRIAL STUDY 134XCP|QS|DFF30783-4496-4134-8201-67C727683A7D|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||MG/KG/DOSE|||UOSM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|2||58||INDUCTION TREATMENT|1968-12-11||||1969-08-11||1965-06-24|1970-09-25|
TRIAL STUDY 134XCP|QS|DFF30783-4496-4134-8201-67C727683A7D|3|||||SHORT-FORM MPQ-2|||CM/MIN|||MEQ|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|3||39||OBSERVATION|1967-11-12||||1966-12-09||1965-11-12|1972-04-26|
TRIAL STUDY 134XCP|QS|DFF30783-4496-4134-8201-67C727683A7D|4|||||SF8 V1.0 STANDARD|||ML/DOSE|||COPIES/UL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|N|4||88||BASELINE|1968-04-25||||1970-01-21||1966-02-18|1960-07-28|
TRIAL STUDY 134XCP|QS|DFF30783-4496-4134-8201-67C727683A7D|5|||||FACIT-FATIGUE 13-ITEM V4|||NMOL/G|||MMHG*MIN/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|Y|5||7||RUN-IN|1967-07-04||||1965-06-26||1969-09-22|1961-01-13|
TRIAL STUDY 134XCP|QS|970170C0-8FF0-4D24-84E8-1195272D55C0|1|||||FPSR|||UMOL/L/MIN|||PMOL/10^9 CELLS|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|1||38||SCREENING|1970-12-13||||1970-07-05||1961-09-23|1971-05-19|
TRIAL STUDY 134XCP|QS|970170C0-8FF0-4D24-84E8-1195272D55C0|2|||||FACT-LYM V4|||LOG10 TCID 50/UL|||CUP|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|U|2||58||RUN-IN|1965-12-17||||1961-02-25||1972-03-13|1965-07-14|
TRIAL STUDY 134XCP|QS|970170C0-8FF0-4D24-84E8-1195272D55C0|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||MMOL/MIN/KPA/L|||JDF UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|NA|3||39||BLINDED TREATMENT|1964-11-29||||1972-06-21||1966-08-20|1973-01-29|
TRIAL STUDY 134XCP|QS|970170C0-8FF0-4D24-84E8-1195272D55C0|4|||||EQ-5D-5L|||MG/MIN|||LINEAR FT*LB|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|Y|4||88||OPEN LABEL TREATMENT|1966-06-12||||1965-08-26||1960-06-18|1966-08-12|
TRIAL STUDY 134XCP|QS|970170C0-8FF0-4D24-84E8-1195272D55C0|5|||||PSQI|||UCI/KG|||G/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1966-09-23||||1967-09-05||1960-09-15|1966-01-08|
TRIAL STUDY 134XCP|QS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1|||||BLCS|||BQ/UG|||10^6 ORGANISMS/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|1||38||OPEN LABEL TREATMENT|1962-06-06||||1962-06-19||1967-12-22|1972-06-05|
TRIAL STUDY 134XCP|QS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2|||||HAQ-DI WITHOUT VAS|||PFU/ANIMAL|||ML/G/H|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|2||58||WASHOUT|1971-03-13||||1960-06-24||1969-02-03|1965-10-09|
TRIAL STUDY 134XCP|QS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|3|||||PHQ SCREENER VERSION|||IU/ML|||CG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|3||39||BLINDED TREATMENT|1962-07-03||||1966-07-10||1961-09-25|1966-03-12|
TRIAL STUDY 134XCP|QS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|4|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||ELISA UNIT/ML|||UKAT/10^12 RBC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|4||88||WASHOUT|1969-02-15||||1967-06-27||1964-11-22|1971-05-07|
TRIAL STUDY 134XCP|QS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|5|||||MADRS|||MCI/KG|||PSI|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|NA|5||7||RUN-IN|1960-08-14||||1970-06-18||1973-04-08|1969-06-24|
TRIAL STUDY 134XCP|QS|69CC47A3-DA90-4919-889E-E0008ED689FA|1|||||ADCS-ADL SEVERE DEMENTIA|||NU/CL|||GTT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|1||38||WASHOUT|1968-05-19||||1967-06-15||1973-05-20|1967-05-14|
TRIAL STUDY 134XCP|QS|69CC47A3-DA90-4919-889E-E0008ED689FA|2|||||FLSI|||DAYS/WK|||BOTTLE|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|2||58||LONG-TERM FOLLOW-UP|1969-07-27||||1965-01-03||1967-01-01|1972-03-31|
TRIAL STUDY 134XCP|QS|69CC47A3-DA90-4919-889E-E0008ED689FA|3|||||SMDDS V1.0|||TBSP|||KM/H|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|U|3||39||OPEN LABEL TREATMENT|1964-02-23||||1961-04-24||1970-06-10|1962-10-08|
TRIAL STUDY 134XCP|QS|69CC47A3-DA90-4919-889E-E0008ED689FA|4|||||SDS|||KEV|||U/G/MIN|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|4||88||WASHOUT|1965-01-09||||1961-04-13||1964-03-11|1968-11-13|
TRIAL STUDY 134XCP|QS|69CC47A3-DA90-4919-889E-E0008ED689FA|5|||||FOSI|||UCI/L|||10^5/HPF|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|U|5||7||SCREENING|1965-09-30||||1964-12-11||1966-11-04|1960-09-16|
TRIAL STUDY 134XCP|QS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||ANTIBODY UNIT|||MJOULE/CM2|NOT DONE||LIKERT SCALE 3-POINT|Y|U|N|1||38||FOLLOW-UP|1965-12-11||||1971-07-27||1969-07-07|1972-09-26|
TRIAL STUDY 134XCP|QS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2|||||BSI-18|||ML/MMHG|||U/G HB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|NA|2||58||FOLLOW-UP|1971-11-30||||1966-10-10||1966-02-24|1971-06-30|
TRIAL STUDY 134XCP|QS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|3|||||EQ-5D-5L|||MG/MOL|||L/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|N|3||39||SCREENING|1964-01-13||||1969-06-26||1963-12-07|1963-10-26|
TRIAL STUDY 134XCP|QS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|4|||||PODCI - PEDIATRIC PARENT REPORTED|||UIU/L|||BEAM BREAKS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|N|4||88||SCREENING|1960-03-25||||1971-10-31||1968-03-05|1966-01-04|
TRIAL STUDY 134XCP|QS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|5|||||CHART-SF INTERVIEW VERSION|||BU|||FOZ_US|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|5||7||FOLLOW-UP|1964-09-19||||1965-01-21||1965-09-04|1968-07-17|
TRIAL STUDY 134XCP|QS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1|||||NSCLC-SAQ V1.0|||PSI|||MPA|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|N|1||38||OPEN LABEL TREATMENT|1970-09-15||||1965-11-12||1972-03-09|1964-08-17|
TRIAL STUDY 134XCP|QS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2|||||HADS|||U/MMOL|||GBQ/UG|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|NA|2||58||OBSERVATION|1970-01-11||||1969-05-14||1968-05-25|1962-08-08|
TRIAL STUDY 134XCP|QS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||MG/DL|||/WK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|3||39||RUN-IN|1962-07-15||||1966-04-18||1966-03-14|1973-03-23|
TRIAL STUDY 134XCP|QS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||STRIP|||MEQ/UL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|N|4||88||RUN-IN|1963-08-01||||1967-11-17||1967-12-30|1960-06-23|
TRIAL STUDY 134XCP|QS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|5|||||WPAI-GH V2.0|||IU/DAY|||MIN*MG/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|5||7||BASELINE|1973-07-30||||1967-04-24||1963-05-05|1967-03-23|
TRIAL STUDY 134XCP|QS|0281E055-F419-4BA2-89CE-23EC7428CDA0|1|||||AQLQ|||GBQ/UG|||M/SEC|NOT DONE||LIKERT SCALE 7-POINT|N|Y|Y|1||38||RUN-IN|1967-07-08||||1973-03-25||1962-02-04|1970-05-26|
TRIAL STUDY 134XCP|QS|0281E055-F419-4BA2-89CE-23EC7428CDA0|2|||||FACIT-DYSPNEA 33 ITEM BANK|||UKAT/10^12 RBC|||ML/ANIMAL|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|2||58||OPEN LABEL TREATMENT|1965-11-16||||1972-08-03||1972-12-18|1964-10-23|
TRIAL STUDY 134XCP|QS|0281E055-F419-4BA2-89CE-23EC7428CDA0|3|||||FACT-P V4|||RATIO|||MMOL|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|3||39||WASHOUT|1961-03-19||||1971-06-25||1967-03-11|1968-09-09|
TRIAL STUDY 134XCP|QS|0281E055-F419-4BA2-89CE-23EC7428CDA0|4|||||DRRI-2|||ML/G/DAY|||TABLET|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|Y|4||88||CONTINUATION TREATMENT|1960-06-10||||1961-09-07||1967-10-07|1962-12-20|
TRIAL STUDY 134XCP|QS|0281E055-F419-4BA2-89CE-23EC7428CDA0|5|||||BPI|||MOL/G|||UU/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|5||7||FOLLOW-UP|1966-12-01||||1962-05-26||1966-11-25|1970-05-07|
TRIAL STUDY 134XCP|QS|23CE1310-DBB3-4135-8E11-2A870CE42D50|1|||||OAB-Q|||U/CL|||10^11/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|NA|1||38||TREATMENT|1968-03-12||||1973-08-24||1969-04-09|1968-12-20|
TRIAL STUDY 134XCP|QS|23CE1310-DBB3-4135-8E11-2A870CE42D50|2|||||PR|||IU|||TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|N|2||58||RUN-IN|1967-05-02||||1966-08-05||1964-03-27|1965-01-06|
TRIAL STUDY 134XCP|QS|23CE1310-DBB3-4135-8E11-2A870CE42D50|3|||||ADCS-ADL MCI|||/2500 WBC|||DAYS/WK|NOT DONE||LIKERT SCALE 7-POINT|NA|N|N|3||39||BLINDED TREATMENT|1962-10-25||||1963-10-08||1965-12-06|1971-08-15|
TRIAL STUDY 134XCP|QS|23CE1310-DBB3-4135-8E11-2A870CE42D50|4|||||NCCN-FACT FOSI-18 V2|||FRACTION OF 1|||MOSM/L|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|4||88||FOLLOW-UP|1969-10-31||||1960-09-18||1963-04-05|1972-12-04|
TRIAL STUDY 134XCP|QS|23CE1310-DBB3-4135-8E11-2A870CE42D50|5|||||PROSQOLI|||MMHG/L/MIN|||FINGERTIP UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|5||7||FOLLOW-UP|1968-12-16||||1971-01-22||1968-05-10|1969-05-20|
TRIAL STUDY 134XCP|QS|CC80D8A2-7D71-428B-9599-C0D0312B8691|1|||||PDDS|||DAYS/WK|||/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|1||38||RUN-IN|1970-06-05||||1962-08-29||1968-02-08|1970-06-09|
TRIAL STUDY 134XCP|QS|CC80D8A2-7D71-428B-9599-C0D0312B8691|2|||||BIS-11|||FFU|||MG/KG/MIN|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|N|2||58||BASELINE|1963-05-28||||1971-12-12||1965-10-25|1962-03-21|
TRIAL STUDY 134XCP|QS|CC80D8A2-7D71-428B-9599-C0D0312B8691|3|||||SOWS SUBJECTIVE|||10^3 CFU/G|||ML/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|3||39||INDUCTION TREATMENT|1964-12-28||||1969-09-04||1966-09-24|1965-06-26|
TRIAL STUDY 134XCP|QS|CC80D8A2-7D71-428B-9599-C0D0312B8691|4|||||DLQI|||MJOULE/CM2|||AMPULE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|4||88||BASELINE|1961-05-09||||1967-09-05||1961-03-14|1962-04-26|
TRIAL STUDY 134XCP|QS|CC80D8A2-7D71-428B-9599-C0D0312B8691|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||G/CAGE|||UL/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|NA|5||7||RUN-IN|1969-09-12||||1965-04-18||1965-11-14|1969-03-15|
TRIAL STUDY 134XCP|QS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1|||||SOAPP-R|||HZ/S|||UM/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|1||38||LONG-TERM FOLLOW-UP|1961-07-02||||1968-03-28||1971-08-26|1964-04-20|
TRIAL STUDY 134XCP|QS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2|||||NCCN-FACT FOSI-18 V2|||CI/ML|||MMHG/SEC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|Y|2||58||CONTINUATION TREATMENT|1965-07-19||||1962-04-23||1963-05-28|1965-02-04|
TRIAL STUDY 134XCP|QS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|3|||||EPDS|||COAT|||LOZENGE|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|3||39||BASELINE|1961-10-15||||1962-05-21||1969-06-12|1962-08-05|
TRIAL STUDY 134XCP|QS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|4|||||MFIS|||NG/DL|||/2500 WBC|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|N|4||88||BASELINE|1965-07-11||||1971-10-18||1967-07-26|1969-04-12|
TRIAL STUDY 134XCP|QS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|5|||||SF12 V1.0 ACUTE|||MN|||UG/KG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|5||7||INDUCTION TREATMENT|1960-06-30||||1964-11-04||1964-06-16|1961-10-12|
TRIAL STUDY 134XCP|QS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1|||||HAMD 6 SELF-REPORT VERSION|||CMOL|||MMHG/L/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|1||38||INDUCTION TREATMENT|1968-01-12||||1967-08-02||1969-08-01|1960-03-19|
TRIAL STUDY 134XCP|QS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2|||||FACIT-FATIGUE 13-ITEM V4|||SEC|||U/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|2||58||OPEN LABEL TREATMENT|1969-07-07||||1961-07-02||1963-04-22|1973-06-09|
TRIAL STUDY 134XCP|QS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|3|||||BIS-11|||CG|||MESF|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|3||39||SCREENING|1967-06-21||||1966-02-23||1973-01-01|1962-12-16|
TRIAL STUDY 134XCP|QS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|4|||||EPDS|||MBQ/UL|||10^7 PFU|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|4||88||OPEN LABEL TREATMENT|1971-08-13||||1973-06-21||1966-02-13|1973-04-11|
TRIAL STUDY 134XCP|QS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|5|||||RPQ|||UGEQ|||DPM/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|5||7||LONG-TERM FOLLOW-UP|1973-02-04||||1972-02-11||1967-05-30|1963-04-22|
TRIAL STUDY 134XCP|QS|3D25A735-6298-4AF4-91CC-AE8D481DF552|1|||||LEC-5 STANDARD VERSION|||MM/H|||PM|NOT DONE||LIKERT SCALE 3-POINT|N|N|N|1||38||RUN-IN|1967-10-24||||1965-04-29||1968-02-26|1961-11-15|
TRIAL STUDY 134XCP|QS|3D25A735-6298-4AF4-91CC-AE8D481DF552|2|||||CDR|||MV|||10^3/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|U|2||58||FOLLOW-UP|1965-04-09||||1972-08-02||1965-11-16|1962-07-20|
TRIAL STUDY 134XCP|QS|3D25A735-6298-4AF4-91CC-AE8D481DF552|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||SUPPOSITORY|||FT2|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|3||39||CONTINUATION TREATMENT|1969-07-20||||1964-02-20||1965-09-01|1972-03-05|
TRIAL STUDY 134XCP|QS|3D25A735-6298-4AF4-91CC-AE8D481DF552|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||/200 HPFS|||PMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|4||88||INDUCTION TREATMENT|1963-08-12||||1972-09-04||1968-03-27|1972-08-23|
TRIAL STUDY 134XCP|QS|3D25A735-6298-4AF4-91CC-AE8D481DF552|5|||||OAB-Q|||UG/G/H|||UG/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|NA|5||7||INDUCTION TREATMENT|1970-04-27||||1962-10-03||1970-05-21|1960-12-20|
TRIAL STUDY 134XCP|QS|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1|||||FACIT-DYSPNEA SF|||MANSON U/ML|||OHM|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|1||38||CONTINUATION TREATMENT|1964-05-19||||1965-05-24||1970-11-16|1962-11-12|
TRIAL STUDY 134XCP|QS|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2|||||ADCS-ADL SEVERE DEMENTIA|||ML/MIN/MMHG|||PG/CELL|NOT DONE||LIKERT SCALE 3-POINT|U|Y|Y|2||58||OBSERVATION|1968-11-19||||1963-11-03||1971-02-22|1973-03-08|
TRIAL STUDY 134XCP|QS|C249E38B-B454-47D9-8D8B-E2F6A434BA21|3|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||WATT|||L/S|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|3||39||INDUCTION TREATMENT|1962-07-03||||1965-09-20||1966-12-24|1967-04-21|
TRIAL STUDY 134XCP|QS|C249E38B-B454-47D9-8D8B-E2F6A434BA21|4|||||IPAQ-SF PHONE VERSION|||MG/MIN|||GMFI|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|4||88||TREATMENT|1972-09-14||||1968-11-09||1967-07-24|1967-10-14|
TRIAL STUDY 134XCP|QS|C249E38B-B454-47D9-8D8B-E2F6A434BA21|5|||||Q-LES-Q|||/10^4|||MM|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|5||7||OBSERVATION|1968-12-22||||1966-06-11||1964-08-30|1960-06-11|
TRIAL STUDY 134XCP|QS|4540D569-1DD0-4984-89DB-6F9A391397FE|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||KBQ|||10^6 COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|1||38||LONG-TERM FOLLOW-UP|1973-05-29||||1972-04-09||1964-10-07|1966-10-28|
TRIAL STUDY 134XCP|QS|4540D569-1DD0-4984-89DB-6F9A391397FE|2|||||CCQ 24 HOUR VERSION|||ENZYME U/G HB|||MIU/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|2||58||BASELINE|1965-09-19||||1969-11-06||1962-09-02|1971-05-08|
TRIAL STUDY 134XCP|QS|4540D569-1DD0-4984-89DB-6F9A391397FE|3|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||SYRINGE|||FRACTION OF 1|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|3||39||BASELINE|1960-08-30||||1967-11-21||1971-08-01|1969-10-15|
TRIAL STUDY 134XCP|QS|4540D569-1DD0-4984-89DB-6F9A391397FE|4|||||BSFS|||CCID 50/DOSE|||ENZYME U/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|U|4||88||LONG-TERM FOLLOW-UP|1969-08-11||||1965-05-01||1961-05-11|1971-12-05|
TRIAL STUDY 134XCP|QS|4540D569-1DD0-4984-89DB-6F9A391397FE|5|||||PHQ-15|||/WK|||PG/DL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|5||7||BLINDED TREATMENT|1966-07-20||||1965-12-20||1973-01-01|1962-06-19|
TRIAL STUDY 134XCP|QS|DC1D666E-4920-4B60-A520-D183BCDE0E85|1|||||NPI|||EVENTS|||MILE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|NA|1||38||RUN-IN|1967-10-12||||1962-11-15||1968-04-27|1963-08-24|
TRIAL STUDY 134XCP|QS|DC1D666E-4920-4B60-A520-D183BCDE0E85|2|||||FACT-B V4|||NGEQ/L|||CI|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|NA|2||58||FOLLOW-UP|1967-01-01||||1972-12-10||1970-04-29|1963-02-28|
TRIAL STUDY 134XCP|QS|DC1D666E-4920-4B60-A520-D183BCDE0E85|3|||||ESS|||U/G|||UEQ|NOT DONE||LIKERT SCALE 7-POINT|U|N|U|3||39||TREATMENT|1971-05-31||||1960-03-01||1964-05-06|1971-01-07|
TRIAL STUDY 134XCP|QS|DC1D666E-4920-4B60-A520-D183BCDE0E85|4|||||COWS|||PPM|||L|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|4||88||BLINDED TREATMENT|1963-06-06||||1970-04-15||1966-06-28|1965-03-12|
TRIAL STUDY 134XCP|QS|DC1D666E-4920-4B60-A520-D183BCDE0E85|5|||||FACT-G V4|||FMOL/L|||SEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|5||7||SCREENING|1962-05-01||||1965-08-06||1967-04-13|1967-07-10|
TRIAL STUDY 134XCP|QS|A015D12B-C03B-4371-8D1F-F03D60542BA7|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||DAYS/MONTH|||FL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|NA|1||38||LONG-TERM FOLLOW-UP|1972-06-24||||1969-02-21||1961-04-16|1971-05-29|
TRIAL STUDY 134XCP|QS|A015D12B-C03B-4371-8D1F-F03D60542BA7|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||M3|||UMOL/L/SEC|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|U|2||58||TREATMENT|1966-10-08||||1964-04-02||1972-12-20|1968-04-14|
TRIAL STUDY 134XCP|QS|A015D12B-C03B-4371-8D1F-F03D60542BA7|3|||||PODCI - PEDIATRIC PARENT REPORTED|||UGEQ|||U/CL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|3||39||SCREENING|1960-05-22||||1965-06-14||1960-01-17|1969-07-17|
TRIAL STUDY 134XCP|QS|A015D12B-C03B-4371-8D1F-F03D60542BA7|4|||||SF8 V1.0 STANDARD|||RING|||MG2/DL2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|4||88||INDUCTION TREATMENT|1970-12-19||||1968-10-26||1960-11-23|1970-03-22|
TRIAL STUDY 134XCP|QS|A015D12B-C03B-4371-8D1F-F03D60542BA7|5|||||AQ20|||PMOL/10^9 CELLS|||/CMH2O|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|N|5||7||LONG-TERM FOLLOW-UP|1961-01-03||||1961-10-08||1963-03-29|1971-07-05|
TRIAL STUDY 134XCP|QS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1|||||Q-LES-Q|||MEQ/KG|||MMOL/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|1||38||OBSERVATION|1961-01-01||||1963-03-08||1967-02-09|1962-01-08|
TRIAL STUDY 134XCP|QS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2|||||BEBQ RETROSPECTIVE|||FINGERTIP UNIT|||NG/L|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|2||58||WASHOUT|1965-04-13||||1970-04-26||1964-03-29|1962-06-19|
TRIAL STUDY 134XCP|QS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|3|||||BWCS|||NGEQ/L|||LOG10 PFU|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|3||39||BASELINE|1971-05-14||||1960-10-07||1971-11-25|1962-09-04|
TRIAL STUDY 134XCP|QS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|4|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||SCM|||CI/UL|NOT DONE||LIKERT SCALE 5-POINT|Y|U|Y|4||88||INDUCTION TREATMENT|1963-02-04||||1963-04-05||1969-06-06|1963-06-27|
TRIAL STUDY 134XCP|QS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|5|||||PGI|||NMOL BCE/MMOL|||MM|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|5||7||TREATMENT|1968-02-24||||1965-09-25||1960-04-02|1971-12-12|
TRIAL STUDY 134XCP|QS|34AC7973-686F-45A2-999A-1A36C7874F91|1|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||DL|||CI|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|1||38||BASELINE|1963-04-23||||1972-05-26||1966-12-13|1969-06-08|
TRIAL STUDY 134XCP|QS|34AC7973-686F-45A2-999A-1A36C7874F91|2|||||GAD-7|||MMOL/MIN/KPA/L|||HZ/S|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|Y|2||58||BASELINE|1962-05-07||||1968-10-31||1967-09-03|1960-07-12|
TRIAL STUDY 134XCP|QS|34AC7973-686F-45A2-999A-1A36C7874F91|3|||||CHART-SF PAPER VERSION|||ARBITRARY U|||U/MG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|U|3||39||BLINDED TREATMENT|1971-01-16||||1972-05-05||1967-10-21|1968-11-13|
TRIAL STUDY 134XCP|QS|34AC7973-686F-45A2-999A-1A36C7874F91|4|||||FACT-B V4|||ARBITRARY U|||ML/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|4||88||BASELINE|1973-04-23||||1967-03-05||1971-03-29|1962-11-09|
TRIAL STUDY 134XCP|QS|34AC7973-686F-45A2-999A-1A36C7874F91|5|||||MNSI|||CI/ML|||/LPF|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|5||7||LONG-TERM FOLLOW-UP|1966-11-15||||1966-07-06||1965-01-26|1963-11-19|
TRIAL STUDY 134XCP|QS|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||AU/ML|||KG/CM|NOT DONE||LIKERT SCALE 7-POINT|Y|N|NA|1||38||TREATMENT|1961-12-03||||1968-08-15||1961-01-11|1972-11-23|
TRIAL STUDY 134XCP|QS|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2|||||SIQR|||WAFER|||10^9 ORGANISMS/G|NOT DONE||LIKERT SCALE 7-POINT|U|NA|U|2||58||RUN-IN|1964-03-21||||1960-07-22||1970-02-25|1968-03-05|
TRIAL STUDY 134XCP|QS|5AE66AC0-ECB6-49A2-859F-871B9A15E624|3|||||PROSQOLI|||EU|||CD/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|NA|3||39||FOLLOW-UP|1971-08-19||||1973-08-30||1962-10-06|1971-07-18|
TRIAL STUDY 134XCP|QS|5AE66AC0-ECB6-49A2-859F-871B9A15E624|4|||||PHQ-15|||ML/MIN/MMHG|||MG/CM2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|Y|4||88||CONTINUATION TREATMENT|1962-02-25||||1963-04-19||1970-08-14|1970-07-27|
TRIAL STUDY 134XCP|QS|5AE66AC0-ECB6-49A2-859F-871B9A15E624|5|||||ADCS-ADL MCI|||UG/DAY|||NMOL/L/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|Y|N|5||7||OBSERVATION|1962-01-19||||1964-05-18||1960-08-08|1972-09-24|
TRIAL STUDY 134XCP|QS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1|||||BSI-18|||MMOL/L|||U/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|U|1||38||BLINDED TREATMENT|1960-08-07||||1969-03-31||1972-12-22|1968-07-21|
TRIAL STUDY 134XCP|QS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2|||||SF12 V2.0 ACUTE|||UMOL/H/MMOL|||MPH|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|2||58||SCREENING|1969-01-16||||1973-04-21||1968-12-14|1968-03-28|
TRIAL STUDY 134XCP|QS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|3|||||MPAI-4|||AMOL|||UV2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|3||39||SCREENING|1969-06-30||||1963-05-07||1961-10-18|1963-08-08|
TRIAL STUDY 134XCP|QS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|4|||||SIQR|||L/KG|||UG/M2/H|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|4||88||INDUCTION TREATMENT|1969-09-26||||1963-05-27||1963-11-15|1968-10-19|
TRIAL STUDY 134XCP|QS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||NMOL/DAY|||NG/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|5||7||OBSERVATION|1970-07-31||||1966-09-14||1961-05-24|1960-06-11|
TRIAL STUDY 134XCP|QS|59A9826F-4C2F-482A-8888-F649544318BE|1|||||LEC-5 STANDARD VERSION|||U/G/MIN|||UG/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|NA|1||38||SCREENING|1966-02-22||||1965-06-09||1963-01-21|1970-03-22|
TRIAL STUDY 134XCP|QS|59A9826F-4C2F-482A-8888-F649544318BE|2|||||WOMAC VA 3.1 INDEX|||BEAM BREAKS|||UG/L FEU|NOT DONE||LIKERT SCALE 7-POINT|N|Y|NA|2||58||BASELINE|1967-06-01||||1973-02-24||1962-05-08|1973-03-11|
TRIAL STUDY 134XCP|QS|59A9826F-4C2F-482A-8888-F649544318BE|3|||||HAEM-A-QOL|||EID 50/DOSE|||NCI|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|3||39||BASELINE|1969-07-01||||1962-11-08||1963-01-22|1966-12-16|
TRIAL STUDY 134XCP|QS|59A9826F-4C2F-482A-8888-F649544318BE|4|||||ADCS-ADL MCI|||MOSM/L|||CMOL/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|N|4||88||LONG-TERM FOLLOW-UP|1961-06-03||||1965-04-24||1964-09-21|1971-11-07|
TRIAL STUDY 134XCP|QS|59A9826F-4C2F-482A-8888-F649544318BE|5|||||FSS|||CM H2O|||UG/M2/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|NA|5||7||SCREENING|1963-04-21||||1961-04-15||1965-02-12|1967-08-01|
TRIAL STUDY 134XCP|QS|B6E55A62-CF0B-4BC6-84DC-038F29518909|1|||||SMDDS V1.0|||CIGARETTE|||KPA/L/SEC|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|1||38||TREATMENT|1962-01-18||||1969-09-27||1967-04-25|1967-08-14|
TRIAL STUDY 134XCP|QS|B6E55A62-CF0B-4BC6-84DC-038F29518909|2|||||CCQ 24 HOUR VERSION|||DYN|||ENZYME U/G HB|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|2||58||SCREENING|1966-05-31||||1969-12-19||1971-11-11|1968-01-11|
TRIAL STUDY 134XCP|QS|B6E55A62-CF0B-4BC6-84DC-038F29518909|3|||||DAD|||CMH2O/ML|||ML/ANIMAL|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|3||39||TREATMENT|1972-07-08||||1961-05-03||1964-11-27|1963-11-06|
TRIAL STUDY 134XCP|QS|B6E55A62-CF0B-4BC6-84DC-038F29518909|4|||||FLU-IIQ TWICE DAILY|||DAMOL/L|||H*%|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|NA|4||88||SCREENING|1968-10-15||||1969-08-03||1966-10-08|1970-08-25|
TRIAL STUDY 134XCP|QS|B6E55A62-CF0B-4BC6-84DC-038F29518909|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||MG/CM2|||HZ/S|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|5||7||OBSERVATION|1965-07-28||||1967-05-16||1961-07-16|1965-09-07|
TRIAL STUDY 134XCP|QS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1|||||SOWS SUBJECTIVE|||M|||LOG10 COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|Y|1||38||FOLLOW-UP|1964-09-09||||1960-04-29||1967-03-08|1963-02-06|
TRIAL STUDY 134XCP|QS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||M|||DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|Y|2||58||RUN-IN|1970-10-27||||1962-10-02||1972-08-25|1964-10-17|
TRIAL STUDY 134XCP|QS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|3|||||GAD-7 V2|||DL|||JAR|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|3||39||OBSERVATION|1963-09-13||||1963-11-27||1967-06-29|1968-08-04|
TRIAL STUDY 134XCP|QS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|4|||||WHODAS 2.0 - 36-ITEM PROXY|||CMHG|||U/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|NA|4||88||SCREENING|1971-06-15||||1965-02-14||1969-07-10|1969-01-08|
TRIAL STUDY 134XCP|QS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|5|||||BLCS|||ML/M2|||10^3 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|N|5||7||RUN-IN|1961-01-03||||1968-04-26||1967-01-27|1970-07-20|
TRIAL STUDY 134XCP|QS|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1|||||IIEF|||%(W/V)|||10^3 ORGANISMS/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1973-04-29||||1964-08-01||1969-03-08|1963-02-03|
TRIAL STUDY 134XCP|QS|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2|||||SF12 V2.0 ACUTE|||KCAL/DAY|||PG/CELL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|NA|2||58||WASHOUT|1970-07-18||||1967-03-18||1967-11-30|1960-04-24|
TRIAL STUDY 134XCP|QS|5577E914-C90D-4CC4-A7A8-D919C29A61D1|3|||||SGRQ-C|||LOG10 CFU/ML|||MNFI|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|3||39||TREATMENT|1971-01-03||||1969-11-15||1973-06-29|1969-08-29|
TRIAL STUDY 134XCP|QS|5577E914-C90D-4CC4-A7A8-D919C29A61D1|4|||||CCQ 24 HOUR VERSION|||M3|||ML/ANIMAL/WK|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|N|4||88||FOLLOW-UP|1964-05-30||||1969-11-21||1972-07-07|1972-07-03|
TRIAL STUDY 134XCP|QS|5577E914-C90D-4CC4-A7A8-D919C29A61D1|5|||||C-SSRS BASELINE|||KUSP|||UG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|N|5||7||TREATMENT|1967-11-20||||1963-11-04||1967-08-20|1964-03-09|
TRIAL STUDY 134XCP|QS|2DBA8940-F59E-4A0D-8858-408D71DD9753|1|||||GAD-7|||MG/M2|||GBQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|Y|1||38||BLINDED TREATMENT|1968-12-23||||1966-02-06||1967-10-14|1969-12-01|
TRIAL STUDY 134XCP|QS|2DBA8940-F59E-4A0D-8858-408D71DD9753|2|||||ACQ|||G/G/DAY|||ML/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|Y|2||58||INDUCTION TREATMENT|1966-04-20||||1970-03-03||1970-01-20|1969-10-08|
TRIAL STUDY 134XCP|QS|2DBA8940-F59E-4A0D-8858-408D71DD9753|3|||||ADCS-ADL SEVERE DEMENTIA|||GBQ/G|||UMOL/L/H|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|3||39||OBSERVATION|1971-10-19||||1962-07-15||1964-07-04|1967-03-06|
TRIAL STUDY 134XCP|QS|2DBA8940-F59E-4A0D-8858-408D71DD9753|4|||||MFIS|||DISK|||STRIP|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|4||88||BLINDED TREATMENT|1964-08-11||||1964-04-25||1961-11-23|1964-10-06|
TRIAL STUDY 134XCP|QS|2DBA8940-F59E-4A0D-8858-408D71DD9753|5|||||ASEX-MALE|||ML/KG|||MG/MOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|NA|5||7||OPEN LABEL TREATMENT|1971-08-29||||1963-02-06||1960-08-18|1965-05-10|
TRIAL STUDY 134XCP|QS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1|||||ASEX-MALE|||WEEKS|||EID 50/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|1||38||OPEN LABEL TREATMENT|1963-11-07||||1961-11-29||1969-09-23|1971-11-02|
TRIAL STUDY 134XCP|QS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2|||||SF8 V1.0 STANDARD|||MPA|||CM2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|N|2||58||OBSERVATION|1960-08-26||||1965-12-13||1963-07-08|1960-06-06|
TRIAL STUDY 134XCP|QS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|3|||||FKSI-15|||NL|||GRAVITATIONAL UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|3||39||FOLLOW-UP|1961-09-15||||1969-09-21||1968-03-11|1970-01-18|
TRIAL STUDY 134XCP|QS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|4|||||FACT-G V4|||AG|||ML/G/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|NA|4||88||BASELINE|1966-05-20||||1971-01-20||1960-11-13|1960-02-15|
TRIAL STUDY 134XCP|QS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|5|||||PEDS-FACIT-F|||UOSM|||APL U|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|5||7||INDUCTION TREATMENT|1966-06-22||||1967-05-07||1970-06-15|1966-04-15|
TRIAL STUDY 134XCP|QS|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||DAMOL/L|||QUANTITY SUFFICIENT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|1||38||WASHOUT|1960-10-15||||1964-05-10||1961-02-21|1962-02-10|
TRIAL STUDY 134XCP|QS|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2|||||BEBQ CONCURRENT|||YEARS|||CP|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|2||58||RUN-IN|1969-11-07||||1972-08-24||1960-07-10|1962-12-14|
TRIAL STUDY 134XCP|QS|0250EC5D-B08F-4010-9653-95E20EDD0CCA|3|||||COWS|||CI/UL|||ML/MMHG|NOT DONE||LIKERT SCALE 3-POINT|NA|U|NA|3||39||FOLLOW-UP|1965-12-06||||1963-09-18||1961-01-07|1968-07-17|
TRIAL STUDY 134XCP|QS|0250EC5D-B08F-4010-9653-95E20EDD0CCA|4|||||C-SSRS BASELINE|||10^3 DNA COPIES/ML|||MBP|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|Y|4||88||FOLLOW-UP|1960-08-05||||1971-03-03||1971-04-12|1968-10-20|
TRIAL STUDY 134XCP|QS|0250EC5D-B08F-4010-9653-95E20EDD0CCA|5|||||SIQ|||BP|||MPL U|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|5||7||INDUCTION TREATMENT|1962-10-07||||1960-01-20||1964-02-02|1967-05-19|
TRIAL STUDY 134XCP|QS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1|||||HAQ-DI WITH VAS|||/2000 RBC|||CD|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|NA|1||38||INDUCTION TREATMENT|1963-02-12||||1965-02-09||1969-10-11|1961-01-19|
TRIAL STUDY 134XCP|QS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2|||||Q-LES-Q-SF|||DEG2|||DMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|2||58||INDUCTION TREATMENT|1960-07-07||||1965-06-23||1970-09-05|1966-10-14|
TRIAL STUDY 134XCP|QS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|3|||||FKSI-15|||G/ANIMAL|||G/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|NA|3||39||SCREENING|1971-10-11||||1960-04-02||1970-10-31|1968-10-18|
TRIAL STUDY 134XCP|QS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|4|||||FACIT-DYSPNEA 33 ITEM BANK|||TUBERCULIN UNIT/ML|||KPA|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|Y|4||88||LONG-TERM FOLLOW-UP|1972-07-07||||1963-03-30||1966-01-05|1966-07-30|
TRIAL STUDY 134XCP|QS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|5|||||BIS-11|||MM3/MM2/YEAR|||FOZ_US|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|U|5||7||OBSERVATION|1969-04-06||||1967-04-10||1971-10-14|1971-10-29|
TRIAL STUDY 134XCP|QS|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1|||||SDS|||DAMOL/L|||ML/M2/H|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|NA|1||38||INDUCTION TREATMENT|1961-09-08||||1960-06-20||1969-06-30|1968-10-25|
TRIAL STUDY 134XCP|QS|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2|||||PODCI - ADOLESCENT PARENT REPORTED|||MG/DL|||NMOL/L/H|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|N|2||58||OBSERVATION|1965-01-12||||1960-04-17||1964-06-21|1966-10-09|
TRIAL STUDY 134XCP|QS|140FFC83-72C9-4BD4-AA44-C98CA42147F3|3|||||QIDS-SR|||UU/L|||GMFI|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|3||39||RUN-IN|1962-01-23||||1960-11-26||1965-07-11|1964-10-07|
TRIAL STUDY 134XCP|QS|140FFC83-72C9-4BD4-AA44-C98CA42147F3|4|||||FACT-LYM V4|||M2|||V/V|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|NA|4||88||SCREENING|1972-07-21||||1960-11-24||1961-09-30|1966-10-14|
TRIAL STUDY 134XCP|QS|140FFC83-72C9-4BD4-AA44-C98CA42147F3|5|||||ASEX-FEMALE|||ML/MMHG|||LX|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|Y|5||7||INDUCTION TREATMENT|1965-03-26||||1966-11-06||1971-03-06|1960-07-08|
TRIAL STUDY 134XCP|QS|7BAC399A-0523-476E-A294-C57309E573AF|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||UGEQ|||PMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|1||38||BLINDED TREATMENT|1960-02-21||||1962-03-17||1962-07-04|1972-09-04|
TRIAL STUDY 134XCP|QS|7BAC399A-0523-476E-A294-C57309E573AF|2|||||MDS-UPDRS|||10^8 PFU|||COAT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|Y|2||58||CONTINUATION TREATMENT|1969-10-06||||1962-05-25||1968-06-04|1961-06-11|
TRIAL STUDY 134XCP|QS|7BAC399A-0523-476E-A294-C57309E573AF|3|||||RDQ|||10^3 CFU/ML|||MEQ/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|3||39||TREATMENT|1971-06-28||||1964-01-06||1972-09-18|1972-04-19|
TRIAL STUDY 134XCP|QS|7BAC399A-0523-476E-A294-C57309E573AF|4|||||T1-DDS|||JOULE|||DPM/0.5 ML|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|N|4||88||BASELINE|1966-05-31||||1963-11-10||1964-05-05|1965-03-26|
TRIAL STUDY 134XCP|QS|7BAC399A-0523-476E-A294-C57309E573AF|5|||||EORTC QLQ-C15-PAL V1.0|||LB|||FOZ_US|NOT DONE||LIKERT SCALE 7-POINT|U|Y|N|5||7||INDUCTION TREATMENT|1971-04-28||||1963-06-10||1970-06-21|1966-11-06|
TRIAL STUDY 134XCP|QS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1|||||WOMAC VA 3.1 INDEX|||IU/MG|||UG/G/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|NA|1||38||SCREENING|1973-07-01||||1972-11-22||1967-05-05|1964-11-28|
TRIAL STUDY 134XCP|QS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2|||||WHODAS 2.0 - 12-ITEM PROXY|||ML/CM3/MIN|||/40 HPFS|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|NA|2||58||FOLLOW-UP|1962-12-19||||1967-02-26||1973-03-26|1972-02-11|
TRIAL STUDY 134XCP|QS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|3|||||HAMD 6 SELF-REPORT VERSION|||UG/M2/H|||MU/L|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|3||39||SCREENING|1968-12-06||||1970-08-19||1969-01-21|1963-05-11|
TRIAL STUDY 134XCP|QS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||MEQ/UL|||TROCHE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|Y|4||88||WASHOUT|1971-06-07||||1967-07-06||1966-05-29|1962-10-16|
TRIAL STUDY 134XCP|QS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||SV|||NMOL BCE/MMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|5||7||INDUCTION TREATMENT|1972-09-01||||1966-04-02||1965-12-26|1972-04-11|
TRIAL STUDY 134XCP|QS|0F180E62-F840-490F-8EB3-F7DDB7132401|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||U.CARR|||UG/MOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|NA|1||38||OBSERVATION|1968-02-29||||1971-05-17||1972-09-17|1966-02-22|
TRIAL STUDY 134XCP|QS|0F180E62-F840-490F-8EB3-F7DDB7132401|2|||||SF8 V1.0 STANDARD|||MM/H|||10^9/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|NA|2||58||TREATMENT|1961-03-18||||1967-10-28||1960-08-22|1966-03-10|
TRIAL STUDY 134XCP|QS|0F180E62-F840-490F-8EB3-F7DDB7132401|3|||||NSCLC-SAQ V1.0|||MU/L|||BOLUS|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|U|3||39||FOLLOW-UP|1971-04-02||||1960-11-05||1966-04-04|1963-06-27|
TRIAL STUDY 134XCP|QS|0F180E62-F840-490F-8EB3-F7DDB7132401|4|||||VFQ-25 SELF ADMINISTERED|||PG/DL|||SV|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|NA|4||88||TREATMENT|1968-12-23||||1963-06-12||1960-01-22|1971-01-21|
TRIAL STUDY 134XCP|QS|0F180E62-F840-490F-8EB3-F7DDB7132401|5|||||PDDS|||NMOL/L/MIN|||PG/CELL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|U|5||7||INDUCTION TREATMENT|1968-07-10||||1973-03-25||1973-08-13|1960-09-16|
TRIAL STUDY 134XCP|QS|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1|||||BEBQ CONCURRENT|||MMAL|||HZ/S|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|NA|1||38||BASELINE|1971-10-03||||1964-10-13||1972-09-15|1961-03-17|
TRIAL STUDY 134XCP|QS|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||BEL|||MG/L FEU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|NA|2||58||TREATMENT|1961-06-27||||1972-06-01||1964-03-27|1966-02-11|
TRIAL STUDY 134XCP|QS|80E7A428-CDDE-453F-B7D1-1B282A1835BF|3|||||FBRSI|||VP/ML|||CAPSULE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|3||39||TREATMENT|1967-10-16||||1962-07-13||1972-06-21|1971-03-24|
TRIAL STUDY 134XCP|QS|80E7A428-CDDE-453F-B7D1-1B282A1835BF|4|||||VFQ-25 SELF ADMINISTERED|||UV|||MG/MOL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|4||88||BASELINE|1960-06-29||||1964-11-22||1968-02-08|1967-12-25|
TRIAL STUDY 134XCP|QS|80E7A428-CDDE-453F-B7D1-1B282A1835BF|5|||||IPAQ-LF PHONE VERSION|||10^9/G|||HR/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|5||7||INDUCTION TREATMENT|1963-03-14||||1972-11-30||1972-06-20|1972-07-06|
TRIAL STUDY 134XCP|QS|F1D265C4-B975-4E74-9545-122A10FE100F|1|||||TSCC|||PACKAGE|||BREATHS/30S|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|1||38||CONTINUATION TREATMENT|1966-09-14||||1966-04-19||1964-07-05|1967-07-16|
TRIAL STUDY 134XCP|QS|F1D265C4-B975-4E74-9545-122A10FE100F|2|||||ESS|||/500 WBC|||UG/G/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|2||58||TREATMENT|1965-02-23||||1966-03-04||1966-12-27|1961-12-20|
TRIAL STUDY 134XCP|QS|F1D265C4-B975-4E74-9545-122A10FE100F|3|||||SGRQ PAST 3 MONTHS VERSION|||FARAD|||G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|3||39||TREATMENT|1966-10-16||||1972-07-23||1971-11-22|1971-07-26|
TRIAL STUDY 134XCP|QS|F1D265C4-B975-4E74-9545-122A10FE100F|4|||||ADAS-COG|||F|||10^3 CFU/G|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|4||88||INDUCTION TREATMENT|1972-04-24||||1963-09-03||1969-05-04|1969-04-17|
TRIAL STUDY 134XCP|QS|F1D265C4-B975-4E74-9545-122A10FE100F|5|||||BORG CR10|||GBQ/G|||DYN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|N|5||7||OBSERVATION|1961-09-13||||1963-05-23||1971-08-15|1971-10-17|
TRIAL STUDY 134XCP|QS|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1|||||SWLS|||FINGERTIP UNIT|||L/MIN/M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|Y|1||38||CONTINUATION TREATMENT|1962-02-09||||1964-07-31||1971-03-23|1960-07-12|
TRIAL STUDY 134XCP|QS|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2|||||AQ20|||DPM|||GPL U/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|2||58||WASHOUT|1966-01-27||||1969-10-03||1960-02-03|1971-01-15|
TRIAL STUDY 134XCP|QS|7A272C35-DB2C-429D-AF31-CC7386DC8F07|3|||||BSFS|||ML/(MIN*100ML)|||FRACTION OF 1|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|U|3||39||SCREENING|1961-11-15||||1967-09-25||1973-04-27|1972-06-02|
TRIAL STUDY 134XCP|QS|7A272C35-DB2C-429D-AF31-CC7386DC8F07|4|||||VFQ-25 SELF ADMINISTERED|||EP U|||GMFI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|4||88||OPEN LABEL TREATMENT|1964-06-04||||1963-10-08||1965-02-06|1966-08-08|
TRIAL STUDY 134XCP|QS|7A272C35-DB2C-429D-AF31-CC7386DC8F07|5|||||PEDS-FACIT-F|||EID 50/DOSE|||DRINK|NOT DONE||LIKERT SCALE 5-POINT|N|N|U|5||7||SCREENING|1966-09-14||||1970-02-07||1965-01-16|1961-04-16|
TRIAL STUDY 134XCP|QS|FBF95CF9-933D-406A-8D67-B1F643C5F554|1|||||C-SSRS ALREADY ENROLLED SUBJECTS|||UG/DL|||ML/G/MIN|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|1||38||LONG-TERM FOLLOW-UP|1967-10-06||||1964-11-05||1967-10-14|1968-01-05|
TRIAL STUDY 134XCP|QS|FBF95CF9-933D-406A-8D67-B1F643C5F554|2|||||NCCN-FACT FBRSI-24 V2|||BAG|||TITER|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|U|2||58||INDUCTION TREATMENT|1966-08-11||||1962-10-16||1968-07-30|1961-08-26|
TRIAL STUDY 134XCP|QS|FBF95CF9-933D-406A-8D67-B1F643C5F554|3|||||BEBQ CONCURRENT|||YEARS|||CM2|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|Y|3||39||TREATMENT|1962-08-28||||1968-05-09||1972-10-28|1963-07-08|
TRIAL STUDY 134XCP|QS|FBF95CF9-933D-406A-8D67-B1F643C5F554|4|||||ODI V2.1A|||ML/M2/DAY|||CAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|NA|4||88||LONG-TERM FOLLOW-UP|1965-09-19||||1966-11-01||1969-07-21|1965-12-05|
TRIAL STUDY 134XCP|QS|FBF95CF9-933D-406A-8D67-B1F643C5F554|5|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||ML|||DEG/MM|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|Y|5||7||RUN-IN|1967-03-25||||1970-01-07||1970-11-30|1971-12-17|
TRIAL STUDY 134XCP|QS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1|||||ESS|||H/WK|||10^4 CFU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|1||38||BLINDED TREATMENT|1965-09-21||||1967-04-30||1970-09-10|1966-12-14|
TRIAL STUDY 134XCP|QS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2|||||FPSR|||UL|||L/L|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|N|2||58||SCREENING|1968-06-04||||1960-08-28||1967-09-05|1961-07-11|
TRIAL STUDY 134XCP|QS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|3|||||SF36 V2.0 STANDARD|||MM3/MM2/YEAR|||PMOL/10^10 CELLS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|N|3||39||BLINDED TREATMENT|1973-07-26||||1968-04-13||1961-08-25|1960-12-15|
TRIAL STUDY 134XCP|QS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|4|||||PHQ-15|||10^3 CFU|||U/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|NA|4||88||WASHOUT|1968-12-11||||1972-12-31||1966-06-02|1960-04-26|
TRIAL STUDY 134XCP|QS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|5|||||GAD-7|||PELLET|||NMOL/L|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1966-02-09||||1960-10-20||1966-05-10|1967-08-03|
TRIAL STUDY 134XCP|QS|391D2418-5359-457B-AEC5-6A48DE04DAFD|1|||||FACIT-FATIGUE 13-ITEM V4|||BU|||10^8/L|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|1||38||SCREENING|1971-04-16||||1960-01-14||1972-08-30|1962-04-19|
TRIAL STUDY 134XCP|QS|391D2418-5359-457B-AEC5-6A48DE04DAFD|2|||||RDQ|||MG/DOSE|||G/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|NA|2||58||RUN-IN|1965-02-12||||1969-03-20||1963-04-21|1961-04-25|
TRIAL STUDY 134XCP|QS|391D2418-5359-457B-AEC5-6A48DE04DAFD|3|||||FBRSI|||NKAT/L|||V/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|Y|3||39||FOLLOW-UP|1965-09-10||||1969-01-12||1962-10-08|1972-09-11|
TRIAL STUDY 134XCP|QS|391D2418-5359-457B-AEC5-6A48DE04DAFD|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||G/KG|||ANSON U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|4||88||RUN-IN|1965-08-20||||1973-08-02||1968-07-18|1962-04-02|
TRIAL STUDY 134XCP|QS|391D2418-5359-457B-AEC5-6A48DE04DAFD|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||UG/KG/DAY|||PM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|NA|5||7||RUN-IN|1969-05-29||||1964-02-06||1961-01-13|1960-09-05|
TRIAL STUDY 134XCP|QS|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||KDA|||L/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|1||38||RUN-IN|1967-10-17||||1962-04-24||1973-02-25|1967-11-22|
TRIAL STUDY 134XCP|QS|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2|||||PDDS|||UMOL/MG/MIN|||10^7 PFU|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|2||58||LONG-TERM FOLLOW-UP|1973-03-15||||1968-04-22||1966-02-04|1971-05-08|
TRIAL STUDY 134XCP|QS|68F706F0-2F0B-4D50-B15C-2DFDD186112E|3|||||NCCN-FACT FOSI-18 V2|||MONTHS|||UMOL/L/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|3||39||SCREENING|1970-04-14||||1965-07-17||1970-10-26|1966-07-16|
TRIAL STUDY 134XCP|QS|68F706F0-2F0B-4D50-B15C-2DFDD186112E|4|||||PHQ SCREENER VERSION|||CUP|||UG/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|U|4||88||INDUCTION TREATMENT|1967-02-14||||1960-09-15||1961-08-26|1972-04-26|
TRIAL STUDY 134XCP|QS|68F706F0-2F0B-4D50-B15C-2DFDD186112E|5|||||GMSS VERSION TYPE 1 DIABETES|||PACK YEAR|||10^9 CFU|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|NA|5||7||OPEN LABEL TREATMENT|1970-10-22||||1964-03-21||1965-07-12|1963-10-21|
TRIAL STUDY 134XCP|QS|E8D4AACE-0832-482D-8266-96B7423F9459|1|||||RAND-36 V1.0|||VG/DOSE|||KALLIKREIN INHIBITOR UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|1||38||OBSERVATION|1965-01-24||||1965-03-31||1972-07-13|1969-12-27|
TRIAL STUDY 134XCP|QS|E8D4AACE-0832-482D-8266-96B7423F9459|2|||||GAD-7|||FEU|||CI/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|U|2||58||CONTINUATION TREATMENT|1963-11-20||||1961-12-06||1962-02-23|1961-09-08|
TRIAL STUDY 134XCP|QS|E8D4AACE-0832-482D-8266-96B7423F9459|3|||||GAD-7 V2|||IU/DAY|||UM/DAY|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|3||39||BLINDED TREATMENT|1960-06-15||||1966-01-19||1960-01-28|1972-06-04|
TRIAL STUDY 134XCP|QS|E8D4AACE-0832-482D-8266-96B7423F9459|4|||||WHODAS 2.0 - 36-ITEM SELF|||10^3 CFU/G|||FFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|4||88||OPEN LABEL TREATMENT|1970-02-13||||1966-01-02||1964-11-05|1973-07-26|
TRIAL STUDY 134XCP|QS|E8D4AACE-0832-482D-8266-96B7423F9459|5|||||CHART-SF INTERVIEW VERSION|||10^6/G|||MEQ/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|Y|5||7||FOLLOW-UP|1964-08-18||||1960-05-15||1967-06-24|1964-06-30|
TRIAL STUDY 134XCP|QS|F358E69F-9B9A-4637-9063-B8FECFF000B2|1|||||CHART-SF INTERVIEW VERSION|||% INHIBITION|||U/G|NOT DONE||LIKERT SCALE 7-POINT|U|NA|NA|1||38||CONTINUATION TREATMENT|1966-09-04||||1971-06-08||1965-10-20|1964-08-27|
TRIAL STUDY 134XCP|QS|F358E69F-9B9A-4637-9063-B8FECFF000B2|2|||||PR|||OZ EQ|||RPM|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|Y|2||58||CONTINUATION TREATMENT|1960-07-15||||1969-11-11||1960-01-19|1972-04-23|
TRIAL STUDY 134XCP|QS|F358E69F-9B9A-4637-9063-B8FECFF000B2|3|||||ADHD-RS-IV HOME VERSION|||UIU/DL|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|NA|3||39||WASHOUT|1973-03-10||||1967-08-16||1961-07-29|1960-08-08|
TRIAL STUDY 134XCP|QS|F358E69F-9B9A-4637-9063-B8FECFF000B2|4|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||PACKAGE|||ML/BREATH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|N|4||88||SCREENING|1968-10-23||||1964-12-15||1970-01-22|1964-12-24|
TRIAL STUDY 134XCP|QS|F358E69F-9B9A-4637-9063-B8FECFF000B2|5|||||WOMAC NRS 3.1 INDEX|||WEBER|||FT2|NOT DONE||LIKERT SCALE 7-POINT|N|U|Y|5||7||CONTINUATION TREATMENT|1971-01-10||||1970-01-27||1968-11-27|1965-03-14|
TRIAL STUDY 134XCP|QS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1|||||GDS|||/CMH2O|||APPLICATION|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|1||38||INDUCTION TREATMENT|1963-02-12||||1968-12-12||1964-11-15|1965-06-19|
TRIAL STUDY 134XCP|QS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2|||||OCI|||L|||UV2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|2||58||OBSERVATION|1972-08-10||||1971-07-08||1964-08-06|1969-10-02|
TRIAL STUDY 134XCP|QS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||VG/KG|||L/H|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|3||39||OBSERVATION|1973-03-19||||1966-07-08||1970-03-21|1966-12-07|
TRIAL STUDY 134XCP|QS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|4|||||EORTC QLQ-CR29 V2.1|||BAU/ML|||IU/MG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|NA|4||88||INDUCTION TREATMENT|1969-06-10||||1963-05-10||1963-10-02|1966-11-28|
TRIAL STUDY 134XCP|QS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|5|||||GOSE|||/100 WBC|||GBQ/MG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|N|5||7||LONG-TERM FOLLOW-UP|1968-10-11||||1972-06-24||1962-01-09|1971-09-05|
TRIAL STUDY 134XCP|QS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1|||||WHODAS 2.0 - 36-ITEM PROXY|||IU/KG|||MMOL/MIN/KPA|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|1||38||BLINDED TREATMENT|1965-12-01||||1973-09-08||1968-07-22|1963-06-12|
TRIAL STUDY 134XCP|QS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2|||||DRRI-2|||RAD|||BQ/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|Y|2||58||TREATMENT|1971-11-10||||1967-10-22||1968-10-23|1967-12-22|
TRIAL STUDY 134XCP|QS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||CS|||CI/UG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|NA|3||39||OBSERVATION|1967-05-30||||1971-08-22||1970-12-11|1973-02-07|
TRIAL STUDY 134XCP|QS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||UCI/KG|||OSM|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|4||88||BASELINE|1966-04-18||||1967-06-13||1965-05-12|1964-09-01|
TRIAL STUDY 134XCP|QS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|5|||||FLSI|||DAGU|||TITER|NOT DONE||LIKERT SCALE 5-POINT|N|N|U|5||7||CONTINUATION TREATMENT|1960-12-18||||1966-08-02||1967-02-16|1967-04-07|
TRIAL STUDY 134XCP|QS|586B4529-9808-4205-B3D6-5C4A1DAFA922|1|||||WPAI-GH V2.0|||WEBER|||DAGU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|1||38||BASELINE|1966-02-20||||1963-01-31||1970-07-21|1971-04-05|
TRIAL STUDY 134XCP|QS|586B4529-9808-4205-B3D6-5C4A1DAFA922|2|||||NCCN-FACT FBRSI-24 V2|||NMOL/MOL|||ML/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|Y|2||58||BASELINE|1968-06-25||||1970-04-17||1972-08-10|1973-07-11|
TRIAL STUDY 134XCP|QS|586B4529-9808-4205-B3D6-5C4A1DAFA922|3|||||FACT-L V4|||ML/MMHG/MIN/L|||10^6 RNA COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|3||39||BLINDED TREATMENT|1960-09-13||||1964-08-19||1961-11-09|1961-12-07|
TRIAL STUDY 134XCP|QS|586B4529-9808-4205-B3D6-5C4A1DAFA922|4|||||GOSE|||KG/CM2|||UG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|4||88||RUN-IN|1962-08-11||||1961-08-28||1960-06-09|1973-04-16|
TRIAL STUDY 134XCP|QS|586B4529-9808-4205-B3D6-5C4A1DAFA922|5|||||HAQ-DI WITHOUT VAS|||MG/M2|||NMOL/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|NA|5||7||SCREENING|1965-09-19||||1966-11-13||1961-09-14|1960-01-24|
TRIAL STUDY 134XCP|QS|54685EFC-EE92-4591-B059-24145A3E6D69|1|||||EPIC-26|||KM|||ML*CMH2O|NOT DONE||LIKERT SCALE 5-POINT|U|N|N|1||38||INDUCTION TREATMENT|1968-11-05||||1966-07-27||1970-11-30|1967-01-12|
TRIAL STUDY 134XCP|QS|54685EFC-EE92-4591-B059-24145A3E6D69|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||APS U|||TROCHE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|2||58||CONTINUATION TREATMENT|1960-02-29||||1964-06-11||1960-08-25|1969-09-02|
TRIAL STUDY 134XCP|QS|54685EFC-EE92-4591-B059-24145A3E6D69|3|||||HCS|||LOG10 COPIES/ML|||MOL/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|3||39||TREATMENT|1967-05-13||||1966-10-21||1973-03-09|1965-07-31|
TRIAL STUDY 134XCP|QS|54685EFC-EE92-4591-B059-24145A3E6D69|4|||||NCCN-FACT FBRSI-24 V2|||SEC|||LOG10 ELISA UNIT/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|4||88||BASELINE|1967-06-11||||1962-04-09||1963-06-28|1966-02-21|
TRIAL STUDY 134XCP|QS|54685EFC-EE92-4591-B059-24145A3E6D69|5|||||WPAI-GH V2.0|||ML/(MIN*100ML)|||BOTTLE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|5||7||CONTINUATION TREATMENT|1966-02-08||||1965-11-11||1965-02-17|1970-12-22|
TRIAL STUDY 134XCP|QS|7BD32505-61D5-4862-8896-B3E41D3EE779|1|||||UPDRS|||MAC50|||CM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|U|1||38||BLINDED TREATMENT|1961-10-31||||1969-08-24||1971-12-26|1965-05-29|
TRIAL STUDY 134XCP|QS|7BD32505-61D5-4862-8896-B3E41D3EE779|2|||||FACT-LYM V4|||G/KG/DAY|||SCOOPFUL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|2||58||CONTINUATION TREATMENT|1962-07-29||||1966-03-12||1969-06-10|1971-09-05|
TRIAL STUDY 134XCP|QS|7BD32505-61D5-4862-8896-B3E41D3EE779|3|||||EQ-5D-5L|||V/SEC|||CAPLET|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|N|3||39||OPEN LABEL TREATMENT|1962-04-27||||1960-08-26||1966-10-10|1968-01-30|
TRIAL STUDY 134XCP|QS|7BD32505-61D5-4862-8896-B3E41D3EE779|4|||||PODCI - ADOLESCENT SELF REPORTED|||BREATHS/30S|||UM/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|4||88||TREATMENT|1968-01-25||||1970-02-24||1973-07-06|1962-11-17|
TRIAL STUDY 134XCP|QS|7BD32505-61D5-4862-8896-B3E41D3EE779|5|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||TESLA|||UG/CM2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|5||7||CONTINUATION TREATMENT|1963-12-11||||1967-04-11||1966-02-19|1964-02-26|
TRIAL STUDY 134XCP|QS|3461C227-E30F-482B-B404-026FE0CA3549|1|||||ADCS-ADL MCI|||PMOL|||MG/MOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|1||38||CONTINUATION TREATMENT|1961-10-01||||1960-05-22||1963-11-08|1960-04-07|
TRIAL STUDY 134XCP|QS|3461C227-E30F-482B-B404-026FE0CA3549|2|||||FACT-G V4|||MOSM/KG|||MAC50|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|2||58||TREATMENT|1969-12-24||||1968-08-01||1967-10-14|1961-07-30|
TRIAL STUDY 134XCP|QS|3461C227-E30F-482B-B404-026FE0CA3549|3|||||AUDIT-SR|||10^3/L|||NMOL/L/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|U|3||39||RUN-IN|1968-01-21||||1965-11-13||1964-04-15|1964-03-29|
TRIAL STUDY 134XCP|QS|3461C227-E30F-482B-B404-026FE0CA3549|4|||||FKSI-DRS V4|||CI/MG|||MBP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|4||88||FOLLOW-UP|1965-01-08||||1972-01-29||1960-05-27|1968-09-08|
TRIAL STUDY 134XCP|QS|3461C227-E30F-482B-B404-026FE0CA3549|5|||||ESS|||MMOL/DAY|||10^9 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|U|5||7||OPEN LABEL TREATMENT|1967-11-30||||1962-04-08||1971-01-07|1960-04-19|
TRIAL STUDY 134XCP|QS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1|||||NCCN-FACT FKSI-19 V2|||UOSM|||BQ/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|1||38||RUN-IN|1968-06-04||||1963-01-05||1963-09-05|1963-03-03|
TRIAL STUDY 134XCP|QS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2|||||FACT-COG V3|||10^3/HPF|||U/KG/H|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|2||58||RUN-IN|1963-08-14||||1960-07-18||1962-07-11|1967-02-21|
TRIAL STUDY 134XCP|QS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|3|||||FACT-BL V4|||PHERESIS UNIT|||TABLET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|Y|3||39||OBSERVATION|1972-07-10||||1971-07-11||1960-12-14|1971-02-06|
TRIAL STUDY 134XCP|QS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|4|||||SF12 V2.0 ACUTE|||/200 HPFS|||G/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|U|4||88||WASHOUT|1965-04-01||||1966-11-23||1962-10-22|1966-11-27|
TRIAL STUDY 134XCP|QS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||DPM/100MG|||U/CL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|Y|5||7||BLINDED TREATMENT|1969-01-03||||1972-07-23||1971-12-15|1968-04-26|
TRIAL STUDY 134XCP|QS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1|||||VFQ-25 INTERVIEWER ADMINISTERED|||10^3 CFU/G|||H*%|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|1||38||LONG-TERM FOLLOW-UP|1965-12-05||||1971-10-17||1973-08-22|1961-12-02|
TRIAL STUDY 134XCP|QS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||SEC|||ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|2||58||FOLLOW-UP|1963-06-08||||1973-05-07||1962-12-11|1964-09-03|
TRIAL STUDY 134XCP|QS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|3|||||TSQM V1.4|||10^4 CFU/ML|||MET*MIN|NOT DONE||LIKERT SCALE 7-POINT|NA|N|NA|3||39||SCREENING|1964-07-24||||1972-12-25||1961-04-21|1960-10-09|
TRIAL STUDY 134XCP|QS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|4|||||AUDIT-SR|||G|||MILE|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|NA|4||88||SCREENING|1963-03-04||||1965-02-05||1967-04-24|1960-01-11|
TRIAL STUDY 134XCP|QS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|5|||||MNSI|||MIN*MG/ML|||UG/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|Y|5||7||CONTINUATION TREATMENT|1960-12-07||||1968-09-03||1970-10-27|1968-06-23|
TRIAL STUDY 134XCP|QS|C7C91F63-87B7-4E62-B5F3-39979F74E955|1|||||WPAI-GH V2.0|||MMOL/KG|||MONTHS|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|N|1||38||WASHOUT|1971-04-17||||1964-09-11||1973-09-03|1972-12-02|
TRIAL STUDY 134XCP|QS|C7C91F63-87B7-4E62-B5F3-39979F74E955|2|||||PSQI|||YD|||MKAT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|2||58||LONG-TERM FOLLOW-UP|1963-03-16||||1960-02-08||1973-07-23|1968-08-21|
TRIAL STUDY 134XCP|QS|C7C91F63-87B7-4E62-B5F3-39979F74E955|3|||||FBRSI|||UM2|||L/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|U|3||39||BLINDED TREATMENT|1967-03-20||||1969-07-23||1964-03-14|1972-03-14|
TRIAL STUDY 134XCP|QS|C7C91F63-87B7-4E62-B5F3-39979F74E955|4|||||EPIC-CP|||/100 HPFS|||MMHG*MIN/L|NOT DONE||LIKERT SCALE 3-POINT|N|U|N|4||88||CONTINUATION TREATMENT|1972-10-08||||1963-10-17||1960-12-13|1972-04-21|
TRIAL STUDY 134XCP|QS|C7C91F63-87B7-4E62-B5F3-39979F74E955|5|||||SF36 V2.0 ACUTE|||/5X10^4 WBC|||NFIU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|N|5||7||SCREENING|1960-05-04||||1966-03-10||1972-03-13|1971-11-10|
TRIAL STUDY 134XCP|QS|D6659F53-6DF6-4F88-BF9A-160E2D057028|1|||||AQ20|||BAU|||TUBERCULIN UNIT|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|1||38||OPEN LABEL TREATMENT|1967-06-13||||1966-01-07||1966-07-09|1960-04-02|
TRIAL STUDY 134XCP|QS|D6659F53-6DF6-4F88-BF9A-160E2D057028|2|||||AUDIT-C|||CI/ML|||UMOL/L/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|2||58||WASHOUT|1970-09-26||||1969-11-12||1970-01-19|1967-02-04|
TRIAL STUDY 134XCP|QS|D6659F53-6DF6-4F88-BF9A-160E2D057028|3|||||MDS-UPDRS|||ML/100G/MIN|||CMHG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|3||39||BASELINE|1971-02-25||||1962-06-07||1967-10-18|1970-09-24|
TRIAL STUDY 134XCP|QS|D6659F53-6DF6-4F88-BF9A-160E2D057028|4|||||MSIS-29 V1|||COPIES/ML|||DL|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|U|4||88||FOLLOW-UP|1961-09-16||||1971-12-02||1961-10-25|1973-06-29|
TRIAL STUDY 134XCP|QS|D6659F53-6DF6-4F88-BF9A-160E2D057028|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||MOL/L|||UG/KG/H|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|5||7||OBSERVATION|1972-04-09||||1968-09-19||1970-02-21|1970-04-18|
TRIAL STUDY 134XCP|QS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1|||||SF12 V2.0 STANDARD|||MIN/DAY|||%|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|1||38||TREATMENT|1966-07-14||||1971-02-20||1965-09-01|1971-10-14|
TRIAL STUDY 134XCP|QS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2|||||IVIS|||10^5/L|||CPM|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|2||58||LONG-TERM FOLLOW-UP|1968-10-16||||1966-03-03||1972-07-01|1969-12-05|
TRIAL STUDY 134XCP|QS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|3|||||YMRS|||UCI/KG|||PACK YEAR|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|U|3||39||OBSERVATION|1972-08-17||||1968-03-29||1962-06-20|1972-12-07|
TRIAL STUDY 134XCP|QS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|4|||||NCCN-FACT FBRSI-24 V2|||PSI|||MOL/L|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|NA|4||88||CONTINUATION TREATMENT|1966-03-28||||1963-02-22||1969-01-22|1966-01-01|
TRIAL STUDY 134XCP|QS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|5|||||PDDS|||AMOL|||MPA|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|N|5||7||TREATMENT|1972-11-24||||1970-02-02||1962-06-07|1970-04-22|
TRIAL STUDY 134XCP|QS|91B36C93-3ADF-4570-B355-BC81B097EEFC|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||10^8 PFU|||KS|NOT DONE||LIKERT SCALE 7-POINT|N|N|Y|1||38||WASHOUT|1972-05-10||||1973-09-02||1969-05-06|1962-03-11|
TRIAL STUDY 134XCP|QS|91B36C93-3ADF-4570-B355-BC81B097EEFC|2|||||RAND-36 V1.0|||BEL|||MG/M2/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|U|2||58||BLINDED TREATMENT|1972-11-06||||1968-01-24||1966-01-07|1961-04-26|
TRIAL STUDY 134XCP|QS|91B36C93-3ADF-4570-B355-BC81B097EEFC|3|||||CCQ 1 WEEK VERSION|||EID 50/DOSE|||UIU/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|3||39||TREATMENT|1965-12-01||||1968-12-08||1964-06-23|1971-05-14|
TRIAL STUDY 134XCP|QS|91B36C93-3ADF-4570-B355-BC81B097EEFC|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||DPM|||L/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|4||88||OBSERVATION|1971-11-21||||1964-04-27||1965-08-15|1963-01-25|
TRIAL STUDY 134XCP|QS|91B36C93-3ADF-4570-B355-BC81B097EEFC|5|||||SF10 V1.0 CHILDREN STANDARD|||10^12 IU/L|||DROP|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|NA|5||7||BASELINE|1962-05-11||||1961-11-11||1966-10-14|1963-12-14|
TRIAL STUDY 134XCP|QS|ADD0DDE5-166F-4C20-B3C3-31B131509771|1|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||MMAL|||HENRY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|Y|1||38||OBSERVATION|1961-01-13||||1968-02-14||1967-11-06|1972-05-05|
TRIAL STUDY 134XCP|QS|ADD0DDE5-166F-4C20-B3C3-31B131509771|2|||||AUDIT-SR|||TITER|||LOG EID 50/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|NA|2||58||SCREENING|1968-05-08||||1966-07-31||1971-02-02|1962-01-15|
TRIAL STUDY 134XCP|QS|ADD0DDE5-166F-4C20-B3C3-31B131509771|3|||||BIS-11|||MG/M2/MIN|||DAGU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|3||39||CONTINUATION TREATMENT|1963-09-21||||1964-11-15||1961-03-02|1962-06-24|
TRIAL STUDY 134XCP|QS|ADD0DDE5-166F-4C20-B3C3-31B131509771|4|||||TSCC|||MMOL|||ML/MMHG/MIN/L|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|4||88||WASHOUT|1968-09-22||||1967-01-22||1961-01-05|1972-01-30|
TRIAL STUDY 134XCP|QS|ADD0DDE5-166F-4C20-B3C3-31B131509771|5|||||PEDS-FACIT-F|||DDU|||CD*S/M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|N|5||7||SCREENING|1966-10-20||||1967-10-08||1971-07-01|1966-12-30|
TRIAL STUDY 134XCP|QS|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1|||||FACT-BMT V4|||UMOL/L/H|||CPM|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|U|1||38||RUN-IN|1964-06-16||||1966-07-10||1966-05-19|1967-06-20|
TRIAL STUDY 134XCP|QS|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2|||||SGRQ-C|||10^9 ORGANISMS/G|||MG/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|2||58||TREATMENT|1968-11-07||||1965-12-13||1970-04-14|1973-06-28|
TRIAL STUDY 134XCP|QS|4265CC9E-26AF-4A14-B9AA-04A246E2523C|3|||||TSQM V1.4|||GLOBULE|||BQ/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|NA|3||39||SCREENING|1970-02-12||||1966-03-23||1961-06-07|1960-06-15|
TRIAL STUDY 134XCP|QS|4265CC9E-26AF-4A14-B9AA-04A246E2523C|4|||||SOAPP-R|||MOSM|||ML/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|U|4||88||LONG-TERM FOLLOW-UP|1961-07-02||||1967-10-19||1969-12-15|1966-06-25|
TRIAL STUDY 134XCP|QS|4265CC9E-26AF-4A14-B9AA-04A246E2523C|5|||||CHART-SF INTERVIEW VERSION|||U/MMOL|||UG/L DDU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|N|5||7||CONTINUATION TREATMENT|1967-04-29||||1969-08-22||1961-05-05|1961-07-17|
TRIAL STUDY 134XCP|QS|96F268D3-7441-415C-95C9-A6B70C1718D5|1|||||Q-LES-Q|||BU|||S^-1(%O2)^-1|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1970-06-21||||1971-12-08||1965-01-20|1972-12-25|
TRIAL STUDY 134XCP|QS|96F268D3-7441-415C-95C9-A6B70C1718D5|2|||||IPAQ-SF PHONE VERSION|||UG/MIN|||ML/ANIMAL/WK|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|U|2||58||BASELINE|1962-12-30||||1961-01-29||1972-07-17|1965-06-16|
TRIAL STUDY 134XCP|QS|96F268D3-7441-415C-95C9-A6B70C1718D5|3|||||ASEX-MALE|||BEATS/MIN|||/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|NA|3||39||INDUCTION TREATMENT|1961-05-31||||1969-11-08||1966-11-03|1965-03-03|
TRIAL STUDY 134XCP|QS|96F268D3-7441-415C-95C9-A6B70C1718D5|4|||||GCGI|||SCOOPFUL|||CONTAINER|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|U|4||88||LONG-TERM FOLLOW-UP|1970-10-08||||1960-04-17||1961-03-18|1962-12-27|
TRIAL STUDY 134XCP|QS|96F268D3-7441-415C-95C9-A6B70C1718D5|5|||||NSCLC-SAQ V1.0|||U/L|||CCID 50/DOSE|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|5||7||OPEN LABEL TREATMENT|1970-09-08||||1963-08-29||1970-07-02|1961-07-21|
TRIAL STUDY 134XCP|QS|15D32D1F-AEE2-474C-956E-461FB087D7B0|1|||||MNSI|||CMH2O*S2/ML|||MAC50|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1960-07-31||||1973-09-05||1960-11-14|1964-01-28|
TRIAL STUDY 134XCP|QS|15D32D1F-AEE2-474C-956E-461FB087D7B0|2|||||DRRI-2|||BQ/MG|||/WK|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|N|2||58||CONTINUATION TREATMENT|1963-10-23||||1964-09-07||1967-12-22|1972-09-03|
TRIAL STUDY 134XCP|QS|15D32D1F-AEE2-474C-956E-461FB087D7B0|3|||||NSCLC-SAQ V1.0|||CMOL|||MMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|Y|3||39||TREATMENT|1967-12-20||||1964-09-21||1963-11-03|1970-05-10|
TRIAL STUDY 134XCP|QS|15D32D1F-AEE2-474C-956E-461FB087D7B0|4|||||OCI|||/LSQN|||10^9/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|4||88||CONTINUATION TREATMENT|1966-03-01||||1964-02-09||1963-07-26|1966-06-17|
TRIAL STUDY 134XCP|QS|15D32D1F-AEE2-474C-956E-461FB087D7B0|5|||||SF10 V1.0 CHILDREN STANDARD|||UG/G/MIN|||DAGU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|U|5||7||TREATMENT|1968-05-12||||1965-08-24||1970-11-27|1968-06-29|
TRIAL STUDY 134XCP|QS|DB42C81A-D644-455D-9D95-42131EF2BFE5|1|||||PHQ-2|||LX|||NKAT/G HB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|N|1||38||LONG-TERM FOLLOW-UP|1962-05-09||||1965-04-10||1968-02-15|1960-03-13|
TRIAL STUDY 134XCP|QS|DB42C81A-D644-455D-9D95-42131EF2BFE5|2|||||CCQ 24 HOUR VERSION|||GPL U|||NG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|2||58||OBSERVATION|1969-09-12||||1964-01-20||1962-08-08|1964-12-13|
TRIAL STUDY 134XCP|QS|DB42C81A-D644-455D-9D95-42131EF2BFE5|3|||||SGRQ PAST 3 MONTHS VERSION|||AU/ML|||MV|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|3||39||FOLLOW-UP|1973-02-19||||1968-05-28||1965-07-25|1971-01-12|
TRIAL STUDY 134XCP|QS|DB42C81A-D644-455D-9D95-42131EF2BFE5|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||L/L|||IU/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|Y|4||88||LONG-TERM FOLLOW-UP|1960-03-17||||1969-05-24||1963-02-15|1961-07-31|
TRIAL STUDY 134XCP|QS|DB42C81A-D644-455D-9D95-42131EF2BFE5|5|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||PNU/ML|||NMOL/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|5||7||OPEN LABEL TREATMENT|1960-10-04||||1969-10-14||1963-06-06|1967-12-24|
TRIAL STUDY 134XCP|QS|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1|||||IPAQ-SF PHONE VERSION|||MIN|||/LSQN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|1||38||OPEN LABEL TREATMENT|1972-07-26||||1964-02-05||1973-04-20|1971-05-07|
TRIAL STUDY 134XCP|QS|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2|||||ESS|||DAGU|||MCI/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|N|2||58||BLINDED TREATMENT|1963-09-21||||1970-10-26||1964-01-11|1968-03-10|
TRIAL STUDY 134XCP|QS|4B01CC59-51D3-4499-9AB1-DF446006CB8D|3|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||MMHG|||10^6 IU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|N|3||39||OBSERVATION|1970-07-29||||1969-07-02||1967-04-12|1961-01-30|
TRIAL STUDY 134XCP|QS|4B01CC59-51D3-4499-9AB1-DF446006CB8D|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||GAUSS|||IN2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|4||88||BLINDED TREATMENT|1969-03-03||||1961-01-31||1969-09-14|1967-09-09|
TRIAL STUDY 134XCP|QS|4B01CC59-51D3-4499-9AB1-DF446006CB8D|5|||||MSWS-12|||EVENTS|||PELLET|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|5||7||FOLLOW-UP|1971-12-24||||1965-07-01||1962-08-22|1967-12-26|
TRIAL STUDY 134XCP|QS|B69774FC-1151-45DD-B329-6C21C2F29603|1|||||DRRI-2|||GRAVITATIONAL UNIT|||NG/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|1||38||OBSERVATION|1962-10-25||||1962-01-25||1961-01-29|1965-05-28|
TRIAL STUDY 134XCP|QS|B69774FC-1151-45DD-B329-6C21C2F29603|2|||||NPI|||10^3 ORGANISMS|||UMOL/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|U|2||58||RUN-IN|1961-03-04||||1969-01-20||1972-09-09|1965-03-16|
TRIAL STUDY 134XCP|QS|B69774FC-1151-45DD-B329-6C21C2F29603|3|||||C-SSRS SINCE LAST VISIT|||NMOL BCE/L|||UL/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|Y|3||39||TREATMENT|1964-09-21||||1971-05-05||1960-05-08|1971-08-28|
TRIAL STUDY 134XCP|QS|B69774FC-1151-45DD-B329-6C21C2F29603|4|||||FACT-L V4|||POUCH|||10^6 U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|4||88||CONTINUATION TREATMENT|1964-02-06||||1966-04-17||1972-07-22|1962-11-01|
TRIAL STUDY 134XCP|QS|B69774FC-1151-45DD-B329-6C21C2F29603|5|||||EPIC-CP|||CMH2O/ML|||G/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|5||7||WASHOUT|1972-01-14||||1966-10-01||1969-07-17|1966-05-15|
TRIAL STUDY 134XCP|QS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1|||||EPIC-26|||ML/S/M2|||MPS U|NOT DONE||LIKERT SCALE 5-POINT|NA|U|U|1||38||WASHOUT|1961-04-25||||1962-06-20||1962-01-24|1970-05-19|
TRIAL STUDY 134XCP|QS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2|||||C-SSRS CHILDREN'S BASELINE|||MPA|||UIU/DL|NOT DONE||LIKERT SCALE 7-POINT|U|Y|NA|2||58||OPEN LABEL TREATMENT|1964-09-06||||1969-07-15||1961-06-03|1967-01-12|
TRIAL STUDY 134XCP|QS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|3|||||EPIC-26|||RING|||MPA|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|NA|3||39||BLINDED TREATMENT|1972-07-10||||1973-01-10||1960-06-16|1963-02-27|
TRIAL STUDY 134XCP|QS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|4|||||NCCN-FACT FOSI-18 V2|||KV|||UG/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|4||88||FOLLOW-UP|1970-12-03||||1963-03-02||1969-07-13|1972-10-31|
TRIAL STUDY 134XCP|QS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|5|||||FACIT-F V4|||L/DAY|||MG/KG/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|5||7||BLINDED TREATMENT|1962-08-11||||1962-03-03||1960-08-01|1960-12-27|
TRIAL STUDY 134XCP|QS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1|||||IPAQ-SF SELF-ADMINISTERED VERSION|||MPL U|||L/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|U|1||38||LONG-TERM FOLLOW-UP|1962-12-31||||1966-11-26||1965-11-21|1968-12-17|
TRIAL STUDY 134XCP|QS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2|||||BORG CR10|||FOZ_US|||PMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|Y|2||58||BLINDED TREATMENT|1962-02-20||||1970-03-03||1962-10-04|1963-02-18|
TRIAL STUDY 134XCP|QS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|3|||||COWS|||DL|||MMHG/L/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|Y|3||39||OBSERVATION|1960-07-05||||1971-12-10||1973-03-11|1973-04-29|
TRIAL STUDY 134XCP|QS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|4|||||WHODAS 2.0 - 36-ITEM PROXY|||G/ANIMAL/WK|||10^3/HPF|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|4||88||BASELINE|1964-09-26||||1966-08-18||1972-09-23|1970-08-15|
TRIAL STUDY 134XCP|QS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|5|||||SIQ-JR|||KG/CM2|||BP|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|NA|5||7||BLINDED TREATMENT|1970-06-25||||1965-02-28||1971-04-24|1964-05-10|
TRIAL STUDY 134XCP|QS|674B4474-6D52-4DE2-8342-EDB28F577BB5|1|||||ADAS-COG|||HEP|||NSEC|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|1||38||OPEN LABEL TREATMENT|1965-06-20||||1960-04-29||1972-10-05|1968-07-30|
TRIAL STUDY 134XCP|QS|674B4474-6D52-4DE2-8342-EDB28F577BB5|2|||||RAND-36 V1.0|||MG/ML/MIN|||LX|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|NA|2||58||LONG-TERM FOLLOW-UP|1970-12-04||||1971-08-04||1969-07-30|1964-09-21|
TRIAL STUDY 134XCP|QS|674B4474-6D52-4DE2-8342-EDB28F577BB5|3|||||PHQ SCREENER VERSION|||TUBERCULIN UNIT/ML|||BQ/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|3||39||RUN-IN|1968-12-07||||1962-06-14||1972-04-21|1962-04-23|
TRIAL STUDY 134XCP|QS|674B4474-6D52-4DE2-8342-EDB28F577BB5|4|||||C-SSRS SCREENING|||CMHG|||PIXELS/IN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|NA|4||88||FOLLOW-UP|1965-10-12||||1960-01-02||1973-01-31|1966-05-01|
TRIAL STUDY 134XCP|QS|674B4474-6D52-4DE2-8342-EDB28F577BB5|5|||||SF12 V1.0 STANDARD|||MET*H|||ENZYME U/G HB|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|5||7||WASHOUT|1961-01-12||||1968-10-24||1966-07-30|1968-07-22|
TRIAL STUDY 134XCP|QS|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1|||||BPI SHORT FORM|||/MONTH|||FG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|1||38||BASELINE|1966-07-20||||1962-04-03||1965-12-26|1960-02-04|
TRIAL STUDY 134XCP|QS|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2|||||SIQ-JR|||MDFI|||TRANSDUCING UNIT|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|2||58||OPEN LABEL TREATMENT|1969-02-28||||1962-10-05||1973-05-10|1966-10-01|
TRIAL STUDY 134XCP|QS|AF634AD4-086A-47EE-A5DB-A4B6833356C7|3|||||ADCS-ADL|||UG/H|||CMH2O*S2/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|3||39||RUN-IN|1973-01-14||||1960-07-22||1971-02-18|1961-05-22|
TRIAL STUDY 134XCP|QS|AF634AD4-086A-47EE-A5DB-A4B6833356C7|4|||||ODI V2.1A|||G/G/DAY|||DPM|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|4||88||FOLLOW-UP|1969-01-04||||1961-01-31||1969-06-13|1973-03-29|
TRIAL STUDY 134XCP|QS|AF634AD4-086A-47EE-A5DB-A4B6833356C7|5|||||NPS|||UV*SEC|||LOG10 ELISA UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|5||7||BASELINE|1972-05-10||||1967-04-16||1965-11-05|1963-11-12|
TRIAL STUDY 134XCP|QS|89298058-EB86-4892-97D6-1B87277DF7FC|1|||||SGRQ PAST 4 WEEKS VERSION|||ELISA UNIT|||UL/DOSE|NOT DONE||LIKERT SCALE 7-POINT|Y|N|N|1||38||INDUCTION TREATMENT|1972-04-16||||1963-01-10||1964-01-10|1962-05-15|
TRIAL STUDY 134XCP|QS|89298058-EB86-4892-97D6-1B87277DF7FC|2|||||BARS|||MG/M2|||ML/DOSE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|2||58||TREATMENT|1971-06-23||||1966-11-21||1962-05-29|1968-08-26|
TRIAL STUDY 134XCP|QS|89298058-EB86-4892-97D6-1B87277DF7FC|3|||||GAD-7 V2|||NL|||LOG10 COPIES/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|N|3||39||BASELINE|1972-08-01||||1965-02-01||1963-11-03|1968-06-24|
TRIAL STUDY 134XCP|QS|89298058-EB86-4892-97D6-1B87277DF7FC|4|||||FOSI|||APL U|||BEL|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|4||88||OPEN LABEL TREATMENT|1971-06-27||||1965-04-21||1973-02-08|1965-05-20|
TRIAL STUDY 134XCP|QS|89298058-EB86-4892-97D6-1B87277DF7FC|5|||||BWCS|||OHM|||DDU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|U|5||7||INDUCTION TREATMENT|1970-04-27||||1969-12-31||1962-02-09|1962-11-11|
TRIAL STUDY 134XCP|QS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1|||||OAB-Q SHORT FORM|||/10^3|||HOMEOPATHIC DILUTION|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|1||38||INDUCTION TREATMENT|1965-08-06||||1960-06-13||1964-03-02|1960-02-26|
TRIAL STUDY 134XCP|QS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2|||||C-SSRS CHILDREN'S BASELINE|||HZ/S|||UKAT/10^12 RBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|2||58||WASHOUT|1968-03-28||||1972-06-10||1961-08-31|1960-07-20|
TRIAL STUDY 134XCP|QS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|3|||||PODCI - ADOLESCENT PARENT REPORTED|||10^3/HPF|||NMOL/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|U|3||39||LONG-TERM FOLLOW-UP|1965-04-02||||1967-11-11||1966-04-22|1963-07-03|
TRIAL STUDY 134XCP|QS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|4|||||NPI|||BOWL|||IU/L|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|N|4||88||RUN-IN|1962-07-04||||1962-05-11||1963-08-31|1973-04-21|
TRIAL STUDY 134XCP|QS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|5|||||EQ-5D-3L|||M/SEC|||ML/H|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|Y|5||7||OPEN LABEL TREATMENT|1969-02-27||||1967-09-18||1960-09-01|1973-07-20|
TRIAL STUDY 134XCP|QS|D5235188-810B-431F-A6EF-E50DAA57F5E7|1|||||BARS|||TAMPON|||U/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|1||38||FOLLOW-UP|1960-05-01||||1961-01-24||1960-07-15|1968-09-22|
TRIAL STUDY 134XCP|QS|D5235188-810B-431F-A6EF-E50DAA57F5E7|2|||||MRS|||G/M2|||UL/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|2||58||BLINDED TREATMENT|1972-12-26||||1960-06-27||1969-09-27|1973-03-01|
TRIAL STUDY 134XCP|QS|D5235188-810B-431F-A6EF-E50DAA57F5E7|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||UG/CM2|||ML/CAGE/WK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|Y|3||39||BLINDED TREATMENT|1967-01-15||||1970-04-08||1970-07-31|1972-05-17|
TRIAL STUDY 134XCP|QS|D5235188-810B-431F-A6EF-E50DAA57F5E7|4|||||SOWS SHORT|||UL/KG/DAY|||CI/MG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|NA|4||88||SCREENING|1967-12-10||||1967-10-22||1962-02-06|1969-04-04|
TRIAL STUDY 134XCP|QS|D5235188-810B-431F-A6EF-E50DAA57F5E7|5|||||OCI|||ANTI-XA IU|||FOZ_US|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|5||7||FOLLOW-UP|1969-01-22||||1961-08-08||1967-09-19|1970-03-19|
TRIAL STUDY 134XCP|QS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||U/ML|||IU|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|N|1||38||BASELINE|1968-06-10||||1960-04-24||1962-01-01|1962-07-03|
TRIAL STUDY 134XCP|QS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2|||||MSIS-29 V2|||BAU|||GENEQ|NOT DONE||LIKERT SCALE 3-POINT|U|Y|N|2||58||TREATMENT|1963-04-28||||1968-02-27||1970-10-09|1971-11-27|
TRIAL STUDY 134XCP|QS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|3|||||FACT-BL V4|||BQ/KG|||DPM/MG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|Y|3||39||FOLLOW-UP|1970-09-16||||1965-06-06||1973-08-27|1973-04-10|
TRIAL STUDY 134XCP|QS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|4|||||C-SSRS BASELINE|||COPIES/UL|||UV*SEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|4||88||WASHOUT|1973-05-02||||1964-05-05||1971-04-11|1966-01-12|
TRIAL STUDY 134XCP|QS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|5|||||PHQ SCREENER VERSION|||MV2/HZ|||ROENTGEN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|N|5||7||BLINDED TREATMENT|1967-08-22||||1962-11-04||1961-03-04|1961-12-27|
TRIAL STUDY 134XCP|QS|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1|||||SGRQ PAST 3 MONTHS VERSION|||CFU/G|||FL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|N|1||38||BLINDED TREATMENT|1968-11-03||||1969-05-19||1971-06-10|1963-10-14|
TRIAL STUDY 134XCP|QS|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2|||||WHODAS 2.0 - 12-ITEM SELF|||HOURS|||SHOCK WAVE|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|2||58||CONTINUATION TREATMENT|1964-04-27||||1971-12-05||1970-03-08|1968-05-08|
TRIAL STUDY 134XCP|QS|E3BB136E-0913-43FB-B760-CBE939F0C4D2|3|||||BLCS|||MOSM|||ANSON U|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|U|3||39||SCREENING|1961-07-23||||1968-02-20||1968-01-06|1972-09-30|
TRIAL STUDY 134XCP|QS|E3BB136E-0913-43FB-B760-CBE939F0C4D2|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||GPL U|||PIXELS/IN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|N|4||88||OPEN LABEL TREATMENT|1960-02-09||||1962-11-05||1960-04-26|1970-02-25|
TRIAL STUDY 134XCP|QS|E3BB136E-0913-43FB-B760-CBE939F0C4D2|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||PUFF|||NFIU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|U|5||7||OPEN LABEL TREATMENT|1961-12-11||||1973-02-17||1967-02-26|1961-08-17|
TRIAL STUDY 134XCP|QS|60C25341-42CE-4532-8F99-25B8305C4ED5|1|||||NPI|||TAMPON|||L/S|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|Y|1||38||CONTINUATION TREATMENT|1964-05-10||||1972-06-06||1967-10-09|1972-12-29|
TRIAL STUDY 134XCP|QS|60C25341-42CE-4532-8F99-25B8305C4ED5|2|||||FBRSI|||LOG10 TCID 50/ML|||PMOL/DAY|NOT DONE||LIKERT SCALE 5-POINT|U|N|NA|2||58||BASELINE|1963-03-31||||1972-03-01||1961-08-09|1969-03-21|
TRIAL STUDY 134XCP|QS|60C25341-42CE-4532-8F99-25B8305C4ED5|3|||||SDS|||CFU/ML|||RPM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|3||39||INDUCTION TREATMENT|1970-02-13||||1971-01-29||1971-05-19|1964-10-31|
TRIAL STUDY 134XCP|QS|60C25341-42CE-4532-8F99-25B8305C4ED5|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||ML/BEAT|||APL U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|4||88||INDUCTION TREATMENT|1965-08-16||||1963-12-04||1965-02-01|1965-02-20|
TRIAL STUDY 134XCP|QS|60C25341-42CE-4532-8F99-25B8305C4ED5|5|||||PI|||/DAY|||AMPULE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|Y|5||7||FOLLOW-UP|1969-08-31||||1971-03-18||1971-09-27|1964-08-17|
TRIAL STUDY 134XCP|QS|42B54D88-E5B5-4828-958B-4B64F07E34B3|1|||||WPAI-GH V2.0|||UMOL/L/SEC|||U/M2/DAY|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|1||38||WASHOUT|1960-06-10||||1966-04-27||1968-11-27|1967-03-30|
TRIAL STUDY 134XCP|QS|42B54D88-E5B5-4828-958B-4B64F07E34B3|2|||||AUDIT-SR|||MMOL/KG|||ELISA UNIT/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|Y|2||58||TREATMENT|1964-12-06||||1963-10-05||1966-11-25|1961-03-01|
TRIAL STUDY 134XCP|QS|42B54D88-E5B5-4828-958B-4B64F07E34B3|3|||||WHODAS 2.0 - 36-ITEM PROXY|||GPS U|||BEATS/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|3||39||FOLLOW-UP|1968-07-04||||1965-03-17||1973-04-03|1967-02-25|
TRIAL STUDY 134XCP|QS|42B54D88-E5B5-4828-958B-4B64F07E34B3|4|||||FACT-C V4|||PPTR|||YD|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|4||88||INDUCTION TREATMENT|1971-01-29||||1967-05-07||1960-10-14|1964-05-28|
TRIAL STUDY 134XCP|QS|42B54D88-E5B5-4828-958B-4B64F07E34B3|5|||||Q-LES-Q|||%(V/V)|||BU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|Y|5||7||BASELINE|1970-04-12||||1962-01-11||1966-07-12|1966-02-13|
TRIAL STUDY 134XCP|QS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1|||||PI|||JOULE|||ML/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|1||38||WASHOUT|1969-06-04||||1971-12-21||1968-09-19|1960-11-15|
TRIAL STUDY 134XCP|QS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2|||||BORG CR10|||MEQ/L|||LOZENGE|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|2||58||OPEN LABEL TREATMENT|1961-01-08||||1973-09-01||1970-10-31|1962-05-21|
TRIAL STUDY 134XCP|QS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|3|||||MADRS|||PG/DL|||KG/MOL|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|3||39||WASHOUT|1971-10-19||||1961-11-27||1971-01-16|1961-02-13|
TRIAL STUDY 134XCP|QS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|4|||||FSS|||MG/ML/MIN|||OZ EQ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|N|4||88||BLINDED TREATMENT|1971-07-27||||1969-04-08||1962-06-17|1960-09-09|
TRIAL STUDY 134XCP|QS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|5|||||WPAI-SHP V2.0|||PFU|||PACK YEAR|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|5||7||OPEN LABEL TREATMENT|1970-03-10||||1960-05-14||1966-05-26|1965-09-09|
TRIAL STUDY 134XCP|QS|1FD985ED-A573-4A00-8902-214A7F182F28|1|||||SGRQ PAST 4 WEEKS VERSION|||DAGU|||UM2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|Y|1||38||OBSERVATION|1961-09-08||||1967-07-26||1961-02-03|1969-09-14|
TRIAL STUDY 134XCP|QS|1FD985ED-A573-4A00-8902-214A7F182F28|2|||||PDDS|||BQ/ML|||SYRINGE|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|2||58||INDUCTION TREATMENT|1962-01-24||||1967-05-22||1960-05-22|1972-02-19|
TRIAL STUDY 134XCP|QS|1FD985ED-A573-4A00-8902-214A7F182F28|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||HR/DAY|||NM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|U|3||39||TREATMENT|1967-07-02||||1967-01-12||1968-10-24|1964-02-09|
TRIAL STUDY 134XCP|QS|1FD985ED-A573-4A00-8902-214A7F182F28|4|||||T1-DDS|||TRANSDUCING UNIT/ML|||SYRINGE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|N|4||88||OPEN LABEL TREATMENT|1973-07-18||||1962-03-24||1962-10-25|1972-02-04|
TRIAL STUDY 134XCP|QS|1FD985ED-A573-4A00-8902-214A7F182F28|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||PL|||ANTI-XA IU|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|5||7||SCREENING|1971-01-21||||1968-09-13||1964-05-22|1967-09-18|
TRIAL STUDY 134XCP|QS|A2FD338A-F994-4399-BD02-99CB299F768E|1|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||AMOL|||G/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|1||38||WASHOUT|1967-10-12||||1973-08-25||1968-11-22|1964-05-08|
TRIAL STUDY 134XCP|QS|A2FD338A-F994-4399-BD02-99CB299F768E|2|||||Q-LES-Q|||MG/H|||VIAL|NOT DONE||LIKERT SCALE 5-POINT|U|Y|Y|2||58||INDUCTION TREATMENT|1972-10-03||||1968-05-31||1960-08-27|1972-09-07|
TRIAL STUDY 134XCP|QS|A2FD338A-F994-4399-BD02-99CB299F768E|3|||||NCCN-FACT FBRSI-24 V2|||FL|||10^6 IU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|U|3||39||RUN-IN|1970-10-26||||1967-05-11||1967-04-14|1969-11-24|
TRIAL STUDY 134XCP|QS|A2FD338A-F994-4399-BD02-99CB299F768E|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||MG/M2/H|||MONTHS|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|4||88||OPEN LABEL TREATMENT|1960-10-01||||1961-02-18||1967-12-23|1966-10-15|
TRIAL STUDY 134XCP|QS|A2FD338A-F994-4399-BD02-99CB299F768E|5|||||FACIT-DYSPNEA 33 ITEM BANK|||MMHG*MIN/L|||MKAT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|5||7||BLINDED TREATMENT|1960-01-28||||1962-09-02||1971-02-23|1968-02-14|
TRIAL STUDY 134XCP|QS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1|||||ACQ|||BISCUIT|||DEG/MM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|N|1||38||RUN-IN|1968-06-07||||1960-02-18||1965-01-17|1972-11-20|
TRIAL STUDY 134XCP|QS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2|||||FOSI|||ANTI-XA IU/ML|||10^8 PFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|U|2||58||BLINDED TREATMENT|1971-04-15||||1970-11-06||1960-01-18|1969-11-18|
TRIAL STUDY 134XCP|QS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|3|||||OAB-Q SHORT FORM|||TCID 50/DOSE|||%(W/V)|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|U|3||39||SCREENING|1972-04-03||||1963-05-27||1965-03-23|1966-01-15|
TRIAL STUDY 134XCP|QS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||U/M2|||UG/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|4||88||INDUCTION TREATMENT|1961-12-11||||1963-08-29||1964-11-27|1970-06-10|
TRIAL STUDY 134XCP|QS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|5|||||ADCS-ADL|||DRUM|||UMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|5||7||OBSERVATION|1963-08-29||||1968-10-08||1962-09-05|1966-09-04|
TRIAL STUDY 134XCP|QS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1|||||PROSQOLI|||VOXEL|||%(W/V)|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|1||38||BLINDED TREATMENT|1967-04-11||||1964-04-15||1960-10-18|1969-12-19|
TRIAL STUDY 134XCP|QS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2|||||BSFS|||UG/KG/H|||NG/MOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|2||58||CONTINUATION TREATMENT|1971-05-01||||1967-04-01||1973-04-24|1965-10-23|
TRIAL STUDY 134XCP|QS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|3|||||CDR|||UCI/L|||10^7 PFU|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|U|3||39||BLINDED TREATMENT|1967-10-18||||1968-12-30||1967-04-29|1964-11-05|
TRIAL STUDY 134XCP|QS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|4|||||DRRI-2|||KPA|||PMOL/L/H|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|Y|4||88||BLINDED TREATMENT|1960-01-29||||1962-10-26||1965-02-11|1962-05-08|
TRIAL STUDY 134XCP|QS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|5|||||DLQI|||CCID 50/DOSE|||EQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|5||7||INDUCTION TREATMENT|1969-02-26||||1972-06-16||1962-08-07|1966-10-29|
TRIAL STUDY 134XCP|QS|A8821AEE-49EB-4687-BB63-361BC3B8B182|1|||||FACT-G V4|||/KG|||MM/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|U|1||38||BASELINE|1971-06-27||||1966-01-02||1973-08-03|1972-01-28|
TRIAL STUDY 134XCP|QS|A8821AEE-49EB-4687-BB63-361BC3B8B182|2|||||FACIT-DYSPNEA 33 ITEM BANK|||LOG10 IU/ML|||MG/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|Y|2||58||OPEN LABEL TREATMENT|1962-05-05||||1970-10-06||1963-08-18|1963-03-31|
TRIAL STUDY 134XCP|QS|A8821AEE-49EB-4687-BB63-361BC3B8B182|3|||||IPAQ-SF PHONE VERSION|||KHZ|||ML/H|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|3||39||BASELINE|1968-11-02||||1964-12-19||1960-03-19|1965-12-03|
TRIAL STUDY 134XCP|QS|A8821AEE-49EB-4687-BB63-361BC3B8B182|4|||||SIQ|||ML/S/M2|||SUPPOSITORY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|Y|4||88||BASELINE|1973-08-09||||1960-03-05||1968-06-09|1967-06-15|
TRIAL STUDY 134XCP|QS|A8821AEE-49EB-4687-BB63-361BC3B8B182|5|||||ADCS-ADL|||UL/DOSE|||MM3/MM2/YEAR|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|5||7||OPEN LABEL TREATMENT|1966-11-03||||1966-10-01||1970-10-19|1971-03-04|
TRIAL STUDY 134XCP|QS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1|||||FAMS|||MV|||KALLIKREIN INHIBITOR UNIT|NOT DONE||LIKERT SCALE 7-POINT|U|U|N|1||38||LONG-TERM FOLLOW-UP|1971-01-07||||1962-10-04||1967-03-08|1963-08-10|
TRIAL STUDY 134XCP|QS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2|||||C-SSRS ALREADY ENROLLED SUBJECTS|||UMOL/DAY|||AMU|NOT DONE||LIKERT SCALE 7-POINT|Y|N|NA|2||58||LONG-TERM FOLLOW-UP|1966-11-19||||1970-01-29||1964-08-03|1969-01-26|
TRIAL STUDY 134XCP|QS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||NG|||LOG10 TCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|NA|3||39||INDUCTION TREATMENT|1968-05-07||||1968-02-18||1968-09-12|1972-04-11|
TRIAL STUDY 134XCP|QS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|4|||||OAB-Q SHORT FORM|||MG/ML/DAY|||MIN/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|U|4||88||WASHOUT|1973-03-14||||1965-02-04||1969-04-03|1970-07-13|
TRIAL STUDY 134XCP|QS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|5|||||NSCLC-SAQ V1.0|||NKAT|||UCI/KG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|5||7||CONTINUATION TREATMENT|1965-09-08||||1969-03-08||1963-11-18|1967-10-24|
TRIAL STUDY 134XCP|QS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1|||||TSCYC|||KIU|||10^3 CFU/G|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|1||38||INDUCTION TREATMENT|1961-04-12||||1970-12-31||1964-05-01|1960-03-05|
TRIAL STUDY 134XCP|QS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2|||||SF36 V1.0 STANDARD|||UG/ML/H|||UG/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|2||58||LONG-TERM FOLLOW-UP|1962-04-05||||1970-02-26||1970-10-15|1973-01-14|
TRIAL STUDY 134XCP|QS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|3|||||C-SSRS SINCE LAST VISIT|||DPM/0.5 ML|||LOG10 ELISA UNIT|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|3||39||CONTINUATION TREATMENT|1969-05-16||||1965-02-20||1967-05-08|1970-10-20|
TRIAL STUDY 134XCP|QS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||CI/UL|||/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|U|4||88||TREATMENT|1963-11-25||||1968-10-19||1966-11-27|1970-12-08|
TRIAL STUDY 134XCP|QS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|5|||||FACT-C V4|||MBQ/UL|||DPM/100MG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|U|5||7||CONTINUATION TREATMENT|1961-10-27||||1967-10-23||1966-05-05|1971-03-10|
TRIAL STUDY 134XCP|QS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1|||||MSIS-29 V1|||MGEQ|||MG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|N|1||38||CONTINUATION TREATMENT|1967-09-10||||1969-04-13||1972-11-11|1964-10-09|
TRIAL STUDY 134XCP|QS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2|||||AQ20|||GRAIN|||L/H|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|NA|2||58||CONTINUATION TREATMENT|1960-03-02||||1966-05-12||1963-03-26|1969-12-25|
TRIAL STUDY 134XCP|QS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|3|||||WLQ|||WEEKS|||ML/ANIMAL/DAY|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|3||39||INDUCTION TREATMENT|1962-06-06||||1970-10-20||1971-08-10|1961-08-17|
TRIAL STUDY 134XCP|QS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|4|||||Q-LES-Q-SF|||MMOL/S|||TUBERCULIN UNIT/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|4||88||BLINDED TREATMENT|1967-02-28||||1967-05-25||1968-12-20|1969-06-13|
TRIAL STUDY 134XCP|QS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|5|||||ASEX-MALE|||AU/ML|||NSEC|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|5||7||INDUCTION TREATMENT|1966-12-09||||1963-07-05||1966-01-18|1968-02-19|
TRIAL STUDY 134XCP|QS|E711C534-E58F-4B41-95CC-24E938D89B61|1|||||C-SSRS ALREADY ENROLLED SUBJECTS|||/MM|||CG|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|1||38||CONTINUATION TREATMENT|1970-02-20||||1960-06-24||1964-08-13|1964-04-27|
TRIAL STUDY 134XCP|QS|E711C534-E58F-4B41-95CC-24E938D89B61|2|||||HAQ-DI WITHOUT VAS|||HR/DAY|||CI/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|2||58||SCREENING|1963-03-15||||1970-04-13||1965-06-09|1971-09-15|
TRIAL STUDY 134XCP|QS|E711C534-E58F-4B41-95CC-24E938D89B61|3|||||EPDS|||KG|||FT3|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|N|3||39||RUN-IN|1961-06-18||||1971-01-19||1967-06-25|1966-01-29|
TRIAL STUDY 134XCP|QS|E711C534-E58F-4B41-95CC-24E938D89B61|4|||||GAD-7|||10^7 CFU/ML|||MOL/MG|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|N|4||88||OPEN LABEL TREATMENT|1967-02-03||||1968-07-16||1965-07-31|1960-02-08|
TRIAL STUDY 134XCP|QS|E711C534-E58F-4B41-95CC-24E938D89B61|5|||||MSIS-29 V2|||PT_US|||UMOL/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|NA|5||7||INDUCTION TREATMENT|1970-11-14||||1970-10-27||1970-06-20|1967-05-24|
TRIAL STUDY 134XCP|QS|83938342-C01F-491A-84A7-F85D327F112D|1|||||SWLS|||MBQ/UL|||APPLICATION|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|NA|1||38||RUN-IN|1967-12-23||||1960-11-21||1963-02-01|1962-07-21|
TRIAL STUDY 134XCP|QS|83938342-C01F-491A-84A7-F85D327F112D|2|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||PT_BR|||KHZ|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|2||58||BASELINE|1965-01-29||||1961-03-25||1966-12-08|1962-08-15|
TRIAL STUDY 134XCP|QS|83938342-C01F-491A-84A7-F85D327F112D|3|||||FIQR|||MOL/ML|||CMH2O*S/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|N|3||39||CONTINUATION TREATMENT|1970-11-27||||1962-11-20||1968-06-08|1963-11-07|
TRIAL STUDY 134XCP|QS|83938342-C01F-491A-84A7-F85D327F112D|4|||||ASEX-FEMALE|||TRANSDUCING UNIT|||STEPS|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|NA|4||88||CONTINUATION TREATMENT|1973-01-17||||1967-05-11||1969-01-17|1964-11-09|
TRIAL STUDY 134XCP|QS|83938342-C01F-491A-84A7-F85D327F112D|5|||||ESS|||%(W/W)|||ML/G/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|5||7||OBSERVATION|1966-02-20||||1972-07-07||1965-11-27|1973-02-13|
TRIAL STUDY 134XCP|QS|731665AB-4418-4943-BFC5-D78F03C8D423|1|||||ADHD-RS-IV HOME VERSION|||UG/MOL|||LOG10 CFU/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1972-04-22||||1972-02-06||1972-01-26|1970-06-28|
TRIAL STUDY 134XCP|QS|731665AB-4418-4943-BFC5-D78F03C8D423|2|||||WHODAS 2.0 - 12-ITEM SELF|||PA|||MOL/MOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|U|2||58||BASELINE|1973-02-03||||1966-10-28||1969-11-14|1965-06-16|
TRIAL STUDY 134XCP|QS|731665AB-4418-4943-BFC5-D78F03C8D423|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||CI/UG|||COPIES/UG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|3||39||SCREENING|1960-02-11||||1968-11-16||1966-01-18|1972-09-12|
TRIAL STUDY 134XCP|QS|731665AB-4418-4943-BFC5-D78F03C8D423|4|||||IPAQ-SF PHONE VERSION|||MMHG/SEC|||IU/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|4||88||INDUCTION TREATMENT|1967-03-09||||1963-03-22||1962-04-13|1961-05-09|
TRIAL STUDY 134XCP|QS|731665AB-4418-4943-BFC5-D78F03C8D423|5|||||HADS|||FG|||/MS|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|Y|5||7||BASELINE|1964-09-28||||1962-08-26||1963-04-09|1968-10-16|
TRIAL STUDY 134XCP|QS|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||HOMEOPATHIC DILUTION|||FOZ_BR|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|U|1||38||OBSERVATION|1967-03-20||||1970-10-12||1972-08-09|1970-10-13|
TRIAL STUDY 134XCP|QS|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2|||||RDQ|||G|||TABLET|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|NA|2||58||FOLLOW-UP|1968-04-11||||1970-05-11||1970-10-26|1965-09-08|
TRIAL STUDY 134XCP|QS|3E337B9F-D718-4FE6-83D8-E05BC77CA872|3|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||/5X10^4 WBC|||BLOCKS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|3||39||BASELINE|1960-04-09||||1960-09-30||1971-01-12|1965-01-13|
TRIAL STUDY 134XCP|QS|3E337B9F-D718-4FE6-83D8-E05BC77CA872|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||U/10^12 RBC|||PHERESIS UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|N|4||88||FOLLOW-UP|1967-02-19||||1964-09-23||1967-03-20|1966-11-08|
TRIAL STUDY 134XCP|QS|3E337B9F-D718-4FE6-83D8-E05BC77CA872|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||LOZENGE|||OHM|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|5||7||LONG-TERM FOLLOW-UP|1964-03-04||||1968-01-13||1964-04-20|1967-06-26|
TRIAL STUDY 134XCP|QS|D5243E6E-2521-4331-ABFB-75112D06F771|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||UMOL/KG/MIN|||10^9/L|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|1||38||BLINDED TREATMENT|1966-11-14||||1969-10-14||1962-01-03|1960-09-07|
TRIAL STUDY 134XCP|QS|D5243E6E-2521-4331-ABFB-75112D06F771|2|||||TSCC|||S*KPA|||10^9 CFU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|NA|2||58||OBSERVATION|1964-05-02||||1966-04-30||1968-08-08|1967-04-13|
TRIAL STUDY 134XCP|QS|D5243E6E-2521-4331-ABFB-75112D06F771|3|||||Q-LES-Q|||PNU/ML|||NG/DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|3||39||WASHOUT|1966-10-16||||1970-06-27||1971-04-04|1971-03-11|
TRIAL STUDY 134XCP|QS|D5243E6E-2521-4331-ABFB-75112D06F771|4|||||MSIS-29 V2|||GBQ/MG|||HR/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|4||88||FOLLOW-UP|1961-08-26||||1969-05-14||1969-11-07|1973-05-24|
TRIAL STUDY 134XCP|QS|D5243E6E-2521-4331-ABFB-75112D06F771|5|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||ML/M2/DAY|||MG/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|5||7||WASHOUT|1961-04-28||||1962-01-03||1971-04-12|1965-09-24|
TRIAL STUDY 134XCP|QS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||CUP|||AU/ML|NOT DONE||LIKERT SCALE 5-POINT|U|NA|N|1||38||TREATMENT|1960-01-27||||1962-02-24||1961-08-15|1967-11-07|
TRIAL STUDY 134XCP|QS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2|||||WOMAC NRS 3.1 INDEX|||10^7 CFU|||FRACTION OF 1|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|U|2||58||WASHOUT|1973-01-27||||1970-08-17||1966-10-24|1962-07-10|
TRIAL STUDY 134XCP|QS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|3|||||BARS|||AMP|||NMOL/L/MIN|NOT DONE||LIKERT SCALE 5-POINT|NA|N|N|3||39||LONG-TERM FOLLOW-UP|1965-12-02||||1967-01-25||1971-01-24|1966-01-27|
TRIAL STUDY 134XCP|QS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||VG/KG|||SBE/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|U|4||88||FOLLOW-UP|1968-06-15||||1971-02-28||1964-01-07|1963-11-07|
TRIAL STUDY 134XCP|QS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|5|||||FACT-LEU V4|||UL/DOSE|||IU/G HB|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|5||7||RUN-IN|1960-11-29||||1963-07-05||1963-03-23|1965-02-22|
TRIAL STUDY 134XCP|QS|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1|||||WOMAC LK 3.1 INDEX|||KN/CM2|||OSM|NOT DONE||LIKERT SCALE 7-POINT|N|Y|U|1||38||LONG-TERM FOLLOW-UP|1962-10-05||||1961-09-21||1970-11-27|1962-11-25|
TRIAL STUDY 134XCP|QS|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||MET*H|||U/M2|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|2||58||OPEN LABEL TREATMENT|1961-10-16||||1969-09-11||1973-03-20|1967-02-22|
TRIAL STUDY 134XCP|QS|5B3E406E-F2A5-4F25-8271-DC1FABA40138|3|||||EORTC QLQ-C15-PAL V1.0|||1/(S*KPA)|||CAPFUL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|NA|3||39||BLINDED TREATMENT|1970-09-29||||1964-09-16||1961-10-01|1973-03-26|
TRIAL STUDY 134XCP|QS|5B3E406E-F2A5-4F25-8271-DC1FABA40138|4|||||IPAQ-LF SELF-ADMINISTERED VERSION|||MMOL/KG|||CAL|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|NA|4||88||FOLLOW-UP|1966-03-20||||1968-04-08||1962-12-09|1964-07-25|
TRIAL STUDY 134XCP|QS|5B3E406E-F2A5-4F25-8271-DC1FABA40138|5|||||EPIC-26|||VG/ML|||PKAT|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|5||7||OPEN LABEL TREATMENT|1973-02-15||||1964-10-28||1964-09-07|1964-03-13|
TRIAL STUDY 134XCP|QS|D5262627-52D7-42F5-B4BA-D7E6FA243959|1|||||WHODAS 2.0 - 12-ITEM SELF|||UG/G/MIN|||MCI/KG|NOT DONE||LIKERT SCALE 3-POINT|NA|N|U|1||38||BLINDED TREATMENT|1970-10-14||||1972-08-09||1963-04-04|1972-01-10|
TRIAL STUDY 134XCP|QS|D5262627-52D7-42F5-B4BA-D7E6FA243959|2|||||SGRQ PAST 3 MONTHS VERSION|||PPB|||MM/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|2||58||OPEN LABEL TREATMENT|1960-03-19||||1967-11-01||1967-05-16|1970-10-26|
TRIAL STUDY 134XCP|QS|D5262627-52D7-42F5-B4BA-D7E6FA243959|3|||||NCCN-FACT FPSI-17 V2|||MEQ/UL|||10^7 TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|3||39||RUN-IN|1963-07-30||||1966-07-18||1967-05-02|1972-03-14|
TRIAL STUDY 134XCP|QS|D5262627-52D7-42F5-B4BA-D7E6FA243959|4|||||FACT-LEU V4|||UU/L|||KCAL/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|4||88||TREATMENT|1966-11-14||||1964-05-09||1970-05-22|1960-07-01|
TRIAL STUDY 134XCP|QS|D5262627-52D7-42F5-B4BA-D7E6FA243959|5|||||SIQ|||WATT|||NCI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|5||7||INDUCTION TREATMENT|1967-10-14||||1970-08-03||1963-06-15|1970-03-12|
TRIAL STUDY 134XCP|QS|C550278D-F171-42D0-8C34-D60824A3FE98|1|||||C-SSRS ALREADY ENROLLED SUBJECTS|||/LPF|||PACK|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|N|1||38||OBSERVATION|1965-08-09||||1965-08-24||1963-12-05|1971-12-16|
TRIAL STUDY 134XCP|QS|C550278D-F171-42D0-8C34-D60824A3FE98|2|||||EORTC QLQ-LC13|||UMOL/L/MIN|||CL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|2||58||TREATMENT|1965-04-22||||1972-07-07||1967-11-06|1962-11-25|
TRIAL STUDY 134XCP|QS|C550278D-F171-42D0-8C34-D60824A3FE98|3|||||WHODAS 2.0 - 36-ITEM PROXY|||USEC|||MGEQ|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|3||39||INDUCTION TREATMENT|1964-10-31||||1965-02-02||1966-09-25|1967-01-27|
TRIAL STUDY 134XCP|QS|C550278D-F171-42D0-8C34-D60824A3FE98|4|||||C-SSRS CHILDREN'S BASELINE|||KCAL|||UG/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|Y|4||88||FOLLOW-UP|1965-07-07||||1970-06-06||1966-11-06|1971-07-14|
TRIAL STUDY 134XCP|QS|C550278D-F171-42D0-8C34-D60824A3FE98|5|||||GDS SHORT FORM|||CI/KG|||EID 50/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|U|5||7||RUN-IN|1960-03-24||||1960-12-30||1962-06-26|1965-04-26|
TRIAL STUDY 134XCP|QS|5E76262E-FE1E-40C9-B147-3C792F768F48|1|||||NCCN-FACT FBLSI-18 V2|||ENZYME U/L|||FMOL/L|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|1||38||INDUCTION TREATMENT|1965-06-19||||1970-05-28||1966-09-30|1968-06-02|
TRIAL STUDY 134XCP|QS|5E76262E-FE1E-40C9-B147-3C792F768F48|2|||||WHODAS 2.0 - 36-ITEM SELF|||ML/MIN|||KCAL/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|2||58||LONG-TERM FOLLOW-UP|1966-06-03||||1968-07-12||1965-08-30|1964-12-27|
TRIAL STUDY 134XCP|QS|5E76262E-FE1E-40C9-B147-3C792F768F48|3|||||ACT|||ML/CAGE/DAY|||TSP|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|3||39||SCREENING|1968-02-09||||1965-04-29||1964-09-20|1968-12-25|
TRIAL STUDY 134XCP|QS|5E76262E-FE1E-40C9-B147-3C792F768F48|4|||||FAMS|||UL/KG/DAY|||EQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|4||88||INDUCTION TREATMENT|1964-07-03||||1966-02-07||1970-03-28|1965-08-09|
TRIAL STUDY 134XCP|QS|5E76262E-FE1E-40C9-B147-3C792F768F48|5|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MM/MIN|||IU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|5||7||INDUCTION TREATMENT|1973-03-31||||1967-10-19||1966-06-22|1972-12-03|
TRIAL STUDY 134XCP|QS|2F21921D-D18C-43EE-A39E-91A93B262B8C|1|||||PGI|||G/CM2|||U/10^12 RBC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|Y|1||38||OPEN LABEL TREATMENT|1971-09-20||||1971-06-14||1968-04-17|1963-10-21|
TRIAL STUDY 134XCP|QS|2F21921D-D18C-43EE-A39E-91A93B262B8C|2|||||AQ20|||MM/H|||/10^4|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|Y|2||58||BASELINE|1969-07-15||||1960-03-18||1970-08-03|1961-12-04|
TRIAL STUDY 134XCP|QS|2F21921D-D18C-43EE-A39E-91A93B262B8C|3|||||FKSI-15|||MEQ/DL|||MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|U|3||39||FOLLOW-UP|1970-10-19||||1960-09-03||1960-10-10|1962-08-31|
TRIAL STUDY 134XCP|QS|2F21921D-D18C-43EE-A39E-91A93B262B8C|4|||||MADRS|||KPA/L/SEC|||PT_BR|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|4||88||LONG-TERM FOLLOW-UP|1961-10-20||||1966-09-09||1966-03-09|1962-07-06|
TRIAL STUDY 134XCP|QS|2F21921D-D18C-43EE-A39E-91A93B262B8C|5|||||ADSD V1.0|||ROENTGEN|||MM/2H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|N|5||7||CONTINUATION TREATMENT|1963-09-15||||1963-12-08||1971-06-11|1970-04-01|
TRIAL STUDY 134XCP|QS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1|||||QIDS-SR|||UCI/KG|||BAU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|1||38||OBSERVATION|1962-01-21||||1966-05-06||1967-09-11|1972-11-28|
TRIAL STUDY 134XCP|QS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||U/KG/MIN|||FL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|NA|2||58||SCREENING|1961-08-01||||1962-11-16||1968-01-22|1969-08-31|
TRIAL STUDY 134XCP|QS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|3|||||WPAI-SHP V2.0|||ML/KG|||SYRINGE|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|3||39||TREATMENT|1973-04-03||||1972-12-03||1969-12-31|1968-11-10|
TRIAL STUDY 134XCP|QS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|4|||||MDQ-T|||NKAT|||DL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|4||88||WASHOUT|1968-03-06||||1960-12-04||1969-08-28|1970-11-14|
TRIAL STUDY 134XCP|QS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|5|||||DLQI|||ML/M2/MIN|||USIEMENS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|5||7||RUN-IN|1971-05-27||||1967-08-28||1969-12-12|1967-04-25|
TRIAL STUDY 134XCP|QS|55985646-0224-4442-90C5-EFEDF990E88C|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||10^3 COPIES/ML|||M3|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|Y|1||38||OBSERVATION|1966-08-07||||1966-01-07||1971-02-04|1973-05-29|
TRIAL STUDY 134XCP|QS|55985646-0224-4442-90C5-EFEDF990E88C|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||UMOL/MG/MIN|||S^-1(%O2)^-1|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|NA|2||58||OBSERVATION|1961-08-09||||1967-01-24||1972-07-16|1964-02-07|
TRIAL STUDY 134XCP|QS|55985646-0224-4442-90C5-EFEDF990E88C|3|||||PHQ-2|||DISK|||LB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|Y|3||39||LONG-TERM FOLLOW-UP|1972-04-12||||1969-08-22||1962-03-24|1971-06-23|
TRIAL STUDY 134XCP|QS|55985646-0224-4442-90C5-EFEDF990E88C|4|||||BIS-11|||MV|||10^4/HPF|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|N|4||88||OBSERVATION|1967-02-20||||1968-03-14||1967-05-04|1967-01-30|
TRIAL STUDY 134XCP|QS|55985646-0224-4442-90C5-EFEDF990E88C|5|||||MSQOL-54|||ML/100G/MIN|||HENRY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|N|5||7||OPEN LABEL TREATMENT|1963-02-16||||1967-01-28||1969-09-04|1963-07-24|
TRIAL STUDY 134XCP|QS|86509C90-3C57-4755-A06F-79C620779371|1|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||10^5/HPF|||TABLET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|1||38||SCREENING|1967-07-25||||1963-10-03||1963-08-28|1961-09-18|
TRIAL STUDY 134XCP|QS|86509C90-3C57-4755-A06F-79C620779371|2|||||HAQ-DI WITH VAS|||UG/KG|||ML/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|2||58||TREATMENT|1973-01-07||||1972-09-24||1962-03-17|1972-07-31|
TRIAL STUDY 134XCP|QS|86509C90-3C57-4755-A06F-79C620779371|3|||||SF12 V2.0 ACUTE|||PFU/ML|||MET*MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|U|3||39||INDUCTION TREATMENT|1960-07-11||||1963-08-19||1964-03-14|1965-12-14|
TRIAL STUDY 134XCP|QS|86509C90-3C57-4755-A06F-79C620779371|4|||||WHODAS 2.0 - 36-ITEM PROXY|||DDU|||AMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|4||88||CONTINUATION TREATMENT|1962-11-01||||1970-07-22||1970-01-28|1961-02-23|
TRIAL STUDY 134XCP|QS|86509C90-3C57-4755-A06F-79C620779371|5|||||TSCC|||UG/G/MIN|||UU/DL|NOT DONE||LIKERT SCALE 3-POINT|U|U|U|5||7||WASHOUT|1964-04-07||||1967-06-23||1970-09-27|1970-02-16|
TRIAL STUDY 134XCP|QS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1|||||NCCN-FACT FBLSI-18 V2|||DPM/0.5 ML|||ML/KG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|U|1||38||TREATMENT|1972-01-16||||1973-09-05||1961-06-26|1964-02-06|
TRIAL STUDY 134XCP|QS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2|||||RDQ|||HZ/S|||SV|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|2||58||FOLLOW-UP|1960-02-18||||1971-07-11||1963-12-06|1971-11-08|
TRIAL STUDY 134XCP|QS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|3|||||WOMAC NRS 3.1 INDEX|||CMHG|||UIU/DL|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|3||39||BASELINE|1960-08-10||||1972-01-17||1972-08-04|1972-05-30|
TRIAL STUDY 134XCP|QS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|4|||||Q-LES-Q-SF|||LOG10 PFU/ML|||UG/KG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|4||88||TREATMENT|1965-11-25||||1960-03-18||1966-07-05|1972-08-24|
TRIAL STUDY 134XCP|QS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|5|||||FACT-L V4|||EU|||ML/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|Y|5||7||BLINDED TREATMENT|1968-04-11||||1972-05-05||1962-05-29|1972-11-07|
TRIAL STUDY 134XCP|QS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||FRAMES/S|||DB|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|U|1||38||OBSERVATION|1972-07-20||||1967-05-20||1960-07-26|1967-09-29|
TRIAL STUDY 134XCP|QS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2|||||COMM|||OSM|||10^6 IU|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|U|2||58||FOLLOW-UP|1972-12-05||||1970-09-21||1965-08-01|1970-12-27|
TRIAL STUDY 134XCP|QS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|3|||||MRS|||U/CL|||DMOL|NOT DONE||LIKERT SCALE 7-POINT|U|Y|N|3||39||CONTINUATION TREATMENT|1961-06-01||||1961-07-14||1964-09-10|1965-10-09|
TRIAL STUDY 134XCP|QS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|4|||||FAQ-NACC VERSION|||IU/L|||RING|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|4||88||CONTINUATION TREATMENT|1970-10-31||||1970-04-23||1963-09-10|1971-09-10|
TRIAL STUDY 134XCP|QS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|5|||||UPS|||L/S|||U/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|5||7||INDUCTION TREATMENT|1962-08-20||||1966-06-10||1970-07-18|1962-01-01|
TRIAL STUDY 134XCP|QS|0FFBFF7C-7C64-411E-8D07-C959F0886023|1|||||GOSE|||MJOULE/CM2|||100 IU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|1||38||LONG-TERM FOLLOW-UP|1967-10-02||||1960-04-27||1967-11-01|1961-11-09|
TRIAL STUDY 134XCP|QS|0FFBFF7C-7C64-411E-8D07-C959F0886023|2|||||HCS|||/MM|||BOTTLE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|2||58||OBSERVATION|1969-10-25||||1963-04-03||1960-06-23|1967-12-02|
TRIAL STUDY 134XCP|QS|0FFBFF7C-7C64-411E-8D07-C959F0886023|3|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||MN|||POUCH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|U|3||39||FOLLOW-UP|1963-06-08||||1970-02-25||1962-10-02|1972-08-22|
TRIAL STUDY 134XCP|QS|0FFBFF7C-7C64-411E-8D07-C959F0886023|4|||||FACT-C V4|||KCAL|||NMOL/L/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|U|4||88||BASELINE|1964-11-15||||1967-12-26||1973-06-17|1966-03-07|
TRIAL STUDY 134XCP|QS|0FFBFF7C-7C64-411E-8D07-C959F0886023|5|||||FKSI-15|||PG/L|||10^9 CFU/G|NOT DONE||LIKERT SCALE 7-POINT|N|N|U|5||7||LONG-TERM FOLLOW-UP|1971-07-22||||1966-01-09||1963-09-25|1966-06-10|
TRIAL STUDY 134XCP|QS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1|||||GDS|||DAYS/MONTH|||FINGERTIP UNIT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|1||38||INDUCTION TREATMENT|1970-11-21||||1963-01-31||1960-07-15|1963-06-26|
TRIAL STUDY 134XCP|QS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2|||||FSS|||KG|||NMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|2||58||BLINDED TREATMENT|1969-04-04||||1960-05-17||1963-04-09|1967-01-03|
TRIAL STUDY 134XCP|QS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|3|||||SF36 V1.0 ACUTE|||MG|||TSP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|3||39||OBSERVATION|1960-12-17||||1961-03-11||1962-05-22|1963-02-15|
TRIAL STUDY 134XCP|QS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||V/V|||PPB|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|4||88||LONG-TERM FOLLOW-UP|1973-01-11||||1964-04-02||1971-02-06|1961-07-16|
TRIAL STUDY 134XCP|QS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|5|||||FACIT-FATIGUE 13-ITEM V4|||10^12/L|||/MBP|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|5||7||INDUCTION TREATMENT|1962-06-11||||1966-04-22||1965-11-15|1971-08-31|
TRIAL STUDY 134XCP|QS|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1|||||BORG CR10|||ML/SEC/1.73M2|||HZ|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|NA|1||38||RUN-IN|1966-03-30||||1971-01-17||1963-04-22|1961-05-05|
TRIAL STUDY 134XCP|QS|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2|||||ASEX-MALE|||HR/DAY|||SHOCK WAVE|NOT DONE||LIKERT SCALE 7-POINT|U|N|Y|2||58||RUN-IN|1964-01-07||||1964-08-10||1973-02-17|1960-08-25|
TRIAL STUDY 134XCP|QS|5DC5F780-264A-4EB1-BEA5-28209D416FEB|3|||||FBRSI|||GENEQ/ML|||NG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|3||39||WASHOUT|1962-07-22||||1966-10-01||1966-06-04|1963-07-25|
TRIAL STUDY 134XCP|QS|5DC5F780-264A-4EB1-BEA5-28209D416FEB|4|||||C-SSRS BASELINE|||PKAT/L|||/VF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|4||88||TREATMENT|1972-02-20||||1962-12-07||1962-07-10|1967-11-13|
TRIAL STUDY 134XCP|QS|5DC5F780-264A-4EB1-BEA5-28209D416FEB|5|||||HAEM-A-QOL|||LX|||10^6 ORGANISMS/MG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|5||7||SCREENING|1967-08-06||||1971-07-08||1972-05-26|1969-09-17|
TRIAL STUDY 134XCP|QS|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1|||||AUDIT-SR|||DROP|||MG/KG/MIN|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|1||38||WASHOUT|1964-05-19||||1966-03-07||1970-09-22|1961-05-10|
TRIAL STUDY 134XCP|QS|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2|||||HAQ-DI WITHOUT VAS|||SPRAY|||UMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|2||58||BASELINE|1970-04-28||||1970-01-08||1961-12-22|1966-12-29|
TRIAL STUDY 134XCP|QS|DDBCA084-DD05-4FA0-9083-7CD31CECA420|3|||||PR|||MEQ/L|||10^9 ORGANISMS/MG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|3||39||SCREENING|1964-05-12||||1969-04-26||1963-11-26|1972-02-08|
TRIAL STUDY 134XCP|QS|DDBCA084-DD05-4FA0-9083-7CD31CECA420|4|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||10^6 DNA COPIES/ML|||/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|4||88||BLINDED TREATMENT|1961-07-17||||1972-04-21||1968-11-08|1973-03-15|
TRIAL STUDY 134XCP|QS|DDBCA084-DD05-4FA0-9083-7CD31CECA420|5|||||EPIC-26|||MM/MIN|||10^7 PFU|NOT DONE||LIKERT SCALE 5-POINT|N|U|NA|5||7||BLINDED TREATMENT|1967-08-10||||1963-10-08||1964-07-25|1961-12-01|
TRIAL STUDY 134XCP|QS|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1|||||FACT-BL V4|||CCID 50/ML|||KV|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|1||38||CONTINUATION TREATMENT|1966-05-13||||1973-03-24||1968-02-02|1968-03-08|
TRIAL STUDY 134XCP|QS|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2|||||SGRQ-C|||UMOL/KG/MIN|||CFU/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|N|2||58||FOLLOW-UP|1969-12-23||||1971-12-05||1963-07-02|1968-09-07|
TRIAL STUDY 134XCP|QS|65A5AAA6-A817-45F8-9BA8-584E9627AB26|3|||||PGI|||MM/2H|||S*KPA|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|3||39||SCREENING|1966-01-26||||1967-05-30||1963-11-03|1966-05-15|
TRIAL STUDY 134XCP|QS|65A5AAA6-A817-45F8-9BA8-584E9627AB26|4|||||FBRSI|||10^9 ORGANISMS/G|||PMOL/10^9 CELLS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|4||88||SCREENING|1970-10-03||||1965-05-24||1966-07-24|1962-02-27|
TRIAL STUDY 134XCP|QS|65A5AAA6-A817-45F8-9BA8-584E9627AB26|5|||||PSQI|||MV*MIN|||U.CARR|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|5||7||FOLLOW-UP|1969-06-16||||1972-01-12||1962-05-30|1971-11-13|
TRIAL STUDY 134XCP|QS|854AD9A5-A869-41C7-9AF0-43383CE64B86|1|||||SF12 V1.0 STANDARD|||WEEKS|||%(W/V)|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|1||38||FOLLOW-UP|1973-03-13||||1964-09-12||1965-06-08|1966-06-11|
TRIAL STUDY 134XCP|QS|854AD9A5-A869-41C7-9AF0-43383CE64B86|2|||||FACIT-DYSPNEA 33 ITEM BANK|||PKAT/L|||MM/SEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|2||58||LONG-TERM FOLLOW-UP|1968-05-02||||1969-11-21||1962-06-07|1970-07-18|
TRIAL STUDY 134XCP|QS|854AD9A5-A869-41C7-9AF0-43383CE64B86|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||NEEDLE GAUGE|||UMOL/L/H|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|3||39||OBSERVATION|1964-06-23||||1964-10-08||1971-04-09|1972-12-09|
TRIAL STUDY 134XCP|QS|854AD9A5-A869-41C7-9AF0-43383CE64B86|4|||||VFQ-25 SELF ADMINISTERED|||BOTTLE|||10^4/HPF|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|4||88||RUN-IN|1961-09-16||||1961-10-01||1969-11-03|1962-12-17|
TRIAL STUDY 134XCP|QS|854AD9A5-A869-41C7-9AF0-43383CE64B86|5|||||SF36 V2.0 ACUTE|||CAPLET|||MOSM/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|5||7||INDUCTION TREATMENT|1968-03-16||||1969-07-28||1964-05-29|1964-11-15|
TRIAL STUDY 134XCP|QS|008F02C8-B28A-490E-A77A-F32584DA06FA|1|||||WOMAC VA 3.1 INDEX|||JDF UNIT|||ELISA UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|1||38||TREATMENT|1965-05-16||||1966-05-22||1969-07-05|1963-12-21|
TRIAL STUDY 134XCP|QS|008F02C8-B28A-490E-A77A-F32584DA06FA|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||BAG|||U/M2/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|2||58||FOLLOW-UP|1969-01-06||||1968-08-16||1960-01-18|1966-06-18|
TRIAL STUDY 134XCP|QS|008F02C8-B28A-490E-A77A-F32584DA06FA|3|||||BEBQ CONCURRENT|||MMHG*MIN/L|||VIAL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|3||39||FOLLOW-UP|1964-02-15||||1973-03-15||1968-08-30|1968-10-29|
TRIAL STUDY 134XCP|QS|008F02C8-B28A-490E-A77A-F32584DA06FA|4|||||FACT-BRM V4|||LOG10 IU/ML|||MAC50|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|4||88||FOLLOW-UP|1964-09-15||||1966-02-08||1972-05-21|1973-02-28|
TRIAL STUDY 134XCP|QS|008F02C8-B28A-490E-A77A-F32584DA06FA|5|||||EQ-5D-3L|||IU/L|||IU/MMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|5||7||OPEN LABEL TREATMENT|1965-06-18||||1970-08-06||1962-07-03|1962-09-14|
TRIAL STUDY 134XCP|QS|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||GLOBULE|||MG/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|N|1||38||SCREENING|1966-02-28||||1967-07-01||1970-04-21|1964-07-24|
TRIAL STUDY 134XCP|QS|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2|||||EXACT|||UU/L|||KBQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|Y|2||58||CONTINUATION TREATMENT|1971-07-07||||1969-03-12||1962-12-17|1973-08-07|
TRIAL STUDY 134XCP|QS|7C06549D-596C-4C47-BD0B-119DF6CD67AC|3|||||SF36 V1.0 ACUTE|||G/KG/DAY|||10^6 COPIES/ML|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|3||39||OPEN LABEL TREATMENT|1963-02-07||||1973-02-11||1970-08-20|1966-12-20|
TRIAL STUDY 134XCP|QS|7C06549D-596C-4C47-BD0B-119DF6CD67AC|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||AMPULE|||POUCH|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|NA|4||88||BASELINE|1968-06-08||||1962-09-01||1972-12-27|1971-11-15|
TRIAL STUDY 134XCP|QS|7C06549D-596C-4C47-BD0B-119DF6CD67AC|5|||||FACT-COG V3|||CIGAR|||U/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|N|5||7||WASHOUT|1968-09-05||||1966-08-14||1970-06-10|1972-03-16|
TRIAL STUDY 134XCP|QS|39A00D93-61B9-44C5-9672-005A1F9A93EB|1|||||FSS|||10^3 CFU|||U.CARR|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|1||38||RUN-IN|1961-05-08||||1965-07-20||1971-10-24|1963-01-23|
TRIAL STUDY 134XCP|QS|39A00D93-61B9-44C5-9672-005A1F9A93EB|2|||||PARTNER-DDS|||TCID 50/DOSE|||MET*H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|Y|2||58||CONTINUATION TREATMENT|1960-04-04||||1967-04-29||1965-08-08|1969-07-10|
TRIAL STUDY 134XCP|QS|39A00D93-61B9-44C5-9672-005A1F9A93EB|3|||||OAB-Q|||DEG|||VG/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|3||39||CONTINUATION TREATMENT|1964-12-31||||1961-03-18||1971-02-12|1962-03-04|
TRIAL STUDY 134XCP|QS|39A00D93-61B9-44C5-9672-005A1F9A93EB|4|||||EXACT|||PFU|||UKAT|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|NA|4||88||LONG-TERM FOLLOW-UP|1962-07-05||||1964-04-27||1972-07-17|1969-09-11|
TRIAL STUDY 134XCP|QS|39A00D93-61B9-44C5-9672-005A1F9A93EB|5|||||PODCI - ADOLESCENT PARENT REPORTED|||UG/KG|||10^8 PFU|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|N|5||7||RUN-IN|1971-06-21||||1968-05-13||1970-11-16|1964-01-03|
TRIAL STUDY 134XCP|QS|71B78EFA-AE7A-4248-9A59-63885131F1D1|1|||||SF36 V1.0 ACUTE|||MN|||UCI|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|NA|1||38||SCREENING|1962-11-03||||1960-06-11||1969-12-19|1960-09-10|
TRIAL STUDY 134XCP|QS|71B78EFA-AE7A-4248-9A59-63885131F1D1|2|||||EXACT|||QUANTITY SUFFICIENT|||MMOL/S|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|Y|2||58||WASHOUT|1963-04-08||||1966-09-16||1964-09-26|1960-07-08|
TRIAL STUDY 134XCP|QS|71B78EFA-AE7A-4248-9A59-63885131F1D1|3|||||HADS|||SV|||KG/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|3||39||SCREENING|1963-05-04||||1961-07-11||1968-07-28|1962-04-24|
TRIAL STUDY 134XCP|QS|71B78EFA-AE7A-4248-9A59-63885131F1D1|4|||||PDQUALIF|||ML/S|||KUSP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|4||88||RUN-IN|1962-05-29||||1973-04-17||1970-01-06|1966-09-10|
TRIAL STUDY 134XCP|QS|71B78EFA-AE7A-4248-9A59-63885131F1D1|5|||||FOSI|||10^9 ORGANISMS/G|||V/SEC|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|5||7||WASHOUT|1964-12-06||||1962-12-01||1964-01-24|1972-11-06|
TRIAL STUDY 134XCP|QS|CE28B885-422E-471D-895C-DE8F41CD9FE9|1|||||CDLQ|||AU/ML|||MBP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|1||38||CONTINUATION TREATMENT|1967-04-06||||1965-03-11||1972-04-17|1967-02-03|
TRIAL STUDY 134XCP|QS|CE28B885-422E-471D-895C-DE8F41CD9FE9|2|||||SF36 V2.0 ACUTE|||MMOL/L|||MEQ/MMOL|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|2||58||CONTINUATION TREATMENT|1965-11-24||||1962-03-22||1968-11-26|1969-08-23|
TRIAL STUDY 134XCP|QS|CE28B885-422E-471D-895C-DE8F41CD9FE9|3|||||MPAI-4|||SYRINGE|||RFU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|N|3||39||RUN-IN|1971-01-07||||1970-12-03||1966-03-03|1969-09-02|
TRIAL STUDY 134XCP|QS|CE28B885-422E-471D-895C-DE8F41CD9FE9|4|||||PEDS-FACIT-F|||GTT|||HOURS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|U|4||88||OBSERVATION|1960-06-18||||1960-05-22||1964-12-20|1966-08-28|
TRIAL STUDY 134XCP|QS|CE28B885-422E-471D-895C-DE8F41CD9FE9|5|||||MSIS-29 V2|||PFU/ANIMAL|||COPIES/UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|5||7||OPEN LABEL TREATMENT|1972-06-11||||1967-05-19||1967-09-14|1965-04-20|
TRIAL STUDY 134XCP|QS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1|||||BIS-11|||ML/M2/DAY|||/WK|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|Y|1||38||INDUCTION TREATMENT|1960-01-18||||1972-02-09||1968-05-31|1962-06-29|
TRIAL STUDY 134XCP|QS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2|||||FAMS|||MM|||UG/M2/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|2||58||CONTINUATION TREATMENT|1964-06-09||||1966-04-20||1967-04-17|1962-11-19|
TRIAL STUDY 134XCP|QS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|3|||||BIS-11|||10^3 ORGANISMS|||UG/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|3||39||TREATMENT|1966-07-23||||1963-06-11||1968-09-23|1966-01-25|
TRIAL STUDY 134XCP|QS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|4|||||PROSQOLI|||LINEAR FT*LB|||10^9 CFU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|Y|4||88||INDUCTION TREATMENT|1971-01-29||||1966-09-24||1960-05-17|1963-09-27|
TRIAL STUDY 134XCP|QS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|5|||||EXACT|||UG/H|||KCAL/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|5||7||INDUCTION TREATMENT|1971-09-16||||1965-09-01||1967-06-07|1968-07-23|
TRIAL STUDY 134XCP|QS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1|||||MNSI|||BOX|||ML/CAGE/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|1||38||TREATMENT|1973-02-22||||1961-11-19||1960-08-30|1967-06-30|
TRIAL STUDY 134XCP|QS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2|||||DRRI-2|||CAPLET|||G/DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|U|2||58||SCREENING|1960-05-10||||1966-01-25||1960-09-10|1970-11-05|
TRIAL STUDY 134XCP|QS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|3|||||BIS-11|||10^9 ORGANISMS/G|||UMOL/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|3||39||BASELINE|1968-08-18||||1968-01-01||1963-10-22|1964-04-06|
TRIAL STUDY 134XCP|QS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|4|||||PEDS-FACIT-F|||U/KG|||CI/UL|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|U|4||88||WASHOUT|1965-06-18||||1971-03-26||1962-12-22|1966-09-09|
TRIAL STUDY 134XCP|QS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|5|||||AUDIT-C|||BAU|||VIRTUAL PIXEL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1967-03-01||||1961-06-06||1971-06-04|1964-01-31|
TRIAL STUDY 134XCP|QS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1|||||IBDQ|||ML/CAGE/DAY|||RFU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|Y|1||38||BLINDED TREATMENT|1972-07-02||||1967-10-08||1962-03-17|1968-05-23|
TRIAL STUDY 134XCP|QS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2|||||AQLQ|||10^7 PFU|||NG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|U|2||58||WASHOUT|1973-01-17||||1961-03-30||1972-12-10|1965-06-03|
TRIAL STUDY 134XCP|QS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|3|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||PACK|||CMHG|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|3||39||TREATMENT|1963-04-05||||1965-08-04||1967-12-29|1965-11-15|
TRIAL STUDY 134XCP|QS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|4|||||ODI V2.1A|||OSM|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|N|4||88||BLINDED TREATMENT|1964-01-27||||1968-11-07||1971-01-17|1964-04-25|
TRIAL STUDY 134XCP|QS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|5|||||NCCN-FACT FPSI-17 V2|||AMOL|||/MM|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|5||7||TREATMENT|1961-11-06||||1962-09-10||1962-12-03|1961-01-10|
TRIAL STUDY 134XCP|QS|3AA56307-0D09-4C82-91B6-717A7C503EFE|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||CG|||DAGU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|U|1||38||INDUCTION TREATMENT|1964-05-23||||1964-12-30||1967-01-21|1965-11-30|
TRIAL STUDY 134XCP|QS|3AA56307-0D09-4C82-91B6-717A7C503EFE|2|||||WHODAS 2.0 - 36-ITEM PROXY|||OSM|||ML/G/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|U|2||58||OPEN LABEL TREATMENT|1966-06-28||||1973-04-25||1968-12-17|1962-05-07|
TRIAL STUDY 134XCP|QS|3AA56307-0D09-4C82-91B6-717A7C503EFE|3|||||BEBQ CONCURRENT|||MBQ|||BAR|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|NA|3||39||SCREENING|1968-01-16||||1963-02-12||1972-01-22|1960-09-21|
TRIAL STUDY 134XCP|QS|3AA56307-0D09-4C82-91B6-717A7C503EFE|4|||||C-SSRS BASELINE|||ML/BREATH|||LOG EID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|Y|4||88||OBSERVATION|1964-10-11||||1973-03-17||1963-10-11|1972-07-28|
TRIAL STUDY 134XCP|QS|3AA56307-0D09-4C82-91B6-717A7C503EFE|5|||||HAQ-DI WITH VAS|||HZ/S|||SBE/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|N|5||7||RUN-IN|1965-04-27||||1971-06-21||1973-07-13|1962-06-15|
TRIAL STUDY 134XCP|QS|811AE318-625A-4913-8B18-2D318AF04EAC|1|||||FACT-LEU V4|||10^6 COPIES/ML|||CI/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|1||38||BLINDED TREATMENT|1963-06-24||||1971-08-31||1971-11-14|1971-04-12|
TRIAL STUDY 134XCP|QS|811AE318-625A-4913-8B18-2D318AF04EAC|2|||||BWCS|||FT|||UG/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|N|2||58||RUN-IN|1963-09-15||||1972-06-03||1968-09-17|1968-04-11|
TRIAL STUDY 134XCP|QS|811AE318-625A-4913-8B18-2D318AF04EAC|3|||||EPIC-CP|||JAR|||/MM2|NOT DONE||LIKERT SCALE 3-POINT|U|N|N|3||39||SCREENING|1962-04-13||||1965-04-09||1968-04-05|1965-03-29|
TRIAL STUDY 134XCP|QS|811AE318-625A-4913-8B18-2D318AF04EAC|4|||||EPDS|||RAD|||ML/MIN/1.73M2|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|NA|4||88||BLINDED TREATMENT|1965-12-25||||1969-04-02||1961-07-16|1971-08-20|
TRIAL STUDY 134XCP|QS|811AE318-625A-4913-8B18-2D318AF04EAC|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||G/ANIMAL/DAY|||ML/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|NA|5||7||RUN-IN|1968-11-06||||1972-07-09||1970-10-22|1967-04-16|
TRIAL STUDY 134XCP|QS|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1|||||SIQR|||GTT|||G/CAGE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|Y|1||38||RUN-IN|1970-01-23||||1968-01-14||1962-02-21|1971-01-30|
TRIAL STUDY 134XCP|QS|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2|||||CDLQ|||HPA|||CONTAINER|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|2||58||LONG-TERM FOLLOW-UP|1966-11-07||||1970-10-28||1971-02-03|1969-01-02|
TRIAL STUDY 134XCP|QS|E8F0AF72-5DB4-41D5-814E-5E280A027E94|3|||||PSQI|||ABSORBANCE U|||ML*CMH2O|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|U|3||39||CONTINUATION TREATMENT|1971-06-15||||1965-09-26||1963-01-11|1963-09-03|
TRIAL STUDY 134XCP|QS|E8F0AF72-5DB4-41D5-814E-5E280A027E94|4|||||AQ20|||NMOL/KG/DAY|||H*%|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|4||88||OPEN LABEL TREATMENT|1964-08-01||||1969-01-31||1961-08-03|1970-09-02|
TRIAL STUDY 134XCP|QS|E8F0AF72-5DB4-41D5-814E-5E280A027E94|5|||||DLQI|||/LSQN|||ML/CAGE|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|5||7||LONG-TERM FOLLOW-UP|1967-02-12||||1963-02-02||1960-04-22|1970-08-23|
TRIAL STUDY 134XCP|QS|3B726736-01B3-4A69-ABFB-C6255E341E69|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||10^12 IU/L|||WEBER|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|1||38||OBSERVATION|1971-10-17||||1970-07-24||1960-12-03|1962-06-19|
TRIAL STUDY 134XCP|QS|3B726736-01B3-4A69-ABFB-C6255E341E69|2|||||SIQR|||DAMOL/L|||S^-1(%O2)^-1|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|NA|2||58||WASHOUT|1970-07-06||||1968-12-02||1963-01-05|1968-08-22|
TRIAL STUDY 134XCP|QS|3B726736-01B3-4A69-ABFB-C6255E341E69|3|||||FACT-C V4|||MEQ|||10^8 PFU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|U|3||39||RUN-IN|1965-11-27||||1960-01-17||1968-03-01|1973-07-27|
TRIAL STUDY 134XCP|QS|3B726736-01B3-4A69-ABFB-C6255E341E69|4|||||WHODAS 2.0 - 12-ITEM SELF|||MEQ/MMOL|||K|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|NA|4||88||BASELINE|1962-06-10||||1971-07-24||1967-07-03|1965-10-26|
TRIAL STUDY 134XCP|QS|3B726736-01B3-4A69-ABFB-C6255E341E69|5|||||FKSI-DRS V4|||ML/ANIMAL/DAY|||H*%|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|5||7||FOLLOW-UP|1963-12-12||||1970-01-03||1966-03-13|1969-03-19|
TRIAL STUDY 134XCP|QS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1|||||MRS|||SHOCK WAVE|||VIRTUAL PIXEL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|N|1||38||BASELINE|1963-10-28||||1965-07-22||1962-06-12|1963-07-02|
TRIAL STUDY 134XCP|QS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2|||||FACT-L V4|||ECL UNIT|||TSP EQ|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|NA|2||58||FOLLOW-UP|1972-02-09||||1962-12-18||1970-06-05|1960-07-20|
TRIAL STUDY 134XCP|QS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|3|||||NCCN-FACT FPSI-17 V2|||CYLINDER|||HZ/S|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|N|3||39||BASELINE|1969-01-26||||1969-11-03||1962-08-09|1960-02-11|
TRIAL STUDY 134XCP|QS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|4|||||FACT-C V4|||SQU/ML|||UMOL/L/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|4||88||RUN-IN|1966-12-12||||1963-09-05||1963-08-24|1962-12-08|
TRIAL STUDY 134XCP|QS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|5|||||PHQ SCREENER VERSION|||MG/KG/WEEK|||NU/CL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|5||7||BASELINE|1973-05-16||||1968-08-30||1973-05-06|1968-08-27|
TRIAL STUDY 134XCP|QS|0535EF31-5388-4CC0-8567-44F4C20975EC|1|||||VFQ-25 SELF ADMINISTERED|||CAPLET|||PIPE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|1||38||FOLLOW-UP|1970-11-28||||1965-07-14||1964-03-13|1968-03-27|
TRIAL STUDY 134XCP|QS|0535EF31-5388-4CC0-8567-44F4C20975EC|2|||||WPAI-GH V2.0|||NMOL/G|||GLOBULE|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|2||58||INDUCTION TREATMENT|1972-02-06||||1963-09-07||1965-02-26|1967-01-28|
TRIAL STUDY 134XCP|QS|0535EF31-5388-4CC0-8567-44F4C20975EC|3|||||RPQ|||ELISA UNIT/DOSE|||GPS U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|NA|3||39||RUN-IN|1970-02-18||||1971-04-19||1960-08-15|1963-01-27|
TRIAL STUDY 134XCP|QS|0535EF31-5388-4CC0-8567-44F4C20975EC|4|||||EORTC QLQ-C15-PAL V1.0|||UG/ML/H|||CY/CM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|NA|4||88||OBSERVATION|1971-10-31||||1963-12-06||1963-04-26|1968-07-10|
TRIAL STUDY 134XCP|QS|0535EF31-5388-4CC0-8567-44F4C20975EC|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||CFU/ML|||DNA COPIES/UG|NOT DONE||LIKERT SCALE 7-POINT|NA|N|Y|5||7||SCREENING|1960-06-21||||1972-12-07||1964-03-16|1967-09-21|
TRIAL STUDY 134XCP|QS|F149BD98-0802-4C18-8599-426C5258D513|1|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||ML/S|||OSM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|1||38||BLINDED TREATMENT|1964-05-13||||1968-12-18||1968-08-24|1967-10-09|
TRIAL STUDY 134XCP|QS|F149BD98-0802-4C18-8599-426C5258D513|2|||||EQ-5D-3L|||M/SEC|||UG/G/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|2||58||OBSERVATION|1972-10-24||||1967-11-23||1963-11-25|1968-07-08|
TRIAL STUDY 134XCP|QS|F149BD98-0802-4C18-8599-426C5258D513|3|||||SWLS|||CAL|||CI/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|3||39||INDUCTION TREATMENT|1971-12-19||||1965-12-19||1960-09-23|1960-07-16|
TRIAL STUDY 134XCP|QS|F149BD98-0802-4C18-8599-426C5258D513|4|||||FACT-HEP V4|||PSI|||UG/ML/H|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|4||88||INDUCTION TREATMENT|1965-09-08||||1970-06-12||1962-01-24|1963-12-09|
TRIAL STUDY 134XCP|QS|F149BD98-0802-4C18-8599-426C5258D513|5|||||AUDIT-SR|||10^6/EJACULATE U|||CAPFUL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|5||7||CONTINUATION TREATMENT|1964-02-07||||1973-08-05||1971-11-06|1965-12-27|
TRIAL STUDY 134XCP|QS|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1|||||MSIS-29 V2|||AMFI|||KG/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|N|1||38||SCREENING|1965-06-14||||1967-01-21||1960-12-12|1967-02-28|
TRIAL STUDY 134XCP|QS|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2|||||ADCS-CGIC|||FL|||JDF UNIT|NOT DONE||LIKERT SCALE 5-POINT|N|Y|Y|2||58||TREATMENT|1973-06-11||||1965-06-28||1972-11-13|1970-12-07|
TRIAL STUDY 134XCP|QS|5A31D035-90D2-4BD0-AE08-839862D6E0DF|3|||||SOAPP-R|||YD|||APL U/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|N|Y|3||39||INDUCTION TREATMENT|1973-05-09||||1962-06-07||1960-12-23|1962-04-23|
TRIAL STUDY 134XCP|QS|5A31D035-90D2-4BD0-AE08-839862D6E0DF|4|||||IVIS|||%/MIN|||BP|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|4||88||TREATMENT|1973-04-08||||1963-02-27||1971-11-07|1969-10-10|
TRIAL STUDY 134XCP|QS|5A31D035-90D2-4BD0-AE08-839862D6E0DF|5|||||SGRQ PAST 3 MONTHS VERSION|||UG/DL|||10^10/L|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|Y|5||7||INDUCTION TREATMENT|1960-06-29||||1971-01-25||1963-04-03|1966-04-05|
TRIAL STUDY 134XCP|QS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1|||||GMSS VERSION TYPE 1 DIABETES|||VP/ML|||10^9 ORGANISMS/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|NA|1||38||BASELINE|1963-11-21||||1960-12-16||1972-04-20|1963-06-03|
TRIAL STUDY 134XCP|QS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2|||||NPI|||10^4/HPF|||L/S/KPA|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|Y|2||58||TREATMENT|1969-10-06||||1969-01-02||1971-04-19|1963-10-09|
TRIAL STUDY 134XCP|QS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|3|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||BU/ML|||10^3 CFU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|3||39||OPEN LABEL TREATMENT|1963-07-29||||1967-05-03||1971-10-15|1963-01-01|
TRIAL STUDY 134XCP|QS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|4|||||SF12 V2.0 STANDARD|||BEAM BREAKS|||IU/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|Y|4||88||RUN-IN|1968-11-30||||1971-07-04||1964-09-11|1967-04-23|
TRIAL STUDY 134XCP|QS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||CMH2O/ML|||UG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|Y|5||7||OPEN LABEL TREATMENT|1960-12-19||||1972-02-07||1973-08-06|1960-10-09|
TRIAL STUDY 134XCP|QS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1|||||BEBQ RETROSPECTIVE|||HZ/S|||10^5/HPF|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|Y|1||38||OPEN LABEL TREATMENT|1963-11-19||||1960-02-21||1966-10-19|1968-09-30|
TRIAL STUDY 134XCP|QS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2|||||WHODAS 2.0 - 36-ITEM SELF|||ML/H|||MCI/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|U|2||58||SCREENING|1972-12-05||||1963-05-19||1965-07-25|1960-10-18|
TRIAL STUDY 134XCP|QS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||M3|||ML/KG/H|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|U|3||39||BLINDED TREATMENT|1961-06-28||||1961-06-01||1961-02-08|1970-12-30|
TRIAL STUDY 134XCP|QS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|4|||||ANSD V1.0|||UL/KG/DAY|||LOG10 TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|U|4||88||OPEN LABEL TREATMENT|1960-06-04||||1972-12-22||1960-11-13|1970-10-06|
TRIAL STUDY 134XCP|QS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|5|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||COPIES/UL|||ENZYME U/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|5||7||WASHOUT|1971-01-20||||1972-01-01||1969-05-30|1971-12-08|
TRIAL STUDY 134XCP|QS|9C9398A4-38BC-40A7-880D-4549A676F69B|1|||||WOMAC VA 3.1 INDEX|||%/S|||G/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|Y|1||38||RUN-IN|1962-08-17||||1966-07-03||1962-03-13|1972-05-21|
TRIAL STUDY 134XCP|QS|9C9398A4-38BC-40A7-880D-4549A676F69B|2|||||EORTC QLQ-CR29 V2.1|||MG/M2|||NCI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|2||58||RUN-IN|1961-07-31||||1970-06-26||1961-12-01|1971-11-26|
TRIAL STUDY 134XCP|QS|9C9398A4-38BC-40A7-880D-4549A676F69B|3|||||C-SSRS SINCE LAST VISIT|||PG/DL|||BISCUIT|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|3||39||CONTINUATION TREATMENT|1968-07-26||||1973-04-01||1970-09-05|1969-08-07|
TRIAL STUDY 134XCP|QS|9C9398A4-38BC-40A7-880D-4549A676F69B|4|||||NCCN-FACT FBLSI-18 V2|||GBQ/UG|||RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|Y|4||88||FOLLOW-UP|1970-01-30||||1970-02-19||1968-09-28|1965-10-21|
TRIAL STUDY 134XCP|QS|9C9398A4-38BC-40A7-880D-4549A676F69B|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||MG/MOL|||G/U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|N|5||7||INDUCTION TREATMENT|1961-07-09||||1964-08-15||1964-01-28|1966-03-14|
TRIAL STUDY 134XCP|QS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1|||||SF10 V1.0 CHILDREN STANDARD|||IU/DL|||ML/CM H2O|NOT DONE||LIKERT SCALE 3-POINT|U|U|Y|1||38||FOLLOW-UP|1969-01-19||||1967-06-20||1964-07-12|1966-03-29|
TRIAL STUDY 134XCP|QS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2|||||BEBQ RETROSPECTIVE|||MS2|||CM/S|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|2||58||CONTINUATION TREATMENT|1960-08-23||||1966-05-14||1964-04-23|1963-03-29|
TRIAL STUDY 134XCP|QS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|3|||||FAS-NACC UDS V3.0|||UG/DOSE|||ML/CM3/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|3||39||TREATMENT|1965-02-27||||1969-09-14||1969-11-29|1967-03-28|
TRIAL STUDY 134XCP|QS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|4|||||WPAI-SHP V2.0|||/100 WBC|||KAT|NOT DONE||LIKERT SCALE 7-POINT|Y|N|NA|4||88||INDUCTION TREATMENT|1966-03-12||||1967-07-07||1960-09-28|1966-11-19|
TRIAL STUDY 134XCP|QS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|5|||||FACT-LEU V4|||SEC|||DAYS/WK|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|N|5||7||RUN-IN|1966-10-17||||1962-10-04||1968-09-16|1970-08-25|
TRIAL STUDY 134XCP|QS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1|||||BEBQ RETROSPECTIVE|||SV|||U/G/H|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|U|1||38||WASHOUT|1965-06-15||||1960-08-06||1972-05-15|1971-09-14|
TRIAL STUDY 134XCP|QS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2|||||GOSE|||PFU/ANIMAL|||ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|U|2||58||INDUCTION TREATMENT|1961-07-08||||1973-02-15||1961-07-11|1972-06-10|
TRIAL STUDY 134XCP|QS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|3|||||PROSQOLI|||ML/KG/H|||ML/DOSE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|N|3||39||WASHOUT|1960-04-04||||1960-11-14||1969-09-23|1961-03-26|
TRIAL STUDY 134XCP|QS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|4|||||SIQR|||ML/100G/MIN|||GY/H|NOT DONE||LIKERT SCALE 7-POINT|N|N|NA|4||88||CONTINUATION TREATMENT|1970-08-12||||1973-05-18||1970-10-26|1973-04-25|
TRIAL STUDY 134XCP|QS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|5|||||TSCC|||CCID 50/DOSE|||APS U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|NA|5||7||OPEN LABEL TREATMENT|1971-03-23||||1963-12-25||1971-06-16|1961-06-18|
TRIAL STUDY 134XCP|QS|1E049F70-8E29-458F-BF37-13450BC9227E|1|||||TSQM V1.4|||GENEQ/ML|||FG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|1||38||CONTINUATION TREATMENT|1966-02-21||||1965-02-17||1962-12-15|1963-03-07|
TRIAL STUDY 134XCP|QS|1E049F70-8E29-458F-BF37-13450BC9227E|2|||||MDS-UPDRS|||DAGU|||G/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|NA|2||58||SCREENING|1962-04-03||||1968-06-01||1965-05-15|1960-07-10|
TRIAL STUDY 134XCP|QS|1E049F70-8E29-458F-BF37-13450BC9227E|3|||||NCCN-FACT FPSI-17 V2|||U/M2/DAY|||10^3 DNA COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|U|3||39||OBSERVATION|1972-08-02||||1972-05-27||1967-03-24|1967-06-09|
TRIAL STUDY 134XCP|QS|1E049F70-8E29-458F-BF37-13450BC9227E|4|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||UG/KG/DAY|||NG/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|N|4||88||OBSERVATION|1965-02-25||||1964-03-23||1964-05-08|1962-01-19|
TRIAL STUDY 134XCP|QS|1E049F70-8E29-458F-BF37-13450BC9227E|5|||||FACT-B V4|||BQ/UG|||PPM|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|Y|5||7||FOLLOW-UP|1971-02-28||||1960-11-12||1972-11-14|1966-09-29|
TRIAL STUDY 134XCP|QS|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1|||||SOWS SUBJECTIVE|||MG/KG/MIN|||G/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|1||38||SCREENING|1970-10-05||||1965-02-26||1970-02-01|1969-07-11|
TRIAL STUDY 134XCP|QS|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||L|||MHZ|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|U|2||58||WASHOUT|1962-06-25||||1962-12-03||1970-06-09|1962-01-14|
TRIAL STUDY 134XCP|QS|7A612F0F-943A-4283-9A11-B8E8E8D68D66|3|||||COWS|||CMOL|||ML/KG/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|N|3||39||RUN-IN|1965-06-13||||1960-10-18||1969-10-07|1973-03-10|
TRIAL STUDY 134XCP|QS|7A612F0F-943A-4283-9A11-B8E8E8D68D66|4|||||VFQ-25 INTERVIEWER ADMINISTERED|||KA_U/DL|||PFU/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|U|4||88||LONG-TERM FOLLOW-UP|1964-03-23||||1961-03-15||1973-08-16|1961-05-21|
TRIAL STUDY 134XCP|QS|7A612F0F-943A-4283-9A11-B8E8E8D68D66|5|||||CDR|||/10^3|||GENEQ/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|5||7||LONG-TERM FOLLOW-UP|1966-08-23||||1964-03-30||1969-03-05|1963-05-07|
TRIAL STUDY 134XCP|QS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1|||||WHODAS 2.0 - 12-ITEM SELF|||10^4/HPF|||10^6 CFU/G|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|Y|1||38||OBSERVATION|1973-07-16||||1969-07-10||1967-02-04|1972-11-15|
TRIAL STUDY 134XCP|QS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2|||||SIQR|||COPIES/UL|||ML/MIN/MMHG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|N|2||58||BASELINE|1964-05-20||||1962-07-08||1972-06-24|1967-09-11|
TRIAL STUDY 134XCP|QS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|3|||||SF8 V1.0 STANDARD|||FMOL/L|||NM|NOT DONE||LIKERT SCALE 7-POINT|N|NA|N|3||39||LONG-TERM FOLLOW-UP|1969-02-28||||1965-06-28||1962-06-17|1963-08-28|
TRIAL STUDY 134XCP|QS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|4|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||FL|||ELISA UNIT/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|Y|4||88||BLINDED TREATMENT|1967-12-25||||1963-09-12||1962-04-26|1965-11-09|
TRIAL STUDY 134XCP|QS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|5|||||FKSI-15|||G/L|||CL|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|5||7||TREATMENT|1971-09-29||||1965-11-13||1972-10-11|1961-01-11|
TRIAL STUDY 134XCP|QS|8C86A799-2717-46E8-99C2-76D11AAB54D7|1|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||MESF|||BQ/UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|Y|1||38||BLINDED TREATMENT|1964-02-12||||1969-07-20||1971-01-01|1970-11-02|
TRIAL STUDY 134XCP|QS|8C86A799-2717-46E8-99C2-76D11AAB54D7|2|||||WPAI-GH V2.0|||INHALATION|||EP U|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|N|2||58||LONG-TERM FOLLOW-UP|1968-12-13||||1961-11-18||1964-07-08|1968-06-12|
TRIAL STUDY 134XCP|QS|8C86A799-2717-46E8-99C2-76D11AAB54D7|3|||||ADCS-ADL SEVERE DEMENTIA|||BAU/ML|||RATIO|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|N|3||39||RUN-IN|1961-10-30||||1961-04-15||1972-03-12|1966-05-04|
TRIAL STUDY 134XCP|QS|8C86A799-2717-46E8-99C2-76D11AAB54D7|4|||||COPD ASSESSMENT TEST|||MET*MIN|||COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|NA|4||88||OPEN LABEL TREATMENT|1972-08-02||||1964-08-17||1963-11-28|1968-10-28|
TRIAL STUDY 134XCP|QS|8C86A799-2717-46E8-99C2-76D11AAB54D7|5|||||LEC-5 STANDARD VERSION|||IU/MG|||MMOL/G|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|Y|5||7||LONG-TERM FOLLOW-UP|1966-11-04||||1964-06-07||1970-09-29|1962-05-04|
TRIAL STUDY 134XCP|QS|727807A8-A180-4589-A553-E3C82E1D3CF2|1|||||RDQ|||MIN|||DAYS|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|NA|1||38||OBSERVATION|1963-08-12||||1970-11-02||1964-05-23|1961-10-17|
TRIAL STUDY 134XCP|QS|727807A8-A180-4589-A553-E3C82E1D3CF2|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||U/M2|||MASK|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|2||58||BLINDED TREATMENT|1969-08-01||||1966-12-25||1968-12-30|1963-07-29|
TRIAL STUDY 134XCP|QS|727807A8-A180-4589-A553-E3C82E1D3CF2|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||KG/MOL|||EIA UNIT|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|3||39||CONTINUATION TREATMENT|1968-11-01||||1964-12-26||1971-09-18|1968-03-11|
TRIAL STUDY 134XCP|QS|727807A8-A180-4589-A553-E3C82E1D3CF2|4|||||FACT-LYM V4|||MS/MMHG|||UV*SEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|4||88||OBSERVATION|1962-08-09||||1961-09-08||1973-03-10|1962-05-27|
TRIAL STUDY 134XCP|QS|727807A8-A180-4589-A553-E3C82E1D3CF2|5|||||FLU-IIQ TWICE DAILY|||U/L|||MG/KG/WEEK|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|NA|5||7||OPEN LABEL TREATMENT|1969-07-20||||1970-11-20||1966-07-27|1971-01-19|
TRIAL STUDY 134XCP|QS|BFFB5321-5FC7-4465-8579-D75865306359|1|||||MDQ-T|||U/G/MIN|||10^6 CFU/ML|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|1||38||OPEN LABEL TREATMENT|1969-04-08||||1968-04-09||1967-12-29|1973-04-21|
TRIAL STUDY 134XCP|QS|BFFB5321-5FC7-4465-8579-D75865306359|2|||||FACT-L V4|||ML/M2/MIN|||10^9/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|2||58||FOLLOW-UP|1961-08-13||||1971-01-24||1964-12-08|1967-07-21|
TRIAL STUDY 134XCP|QS|BFFB5321-5FC7-4465-8579-D75865306359|3|||||SF10 V1.0 CHILDREN STANDARD|||10^12/L|||SEC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|3||39||LONG-TERM FOLLOW-UP|1972-08-11||||1964-05-22||1971-05-19|1973-01-12|
TRIAL STUDY 134XCP|QS|BFFB5321-5FC7-4465-8579-D75865306359|4|||||PCL-5|||DL|||G/MOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|4||88||TREATMENT|1968-08-21||||1963-11-27||1972-12-01|1963-02-11|
TRIAL STUDY 134XCP|QS|BFFB5321-5FC7-4465-8579-D75865306359|5|||||PSQI|||CARTRIDGE|||BOTTLE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|5||7||LONG-TERM FOLLOW-UP|1964-05-14||||1966-06-02||1961-05-08|1967-04-18|
TRIAL STUDY 134XCP|QS|12F9A745-F76D-4222-B37E-22AF93981ECE|1|||||BWCS|||TRANSDUCING UNIT/ML|||FMOL/L/SEC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|U|1||38||TREATMENT|1973-01-16||||1973-06-08||1973-03-27|1972-03-04|
TRIAL STUDY 134XCP|QS|12F9A745-F76D-4222-B37E-22AF93981ECE|2|||||LEC-5 STANDARD VERSION|||U/KG|||VG/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|N|2||58||LONG-TERM FOLLOW-UP|1972-12-11||||1973-05-23||1973-03-08|1960-04-25|
TRIAL STUDY 134XCP|QS|12F9A745-F76D-4222-B37E-22AF93981ECE|3|||||MNSI|||FT|||AMU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|3||39||OPEN LABEL TREATMENT|1964-10-15||||1964-10-31||1962-03-24|1972-07-16|
TRIAL STUDY 134XCP|QS|12F9A745-F76D-4222-B37E-22AF93981ECE|4|||||COMM|||PT_BR|||MU/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|N|4||88||WASHOUT|1967-10-22||||1971-10-12||1966-06-25|1967-10-29|
TRIAL STUDY 134XCP|QS|12F9A745-F76D-4222-B37E-22AF93981ECE|5|||||SF12 V2.0 STANDARD|||BQ/G|||NMOL/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|U|5||7||TREATMENT|1962-10-06||||1963-02-24||1972-10-05|1962-03-15|
TRIAL STUDY 134XCP|QS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1|||||PHQ-9|||MOL/ML|||STEPS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|N|1||38||WASHOUT|1965-05-05||||1972-01-31||1972-04-18|1964-07-22|
TRIAL STUDY 134XCP|QS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2|||||FACT/GOG-NTX V4|||PFU/ANIMAL|||ENZYME U/G HB|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|N|2||58||OBSERVATION|1967-10-25||||1961-03-02||1965-06-07|1961-03-11|
TRIAL STUDY 134XCP|QS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|3|||||HADS|||PMOL/L/H|||PACKET|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|3||39||FOLLOW-UP|1970-02-06||||1969-02-19||1965-12-21|1971-03-19|
TRIAL STUDY 134XCP|QS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|4|||||FSS|||CM H2O|||ML/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|NA|4||88||BASELINE|1969-09-15||||1967-01-17||1969-08-10|1971-12-02|
TRIAL STUDY 134XCP|QS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|5|||||C-SSRS LIFETIME/RECENT VERSION|||G/CAGE|||NKAT/G HB|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|Y|5||7||FOLLOW-UP|1961-12-06||||1964-02-17||1961-02-23|1971-08-26|
TRIAL STUDY 134XCP|QS|37693A38-D8A0-4313-A4D1-56E282579636|1|||||GOSE|||G/L|||UG/DL|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|1||38||OPEN LABEL TREATMENT|1964-06-19||||1969-09-14||1961-08-07|1967-06-02|
TRIAL STUDY 134XCP|QS|37693A38-D8A0-4313-A4D1-56E282579636|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||M2|||G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|2||58||OPEN LABEL TREATMENT|1972-05-07||||1973-03-20||1966-03-29|1961-06-25|
TRIAL STUDY 134XCP|QS|37693A38-D8A0-4313-A4D1-56E282579636|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||DNA COPIES/ML|||CI/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|3||39||WASHOUT|1967-08-04||||1967-03-04||1962-09-24|1970-01-08|
TRIAL STUDY 134XCP|QS|37693A38-D8A0-4313-A4D1-56E282579636|4|||||FACT-BMT V4|||CCID 50/DOSE|||NG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|Y|4||88||TREATMENT|1965-11-08||||1971-04-13||1962-10-28|1968-05-25|
TRIAL STUDY 134XCP|QS|37693A38-D8A0-4313-A4D1-56E282579636|5|||||GCGI|||10^6 IU/ML|||ENZYME U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|5||7||SCREENING|1972-03-23||||1968-05-22||1971-07-03|1964-02-07|
TRIAL STUDY 134XCP|QS|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||NG/L|||MPL U/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|1||38||INDUCTION TREATMENT|1961-04-27||||1970-01-12||1962-07-09|1967-08-23|
TRIAL STUDY 134XCP|QS|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2|||||WPAI-GH V2.0|||KIT|||MEQ/DL|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|2||58||SCREENING|1967-12-04||||1961-01-01||1970-06-14|1961-09-26|
TRIAL STUDY 134XCP|QS|5C48E0BB-FD52-47F5-8759-6126ECB47B80|3|||||SGRQ-C|||PG|||UG/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|3||39||BASELINE|1961-12-17||||1962-12-30||1971-04-02|1969-12-25|
TRIAL STUDY 134XCP|QS|5C48E0BB-FD52-47F5-8759-6126ECB47B80|4|||||GAD-7|||TROCHE|||ML/M2/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|Y|4||88||WASHOUT|1964-09-29||||1963-12-01||1966-11-10|1961-06-22|
TRIAL STUDY 134XCP|QS|5C48E0BB-FD52-47F5-8759-6126ECB47B80|5|||||COWS|||G/DAY|||MM2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|NA|5||7||BASELINE|1966-03-03||||1968-04-13||1970-05-01|1969-02-22|
TRIAL STUDY 134XCP|QS|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1|||||MHIS-NACC|||UG/KG/H|||DAYS/MONTH|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|1||38||BLINDED TREATMENT|1971-06-29||||1963-03-04||1963-06-28|1964-06-26|
TRIAL STUDY 134XCP|QS|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2|||||WPAI-SHP V2.0|||APL U/ML|||WEEKS|NOT DONE||LIKERT SCALE 3-POINT|U|NA|Y|2||58||TREATMENT|1972-11-26||||1967-06-12||1968-08-30|1965-05-28|
TRIAL STUDY 134XCP|QS|5B420A5A-DB2C-48D2-8E9B-97639F49F182|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||NCI|||UMOL/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|3||39||OPEN LABEL TREATMENT|1967-05-16||||1960-05-14||1966-02-04|1961-09-20|
TRIAL STUDY 134XCP|QS|5B420A5A-DB2C-48D2-8E9B-97639F49F182|4|||||UPDRS|||VG/DOSE|||MM3/MM2/YEAR|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|U|4||88||FOLLOW-UP|1969-05-25||||1960-07-27||1971-08-22|1972-09-20|
TRIAL STUDY 134XCP|QS|5B420A5A-DB2C-48D2-8E9B-97639F49F182|5|||||FACIT-F V4|||ANTI-XA IU|||MG/M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|NA|5||7||INDUCTION TREATMENT|1973-02-25||||1962-05-02||1972-09-26|1965-03-21|
TRIAL STUDY 134XCP|QS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1|||||SF36 V2.0 ACUTE|||DIOPTER|||UG/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|NA|1||38||RUN-IN|1964-02-12||||1971-03-18||1964-07-15|1971-04-25|
TRIAL STUDY 134XCP|QS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2|||||SDS|||10^6 IU|||10^8 PFU|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|2||58||SCREENING|1963-10-10||||1970-08-13||1966-03-25|1962-09-06|
TRIAL STUDY 134XCP|QS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|3|||||FACIT-FATIGUE 13-ITEM V4|||MV|||ML/ANIMAL/WK|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|3||39||RUN-IN|1970-03-11||||1969-01-11||1966-09-20|1966-07-09|
TRIAL STUDY 134XCP|QS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||MIN|||/10^4|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|U|4||88||OBSERVATION|1963-03-17||||1966-01-09||1964-07-10|1972-09-10|
TRIAL STUDY 134XCP|QS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|5|||||ACT|||ML/MMHG/MIN/L|||LINEAR FT*LB|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|5||7||RUN-IN|1966-08-03||||1963-12-03||1970-06-28|1968-05-02|
TRIAL STUDY 134XCP|QS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1|||||MFIS|||GY|||U/G/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|1||38||BLINDED TREATMENT|1972-07-10||||1969-09-23||1970-12-08|1966-10-29|
TRIAL STUDY 134XCP|QS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2|||||SF10 V1.0 CHILDREN STANDARD|||MMOL/MIN/KPA|||10^7 PFU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|NA|2||58||FOLLOW-UP|1962-08-09||||1971-02-27||1967-05-25|1967-04-17|
TRIAL STUDY 134XCP|QS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|3|||||BPI SHORT FORM|||ELISA UNIT/DOSE|||FMOL/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|3||39||RUN-IN|1962-10-17||||1966-08-02||1967-05-11|1964-01-12|
TRIAL STUDY 134XCP|QS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|4|||||ACT|||LOG10 TCID 50/ML|||BQ/UG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|N|4||88||OPEN LABEL TREATMENT|1964-02-10||||1971-09-11||1968-08-21|1967-09-10|
TRIAL STUDY 134XCP|QS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|5|||||SF10 V1.0 CHILDREN STANDARD|||NU/CL|||CGY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|U|5||7||OBSERVATION|1972-05-20||||1966-09-03||1968-10-27|1971-11-05|
TRIAL STUDY 134XCP|QS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||MOL/ML|||MGEQ|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|1||38||FOLLOW-UP|1965-02-06||||1963-12-27||1970-01-30|1968-01-02|
TRIAL STUDY 134XCP|QS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2|||||SF12 V1.0 STANDARD|||LENS|||NG/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|2||58||RUN-IN|1966-03-08||||1962-05-08||1962-03-10|1960-11-04|
TRIAL STUDY 134XCP|QS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||10^7 CFU/ML|||MM/SEC|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|3||39||SCREENING|1969-11-09||||1962-12-12||1971-07-26|1961-03-16|
TRIAL STUDY 134XCP|QS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|4|||||BIS-11|||CM/MIN|||WATT|NOT DONE||LIKERT SCALE 3-POINT|N|Y|U|4||88||OBSERVATION|1961-02-27||||1967-08-22||1973-02-10|1964-06-12|
TRIAL STUDY 134XCP|QS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|5|||||BORG CR10|||/MIN|||UIU/L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|5||7||OBSERVATION|1966-02-26||||1969-05-17||1962-06-23|1970-05-09|
TRIAL STUDY 134XCP|QS|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1|||||FSS|||ML/ANIMAL|||DDU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|1||38||CONTINUATION TREATMENT|1971-10-16||||1966-11-25||1972-05-19|1963-03-22|
TRIAL STUDY 134XCP|QS|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2|||||EPIC-CP|||VP/ML|||L/S|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|U|2||58||LONG-TERM FOLLOW-UP|1962-03-25||||1963-06-10||1965-05-26|1969-11-27|
TRIAL STUDY 134XCP|QS|9B95CE9F-E755-463A-92EC-07A55EE8A58F|3|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||V/V|||H/WK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|Y|3||39||FOLLOW-UP|1964-01-26||||1965-05-15||1970-07-08|1973-02-07|
TRIAL STUDY 134XCP|QS|9B95CE9F-E755-463A-92EC-07A55EE8A58F|4|||||ADCS-ADL SEVERE DEMENTIA|||LX|||PMOL/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|U|4||88||CONTINUATION TREATMENT|1967-02-08||||1965-05-08||1966-11-21|1962-01-15|
TRIAL STUDY 134XCP|QS|9B95CE9F-E755-463A-92EC-07A55EE8A58F|5|||||EXPANDED DRS-PI CAREGIVER VERSION|||ML/CM3/MIN|||MMOL/S|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|U|5||7||BASELINE|1962-04-03||||1967-03-31||1968-10-05|1963-03-25|
TRIAL STUDY 134XCP|QS|ED388A78-3B06-4529-861A-0174E7F345C2|1|||||BWCS|||PACKET|||STEPS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|NA|1||38||BASELINE|1960-08-19||||1963-08-10||1971-10-27|1963-06-10|
TRIAL STUDY 134XCP|QS|ED388A78-3B06-4529-861A-0174E7F345C2|2|||||WOMAC NRS 3.1 INDEX|||IMPLANT|||G/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|N|2||58||CONTINUATION TREATMENT|1970-09-26||||1962-08-13||1966-07-11|1966-01-09|
TRIAL STUDY 134XCP|QS|ED388A78-3B06-4529-861A-0174E7F345C2|3|||||BARS|||JOULE|||ANTI-XA IU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|Y|3||39||OBSERVATION|1963-02-03||||1969-08-30||1970-02-17|1963-11-11|
TRIAL STUDY 134XCP|QS|ED388A78-3B06-4529-861A-0174E7F345C2|4|||||SF36 V1.0 STANDARD|||NKAT|||IU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|NA|4||88||LONG-TERM FOLLOW-UP|1970-04-19||||1971-05-07||1969-08-13|1960-11-13|
TRIAL STUDY 134XCP|QS|ED388A78-3B06-4529-861A-0174E7F345C2|5|||||BEBQ RETROSPECTIVE|||PMOL/10^9 CELLS|||NFIU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|NA|5||7||OBSERVATION|1962-02-03||||1962-04-15||1969-03-31|1968-02-09|
TRIAL STUDY 134XCP|QS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||UKAT/L|||MMOL/MOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|1||38||RUN-IN|1968-11-13||||1967-11-06||1967-01-28|1964-03-26|
TRIAL STUDY 134XCP|QS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2|||||ADHD-RS-IV HOME VERSION|||L/MIN/M2|||JOULE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|NA|2||58||WASHOUT|1968-04-19||||1964-04-27||1962-02-02|1964-07-13|
TRIAL STUDY 134XCP|QS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|3|||||CDLQ|||10^3 CFU|||STRIP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|N|3||39||OBSERVATION|1966-04-20||||1968-03-18||1964-03-27|1964-11-23|
TRIAL STUDY 134XCP|QS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|4|||||ACT|||UG/MOL|||IU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|NA|4||88||OPEN LABEL TREATMENT|1967-06-21||||1963-10-04||1968-03-18|1971-08-26|
TRIAL STUDY 134XCP|QS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|5|||||COPD ASSESSMENT TEST|||10^9 CFU/ML|||LM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|NA|5||7||OBSERVATION|1962-12-14||||1965-12-02||1966-07-13|1967-03-29|
TRIAL STUDY 134XCP|QS|172AB680-362D-488C-9DF1-E1C8E386980D|1|||||C-SSRS BASELINE|||MM|||TUBERCULIN UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|1||38||FOLLOW-UP|1973-04-28||||1968-07-27||1962-08-05|1965-06-14|
TRIAL STUDY 134XCP|QS|172AB680-362D-488C-9DF1-E1C8E386980D|2|||||FACIT-DYSPNEA 33 ITEM BANK|||LOG10 IU/ML|||10^9 ORGANISMS/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|NA|2||58||OBSERVATION|1966-06-15||||1961-03-25||1967-01-06|1962-02-25|
TRIAL STUDY 134XCP|QS|172AB680-362D-488C-9DF1-E1C8E386980D|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||AFU|||CIGAR|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|Y|3||39||TREATMENT|1970-07-16||||1966-01-16||1966-12-21|1968-09-25|
TRIAL STUDY 134XCP|QS|172AB680-362D-488C-9DF1-E1C8E386980D|4|||||MDS-UPDRS|||CARTRIDGE|||CM H2O|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|4||88||BLINDED TREATMENT|1973-06-03||||1969-12-01||1968-06-18|1963-03-15|
TRIAL STUDY 134XCP|QS|172AB680-362D-488C-9DF1-E1C8E386980D|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||MEQ/G|||G/ANIMAL/WK|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|Y|5||7||RUN-IN|1962-10-04||||1963-10-12||1965-01-09|1964-02-28|
TRIAL STUDY 134XCP|QS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1|||||UPDRS|||PG/DL|||%(V/V)|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|1||38||BASELINE|1970-09-09||||1968-12-27||1961-04-09|1973-04-19|
TRIAL STUDY 134XCP|QS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2|||||UPDRS|||CAL|||10^3 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|Y|2||58||FOLLOW-UP|1968-04-16||||1966-10-11||1961-02-28|1972-05-06|
TRIAL STUDY 134XCP|QS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||BAU|||UG/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|N|3||39||LONG-TERM FOLLOW-UP|1967-08-23||||1967-08-14||1963-12-05|1962-11-02|
TRIAL STUDY 134XCP|QS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|4|||||PI|||10^6/L|||ENZYME U/L|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|4||88||OBSERVATION|1964-09-15||||1969-03-09||1971-06-17|1967-11-24|
TRIAL STUDY 134XCP|QS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|5|||||ACQ|||ENZYME U/L|||WATT|NOT DONE||LIKERT SCALE 3-POINT|N|U|Y|5||7||SCREENING|1973-06-18||||1967-06-14||1961-08-17|1970-03-20|
TRIAL STUDY 134XCP|QS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1|||||FAQ-NACC VERSION|||BQ|||10^3 DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|N|1||38||WASHOUT|1961-09-04||||1960-08-14||1969-01-03|1960-05-13|
TRIAL STUDY 134XCP|QS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2|||||EORTC QLQ-C30 V3.0|||CCID 50/DOSE|||PFU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|2||58||RUN-IN|1971-03-11||||1971-07-04||1967-04-30|1961-05-10|
TRIAL STUDY 134XCP|QS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||PMOL/DAY|||NFIU|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|3||39||SCREENING|1961-11-02||||1964-03-01||1972-10-06|1962-08-22|
TRIAL STUDY 134XCP|QS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|4|||||FPSR|||GBQ/UG|||MG/M2|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|4||88||RUN-IN|1964-12-29||||1969-11-12||1965-02-27|1972-06-13|
TRIAL STUDY 134XCP|QS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|5|||||AQLQ|||GRAVITATIONAL UNIT|||UG/MIN|NOT DONE||LIKERT SCALE 3-POINT|NA|N|N|5||7||BLINDED TREATMENT|1970-06-03||||1968-07-12||1973-04-11|1967-05-28|
TRIAL STUDY 134XCP|QS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1|||||BIS-11|||MM/2H|||10^3 COPIES/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|1||38||RUN-IN|1963-07-31||||1965-08-03||1963-07-31|1969-01-01|
TRIAL STUDY 134XCP|QS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2|||||WHODAS 2.0 - 12-ITEM SELF|||UCI/KG|||/CMH2O|NOT DONE||LIKERT SCALE 5-POINT|NA|N|NA|2||58||WASHOUT|1963-09-07||||1965-11-27||1960-09-24|1971-01-11|
TRIAL STUDY 134XCP|QS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|3|||||CES|||UIU/L|||PIPE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|3||39||OBSERVATION|1967-06-23||||1960-09-29||1963-12-28|1963-02-25|
TRIAL STUDY 134XCP|QS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|4|||||SGRQ PAST 4 WEEKS VERSION|||MMU/ML|||UG/M2/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|4||88||BLINDED TREATMENT|1969-04-14||||1970-05-11||1960-02-27|1960-11-15|
TRIAL STUDY 134XCP|QS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||UKAT/10^12 RBC|||DB|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|5||7||SCREENING|1965-01-12||||1969-11-02||1962-06-18|1972-04-17|
TRIAL STUDY 134XCP|QS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1|||||WLQ|||SFC/10^6 PBMC|||PLUG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|1||38||INDUCTION TREATMENT|1967-06-15||||1961-11-09||1964-12-15|1963-02-24|
TRIAL STUDY 134XCP|QS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||GRAVITATIONAL UNIT|||HENRY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|Y|2||58||INDUCTION TREATMENT|1962-02-26||||1963-11-30||1973-06-18|1962-08-11|
TRIAL STUDY 134XCP|QS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|3|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||/10^3|||AMP|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|NA|3||39||LONG-TERM FOLLOW-UP|1962-04-04||||1972-05-18||1961-08-27|1970-11-14|
TRIAL STUDY 134XCP|QS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|4|||||COWS|||M3|||KIT|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|4||88||RUN-IN|1969-03-04||||1970-04-29||1967-06-10|1970-05-26|
TRIAL STUDY 134XCP|QS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|5|||||ASEX-FEMALE|||UMOL/H/MMOL|||VOXEL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|5||7||BASELINE|1969-07-05||||1971-01-10||1967-09-23|1966-07-17|
TRIAL STUDY 134XCP|QS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1|||||FKSI-15|||10^6 COPIES/ML|||CARTRIDGE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1963-11-18||||1963-05-19||1971-12-21|1971-03-03|
TRIAL STUDY 134XCP|QS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2|||||GOSE|||/10^5|||PG/CELL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|N|2||58||OPEN LABEL TREATMENT|1965-04-23||||1967-04-14||1963-04-22|1963-12-07|
TRIAL STUDY 134XCP|QS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|3|||||WHODAS 2.0 - 12-ITEM PROXY|||CONTAINER|||MCI/KG|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|3||39||INDUCTION TREATMENT|1966-04-08||||1973-01-18||1970-11-29|1966-08-05|
TRIAL STUDY 134XCP|QS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||10^3 ORGANISMS/G|||ML/DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|4||88||OPEN LABEL TREATMENT|1967-02-07||||1971-09-21||1968-04-22|1966-11-04|
TRIAL STUDY 134XCP|QS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|5|||||PCL-5|||M/SEC|||TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|NA|5||7||WASHOUT|1963-12-02||||1966-02-24||1964-12-07|1960-04-09|
TRIAL STUDY 134XCP|QS|740D80F1-8BD5-4409-8087-E48F94363362|1|||||PDQUALIF|||MEQ|||NG/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|1||38||RUN-IN|1970-04-07||||1961-06-08||1966-02-19|1972-08-19|
TRIAL STUDY 134XCP|QS|740D80F1-8BD5-4409-8087-E48F94363362|2|||||GOSE|||CD|||/100 HPFS|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|2||58||OPEN LABEL TREATMENT|1963-11-23||||1970-05-05||1961-02-10|1971-02-01|
TRIAL STUDY 134XCP|QS|740D80F1-8BD5-4409-8087-E48F94363362|3|||||FACIT-FATIGUE 13-ITEM V4|||PIXELS/CM|||KG/CM|NOT DONE||LIKERT SCALE 3-POINT|NA|U|Y|3||39||INDUCTION TREATMENT|1962-07-04||||1967-07-06||1971-03-21|1966-12-21|
TRIAL STUDY 134XCP|QS|740D80F1-8BD5-4409-8087-E48F94363362|4|||||FACT-COG V3|||EIA UNIT|||10^3/HPF|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|Y|4||88||FOLLOW-UP|1964-12-01||||1967-06-28||1970-02-14|1964-03-12|
TRIAL STUDY 134XCP|QS|740D80F1-8BD5-4409-8087-E48F94363362|5|||||PARTNER-DDS|||LOG EID 50/DOSE|||FMOL/G|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|5||7||WASHOUT|1970-03-18||||1972-07-17||1964-11-11|1971-10-11|
TRIAL STUDY 134XCP|QS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1|||||DAD|||BEL|||MMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|Y|1||38||BLINDED TREATMENT|1969-01-03||||1969-07-07||1965-11-29|1966-03-25|
TRIAL STUDY 134XCP|QS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2|||||QIDS-SR|||BAU/ML|||IU/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|2||58||RUN-IN|1962-05-09||||1962-04-19||1965-02-01|1962-09-02|
TRIAL STUDY 134XCP|QS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|3|||||PI|||NMOL/G|||10^9 CFU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|3||39||SCREENING|1969-04-10||||1960-11-02||1967-11-10|1969-10-26|
TRIAL STUDY 134XCP|QS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MG/KG/WEEK|||GPS U|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|4||88||CONTINUATION TREATMENT|1968-08-06||||1970-04-30||1967-02-09|1960-04-02|
TRIAL STUDY 134XCP|QS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|5|||||SOAPP-R|||ML/DL|||CCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|5||7||BLINDED TREATMENT|1968-10-07||||1960-09-12||1960-08-27|1973-07-04|
TRIAL STUDY 134XCP|QS|12AD3838-F986-4A27-8AEE-59C387988B0F|1|||||EXACT|||PKAT/L|||10^6 CFU|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|1||38||LONG-TERM FOLLOW-UP|1966-07-15||||1962-10-13||1970-08-18|1967-09-12|
TRIAL STUDY 134XCP|QS|12AD3838-F986-4A27-8AEE-59C387988B0F|2|||||WPAI-SHP V2.0|||KG/M2|||ML/KG/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|2||58||LONG-TERM FOLLOW-UP|1964-08-21||||1962-11-02||1960-07-12|1970-10-25|
TRIAL STUDY 134XCP|QS|12AD3838-F986-4A27-8AEE-59C387988B0F|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||ML/(MIN*100ML)|||EID 50/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|NA|3||39||BLINDED TREATMENT|1965-05-10||||1973-05-08||1963-01-07|1965-08-14|
TRIAL STUDY 134XCP|QS|12AD3838-F986-4A27-8AEE-59C387988B0F|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||/2500 WBC|||U/KG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|N|4||88||OPEN LABEL TREATMENT|1968-12-02||||1962-06-16||1961-06-13|1968-10-16|
TRIAL STUDY 134XCP|QS|12AD3838-F986-4A27-8AEE-59C387988B0F|5|||||YMRS|||MPH|||/VF|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|U|5||7||RUN-IN|1960-07-22||||1965-05-01||1968-09-10|1969-10-06|
TRIAL STUDY 134XCP|QS|441F1A21-6350-478A-9719-75B053182B78|1|||||FAQ-NACC VERSION|||ML/CM H2O|||10^11/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|1||38||CONTINUATION TREATMENT|1960-10-19||||1960-11-21||1968-10-07|1972-08-12|
TRIAL STUDY 134XCP|QS|441F1A21-6350-478A-9719-75B053182B78|2|||||MNSI|||UG/MIN|||UM|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|2||58||TREATMENT|1965-07-13||||1971-09-10||1969-05-12|1969-05-16|
TRIAL STUDY 134XCP|QS|441F1A21-6350-478A-9719-75B053182B78|3|||||FKSI-15|||UOSM|||10^6/EJACULATE U|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|Y|3||39||OPEN LABEL TREATMENT|1964-11-21||||1969-01-06||1966-06-06|1962-10-22|
TRIAL STUDY 134XCP|QS|441F1A21-6350-478A-9719-75B053182B78|4|||||BEBQ RETROSPECTIVE|||ABSORBANCE U|||MPL U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|4||88||CONTINUATION TREATMENT|1964-01-20||||1960-08-30||1966-02-28|1961-09-14|
TRIAL STUDY 134XCP|QS|441F1A21-6350-478A-9719-75B053182B78|5|||||FACT-C V4|||UG/G/H|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|5||7||BLINDED TREATMENT|1972-11-17||||1961-03-31||1970-12-28|1963-03-25|
TRIAL STUDY 134XCP|QS|A69520E2-01A5-4CBC-AFC9-00324531779F|1|||||SF12 V1.0 ACUTE|||AGU/ML|||MS2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|1||38||RUN-IN|1966-03-20||||1968-04-14||1972-10-14|1973-02-08|
TRIAL STUDY 134XCP|QS|A69520E2-01A5-4CBC-AFC9-00324531779F|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||MMHG|||TRACE|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|2||58||FOLLOW-UP|1970-10-27||||1971-12-20||1971-01-21|1960-12-15|
TRIAL STUDY 134XCP|QS|A69520E2-01A5-4CBC-AFC9-00324531779F|3|||||ESS|||10^8/L|||NM|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|3||39||INDUCTION TREATMENT|1966-05-12||||1965-05-17||1963-06-03|1964-12-01|
TRIAL STUDY 134XCP|QS|A69520E2-01A5-4CBC-AFC9-00324531779F|4|||||UPDRS|||LOG10 CCID 50/DOSE|||MM2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|4||88||WASHOUT|1970-12-19||||1969-06-28||1970-08-14|1970-04-01|
TRIAL STUDY 134XCP|QS|A69520E2-01A5-4CBC-AFC9-00324531779F|5|||||MDQ-T|||10^3 RNA COPIES/ML|||ABSORBANCE U/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|NA|5||7||WASHOUT|1963-04-15||||1963-11-22||1967-02-22|1961-02-10|
TRIAL STUDY 134XCP|QS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1|||||FACT-HEP V4|||DAGU/ML|||MG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|1||38||SCREENING|1967-05-25||||1962-12-20||1961-04-30|1963-06-05|
TRIAL STUDY 134XCP|QS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2|||||SGRQ-C|||GPL U|||FT3|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|U|2||58||BASELINE|1967-02-02||||1969-03-26||1969-07-24|1967-02-13|
TRIAL STUDY 134XCP|QS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|3|||||CHART-SF INTERVIEW VERSION|||APL U|||U/MMOL|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|NA|3||39||OPEN LABEL TREATMENT|1973-01-16||||1973-04-16||1971-10-19|1962-07-15|
TRIAL STUDY 134XCP|QS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|4|||||Q-LES-Q|||MEQ/KG|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|NA|4||88||INDUCTION TREATMENT|1963-05-26||||1963-11-13||1965-01-03|1964-09-13|
TRIAL STUDY 134XCP|QS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||UL/KG/DAY|||GBQ/G|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|NA|5||7||FOLLOW-UP|1961-09-02||||1960-07-16||1971-03-17|1966-08-05|
TRIAL STUDY 134XCP|QS|C361B153-4623-4F03-9D81-8316B1046F35|1|||||SF36 V1.0 STANDARD|||TBSP|||BQ/MG|NOT DONE||LIKERT SCALE 5-POINT|U|Y|Y|1||38||FOLLOW-UP|1963-05-01||||1960-07-11||1970-10-27|1970-11-14|
TRIAL STUDY 134XCP|QS|C361B153-4623-4F03-9D81-8316B1046F35|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||FARAD|||PACK|NOT DONE||LIKERT SCALE 7-POINT|Y|U|Y|2||58||FOLLOW-UP|1967-05-27||||1963-02-03||1960-03-30|1968-09-19|
TRIAL STUDY 134XCP|QS|C361B153-4623-4F03-9D81-8316B1046F35|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||PRESSOR UNITS|||/MBP|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|NA|3||39||FOLLOW-UP|1969-10-14||||1969-02-04||1961-06-19|1972-04-06|
TRIAL STUDY 134XCP|QS|C361B153-4623-4F03-9D81-8316B1046F35|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||MCI|||HOMEOPATHIC DILUTION|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|U|4||88||LONG-TERM FOLLOW-UP|1962-07-26||||1971-09-19||1961-03-28|1970-02-20|
TRIAL STUDY 134XCP|QS|C361B153-4623-4F03-9D81-8316B1046F35|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||MM/2H|||FOZ_US|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|U|5||7||FOLLOW-UP|1964-05-21||||1968-04-20||1972-02-05|1969-04-20|
TRIAL STUDY 134XCP|QS|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1|||||EORTC QLQ-LC13|||ANTI-XA IU/ML|||MM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|1||38||OBSERVATION|1973-01-07||||1969-05-10||1960-01-08|1970-05-12|
TRIAL STUDY 134XCP|QS|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2|||||EPIC-26|||UCI|||IN2|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|2||58||BLINDED TREATMENT|1967-02-16||||1969-01-18||1963-05-27|1961-09-04|
TRIAL STUDY 134XCP|QS|8FF0A93C-26D1-49E9-853F-B063A958FE1E|3|||||PSQI|||U/M2/DAY|||PT_BR|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|3||39||BASELINE|1968-04-04||||1970-10-22||1968-07-01|1967-07-19|
TRIAL STUDY 134XCP|QS|8FF0A93C-26D1-49E9-853F-B063A958FE1E|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||TBSP|||U/MG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|4||88||WASHOUT|1970-01-05||||1962-04-01||1963-09-13|1968-01-02|
TRIAL STUDY 134XCP|QS|8FF0A93C-26D1-49E9-853F-B063A958FE1E|5|||||PODCI - ADOLESCENT SELF REPORTED|||CFU/ML|||UL/KG/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|5||7||SCREENING|1969-09-01||||1960-07-01||1969-05-09|1967-04-18|
TRIAL STUDY 134XCP|QS|31D8814B-5542-4540-B955-24410D42F1EF|1|||||FIQR|||GBQ/UG|||PACKAGE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|1||38||BLINDED TREATMENT|1969-04-24||||1963-01-11||1969-10-20|1971-09-26|
TRIAL STUDY 134XCP|QS|31D8814B-5542-4540-B955-24410D42F1EF|2|||||FACT-COG V3|||MG|||PKAT/L|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|2||58||TREATMENT|1967-09-14||||1967-04-11||1967-09-13|1965-08-06|
TRIAL STUDY 134XCP|QS|31D8814B-5542-4540-B955-24410D42F1EF|3|||||EORTC QLQ-LC13|||MOL/MG|||L/MIN/M2|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|3||39||OPEN LABEL TREATMENT|1960-03-30||||1970-09-18||1970-09-03|1968-07-02|
TRIAL STUDY 134XCP|QS|31D8814B-5542-4540-B955-24410D42F1EF|4|||||MHIS-NACC|||ML/S|||MOL/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|N|4||88||TREATMENT|1970-11-02||||1963-10-09||1964-03-23|1971-10-15|
TRIAL STUDY 134XCP|QS|31D8814B-5542-4540-B955-24410D42F1EF|5|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||PG/L|||L/L|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|5||7||OPEN LABEL TREATMENT|1968-02-16||||1965-09-22||1966-03-01|1962-03-30|
TRIAL STUDY 134XCP|QS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1|||||FBRSI|||LOG10 COPIES/ML|||RATIO|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|1||38||OBSERVATION|1968-04-07||||1964-10-25||1972-08-05|1971-09-10|
TRIAL STUDY 134XCP|QS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2|||||DAD|||U/KG/MIN|||ARBITRARY U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|U|2||58||BASELINE|1960-03-25||||1964-06-23||1967-07-10|1969-06-04|
TRIAL STUDY 134XCP|QS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|3|||||FACT-HEP V4|||NMOL/KG/DAY|||ANTI-XA IU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|NA|3||39||CONTINUATION TREATMENT|1964-11-13||||1960-12-21||1969-12-21|1972-01-14|
TRIAL STUDY 134XCP|QS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||V|||UEQ/L|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|4||88||CONTINUATION TREATMENT|1971-05-08||||1960-08-07||1969-05-19|1966-09-12|
TRIAL STUDY 134XCP|QS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|5|||||WHODAS 2.0 - 36-ITEM PROXY|||ML/MMHG|||DDU|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|5||7||BLINDED TREATMENT|1968-11-28||||1966-10-11||1965-07-02|1967-11-13|
TRIAL STUDY 134XCP|QS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1|||||BARS|||KN/CM2|||UEQ|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|1||38||SCREENING|1973-08-07||||1969-04-17||1966-03-05|1962-03-23|
TRIAL STUDY 134XCP|QS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2|||||SIQR|||10^9/DOSE|||KPA|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|Y|2||58||INDUCTION TREATMENT|1967-01-02||||1970-03-01||1973-08-11|1970-12-04|
TRIAL STUDY 134XCP|QS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|3|||||EPIC-26|||AMU|||ML/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|NA|3||39||BLINDED TREATMENT|1962-05-16||||1964-12-21||1971-05-15|1968-05-19|
TRIAL STUDY 134XCP|QS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|4|||||SF12 V1.0 ACUTE|||U/M2/MIN|||MG/DAY|NOT DONE||LIKERT SCALE 5-POINT|N|N|U|4||88||WASHOUT|1969-09-12||||1968-06-27||1961-07-28|1964-06-21|
TRIAL STUDY 134XCP|QS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|5|||||C-SSRS SCREENING|||MV|||GY/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|Y|5||7||LONG-TERM FOLLOW-UP|1972-06-04||||1968-12-28||1960-07-02|1971-08-21|
TRIAL STUDY 134XCP|QS|15BFC17A-2F55-441A-AB99-76D270D62367|1|||||ODI V2.1A|||LOG10 TCID 50/UL|||ML/(MIN*100ML)|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|1||38||RUN-IN|1967-05-20||||1964-08-16||1962-09-24|1967-07-26|
TRIAL STUDY 134XCP|QS|15BFC17A-2F55-441A-AB99-76D270D62367|2|||||SOAPP-R|||CM H2O|||/4.0 ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|2||58||OPEN LABEL TREATMENT|1962-07-15||||1960-04-11||1962-06-29|1964-10-06|
TRIAL STUDY 134XCP|QS|15BFC17A-2F55-441A-AB99-76D270D62367|3|||||AQ20|||10^6 CFU|||LOG10 ELISA UNIT/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|3||39||WASHOUT|1971-12-18||||1961-07-27||1966-03-22|1966-09-27|
TRIAL STUDY 134XCP|QS|15BFC17A-2F55-441A-AB99-76D270D62367|4|||||PR|||V/V|||UG/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|4||88||BASELINE|1966-06-30||||1965-12-03||1969-05-13|1970-05-03|
TRIAL STUDY 134XCP|QS|15BFC17A-2F55-441A-AB99-76D270D62367|5|||||WOMAC NRS 3.1 INDEX|||CUP EQ|||TABLET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|5||7||TREATMENT|1966-01-10||||1966-10-02||1960-05-19|1961-03-27|
TRIAL STUDY 134XCP|QS|CA231D77-1A1F-49F3-8172-06709A1330B7|1|||||BPI SHORT FORM|||IU/L|||10^8 PFU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|NA|1||38||RUN-IN|1973-03-13||||1964-01-08||1968-08-30|1962-04-14|
TRIAL STUDY 134XCP|QS|CA231D77-1A1F-49F3-8172-06709A1330B7|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||G/DAY|||ECL UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|U|2||58||OBSERVATION|1968-08-25||||1971-07-04||1971-05-07|1970-04-27|
TRIAL STUDY 134XCP|QS|CA231D77-1A1F-49F3-8172-06709A1330B7|3|||||OAB-Q SHORT FORM|||PKAT/L|||MET*H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1972-07-15||||1965-03-05||1963-07-04|1969-09-17|
TRIAL STUDY 134XCP|QS|CA231D77-1A1F-49F3-8172-06709A1330B7|4|||||LEC-5 STANDARD VERSION|||TABLET|||LM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|N|4||88||BLINDED TREATMENT|1968-06-13||||1962-06-12||1963-02-12|1961-12-26|
TRIAL STUDY 134XCP|QS|CA231D77-1A1F-49F3-8172-06709A1330B7|5|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||10^3 ORGANISMS|||ABSORBANCE U/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|5||7||INDUCTION TREATMENT|1972-04-05||||1963-09-03||1966-07-08|1969-11-01|
TRIAL STUDY 134XCP|QS|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1|||||FACIT-F V4|||AU/ML|||UMOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|N|1||38||OPEN LABEL TREATMENT|1961-10-25||||1963-05-20||1963-09-19|1973-06-17|
TRIAL STUDY 134XCP|QS|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2|||||BARS|||L/DAY|||PATCH|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|N|2||58||RUN-IN|1970-08-30||||1969-01-25||1965-12-26|1965-04-11|
TRIAL STUDY 134XCP|QS|7A4D6074-E870-40E8-B567-D069BCB7DA9F|3|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||CD|||CAL|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|3||39||CONTINUATION TREATMENT|1972-11-17||||1963-09-14||1963-05-23|1963-01-17|
TRIAL STUDY 134XCP|QS|7A4D6074-E870-40E8-B567-D069BCB7DA9F|4|||||MMRC|||NU/CL|||PACK YEAR|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|U|4||88||SCREENING|1970-06-18||||1964-04-03||1965-06-02|1963-02-26|
TRIAL STUDY 134XCP|QS|7A4D6074-E870-40E8-B567-D069BCB7DA9F|5|||||SOAPP-R|||TRANSDUCING UNIT|||KAT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|5||7||BLINDED TREATMENT|1971-12-13||||1965-06-12||1968-04-21|1972-04-30|
TRIAL STUDY 134XCP|QS|3DDD2A7E-B955-424B-B485-54E81D0E0699|1|||||ADCS-CGIC|||PG|||MG/L FEU|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|1||38||WASHOUT|1968-01-14||||1971-01-06||1966-11-05|1971-01-15|
TRIAL STUDY 134XCP|QS|3DDD2A7E-B955-424B-B485-54E81D0E0699|2|||||PDDS|||APL U/ML|||NKAT/L|NOT DONE||LIKERT SCALE 5-POINT|N|N|Y|2||58||SCREENING|1971-07-11||||1971-07-07||1963-05-10|1961-09-06|
TRIAL STUDY 134XCP|QS|3DDD2A7E-B955-424B-B485-54E81D0E0699|3|||||BEBQ CONCURRENT|||STRIP|||U/M2/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|N|3||39||FOLLOW-UP|1969-03-27||||1971-11-24||1961-07-01|1970-08-10|
TRIAL STUDY 134XCP|QS|3DDD2A7E-B955-424B-B485-54E81D0E0699|4|||||FAMS|||PT_BR|||PMOL/10^9 CELLS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|Y|4||88||INDUCTION TREATMENT|1960-01-22||||1964-03-27||1972-09-24|1964-01-11|
TRIAL STUDY 134XCP|QS|3DDD2A7E-B955-424B-B485-54E81D0E0699|5|||||CDLQ|||TAMPON|||UG/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|NA|U|5||7||SCREENING|1964-10-03||||1963-07-06||1962-01-05|1967-03-11|
TRIAL STUDY 134XCP|QS|D6757E79-3104-468E-BADC-8CCB51BFAE87|1|||||IBDQ|||NMOL/L|||10^12/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|NA|1||38||BLINDED TREATMENT|1972-12-09||||1962-12-11||1967-02-22|1962-04-15|
TRIAL STUDY 134XCP|QS|D6757E79-3104-468E-BADC-8CCB51BFAE87|2|||||SOWS SHORT|||USEC|||NG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|NA|2||58||LONG-TERM FOLLOW-UP|1972-08-10||||1966-09-28||1961-09-14|1964-09-26|
TRIAL STUDY 134XCP|QS|D6757E79-3104-468E-BADC-8CCB51BFAE87|3|||||AUDIT-C|||10^6 DNA COPIES/ML|||NMOL/L/H|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|3||39||FOLLOW-UP|1968-10-07||||1967-06-20||1964-03-09|1971-09-10|
TRIAL STUDY 134XCP|QS|D6757E79-3104-468E-BADC-8CCB51BFAE87|4|||||TSCC|||DNA COPIES/UG|||NMOL/ML/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|4||88||CONTINUATION TREATMENT|1968-07-16||||1968-12-20||1966-03-22|1964-06-19|
TRIAL STUDY 134XCP|QS|D6757E79-3104-468E-BADC-8CCB51BFAE87|5|||||MSIS-29 V1|||UOSM|||CUP|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|U|5||7||OPEN LABEL TREATMENT|1964-09-19||||1962-03-03||1964-10-28|1964-10-31|
TRIAL STUDY 134XCP|QS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||IU|||ML*CMH2O|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|Y|1||38||RUN-IN|1965-05-29||||1972-10-14||1969-02-07|1964-05-13|
TRIAL STUDY 134XCP|QS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2|||||WHODAS 2.0 - 12-ITEM PROXY|||OZ|||KIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|2||58||OPEN LABEL TREATMENT|1960-11-17||||1969-12-02||1966-09-04|1961-09-13|
TRIAL STUDY 134XCP|QS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|3|||||PHQ SCREENER VERSION|||PLUG|||AMOL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|3||39||RUN-IN|1967-03-01||||1967-06-19||1963-04-16|1967-10-26|
TRIAL STUDY 134XCP|QS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|4|||||VFQ-25 SELF ADMINISTERED|||UOSM|||USP U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|4||88||BLINDED TREATMENT|1967-03-18||||1970-01-09||1960-09-07|1966-03-19|
TRIAL STUDY 134XCP|QS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|5|||||PHQ-15|||BQ/UL|||MMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|N|5||7||BLINDED TREATMENT|1971-10-22||||1966-02-05||1960-03-30|1971-08-04|
TRIAL STUDY 134XCP|QS|FBAA59F4-154C-40CC-B740-A87769BFEC45|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||NMOL/G|||U/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|N|1||38||WASHOUT|1967-03-12||||1963-05-18||1970-12-29|1971-04-03|
TRIAL STUDY 134XCP|QS|FBAA59F4-154C-40CC-B740-A87769BFEC45|2|||||RDQ|||KG/M2|||ML/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|NA|2||58||OPEN LABEL TREATMENT|1964-02-01||||1960-11-06||1965-03-17|1964-02-28|
TRIAL STUDY 134XCP|QS|FBAA59F4-154C-40CC-B740-A87769BFEC45|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||GBQ/UG|||ML/DL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|N|3||39||RUN-IN|1971-08-03||||1965-09-06||1968-08-11|1968-11-07|
TRIAL STUDY 134XCP|QS|FBAA59F4-154C-40CC-B740-A87769BFEC45|4|||||HAEM-A-QOL|||CIGARETTE|||FRACTION OF 1|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|4||88||WASHOUT|1969-02-21||||1963-12-28||1961-06-04|1969-11-16|
TRIAL STUDY 134XCP|QS|FBAA59F4-154C-40CC-B740-A87769BFEC45|5|||||BLCS|||UM|||CM H2O|NOT DONE||LIKERT SCALE 5-POINT|N|NA|N|5||7||CONTINUATION TREATMENT|1963-03-27||||1973-01-19||1969-03-19|1962-07-22|
TRIAL STUDY 134XCP|QS|9A9E638B-426B-4F3E-8363-50DC2617FD63|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||MOSM|||SCOOPFUL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|1||38||RUN-IN|1960-05-03||||1963-08-24||1967-11-08|1970-02-01|
TRIAL STUDY 134XCP|QS|9A9E638B-426B-4F3E-8363-50DC2617FD63|2|||||CGI|||G/MOL|||CARTRIDGE|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|NA|2||58||WASHOUT|1970-11-20||||1965-10-13||1972-07-03|1968-11-06|
TRIAL STUDY 134XCP|QS|9A9E638B-426B-4F3E-8363-50DC2617FD63|3|||||PEDS-FACIT-F|||UMOL/MOL|||PKAT|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|3||39||FOLLOW-UP|1962-12-10||||1965-03-23||1973-01-17|1967-12-09|
TRIAL STUDY 134XCP|QS|9A9E638B-426B-4F3E-8363-50DC2617FD63|4|||||WHODAS 2.0 - 36-ITEM PROXY|||PHERESIS UNIT|||KG/M2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|Y|4||88||OPEN LABEL TREATMENT|1968-01-03||||1966-10-22||1971-01-20|1967-07-28|
TRIAL STUDY 134XCP|QS|9A9E638B-426B-4F3E-8363-50DC2617FD63|5|||||MMRC|||LOG10 COPIES/ML|||MG/M2/DAY|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|5||7||SCREENING|1965-07-09||||1967-04-07||1966-05-26|1962-12-27|
TRIAL STUDY 134XCP|QS|9995CD08-2650-4711-8F04-E41183E28B21|1|||||NPI|||MCI/L|||MMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|U|1||38||TREATMENT|1964-10-13||||1964-09-10||1967-12-25|1972-01-23|
TRIAL STUDY 134XCP|QS|9995CD08-2650-4711-8F04-E41183E28B21|2|||||PHQ-9|||BQ/KG|||MIU/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|N|2||58||BLINDED TREATMENT|1964-03-16||||1966-10-01||1971-03-27|1960-04-27|
TRIAL STUDY 134XCP|QS|9995CD08-2650-4711-8F04-E41183E28B21|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||YEARS|||CMH2O/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|Y|3||39||OBSERVATION|1964-06-12||||1967-04-21||1968-07-03|1968-10-11|
TRIAL STUDY 134XCP|QS|9995CD08-2650-4711-8F04-E41183E28B21|4|||||ASEX-MALE|||H/WK|||UMOL/MOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|N|4||88||RUN-IN|1970-04-29||||1970-07-22||1968-04-17|1965-05-29|
TRIAL STUDY 134XCP|QS|9995CD08-2650-4711-8F04-E41183E28B21|5|||||FACT-C V4|||ML/ANIMAL/WK|||DPM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|5||7||BASELINE|1963-06-17||||1962-07-24||1970-12-26|1965-10-30|
TRIAL STUDY 134XCP|QS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1|||||LEC-5 STANDARD VERSION|||UG|||HEP|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|1||38||BASELINE|1972-06-27||||1968-01-08||1962-11-04|1966-08-24|
TRIAL STUDY 134XCP|QS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2|||||COWS|||NKAT/L|||MOL/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|N|2||58||BLINDED TREATMENT|1962-09-17||||1965-02-06||1973-08-20|1961-01-13|
TRIAL STUDY 134XCP|QS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|3|||||BPI|||CMH2O/ML|||UMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|3||39||BASELINE|1971-01-05||||1965-12-31||1962-12-12|1963-06-23|
TRIAL STUDY 134XCP|QS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|4|||||NCCN-FACT FKSI-19 V2|||ML/M2/H|||SEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|NA|4||88||BASELINE|1960-06-15||||1972-05-18||1972-05-08|1968-05-19|
TRIAL STUDY 134XCP|QS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|5|||||OAB-Q SHORT FORM|||BREATHS/30S|||ML/KG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|5||7||RUN-IN|1965-12-02||||1970-09-16||1968-05-22|1970-10-14|
TRIAL STUDY 134XCP|QS|DE805225-C632-46E6-B673-DA0D864D47F7|1|||||SGRQ PAST 3 MONTHS VERSION|||EP U|||MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|Y|1||38||RUN-IN|1964-10-20||||1963-11-09||1964-12-09|1963-01-03|
TRIAL STUDY 134XCP|QS|DE805225-C632-46E6-B673-DA0D864D47F7|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||U/ANIMAL|||M/SEC2|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|2||58||CONTINUATION TREATMENT|1962-08-28||||1964-06-09||1971-08-03|1968-03-11|
TRIAL STUDY 134XCP|QS|DE805225-C632-46E6-B673-DA0D864D47F7|3|||||SF10 V1.0 CHILDREN ACUTE|||ELISA UNIT/DOSE|||MEQ/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|3||39||LONG-TERM FOLLOW-UP|1970-01-27||||1962-06-05||1963-01-06|1966-02-26|
TRIAL STUDY 134XCP|QS|DE805225-C632-46E6-B673-DA0D864D47F7|4|||||COMM|||/MM2|||CYCLE/MIN|NOT DONE||LIKERT SCALE 5-POINT|U|N|U|4||88||LONG-TERM FOLLOW-UP|1967-08-12||||1964-09-16||1969-02-10|1963-11-13|
TRIAL STUDY 134XCP|QS|DE805225-C632-46E6-B673-DA0D864D47F7|5|||||ASEX-FEMALE|||PSEC|||CAPLET|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|N|5||7||TREATMENT|1972-10-27||||1960-11-17||1969-03-17|1967-04-27|
TRIAL STUDY 134XCP|QS|9C921E89-706F-46E8-ADE3-A806289D43A5|1|||||EORTC QLQ-C30 V3.0|||FMOL/G|||NG/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|1||38||OBSERVATION|1969-09-09||||1960-04-22||1965-08-04|1972-07-25|
TRIAL STUDY 134XCP|QS|9C921E89-706F-46E8-ADE3-A806289D43A5|2|||||PHQ-2|||UKAT|||ML/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|2||58||RUN-IN|1964-03-15||||1968-08-18||1963-08-23|1972-12-30|
TRIAL STUDY 134XCP|QS|9C921E89-706F-46E8-ADE3-A806289D43A5|3|||||MADRS|||/10^5|||/4.0 ML|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|3||39||CONTINUATION TREATMENT|1965-05-06||||1970-12-01||1966-07-15|1964-07-03|
TRIAL STUDY 134XCP|QS|9C921E89-706F-46E8-ADE3-A806289D43A5|4|||||SF12 V2.0 ACUTE|||LOG10 ELISA UNIT/DOSE|||U/MMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|4||88||OBSERVATION|1971-03-06||||1962-12-07||1970-12-12|1961-09-22|
TRIAL STUDY 134XCP|QS|9C921E89-706F-46E8-ADE3-A806289D43A5|5|||||MHIS-NACC|||DPM|||VP/DOSE|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|Y|5||7||INDUCTION TREATMENT|1970-10-26||||1961-06-29||1963-11-22|1960-04-28|
TRIAL STUDY 134XCP|QS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1|||||UPS|||FOZ_US|||LOG10 TCID 50/UL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|Y|1||38||RUN-IN|1967-09-29||||1963-04-21||1969-02-15|1962-06-11|
TRIAL STUDY 134XCP|QS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2|||||PROSQOLI|||MMOL/L|||MEQ/MMOL|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|2||58||SCREENING|1964-01-11||||1964-12-04||1968-07-17|1963-05-15|
TRIAL STUDY 134XCP|QS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|3|||||SIQ-JR|||10^8/L|||LOG10 ELISA UNIT/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|3||39||INDUCTION TREATMENT|1961-09-01||||1963-11-24||1962-02-19|1970-12-03|
TRIAL STUDY 134XCP|QS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|4|||||FLU-IIQ ONCE DAILY|||G|||UCI/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|NA|4||88||OBSERVATION|1965-06-16||||1969-06-08||1971-03-30|1961-08-12|
TRIAL STUDY 134XCP|QS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|5|||||PEDS-FACIT-F|||F|||GTT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|NA|5||7||BASELINE|1962-05-09||||1960-08-20||1963-02-10|1971-05-22|
TRIAL STUDY 134XCP|QS|17C2A52E-1232-4CBB-A809-9DC2C863366A|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||LOG10 IU/ML|||MS/MMHG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|1||38||FOLLOW-UP|1972-12-01||||1970-04-29||1970-08-24|1962-01-07|
TRIAL STUDY 134XCP|QS|17C2A52E-1232-4CBB-A809-9DC2C863366A|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||UG/L DDU|||ARBITRARY U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|2||58||INDUCTION TREATMENT|1961-04-04||||1967-12-22||1971-01-11|1965-08-27|
TRIAL STUDY 134XCP|QS|17C2A52E-1232-4CBB-A809-9DC2C863366A|3|||||ODI V2.1A|||CFU/ML|||ML/MMHG/MIN/L|NOT DONE||LIKERT SCALE 3-POINT|U|U|N|3||39||RUN-IN|1967-04-02||||1962-10-27||1971-06-25|1965-04-20|
TRIAL STUDY 134XCP|QS|17C2A52E-1232-4CBB-A809-9DC2C863366A|4|||||HAEM-A-QOL|||BAU/ML|||10^4/HPF|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|4||88||BASELINE|1965-03-14||||1972-06-03||1968-02-06|1971-08-17|
TRIAL STUDY 134XCP|QS|17C2A52E-1232-4CBB-A809-9DC2C863366A|5|||||HAQ-DI WITHOUT VAS|||10^6 DNA COPIES/ML|||10^9 ORGANISMS/MG|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|N|5||7||WASHOUT|1970-06-06||||1963-11-03||1966-05-26|1969-11-09|
TRIAL STUDY 134XCP|QS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1|||||MSIS-29 V2|||JAR|||L/H/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|U|1||38||FOLLOW-UP|1972-02-03||||1961-06-03||1968-08-28|1960-08-08|
TRIAL STUDY 134XCP|QS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2|||||SIQ|||NSEC|||VG/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|2||58||CONTINUATION TREATMENT|1961-02-27||||1971-07-11||1965-02-28|1968-01-08|
TRIAL STUDY 134XCP|QS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||ML/S/M2|||ML/ANIMAL/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|3||39||WASHOUT|1966-05-01||||1969-08-13||1967-03-19|1972-06-28|
TRIAL STUDY 134XCP|QS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|4|||||EQ-5D-3L|||NG|||10^5/HPF|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|N|4||88||OPEN LABEL TREATMENT|1967-12-02||||1960-02-21||1960-02-17|1971-10-02|
TRIAL STUDY 134XCP|QS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|5|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||/HPF|||TBSP|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|5||7||RUN-IN|1973-05-30||||1969-12-27||1960-10-25|1965-08-04|
TRIAL STUDY 134XCP|QS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1|||||MNSI|||USP U|||10^9 CFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|Y|1||38||BLINDED TREATMENT|1964-01-22||||1971-08-06||1968-12-21|1969-02-05|
TRIAL STUDY 134XCP|QS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2|||||FACT-B V4|||BREATHS/MIN|||CIGAR|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|Y|2||58||OPEN LABEL TREATMENT|1966-09-07||||1965-02-19||1965-05-21|1971-05-05|
TRIAL STUDY 134XCP|QS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|3|||||OAB-Q|||PSEC|||ABSORBANCE U/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|3||39||TREATMENT|1968-08-25||||1960-03-31||1968-03-22|1967-04-17|
TRIAL STUDY 134XCP|QS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||ML/(MIN*100ML)|||UU/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|NA|4||88||WASHOUT|1963-06-25||||1968-11-13||1963-05-06|1969-03-28|
TRIAL STUDY 134XCP|QS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|5|||||ADCS-ADL|||UG/G/H|||FMOL/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|N|5||7||INDUCTION TREATMENT|1960-01-10||||1964-09-15||1965-08-11|1970-08-02|
TRIAL STUDY 134XCP|QS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1|||||WPAI-SHP V2.0|||UG/L FEU|||MOSM/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|U|1||38||WASHOUT|1970-08-16||||1964-03-16||1972-02-22|1972-08-22|
TRIAL STUDY 134XCP|QS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2|||||MDS-UPDRS|||10^6 ORGANISMS|||PIXEL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|N|2||58||WASHOUT|1962-05-15||||1969-05-25||1971-08-02|1960-01-11|
TRIAL STUDY 134XCP|QS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|3|||||NCCN-FACT FPSI-17 V2|||OZ EQ|||ABSORBANCE U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|U|3||39||OPEN LABEL TREATMENT|1961-05-24||||1965-02-07||1964-03-07|1967-03-18|
TRIAL STUDY 134XCP|QS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|4|||||C-SSRS CHILDREN'S BASELINE|||AFU|||DPM/0.5 ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|NA|4||88||CONTINUATION TREATMENT|1960-06-08||||1960-08-20||1968-08-02|1973-08-13|
TRIAL STUDY 134XCP|QS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|5|||||PHQ SCREENER VERSION|||BQ/G|||PPTH|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|U|5||7||OBSERVATION|1965-01-08||||1962-12-16||1972-08-26|1967-12-15|
TRIAL STUDY 134XCP|QS|585A17D7-12A3-40C8-811F-339497B9D09C|1|||||PHQ-9|||MEQ|||CAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|Y|1||38||INDUCTION TREATMENT|1962-04-30||||1961-09-04||1969-11-23|1972-09-12|
TRIAL STUDY 134XCP|QS|585A17D7-12A3-40C8-811F-339497B9D09C|2|||||DRRI-2|||DAYS/MONTH|||PL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|N|2||58||SCREENING|1960-08-29||||1963-11-12||1965-03-23|1965-02-05|
TRIAL STUDY 134XCP|QS|585A17D7-12A3-40C8-811F-339497B9D09C|3|||||Q-LES-Q-SF|||/MM2|||/10^3|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|3||39||SCREENING|1972-05-18||||1967-12-21||1966-11-03|1965-03-26|
TRIAL STUDY 134XCP|QS|585A17D7-12A3-40C8-811F-339497B9D09C|4|||||FAMS|||NKAT|||10^6/L|NOT DONE||LIKERT SCALE 7-POINT|Y|N|U|4||88||BLINDED TREATMENT|1961-06-11||||1970-01-01||1967-11-29|1965-01-31|
TRIAL STUDY 134XCP|QS|585A17D7-12A3-40C8-811F-339497B9D09C|5|||||HAMD 6 SELF-REPORT VERSION|||PPTR|||PMOL/10^10 CELLS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|5||7||TREATMENT|1964-12-15||||1964-08-06||1961-06-05|1960-12-26|
TRIAL STUDY 134XCP|QS|D777661E-DF03-4221-88CC-34EB805EF5DB|1|||||MSIS-29 V1|||10^6 DNA COPIES/ML|||/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|1||38||FOLLOW-UP|1968-12-28||||1969-11-13||1972-03-04|1962-05-18|
TRIAL STUDY 134XCP|QS|D777661E-DF03-4221-88CC-34EB805EF5DB|2|||||FACT-COG V3|||MOL/MG|||C|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|N|2||58||FOLLOW-UP|1960-03-18||||1967-08-20||1969-11-14|1967-06-11|
TRIAL STUDY 134XCP|QS|D777661E-DF03-4221-88CC-34EB805EF5DB|3|||||PGI|||MN|||CI/MG|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|3||39||TREATMENT|1967-10-19||||1961-05-21||1962-03-31|1965-02-04|
TRIAL STUDY 134XCP|QS|D777661E-DF03-4221-88CC-34EB805EF5DB|4|||||BIS-11|||10^5/HPF|||UMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|4||88||WASHOUT|1961-01-01||||1963-04-04||1967-02-18|1969-11-10|
TRIAL STUDY 134XCP|QS|D777661E-DF03-4221-88CC-34EB805EF5DB|5|||||FACIT-DYSPNEA SF|||PACK YEAR|||G/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|5||7||BLINDED TREATMENT|1965-09-20||||1961-08-10||1962-08-23|1961-05-24|
TRIAL STUDY 134XCP|QS|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1|||||IDS-SR|||10^6 CFU/G|||G/ANIMAL/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|Y|1||38||LONG-TERM FOLLOW-UP|1969-09-25||||1971-07-18||1966-09-28|1966-11-21|
TRIAL STUDY 134XCP|QS|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2|||||MDQ-T|||ML/DL|||PACK|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|2||58||SCREENING|1969-05-25||||1973-03-19||1966-12-26|1971-07-25|
TRIAL STUDY 134XCP|QS|67828FC5-94DE-4A68-83DE-F86AA8F86D72|3|||||DLQI|||BU|||UU/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|3||39||OBSERVATION|1961-06-13||||1968-08-13||1962-02-24|1966-08-05|
TRIAL STUDY 134XCP|QS|67828FC5-94DE-4A68-83DE-F86AA8F86D72|4|||||SF10 V1.0 CHILDREN ACUTE|||CMOL|||CI/UL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|Y|4||88||INDUCTION TREATMENT|1972-10-09||||1962-05-07||1963-12-23|1963-08-29|
TRIAL STUDY 134XCP|QS|67828FC5-94DE-4A68-83DE-F86AA8F86D72|5|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||MM3/MM2/YEAR|||MMOL2/L2|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|5||7||OPEN LABEL TREATMENT|1964-05-01||||1969-03-26||1973-07-28|1971-08-30|
TRIAL STUDY 134XCP|QS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||MEQ/ML|||PIPE|NOT DONE||LIKERT SCALE 7-POINT|N|N|N|1||38||FOLLOW-UP|1968-10-10||||1960-04-26||1965-10-05|1968-07-05|
TRIAL STUDY 134XCP|QS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2|||||FACT/GOG-NTX V4|||PLUG|||NMOL/L/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|Y|2||58||WASHOUT|1964-11-30||||1970-05-04||1969-09-28|1962-10-20|
TRIAL STUDY 134XCP|QS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|3|||||YMRS|||NMOL|||DDU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|NA|3||39||WASHOUT|1970-10-16||||1965-10-09||1968-12-14|1966-01-20|
TRIAL STUDY 134XCP|QS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|4|||||MMRC|||SCOOPFUL|||FRAMES/S|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|N|4||88||FOLLOW-UP|1973-04-22||||1961-02-21||1972-02-07|1961-05-25|
TRIAL STUDY 134XCP|QS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|5|||||SWLS|||DROP|||BQ/UG|NOT DONE||LIKERT SCALE 3-POINT|NA|N|Y|5||7||INDUCTION TREATMENT|1961-11-22||||1970-09-04||1972-04-07|1973-08-10|
TRIAL STUDY 134XCP|QS|650E5DFA-08CC-413C-B43D-070E61353E6E|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||S^-1(%O2)^-1|||ANTI-XA IU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|1||38||CONTINUATION TREATMENT|1972-06-24||||1969-10-10||1962-01-06|1961-04-23|
TRIAL STUDY 134XCP|QS|650E5DFA-08CC-413C-B43D-070E61353E6E|2|||||OAB-Q SHORT FORM|||MIN/DAY|||10^4/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|U|2||58||LONG-TERM FOLLOW-UP|1969-07-03||||1966-01-10||1972-06-09|1960-11-16|
TRIAL STUDY 134XCP|QS|650E5DFA-08CC-413C-B43D-070E61353E6E|3|||||WHODAS 2.0 - 12-ITEM SELF|||CGY|||OHM|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|3||39||OPEN LABEL TREATMENT|1972-11-28||||1970-05-28||1970-09-21|1969-12-30|
TRIAL STUDY 134XCP|QS|650E5DFA-08CC-413C-B43D-070E61353E6E|4|||||SOWS SHORT|||10^6 CFU/G|||STEPS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|4||88||TREATMENT|1961-08-25||||1967-02-12||1963-04-30|1972-01-04|
TRIAL STUDY 134XCP|QS|650E5DFA-08CC-413C-B43D-070E61353E6E|5|||||NCCN-FACT FPSI-17 V2|||BEAM BREAKS|||NMOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|5||7||INDUCTION TREATMENT|1960-07-26||||1961-04-15||1973-01-31|1963-12-25|
TRIAL STUDY 134XCP|QS|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1|||||MDS-UPDRS|||MV2/HZ|||AMU|NOT DONE||LIKERT SCALE 3-POINT|N|N|Y|1||38||FOLLOW-UP|1968-03-26||||1972-08-08||1966-05-15|1965-09-16|
TRIAL STUDY 134XCP|QS|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2|||||SOWS SHORT|||10^5/HPF|||U/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|NA|2||58||LONG-TERM FOLLOW-UP|1965-01-15||||1971-12-07||1968-09-10|1961-05-14|
TRIAL STUDY 134XCP|QS|71716F05-3ABE-4A2A-B9DD-2201A63087ED|3|||||OCI|||%(W/V)|||M/SEC2|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|U|3||39||BASELINE|1969-03-21||||1972-09-28||1971-10-23|1964-06-23|
TRIAL STUDY 134XCP|QS|71716F05-3ABE-4A2A-B9DD-2201A63087ED|4|||||FACT-HEP V4|||MG/G/MIN|||%(V/V)|NOT DONE||LIKERT SCALE 7-POINT|U|NA|N|4||88||LONG-TERM FOLLOW-UP|1973-03-31||||1969-05-03||1968-05-07|1968-02-09|
TRIAL STUDY 134XCP|QS|71716F05-3ABE-4A2A-B9DD-2201A63087ED|5|||||ADSD V1.0|||JOULE|||MM3/MM2/YEAR|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|5||7||SCREENING|1960-05-01||||1964-04-01||1972-01-14|1973-08-19|
TRIAL STUDY 134XCP|QS|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1|||||SOAPP-R|||DEG/S|||MOL/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|Y|1||38||BLINDED TREATMENT|1963-05-21||||1969-06-30||1962-02-24|1961-12-12|
TRIAL STUDY 134XCP|QS|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2|||||BPI SHORT FORM|||ML/MIN|||MG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|2||58||OBSERVATION|1964-06-30||||1965-03-19||1964-05-02|1966-05-21|
TRIAL STUDY 134XCP|QS|EF9208B0-4DF0-4029-AB67-8F87662D3E90|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||L/H|||GY/H|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|3||39||BASELINE|1961-02-07||||1967-03-19||1961-02-19|1970-11-17|
TRIAL STUDY 134XCP|QS|EF9208B0-4DF0-4029-AB67-8F87662D3E90|4|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||FT3|||10^6 U|NOT DONE||LIKERT SCALE 5-POINT|N|N|Y|4||88||LONG-TERM FOLLOW-UP|1969-02-22||||1966-01-16||1968-04-14|1970-10-17|
TRIAL STUDY 134XCP|QS|EF9208B0-4DF0-4029-AB67-8F87662D3E90|5|||||AUDIT-C|||NEEDLE GAUGE|||LOG10 CFU/ML|NOT DONE||LIKERT SCALE 3-POINT|N|N|Y|5||7||BLINDED TREATMENT|1960-12-21||||1961-10-22||1972-01-15|1964-06-18|
TRIAL STUDY 134XCP|QS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1|||||CCQ 24 HOUR VERSION|||NMOL BCE/NMOL|||MV/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|Y|1||38||CONTINUATION TREATMENT|1963-09-18||||1960-07-19||1966-11-12|1963-10-03|
TRIAL STUDY 134XCP|QS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||ML/CM|||LOZENGE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|2||58||WASHOUT|1963-02-18||||1964-12-14||1966-10-02|1968-01-05|
TRIAL STUDY 134XCP|QS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|3|||||C-SSRS BASELINE|||ML/MIN|||KA_U/DL|NOT DONE||LIKERT SCALE 7-POINT|U|NA|N|3||39||CONTINUATION TREATMENT|1962-08-27||||1971-03-09||1968-10-04|1971-03-18|
TRIAL STUDY 134XCP|QS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|4|||||FACIT-F V4|||KHZ|||G/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|4||88||FOLLOW-UP|1962-03-17||||1967-06-30||1966-10-28|1960-12-05|
TRIAL STUDY 134XCP|QS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|5|||||COMM|||HOUNSFIELD UNIT|||MMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|NA|5||7||OBSERVATION|1963-09-12||||1968-07-08||1962-04-16|1971-05-18|
TRIAL STUDY 134XCP|QS|25580765-CB09-4BE3-8DED-C0068C69E9C4|1|||||MMRC|||PMOL/L|||/WK|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|1||38||WASHOUT|1962-08-12||||1964-11-26||1971-10-29|1967-05-19|
TRIAL STUDY 134XCP|QS|25580765-CB09-4BE3-8DED-C0068C69E9C4|2|||||EPDS|||GPL U|||SCOOPFUL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|N|2||58||SCREENING|1970-03-23||||1966-07-05||1964-06-13|1972-08-21|
TRIAL STUDY 134XCP|QS|25580765-CB09-4BE3-8DED-C0068C69E9C4|3|||||PARTNER-DDS|||ML/CM|||M/SEC2|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|3||39||INDUCTION TREATMENT|1971-11-17||||1971-04-03||1963-10-15|1965-12-03|
TRIAL STUDY 134XCP|QS|25580765-CB09-4BE3-8DED-C0068C69E9C4|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||NM|||PACKET|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|4||88||CONTINUATION TREATMENT|1962-08-27||||1969-04-16||1967-11-10|1965-06-26|
TRIAL STUDY 134XCP|QS|25580765-CB09-4BE3-8DED-C0068C69E9C4|5|||||OAB-Q SHORT FORM|||GBQ/UG|||KCAL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|NA|5||7||FOLLOW-UP|1966-03-05||||1971-07-17||1962-01-02|1964-10-19|
TRIAL STUDY 134XCP|QS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||CG|||CI/G|NOT DONE||LIKERT SCALE 7-POINT|U|U|N|1||38||INDUCTION TREATMENT|1966-10-13||||1971-10-28||1971-10-24|1966-12-04|
TRIAL STUDY 134XCP|QS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2|||||FACT/GOG-NTX V4|||G/M2/DAY|||TROCHE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|2||58||TREATMENT|1961-08-24||||1962-03-05||1965-09-21|1966-06-05|
TRIAL STUDY 134XCP|QS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|3|||||SGRQ PAST 4 WEEKS VERSION|||10^9/DOSE|||U/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|3||39||SCREENING|1962-06-18||||1965-03-17||1973-08-18|1970-02-14|
TRIAL STUDY 134XCP|QS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|4|||||PARENT-DDS|||MKAT|||10^6 ORGANISMS/MG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|4||88||WASHOUT|1962-05-25||||1968-04-04||1971-07-28|1963-12-11|
TRIAL STUDY 134XCP|QS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|5|||||HAQ-DI WITH VAS|||10^4 CFU|||MGEQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|NA|5||7||OPEN LABEL TREATMENT|1970-02-24||||1972-07-24||1962-04-10|1966-07-18|
TRIAL STUDY 134XCP|QS|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1|||||ADCS-ADL MCI|||UG/H|||PG/CELL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|1||38||FOLLOW-UP|1971-06-14||||1968-05-05||1968-10-12|1964-05-30|
TRIAL STUDY 134XCP|QS|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2|||||AQLQ|||ML|||MPL U/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|U|2||58||OBSERVATION|1971-09-18||||1972-03-16||1973-02-09|1963-11-07|
TRIAL STUDY 134XCP|QS|A902F087-3BF4-4387-80F9-DDCDDCE1813E|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||EVENTS|||CS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|3||39||OBSERVATION|1963-09-15||||1968-09-26||1969-09-18|1973-06-15|
TRIAL STUDY 134XCP|QS|A902F087-3BF4-4387-80F9-DDCDDCE1813E|4|||||SF12 V1.0 ACUTE|||KG/CM|||WAFER|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|N|4||88||FOLLOW-UP|1964-11-24||||1963-03-19||1964-11-14|1969-07-27|
TRIAL STUDY 134XCP|QS|A902F087-3BF4-4387-80F9-DDCDDCE1813E|5|||||OCI|||UG/MOL|||FL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|5||7||LONG-TERM FOLLOW-UP|1966-12-17||||1968-12-07||1963-03-13|1962-03-27|
TRIAL STUDY 134XCP|QS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1|||||BARS|||MCI/L|||UKAT/10^12 RBC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|N|1||38||INDUCTION TREATMENT|1973-05-21||||1960-07-30||1972-04-18|1966-05-17|
TRIAL STUDY 134XCP|QS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2|||||VFQ-25 SELF ADMINISTERED|||MS2|||CMH2O*S2/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|2||58||OPEN LABEL TREATMENT|1960-03-11||||1970-11-02||1970-08-06|1968-03-10|
TRIAL STUDY 134XCP|QS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|3|||||Q-LES-Q-SF|||EJACULATE U|||10^9 CFU/ML|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|3||39||OPEN LABEL TREATMENT|1971-05-16||||1968-09-14||1964-05-04|1970-02-24|
TRIAL STUDY 134XCP|QS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|4|||||ACT|||10^7 PFU|||F|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|NA|4||88||OBSERVATION|1970-03-21||||1965-03-28||1972-12-18|1970-09-26|
TRIAL STUDY 134XCP|QS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|5|||||MMRC|||DPM/100MG|||CS|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|5||7||BASELINE|1968-09-17||||1965-07-31||1968-03-29|1966-04-25|
TRIAL STUDY 134XCP|QS|415F9206-A793-437C-B227-BD245DBF40AB|1|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||MEQ|||MG/ML/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|Y|1||38||LONG-TERM FOLLOW-UP|1967-09-03||||1969-08-20||1969-04-05|1972-05-24|
TRIAL STUDY 134XCP|QS|415F9206-A793-437C-B227-BD245DBF40AB|2|||||MNSI|||BQ|||PSEC|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|2||58||SCREENING|1962-06-07||||1968-08-22||1966-12-29|1966-08-27|
TRIAL STUDY 134XCP|QS|415F9206-A793-437C-B227-BD245DBF40AB|3|||||FACT-C V4|||USEC|||ML/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|U|3||39||FOLLOW-UP|1960-10-02||||1969-07-25||1973-03-16|1960-05-30|
TRIAL STUDY 134XCP|QS|415F9206-A793-437C-B227-BD245DBF40AB|4|||||CGI|||M3|||GBQ/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|4||88||TREATMENT|1960-01-04||||1964-11-21||1966-07-19|1962-09-08|
TRIAL STUDY 134XCP|QS|415F9206-A793-437C-B227-BD245DBF40AB|5|||||WOMAC VA 3.1 INDEX|||G/ANIMAL|||UL/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|5||7||RUN-IN|1961-11-12||||1971-10-24||1960-04-26|1960-03-10|
TRIAL STUDY 134XCP|QS|C580BA02-D031-4875-AC02-347AA65C4C6C|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||UCI/L|||MEQ/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|1||38||BLINDED TREATMENT|1960-01-01||||1961-09-18||1968-01-06|1965-02-09|
TRIAL STUDY 134XCP|QS|C580BA02-D031-4875-AC02-347AA65C4C6C|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||10^3 ORGANISMS/G|||/CMH2O|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|2||58||LONG-TERM FOLLOW-UP|1962-02-09||||1965-05-08||1970-02-02|1964-02-12|
TRIAL STUDY 134XCP|QS|C580BA02-D031-4875-AC02-347AA65C4C6C|3|||||FAQ-NACC VERSION|||S/H|||GY|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|3||39||LONG-TERM FOLLOW-UP|1966-09-10||||1969-06-16||1964-06-01|1962-10-25|
TRIAL STUDY 134XCP|QS|C580BA02-D031-4875-AC02-347AA65C4C6C|4|||||RPQ|||UMOL|||ML/MMHG|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|4||88||RUN-IN|1960-09-30||||1965-05-24||1971-11-12|1968-11-17|
TRIAL STUDY 134XCP|QS|C580BA02-D031-4875-AC02-347AA65C4C6C|5|||||MSWS-12|||DPM/100MG|||MMU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|5||7||CONTINUATION TREATMENT|1968-02-26||||1961-08-21||1963-07-23|1970-06-07|
TRIAL STUDY 134XCP|QS|4DD6944D-662E-4C9A-A663-601B657BCF5E|1|||||TSCC|||BQ/MG|||PACKAGE|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|U|1||38||BLINDED TREATMENT|1968-07-14||||1960-11-23||1967-04-13|1965-04-03|
TRIAL STUDY 134XCP|QS|4DD6944D-662E-4C9A-A663-601B657BCF5E|2|||||OCI|||MMOL/DAY|||MN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|N|2||58||OBSERVATION|1964-04-04||||1963-11-10||1960-02-20|1970-08-13|
TRIAL STUDY 134XCP|QS|4DD6944D-662E-4C9A-A663-601B657BCF5E|3|||||NCCN-FACT FHNSI-22 V2|||IU/DAY|||KIU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|Y|3||39||RUN-IN|1961-01-14||||1965-03-06||1967-02-10|1961-10-29|
TRIAL STUDY 134XCP|QS|4DD6944D-662E-4C9A-A663-601B657BCF5E|4|||||NCCN-FACT FBRSI-24 V2|||MOSM/L|||CI/UL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|U|4||88||CONTINUATION TREATMENT|1960-09-21||||1972-06-23||1960-01-11|1964-02-16|
TRIAL STUDY 134XCP|QS|4DD6944D-662E-4C9A-A663-601B657BCF5E|5|||||NPI|||KPA|||ML/M2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|5||7||OBSERVATION|1961-11-14||||1965-07-22||1965-03-03|1968-09-26|
TRIAL STUDY 134XCP|QS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1|||||NPI|||BEATS/MIN|||CCID 50/ML|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|1||38||BASELINE|1963-06-06||||1969-12-31||1964-12-21|1968-06-16|
TRIAL STUDY 134XCP|QS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2|||||AUDIT-C|||ABSORBANCE U/MIN|||U/M2/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|2||58||WASHOUT|1965-09-14||||1961-02-09||1962-06-06|1968-10-01|
TRIAL STUDY 134XCP|QS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|3|||||COWS|||10^9 CFU|||TRACE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|Y|3||39||OBSERVATION|1971-05-02||||1972-11-10||1961-04-14|1962-03-06|
TRIAL STUDY 134XCP|QS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|4|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||MG/ANIMAL|||PA|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|U|4||88||OBSERVATION|1966-12-15||||1965-02-11||1960-02-03|1965-01-16|
TRIAL STUDY 134XCP|QS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|5|||||PR|||ML/M2/MIN|||ML/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|U|5||7||SCREENING|1961-11-23||||1964-09-28||1969-10-16|1961-08-10|
TRIAL STUDY 134XCP|QS|69A130F1-44A1-4091-BF0C-FF8087CC9940|1|||||RDQ|||IU/MG|||ML/KG/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1968-09-11||||1963-03-02||1964-01-17|1962-10-17|
TRIAL STUDY 134XCP|QS|69A130F1-44A1-4091-BF0C-FF8087CC9940|2|||||VFQ-25 INTERVIEWER ADMINISTERED|||10^9 ORGANISMS/MG|||PMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|NA|2||58||INDUCTION TREATMENT|1963-07-29||||1963-11-26||1961-12-25|1970-06-10|
TRIAL STUDY 134XCP|QS|69A130F1-44A1-4091-BF0C-FF8087CC9940|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||AMFI|||PT_BR|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|3||39||INDUCTION TREATMENT|1961-05-08||||1960-04-08||1963-05-13|1971-10-05|
TRIAL STUDY 134XCP|QS|69A130F1-44A1-4091-BF0C-FF8087CC9940|4|||||FACT-BMT V4|||10^7 CFU/ML|||CI/L|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|4||88||RUN-IN|1972-08-19||||1960-11-02||1964-02-07|1971-07-20|
TRIAL STUDY 134XCP|QS|69A130F1-44A1-4091-BF0C-FF8087CC9940|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||DB|||DAGU|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|5||7||RUN-IN|1967-06-21||||1969-09-24||1963-05-18|1963-04-19|
TRIAL STUDY 134XCP|QS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1|||||ESS|||/SEC|||/2500 WBC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|Y|1||38||LONG-TERM FOLLOW-UP|1973-01-01||||1965-12-04||1962-04-24|1973-07-11|
TRIAL STUDY 134XCP|QS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2|||||HADS|||TUBERCULIN UNIT/ML|||LENS|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|2||58||LONG-TERM FOLLOW-UP|1969-09-02||||1966-08-28||1968-07-26|1965-05-24|
TRIAL STUDY 134XCP|QS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|3|||||HADS|||ML/MMHG|||KS|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|Y|3||39||RUN-IN|1962-06-18||||1964-03-26||1963-03-06|1965-04-17|
TRIAL STUDY 134XCP|QS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|4|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||MG/M2/H|||MSEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|U|4||88||LONG-TERM FOLLOW-UP|1972-12-29||||1971-05-31||1962-06-03|1973-01-13|
TRIAL STUDY 134XCP|QS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|5|||||FAMS|||TCID 50/DOSE|||STEPS/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|Y|5||7||RUN-IN|1967-05-14||||1972-08-27||1963-10-03|1969-08-16|
TRIAL STUDY 134XCP|QS|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1|||||PROSQOLI|||KA_U/DL|||FMOL/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|1||38||RUN-IN|1960-07-07||||1971-09-18||1961-09-07|1970-10-28|
TRIAL STUDY 134XCP|QS|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2|||||SWLS|||TORR|||L/H|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|2||58||LONG-TERM FOLLOW-UP|1970-02-17||||1966-10-16||1967-05-26|1961-03-03|
TRIAL STUDY 134XCP|QS|96C60715-2EDE-40FD-B41C-ECD1E5065C81|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||PMOL/DL|||SCOOPFUL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|Y|3||39||OBSERVATION|1960-03-04||||1960-07-14||1965-10-24|1960-01-16|
TRIAL STUDY 134XCP|QS|96C60715-2EDE-40FD-B41C-ECD1E5065C81|4|||||WHODAS 2.0 - 36-ITEM SELF|||UG/L/H|||ML/CAGE/WK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|Y|4||88||WASHOUT|1966-07-14||||1972-04-25||1973-02-04|1968-07-24|
TRIAL STUDY 134XCP|QS|96C60715-2EDE-40FD-B41C-ECD1E5065C81|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||FEU|||MEQ/KG|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|5||7||RUN-IN|1969-09-24||||1966-05-12||1960-10-25|1966-01-04|
TRIAL STUDY 134XCP|QS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1|||||SDS|||CMOL/L|||L/H/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|1||38||OBSERVATION|1972-03-12||||1967-12-06||1965-03-27|1963-01-12|
TRIAL STUDY 134XCP|QS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2|||||MSIS-29 V2|||KG|||UG/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|2||58||INDUCTION TREATMENT|1971-10-01||||1968-08-16||1969-08-19|1971-08-31|
TRIAL STUDY 134XCP|QS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|3|||||MMRC|||MMOL/MIN/KPA|||HZ|NOT DONE||LIKERT SCALE 5-POINT|N|NA|NA|3||39||SCREENING|1960-06-04||||1962-12-19||1961-10-29|1968-09-30|
TRIAL STUDY 134XCP|QS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|4|||||EPIC-CP|||MCI/KG|||UMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|4||88||FOLLOW-UP|1967-10-21||||1972-05-20||1961-07-27|1960-11-01|
TRIAL STUDY 134XCP|QS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||G/DAY|||BEATS/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|NA|5||7||TREATMENT|1964-02-08||||1964-02-17||1970-02-23|1963-10-07|
TRIAL STUDY 134XCP|QS|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1|||||CGI|||DEG|||/2000 RBC|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|N|1||38||CONTINUATION TREATMENT|1961-06-04||||1971-08-03||1968-09-13|1971-03-10|
TRIAL STUDY 134XCP|QS|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2|||||EORTC QLQ-CR29 V2.1|||GBQ/G|||10^9/G|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|2||58||BLINDED TREATMENT|1970-09-18||||1970-11-15||1963-02-07|1972-01-13|
TRIAL STUDY 134XCP|QS|8452DD7A-4DC9-4BDF-B670-AE5B49292805|3|||||FACT-B V4|||KIT|||GY/H|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|3||39||FOLLOW-UP|1969-09-19||||1969-12-30||1960-11-25|1962-06-03|
TRIAL STUDY 134XCP|QS|8452DD7A-4DC9-4BDF-B670-AE5B49292805|4|||||HCS|||CMH2O/ML|||MMOL/S|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1972-12-28||||1969-10-24||1971-03-23|1960-02-20|
TRIAL STUDY 134XCP|QS|8452DD7A-4DC9-4BDF-B670-AE5B49292805|5|||||FACT-BL V4|||10^7 CFU|||BQ/UG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|5||7||BASELINE|1961-12-22||||1970-12-14||1960-04-23|1969-11-26|
TRIAL STUDY 134XCP|QS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1|||||SHORT-FORM MPQ-2|||MET*H|||G/ANIMAL|NOT DONE||LIKERT SCALE 5-POINT|N|U|NA|1||38||RUN-IN|1970-02-01||||1961-05-20||1963-06-30|1967-09-13|
TRIAL STUDY 134XCP|QS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2|||||GMSS VERSION TYPE 1 DIABETES|||CMOL/L|||UL|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|2||58||LONG-TERM FOLLOW-UP|1971-03-07||||1966-11-17||1965-10-21|1967-05-27|
TRIAL STUDY 134XCP|QS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|3|||||EORTC QLQ-C15-PAL V1.0|||PMOL/DL|||UMOL/MOL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|3||39||TREATMENT|1960-10-11||||1972-08-24||1962-08-21|1969-01-09|
TRIAL STUDY 134XCP|QS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|4|||||EQ-5D-3L|||UMOL/MIN|||GBQ/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|4||88||RUN-IN|1966-03-13||||1970-05-03||1973-08-28|1960-10-15|
TRIAL STUDY 134XCP|QS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|5|||||DLQI|||UMOL/H/MMOL|||10^6 COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|N|5||7||TREATMENT|1966-11-28||||1967-12-13||1970-03-26|1960-11-15|
TRIAL STUDY 134XCP|QS|30108497-140B-499E-8924-8BFCDC57457A|1|||||SOBDA|||SACHET|||MMOL/MOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|1||38||RUN-IN|1967-06-28||||1961-02-08||1972-11-14|1969-12-16|
TRIAL STUDY 134XCP|QS|30108497-140B-499E-8924-8BFCDC57457A|2|||||BWCS|||IU/DL|||S/H|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|2||58||WASHOUT|1961-07-03||||1972-09-16||1967-11-20|1972-11-27|
TRIAL STUDY 134XCP|QS|30108497-140B-499E-8924-8BFCDC57457A|3|||||SF8 V1.0 ACUTE|||10^6/HPF|||10^4/HPF|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|3||39||FOLLOW-UP|1973-03-03||||1969-08-16||1963-11-08|1964-07-11|
TRIAL STUDY 134XCP|QS|30108497-140B-499E-8924-8BFCDC57457A|4|||||IPAQ-LF PHONE VERSION|||MG/H|||H*%|NOT DONE||LIKERT SCALE 5-POINT|Y|N|NA|4||88||BLINDED TREATMENT|1961-07-12||||1966-02-09||1966-01-18|1961-04-20|
TRIAL STUDY 134XCP|QS|30108497-140B-499E-8924-8BFCDC57457A|5|||||SDS|||G/ANIMAL/DAY|||/10^4|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|U|5||7||TREATMENT|1971-01-09||||1968-09-04||1970-07-16|1964-03-30|
TRIAL STUDY 134XCP|QS|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||UMOL/DL|||U/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|1||38||OPEN LABEL TREATMENT|1969-05-20||||1964-12-10||1972-02-25|1964-07-02|
TRIAL STUDY 134XCP|QS|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||IU/DL|||BE/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|2||58||SCREENING|1973-06-13||||1970-10-03||1965-05-02|1967-11-10|
TRIAL STUDY 134XCP|QS|5FFEF358-5014-497F-A091-6EF27A1BCF7D|3|||||MNSI|||LOZENGE|||BU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|3||39||RUN-IN|1969-09-24||||1961-07-30||1970-05-17|1971-06-05|
TRIAL STUDY 134XCP|QS|5FFEF358-5014-497F-A091-6EF27A1BCF7D|4|||||PODCI - ADOLESCENT SELF REPORTED|||ML/M2|||UL/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|NA|4||88||RUN-IN|1960-08-08||||1972-08-08||1962-10-26|1972-11-02|
TRIAL STUDY 134XCP|QS|5FFEF358-5014-497F-A091-6EF27A1BCF7D|5|||||EXACT|||U/KG|||HENRY|NOT DONE||LIKERT SCALE 5-POINT|U|NA|N|5||7||WASHOUT|1968-02-03||||1965-08-12||1972-09-17|1969-01-18|
TRIAL STUDY 134XCP|QS|9DFBE459-22E4-4BA7-A993-AC06D6644562|1|||||GMSS VERSION TYPE 1 DIABETES|||CCID 50/ML|||PMOL/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|N|1||38||WASHOUT|1971-03-14||||1961-12-13||1972-03-08|1971-06-07|
TRIAL STUDY 134XCP|QS|9DFBE459-22E4-4BA7-A993-AC06D6644562|2|||||Q-LES-Q-SF|||MPA|||L/DAY|NOT DONE||LIKERT SCALE 5-POINT|N|U|N|2||58||INDUCTION TREATMENT|1970-01-30||||1969-07-09||1966-10-30|1965-02-02|
TRIAL STUDY 134XCP|QS|9DFBE459-22E4-4BA7-A993-AC06D6644562|3|||||PARENT-DDS|||U/KG|||UV2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|3||39||LONG-TERM FOLLOW-UP|1972-07-03||||1965-05-10||1966-04-17|1971-05-21|
TRIAL STUDY 134XCP|QS|9DFBE459-22E4-4BA7-A993-AC06D6644562|4|||||ADCS-ADL|||GY/H|||HZ|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|4||88||BLINDED TREATMENT|1963-11-03||||1961-01-06||1966-09-23|1962-09-14|
TRIAL STUDY 134XCP|QS|9DFBE459-22E4-4BA7-A993-AC06D6644562|5|||||WOMAC LK 3.1 INDEX|||DEG|||MM/2H|NOT DONE||LIKERT SCALE 5-POINT|N|NA|N|5||7||TREATMENT|1969-01-16||||1967-03-15||1970-04-03|1970-11-21|
TRIAL STUDY 134XCP|QS|850B35FA-69C7-44AD-A471-964C59C4CFD8|1|||||SIQR|||U|||ANTIBODY UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|1||38||RUN-IN|1966-11-20||||1973-04-21||1962-11-29|1968-09-15|
TRIAL STUDY 134XCP|QS|850B35FA-69C7-44AD-A471-964C59C4CFD8|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||LENS|||ML/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|N|2||58||BASELINE|1972-07-25||||1972-10-23||1964-07-23|1971-05-21|
TRIAL STUDY 134XCP|QS|850B35FA-69C7-44AD-A471-964C59C4CFD8|3|||||ADSD V1.0|||SPRAY|||10^6/HPF|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|NA|3||39||CONTINUATION TREATMENT|1964-06-13||||1962-07-31||1960-07-12|1970-05-05|
TRIAL STUDY 134XCP|QS|850B35FA-69C7-44AD-A471-964C59C4CFD8|4|||||FACIT-FATIGUE 13-ITEM V4|||DAGU/ML|||BQ/UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|N|4||88||RUN-IN|1963-08-26||||1969-04-08||1973-04-17|1964-07-31|
TRIAL STUDY 134XCP|QS|850B35FA-69C7-44AD-A471-964C59C4CFD8|5|||||COWS|||DPM/MG|||VIAL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|N|5||7||FOLLOW-UP|1966-08-06||||1970-11-22||1961-01-01|1973-05-05|
TRIAL STUDY 134XCP|QS|981B890E-1257-4F04-A974-6006401F78CC|1|||||ADSD V1.0|||G/DAY|||U/G/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|Y|1||38||BASELINE|1968-02-14||||1965-08-14||1965-06-01|1965-06-10|
TRIAL STUDY 134XCP|QS|981B890E-1257-4F04-A974-6006401F78CC|2|||||EXACT|||BU|||G/CAGE/WK|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|Y|2||58||FOLLOW-UP|1969-07-06||||1962-09-06||1965-12-27|1961-05-31|
TRIAL STUDY 134XCP|QS|981B890E-1257-4F04-A974-6006401F78CC|3|||||MDQ-T|||/DAY|||DIP|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|3||39||OBSERVATION|1961-06-16||||1972-06-26||1965-06-02|1962-11-15|
TRIAL STUDY 134XCP|QS|981B890E-1257-4F04-A974-6006401F78CC|4|||||SMDDS V1.0|||IU/MG|||KBQ/UL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|4||88||OBSERVATION|1962-06-30||||1966-04-28||1971-05-09|1960-10-24|
TRIAL STUDY 134XCP|QS|981B890E-1257-4F04-A974-6006401F78CC|5|||||NSCLC-SAQ V1.0|||IU/MG|||10^6 ORGANISMS/G|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|NA|5||7||RUN-IN|1962-11-13||||1969-02-14||1972-12-24|1971-03-15|
TRIAL STUDY 134XCP|QS|52FF8D96-64AD-498D-8B28-3DDD015796E3|1|||||LEC-5 STANDARD VERSION|||MMHG|||FINGERTIP UNIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|Y|1||38||SCREENING|1969-04-12||||1971-08-22||1972-11-21|1970-01-24|
TRIAL STUDY 134XCP|QS|52FF8D96-64AD-498D-8B28-3DDD015796E3|2|||||DRRI-2|||GBQ/UG|||10^9/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|2||58||OBSERVATION|1960-06-22||||1972-02-28||1961-02-03|1964-02-13|
TRIAL STUDY 134XCP|QS|52FF8D96-64AD-498D-8B28-3DDD015796E3|3|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||SYRINGE|||DPM/MG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|3||39||RUN-IN|1961-08-31||||1961-02-14||1966-01-16|1972-02-11|
TRIAL STUDY 134XCP|QS|52FF8D96-64AD-498D-8B28-3DDD015796E3|4|||||FAMS|||GBQ/UG|||NSEC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|4||88||RUN-IN|1971-12-30||||1967-06-01||1969-06-27|1972-10-14|
TRIAL STUDY 134XCP|QS|52FF8D96-64AD-498D-8B28-3DDD015796E3|5|||||AQ20|||10^3 RNA COPIES/ML|||LOG10 IU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|NA|5||7||BLINDED TREATMENT|1969-05-29||||1967-09-11||1962-11-06|1965-12-03|
TRIAL STUDY 134XCP|QS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||LOG10 TCID 50/DOSE|||10^6/EJACULATE U|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|N|1||38||BLINDED TREATMENT|1971-09-15||||1964-01-25||1962-04-07|1970-05-22|
TRIAL STUDY 134XCP|QS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||CYCLE/MIN|||MG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|N|2||58||WASHOUT|1968-10-31||||1964-06-12||1971-10-14|1966-09-15|
TRIAL STUDY 134XCP|QS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|3|||||IVIS|||APL U|||M3|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|N|3||39||RUN-IN|1962-12-18||||1964-03-15||1969-01-19|1962-10-09|
TRIAL STUDY 134XCP|QS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|4|||||ACT|||MV/SEC|||ML/CAGE/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|NA|4||88||OBSERVATION|1970-07-11||||1965-03-31||1962-01-10|1960-02-04|
TRIAL STUDY 134XCP|QS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||FMOL|||10^3 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|5||7||OPEN LABEL TREATMENT|1961-05-08||||1967-02-13||1964-09-03|1963-07-11|
TRIAL STUDY 134XCP|QS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1|||||CHART-SF PAPER VERSION|||U/L|||DYN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|U|1||38||OPEN LABEL TREATMENT|1972-12-07||||1965-04-05||1965-12-26|1970-11-08|
TRIAL STUDY 134XCP|QS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2|||||RPQ|||CPM|||PIPE|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|2||58||RUN-IN|1970-12-28||||1972-08-04||1969-06-12|1967-03-14|
TRIAL STUDY 134XCP|QS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|3|||||HCS|||L/S/KPA|||APPLICATION|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|N|3||39||FOLLOW-UP|1963-07-03||||1966-04-09||1965-11-16|1960-04-14|
TRIAL STUDY 134XCP|QS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||NSEC|||IU/KG/H|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|4||88||SCREENING|1971-06-12||||1965-12-05||1970-01-13|1968-06-25|
TRIAL STUDY 134XCP|QS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|5|||||IDS-SR|||DIP|||ML/M2/H|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|5||7||BASELINE|1971-11-18||||1963-05-24||1965-12-18|1964-12-08|
TRIAL STUDY 134XCP|QS|CD65CBB8-D056-4738-93A8-FF465534961B|1|||||SF12 V1.0 ACUTE|||VOXEL|||CCID 50/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|U|1||38||OPEN LABEL TREATMENT|1963-10-27||||1964-01-04||1973-01-27|1965-11-06|
TRIAL STUDY 134XCP|QS|CD65CBB8-D056-4738-93A8-FF465534961B|2|||||HAEM-A-QOL|||MDFI|||10^6 COPIES/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|Y|2||58||CONTINUATION TREATMENT|1969-09-15||||1964-08-24||1965-07-21|1967-01-31|
TRIAL STUDY 134XCP|QS|CD65CBB8-D056-4738-93A8-FF465534961B|3|||||SF10 V1.0 CHILDREN STANDARD|||COPIES/ML|||%(W/W)|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|3||39||TREATMENT|1960-02-10||||1969-08-08||1966-01-10|1962-04-03|
TRIAL STUDY 134XCP|QS|CD65CBB8-D056-4738-93A8-FF465534961B|4|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||ABSORBANCE U/ML|||UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|N|4||88||RUN-IN|1961-04-20||||1966-07-20||1965-01-22|1966-04-19|
TRIAL STUDY 134XCP|QS|CD65CBB8-D056-4738-93A8-FF465534961B|5|||||PODCI - PEDIATRIC PARENT REPORTED|||CYCLE/MIN|||FG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|5||7||CONTINUATION TREATMENT|1960-08-27||||1973-07-10||1969-11-01|1971-03-17|
TRIAL STUDY 134XCP|QS|7F014394-ABE2-45F8-891F-2DE808762532|1|||||NPS|||FT3|||OHM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|Y|1||38||OBSERVATION|1964-12-13||||1968-01-19||1972-03-29|1972-05-01|
TRIAL STUDY 134XCP|QS|7F014394-ABE2-45F8-891F-2DE808762532|2|||||WHODAS 2.0 - 36-ITEM PROXY|||CCID 50/ML|||BQ/MG|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|2||58||WASHOUT|1964-10-17||||1963-09-23||1960-07-21|1960-07-30|
TRIAL STUDY 134XCP|QS|7F014394-ABE2-45F8-891F-2DE808762532|3|||||SGRQ-C|||UCI/KG|||MILE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|NA|3||39||BLINDED TREATMENT|1971-02-15||||1973-04-13||1960-05-28|1965-11-14|
TRIAL STUDY 134XCP|QS|7F014394-ABE2-45F8-891F-2DE808762532|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||GTT|||PELLET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|Y|4||88||FOLLOW-UP|1965-07-05||||1962-07-01||1971-02-06|1972-04-25|
TRIAL STUDY 134XCP|QS|7F014394-ABE2-45F8-891F-2DE808762532|5|||||FKSI-15|||MG/L FEU|||S^-1(%O2)^-1|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|5||7||BASELINE|1964-02-15||||1964-07-04||1968-10-07|1967-10-03|
TRIAL STUDY 134XCP|QS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1|||||EXPANDED DRS-PI CAREGIVER VERSION|||/2500 WBC|||TESLA|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|1||38||RUN-IN|1962-05-20||||1965-11-24||1973-02-25|1973-04-05|
TRIAL STUDY 134XCP|QS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2|||||WHODAS 2.0 - 12-ITEM PROXY|||BLOCKS|||10^8 PFU|NOT DONE||LIKERT SCALE 7-POINT|NA|N|Y|2||58||TREATMENT|1960-01-13||||1962-01-08||1967-06-23|1969-10-01|
TRIAL STUDY 134XCP|QS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||CI/ML|||BU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|3||39||FOLLOW-UP|1971-03-10||||1969-02-23||1971-02-28|1971-08-07|
TRIAL STUDY 134XCP|QS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|4|||||FBRSI|||CD/M2|||M|NOT DONE||LIKERT SCALE 3-POINT|N|N|U|4||88||BLINDED TREATMENT|1965-12-13||||1967-04-28||1967-07-07|1961-08-22|
TRIAL STUDY 134XCP|QS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|5|||||LEC-5 STANDARD VERSION|||MEQ/MMOL|||MPL U/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|U|NA|5||7||LONG-TERM FOLLOW-UP|1973-02-12||||1963-11-08||1964-12-14|1971-01-04|
TRIAL STUDY 134XCP|QS|FB781158-BB8A-4A75-BD55-00D6A5C72720|1|||||EQ-5D-3L|||ML/M2/DAY|||RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|U|1||38||SCREENING|1961-05-19||||1968-04-02||1960-02-22|1967-04-01|
TRIAL STUDY 134XCP|QS|FB781158-BB8A-4A75-BD55-00D6A5C72720|2|||||ADHD-RS-IV HOME VERSION|||BOWL|||ML/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|2||58||RUN-IN|1973-04-04||||1969-07-30||1962-09-10|1965-12-08|
TRIAL STUDY 134XCP|QS|FB781158-BB8A-4A75-BD55-00D6A5C72720|3|||||NCCN-FACT FKSI-19 V2|||BQ/UG|||LOZENGE|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|NA|3||39||BASELINE|1971-09-25||||1972-07-01||1970-01-24|1967-07-16|
TRIAL STUDY 134XCP|QS|FB781158-BB8A-4A75-BD55-00D6A5C72720|4|||||NCCN-FACT FBRSI-24 V2|||EQ|||PT_BR|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|4||88||CONTINUATION TREATMENT|1969-05-01||||1963-08-25||1972-03-27|1967-01-11|
TRIAL STUDY 134XCP|QS|FB781158-BB8A-4A75-BD55-00D6A5C72720|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||G/G/DAY|||UG/L DDU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|N|5||7||WASHOUT|1972-10-04||||1966-12-03||1965-06-26|1963-02-14|
TRIAL STUDY 134XCP|QS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1|||||EQ-5D-3L|||CCID 50/DOSE|||PT_US|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|1||38||BLINDED TREATMENT|1967-04-14||||1972-08-03||1972-04-18|1967-03-21|
TRIAL STUDY 134XCP|QS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2|||||SDS|||MG/ANIMAL|||G/ANIMAL/WK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|NA|2||58||SCREENING|1969-08-05||||1973-04-30||1964-07-25|1967-04-21|
TRIAL STUDY 134XCP|QS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|3|||||FACIT-DYSPNEA 33 ITEM BANK|||MET|||CIGARETTE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|N|3||39||OPEN LABEL TREATMENT|1972-11-01||||1960-02-06||1973-07-17|1971-05-29|
TRIAL STUDY 134XCP|QS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|4|||||WOMAC VA 3.1 INDEX|||DPM/100MG|||ML/SEC/1.73M2|NOT DONE||LIKERT SCALE 3-POINT|NA|N|U|4||88||BLINDED TREATMENT|1969-03-25||||1970-05-13||1973-06-26|1973-01-29|
TRIAL STUDY 134XCP|QS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|5|||||MNSI|||%/S|||NG/MOL|NOT DONE||LIKERT SCALE 3-POINT|Y|N|U|5||7||LONG-TERM FOLLOW-UP|1968-09-05||||1967-09-04||1965-10-27|1968-02-21|
TRIAL STUDY 134XCP|QS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1|||||ASEX-MALE|||FMOL/G|||/7.5 ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|N|1||38||WASHOUT|1965-09-29||||1973-08-04||1972-07-23|1968-08-25|
TRIAL STUDY 134XCP|QS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2|||||PHQ SCREENER VERSION|||G/ANIMAL|||NFIU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|2||58||OBSERVATION|1964-04-22||||1969-05-13||1968-04-09|1972-10-01|
TRIAL STUDY 134XCP|QS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|3|||||ADSD V1.0|||FMOL/G|||AU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|3||39||TREATMENT|1961-06-29||||1973-04-29||1973-08-20|1969-06-03|
TRIAL STUDY 134XCP|QS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|4|||||WOMAC VA 3.1 INDEX|||IU/MMOL|||10^6 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|4||88||WASHOUT|1967-04-12||||1962-12-19||1969-02-25|1970-03-08|
TRIAL STUDY 134XCP|QS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|5|||||ADCS-ADL|||PA|||DEG/MM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|N|5||7||INDUCTION TREATMENT|1960-02-22||||1971-07-06||1960-12-04|1972-09-29|
TRIAL STUDY 134XCP|QS|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1|||||MADRS|||MMOL/S|||MG/KG/H|NOT DONE||LIKERT SCALE 7-POINT|U|U|Y|1||38||CONTINUATION TREATMENT|1968-11-16||||1966-04-16||1960-04-06|1965-04-20|
TRIAL STUDY 134XCP|QS|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2|||||OAB-Q SHORT FORM|||G/G|||10^6 DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|2||58||OPEN LABEL TREATMENT|1972-12-24||||1965-06-29||1965-06-22|1968-05-03|
TRIAL STUDY 134XCP|QS|505A1BB6-135A-4839-BB9E-6DD37F49DC45|3|||||EPDS|||MILE|||MIU/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|U|3||39||RUN-IN|1971-01-06||||1963-08-23||1971-03-19|1972-12-14|
TRIAL STUDY 134XCP|QS|505A1BB6-135A-4839-BB9E-6DD37F49DC45|4|||||EQ-5D-3L|||ABSORBANCE U|||PMOL/10^9 CELLS|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|NA|4||88||RUN-IN|1964-06-12||||1971-10-21||1965-07-09|1960-03-13|
TRIAL STUDY 134XCP|QS|505A1BB6-135A-4839-BB9E-6DD37F49DC45|5|||||NCCN-FACT FBLSI-18 V2|||UKAT/10^12 RBC|||MET|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|5||7||INDUCTION TREATMENT|1962-08-16||||1966-12-25||1970-01-18|1964-09-28|
TRIAL STUDY 134XCP|QS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I|||DAYS|||MV|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|1||38||CONTINUATION TREATMENT|1968-03-17||||1973-04-28||1970-09-19|1962-01-31|
TRIAL STUDY 134XCP|QS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2|||||PI|||CI/UL|||ANTI-XA IU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|2||58||FOLLOW-UP|1973-05-23||||1969-01-22||1972-06-03|1966-11-06|
TRIAL STUDY 134XCP|QS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|3|||||VFQ-25 SELF ADMINISTERED|||MET|||PACKET|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|N|3||39||OBSERVATION|1964-12-13||||1972-10-09||1960-02-22|1964-01-11|
TRIAL STUDY 134XCP|QS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|4|||||OCI|||%/MIN|||COULOMB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|4||88||CONTINUATION TREATMENT|1969-07-21||||1967-05-16||1973-06-19|1970-11-08|
TRIAL STUDY 134XCP|QS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|5|||||AUDIT-C|||ML/MMHG|||K|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|U|5||7||OPEN LABEL TREATMENT|1970-10-31||||1971-11-16||1964-09-01|1965-06-20|
TRIAL STUDY 134XCP|QS|16F375DC-DC27-461B-969E-1269DC53F4D9|1|||||BPI|||FG|||SCM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|NA|1||38||WASHOUT|1962-05-23||||1970-12-12||1970-05-17|1968-09-03|
TRIAL STUDY 134XCP|QS|16F375DC-DC27-461B-969E-1269DC53F4D9|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||10^4/HPF|||VG/KG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|N|2||58||BLINDED TREATMENT|1973-02-01||||1973-03-05||1961-11-16|1961-08-11|
TRIAL STUDY 134XCP|QS|16F375DC-DC27-461B-969E-1269DC53F4D9|3|||||FACT-BMT V4|||CP|||HENRY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|Y|3||39||WASHOUT|1970-12-31||||1961-09-27||1961-02-03|1967-08-17|
TRIAL STUDY 134XCP|QS|16F375DC-DC27-461B-969E-1269DC53F4D9|4|||||FAQ-NACC VERSION|||MOL/L|||ELISA UNIT/DOSE|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|4||88||WASHOUT|1964-11-21||||1964-08-18||1962-12-25|1970-12-27|
TRIAL STUDY 134XCP|QS|16F375DC-DC27-461B-969E-1269DC53F4D9|5|||||EORTC QLQ-LC13|||/MM|||FARAD|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|5||7||INDUCTION TREATMENT|1965-08-11||||1962-02-06||1967-06-07|1972-12-17|
TRIAL STUDY 134XCP|QS|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||U/L|||U/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|Y|1||38||SCREENING|1963-12-21||||1969-11-27||1963-12-19|1960-07-26|
TRIAL STUDY 134XCP|QS|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||ML/M2|||MET*H|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|2||58||OPEN LABEL TREATMENT|1960-09-15||||1966-09-07||1960-11-19|1970-01-10|
TRIAL STUDY 134XCP|QS|17BF9A68-265F-4FCC-A499-615A1B71A8D6|3|||||FKSI-DRS V4|||PHERESIS UNIT|||UMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|3||39||TREATMENT|1970-01-31||||1962-01-10||1960-02-18|1971-04-11|
TRIAL STUDY 134XCP|QS|17BF9A68-265F-4FCC-A499-615A1B71A8D6|4|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||PFU|||UG/ML/H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|4||88||LONG-TERM FOLLOW-UP|1966-07-07||||1961-04-03||1964-08-24|1966-12-13|
TRIAL STUDY 134XCP|QS|17BF9A68-265F-4FCC-A499-615A1B71A8D6|5|||||ACQ|||HR/DAY|||SQU/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|U|Y|5||7||CONTINUATION TREATMENT|1970-07-09||||1960-10-20||1966-05-15|1965-09-20|
TRIAL STUDY 134XCP|QS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||LOG10 CCID 50/DOSE|||JOULE|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|1||38||RUN-IN|1965-04-01||||1963-04-15||1972-11-03|1963-12-06|
TRIAL STUDY 134XCP|QS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2|||||EORTC QLQ-CR29 V2.1|||GENEQ/ML|||MG/M2/H|NOT DONE||LIKERT SCALE 7-POINT|Y|U|NA|2||58||WASHOUT|1970-11-26||||1966-01-27||1968-11-12|1964-02-15|
TRIAL STUDY 134XCP|QS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|3|||||NCCN-FACT FOSI-18 V2|||GBQ/G|||L/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|NA|3||39||FOLLOW-UP|1970-10-02||||1963-11-08||1969-11-26|1971-04-23|
TRIAL STUDY 134XCP|QS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|4|||||IDS-SR|||CI/G|||UMOL/KG/MIN|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|4||88||FOLLOW-UP|1960-10-09||||1968-04-22||1965-06-02|1962-11-05|
TRIAL STUDY 134XCP|QS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||LOG10 ELISA UNIT|||/10^4|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|U|5||7||INDUCTION TREATMENT|1964-11-06||||1966-01-19||1963-07-11|1964-11-25|
TRIAL STUDY 134XCP|QS|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1|||||MSWS-12|||NMOL BCE/NMOL|||MMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|N|1||38||BLINDED TREATMENT|1962-12-04||||1971-07-13||1965-06-11|1965-12-19|
TRIAL STUDY 134XCP|QS|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||NG|||BQ/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|NA|2||58||BASELINE|1960-07-04||||1966-02-17||1971-09-02|1971-07-22|
TRIAL STUDY 134XCP|QS|B842981B-AD7A-4A03-8E84-D5FC887BAD60|3|||||CES|||MOL/DAY|||UMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|3||39||TREATMENT|1973-06-03||||1973-03-13||1971-01-20|1969-01-27|
TRIAL STUDY 134XCP|QS|B842981B-AD7A-4A03-8E84-D5FC887BAD60|4|||||IBDQ|||UG/G/H|||MU|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|4||88||BASELINE|1962-08-03||||1966-05-24||1967-11-21|1967-12-21|
TRIAL STUDY 134XCP|QS|B842981B-AD7A-4A03-8E84-D5FC887BAD60|5|||||FACT-P V4|||SHOCK WAVE|||STRIP|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|Y|5||7||LONG-TERM FOLLOW-UP|1967-07-04||||1964-07-14||1960-03-27|1970-07-10|
TRIAL STUDY 134XCP|QS|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||DPM/100MG|||KIU|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|NA|1||38||FOLLOW-UP|1967-06-16||||1965-04-04||1965-09-19|1962-07-25|
TRIAL STUDY 134XCP|QS|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2|||||MDS-UPDRS|||CS|||MOSM/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|NA|2||58||INDUCTION TREATMENT|1965-01-04||||1968-05-05||1962-06-08|1966-05-07|
TRIAL STUDY 134XCP|QS|07F7C4E7-7722-4916-AB89-46EF540E2BD7|3|||||BLCS|||U/G HB|||10^8 PFU|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|3||39||BLINDED TREATMENT|1973-01-27||||1966-06-24||1967-11-05|1969-04-30|
TRIAL STUDY 134XCP|QS|07F7C4E7-7722-4916-AB89-46EF540E2BD7|4|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||NMOL BCE/L|||MIN/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|NA|Y|4||88||BLINDED TREATMENT|1970-02-17||||1964-11-07||1970-08-14|1963-10-24|
TRIAL STUDY 134XCP|QS|07F7C4E7-7722-4916-AB89-46EF540E2BD7|5|||||FACT-HEP V4|||/MONTH|||MMOL2/L2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|5||7||WASHOUT|1967-05-23||||1969-08-10||1963-06-16|1968-12-05|
TRIAL STUDY 134XCP|QS|58661394-906E-43F3-8935-150DF240A04C|1|||||SF12 V2.0 ACUTE|||10^6 IU|||MEQ|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|1||38||BASELINE|1968-09-10||||1969-11-13||1961-12-04|1972-03-01|
TRIAL STUDY 134XCP|QS|58661394-906E-43F3-8935-150DF240A04C|2|||||PCL-5|||BAU|||L/L|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|2||58||OPEN LABEL TREATMENT|1971-09-24||||1965-05-27||1969-09-06|1968-05-25|
TRIAL STUDY 134XCP|QS|58661394-906E-43F3-8935-150DF240A04C|3|||||WPAI-GH V2.0|||MS/MMHG|||MANSON U/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|3||39||OBSERVATION|1973-06-27||||1963-07-14||1961-10-12|1973-07-11|
TRIAL STUDY 134XCP|QS|58661394-906E-43F3-8935-150DF240A04C|4|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||U/MMOL|||VIAL|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|4||88||OPEN LABEL TREATMENT|1960-08-03||||1960-08-10||1960-07-15|1962-08-26|
TRIAL STUDY 134XCP|QS|58661394-906E-43F3-8935-150DF240A04C|5|||||NCCN-FACT FBRSI-24 V2|||H/WK|||TUBE|NOT DONE||LIKERT SCALE 5-POINT|N|Y|U|5||7||BLINDED TREATMENT|1962-02-25||||1960-07-26||1960-06-14|1967-07-15|
TRIAL STUDY 134XCP|QS|B70F3694-B764-4B39-BFB9-B1281ED091B8|1|||||BEBQ CONCURRENT|||CUP EQ|||GPS U|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|NA|1||38||OBSERVATION|1962-02-23||||1972-07-18||1970-04-17|1966-01-05|
TRIAL STUDY 134XCP|QS|B70F3694-B764-4B39-BFB9-B1281ED091B8|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||10^3 CFU|||G/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|NA|2||58||WASHOUT|1970-11-02||||1968-09-07||1972-02-17|1966-12-31|
TRIAL STUDY 134XCP|QS|B70F3694-B764-4B39-BFB9-B1281ED091B8|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||L/S|||UL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|3||39||OPEN LABEL TREATMENT|1960-07-11||||1968-06-20||1960-03-22|1962-01-28|
TRIAL STUDY 134XCP|QS|B70F3694-B764-4B39-BFB9-B1281ED091B8|4|||||PR|||10^6/G|||NL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|U|4||88||BLINDED TREATMENT|1971-12-04||||1961-03-06||1966-11-11|1970-08-03|
TRIAL STUDY 134XCP|QS|B70F3694-B764-4B39-BFB9-B1281ED091B8|5|||||FSS|||KN/CM2|||AG|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|NA|5||7||TREATMENT|1967-08-28||||1971-10-12||1966-08-05|1969-10-28|
TRIAL STUDY 134XCP|QS|5B2471DB-807A-44F8-9529-D2319CCFE017|1|||||FACT/GOG-NTX V4|||MPA|||%/S|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|1||38||OPEN LABEL TREATMENT|1960-03-13||||1966-12-22||1967-04-30|1973-04-03|
TRIAL STUDY 134XCP|QS|5B2471DB-807A-44F8-9529-D2319CCFE017|2|||||PGI|||EP U|||MG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|NA|2||58||BASELINE|1965-03-12||||1967-08-21||1960-09-08|1966-05-08|
TRIAL STUDY 134XCP|QS|5B2471DB-807A-44F8-9529-D2319CCFE017|3|||||IBDQ|||10^6 CFU/ML|||NMOL/L/H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|NA|3||39||BASELINE|1960-09-05||||1964-07-09||1971-10-08|1968-09-25|
TRIAL STUDY 134XCP|QS|5B2471DB-807A-44F8-9529-D2319CCFE017|4|||||EQ-5D-3L|||/4.0 ML|||MEQ/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|Y|4||88||CONTINUATION TREATMENT|1960-04-21||||1973-08-12||1966-02-10|1967-06-20|
TRIAL STUDY 134XCP|QS|5B2471DB-807A-44F8-9529-D2319CCFE017|5|||||OCI|||MOL/MG|||PM|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|N|5||7||BLINDED TREATMENT|1969-12-23||||1973-07-29||1961-02-22|1966-01-14|
TRIAL STUDY 134XCP|QS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1|||||MHIS-NACC|||10^6 IU|||DAGU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|1||38||OPEN LABEL TREATMENT|1970-10-11||||1968-03-31||1964-08-15|1963-11-10|
TRIAL STUDY 134XCP|QS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2|||||FACIT-FATIGUE 13-ITEM V4|||NM|||PSI|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|2||58||BASELINE|1965-07-07||||1961-07-15||1968-01-06|1962-11-30|
TRIAL STUDY 134XCP|QS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|3|||||ADSD V1.0|||UG/ML/H|||UCI/L|NOT DONE||LIKERT SCALE 3-POINT|N|NA|U|3||39||OPEN LABEL TREATMENT|1968-11-23||||1961-03-02||1971-10-30|1972-05-08|
TRIAL STUDY 134XCP|QS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|4|||||SIQ-JR|||100 IU/ML|||HEP|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|4||88||WASHOUT|1967-10-26||||1969-11-21||1973-04-24|1969-08-04|
TRIAL STUDY 134XCP|QS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|5|||||SF12 V1.0 ACUTE|||ML/MIN/MMHG|||KIU|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|N|5||7||BLINDED TREATMENT|1971-10-01||||1964-09-29||1964-09-27|1963-06-30|
TRIAL STUDY 134XCP|QS|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1|||||WHODAS 2.0 - 36-ITEM SELF|||DRAM|||NM|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|1||38||INDUCTION TREATMENT|1970-07-21||||1963-06-05||1967-09-10|1963-05-28|
TRIAL STUDY 134XCP|QS|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2|||||GAD-7 V2|||UG/L/H|||MSEC|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|2||58||TREATMENT|1964-07-16||||1960-08-06||1968-04-23|1968-05-31|
TRIAL STUDY 134XCP|QS|A6E00A2C-7DBC-4577-8873-C780F5A6B400|3|||||WPAI-GH V2.0|||GBQ|||CP|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|U|3||39||OPEN LABEL TREATMENT|1968-01-10||||1973-06-02||1968-11-26|1972-05-23|
TRIAL STUDY 134XCP|QS|A6E00A2C-7DBC-4577-8873-C780F5A6B400|4|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||10^4 CFU|||MIN/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|4||88||BASELINE|1971-12-02||||1963-02-22||1960-07-13|1970-09-14|
TRIAL STUDY 134XCP|QS|A6E00A2C-7DBC-4577-8873-C780F5A6B400|5|||||OCI|||KN/CM2|||ML/BREATH|NOT DONE||LIKERT SCALE 5-POINT|Y|U|U|5||7||TREATMENT|1973-07-03||||1961-10-16||1964-03-31|1968-05-05|
TRIAL STUDY 134XCP|QS|06611015-E99C-466B-B0B3-EBE10EA9E627|1|||||BSI-18|||10^3 CFU|||MEQ|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|1||38||SCREENING|1960-04-14||||1968-02-04||1961-01-11|1971-03-31|
TRIAL STUDY 134XCP|QS|06611015-E99C-466B-B0B3-EBE10EA9E627|2|||||EXPANDED DRS-PI SURVIVOR VERSION|||G/M2|||10^3 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|2||58||LONG-TERM FOLLOW-UP|1967-07-18||||1970-07-16||1960-07-23|1969-06-11|
TRIAL STUDY 134XCP|QS|06611015-E99C-466B-B0B3-EBE10EA9E627|3|||||PI|||PG|||FARAD|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|N|3||39||CONTINUATION TREATMENT|1972-03-10||||1971-12-03||1963-03-15|1972-02-09|
TRIAL STUDY 134XCP|QS|06611015-E99C-466B-B0B3-EBE10EA9E627|4|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||ABSORBANCE U/MIN|||ANSON U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|U|4||88||SCREENING|1969-07-29||||1963-05-21||1965-04-12|1968-05-31|
TRIAL STUDY 134XCP|QS|06611015-E99C-466B-B0B3-EBE10EA9E627|5|||||ADCS-ADL SEVERE DEMENTIA|||U/ANIMAL|||/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|5||7||CONTINUATION TREATMENT|1960-11-27||||1970-03-13||1962-09-20|1972-10-03|
TRIAL STUDY 134XCP|QS|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1|||||NCCN-FACT FKSI-19 V2|||ML/DL|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|1||38||OBSERVATION|1971-05-31||||1966-06-03||1960-03-18|1961-04-11|
TRIAL STUDY 134XCP|QS|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2|||||BLCS|||UG/ML/H|||USP U|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|2||58||RUN-IN|1972-06-15||||1966-04-18||1971-07-14|1966-02-13|
TRIAL STUDY 134XCP|QS|5AF91C46-87FC-4714-B956-A4ECFC87C30A|3|||||NPS|||CIGAR|||VP/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|3||39||BLINDED TREATMENT|1962-04-21||||1966-06-20||1968-01-18|1961-05-15|
TRIAL STUDY 134XCP|QS|5AF91C46-87FC-4714-B956-A4ECFC87C30A|4|||||IPAQ-SF PHONE VERSION|||MG/KG|||PNU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|N|4||88||OBSERVATION|1971-06-16||||1971-07-29||1963-09-07|1969-02-07|
TRIAL STUDY 134XCP|QS|5AF91C46-87FC-4714-B956-A4ECFC87C30A|5|||||PHQ SCREENER VERSION|||MAMP|||V/SEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|N|5||7||OBSERVATION|1966-02-06||||1972-06-19||1968-08-12|1973-02-14|
TRIAL STUDY 134XCP|QS|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||ML/KG/MIN|||UKAT/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|U|1||38||FOLLOW-UP|1969-12-13||||1972-12-21||1967-02-19|1964-03-02|
TRIAL STUDY 134XCP|QS|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2|||||PI|||MKAT|||/2500 WBC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|U|2||58||RUN-IN|1963-07-29||||1961-04-30||1965-08-02|1972-12-26|
TRIAL STUDY 134XCP|QS|3DEA7E00-77B9-4710-A37E-577F925BFBD8|3|||||C-SSRS LIFETIME/RECENT VERSION|||L/MIN|||U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|3||39||LONG-TERM FOLLOW-UP|1965-03-06||||1962-12-06||1965-09-29|1972-08-05|
TRIAL STUDY 134XCP|QS|3DEA7E00-77B9-4710-A37E-577F925BFBD8|4|||||TSCYC|||CM/S|||DEG/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|N|4||88||LONG-TERM FOLLOW-UP|1970-01-28||||1970-08-11||1966-07-09|1965-10-26|
TRIAL STUDY 134XCP|QS|3DEA7E00-77B9-4710-A37E-577F925BFBD8|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||UMOL/L|||AMU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|Y|5||7||INDUCTION TREATMENT|1970-10-21||||1968-04-05||1961-08-29|1961-10-07|
TRIAL STUDY 134XCP|QS|DC79E350-1B89-4518-8B42-5858F5270928|1|||||PGI|||ABSORBANCE U|||USP U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|N|1||38||OPEN LABEL TREATMENT|1971-10-21||||1962-11-13||1971-11-08|1960-02-14|
TRIAL STUDY 134XCP|QS|DC79E350-1B89-4518-8B42-5858F5270928|2|||||BPI SHORT FORM|||ML|||PLUG|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|2||58||WASHOUT|1964-05-11||||1960-06-17||1964-02-26|1969-03-03|
TRIAL STUDY 134XCP|QS|DC79E350-1B89-4518-8B42-5858F5270928|3|||||PODCI - PEDIATRIC PARENT REPORTED|||AG|||/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|NA|3||39||OBSERVATION|1960-06-15||||1961-11-22||1968-10-27|1967-10-26|
TRIAL STUDY 134XCP|QS|DC79E350-1B89-4518-8B42-5858F5270928|4|||||FACT-L V4|||NMOL/ML/MIN|||UIU/DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|U|4||88||BASELINE|1966-08-13||||1968-08-10||1968-10-11|1970-03-11|
TRIAL STUDY 134XCP|QS|DC79E350-1B89-4518-8B42-5858F5270928|5|||||ADCS-ADL MCI|||FT2|||DDU|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|5||7||SCREENING|1966-05-30||||1963-09-16||1967-05-05|1960-02-09|
TRIAL STUDY 134XCP|QS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1|||||MADRS|||MMHG/SEC|||UIU/L|NOT DONE||LIKERT SCALE 5-POINT|NA|N|N|1||38||FOLLOW-UP|1972-05-27||||1972-04-01||1972-03-31|1963-09-28|
TRIAL STUDY 134XCP|QS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2|||||SHORT-FORM MPQ-2|||U/CL|||L|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|2||58||BLINDED TREATMENT|1961-07-15||||1964-08-07||1960-04-18|1970-08-03|
TRIAL STUDY 134XCP|QS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|3|||||ANSD V1.0|||PPM|||BQ/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|N|3||39||TREATMENT|1972-07-30||||1964-03-13||1966-09-20|1970-01-12|
TRIAL STUDY 134XCP|QS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|4|||||PODCI - ADOLESCENT PARENT REPORTED|||L/S|||MESF|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|4||88||OPEN LABEL TREATMENT|1968-07-27||||1960-02-19||1961-08-19|1965-10-24|
TRIAL STUDY 134XCP|QS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|5|||||PR|||U/G/DAY|||TITER|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|NA|5||7||OPEN LABEL TREATMENT|1961-11-11||||1973-03-08||1965-02-15|1971-08-15|
TRIAL STUDY 134XCP|QS|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1|||||PARTNER-DDS|||U/G/MIN|||FARAD|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|N|1||38||OPEN LABEL TREATMENT|1967-05-03||||1968-02-16||1973-07-17|1967-09-28|
TRIAL STUDY 134XCP|QS|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2|||||FACIT-DYSPNEA SF|||U/G/MIN|||FIU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|2||58||TREATMENT|1972-08-28||||1968-12-21||1963-12-06|1966-06-24|
TRIAL STUDY 134XCP|QS|7F51014D-D2B5-4956-9DD6-52676EB66ED7|3|||||FLSI|||CCID 50/ML|||IU/DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|U|3||39||FOLLOW-UP|1961-01-20||||1965-09-23||1973-05-26|1970-02-26|
TRIAL STUDY 134XCP|QS|7F51014D-D2B5-4956-9DD6-52676EB66ED7|4|||||AUDIT-SR|||UU/DL|||UMOL/L/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|4||88||SCREENING|1962-10-21||||1971-02-24||1973-05-04|1960-01-20|
TRIAL STUDY 134XCP|QS|7F51014D-D2B5-4956-9DD6-52676EB66ED7|5|||||LEC-5 STANDARD VERSION|||PKAT|||M/SEC2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|NA|5||7||BLINDED TREATMENT|1965-12-22||||1964-10-30||1968-03-28|1964-08-24|
TRIAL STUDY 134XCP|QS|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1|||||NPI|||U/KG/DAY|||LOG10 TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|U|1||38||BASELINE|1965-07-27||||1963-08-07||1973-02-05|1966-05-02|
TRIAL STUDY 134XCP|QS|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2|||||FACIT-F V4|||G/L|||/100 HPFS|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|NA|2||58||INDUCTION TREATMENT|1972-10-08||||1964-01-20||1964-12-26|1961-07-06|
TRIAL STUDY 134XCP|QS|0568B2DD-3184-472D-89C6-66A5CE8AE00F|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||/10^4|||M/SEC|NOT DONE||LIKERT SCALE 7-POINT|U|N|U|3||39||BLINDED TREATMENT|1965-03-12||||1962-08-20||1966-03-11|1967-02-16|
TRIAL STUDY 134XCP|QS|0568B2DD-3184-472D-89C6-66A5CE8AE00F|4|||||SGRQ-C|||ML/DAY|||MV/SEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|4||88||INDUCTION TREATMENT|1961-04-29||||1963-06-22||1962-11-23|1971-05-03|
TRIAL STUDY 134XCP|QS|0568B2DD-3184-472D-89C6-66A5CE8AE00F|5|||||SOWS SHORT|||TABLET|||MG/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|5||7||TREATMENT|1960-07-15||||1966-02-13||1966-09-26|1964-09-16|
TRIAL STUDY 134XCP|QS|275DC6A6-598C-4997-A442-4A3916AC42BD|1|||||PI|||MU/L|||MG/KG/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|U|1||38||RUN-IN|1961-09-11||||1962-09-27||1964-06-16|1969-01-22|
TRIAL STUDY 134XCP|QS|275DC6A6-598C-4997-A442-4A3916AC42BD|2|||||FACIT-FATIGUE 13-ITEM V4|||UG/KG/MIN|||10^6 ORGANISMS|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|2||58||BLINDED TREATMENT|1971-04-24||||1972-12-18||1970-08-26|1973-06-01|
TRIAL STUDY 134XCP|QS|275DC6A6-598C-4997-A442-4A3916AC42BD|3|||||NCCN-FACT FHNSI-22 V2|||PPB|||ML/M2/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|3||39||LONG-TERM FOLLOW-UP|1964-11-27||||1971-04-22||1964-06-08|1964-05-10|
TRIAL STUDY 134XCP|QS|275DC6A6-598C-4997-A442-4A3916AC42BD|4|||||GCGI|||UL/ML|||G/MOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|Y|4||88||BLINDED TREATMENT|1970-02-01||||1961-03-28||1971-04-19|1960-11-07|
TRIAL STUDY 134XCP|QS|275DC6A6-598C-4997-A442-4A3916AC42BD|5|||||RPQ|||F|||U/KG/H|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|5||7||CONTINUATION TREATMENT|1960-02-25||||1967-11-28||1960-02-05|1964-12-16|
TRIAL STUDY 134XCP|QS|B949F90F-524D-4494-A63C-A05F56421EA1|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||G|||KAT|NOT DONE||LIKERT SCALE 3-POINT|N|N|NA|1||38||FOLLOW-UP|1962-04-03||||1972-02-22||1968-06-18|1963-11-24|
TRIAL STUDY 134XCP|QS|B949F90F-524D-4494-A63C-A05F56421EA1|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||CP|||MET|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|Y|U|2||58||FOLLOW-UP|1968-01-05||||1963-07-27||1960-12-23|1966-05-16|
TRIAL STUDY 134XCP|QS|B949F90F-524D-4494-A63C-A05F56421EA1|3|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||DAMOL/L|||GAUSS|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|Y|3||39||RUN-IN|1971-08-26||||1965-03-20||1961-05-12|1969-05-08|
TRIAL STUDY 134XCP|QS|B949F90F-524D-4494-A63C-A05F56421EA1|4|||||FAS-NACC UDS V3.0|||TESLA|||ML/(MIN*100ML)|NOT DONE||LIKERT SCALE 5-POINT|U|NA|U|4||88||INDUCTION TREATMENT|1960-12-31||||1960-12-10||1972-05-03|1973-07-10|
TRIAL STUDY 134XCP|QS|B949F90F-524D-4494-A63C-A05F56421EA1|5|||||EQ-5D-5L|||GRAIN|||ANTI-XA IU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|U|5||7||INDUCTION TREATMENT|1965-03-29||||1966-10-31||1963-08-07|1965-05-24|
TRIAL STUDY 134XCP|QS|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1|||||PDQUALIF|||MMOL/DAY|||TRACE|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|N|1||38||OPEN LABEL TREATMENT|1966-05-19||||1962-11-08||1965-07-27|1973-01-03|
TRIAL STUDY 134XCP|QS|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2|||||MSIS-29 V2|||UG/M2/H|||RNA COPIES/ML|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|N|2||58||RUN-IN|1969-03-21||||1964-03-24||1963-08-28|1968-01-10|
TRIAL STUDY 134XCP|QS|152411EA-E7DA-4230-A8A6-163C8A8C0A58|3|||||DRRI-2|||SUPPOSITORY|||PMOL/10^10 CELLS|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|Y|3||39||OPEN LABEL TREATMENT|1969-12-26||||1963-03-21||1970-09-04|1965-01-15|
TRIAL STUDY 134XCP|QS|152411EA-E7DA-4230-A8A6-163C8A8C0A58|4|||||NSCLC-SAQ V1.0|||10^11/L|||ML/ANIMAL/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|4||88||WASHOUT|1961-11-07||||1967-05-22||1965-04-29|1968-04-18|
TRIAL STUDY 134XCP|QS|152411EA-E7DA-4230-A8A6-163C8A8C0A58|5|||||GDS|||AFU|||TUBE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|Y|Y|5||7||INDUCTION TREATMENT|1963-01-26||||1972-01-08||1968-02-06|1967-09-28|
TRIAL STUDY 134XCP|QS|AB78662C-F90A-4193-9AC7-5621B497A18F|1|||||OCI|||PG/DL|||BOWL|NOT DONE||LIKERT SCALE 7-POINT|N|N|NA|1||38||OPEN LABEL TREATMENT|1971-06-23||||1967-10-11||1963-07-19|1961-08-20|
TRIAL STUDY 134XCP|QS|AB78662C-F90A-4193-9AC7-5621B497A18F|2|||||BIS-11|||MG/DAY|||ML/MIN/MMHG|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|N|2||58||OPEN LABEL TREATMENT|1967-10-17||||1967-11-25||1973-08-01|1971-03-26|
TRIAL STUDY 134XCP|QS|AB78662C-F90A-4193-9AC7-5621B497A18F|3|||||FACT-BMT V4|||CUP|||ML/M2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|3||39||BLINDED TREATMENT|1969-06-21||||1967-04-19||1960-03-01|1960-12-13|
TRIAL STUDY 134XCP|QS|AB78662C-F90A-4193-9AC7-5621B497A18F|4|||||SF36 V1.0 STANDARD|||PIXELS/IN|||KS|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|4||88||SCREENING|1965-07-17||||1964-05-02||1963-10-09|1969-07-01|
TRIAL STUDY 134XCP|QS|AB78662C-F90A-4193-9AC7-5621B497A18F|5|||||SF12 V1.0 STANDARD|||UMOL/MG/MIN|||10^7 PFU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|5||7||CONTINUATION TREATMENT|1960-10-18||||1966-05-10||1961-01-25|1966-05-31|
TRIAL STUDY 134XCP|QS|84CD31FD-BCB9-4439-84F7-11C63D578108|1|||||HADS|||AG|||10^8/L|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|1||38||OBSERVATION|1969-05-26||||1967-02-27||1972-04-28|1967-02-10|
TRIAL STUDY 134XCP|QS|84CD31FD-BCB9-4439-84F7-11C63D578108|2|||||WHODAS 2.0 - 36-ITEM PROXY|||BREATHS/MIN|||MEQ/KG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|2||58||TREATMENT|1972-08-09||||1966-01-11||1962-05-20|1968-11-11|
TRIAL STUDY 134XCP|QS|84CD31FD-BCB9-4439-84F7-11C63D578108|3|||||CHART-SF INTERVIEW VERSION|||MM/SEC|||U/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|3||39||CONTINUATION TREATMENT|1967-04-02||||1971-09-16||1960-06-15|1970-09-21|
TRIAL STUDY 134XCP|QS|84CD31FD-BCB9-4439-84F7-11C63D578108|4|||||SIQ-JR|||CM|||SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|N|4||88||LONG-TERM FOLLOW-UP|1967-01-05||||1969-06-14||1960-03-09|1963-03-06|
TRIAL STUDY 134XCP|QS|84CD31FD-BCB9-4439-84F7-11C63D578108|5|||||GAD-7|||ML/KG/DAY|||G/CAGE/DAY|NOT DONE||LIKERT SCALE 7-POINT|NA|N|NA|5||7||OPEN LABEL TREATMENT|1968-01-23||||1962-09-22||1964-10-16|1964-09-17|
TRIAL STUDY 134XCP|QS|BB9A976D-48AC-4618-9BA1-683D97240F2B|1|||||ADHD-RS-IV HOME VERSION|||LOG10 CFU/ML|||IU/L|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|Y|1||38||OPEN LABEL TREATMENT|1967-11-26||||1971-12-02||1961-10-01|1972-10-29|
TRIAL STUDY 134XCP|QS|BB9A976D-48AC-4618-9BA1-683D97240F2B|2|||||ADSD V1.0|||UG/KG/H|||/5X10^4 WBC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|NA|2||58||SCREENING|1967-04-19||||1962-11-08||1967-07-30|1963-05-02|
TRIAL STUDY 134XCP|QS|BB9A976D-48AC-4618-9BA1-683D97240F2B|3|||||SIQ-JR|||KIU|||PSI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|Y|3||39||BLINDED TREATMENT|1968-11-17||||1972-04-22||1960-02-04|1965-07-31|
TRIAL STUDY 134XCP|QS|BB9A976D-48AC-4618-9BA1-683D97240F2B|4|||||COMM|||MG/KG|||CI/UG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|4||88||OPEN LABEL TREATMENT|1964-08-17||||1972-07-27||1971-07-03|1965-07-09|
TRIAL STUDY 134XCP|QS|BB9A976D-48AC-4618-9BA1-683D97240F2B|5|||||BEBQ CONCURRENT|||BQ/UL|||M/SEC2|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|U|5||7||LONG-TERM FOLLOW-UP|1967-10-13||||1967-02-18||1971-04-13|1969-07-04|
TRIAL STUDY 134XCP|QS|FA440C9B-0D7A-4656-BF17-D46289567FB0|1|||||TSCC|||PACKET|||NMOL/ML/MIN|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|1||38||BLINDED TREATMENT|1965-05-17||||1967-05-25||1971-04-16|1964-04-04|
TRIAL STUDY 134XCP|QS|FA440C9B-0D7A-4656-BF17-D46289567FB0|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||MG/M2|||G/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|U|2||58||RUN-IN|1962-09-03||||1965-11-04||1964-05-04|1965-12-31|
TRIAL STUDY 134XCP|QS|FA440C9B-0D7A-4656-BF17-D46289567FB0|3|||||PGI|||CPM|||SFC/10^6 PBMC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|3||39||OBSERVATION|1973-03-20||||1960-04-09||1968-04-04|1962-05-25|
TRIAL STUDY 134XCP|QS|FA440C9B-0D7A-4656-BF17-D46289567FB0|4|||||PARENT-DDS|||FIU|||NMOL/KG/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|4||88||OBSERVATION|1973-02-08||||1973-03-20||1971-04-13|1968-08-08|
TRIAL STUDY 134XCP|QS|FA440C9B-0D7A-4656-BF17-D46289567FB0|5|||||PODCI - ADOLESCENT PARENT REPORTED|||AMOL|||MAMP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|U|5||7||BASELINE|1968-07-15||||1969-04-02||1970-10-02|1964-04-07|
TRIAL STUDY 134XCP|QS|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1|||||PHQ-15|||10^3 ORGANISMS/ML|||DEG/S|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|1||38||OBSERVATION|1963-08-11||||1967-12-16||1965-12-11|1972-04-27|
TRIAL STUDY 134XCP|QS|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2|||||SF36 V1.0 STANDARD|||MEQ/G|||EJACULATE U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|Y|N|2||58||TREATMENT|1970-10-31||||1962-07-04||1970-08-18|1964-05-31|
TRIAL STUDY 134XCP|QS|1706BA4E-D2AB-4877-974A-17BDBD834FFF|3|||||EXPANDED DRS-PI CAREGIVER VERSION|||CI|||BREATHS/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|3||39||SCREENING|1967-03-26||||1970-07-15||1970-01-09|1966-10-24|
TRIAL STUDY 134XCP|QS|1706BA4E-D2AB-4877-974A-17BDBD834FFF|4|||||COMM|||PNU/ML|||10^3/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|N|4||88||RUN-IN|1965-01-24||||1963-02-28||1964-10-08|1971-02-03|
TRIAL STUDY 134XCP|QS|1706BA4E-D2AB-4877-974A-17BDBD834FFF|5|||||FACIT-DYSPNEA 33 ITEM BANK|||DPM/ML|||TROCHE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|5||7||FOLLOW-UP|1969-01-20||||1962-06-12||1969-04-21|1968-07-22|
TRIAL STUDY 134XCP|QS|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1|||||MDS-UPDRS|||BREATHS/MIN|||U/G HB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|1||38||CONTINUATION TREATMENT|1968-08-28||||1962-01-24||1968-01-11|1963-10-25|
TRIAL STUDY 134XCP|QS|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2|||||FACIT-DYSPNEA 33 ITEM BANK|||DPM/MG|||TRANSDUCING UNIT/ML|NOT DONE||LIKERT SCALE 5-POINT|N|U|NA|2||58||CONTINUATION TREATMENT|1967-03-17||||1967-02-15||1967-12-09|1962-10-11|
TRIAL STUDY 134XCP|QS|15E3DD06-7F28-499B-9CF5-6EE5875095B5|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||FFU|||KBQ/UL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|U|3||39||OBSERVATION|1973-02-18||||1963-03-15||1969-01-17|1964-04-12|
TRIAL STUDY 134XCP|QS|15E3DD06-7F28-499B-9CF5-6EE5875095B5|4|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||LOG10 TCID 50/ML|||ANTIBODY UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|Y|4||88||BLINDED TREATMENT|1970-04-18||||1966-10-19||1967-02-16|1966-10-20|
TRIAL STUDY 134XCP|QS|15E3DD06-7F28-499B-9CF5-6EE5875095B5|5|||||OCI|||NG/DL|||10^8/L|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|U|5||7||TREATMENT|1966-03-21||||1962-03-29||1966-10-26|1965-02-19|
TRIAL STUDY 134XCP|QS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1|||||PODCI - ADOLESCENT SELF REPORTED|||UG/MIN|||UL/DOSE|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|1||38||RUN-IN|1965-01-16||||1966-12-31||1970-01-19|1973-05-14|
TRIAL STUDY 134XCP|QS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2|||||TSCC|||BOLUS|||MPA|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|U|N|2||58||BLINDED TREATMENT|1972-08-21||||1967-03-07||1966-05-05|1961-09-07|
TRIAL STUDY 134XCP|QS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|3|||||SGRQ-C|||MOSM/L|||L/S|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|N|3||39||BASELINE|1966-04-01||||1966-07-06||1971-04-19|1962-09-03|
TRIAL STUDY 134XCP|QS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|4|||||WPAI-GH V2.0|||CM/MIN|||UG/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|4||88||OPEN LABEL TREATMENT|1968-09-04||||1968-10-10||1967-09-27|1971-06-13|
TRIAL STUDY 134XCP|QS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|5|||||SHORT-FORM MPQ-2|||FT|||DROP|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|5||7||RUN-IN|1967-05-24||||1971-05-30||1960-07-13|1966-03-13|
TRIAL STUDY 134XCP|QS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1|||||IIEF|||CAPSULE|||USEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|1||38||FOLLOW-UP|1970-04-18||||1973-07-07||1973-02-14|1964-01-24|
TRIAL STUDY 134XCP|QS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2|||||SOBDA|||VG/KG|||MM/SEC|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|2||58||BLINDED TREATMENT|1964-11-24||||1967-03-08||1960-06-27|1964-10-28|
TRIAL STUDY 134XCP|QS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|3|||||IDS-SR|||ELISA UNIT/DOSE|||BU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|3||39||BLINDED TREATMENT|1965-02-05||||1964-06-20||1973-01-09|1966-06-23|
TRIAL STUDY 134XCP|QS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|4|||||IPAQ-SF SELF-ADMINISTERED VERSION|||ANSON U|||G/CAGE|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|4||88||CONTINUATION TREATMENT|1972-05-24||||1968-12-27||1961-03-26|1967-09-27|
TRIAL STUDY 134XCP|QS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||LINEAR FT*LB|||CIGAR|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|5||7||INDUCTION TREATMENT|1970-02-14||||1965-11-27||1966-09-09|1965-06-07|
TRIAL STUDY 134XCP|QS|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1|||||ADCS-ADL MCI|||STRIP|||U/10^12 RBC|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|1||38||BASELINE|1970-05-21||||1960-08-26||1972-10-14|1969-06-23|
TRIAL STUDY 134XCP|QS|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||/MM2|||LOG10 CCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|U|2||58||RUN-IN|1963-08-17||||1968-08-28||1963-07-04|1971-06-08|
TRIAL STUDY 134XCP|QS|87ED1C08-AF47-4827-A897-E8FC24A69ECC|3|||||SF36 V1.0 ACUTE|||CM2|||YD|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|U|3||39||BASELINE|1960-11-26||||1967-01-23||1964-04-23|1966-04-03|
TRIAL STUDY 134XCP|QS|87ED1C08-AF47-4827-A897-E8FC24A69ECC|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||SIEMENS|||LOG10 TCID 50/UL|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|4||88||OBSERVATION|1965-05-23||||1964-08-11||1967-12-16|1967-06-30|
TRIAL STUDY 134XCP|QS|87ED1C08-AF47-4827-A897-E8FC24A69ECC|5|||||NCCN-FACT FBRSI-24 V2|||MMOL2/L2|||DAGU|NOT DONE||LIKERT SCALE 5-POINT|NA|U|U|5||7||FOLLOW-UP|1967-08-07||||1972-03-14||1965-09-20|1970-02-19|
TRIAL STUDY 134XCP|QS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1|||||EPIC-CP|||UEQ|||TBSP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|Y|1||38||CONTINUATION TREATMENT|1968-07-16||||1969-01-03||1964-07-15|1966-03-21|
TRIAL STUDY 134XCP|QS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||CY/CM|||LOG10 PFU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|NA|2||58||FOLLOW-UP|1966-12-29||||1971-06-26||1966-07-31|1969-09-05|
TRIAL STUDY 134XCP|QS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|3|||||WPAI-GH V2.0|||SYRINGE|||PSI|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|N|3||39||LONG-TERM FOLLOW-UP|1965-06-19||||1964-04-20||1961-07-15|1966-04-16|
TRIAL STUDY 134XCP|QS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|4|||||NCCN-FACT FPSI-17 V2|||10^9/DOSE|||CI/MG|NOT DONE||LIKERT SCALE 5-POINT|Y|N|Y|4||88||INDUCTION TREATMENT|1962-02-16||||1973-04-09||1968-07-07|1970-11-01|
TRIAL STUDY 134XCP|QS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|5|||||OCI|||L/MIN/M2|||UCI|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|Y|5||7||FOLLOW-UP|1964-02-24||||1964-07-24||1962-07-19|1971-05-08|
TRIAL STUDY 134XCP|QS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1|||||ADCS-ADL MCI|||DPM/100MG|||MM/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|NA|1||38||OBSERVATION|1961-12-20||||1964-02-27||1964-01-31|1970-05-24|
TRIAL STUDY 134XCP|QS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||APL U|||U/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|2||58||OPEN LABEL TREATMENT|1965-11-07||||1965-04-27||1969-08-28|1961-11-16|
TRIAL STUDY 134XCP|QS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|3|||||SIQR|||/LSQN|||TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|Y|3||39||FOLLOW-UP|1965-10-09||||1969-12-20||1969-03-19|1962-01-01|
TRIAL STUDY 134XCP|QS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||MCI/L|||UM/S|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|4||88||CONTINUATION TREATMENT|1962-07-22||||1968-02-14||1969-05-28|1963-10-11|
TRIAL STUDY 134XCP|QS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|5|||||SGRQ PAST 4 WEEKS VERSION|||MGEQ|||PMOL/DL|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|N|5||7||OPEN LABEL TREATMENT|1966-11-02||||1969-11-03||1960-07-31|1971-04-07|
TRIAL STUDY 134XCP|QS|C817A043-1331-47AB-A627-D85893F9D61A|1|||||PCL-5|||10^7 CFU/ML|||NSEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|Y|1||38||TREATMENT|1962-11-05||||1973-01-19||1962-08-02|1966-02-25|
TRIAL STUDY 134XCP|QS|C817A043-1331-47AB-A627-D85893F9D61A|2|||||ACQ|||10^10/L|||DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|2||58||INDUCTION TREATMENT|1967-12-18||||1964-09-01||1960-06-22|1961-02-01|
TRIAL STUDY 134XCP|QS|C817A043-1331-47AB-A627-D85893F9D61A|3|||||SF12 V1.0 ACUTE|||10^3 ORGANISMS/ML|||BU/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|U|NA|3||39||CONTINUATION TREATMENT|1963-08-11||||1967-08-11||1967-02-10|1965-10-25|
TRIAL STUDY 134XCP|QS|C817A043-1331-47AB-A627-D85893F9D61A|4|||||FOSI|||MMHG*MIN/L|||SACHET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|4||88||FOLLOW-UP|1973-08-25||||1971-11-06||1970-11-07|1967-02-06|
TRIAL STUDY 134XCP|QS|C817A043-1331-47AB-A627-D85893F9D61A|5|||||EPDS|||MU|||UG/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|Y|5||7||INDUCTION TREATMENT|1973-08-20||||1967-04-22||1973-03-27|1969-05-14|
TRIAL STUDY 134XCP|QS|DDD6F5D1-AE97-412C-A161-869C4178223A|1|||||BWCS|||ANTI-XA IU/ML|||% INHIBITION|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|1||38||CONTINUATION TREATMENT|1968-03-09||||1966-03-03||1966-09-04|1965-01-06|
TRIAL STUDY 134XCP|QS|DDD6F5D1-AE97-412C-A161-869C4178223A|2|||||SF10 V1.0 CHILDREN ACUTE|||MMOL/G|||DRINK|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|2||58||OPEN LABEL TREATMENT|1966-01-28||||1961-01-07||1973-07-24|1970-12-20|
TRIAL STUDY 134XCP|QS|DDD6F5D1-AE97-412C-A161-869C4178223A|3|||||CGI|||ML/MMHG|||10^7 PFU|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|3||39||INDUCTION TREATMENT|1972-09-29||||1968-04-26||1972-12-18|1964-09-19|
TRIAL STUDY 134XCP|QS|DDD6F5D1-AE97-412C-A161-869C4178223A|4|||||SF10 V1.0 CHILDREN ACUTE|||PFU/DOSE|||TAMPON|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|N|4||88||FOLLOW-UP|1961-08-26||||1960-06-06||1970-02-07|1972-05-31|
TRIAL STUDY 134XCP|QS|DDD6F5D1-AE97-412C-A161-869C4178223A|5|||||ACQ|||BEL|||MPH|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|N|5||7||SCREENING|1966-03-05||||1962-11-30||1966-07-03|1972-01-13|
TRIAL STUDY 134XCP|QS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1|||||NCCN-FACT FHNSI-22 V2|||TORR|||BISCUIT|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|U|1||38||WASHOUT|1969-02-16||||1968-07-16||1967-07-27|1970-01-11|
TRIAL STUDY 134XCP|QS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||ML/BREATH|||BLOCKS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|NA|2||58||LONG-TERM FOLLOW-UP|1973-05-15||||1970-05-22||1971-03-12|1964-09-18|
TRIAL STUDY 134XCP|QS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|3|||||WHODAS 2.0 - 12-ITEM SELF|||DPM/100MG|||FMOL/L/SEC|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|NA|3||39||CONTINUATION TREATMENT|1966-09-05||||1961-07-27||1972-09-20|1968-11-30|
TRIAL STUDY 134XCP|QS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|4|||||PDDS|||CS|||MIN/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|4||88||WASHOUT|1963-07-09||||1969-03-13||1972-07-18|1960-10-19|
TRIAL STUDY 134XCP|QS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|5|||||Q-LES-Q-SF|||ELISA UNIT/ML|||NMOL/KG/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|N|5||7||BASELINE|1962-02-25||||1972-03-25||1973-07-09|1962-01-02|
TRIAL STUDY 134XCP|QS|25FB07EA-3CB8-430D-B775-CA0E9918C069|1|||||GCGI|||/LSQN|||LX|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|N|1||38||OBSERVATION|1973-02-13||||1967-08-20||1971-11-01|1972-02-23|
TRIAL STUDY 134XCP|QS|25FB07EA-3CB8-430D-B775-CA0E9918C069|2|||||FKSI-15|||CIGARETTE|||STEPS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|2||58||LONG-TERM FOLLOW-UP|1971-12-18||||1965-01-10||1964-10-07|1965-06-29|
TRIAL STUDY 134XCP|QS|25FB07EA-3CB8-430D-B775-CA0E9918C069|3|||||CHART-SF INTERVIEW VERSION|||UMOL/MOL|||10^9 ORGANISMS/MG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|3||39||INDUCTION TREATMENT|1961-12-20||||1973-07-31||1960-08-16|1971-02-05|
TRIAL STUDY 134XCP|QS|25FB07EA-3CB8-430D-B775-CA0E9918C069|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT|||KG/MOL|||HOMEOPATHIC DILUTION|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|Y|4||88||TREATMENT|1971-07-22||||1973-06-06||1973-08-16|1965-03-29|
TRIAL STUDY 134XCP|QS|25FB07EA-3CB8-430D-B775-CA0E9918C069|5|||||PHQ SCREENER VERSION|||U/G HB|||NMOL/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|N|5||7||OBSERVATION|1970-01-23||||1969-07-26||1972-06-13|1962-10-07|
TRIAL STUDY 134XCP|QS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||EID 50/ML|||EIA UNIT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|NA|1||38||OBSERVATION|1963-12-11||||1967-10-23||1973-08-28|1973-01-26|
TRIAL STUDY 134XCP|QS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2|||||OAB-Q|||RNA COPIES/ML|||ML/MIN/1.73M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|NA|2||58||OBSERVATION|1960-01-01||||1966-02-04||1969-03-01|1971-10-14|
TRIAL STUDY 134XCP|QS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||10^9/G|||MG/H|NOT DONE||LIKERT SCALE 5-POINT|N|N|NA|3||39||BLINDED TREATMENT|1967-11-18||||1965-08-18||1961-06-20|1972-10-17|
TRIAL STUDY 134XCP|QS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|4|||||PEDS-FACIT-F|||BQ/ML|||KBQ|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|4||88||BLINDED TREATMENT|1962-07-01||||1962-01-06||1960-06-20|1967-06-07|
TRIAL STUDY 134XCP|QS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|5|||||SF10 V1.0 CHILDREN ACUTE|||10^7/L|||MG/G/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|5||7||CONTINUATION TREATMENT|1965-06-12||||1961-09-27||1973-02-22|1965-05-10|
TRIAL STUDY 134XCP|QS|B49B9695-9815-4B7B-9F96-4EE6A4432062|1|||||SHORT-FORM MPQ-2|||G/U|||SFC/10^6 PBMC|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|1||38||CONTINUATION TREATMENT|1963-12-27||||1963-03-30||1970-02-11|1962-01-20|
TRIAL STUDY 134XCP|QS|B49B9695-9815-4B7B-9F96-4EE6A4432062|2|||||RPQ|||CIGAR|||BAU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|N|2||58||WASHOUT|1970-05-09||||1972-03-15||1965-12-04|1965-04-06|
TRIAL STUDY 134XCP|QS|B49B9695-9815-4B7B-9F96-4EE6A4432062|3|||||UPS|||MG/M2/H|||UL/DOSE|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|3||39||CONTINUATION TREATMENT|1973-01-02||||1971-12-20||1972-07-26|1964-05-04|
TRIAL STUDY 134XCP|QS|B49B9695-9815-4B7B-9F96-4EE6A4432062|4|||||IIEF|||ML/H|||100 IU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|U|4||88||BLINDED TREATMENT|1971-11-14||||1968-10-06||1961-05-21|1969-07-19|
TRIAL STUDY 134XCP|QS|B49B9695-9815-4B7B-9F96-4EE6A4432062|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||L/L|||PELLET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|NA|5||7||OPEN LABEL TREATMENT|1966-07-25||||1971-12-07||1962-08-13|1969-04-12|
TRIAL STUDY 134XCP|QS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1|||||NCCN-FACT FPSI-17 V2|||DEG2|||PMOL|NOT DONE||LIKERT SCALE 5-POINT|U|NA|Y|1||38||RUN-IN|1960-05-02||||1961-10-21||1972-03-27|1966-10-24|
TRIAL STUDY 134XCP|QS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||WEEKS|||KG/M2|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|2||58||RUN-IN|1960-07-27||||1967-09-16||1973-04-09|1968-09-13|
TRIAL STUDY 134XCP|QS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|3|||||SF10 V1.0 CHILDREN ACUTE|||MIN/DAY|||UG/G/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|3||39||OBSERVATION|1960-10-08||||1968-01-20||1961-02-26|1973-02-03|
TRIAL STUDY 134XCP|QS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|4|||||ADHD-RS-IV HOME VERSION|||SPRAY|||MMOL/MOL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|N|U|4||88||INDUCTION TREATMENT|1972-03-17||||1967-12-05||1962-03-29|1972-11-24|
TRIAL STUDY 134XCP|QS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|5|||||BPI SHORT FORM|||GRAIN|||PMOL/10^10 CELLS|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|Y|5||7||INDUCTION TREATMENT|1965-08-20||||1963-10-31||1971-10-25|1971-10-17|
TRIAL STUDY 134XCP|QS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1|||||AQLQ|||MEQ/KG|||ML/KG|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|1||38||OPEN LABEL TREATMENT|1972-02-25||||1965-04-08||1968-08-05|1967-06-29|
TRIAL STUDY 134XCP|QS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2|||||SDS|||10^3 ORGANISMS|||IU/DL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|N|2||58||BLINDED TREATMENT|1960-08-08||||1970-01-20||1965-10-11|1967-04-13|
TRIAL STUDY 134XCP|QS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|3|||||HAEM-A-QOL|||10^4/L|||ML/G/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|Y|3||39||LONG-TERM FOLLOW-UP|1965-02-01||||1966-03-07||1969-11-28|1965-08-26|
TRIAL STUDY 134XCP|QS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|4|||||FACIT-DYSPNEA 33 ITEM BANK|||KPA/L/SEC|||/CMH2O|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|NA|4||88||INDUCTION TREATMENT|1969-06-05||||1967-09-11||1973-02-25|1964-10-31|
TRIAL STUDY 134XCP|QS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|5|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||MAC50|||NG/MOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|U|5||7||WASHOUT|1964-04-24||||1968-03-01||1973-02-25|1969-01-11|
TRIAL STUDY 134XCP|QS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1|||||ESS|||EVENTS|||KALLIKREIN INHIBITOR UNIT|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|N|1||38||RUN-IN|1968-06-24||||1971-03-21||1964-03-25|1972-10-22|
TRIAL STUDY 134XCP|QS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2|||||ADCS-ADL MCI|||FIU|||PMOL/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|2||58||OBSERVATION|1968-12-31||||1969-05-18||1972-05-17|1971-12-07|
TRIAL STUDY 134XCP|QS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|3|||||ASEX-MALE|||K|||BAU/ML|NOT DONE||LIKERT SCALE 3-POINT|U|Y|N|3||39||OPEN LABEL TREATMENT|1969-09-06||||1966-07-30||1968-10-28|1961-01-27|
TRIAL STUDY 134XCP|QS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|4|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||MESF|||ML/MIN/MMHG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|N|4||88||INDUCTION TREATMENT|1971-06-27||||1968-06-20||1962-06-27|1966-02-25|
TRIAL STUDY 134XCP|QS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|5|||||FACT/GOG-NTX V4|||%/S|||UMOL/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|U|5||7||FOLLOW-UP|1968-11-21||||1966-01-21||1961-01-25|1969-12-02|
TRIAL STUDY 134XCP|QS|07A934C8-0237-4B37-9FDD-503B8BF94357|1|||||GAD-7|||FT2|||AMFI|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|1||38||BLINDED TREATMENT|1962-09-02||||1968-12-15||1965-05-08|1962-10-30|
TRIAL STUDY 134XCP|QS|07A934C8-0237-4B37-9FDD-503B8BF94357|2|||||WPAI-GH V2.0|||PPTH|||L/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|2||58||FOLLOW-UP|1962-08-23||||1961-11-04||1973-08-31|1968-02-01|
TRIAL STUDY 134XCP|QS|07A934C8-0237-4B37-9FDD-503B8BF94357|3|||||FACT-COG V3|||G/CAGE|||BQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|U|3||39||OBSERVATION|1973-01-05||||1972-11-21||1965-05-08|1969-07-08|
TRIAL STUDY 134XCP|QS|07A934C8-0237-4B37-9FDD-503B8BF94357|4|||||RPQ|||L/MIN/M2|||KBQ|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|NA|4||88||BLINDED TREATMENT|1970-11-09||||1969-01-02||1963-11-17|1965-06-27|
TRIAL STUDY 134XCP|QS|07A934C8-0237-4B37-9FDD-503B8BF94357|5|||||AQLQ|||APS U|||PATCH|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|Y|5||7||BLINDED TREATMENT|1966-01-09||||1970-03-01||1964-01-16|1962-09-21|
TRIAL STUDY 134XCP|QS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1|||||SOAPP-R|||10^6/G|||DRINK|NOT DONE||LIKERT SCALE 3-POINT|Y|U|N|1||38||BASELINE|1965-01-16||||1966-12-19||1968-07-07|1960-09-25|
TRIAL STUDY 134XCP|QS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2|||||NSCLC-SAQ V1.0|||L/S/KPA|||VG/KG|NOT DONE||LIKERT SCALE 7-POINT|U|U|NA|2||58||TREATMENT|1960-09-15||||1961-11-08||1961-03-30|1969-06-17|
TRIAL STUDY 134XCP|QS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|3|||||LEC-5 STANDARD VERSION|||G/CAGE/DAY|||INHALATION|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|Y|3||39||INDUCTION TREATMENT|1969-01-29||||1971-11-02||1968-02-15|1961-08-14|
TRIAL STUDY 134XCP|QS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||LINEAR FT*LB|||EJACULATE U|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|4||88||BASELINE|1973-08-10||||1971-05-28||1972-10-17|1969-01-26|
TRIAL STUDY 134XCP|QS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|5|||||MFIS|||CI/G|||MAMP|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|5||7||WASHOUT|1962-07-05||||1964-06-21||1966-04-06|1963-02-04|
TRIAL STUDY 134XCP|QS|10E1249E-10AC-45E8-9896-84C7B0F548BC|1|||||CHART-SF INTERVIEW VERSION|||PIXELS/IN|||LOG10 IU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|Y|1||38||INDUCTION TREATMENT|1968-06-28||||1962-08-04||1961-05-20|1964-12-30|
TRIAL STUDY 134XCP|QS|10E1249E-10AC-45E8-9896-84C7B0F548BC|2|||||SF12 V2.0 ACUTE|||NKAT/L|||PLUG|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|2||58||CONTINUATION TREATMENT|1962-01-05||||1970-09-09||1966-08-20|1962-01-09|
TRIAL STUDY 134XCP|QS|10E1249E-10AC-45E8-9896-84C7B0F548BC|3|||||GDS|||UMOL/DL|||L/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|3||39||TREATMENT|1972-08-22||||1970-10-17||1970-10-27|1966-12-07|
TRIAL STUDY 134XCP|QS|10E1249E-10AC-45E8-9896-84C7B0F548BC|4|||||TSCC|||CI/L|||G/ANIMAL|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|Y|4||88||OPEN LABEL TREATMENT|1962-02-27||||1969-09-15||1963-06-12|1972-12-09|
TRIAL STUDY 134XCP|QS|10E1249E-10AC-45E8-9896-84C7B0F548BC|5|||||FBRSI|||CI/ML|||MG/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|N|5||7||BLINDED TREATMENT|1967-02-28||||1970-12-18||1964-01-15|1967-06-24|
TRIAL STUDY 134XCP|QS|6CA97CE0-D120-4E14-A82F-4799D2699110|1|||||SHORT-FORM MPQ-2|||MG/MOL|||VOXEL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|N|1||38||LONG-TERM FOLLOW-UP|1965-05-23||||1963-11-06||1964-01-21|1972-06-22|
TRIAL STUDY 134XCP|QS|6CA97CE0-D120-4E14-A82F-4799D2699110|2|||||WHODAS 2.0 - 12-ITEM PROXY|||UG/M2|||POUCH|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|Y|2||58||SCREENING|1970-11-27||||1970-11-15||1962-03-09|1967-01-29|
TRIAL STUDY 134XCP|QS|6CA97CE0-D120-4E14-A82F-4799D2699110|3|||||CES|||RAD|||10^3 COPIES/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|NA|3||39||INDUCTION TREATMENT|1965-11-18||||1968-10-31||1964-12-23|1969-06-07|
TRIAL STUDY 134XCP|QS|6CA97CE0-D120-4E14-A82F-4799D2699110|4|||||SF8 V1.0 STANDARD|||AMPULE|||10^6/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|Y|4||88||OBSERVATION|1964-08-10||||1966-12-02||1962-09-25|1971-04-26|
TRIAL STUDY 134XCP|QS|6CA97CE0-D120-4E14-A82F-4799D2699110|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||FMOL/L|||MM3/MM2/YEAR|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|U|5||7||OPEN LABEL TREATMENT|1963-05-06||||1969-06-20||1969-04-28|1968-06-22|
TRIAL STUDY 134XCP|QS|D807C3F6-0955-4742-A29B-815682559530|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||CIGARETTE|||UG/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|1||38||TREATMENT|1969-07-07||||1965-07-08||1967-03-30|1972-04-25|
TRIAL STUDY 134XCP|QS|D807C3F6-0955-4742-A29B-815682559530|2|||||COWS|||10^9 ORGANISMS|||G/U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|U|2||58||TREATMENT|1968-02-05||||1971-11-21||1963-07-01|1970-08-07|
TRIAL STUDY 134XCP|QS|D807C3F6-0955-4742-A29B-815682559530|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||MAC50|||LX|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|Y|N|3||39||RUN-IN|1966-05-09||||1963-04-02||1961-01-27|1964-04-10|
TRIAL STUDY 134XCP|QS|D807C3F6-0955-4742-A29B-815682559530|4|||||MSWS-12|||G/CAGE/WK|||GPS U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|N|4||88||WASHOUT|1964-08-16||||1964-12-02||1968-03-10|1964-03-03|
TRIAL STUDY 134XCP|QS|D807C3F6-0955-4742-A29B-815682559530|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||BQ/MG|||AGU/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|5||7||TREATMENT|1971-07-19||||1972-12-29||1961-09-08|1965-09-13|
TRIAL STUDY 134XCP|QS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1|||||NCCN-FACT FBRSI-24 V2|||COPIES/UG|||NMOL/L/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|1||38||BASELINE|1973-01-07||||1969-07-21||1970-04-03|1965-02-16|
TRIAL STUDY 134XCP|QS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2|||||WHODAS 2.0 - 36-ITEM PROXY|||UMOL/H/MMOL|||MG/CM2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|2||58||OPEN LABEL TREATMENT|1967-09-03||||1961-09-03||1968-09-21|1960-01-02|
TRIAL STUDY 134XCP|QS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|3|||||RDQ|||10^6 ORGANISMS/MG|||L/S|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|3||39||OPEN LABEL TREATMENT|1968-06-10||||1966-02-21||1961-09-12|1969-05-30|
TRIAL STUDY 134XCP|QS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|4|||||FAMS|||U/G|||/10^3|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|4||88||BASELINE|1970-03-13||||1964-12-30||1962-10-22|1970-03-28|
TRIAL STUDY 134XCP|QS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|5|||||FAQ-NACC VERSION|||CI/KG|||BEAM BREAKS|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|5||7||BLINDED TREATMENT|1969-07-24||||1972-12-04||1972-02-05|1970-11-03|
TRIAL STUDY 134XCP|QS|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||G/U|||AGU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|NA|1||38||SCREENING|1971-06-28||||1966-08-04||1966-12-17|1961-04-11|
TRIAL STUDY 134XCP|QS|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||RPM|||/SEC|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|N|U|2||58||FOLLOW-UP|1970-11-16||||1960-08-20||1966-06-20|1965-04-16|
TRIAL STUDY 134XCP|QS|38C36B22-EC60-4D40-A1B6-71B17F8C8625|3|||||IPAQ-LF PHONE VERSION|||U/MMOL|||MG/KG/MIN|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|U|3||39||WASHOUT|1963-03-02||||1964-10-08||1971-09-01|1967-01-01|
TRIAL STUDY 134XCP|QS|38C36B22-EC60-4D40-A1B6-71B17F8C8625|4|||||ADCS-ADL MCI|||VG/KG|||BEAM BREAKS|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|U|4||88||BLINDED TREATMENT|1964-09-16||||1961-04-19||1968-07-23|1965-10-19|
TRIAL STUDY 134XCP|QS|38C36B22-EC60-4D40-A1B6-71B17F8C8625|5|||||NPI|||100 IU/ML|||10^9 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|N|5||7||BLINDED TREATMENT|1960-05-03||||1973-08-02||1968-01-10|1966-03-27|
TRIAL STUDY 134XCP|QS|E2F4144C-543D-4F55-A94E-58F244FB21D1|1|||||GOSE|||10^9/L|||EQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|1||38||SCREENING|1965-03-20||||1962-02-09||1965-03-02|1971-10-18|
TRIAL STUDY 134XCP|QS|E2F4144C-543D-4F55-A94E-58F244FB21D1|2|||||SF8 V1.0 STANDARD|||UMOL/MIN|||MOSM|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|N|2||58||LONG-TERM FOLLOW-UP|1971-08-08||||1965-06-22||1967-09-17|1965-02-28|
TRIAL STUDY 134XCP|QS|E2F4144C-543D-4F55-A94E-58F244FB21D1|3|||||PARTNER-DDS|||CIGAR|||RING|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|U|3||39||FOLLOW-UP|1964-11-21||||1965-04-11||1963-10-14|1962-07-06|
TRIAL STUDY 134XCP|QS|E2F4144C-543D-4F55-A94E-58F244FB21D1|4|||||EORTC QLQ-C15-PAL V1.0|||MAMP|||U/G HB|NOT DONE||LIKERT SCALE 3-POINT|U|N|Y|4||88||OPEN LABEL TREATMENT|1963-10-31||||1964-06-17||1969-03-16|1960-07-07|
TRIAL STUDY 134XCP|QS|E2F4144C-543D-4F55-A94E-58F244FB21D1|5|||||SOBDA|||FT3|||IN2|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|N|5||7||BASELINE|1964-11-16||||1971-03-09||1961-10-22|1962-09-09|
TRIAL STUDY 134XCP|QS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1|||||MPAI-4|||FINGERTIP UNIT|||CARTRIDGE|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|Y|1||38||TREATMENT|1968-11-29||||1972-11-30||1965-05-18|1962-04-13|
TRIAL STUDY 134XCP|QS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2|||||IPAQ-LF PHONE VERSION|||MM/MIN|||EU|NOT DONE||LIKERT SCALE 3-POINT|U|NA|NA|2||58||OBSERVATION|1961-11-01||||1968-01-03||1966-11-12|1968-02-17|
TRIAL STUDY 134XCP|QS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|3|||||BEBQ CONCURRENT|||UL/DOSE|||MASK|NOT DONE||LIKERT SCALE 3-POINT|U|NA|U|3||39||CONTINUATION TREATMENT|1963-12-09||||1964-09-13||1964-09-18|1964-10-16|
TRIAL STUDY 134XCP|QS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|4|||||MSIS-29 V2|||NG|||P|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|U|4||88||BLINDED TREATMENT|1961-11-04||||1973-05-15||1964-10-09|1971-09-17|
TRIAL STUDY 134XCP|QS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|5|||||PHQ-15|||MBP|||VG/ML|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|5||7||FOLLOW-UP|1965-06-03||||1971-08-21||1963-06-29|1961-02-13|
TRIAL STUDY 134XCP|QS|49B857CF-22F2-406F-A269-54944B23C236|1|||||CCQ 24 HOUR VERSION|||FOZ_BR|||10^9 ORGANISMS/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|U|1||38||WASHOUT|1961-01-02||||1962-09-20||1960-01-19|1969-09-07|
TRIAL STUDY 134XCP|QS|49B857CF-22F2-406F-A269-54944B23C236|2|||||MSIS-29 V2|||CMH2O*S2/ML|||KHZ|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|2||58||OBSERVATION|1972-02-03||||1963-04-03||1966-11-11|1963-01-21|
TRIAL STUDY 134XCP|QS|49B857CF-22F2-406F-A269-54944B23C236|3|||||SOBDA|||CMOL/L|||ML/G/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|3||39||TREATMENT|1964-02-15||||1967-06-05||1965-02-11|1962-09-24|
TRIAL STUDY 134XCP|QS|49B857CF-22F2-406F-A269-54944B23C236|4|||||IPAQ-LF PHONE VERSION|||% INHIBITION|||MG/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|4||88||RUN-IN|1961-11-16||||1967-10-23||1972-03-28|1961-03-27|
TRIAL STUDY 134XCP|QS|49B857CF-22F2-406F-A269-54944B23C236|5|||||MRS|||10^3 ORGANISMS|||10^4/HPF|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|U|5||7||WASHOUT|1960-09-03||||1970-05-07||1967-06-16|1968-06-14|
TRIAL STUDY 134XCP|QS|E09B394B-9E48-4132-B430-991DF1953A81|1|||||WOMAC VA 3.1 INDEX|||PATCH|||KG/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|1||38||CONTINUATION TREATMENT|1969-05-22||||1973-06-15||1965-10-27|1971-12-25|
TRIAL STUDY 134XCP|QS|E09B394B-9E48-4132-B430-991DF1953A81|2|||||MMRC|||IU/KG/H|||APL U/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|Y|2||58||BASELINE|1962-12-25||||1970-09-12||1973-03-04|1963-02-04|
TRIAL STUDY 134XCP|QS|E09B394B-9E48-4132-B430-991DF1953A81|3|||||PI|||UOSM|||CMHG|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|3||39||INDUCTION TREATMENT|1969-06-28||||1962-03-26||1960-02-06|1966-10-06|
TRIAL STUDY 134XCP|QS|E09B394B-9E48-4132-B430-991DF1953A81|4|||||CDLQ|||MET*H|||GRAVITATIONAL UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|4||88||INDUCTION TREATMENT|1960-09-25||||1968-12-01||1964-10-09|1963-02-18|
TRIAL STUDY 134XCP|QS|E09B394B-9E48-4132-B430-991DF1953A81|5|||||FKSI-15|||SUPPOSITORY|||DNA COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|NA|5||7||OBSERVATION|1962-03-04||||1961-09-01||1966-05-31|1963-03-25|
TRIAL STUDY 134XCP|QS|5FB65CB2-DB12-4D00-818E-C51992DC7273|1|||||HAQ-DI WITHOUT VAS|||MKAT|||NEEDLE GAUGE|NOT DONE||LIKERT SCALE 7-POINT|N|U|NA|1||38||BLINDED TREATMENT|1962-02-18||||1960-12-06||1966-01-11|1965-04-02|
TRIAL STUDY 134XCP|QS|5FB65CB2-DB12-4D00-818E-C51992DC7273|2|||||EORTC QLQ-LC13|||BP|||CY/CM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|2||58||BLINDED TREATMENT|1967-05-14||||1966-10-27||1961-03-13|1972-09-03|
TRIAL STUDY 134XCP|QS|5FB65CB2-DB12-4D00-818E-C51992DC7273|3|||||FACT-TAXANE V4|||COULOMB|||KAT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|NA|3||39||BASELINE|1961-09-16||||1972-05-15||1967-01-24|1962-04-20|
TRIAL STUDY 134XCP|QS|5FB65CB2-DB12-4D00-818E-C51992DC7273|4|||||EQ-5D-5L|||L/H|||MU/G|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|NA|4||88||OPEN LABEL TREATMENT|1962-03-06||||1967-10-28||1971-10-27|1972-03-08|
TRIAL STUDY 134XCP|QS|5FB65CB2-DB12-4D00-818E-C51992DC7273|5|||||FACT-LEU V4|||UM|||COPIES/UG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|U|5||7||BASELINE|1961-04-11||||1972-10-13||1969-01-21|1968-03-22|
TRIAL STUDY 134XCP|QS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1|||||SOWS SHORT|||L|||L/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|1||38||TREATMENT|1961-07-02||||1968-07-14||1962-08-13|1963-11-05|
TRIAL STUDY 134XCP|QS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2|||||IBDQ|||10^4 CFU/ML|||KM|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|2||58||SCREENING|1965-05-22||||1969-01-25||1961-06-09|1960-10-15|
TRIAL STUDY 134XCP|QS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|3|||||IPAQ-LF SELF-ADMINISTERED VERSION|||KS|||FL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|N|3||39||WASHOUT|1969-07-15||||1970-06-05||1962-05-07|1962-11-06|
TRIAL STUDY 134XCP|QS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|4|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||10^6 DNA COPIES/ML|||F|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|4||88||BLINDED TREATMENT|1971-11-24||||1961-08-11||1966-03-06|1970-09-12|
TRIAL STUDY 134XCP|QS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|5|||||IPAQ-SF PHONE VERSION|||CD/M2|||BU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|5||7||OPEN LABEL TREATMENT|1966-01-31||||1965-12-15||1964-12-11|1963-01-20|
TRIAL STUDY 134XCP|QS|CB6A1101-1EF8-476D-BD15-B60EF323D740|1|||||MFIS|||UCI/L|||KG/CM2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|1||38||FOLLOW-UP|1969-10-11||||1966-09-12||1970-03-09|1972-10-16|
TRIAL STUDY 134XCP|QS|CB6A1101-1EF8-476D-BD15-B60EF323D740|2|||||FACT-LEU V4|||BQ/UL|||U/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|N|2||58||WASHOUT|1968-09-30||||1971-04-20||1968-11-22|1965-12-09|
TRIAL STUDY 134XCP|QS|CB6A1101-1EF8-476D-BD15-B60EF323D740|3|||||FAQ-NACC VERSION|||MCI/L|||PMOL/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|3||39||CONTINUATION TREATMENT|1973-05-15||||1971-03-09||1970-06-24|1961-10-15|
TRIAL STUDY 134XCP|QS|CB6A1101-1EF8-476D-BD15-B60EF323D740|4|||||FAQ-NACC VERSION|||/2000 RBC|||%(V/V)|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|4||88||OPEN LABEL TREATMENT|1965-08-28||||1973-09-02||1970-08-27|1967-10-17|
TRIAL STUDY 134XCP|QS|CB6A1101-1EF8-476D-BD15-B60EF323D740|5|||||FSS|||/10^4|||10^4/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|5||7||INDUCTION TREATMENT|1962-07-21||||1972-09-22||1963-12-05|1973-01-15|
TRIAL STUDY 134XCP|QS|3AED1654-6D9A-40EE-A560-99F51C469D63|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||UV|||UG/KG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|Y|1||38||RUN-IN|1966-02-07||||1962-05-06||1960-06-26|1970-04-09|
TRIAL STUDY 134XCP|QS|3AED1654-6D9A-40EE-A560-99F51C469D63|2|||||NCCN-FACT FOSI-18 V2|||WATT|||ML/ANIMAL/WK|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|Y|2||58||INDUCTION TREATMENT|1972-10-29||||1964-03-24||1961-04-14|1961-11-05|
TRIAL STUDY 134XCP|QS|3AED1654-6D9A-40EE-A560-99F51C469D63|3|||||TSCC|||UU/DL|||PA|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|NA|3||39||WASHOUT|1960-03-06||||1973-01-17||1967-07-17|1967-02-12|
TRIAL STUDY 134XCP|QS|3AED1654-6D9A-40EE-A560-99F51C469D63|4|||||SOBDA|||ENZYME U/M2|||BU/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|4||88||BASELINE|1965-11-23||||1962-03-27||1969-03-22|1965-04-28|
TRIAL STUDY 134XCP|QS|3AED1654-6D9A-40EE-A560-99F51C469D63|5|||||MMRC|||HOURS|||10^7/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|Y|5||7||OBSERVATION|1973-05-23||||1966-01-05||1961-06-13|1960-06-08|
TRIAL STUDY 134XCP|QS|4C13FD80-8950-4194-B76C-F46B643BED82|1|||||MFIS|||/KG|||MG/ML/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|N|1||38||LONG-TERM FOLLOW-UP|1965-12-04||||1960-12-07||1971-07-24|1972-01-12|
TRIAL STUDY 134XCP|QS|4C13FD80-8950-4194-B76C-F46B643BED82|2|||||ODI V2.1A|||EID 50/ML|||MG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|N|2||58||BASELINE|1970-05-08||||1970-06-06||1971-03-12|1969-10-16|
TRIAL STUDY 134XCP|QS|4C13FD80-8950-4194-B76C-F46B643BED82|3|||||FACT-HEP V4|||LX|||KPA/L/SEC|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|U|3||39||SCREENING|1969-08-16||||1971-04-06||1971-08-21|1969-11-14|
TRIAL STUDY 134XCP|QS|4C13FD80-8950-4194-B76C-F46B643BED82|4|||||HAQ-DI WITHOUT VAS|||MS/MMHG|||U/M2/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|4||88||LONG-TERM FOLLOW-UP|1964-02-28||||1973-06-08||1962-11-18|1962-09-02|
TRIAL STUDY 134XCP|QS|4C13FD80-8950-4194-B76C-F46B643BED82|5|||||FKSI-15|||KG/CM2|||GY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|5||7||INDUCTION TREATMENT|1965-07-22||||1970-12-27||1973-08-20|1962-05-04|
TRIAL STUDY 134XCP|QS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1|||||PI|||GRAIN|||MG2/DL2|NOT DONE||LIKERT SCALE 7-POINT|N|Y|N|1||38||CONTINUATION TREATMENT|1961-05-01||||1965-11-11||1971-04-16|1963-03-06|
TRIAL STUDY 134XCP|QS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2|||||VFQ-25 INTERVIEWER ADMINISTERED|||UG/G/H|||IU/MMOL|NOT DONE||LIKERT SCALE 5-POINT|N|NA|N|2||58||TREATMENT|1961-04-07||||1967-06-13||1963-12-23|1968-09-15|
TRIAL STUDY 134XCP|QS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|3|||||VFQ-25 SELF ADMINISTERED|||BQ/UL|||BQ/UL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|N|3||39||LONG-TERM FOLLOW-UP|1961-03-08||||1972-09-17||1972-07-07|1969-03-02|
TRIAL STUDY 134XCP|QS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|4|||||SOWS SUBJECTIVE|||/LSQN|||UKAT/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|N|4||88||CONTINUATION TREATMENT|1969-12-29||||1967-10-18||1971-10-13|1971-07-08|
TRIAL STUDY 134XCP|QS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|5|||||FACIT-FATIGUE 13-ITEM V4|||10^9 CFU|||SPRAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|5||7||OPEN LABEL TREATMENT|1965-04-02||||1964-03-20||1960-07-22|1967-05-31|
TRIAL STUDY 134XCP|QS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||10^7 TCID 50/DOSE|||MEQ/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|1||38||SCREENING|1967-09-06||||1965-05-16||1963-06-09|1960-10-15|
TRIAL STUDY 134XCP|QS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||PM|||MNFI|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|Y|2||58||BLINDED TREATMENT|1966-07-21||||1960-10-20||1972-10-06|1971-10-09|
TRIAL STUDY 134XCP|QS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|3|||||ASEX-FEMALE|||UCI|||L/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|NA|3||39||LONG-TERM FOLLOW-UP|1966-09-29||||1973-03-01||1968-05-25|1967-04-28|
TRIAL STUDY 134XCP|QS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|4|||||SGRQ PAST 3 MONTHS VERSION|||GPL U|||AMP|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|N|U|4||88||CONTINUATION TREATMENT|1966-09-14||||1961-09-25||1964-04-29|1963-06-27|
TRIAL STUDY 134XCP|QS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|5|||||FAS-NACC UDS V3.0|||PHERESIS UNIT|||LOG EID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|Y|5||7||OBSERVATION|1973-09-05||||1966-02-26||1965-05-05|1971-11-21|
TRIAL STUDY 134XCP|QS|CFFA0003-098B-486E-82DB-30838F6541DD|1|||||FACT-BRM V4|||IU|||PSI|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|1||38||INDUCTION TREATMENT|1964-07-05||||1966-08-08||1967-04-20|1961-04-20|
TRIAL STUDY 134XCP|QS|CFFA0003-098B-486E-82DB-30838F6541DD|2|||||NPI|||KBQ|||LX|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|2||58||BLINDED TREATMENT|1968-11-27||||1965-10-06||1960-12-06|1971-11-13|
TRIAL STUDY 134XCP|QS|CFFA0003-098B-486E-82DB-30838F6541DD|3|||||DRRI-2|||10^8/L|||FMOL|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|3||39||CONTINUATION TREATMENT|1961-12-30||||1961-12-25||1973-04-20|1968-10-09|
TRIAL STUDY 134XCP|QS|CFFA0003-098B-486E-82DB-30838F6541DD|4|||||WPAI-GH V2.0|||LOG10 TCID 50/DOSE|||G/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|N|4||88||OPEN LABEL TREATMENT|1960-05-10||||1960-10-09||1960-11-09|1972-01-31|
TRIAL STUDY 134XCP|QS|CFFA0003-098B-486E-82DB-30838F6541DD|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||CS|||MEQ/MMOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|5||7||BLINDED TREATMENT|1965-04-08||||1964-03-01||1972-08-12|1966-07-21|
TRIAL STUDY 134XCP|QS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1|||||PHQ-2|||GPELISA UNIT/ML|||%(W/W)|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|1||38||OBSERVATION|1963-02-12||||1972-11-23||1965-11-19|1965-06-01|
TRIAL STUDY 134XCP|QS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2|||||HAQ-DI WITHOUT VAS|||M2|||PT_BR|NOT DONE||VERBAL RATING SCALE 4-POINT|U|N|Y|2||58||SCREENING|1968-04-15||||1965-07-20||1966-05-23|1970-05-14|
TRIAL STUDY 134XCP|QS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|3|||||PHQ-9|||G/DL|||GY/H|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|3||39||WASHOUT|1966-03-19||||1968-09-20||1967-06-26|1969-09-26|
TRIAL STUDY 134XCP|QS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||K|||/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|4||88||LONG-TERM FOLLOW-UP|1972-02-15||||1972-04-28||1968-03-14|1962-07-07|
TRIAL STUDY 134XCP|QS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|5|||||SIQ-JR|||CUP|||10^10/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|N|5||7||OBSERVATION|1970-12-24||||1969-02-15||1967-10-27|1964-09-14|
TRIAL STUDY 134XCP|QS|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1|||||EORTC QLQ-C15-PAL V1.0|||JDF UNIT|||OI50|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|Y|1||38||RUN-IN|1963-06-23||||1971-03-02||1964-10-08|1966-10-15|
TRIAL STUDY 134XCP|QS|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2|||||ANSD V1.0|||U/M2/DAY|||LOG10 IU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|2||58||LONG-TERM FOLLOW-UP|1964-12-13||||1968-09-18||1962-08-11|1962-12-31|
TRIAL STUDY 134XCP|QS|3F29184F-1963-4EC7-881A-61C9DEF95D2D|3|||||PHQ-2|||MG/G/MIN|||1/(S*KPA)|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|N|3||39||RUN-IN|1972-03-10||||1971-10-31||1960-06-28|1964-11-24|
TRIAL STUDY 134XCP|QS|3F29184F-1963-4EC7-881A-61C9DEF95D2D|4|||||CCQ 1 WEEK VERSION|||ELISA UNIT/DOSE|||NSEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|N|Y|4||88||INDUCTION TREATMENT|1965-10-25||||1964-04-12||1972-06-30|1964-12-07|
TRIAL STUDY 134XCP|QS|3F29184F-1963-4EC7-881A-61C9DEF95D2D|5|||||EPIC-CP|||PKAT/L|||MMU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|U|5||7||INDUCTION TREATMENT|1973-03-29||||1968-04-01||1967-07-28|1972-04-15|
TRIAL STUDY 134XCP|QS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||PIXEL|||/4.0 ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|1||38||OPEN LABEL TREATMENT|1962-03-09||||1968-02-21||1969-05-09|1963-07-18|
TRIAL STUDY 134XCP|QS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2|||||ADCS-ADL MCI|||JAR|||ECL UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|N|2||58||OBSERVATION|1960-03-14||||1973-04-08||1967-05-25|1971-12-07|
TRIAL STUDY 134XCP|QS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|3|||||MSWS-12|||TCID 50/DOSE|||ML/DOSE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|U|3||39||OPEN LABEL TREATMENT|1963-06-21||||1965-09-13||1968-02-10|1973-06-25|
TRIAL STUDY 134XCP|QS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|4|||||FACT-BL V4|||IN|||MCI/L|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|4||88||TREATMENT|1968-06-14||||1966-12-26||1960-06-12|1966-07-14|
TRIAL STUDY 134XCP|QS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|5|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT|||VG/DOSE|||BQ|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|5||7||BLINDED TREATMENT|1964-09-12||||1961-05-27||1968-01-05|1962-11-02|
TRIAL STUDY 134XCP|QS|D9C32CF1-51C7-412D-A030-682B2860F89D|1|||||GDS SHORT FORM|||IN|||LINEAR FT*LB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|U|NA|1||38||LONG-TERM FOLLOW-UP|1963-07-16||||1960-04-18||1963-01-21|1966-10-31|
TRIAL STUDY 134XCP|QS|D9C32CF1-51C7-412D-A030-682B2860F89D|2|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||MBQ/UL|||ML/G/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|NA|2||58||BLINDED TREATMENT|1966-11-28||||1973-03-17||1971-12-14|1966-12-02|
TRIAL STUDY 134XCP|QS|D9C32CF1-51C7-412D-A030-682B2860F89D|3|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||10^9 ORGANISMS|||K|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|U|3||39||SCREENING|1966-06-11||||1962-08-28||1972-12-17|1971-01-05|
TRIAL STUDY 134XCP|QS|D9C32CF1-51C7-412D-A030-682B2860F89D|4|||||HAMD 6 SELF-REPORT VERSION|||AMP|||EID 50/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|U|4||88||SCREENING|1969-08-04||||1961-08-24||1971-10-05|1961-01-27|
TRIAL STUDY 134XCP|QS|D9C32CF1-51C7-412D-A030-682B2860F89D|5|||||FACT-C V4|||UG/KG/DAY|||DAYS/WK|NOT DONE||LIKERT SCALE 3-POINT|NA|U|U|5||7||OPEN LABEL TREATMENT|1963-06-08||||1973-07-20||1972-09-08|1961-11-04|
TRIAL STUDY 134XCP|QS|102F6B51-5A86-497B-A36D-13FB77928C39|1|||||SF36 V2.0 STANDARD|||FMOL/L/SEC|||MU/G|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|Y|1||38||BASELINE|1967-08-04||||1962-07-17||1968-06-09|1969-10-29|
TRIAL STUDY 134XCP|QS|102F6B51-5A86-497B-A36D-13FB77928C39|2|||||IPAQ-LF SELF-ADMINISTERED VERSION|||10^9 CFU|||WEBER|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|U|2||58||WASHOUT|1973-01-13||||1964-08-26||1963-12-17|1968-11-13|
TRIAL STUDY 134XCP|QS|102F6B51-5A86-497B-A36D-13FB77928C39|3|||||OCI|||PNU/ML|||CM H2O|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|U|N|3||39||CONTINUATION TREATMENT|1968-05-02||||1971-01-12||1967-07-30|1966-03-12|
TRIAL STUDY 134XCP|QS|102F6B51-5A86-497B-A36D-13FB77928C39|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||/10^3|||UL/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|NA|4||88||OPEN LABEL TREATMENT|1961-02-25||||1968-09-18||1963-03-30|1961-04-28|
TRIAL STUDY 134XCP|QS|102F6B51-5A86-497B-A36D-13FB77928C39|5|||||Q-LES-Q|||KG/CM2|||ABSORBANCE U/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|U|U|5||7||FOLLOW-UP|1966-07-17||||1967-04-14||1970-02-14|1962-09-21|
TRIAL STUDY 134XCP|QS|C123D04C-1AA4-418D-B68C-EC9D410376F0|1|||||MNSI|||/MONTH|||V/V|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|U|1||38||INDUCTION TREATMENT|1962-08-07||||1961-02-11||1965-01-25|1967-02-26|
TRIAL STUDY 134XCP|QS|C123D04C-1AA4-418D-B68C-EC9D410376F0|2|||||YMRS|||10^3/L|||DEG/S|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|2||58||RUN-IN|1964-01-26||||1963-12-26||1969-04-09|1964-07-03|
TRIAL STUDY 134XCP|QS|C123D04C-1AA4-418D-B68C-EC9D410376F0|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD|||MMAL|||USP U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|Y|3||39||FOLLOW-UP|1965-07-11||||1972-08-23||1962-02-21|1965-06-02|
TRIAL STUDY 134XCP|QS|C123D04C-1AA4-418D-B68C-EC9D410376F0|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||COULOMB|||DAMOL/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|U|4||88||INDUCTION TREATMENT|1971-04-29||||1964-10-24||1964-06-08|1971-03-22|
TRIAL STUDY 134XCP|QS|C123D04C-1AA4-418D-B68C-EC9D410376F0|5|||||DLQI|||CMHG|||PNU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|U|5||7||OBSERVATION|1960-06-05||||1960-11-21||1961-08-30|1964-12-20|
TRIAL STUDY 134XCP|QS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1|||||Q-LES-Q-SF|||S*KPA|||CG|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|1||38||INDUCTION TREATMENT|1972-04-14||||1966-07-14||1962-07-25|1967-11-15|
TRIAL STUDY 134XCP|QS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2|||||Q-LES-Q-SF|||ML*CMH2O|||10^7 CFU/ML|NOT DONE||LIKERT SCALE 5-POINT|NA|U|Y|2||58||OBSERVATION|1966-12-28||||1963-04-11||1963-12-10|1973-07-14|
TRIAL STUDY 134XCP|QS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|3|||||PARENT-DDS|||VG/ML|||KAT|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|3||39||SCREENING|1965-04-14||||1966-09-03||1961-10-15|1970-05-16|
TRIAL STUDY 134XCP|QS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|4|||||FAMS|||GMFI|||10^6 IU|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|U|4||88||OBSERVATION|1960-08-23||||1972-06-06||1972-02-28|1966-02-11|
TRIAL STUDY 134XCP|QS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|5|||||UPS|||10^10/L|||BQ|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|5||7||BASELINE|1963-07-22||||1971-11-20||1969-09-08|1965-07-26|
TRIAL STUDY 134XCP|QS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD|||U/G|||VIAL|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|U|1||38||RUN-IN|1961-11-27||||1962-04-05||1965-06-01|1962-04-27|
TRIAL STUDY 134XCP|QS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2|||||PROSQOLI|||NMOL/L/MIN|||ML/CM3/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|2||58||OBSERVATION|1969-08-09||||1966-02-25||1964-12-16|1969-02-05|
TRIAL STUDY 134XCP|QS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|3|||||ACQ|||/MS|||ML/CAGE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|3||39||BASELINE|1971-10-22||||1972-02-18||1969-04-05|1972-06-15|
TRIAL STUDY 134XCP|QS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||AMP|||AU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|Y|4||88||INDUCTION TREATMENT|1960-09-28||||1970-02-06||1972-01-16|1963-07-16|
TRIAL STUDY 134XCP|QS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|5|||||IPAQ-LF PHONE VERSION|||L/L|||DEG2|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|5||7||SCREENING|1962-02-21||||1966-12-16||1972-08-14|1967-12-28|
TRIAL STUDY 134XCP|QS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1|||||FACT-L V4|||PIXELS/IN|||FOZ_BR|NOT DONE||LIKERT SCALE 5-POINT|U|N|NA|1||38||BASELINE|1965-05-09||||1970-03-29||1967-07-09|1964-06-10|
TRIAL STUDY 134XCP|QS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2|||||EORTC QLQ-C30 V3.0|||EQ|||LX|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|N|2||58||INDUCTION TREATMENT|1966-04-22||||1965-03-14||1972-11-22|1971-10-06|
TRIAL STUDY 134XCP|QS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|3|||||RAND-36 V1.0|||ML/M2|||L/KG|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|3||39||BASELINE|1969-12-19||||1970-12-04||1965-02-03|1960-10-22|
TRIAL STUDY 134XCP|QS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|4|||||IVIS|||MPH|||10^7 CFU/ML|NOT DONE||LIKERT SCALE 7-POINT|U|U|N|4||88||BASELINE|1966-12-17||||1969-01-16||1960-02-24|1972-08-26|
TRIAL STUDY 134XCP|QS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|5|||||FACT-BMT V4|||BQ/UG|||MG/M2/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|NA|5||7||OBSERVATION|1964-03-23||||1964-03-31||1961-02-28|1963-10-06|
TRIAL STUDY 134XCP|QS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1|||||FKSI-15|||FL|||%(V/V)|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|1||38||SCREENING|1963-10-17||||1968-01-11||1960-09-03|1966-06-27|
TRIAL STUDY 134XCP|QS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2|||||WOMAC LK 3.1 INDEX|||NEEDLE GAUGE|||DAGU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|2||58||TREATMENT|1969-07-26||||1973-06-17||1963-05-25|1962-09-10|
TRIAL STUDY 134XCP|QS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|3|||||RPQ|||MMOL/L|||S/H|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|Y|3||39||TREATMENT|1965-07-20||||1971-09-21||1969-01-29|1966-06-04|
TRIAL STUDY 134XCP|QS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||VIAL|||PG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|4||88||OPEN LABEL TREATMENT|1963-08-14||||1961-10-28||1964-09-26|1972-09-21|
TRIAL STUDY 134XCP|QS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|5|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||UMOL/H/MMOL|||10^6 CFU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|Y|5||7||SCREENING|1961-05-10||||1970-02-27||1964-05-27|1966-08-18|
TRIAL STUDY 134XCP|QS|E3310689-5727-4970-A675-A58931E406FA|1|||||FACT/GOG-NTX V4|||KDA|||%|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|1||38||LONG-TERM FOLLOW-UP|1962-08-23||||1966-06-01||1962-05-05|1973-05-22|
TRIAL STUDY 134XCP|QS|E3310689-5727-4970-A675-A58931E406FA|2|||||BEBQ CONCURRENT|||MMOL|||MG/L FEU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|U|2||58||BLINDED TREATMENT|1969-06-06||||1971-04-14||1968-01-03|1965-03-25|
TRIAL STUDY 134XCP|QS|E3310689-5727-4970-A675-A58931E406FA|3|||||WHODAS 2.0 - 12-ITEM INTERVIEWER|||DRINK|||MPH|NOT DONE||LIKERT SCALE 7-POINT|N|U|Y|3||39||INDUCTION TREATMENT|1963-10-31||||1962-05-30||1960-03-29|1970-03-28|
TRIAL STUDY 134XCP|QS|E3310689-5727-4970-A675-A58931E406FA|4|||||SOBDA|||PA|||WAFER|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|4||88||TREATMENT|1962-02-18||||1972-05-17||1970-03-22|1962-05-06|
TRIAL STUDY 134XCP|QS|E3310689-5727-4970-A675-A58931E406FA|5|||||BEBQ CONCURRENT|||10^9 ORGANISMS/G|||NCI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|5||7||SCREENING|1971-07-29||||1965-01-14||1971-07-05|1966-03-29|
TRIAL STUDY 134XCP|QS|D5359BBA-960E-4392-996A-BCDD8637894A|1|||||SIQ|||UMOL/DAY|||U/G HB|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|1||38||LONG-TERM FOLLOW-UP|1969-07-26||||1968-08-08||1964-10-15|1963-03-10|
TRIAL STUDY 134XCP|QS|D5359BBA-960E-4392-996A-BCDD8637894A|2|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||MOL/L|||ENZYME U/M2|NOT DONE||LIKERT SCALE 7-POINT|N|NA|NA|2||58||BLINDED TREATMENT|1963-02-01||||1962-10-27||1972-05-16|1961-12-13|
TRIAL STUDY 134XCP|QS|D5359BBA-960E-4392-996A-BCDD8637894A|3|||||MSWS-12|||LOG10 ELISA UNIT|||MG/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|U|3||39||OBSERVATION|1963-10-25||||1970-05-06||1968-01-11|1967-05-26|
TRIAL STUDY 134XCP|QS|D5359BBA-960E-4392-996A-BCDD8637894A|4|||||OCI|||UMOL/KG/MIN|||U/KG|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|4||88||TREATMENT|1972-11-17||||1964-08-19||1972-09-25|1969-11-23|
TRIAL STUDY 134XCP|QS|D5359BBA-960E-4392-996A-BCDD8637894A|5|||||SOWS SUBJECTIVE|||KBQ/UL|||MET*H|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|N|5||7||FOLLOW-UP|1968-10-31||||1971-11-04||1960-09-27|1964-06-02|
TRIAL STUDY 134XCP|QS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1|||||FACT-P V4|||ML/DL|||100 IU/ML|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|1||38||CONTINUATION TREATMENT|1973-04-17||||1965-03-19||1961-10-05|1963-07-01|
TRIAL STUDY 134XCP|QS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2|||||SF12 V2.0 STANDARD|||PT_BR|||/10^4|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|U|U|2||58||RUN-IN|1967-03-25||||1961-01-05||1962-01-06|1964-09-10|
TRIAL STUDY 134XCP|QS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|3|||||SF8 V1.0 ACUTE|||NKAT/G HB|||10^6 CFU/G|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|U|3||39||LONG-TERM FOLLOW-UP|1961-09-13||||1969-12-28||1961-06-28|1965-07-11|
TRIAL STUDY 134XCP|QS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|4|||||FKSI-DRS V4|||L/L|||CFU/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|Y|4||88||INDUCTION TREATMENT|1970-05-14||||1969-03-21||1972-09-12|1966-11-27|
TRIAL STUDY 134XCP|QS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|5|||||NCCN-FACT FOSI-18 V2|||NMOL/DAY|||MM/2H|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|5||7||SCREENING|1965-11-24||||1960-11-19||1963-08-18|1965-02-26|
TRIAL STUDY 134XCP|QS|EED3F55E-892E-46C6-8B0A-30D2E1112072|1|||||WHODAS 2.0 - 12-ITEM SELF|||GBQ/UG|||DPM/MG|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|1||38||CONTINUATION TREATMENT|1963-01-19||||1969-12-05||1966-12-25|1967-06-26|
TRIAL STUDY 134XCP|QS|EED3F55E-892E-46C6-8B0A-30D2E1112072|2|||||C-SSRS SCREENING|||MPA|||PELLET|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|2||58||OBSERVATION|1971-05-28||||1968-12-18||1962-03-05|1961-03-17|
TRIAL STUDY 134XCP|QS|EED3F55E-892E-46C6-8B0A-30D2E1112072|3|||||ACT|||MG|||ML/M2|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|3||39||OBSERVATION|1973-08-21||||1969-06-02||1970-02-15|1960-12-23|
TRIAL STUDY 134XCP|QS|EED3F55E-892E-46C6-8B0A-30D2E1112072|4|||||IPAQ-SF SELF-ADMINISTERED VERSION|||AU/ML|||G/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|4||88||CONTINUATION TREATMENT|1967-12-20||||1970-04-24||1961-08-13|1960-06-29|
TRIAL STUDY 134XCP|QS|EED3F55E-892E-46C6-8B0A-30D2E1112072|5|||||ADCS-ADL SEVERE DEMENTIA|||L/H/M2|||MU/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|U|5||7||TREATMENT|1964-07-21||||1968-10-31||1967-01-24|1968-04-18|
TRIAL STUDY 134XCP|QS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1|||||PEDS-FACIT-F|||MAC50|||NKAT/L|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|1||38||CONTINUATION TREATMENT|1964-09-05||||1973-01-09||1966-02-06|1963-09-24|
TRIAL STUDY 134XCP|QS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2|||||SF12 V2.0 STANDARD|||10^6 U|||UG/DAY|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|2||58||RUN-IN|1963-07-08||||1967-02-08||1961-10-20|1967-02-02|
TRIAL STUDY 134XCP|QS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|3|||||IBDQ|||MM/H|||10^7 PFU|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|U|3||39||OBSERVATION|1971-02-19||||1965-10-11||1966-03-17|1968-12-15|
TRIAL STUDY 134XCP|QS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|4|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||ML/CM H2O|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|4||88||BLINDED TREATMENT|1970-10-01||||1968-04-16||1973-03-08|1967-10-16|
TRIAL STUDY 134XCP|QS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||ML/H|||KA_U/DL|NOT DONE||LIKERT SCALE 5-POINT|U|U|Y|5||7||BASELINE|1965-12-29||||1971-03-10||1969-09-19|1971-11-07|
TRIAL STUDY 134XCP|QS|B865DADD-9A4E-4521-A2E8-104D709F4144|1|||||GCGI|||MET|||MIN*MG/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|N|1||38||INDUCTION TREATMENT|1963-08-02||||1965-01-23||1967-10-22|1960-08-07|
TRIAL STUDY 134XCP|QS|B865DADD-9A4E-4521-A2E8-104D709F4144|2|||||SF8 V1.0 ACUTE|||BLOCKS|||MIN/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|2||58||BASELINE|1962-04-15||||1973-02-23||1968-04-17|1969-09-20|
TRIAL STUDY 134XCP|QS|B865DADD-9A4E-4521-A2E8-104D709F4144|3|||||FACIT-DYSPNEA SF|||NMOL|||L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|U|NA|3||39||SCREENING|1971-01-22||||1963-09-12||1961-03-11|1973-07-25|
TRIAL STUDY 134XCP|QS|B865DADD-9A4E-4521-A2E8-104D709F4144|4|||||CDR|||NEWTON|||UG/ML/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|NA|4||88||BASELINE|1962-12-19||||1961-12-01||1970-03-14|1972-07-08|
TRIAL STUDY 134XCP|QS|B865DADD-9A4E-4521-A2E8-104D709F4144|5|||||ANSD V1.0|||10^5/HPF|||L/S/KPA|NOT DONE||LIKERT SCALE 3-POINT|N|U|NA|5||7||FOLLOW-UP|1969-09-23||||1963-05-18||1972-08-28|1961-12-14|
TRIAL STUDY 134XCP|QS|D8C78860-7893-4239-8F29-A0EE98C90310|1|||||YMRS|||VP/DOSE|||MMHG/L/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|1||38||OBSERVATION|1972-06-21||||1966-01-07||1968-05-09|1961-02-15|
TRIAL STUDY 134XCP|QS|D8C78860-7893-4239-8F29-A0EE98C90310|2|||||WHODAS 2.0 - 36-ITEM SELF|||BQ/L|||C|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|NA|NA|2||58||SCREENING|1971-01-27||||1960-11-14||1964-03-23|1972-07-03|
TRIAL STUDY 134XCP|QS|D8C78860-7893-4239-8F29-A0EE98C90310|3|||||NCCN-FACT FPSI-17 V2|||BOX|||MPL U/ML|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|3||39||OBSERVATION|1969-10-14||||1971-05-24||1961-08-24|1960-07-07|
TRIAL STUDY 134XCP|QS|D8C78860-7893-4239-8F29-A0EE98C90310|4|||||GDS|||DISK|||ML/S/M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|N|4||88||OBSERVATION|1966-09-27||||1968-01-20||1971-03-02|1968-11-08|
TRIAL STUDY 134XCP|QS|D8C78860-7893-4239-8F29-A0EE98C90310|5|||||EORTC QLQ-LC13|||NG|||10^8 PFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|U|5||7||OPEN LABEL TREATMENT|1968-08-28||||1961-12-05||1962-12-13|1961-07-18|
TRIAL STUDY 134XCP|QS|841D0118-C3F9-4169-B43E-D88CEB2795BA|1|||||FLSI|||BLOCKS|||MNFI|NOT DONE||LIKERT SCALE 3-POINT|N|NA|NA|1||38||LONG-TERM FOLLOW-UP|1966-04-05||||1966-04-15||1972-12-16|1969-12-25|
TRIAL STUDY 134XCP|QS|841D0118-C3F9-4169-B43E-D88CEB2795BA|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||VIRTUAL PIXEL|||ML/G/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|2||58||LONG-TERM FOLLOW-UP|1971-07-11||||1968-07-06||1961-08-22|1968-02-11|
TRIAL STUDY 134XCP|QS|841D0118-C3F9-4169-B43E-D88CEB2795BA|3|||||SF36 V2.0 ACUTE|||MG/KG/DOSE|||ML/M2/MIN|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|NA|3||39||WASHOUT|1966-09-09||||1966-02-15||1972-02-19|1969-08-08|
TRIAL STUDY 134XCP|QS|841D0118-C3F9-4169-B43E-D88CEB2795BA|4|||||FACIT-DYSPNEA SF|||KAT|||SFC/10^6 PBMC|NOT DONE||LIKERT SCALE 7-POINT|NA|U|NA|4||88||TREATMENT|1967-11-24||||1970-05-01||1962-05-06|1972-12-12|
TRIAL STUDY 134XCP|QS|841D0118-C3F9-4169-B43E-D88CEB2795BA|5|||||COMM|||FL|||ML/CM H2O|NOT DONE||LIKERT SCALE 5-POINT|N|U|NA|5||7||INDUCTION TREATMENT|1973-03-25||||1970-09-09||1972-10-29|1962-02-04|
TRIAL STUDY 134XCP|QS|9C3C0334-F7A4-4530-A6D3-574C039979E7|1|||||FACIT-DYSPNEA SF|||10^3 CFU|||CI/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|N|1||38||INDUCTION TREATMENT|1971-06-16||||1971-05-20||1963-11-28|1971-08-29|
TRIAL STUDY 134XCP|QS|9C3C0334-F7A4-4530-A6D3-574C039979E7|2|||||FLSI|||SCOOPFUL|||L|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|2||58||OBSERVATION|1973-04-14||||1969-09-02||1972-03-05|1965-07-08|
TRIAL STUDY 134XCP|QS|9C3C0334-F7A4-4530-A6D3-574C039979E7|3|||||PROSQOLI|||G/M2/DAY|||UL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|N|3||39||CONTINUATION TREATMENT|1960-06-04||||1966-11-02||1972-09-27|1964-01-05|
TRIAL STUDY 134XCP|QS|9C3C0334-F7A4-4530-A6D3-574C039979E7|4|||||DAD|||MSEC|||AMFI|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|U|4||88||SCREENING|1969-10-17||||1969-12-11||1971-04-27|1968-01-14|
TRIAL STUDY 134XCP|QS|9C3C0334-F7A4-4530-A6D3-574C039979E7|5|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN|||CY/CM|||/HPF|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|5||7||RUN-IN|1967-10-02||||1963-10-05||1964-08-18|1966-07-03|
TRIAL STUDY 134XCP|QS|FE955CB9-9992-4521-8788-7597AF40F214|1|||||GAD-7|||1/(S*KPA)|||UG/KG/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|1||38||OPEN LABEL TREATMENT|1970-02-02||||1968-05-13||1966-08-23|1962-06-09|
TRIAL STUDY 134XCP|QS|FE955CB9-9992-4521-8788-7597AF40F214|2|||||BPI SHORT FORM|||10^3 DNA COPIES/ML|||UG/MOL|NOT DONE||LIKERT SCALE 5-POINT|N|NA|U|2||58||RUN-IN|1960-10-08||||1971-12-17||1961-04-04|1967-03-22|
TRIAL STUDY 134XCP|QS|FE955CB9-9992-4521-8788-7597AF40F214|3|||||FIQR|||ML/CM|||DL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|Y|3||39||OBSERVATION|1963-06-22||||1966-01-08||1969-12-29|1966-11-29|
TRIAL STUDY 134XCP|QS|FE955CB9-9992-4521-8788-7597AF40F214|4|||||FACT-TAXANE V4|||IU/L|||S*KPA|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|4||88||CONTINUATION TREATMENT|1965-01-22||||1969-01-29||1973-02-07|1961-04-13|
TRIAL STUDY 134XCP|QS|FE955CB9-9992-4521-8788-7597AF40F214|5|||||TSCC|||MCI/L|||DPM/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|N|5||7||BASELINE|1963-01-06||||1972-02-11||1964-06-16|1969-12-24|
TRIAL STUDY 134XCP|QS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1|||||ASEX-FEMALE|||NMOL/G|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|1||38||SCREENING|1972-12-24||||1965-08-17||1961-04-22|1967-12-04|
TRIAL STUDY 134XCP|QS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2|||||SMDDS V1.0|||COPIES/UG|||LOG10 PFU|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|2||58||SCREENING|1965-11-25||||1962-04-05||1966-03-07|1965-12-26|
TRIAL STUDY 134XCP|QS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|3|||||AUDIT-SR|||ABSORBANCE U/MIN|||YEARS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|U|3||39||RUN-IN|1970-08-18||||1963-12-25||1973-02-04|1962-07-21|
TRIAL STUDY 134XCP|QS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|4|||||TSCC|||UV|||AMU|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|NA|4||88||WASHOUT|1968-08-12||||1968-01-03||1971-12-22|1970-04-25|
TRIAL STUDY 134XCP|QS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|5|||||PODCI - ADOLESCENT SELF REPORTED|||BISCUIT|||PMOL/DL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|5||7||WASHOUT|1961-10-29||||1972-06-03||1961-11-03|1965-01-04|
TRIAL STUDY 134XCP|QS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||10^6 COPIES/ML|||DAGU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|1||38||TREATMENT|1967-10-08||||1963-09-20||1965-04-05|1966-05-21|
TRIAL STUDY 134XCP|QS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2|||||YMRS|||M/SEC|||MBQ/UL|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|2||58||BLINDED TREATMENT|1961-10-08||||1966-07-15||1963-03-25|1960-06-07|
TRIAL STUDY 134XCP|QS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|3|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||NMOL BCE/MMOL|||ENZYME U/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|3||39||BASELINE|1967-05-06||||1969-11-06||1967-07-26|1964-06-28|
TRIAL STUDY 134XCP|QS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|4|||||FACT-TAXANE V4|||CM H2O|||10^3 ORGANISMS/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|U|4||88||LONG-TERM FOLLOW-UP|1961-06-27||||1964-05-25||1966-02-23|1970-03-29|
TRIAL STUDY 134XCP|QS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|5|||||C-SSRS SCREENING|||LOG10 CFU/G|||CFU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|U|5||7||BASELINE|1960-09-08||||1963-09-14||1960-12-07|1963-02-09|
TRIAL STUDY 134XCP|QS|28B6CF51-A007-4CED-8247-37BD468F41C5|1|||||SF12 V2.0 ACUTE|||MM/MIN|||CUP EQ|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|N|1||38||INDUCTION TREATMENT|1960-01-20||||1961-09-18||1962-10-12|1964-08-29|
TRIAL STUDY 134XCP|QS|28B6CF51-A007-4CED-8247-37BD468F41C5|2|||||EORTC QLQ-C15-PAL V1.0|||DEG|||MMHG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|2||58||BASELINE|1964-09-10||||1970-12-30||1963-07-24|1963-04-29|
TRIAL STUDY 134XCP|QS|28B6CF51-A007-4CED-8247-37BD468F41C5|3|||||MFIS|||AMFI|||UG/L/H|NOT DONE||LIKERT SCALE 7-POINT|U|U|N|3||39||RUN-IN|1960-02-08||||1970-01-17||1960-02-09|1972-12-14|
TRIAL STUDY 134XCP|QS|28B6CF51-A007-4CED-8247-37BD468F41C5|4|||||SF36 V2.0 ACUTE|||U/ML|||MPH|NOT DONE||LIKERT SCALE 5-POINT|N|N|N|4||88||OPEN LABEL TREATMENT|1966-12-19||||1962-08-11||1960-03-01|1965-04-01|
TRIAL STUDY 134XCP|QS|28B6CF51-A007-4CED-8247-37BD468F41C5|5|||||MDQ-T|||NKAT|||MG/G/MIN|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|U|5||7||CONTINUATION TREATMENT|1965-11-05||||1973-05-01||1968-03-09|1960-02-28|
TRIAL STUDY 134XCP|QS|4E600C41-1B27-4042-B48E-B60489701D2D|1|||||PHQ SCREENER VERSION|||UG/MIN|||MEQ/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|N|1||38||RUN-IN|1963-06-30||||1964-09-19||1961-01-17|1966-01-22|
TRIAL STUDY 134XCP|QS|4E600C41-1B27-4042-B48E-B60489701D2D|2|||||WHODAS 2.0 - 12-ITEM PROXY|||10^6 IU/ML|||L/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|N|U|2||58||SCREENING|1967-11-04||||1969-05-12||1969-07-11|1963-11-20|
TRIAL STUDY 134XCP|QS|4E600C41-1B27-4042-B48E-B60489701D2D|3|||||PARTNER-DDS|||L/S|||MMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|3||39||BLINDED TREATMENT|1968-06-06||||1962-09-10||1973-06-11|1970-09-04|
TRIAL STUDY 134XCP|QS|4E600C41-1B27-4042-B48E-B60489701D2D|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||UMOL/DL|||MSEC|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|N|4||88||LONG-TERM FOLLOW-UP|1965-10-17||||1969-07-18||1962-11-22|1968-02-27|
TRIAL STUDY 134XCP|QS|4E600C41-1B27-4042-B48E-B60489701D2D|5|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III|||G/ANIMAL/WK|||PFU/ANIMAL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|U|5||7||SCREENING|1964-02-23||||1968-07-26||1973-08-20|1966-03-28|
TRIAL STUDY 134XCP|QS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1|||||GOSE|||M|||CI/MG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|Y|1||38||BLINDED TREATMENT|1961-08-20||||1965-07-01||1960-02-01|1961-12-27|
TRIAL STUDY 134XCP|QS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2|||||EPDS|||MM/SEC|||STEPS|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|Y|2||58||TREATMENT|1970-12-22||||1969-03-07||1973-03-08|1973-06-11|
TRIAL STUDY 134XCP|QS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|3|||||EPDS|||MG/G/H|||U/G HB|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|3||39||SCREENING|1967-08-25||||1968-04-01||1970-05-30|1972-11-21|
TRIAL STUDY 134XCP|QS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|4|||||PARENT-DDS|||ENZYME U/L|||SACHET|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|4||88||TREATMENT|1972-03-10||||1961-09-23||1968-10-23|1964-05-31|
TRIAL STUDY 134XCP|QS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|5|||||DAD|||MET|||10^12 IU/L|NOT DONE||LIKERT SCALE 7-POINT|U|U|U|5||7||INDUCTION TREATMENT|1966-08-04||||1962-09-04||1973-06-19|1963-02-26|
TRIAL STUDY 134XCP|QS|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1|||||FACT-HEP V4|||EQ|||DEG2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|Y|U|1||38||BLINDED TREATMENT|1965-03-12||||1965-01-30||1971-06-24|1963-04-25|
TRIAL STUDY 134XCP|QS|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2|||||FLSI|||10^6 CFU|||MIN*MG/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|2||58||OBSERVATION|1965-09-12||||1972-04-08||1967-07-28|1960-08-14|
TRIAL STUDY 134XCP|QS|00D760E7-DC21-41A8-AD28-FF48A5C21E83|3|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||100 IU/ML|||UG/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|NA|3||39||RUN-IN|1960-02-14||||1960-01-24||1965-12-02|1965-12-29|
TRIAL STUDY 134XCP|QS|00D760E7-DC21-41A8-AD28-FF48A5C21E83|4|||||FBRSI|||ML/M2/MIN|||NMOL/ML/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|4||88||WASHOUT|1965-07-03||||1960-01-23||1971-02-14|1968-05-05|
TRIAL STUDY 134XCP|QS|00D760E7-DC21-41A8-AD28-FF48A5C21E83|5|||||GAD-7|||PPB|||KG/CM2|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|NA|5||7||INDUCTION TREATMENT|1971-06-02||||1964-03-20||1973-07-15|1960-03-17|
TRIAL STUDY 134XCP|QS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1|||||EPIC-26|||ENZYME U|||10^6/HPF|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|N|1||38||WASHOUT|1962-09-06||||1967-12-10||1968-08-13|1965-05-01|
TRIAL STUDY 134XCP|QS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2|||||MADRS|||NMOL BCE/L|||MG/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|N|2||58||OPEN LABEL TREATMENT|1973-05-19||||1965-10-08||1971-10-27|1971-01-20|
TRIAL STUDY 134XCP|QS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|3|||||ANSD V1.0|||LOG10 CFU/ML|||C|NOT DONE||LIKERT SCALE 5-POINT|U|N|NA|3||39||RUN-IN|1967-10-18||||1968-08-03||1960-03-20|1971-11-06|
TRIAL STUDY 134XCP|QS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|4|||||EORTC QLQ-C30 V3.0|||MCI|||LOG10 TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|N|4||88||SCREENING|1965-08-22||||1967-09-02||1965-11-15|1970-05-19|
TRIAL STUDY 134XCP|QS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|5|||||FACIT-FATIGUE 13-ITEM V4|||MG/KG/H|||MGEQ|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|Y|5||7||INDUCTION TREATMENT|1960-03-07||||1971-02-22||1972-05-15|1969-11-09|
TRIAL STUDY 134XCP|QS|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1|||||SF10 V1.0 CHILDREN ACUTE|||U/ML|||UMOL/L/MIN|NOT DONE||LIKERT SCALE 5-POINT|N|Y|NA|1||38||BASELINE|1964-05-25||||1971-03-20||1969-05-23|1961-11-08|
TRIAL STUDY 134XCP|QS|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2|||||EORTC QLQ-CR29 V2.1|||L/H|||GAUSS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|Y|2||58||WASHOUT|1963-06-28||||1972-05-09||1971-07-27|1962-03-02|
TRIAL STUDY 134XCP|QS|4EC25C9E-F259-405B-8B7D-3C9640FB9748|3|||||EXACT|||MOL|||MU/G|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|U|3||39||FOLLOW-UP|1965-11-11||||1965-07-31||1961-03-04|1963-01-31|
TRIAL STUDY 134XCP|QS|4EC25C9E-F259-405B-8B7D-3C9640FB9748|4|||||FPSR|||HPA|||PACKAGE|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|4||88||FOLLOW-UP|1964-02-17||||1963-03-05||1968-04-27|1967-10-21|
TRIAL STUDY 134XCP|QS|4EC25C9E-F259-405B-8B7D-3C9640FB9748|5|||||EPDS|||IU/L|||MOL/L|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|N|5||7||RUN-IN|1971-08-07||||1968-04-21||1961-05-25|1970-01-30|
TRIAL STUDY 134XCP|QS|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1|||||HCS|||ARBITRARY U|||UG/KG/DAY|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|1||38||TREATMENT|1971-02-26||||1964-03-03||1961-07-02|1962-03-13|
TRIAL STUDY 134XCP|QS|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2|||||AQ20|||IMPLANT|||DPM/0.5 ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|N|2||58||BLINDED TREATMENT|1971-07-03||||1962-09-11||1973-08-06|1967-07-12|
TRIAL STUDY 134XCP|QS|FF1CC617-040D-42E9-AD31-32E7B8DAED24|3|||||MSIS-29 V1|||FMOL/L/SEC|||KPA/L/SEC|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|Y|3||39||BLINDED TREATMENT|1964-06-25||||1969-05-12||1966-06-21|1965-09-09|
TRIAL STUDY 134XCP|QS|FF1CC617-040D-42E9-AD31-32E7B8DAED24|4|||||ODI V2.1A|||G/G|||MCI/KG|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|4||88||FOLLOW-UP|1968-06-05||||1965-01-08||1965-02-06|1961-05-09|
TRIAL STUDY 134XCP|QS|FF1CC617-040D-42E9-AD31-32E7B8DAED24|5|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||MG/M2/H|||TCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|U|5||7||CONTINUATION TREATMENT|1970-09-10||||1971-05-13||1962-07-18|1969-05-27|
TRIAL STUDY 134XCP|QS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1|||||FLSI|||UMOL/DAY|||VP/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|Y|1||38||INDUCTION TREATMENT|1962-04-17||||1969-04-18||1961-02-05|1962-02-10|
TRIAL STUDY 134XCP|QS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III|||10^4/HPF|||BQ/UL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|Y|Y|2||58||FOLLOW-UP|1966-05-23||||1969-06-07||1960-09-16|1968-11-17|
TRIAL STUDY 134XCP|QS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|3|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||ML/MIN|||G/ANIMAL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|NA|Y|3||39||TREATMENT|1962-10-04||||1961-12-11||1968-09-03|1972-06-21|
TRIAL STUDY 134XCP|QS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|4|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||U/L|||BQ/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|4||88||SCREENING|1972-03-22||||1965-07-19||1969-02-06|1968-10-28|
TRIAL STUDY 134XCP|QS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|5|||||ACT|||L/S|||NEEDLE GAUGE|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|5||7||OPEN LABEL TREATMENT|1971-10-06||||1973-03-06||1966-07-28|1970-01-20|
TRIAL STUDY 134XCP|QS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1|||||C-SSRS LIFETIME/RECENT VERSION|||LOG10 PFU/ML|||ROENTGEN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|N|1||38||CONTINUATION TREATMENT|1966-03-27||||1960-06-03||1964-08-13|1961-11-09|
TRIAL STUDY 134XCP|QS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2|||||SMDDS V1.0|||UG/L|||LOG10 TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|2||58||BASELINE|1967-08-19||||1961-01-08||1969-07-18|1962-04-04|
TRIAL STUDY 134XCP|QS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|3|||||GMSS VERSION TYPE 1 DIABETES|||/WK|||MET*H|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|3||39||RUN-IN|1968-11-01||||1969-05-03||1963-03-30|1969-02-15|
TRIAL STUDY 134XCP|QS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|4|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||ML/S/M2|||CI/UG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|Y|4||88||BLINDED TREATMENT|1964-07-09||||1964-07-10||1964-07-08|1966-07-08|
TRIAL STUDY 134XCP|QS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|5|||||FACT-C V4|||EIA UNIT|||CARTRIDGE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|N|5||7||SCREENING|1970-10-22||||1965-04-24||1960-09-22|1965-04-08|
TRIAL STUDY 134XCP|QS|BFA83769-F31F-49AE-8C43-49046C719D69|1|||||FOSI|||MEQ/ML|||USIEMENS|NOT DONE||LIKERT SCALE 7-POINT|N|Y|Y|1||38||LONG-TERM FOLLOW-UP|1960-03-16||||1968-07-23||1971-09-03|1970-02-09|
TRIAL STUDY 134XCP|QS|BFA83769-F31F-49AE-8C43-49046C719D69|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||KCAL|||L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|Y|2||58||WASHOUT|1971-05-18||||1964-11-02||1960-11-01|1973-06-29|
TRIAL STUDY 134XCP|QS|BFA83769-F31F-49AE-8C43-49046C719D69|3|||||C-SSRS CHILDREN'S BASELINE|||BQ/UG|||OSM|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|3||39||CONTINUATION TREATMENT|1964-01-24||||1965-06-09||1966-11-09|1965-04-12|
TRIAL STUDY 134XCP|QS|BFA83769-F31F-49AE-8C43-49046C719D69|4|||||FACT-LEU V4|||UMOL/L/MIN|||SQU/ML|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|4||88||CONTINUATION TREATMENT|1968-07-15||||1962-12-14||1967-12-16|1962-11-17|
TRIAL STUDY 134XCP|QS|BFA83769-F31F-49AE-8C43-49046C719D69|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||UMOL/L|||NG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|NA|5||7||SCREENING|1967-10-26||||1960-07-28||1965-05-24|1964-12-26|
TRIAL STUDY 134XCP|QS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1|||||EPIC-26|||LOG10 TCID 50/ML|||UL/KG/DAY|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|Y|1||38||CONTINUATION TREATMENT|1967-03-11||||1968-11-08||1969-03-22|1967-02-05|
TRIAL STUDY 134XCP|QS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2|||||FLU-IIQ ONCE DAILY|||MG/DL|||UIU/L|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|NA|2||58||INDUCTION TREATMENT|1967-10-05||||1966-07-16||1967-10-22|1966-08-16|
TRIAL STUDY 134XCP|QS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|3|||||FAMS|||MANSON U/ML|||MBQ|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|Y|3||39||CONTINUATION TREATMENT|1970-03-07||||1965-03-13||1969-09-19|1965-12-01|
TRIAL STUDY 134XCP|QS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|4|||||EXPANDED DRS-PI SURVIVOR VERSION|||PA|||SBE/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|U|4||88||RUN-IN|1972-06-22||||1961-02-21||1961-02-08|1964-05-14|
TRIAL STUDY 134XCP|QS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|5|||||OAB-Q SHORT FORM|||UG/L|||UG|NOT DONE||LIKERT SCALE 3-POINT|NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1968-07-22||||1971-10-04||1969-09-16|1972-08-19|
TRIAL STUDY 134XCP|QS|91838668-D463-4728-A581-2E1987592885|1|||||BEBQ CONCURRENT|||STEPS/MIN|||TORR|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|1||38||FOLLOW-UP|1973-02-27||||1972-06-26||1971-11-30|1963-04-11|
TRIAL STUDY 134XCP|QS|91838668-D463-4728-A581-2E1987592885|2|||||CES|||BQ/KG|||NEWTON|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|U|2||58||INDUCTION TREATMENT|1968-07-20||||1961-04-24||1963-10-22|1968-08-06|
TRIAL STUDY 134XCP|QS|91838668-D463-4728-A581-2E1987592885|3|||||SF36 V1.0 STANDARD|||G/ANIMAL/WK|||BU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|3||39||INDUCTION TREATMENT|1971-12-23||||1967-06-16||1962-09-29|1962-02-09|
TRIAL STUDY 134XCP|QS|91838668-D463-4728-A581-2E1987592885|4|||||ANSD V1.0|||MEQ/UL|||AMFI|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|NA|4||88||BASELINE|1967-07-08||||1967-12-03||1970-09-17|1966-03-15|
TRIAL STUDY 134XCP|QS|91838668-D463-4728-A581-2E1987592885|5|||||FACT-C V4|||MMOL|||M2|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|U|5||7||FOLLOW-UP|1965-10-22||||1972-12-06||1969-09-01|1963-01-18|
TRIAL STUDY 134XCP|QS|DE440A90-82D5-4269-A48B-47E2F5495440|1|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||DNA COPIES/UG|||APPLICATION|NOT DONE||LIKERT SCALE 3-POINT|N|U|N|1||38||BLINDED TREATMENT|1972-12-29||||1964-09-27||1971-10-20|1964-07-18|
TRIAL STUDY 134XCP|QS|DE440A90-82D5-4269-A48B-47E2F5495440|2|||||EPDS|||TCID 50/DOSE|||CM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|2||58||BASELINE|1969-11-13||||1964-07-17||1966-04-06|1969-09-01|
TRIAL STUDY 134XCP|QS|DE440A90-82D5-4269-A48B-47E2F5495440|3|||||WOMAC VA 3.1 INDEX|||FRAMES/S|||TSP EQ|NOT DONE||LIKERT SCALE 3-POINT|N|Y|N|3||39||WASHOUT|1973-04-03||||1967-03-06||1972-08-04|1971-07-31|
TRIAL STUDY 134XCP|QS|DE440A90-82D5-4269-A48B-47E2F5495440|4|||||GMSS VERSION TYPE 1 DIABETES|||G/ANIMAL/WK|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|4||88||CONTINUATION TREATMENT|1971-04-10||||1972-03-02||1961-12-08|1970-09-08|
TRIAL STUDY 134XCP|QS|DE440A90-82D5-4269-A48B-47E2F5495440|5|||||IDS-SR|||PPTH|||CD*S/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|N|5||7||FOLLOW-UP|1967-11-27||||1960-07-05||1962-11-03|1970-05-28|
TRIAL STUDY 134XCP|QS|74CA3A61-3179-43F1-8721-2582F50C44EF|1|||||WPAI-SHP V2.0|||MGEQ|||AFU|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|1||38||WASHOUT|1973-05-05||||1963-06-20||1962-09-16|1963-07-08|
TRIAL STUDY 134XCP|QS|74CA3A61-3179-43F1-8721-2582F50C44EF|2|||||IPAQ-SF PHONE VERSION|||FRAMES/S|||NGEQ/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|U|2||58||TREATMENT|1971-02-18||||1972-10-16||1970-03-12|1967-10-27|
TRIAL STUDY 134XCP|QS|74CA3A61-3179-43F1-8721-2582F50C44EF|3|||||IPAQ-SF PHONE VERSION|||U/G/MIN|||RATIO|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|Y|3||39||SCREENING|1964-11-19||||1964-03-31||1966-10-22|1962-11-05|
TRIAL STUDY 134XCP|QS|74CA3A61-3179-43F1-8721-2582F50C44EF|4|||||NPI|||MG/KG/MIN|||KS|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|4||88||SCREENING|1973-06-16||||1971-08-21||1967-11-27|1960-04-03|
TRIAL STUDY 134XCP|QS|74CA3A61-3179-43F1-8721-2582F50C44EF|5|||||YMRS|||BAU|||NMOL/DAY|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|NA|5||7||SCREENING|1961-10-25||||1969-12-12||1968-10-31|1967-11-23|
TRIAL STUDY 134XCP|QS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||TABLET|||AG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|Y|1||38||SCREENING|1961-08-25||||1972-03-13||1968-05-25|1960-06-18|
TRIAL STUDY 134XCP|QS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2|||||NCCN-FACT FHNSI-22 V2|||KN/CM2|||MCI/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|2||58||LONG-TERM FOLLOW-UP|1961-10-21||||1964-10-30||1967-08-05|1972-07-09|
TRIAL STUDY 134XCP|QS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|3|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||H/WK|||/MM|NOT DONE||LIKERT SCALE 3-POINT|U|U|NA|3||39||OPEN LABEL TREATMENT|1960-01-27||||1966-08-10||1965-09-11|1968-11-06|
TRIAL STUDY 134XCP|QS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|4|||||ASEX-MALE|||UKAT/L|||G|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|4||88||TREATMENT|1969-06-11||||1968-07-10||1971-11-06|1963-08-12|
TRIAL STUDY 134XCP|QS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|5|||||UPDRS|||ELISA UNIT/DOSE|||CM H2O|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|U|5||7||OBSERVATION|1968-10-27||||1966-07-07||1964-02-16|1963-08-06|
TRIAL STUDY 134XCP|QS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1|||||FAS-NACC UDS V3.0|||CAL|||CFU/ML|NOT DONE||LIKERT SCALE 3-POINT|NA|U|U|1||38||LONG-TERM FOLLOW-UP|1972-08-23||||1960-08-01||1967-12-23|1960-10-05|
TRIAL STUDY 134XCP|QS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||10^3 CFU/ML|||DYN|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|N|2||58||OPEN LABEL TREATMENT|1967-01-15||||1963-03-28||1969-02-06|1970-08-17|
TRIAL STUDY 134XCP|QS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|3|||||TSCYC|||MEQ/L|||MG/MOL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|3||39||OBSERVATION|1963-06-03||||1962-02-08||1972-08-26|1964-07-28|
TRIAL STUDY 134XCP|QS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|4|||||FACT-HEP V4|||U/M2/DAY|||CM/S|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|Y|4||88||CONTINUATION TREATMENT|1964-01-17||||1972-12-25||1962-10-24|1966-07-26|
TRIAL STUDY 134XCP|QS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|5|||||BIS-11|||VG/KG|||AMU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|5||7||SCREENING|1960-03-24||||1970-12-13||1970-07-19|1960-07-27|
TRIAL STUDY 134XCP|QS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1|||||FLU-IIQ TWICE DAILY|||G/M2|||DPM/0.5 ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|U|1||38||RUN-IN|1963-04-01||||1972-03-16||1960-07-12|1967-02-22|
TRIAL STUDY 134XCP|QS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||ENZYME U/M2|||CCID 50/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|NA|2||58||CONTINUATION TREATMENT|1964-11-03||||1972-09-29||1960-02-14|1969-04-01|
TRIAL STUDY 134XCP|QS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|3|||||AUDIT-C|||STRIP|||UGEQ/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|N|3||39||CONTINUATION TREATMENT|1960-07-15||||1973-05-18||1968-10-08|1970-03-15|
TRIAL STUDY 134XCP|QS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|4|||||SWLS|||CM2|||L/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|4||88||BLINDED TREATMENT|1964-09-26||||1970-02-27||1962-01-15|1971-05-28|
TRIAL STUDY 134XCP|QS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|5|||||HAMD 6 SELF-REPORT VERSION|||FMOL/G|||UG/L|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|U|5||7||OBSERVATION|1970-05-16||||1964-03-10||1962-12-19|1972-10-21|
TRIAL STUDY 134XCP|QS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1|||||FAS-NACC UDS V3.0|||DRINK|||MM|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|NA|1||38||OBSERVATION|1963-01-31||||1971-11-18||1972-09-27|1961-11-28|
TRIAL STUDY 134XCP|QS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2|||||PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT|||ELISA UNIT/DOSE|||SHOCK WAVE|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|2||58||CONTINUATION TREATMENT|1971-05-24||||1961-07-30||1962-01-11|1967-06-13|
TRIAL STUDY 134XCP|QS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|3|||||FACT/GOG-NTX V4|||LOG10 CCID 50/DOSE|||CCID 50/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|N|3||39||TREATMENT|1968-04-11||||1960-04-01||1972-10-08|1967-08-19|
TRIAL STUDY 134XCP|QS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|4|||||IPAQ-LF PHONE VERSION|||PMOL/G|||G/L|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|4||88||WASHOUT|1966-02-12||||1966-08-03||1972-10-02|1968-06-30|
TRIAL STUDY 134XCP|QS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|5|||||COWS|||U/G/H|||MMOL/MIN/KPA/L|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|5||7||SCREENING|1973-01-30||||1961-03-11||1962-02-28|1963-03-29|
TRIAL STUDY 134XCP|QS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I|||10^6/EJACULATE U|||UMOL/L|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|N|N|1||38||OBSERVATION|1964-05-13||||1969-11-16||1961-03-06|1960-06-04|
TRIAL STUDY 134XCP|QS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2|||||COMM|||GRAVITATIONAL UNIT|||TESLA|NOT DONE||VERBAL RATING SCALE 5-POINT|N|N|NA|2||58||BLINDED TREATMENT|1968-09-13||||1969-11-23||1966-12-02|1961-05-31|
TRIAL STUDY 134XCP|QS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|3|||||CHART-SF INTERVIEW VERSION|||LOG10 CFU/ML|||G/ANIMAL/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|U|3||39||CONTINUATION TREATMENT|1971-10-23||||1968-04-30||1960-09-15|1962-10-23|
TRIAL STUDY 134XCP|QS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|4|||||FACT-P V4|||L/MIN|||LOG10 COPIES/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|U|4||88||BASELINE|1971-01-11||||1968-11-20||1971-10-15|1971-03-21|
TRIAL STUDY 134XCP|QS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|5|||||MADRS|||FINGERTIP UNIT|||BEL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|N|5||7||WASHOUT|1960-10-28||||1967-03-28||1973-07-20|1972-08-29|
TRIAL STUDY 134XCP|QS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||LX|||GBQ/MG|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|1||38||INDUCTION TREATMENT|1966-05-29||||1970-01-25||1970-08-26|1963-05-21|
TRIAL STUDY 134XCP|QS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2|||||NCCN-FACT FHNSI-22 V2|||BU|||U/CL|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|2||58||WASHOUT|1961-12-16||||1967-11-14||1960-04-09|1962-08-18|
TRIAL STUDY 134XCP|QS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|3|||||C-SSRS BASELINE|||PA|||SACHET|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|U|3||39||FOLLOW-UP|1970-12-06||||1968-10-30||1967-11-23|1969-01-20|
TRIAL STUDY 134XCP|QS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|4|||||DLQI|||DAGU/ML|||CI/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|4||88||WASHOUT|1962-02-06||||1966-05-16||1964-09-29|1963-01-10|
TRIAL STUDY 134XCP|QS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|5|||||FACT-TAXANE V4|||CP|||VG/DOSE|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|N|5||7||CONTINUATION TREATMENT|1972-10-03||||1972-08-26||1967-08-21|1970-08-15|
TRIAL STUDY 134XCP|QS|687E56D1-7E45-4598-819A-A0D8D770F406|1|||||AUDIT-C|||HENRY|||MG/M2/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|1||38||SCREENING|1963-07-25||||1963-04-10||1969-10-02|1965-10-01|
TRIAL STUDY 134XCP|QS|687E56D1-7E45-4598-819A-A0D8D770F406|2|||||FACT-BL V4|||APL U|||HR/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|U|2||58||INDUCTION TREATMENT|1967-11-08||||1961-05-04||1960-01-15|1969-11-07|
TRIAL STUDY 134XCP|QS|687E56D1-7E45-4598-819A-A0D8D770F406|3|||||SMDDS V1.0|||DL|||UG/KG/MIN|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|NA|3||39||SCREENING|1970-02-19||||1972-03-22||1966-02-28|1961-04-23|
TRIAL STUDY 134XCP|QS|687E56D1-7E45-4598-819A-A0D8D770F406|4|||||FOSI|||/LPF|||TRANSDUCING UNIT/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|N|4||88||BASELINE|1969-02-14||||1973-09-04||1962-07-11|1969-03-09|
TRIAL STUDY 134XCP|QS|687E56D1-7E45-4598-819A-A0D8D770F406|5|||||SF10 V1.0 CHILDREN ACUTE|||VG/ML|||WEEKS|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|5||7||BLINDED TREATMENT|1971-04-01||||1973-01-27||1970-10-27|1965-02-13|
TRIAL STUDY 134XCP|QS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1|||||CES|||PMOL/DL|||NKAT/G HB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|1||38||SCREENING|1969-03-18||||1971-10-05||1965-06-28|1969-07-31|
TRIAL STUDY 134XCP|QS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT|||IU/L|||DEG/MM|NOT DONE||LIKERT SCALE 7-POINT|Y|U|N|2||58||LONG-TERM FOLLOW-UP|1960-04-29||||1970-10-24||1969-06-18|1970-06-02|
TRIAL STUDY 134XCP|QS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|3|||||CDR|||GPELISA UNIT/ML|||10^9 ORGANISMS/MG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|U|3||39||OPEN LABEL TREATMENT|1972-05-17||||1963-06-15||1962-09-15|1970-08-27|
TRIAL STUDY 134XCP|QS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||COAT|||P|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|Y|4||88||SCREENING|1960-05-04||||1964-09-25||1970-08-08|1962-06-09|
TRIAL STUDY 134XCP|QS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|5|||||VFQ-25 SELF ADMINISTERED|||NFIU|||BISCUIT|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|N|5||7||TREATMENT|1970-01-05||||1961-06-23||1963-10-17|1962-06-09|
TRIAL STUDY 134XCP|QS|F536FDD9-881B-41AD-B863-FE8AB14062A1|1|||||HAQ-DI WITHOUT VAS|||10^6 IU/ML|||CMOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|N|NA|1||38||RUN-IN|1966-05-31||||1972-05-19||1968-02-27|1972-09-05|
TRIAL STUDY 134XCP|QS|F536FDD9-881B-41AD-B863-FE8AB14062A1|2|||||Q-LES-Q-SF|||MMOL|||IMPLANT|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|U|2||58||CONTINUATION TREATMENT|1968-11-28||||1969-10-22||1973-02-17|1967-09-10|
TRIAL STUDY 134XCP|QS|F536FDD9-881B-41AD-B863-FE8AB14062A1|3|||||DAD|||UG/L DDU|||FRAMES/S|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|Y|3||39||INDUCTION TREATMENT|1972-08-04||||1961-11-23||1967-10-26|1963-10-22|
TRIAL STUDY 134XCP|QS|F536FDD9-881B-41AD-B863-FE8AB14062A1|4|||||EXACT|||IU/DAY|||/KG|NOT DONE||LIKERT SCALE 5-POINT|NA|N|NA|4||88||CONTINUATION TREATMENT|1972-02-04||||1968-03-11||1960-11-12|1966-08-03|
TRIAL STUDY 134XCP|QS|F536FDD9-881B-41AD-B863-FE8AB14062A1|5|||||SF12 V1.0 ACUTE|||10^3/HPF|||KS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|NA|5||7||OPEN LABEL TREATMENT|1969-06-16||||1966-01-01||1961-06-08|1967-09-22|
TRIAL STUDY 134XCP|QS|CB726766-A812-45B3-95CA-D1AD8F697FD3|1|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||CAPFUL|||POUCH|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|Y|1||38||BLINDED TREATMENT|1961-01-14||||1971-09-27||1965-07-27|1962-05-04|
TRIAL STUDY 134XCP|QS|CB726766-A812-45B3-95CA-D1AD8F697FD3|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||IMPLANT|||UG/M2/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|U|2||58||SCREENING|1966-10-19||||1973-03-01||1964-04-09|1965-11-05|
TRIAL STUDY 134XCP|QS|CB726766-A812-45B3-95CA-D1AD8F697FD3|3|||||FACT-LYM V4|||%|||MG/KG/WEEK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|NA|N|3||39||OPEN LABEL TREATMENT|1969-11-15||||1968-07-09||1966-04-04|1966-05-28|
TRIAL STUDY 134XCP|QS|CB726766-A812-45B3-95CA-D1AD8F697FD3|4|||||EPIC-CP|||UMOL/L/SEC|||10^6 CFU/G|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|U|U|4||88||BASELINE|1963-01-04||||1969-12-15||1965-08-22|1965-02-02|
TRIAL STUDY 134XCP|QS|CB726766-A812-45B3-95CA-D1AD8F697FD3|5|||||FOSI|||10^6 ORGANISMS|||%/MIN|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|5||7||OPEN LABEL TREATMENT|1969-06-17||||1969-05-07||1962-02-19|1969-12-14|
TRIAL STUDY 134XCP|QS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1|||||FACIT-DYSPNEA SF|||ELISA UNIT|||%|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|NA|1||38||OBSERVATION|1965-06-19||||1967-07-02||1964-12-22|1972-12-02|
TRIAL STUDY 134XCP|QS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2|||||NPI|||NMOL|||/H|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|2||58||INDUCTION TREATMENT|1963-06-18||||1967-04-21||1967-02-08|1968-05-20|
TRIAL STUDY 134XCP|QS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|3|||||SGRQ PAST 4 WEEKS VERSION|||SV|||ML/KG/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|NA|3||39||BASELINE|1961-10-11||||1967-09-17||1964-05-29|1972-04-24|
TRIAL STUDY 134XCP|QS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|4|||||PROSQOLI|||BQ|||MG/M2/MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|U|4||88||WASHOUT|1969-08-23||||1968-06-04||1963-05-31|1962-08-26|
TRIAL STUDY 134XCP|QS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|5|||||WHODAS 2.0 - 12-ITEM SELF|||G/M2|||G/DL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|NA|5||7||INDUCTION TREATMENT|1963-08-07||||1972-10-31||1966-12-24|1973-03-18|
TRIAL STUDY 134XCP|QS|20DC654F-595C-410D-A340-465A23434D42|1|||||AQLQ|||KBQ/UL|||PMOL/10^9 CELLS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|NA|1||38||WASHOUT|1962-12-04||||1963-12-15||1964-05-25|1968-03-16|
TRIAL STUDY 134XCP|QS|20DC654F-595C-410D-A340-465A23434D42|2|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||U/M2/MIN|||BP|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|Y|2||58||OBSERVATION|1965-10-11||||1970-01-26||1973-01-14|1960-06-05|
TRIAL STUDY 134XCP|QS|20DC654F-595C-410D-A340-465A23434D42|3|||||GMSS VERSION TYPE 1 DIABETES|||ML/DAY|||BISCUIT|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|N|3||39||CONTINUATION TREATMENT|1965-02-26||||1970-05-20||1969-06-30|1969-11-09|
TRIAL STUDY 134XCP|QS|20DC654F-595C-410D-A340-465A23434D42|4|||||FPSR|||G/CAGE/DAY|||PPB|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|N|4||88||SCREENING|1963-05-08||||1968-07-14||1972-08-09|1969-07-22|
TRIAL STUDY 134XCP|QS|20DC654F-595C-410D-A340-465A23434D42|5|||||FAS-NACC UDS V3.0|||10^9/G|||FMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|U|5||7||BLINDED TREATMENT|1961-02-15||||1973-07-24||1965-03-22|1972-11-30|
TRIAL STUDY 134XCP|QS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT|||UG/H|||MASK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|Y|1||38||CONTINUATION TREATMENT|1967-08-20||||1964-02-23||1964-04-08|1971-08-16|
TRIAL STUDY 134XCP|QS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||UV2|||P|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|N|2||58||LONG-TERM FOLLOW-UP|1970-10-16||||1964-03-23||1961-08-04|1960-10-05|
TRIAL STUDY 134XCP|QS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|3|||||IPAQ-SF SELF-ADMINISTERED VERSION|||PHERESIS UNIT|||MMOL/MIN/KPA/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|3||39||WASHOUT|1964-09-26||||1968-03-16||1969-01-23|1962-02-04|
TRIAL STUDY 134XCP|QS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|4|||||FACIT-FATIGUE 13-ITEM V4|||MG/G/H|||ML/KG|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|4||88||FOLLOW-UP|1970-06-19||||1969-05-08||1972-10-18|1968-08-12|
TRIAL STUDY 134XCP|QS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MOSM/L|||BAU/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|5||7||SCREENING|1973-05-11||||1964-06-17||1968-09-03|1966-12-03|
TRIAL STUDY 134XCP|QS|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1|||||ASEX-FEMALE|||FMOL/L|||MMOL/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|1||38||INDUCTION TREATMENT|1965-01-15||||1962-09-02||1966-08-02|1961-03-16|
TRIAL STUDY 134XCP|QS|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2|||||FACT-BMT V4|||RING|||PMOL/10^9 CELLS|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|2||58||SCREENING|1970-04-14||||1971-05-24||1972-06-01|1960-10-16|
TRIAL STUDY 134XCP|QS|4EA8DC88-09C8-4954-A469-D8E12F01CB56|3|||||IPAQ-SF PHONE VERSION|||10^3/L|||MG/M2/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|N|3||39||BASELINE|1967-10-09||||1970-08-16||1960-06-01|1962-01-06|
TRIAL STUDY 134XCP|QS|4EA8DC88-09C8-4954-A469-D8E12F01CB56|4|||||NCCN-FACT FPSI-17 V2|||MV2/HZ|||CUP|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|4||88||OPEN LABEL TREATMENT|1968-03-23||||1962-09-02||1963-01-04|1964-03-21|
TRIAL STUDY 134XCP|QS|4EA8DC88-09C8-4954-A469-D8E12F01CB56|5|||||C-SSRS BASELINE/SCREENING VERSION|||ENZYME U/L|||ENZYME U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|NA|5||7||BLINDED TREATMENT|1968-12-06||||1969-09-30||1961-07-30|1972-01-15|
TRIAL STUDY 134XCP|QS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1|||||WPAI-SHP V2.0|||UCI/L|||MIN|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|Y|1||38||OPEN LABEL TREATMENT|1965-11-18||||1968-05-30||1968-04-22|1963-03-12|
TRIAL STUDY 134XCP|QS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2|||||YMRS|||PG/L|||BEL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|2||58||BASELINE|1965-06-04||||1962-02-20||1968-11-19|1960-04-30|
TRIAL STUDY 134XCP|QS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|3|||||COPD ASSESSMENT TEST|||DAYS|||UG/M2/DAY|NOT DONE||LIKERT SCALE 3-POINT|N|Y|Y|3||39||SCREENING|1970-10-08||||1968-07-30||1963-11-04|1970-04-07|
TRIAL STUDY 134XCP|QS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|4|||||MSIS-29 V1|||L/H/M2|||/MM2|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|N|4||88||BLINDED TREATMENT|1960-05-04||||1963-09-12||1967-11-26|1964-12-18|
TRIAL STUDY 134XCP|QS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|5|||||NCCN-FACT FBLSI-18 V2|||P|||DEG/MM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|NA|5||7||BLINDED TREATMENT|1965-01-10||||1970-10-02||1969-09-09|1966-07-09|
TRIAL STUDY 134XCP|QS|521B1614-9092-4F89-A47F-728C66E01B23|1|||||FLSI|||DDU|||MOL/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|N|1||38||FOLLOW-UP|1960-01-21||||1963-08-21||1973-03-10|1961-05-04|
TRIAL STUDY 134XCP|QS|521B1614-9092-4F89-A47F-728C66E01B23|2|||||TSCYC|||UMOL/L/MIN|||PPTH|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|2||58||INDUCTION TREATMENT|1973-01-17||||1960-08-24||1971-08-14|1961-09-07|
TRIAL STUDY 134XCP|QS|521B1614-9092-4F89-A47F-728C66E01B23|3|||||FAMS|||PACKAGE|||MG/M2|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|Y|3||39||OBSERVATION|1961-02-21||||1971-10-08||1963-11-09|1968-02-21|
TRIAL STUDY 134XCP|QS|521B1614-9092-4F89-A47F-728C66E01B23|4|||||PHQ-2|||BQ/MG|||ABSORBANCE U|NOT DONE||VISUAL ANALOG SCALE (100 MM)|N|N|Y|4||88||WASHOUT|1963-12-06||||1973-04-07||1960-07-19|1961-02-06|
TRIAL STUDY 134XCP|QS|521B1614-9092-4F89-A47F-728C66E01B23|5|||||CDR|||U/MG|||UG/M2|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|U|U|5||7||WASHOUT|1962-09-07||||1960-03-27||1962-07-28|1967-08-20|
TRIAL STUDY 134XCP|QS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1|||||PARENT-DDS|||GY|||MET|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|U|1||38||CONTINUATION TREATMENT|1966-01-09||||1967-12-31||1963-10-23|1970-06-10|
TRIAL STUDY 134XCP|QS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2|||||C-SSRS SCREENING|||MEQ/DL|||KDA|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|Y|2||58||TREATMENT|1961-09-10||||1961-05-07||1963-02-13|1961-07-28|
TRIAL STUDY 134XCP|QS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|3|||||NPS|||ML/MMHG|||WEEKS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|NA|3||39||LONG-TERM FOLLOW-UP|1962-10-27||||1972-03-20||1963-01-14|1969-09-12|
TRIAL STUDY 134XCP|QS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|4|||||ACT|||PG/L|||MG/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|4||88||CONTINUATION TREATMENT|1967-09-10||||1963-01-22||1965-03-07|1962-08-21|
TRIAL STUDY 134XCP|QS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|5|||||PHQ-9|||ELISA UNIT/ML|||ML/MIN/MMHG|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|NA|5||7||TREATMENT|1960-04-03||||1966-04-30||1961-04-06|1972-02-13|
TRIAL STUDY 134XCP|QS|FF6B8B49-3C82-459D-A35D-61136FC594D2|1|||||IPAQ-LF PHONE VERSION|||DAYS/WK|||CMH2O*S2/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|U|1||38||OBSERVATION|1969-03-10||||1966-09-15||1973-04-09|1962-11-08|
TRIAL STUDY 134XCP|QS|FF6B8B49-3C82-459D-A35D-61136FC594D2|2|||||YMRS|||MM/SEC|||FINGERTIP UNIT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|NA|N|2||58||BASELINE|1964-12-02||||1973-02-20||1973-01-17|1965-03-29|
TRIAL STUDY 134XCP|QS|FF6B8B49-3C82-459D-A35D-61136FC594D2|3|||||FOSI|||RING|||G/CAGE/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|N|N|NA|3||39||BLINDED TREATMENT|1964-05-13||||1968-12-31||1961-10-19|1961-10-31|
TRIAL STUDY 134XCP|QS|FF6B8B49-3C82-459D-A35D-61136FC594D2|4|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||CI|||CAPFUL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|NA|4||88||SCREENING|1961-05-03||||1967-09-05||1971-12-02|1966-07-11|
TRIAL STUDY 134XCP|QS|FF6B8B49-3C82-459D-A35D-61136FC594D2|5|||||SIQ|||10^6 IU|||GPL U|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|5||7||OBSERVATION|1971-02-08||||1971-02-17||1970-07-06|1962-04-13|
TRIAL STUDY 134XCP|QS|2196D9F4-937A-4662-B24B-AC9D472E0393|1|||||WOMAC NRS 3.1 INDEX|||10^7/L|||AMFI|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|NA|N|1||38||RUN-IN|1960-12-31||||1961-07-30||1960-05-01|1960-07-09|
TRIAL STUDY 134XCP|QS|2196D9F4-937A-4662-B24B-AC9D472E0393|2|||||BARS|||CAL|||UGEQ|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|NA|2||58||SCREENING|1968-03-31||||1966-08-18||1963-02-13|1963-06-04|
TRIAL STUDY 134XCP|QS|2196D9F4-937A-4662-B24B-AC9D472E0393|3|||||DLQI|||KG/L|||10^4 CFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|3||39||TREATMENT|1963-06-14||||1969-04-03||1967-05-30|1966-11-29|
TRIAL STUDY 134XCP|QS|2196D9F4-937A-4662-B24B-AC9D472E0393|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||MG/DL|||10^9 CFU/ML|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|U|4||88||OBSERVATION|1965-06-19||||1963-06-08||1960-11-06|1961-06-25|
TRIAL STUDY 134XCP|QS|2196D9F4-937A-4662-B24B-AC9D472E0393|5|||||FACT-LEU V4|||PACKET|||MG/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|5||7||SCREENING|1972-01-26||||1963-04-23||1963-02-08|1971-09-28|
TRIAL STUDY 134XCP|QS|F192452A-4088-46AA-9DD1-8D14809E18F6|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||U/G|||M3|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|U|Y|1||38||INDUCTION TREATMENT|1968-06-11||||1971-11-22||1963-12-21|1963-11-04|
TRIAL STUDY 134XCP|QS|F192452A-4088-46AA-9DD1-8D14809E18F6|2|||||MDS-UPDRS|||OSM|||G/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|U|2||58||OPEN LABEL TREATMENT|1963-12-20||||1971-10-28||1965-03-25|1969-09-12|
TRIAL STUDY 134XCP|QS|F192452A-4088-46AA-9DD1-8D14809E18F6|3|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||TABLET|||RFU|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|NA|Y|3||39||BLINDED TREATMENT|1973-08-27||||1972-01-23||1961-07-02|1969-10-27|
TRIAL STUDY 134XCP|QS|F192452A-4088-46AA-9DD1-8D14809E18F6|4|||||ODI V2.1A|||CM/MIN|||G/ANIMAL/WK|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|N|4||88||FOLLOW-UP|1965-04-13||||1960-02-17||1966-03-02|1963-04-23|
TRIAL STUDY 134XCP|QS|F192452A-4088-46AA-9DD1-8D14809E18F6|5|||||RDQ|||10^3 CFU/ML|||10^4/HPF|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|5||7||RUN-IN|1961-11-30||||1964-03-04||1970-04-30|1969-11-23|
TRIAL STUDY 134XCP|QS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1|||||NCCN-FACT FPSI-17 V2|||/200 HPFS|||HR/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|1||38||LONG-TERM FOLLOW-UP|1961-07-23||||1962-04-26||1972-04-04|1972-05-17|
TRIAL STUDY 134XCP|QS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2|||||SOAPP-R|||MG/CM2|||WEBER|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|NA|2||58||WASHOUT|1962-05-22||||1973-06-24||1967-03-31|1964-06-28|
TRIAL STUDY 134XCP|QS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|3|||||T1-DDS|||MG/ML/DAY|||M2|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|Y|3||39||INDUCTION TREATMENT|1968-01-06||||1963-08-05||1973-03-10|1973-07-26|
TRIAL STUDY 134XCP|QS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|4|||||RAND-36 V1.0|||BEAM BREAKS|||U/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|U|4||88||TREATMENT|1967-03-17||||1962-08-04||1968-10-07|1971-09-25|
TRIAL STUDY 134XCP|QS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|5|||||NCCN-FACT FOSI-18 V2|||MG/H|||HOUNSFIELD UNIT|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|N|U|5||7||OPEN LABEL TREATMENT|1967-03-09||||1971-01-30||1966-05-24|1964-10-15|
TRIAL STUDY 134XCP|QS|0D51A87E-2597-4B2D-A7B5-E533790E917D|1|||||AQLQ|||10^6 IU|||UG/M2/DAY|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|N|1||38||SCREENING|1972-09-17||||1964-09-17||1963-09-06|1964-08-02|
TRIAL STUDY 134XCP|QS|0D51A87E-2597-4B2D-A7B5-E533790E917D|2|||||FACT-TAXANE V4|||ML/KG/DAY|||/10^5|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|U|2||58||LONG-TERM FOLLOW-UP|1965-02-18||||1970-09-08||1968-03-27|1965-08-10|
TRIAL STUDY 134XCP|QS|0D51A87E-2597-4B2D-A7B5-E533790E917D|3|||||AQ20|||BEL|||LOZENGE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|U|3||39||BLINDED TREATMENT|1961-02-24||||1960-04-06||1967-06-21|1964-07-02|
TRIAL STUDY 134XCP|QS|0D51A87E-2597-4B2D-A7B5-E533790E917D|4|||||VFQ-25 SELF ADMINISTERED|||CY/CM|||MV/SEC|NOT DONE||LIKERT SCALE 3-POINT|U|U|NA|4||88||BLINDED TREATMENT|1967-08-31||||1965-02-23||1966-02-24|1961-08-10|
TRIAL STUDY 134XCP|QS|0D51A87E-2597-4B2D-A7B5-E533790E917D|5|||||HAQ-DI WITHOUT VAS|||MG/L|||PG/CELL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|Y|N|5||7||LONG-TERM FOLLOW-UP|1972-06-24||||1960-08-08||1963-11-24|1967-06-24|
TRIAL STUDY 134XCP|QS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1|||||FACIT-DYSPNEA 33 ITEM BANK|||FT|||10^6 CFU/G|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|Y|1||38||SCREENING|1967-12-03||||1966-08-10||1968-07-14|1968-03-20|
TRIAL STUDY 134XCP|QS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||/10^5|||/40 HPFS|NOT DONE||LIKERT SCALE 3-POINT|N|NA|N|2||58||WASHOUT|1965-10-15||||1962-05-31||1973-02-24|1964-08-26|
TRIAL STUDY 134XCP|QS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|3|||||SF36 V2.0 STANDARD|||PMOL/L|||PMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|Y|N|3||39||TREATMENT|1965-07-07||||1965-09-03||1970-01-09|1969-12-11|
TRIAL STUDY 134XCP|QS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|4|||||FACT-G V4|||MET*H|||10^3/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|4||88||OBSERVATION|1968-09-17||||1970-04-04||1962-01-11|1969-05-19|
TRIAL STUDY 134XCP|QS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|5|||||BEBQ RETROSPECTIVE|||G/DAY|||PL|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|N|U|5||7||FOLLOW-UP|1965-04-25||||1960-12-17||1968-12-02|1967-05-10|
TRIAL STUDY 134XCP|QS|16075684-F04D-4CB8-970A-0819378790EB|1|||||FACIT-FATIGUE 13-ITEM V4|||UG/G/MIN|||ML/DOSE|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|N|1||38||OBSERVATION|1962-02-18||||1961-10-21||1963-11-14|1961-07-10|
TRIAL STUDY 134XCP|QS|16075684-F04D-4CB8-970A-0819378790EB|2|||||C-SSRS SCREENING|||F|||EU|NOT DONE||LIKERT SCALE 3-POINT|NA|U|U|2||58||BLINDED TREATMENT|1970-01-06||||1970-05-08||1965-06-03|1965-08-22|
TRIAL STUDY 134XCP|QS|16075684-F04D-4CB8-970A-0819378790EB|3|||||VFQ-25 SELF ADMINISTERED|||GRAIN|||NMOL BCE/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|U|3||39||RUN-IN|1967-10-02||||1970-07-20||1963-03-29|1963-07-26|
TRIAL STUDY 134XCP|QS|16075684-F04D-4CB8-970A-0819378790EB|4|||||ADCS-ADL|||UKAT/10^12 RBC|||KG/CM|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|4||88||WASHOUT|1961-04-10||||1972-11-28||1970-11-24|1960-01-29|
TRIAL STUDY 134XCP|QS|16075684-F04D-4CB8-970A-0819378790EB|5|||||WOMAC LK 3.1 INDEX|||U/MG|||PFU|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|U|5||7||TREATMENT|1960-12-04||||1965-12-14||1972-02-15|1960-01-21|
TRIAL STUDY 134XCP|QS|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1|||||C-SSRS SINCE LAST VISIT|||OSM|||UG/ANIMAL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|N|1||38||TREATMENT|1963-09-03||||1968-01-09||1967-04-26|1971-11-11|
TRIAL STUDY 134XCP|QS|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2|||||RPQ|||FRAMES/S|||VG/DOSE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|2||58||LONG-TERM FOLLOW-UP|1960-04-11||||1966-03-21||1966-07-16|1964-11-04|
TRIAL STUDY 134XCP|QS|3527E844-D4D5-480A-B6D6-04C5DC0A3380|3|||||HAQ-DI WITHOUT VAS|||BAU/ML|||MM/SEC|NOT DONE||LIKERT SCALE 3-POINT|N|Y|NA|3||39||BLINDED TREATMENT|1969-06-26||||1972-02-04||1971-10-08|1960-11-29|
TRIAL STUDY 134XCP|QS|3527E844-D4D5-480A-B6D6-04C5DC0A3380|4|||||WPAI-GH V2.0|||PPM|||L/S|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|4||88||BLINDED TREATMENT|1961-06-15||||1966-07-08||1969-08-17|1972-12-20|
TRIAL STUDY 134XCP|QS|3527E844-D4D5-480A-B6D6-04C5DC0A3380|5|||||SF10 V1.0 CHILDREN STANDARD|||PLUG|||MG/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|Y|5||7||LONG-TERM FOLLOW-UP|1968-09-18||||1968-05-08||1960-08-17|1965-12-29|
TRIAL STUDY 134XCP|QS|DFB0DF52-4D95-4A26-B28F-071774D78426|1|||||EORTC QLQ-LC13|||MV|||U/KG|NOT DONE||LIKERT SCALE 3-POINT|Y|N|N|1||38||TREATMENT|1962-03-20||||1961-01-03||1969-05-22|1960-07-22|
TRIAL STUDY 134XCP|QS|DFB0DF52-4D95-4A26-B28F-071774D78426|2|||||TSQM V1.4|||BLOCKS|||STEPS/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|NA|2||58||RUN-IN|1971-07-16||||1970-01-23||1960-06-03|1960-10-10|
TRIAL STUDY 134XCP|QS|DFB0DF52-4D95-4A26-B28F-071774D78426|3|||||FAMS|||SHOCK WAVE|||MG/M2/DAY|NOT DONE||LIKERT SCALE 7-POINT|U|NA|Y|3||39||INDUCTION TREATMENT|1969-11-09||||1963-11-29||1970-03-18|1967-01-28|
TRIAL STUDY 134XCP|QS|DFB0DF52-4D95-4A26-B28F-071774D78426|4|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||MAC50|||MOSM/L|NOT DONE||LIKERT SCALE 5-POINT|NA|N|Y|4||88||LONG-TERM FOLLOW-UP|1971-05-21||||1973-02-05||1965-07-26|1963-08-04|
TRIAL STUDY 134XCP|QS|DFB0DF52-4D95-4A26-B28F-071774D78426|5|||||SIQ|||UIU/DL|||AMPULE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|NA|NA|5||7||CONTINUATION TREATMENT|1964-06-26||||1973-01-15||1966-12-17|1964-09-09|
TRIAL STUDY 134XCP|QS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1|||||OAB-Q|||10^3 CFU/ML|||AFU|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|N|1||38||SCREENING|1966-01-28||||1961-12-24||1970-10-19|1970-04-23|
TRIAL STUDY 134XCP|QS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||MMOL/MIN/KPA|||BQ/UG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|2||58||INDUCTION TREATMENT|1973-01-08||||1960-03-21||1971-06-24|1971-07-28|
TRIAL STUDY 134XCP|QS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|3|||||CCQ 24 HOUR VERSION|||UG/ANIMAL|||ML/M2/DAY|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|NA|3||39||OBSERVATION|1973-06-28||||1965-07-02||1961-04-14|1966-01-31|
TRIAL STUDY 134XCP|QS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|4|||||HAQ-DI WITHOUT VAS|||DRUM|||CD/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|NA|4||88||TREATMENT|1966-09-06||||1965-02-10||1962-11-28|1963-11-22|
TRIAL STUDY 134XCP|QS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|5|||||PHQ-9|||RATIO|||L/H|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|5||7||FOLLOW-UP|1961-11-27||||1965-03-08||1960-03-26|1960-10-18|
TRIAL STUDY 134XCP|QS|CFF20837-0091-467E-ABDE-72645BAFC849|1|||||EXPANDED DRS-PI SURVIVOR VERSION|||G/MOL|||ML/CAGE/WK|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|U|1||38||FOLLOW-UP|1961-09-14||||1965-06-15||1963-11-07|1967-05-18|
TRIAL STUDY 134XCP|QS|CFF20837-0091-467E-ABDE-72645BAFC849|2|||||MSIS-29 V2|||DAMOL/L|||L/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|N|2||58||TREATMENT|1970-11-15||||1962-12-09||1963-01-08|1964-11-05|
TRIAL STUDY 134XCP|QS|CFF20837-0091-467E-ABDE-72645BAFC849|3|||||OCI|||CM|||MSEC|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|3||39||OBSERVATION|1971-04-27||||1961-04-27||1966-07-10|1965-11-11|
TRIAL STUDY 134XCP|QS|CFF20837-0091-467E-ABDE-72645BAFC849|4|||||NSCLC-SAQ V1.0|||10^9 CFU|||FT|NOT DONE||LIKERT SCALE 5-POINT|N|N|U|4||88||WASHOUT|1971-05-18||||1966-09-30||1963-10-31|1973-06-06|
TRIAL STUDY 134XCP|QS|CFF20837-0091-467E-ABDE-72645BAFC849|5|||||NCCN-FACT FOSI-18 V2|||MDFI|||ELISA UNIT/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|U|5||7||INDUCTION TREATMENT|1965-05-14||||1961-04-30||1960-04-08|1968-03-06|
TRIAL STUDY 134XCP|QS|C79756C8-8601-4770-8BC2-7A530428BA82|1|||||SOWS SHORT|||STRIP|||LOG10 TCID 50/UL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|Y|1||38||OBSERVATION|1965-08-10||||1961-11-20||1973-06-06|1960-01-24|
TRIAL STUDY 134XCP|QS|C79756C8-8601-4770-8BC2-7A530428BA82|2|||||BPI|||10^12 IU/L|||MG/KG/WEEK|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|N|2||58||SCREENING|1963-12-07||||1973-05-15||1963-05-21|1966-12-01|
TRIAL STUDY 134XCP|QS|C79756C8-8601-4770-8BC2-7A530428BA82|3|||||SF12 V2.0 STANDARD|||MMU/ML|||10^6 ORGANISMS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|N|U|3||39||WASHOUT|1966-10-27||||1972-01-10||1967-06-14|1962-07-09|
TRIAL STUDY 134XCP|QS|C79756C8-8601-4770-8BC2-7A530428BA82|4|||||BSFS|||PSI|||MBQ/UL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|4||88||BASELINE|1969-05-22||||1968-05-13||1964-03-31|1969-09-18|
TRIAL STUDY 134XCP|QS|C79756C8-8601-4770-8BC2-7A530428BA82|5|||||IPAQ-SF SELF-ADMINISTERED VERSION|||YD|||DL|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|5||7||BASELINE|1961-02-28||||1963-06-16||1973-08-25|1965-12-06|
TRIAL STUDY 134XCP|QS|5533A669-828B-4CA3-BEC3-849CE7384167|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||KG|||/10^4|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|1||38||TREATMENT|1967-12-01||||1964-04-12||1970-09-19|1967-10-23|
TRIAL STUDY 134XCP|QS|5533A669-828B-4CA3-BEC3-849CE7384167|2|||||FACT-HEP V4|||KV|||MSEC|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|U|2||58||INDUCTION TREATMENT|1962-07-10||||1973-02-12||1972-08-08|1963-08-08|
TRIAL STUDY 134XCP|QS|5533A669-828B-4CA3-BEC3-849CE7384167|3|||||NCCN-FACT FKSI-19 V2|||UG/M2/DAY|||TABLET|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|Y|3||39||TREATMENT|1968-12-30||||1970-08-28||1972-12-16|1968-06-23|
TRIAL STUDY 134XCP|QS|5533A669-828B-4CA3-BEC3-849CE7384167|4|||||CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION|||GBQ/UG|||DRINK|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|Y|4||88||RUN-IN|1969-02-13||||1966-04-30||1966-01-03|1967-08-08|
TRIAL STUDY 134XCP|QS|5533A669-828B-4CA3-BEC3-849CE7384167|5|||||AUDIT-C|||BQ/ML|||FG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|U|N|5||7||LONG-TERM FOLLOW-UP|1973-05-03||||1972-12-13||1962-02-06|1967-10-30|
TRIAL STUDY 134XCP|QS|C711ADD3-F398-4161-BE13-B75BEDF91402|1|||||Q-LES-Q-SF|||CI/UG|||DIOPTER|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|1||38||SCREENING|1965-02-17||||1962-04-12||1968-11-30|1964-07-29|
TRIAL STUDY 134XCP|QS|C711ADD3-F398-4161-BE13-B75BEDF91402|2|||||COPD ASSESSMENT TEST|||MM/SEC|||IU/MMOL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|N|2||58||RUN-IN|1963-06-20||||1963-02-11||1965-05-09|1967-12-09|
TRIAL STUDY 134XCP|QS|C711ADD3-F398-4161-BE13-B75BEDF91402|3|||||SF36 V2.0 ACUTE|||RFU|||NL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|NA|3||39||BASELINE|1971-05-29||||1962-04-20||1969-10-12|1964-12-27|
TRIAL STUDY 134XCP|QS|C711ADD3-F398-4161-BE13-B75BEDF91402|4|||||FACT-LEU V4|||AMOL|||NMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|4||88||TREATMENT|1967-05-04||||1961-10-16||1961-06-26|1960-06-22|
TRIAL STUDY 134XCP|QS|C711ADD3-F398-4161-BE13-B75BEDF91402|5|||||CDR|||ML/DOSE|||KBQ|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|N|5||7||SCREENING|1970-10-26||||1968-01-09||1971-01-09|1966-05-29|
TRIAL STUDY 134XCP|QS|2CD70FFA-5977-4718-961B-6D67368F99B8|1|||||MADRS|||HR/DAY|||ML/DL|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|Y|Y|1||38||OBSERVATION|1961-04-06||||1965-02-20||1960-01-31|1964-11-20|
TRIAL STUDY 134XCP|QS|2CD70FFA-5977-4718-961B-6D67368F99B8|2|||||IDS-SR|||UG/L|||IN2|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|N|2||58||WASHOUT|1960-03-11||||1971-11-04||1967-05-20|1968-05-16|
TRIAL STUDY 134XCP|QS|2CD70FFA-5977-4718-961B-6D67368F99B8|3|||||PR|||/SEC|||10^9 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|3||39||BLINDED TREATMENT|1963-12-22||||1966-03-07||1963-11-05|1966-09-22|
TRIAL STUDY 134XCP|QS|2CD70FFA-5977-4718-961B-6D67368F99B8|4|||||CCQ 1 WEEK VERSION|||FOZ_US|||10^3 ORGANISMS/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|N|4||88||CONTINUATION TREATMENT|1960-10-31||||1972-11-07||1966-03-02|1971-06-25|
TRIAL STUDY 134XCP|QS|2CD70FFA-5977-4718-961B-6D67368F99B8|5|||||FLU-IIQ TWICE DAILY|||10^9 CFU|||DPM/100MG|NOT DONE||LIKERT SCALE 5-POINT|N|Y|N|5||7||BLINDED TREATMENT|1970-05-04||||1966-01-02||1962-11-08|1961-03-07|
TRIAL STUDY 134XCP|QS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1|||||GCGI|||LINEAR FT*LB|||MMHG/L/MIN|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|N|1||38||SCREENING|1964-09-17||||1969-10-10||1965-11-19|1963-01-24|
TRIAL STUDY 134XCP|QS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2|||||C-SSRS LIFETIME/RECENT VERSION|||UV|||P|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|NA|2||58||BLINDED TREATMENT|1963-01-24||||1972-06-01||1972-02-14|1971-09-24|
TRIAL STUDY 134XCP|QS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||MEQ/UL|||CONTAINER|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|Y|3||39||FOLLOW-UP|1964-04-24||||1965-10-30||1971-10-02|1972-02-15|
TRIAL STUDY 134XCP|QS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|4|||||SIQR|||ABSORBANCE U/ML|||SBE/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|N|4||88||CONTINUATION TREATMENT|1972-09-26||||1968-10-17||1961-06-19|1961-03-24|
TRIAL STUDY 134XCP|QS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|5|||||SF8 V1.0 STANDARD|||FT2|||MMU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|Y|5||7||SCREENING|1960-04-17||||1964-07-20||1969-07-30|1971-02-15|
TRIAL STUDY 134XCP|QS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1|||||GCGI|||10^6 CFU/ML|||UCI/KG|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|1||38||SCREENING|1971-09-13||||1969-09-14||1965-03-13|1970-07-21|
TRIAL STUDY 134XCP|QS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2|||||IIEF|||S/H|||MPL U/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|U|2||58||OBSERVATION|1962-05-30||||1964-12-15||1965-06-13|1970-12-31|
TRIAL STUDY 134XCP|QS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD|||FFU|||MCI/KG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|U|3||39||OBSERVATION|1962-09-16||||1972-02-05||1964-01-26|1965-06-22|
TRIAL STUDY 134XCP|QS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||ELISA UNIT/DOSE|||BAG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|4||88||OPEN LABEL TREATMENT|1972-10-11||||1964-07-30||1966-12-22|1966-02-26|
TRIAL STUDY 134XCP|QS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|5|||||HAEM-A-QOL|||DNA COPIES/ML|||10^3 CFU|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|Y|Y|5||7||LONG-TERM FOLLOW-UP|1968-05-18||||1970-09-28||1965-02-28|1970-11-13|
TRIAL STUDY 134XCP|QS|43E00B7D-684F-4BAC-A135-E65C22B191AD|1|||||SF12 V1.0 STANDARD|||UMOL/DAY|||KEV|NOT DONE||LIKERT SCALE 5-POINT|U|U|N|1||38||OBSERVATION|1962-11-04||||1970-01-09||1968-03-01|1968-03-27|
TRIAL STUDY 134XCP|QS|43E00B7D-684F-4BAC-A135-E65C22B191AD|2|||||ADCS-ADL MCI|||YEARS|||RATIO|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|U|2||58||CONTINUATION TREATMENT|1965-10-18||||1969-09-04||1970-07-10|1970-03-14|
TRIAL STUDY 134XCP|QS|43E00B7D-684F-4BAC-A135-E65C22B191AD|3|||||C-SSRS SCREENING|||UU/DL|||MM|NOT DONE||LIKERT SCALE 3-POINT|Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1962-04-07||||1972-07-27||1973-03-22|1964-09-09|
TRIAL STUDY 134XCP|QS|43E00B7D-684F-4BAC-A135-E65C22B191AD|4|||||WHODAS 2.0 - 12-ITEM PROXY|||BQ/UG|||10^5/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1962-06-07||||1967-04-23||1969-10-30|1961-09-27|
TRIAL STUDY 134XCP|QS|43E00B7D-684F-4BAC-A135-E65C22B191AD|5|||||PARENT-DDS|||ML/MIN/MMHG|||MCI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|U|5||7||FOLLOW-UP|1971-10-25||||1971-04-13||1960-05-14|1965-10-09|
TRIAL STUDY 134XCP|QS|25680BE0-7CE5-4B76-A48E-2D977A07E749|1|||||FACT-L V4|||PG/DL|||U/MMOL|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|NA|1||38||FOLLOW-UP|1961-05-23||||1964-03-14||1960-12-27|1972-01-09|
TRIAL STUDY 134XCP|QS|25680BE0-7CE5-4B76-A48E-2D977A07E749|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||G/G|||NKAT|NOT DONE||LIKERT SCALE 5-POINT|N|U|Y|2||58||INDUCTION TREATMENT|1965-03-13||||1968-01-17||1969-05-23|1967-03-29|
TRIAL STUDY 134XCP|QS|25680BE0-7CE5-4B76-A48E-2D977A07E749|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL|||UGEQ|||10^6 IU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|NA|N|3||39||CONTINUATION TREATMENT|1968-11-29||||1967-06-26||1967-12-10|1972-01-15|
TRIAL STUDY 134XCP|QS|25680BE0-7CE5-4B76-A48E-2D977A07E749|4|||||FBRSI|||UG/KG/H|||10^7 TCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|Y|4||88||BLINDED TREATMENT|1963-05-20||||1962-07-21||1972-10-03|1973-02-03|
TRIAL STUDY 134XCP|QS|25680BE0-7CE5-4B76-A48E-2D977A07E749|5|||||MDQ-T|||10^3 ORGANISMS/G|||MMOL/DAY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|N|NA|5||7||OPEN LABEL TREATMENT|1969-02-24||||1965-03-04||1963-02-23|1972-09-18|
TRIAL STUDY 134XCP|QS|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1|||||AQ20|||U/DL|||ML/BREATH|NOT DONE||LIKERT SCALE 5-POINT|NA|U|Y|1||38||INDUCTION TREATMENT|1971-06-01||||1969-05-14||1967-05-02|1969-02-02|
TRIAL STUDY 134XCP|QS|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2|||||YMRS|||10^6 CFU/G|||UKAT/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|NA|2||58||TREATMENT|1972-10-01||||1972-10-11||1964-07-23|1965-12-02|
TRIAL STUDY 134XCP|QS|67CA2619-351F-493E-93B2-5CDC9AF99C8B|3|||||AQLQ|||BQ/ML|||U/MMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|U|3||39||WASHOUT|1972-12-26||||1971-06-21||1972-05-18|1968-04-12|
TRIAL STUDY 134XCP|QS|67CA2619-351F-493E-93B2-5CDC9AF99C8B|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||PKAT/L|||/MM|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|N|N|4||88||SCREENING|1962-04-03||||1970-04-23||1961-10-22|1960-07-31|
TRIAL STUDY 134XCP|QS|67CA2619-351F-493E-93B2-5CDC9AF99C8B|5|||||PHQ-15|||BQ/KG|||PMOL/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|N|5||7||BASELINE|1972-12-11||||1973-09-03||1972-11-01|1967-12-13|
TRIAL STUDY 134XCP|QS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1|||||GAD-7 V2|||VP/ML|||10^3 ORGANISMS/G|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|Y|NA|1||38||INDUCTION TREATMENT|1968-12-20||||1960-09-22||1971-03-24|1966-10-31|
TRIAL STUDY 134XCP|QS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2|||||OCI|||KHZ|||10^3 CFU|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|U|2||58||RUN-IN|1964-07-25||||1970-12-12||1973-05-24|1965-09-10|
TRIAL STUDY 134XCP|QS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|3|||||EPDS|||SIEMENS|||KCAL/DAY|NOT DONE||LIKERT SCALE 5-POINT|NA|U|N|3||39||BLINDED TREATMENT|1970-02-21||||1968-03-21||1972-08-06|1969-08-23|
TRIAL STUDY 134XCP|QS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|4|||||C-SSRS CHILDREN'S SINCE LAST VISIT|||LOZENGE|||10^3 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|Y|Y|4||88||WASHOUT|1964-06-17||||1973-01-21||1973-07-29|1962-12-25|
TRIAL STUDY 134XCP|QS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|5|||||MRS|||UG/M2|||QUANTITY SUFFICIENT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|Y|N|5||7||INDUCTION TREATMENT|1964-09-06||||1970-07-23||1967-10-09|1971-08-18|
TRIAL STUDY 134XCP|QS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||G/CAGE/DAY|||MM/H|NOT DONE||LIKERT SCALE 7-POINT|U|N|U|1||38||LONG-TERM FOLLOW-UP|1973-07-31||||1973-01-28||1971-12-27|1960-04-26|
TRIAL STUDY 134XCP|QS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2|||||IPAQ-SF SELF-ADMINISTERED VERSION|||AMOL|||ML/G/DAY|NOT DONE||LIKERT SCALE 3-POINT|Y|N|Y|2||58||RUN-IN|1972-12-07||||1971-09-16||1961-01-16|1970-07-26|
TRIAL STUDY 134XCP|QS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|3|||||CHART-SF INTERVIEW VERSION|||FMOL/G|||10^3 CFU/ML|NOT DONE||LIKERT SCALE 7-POINT|N|NA|U|3||39||RUN-IN|1972-09-27||||1960-01-13||1967-07-05|1969-12-30|
TRIAL STUDY 134XCP|QS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|4|||||SF36 V1.0 STANDARD|||MOL|||ML/BREATH|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|N|N|4||88||LONG-TERM FOLLOW-UP|1966-05-16||||1967-09-04||1961-04-04|1962-01-16|
TRIAL STUDY 134XCP|QS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|5|||||WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER|||10^9 CFU|||UL/DOSE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|NA|5||7||FOLLOW-UP|1964-02-18||||1967-12-17||1971-11-29|1967-04-18|
TRIAL STUDY 134XCP|QS|51B01BE3-230D-4AE0-A229-81EF519EA932|1|||||OAB-Q SHORT FORM|||GAUSS|||KS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|1||38||FOLLOW-UP|1960-09-06||||1964-02-02||1965-01-28|1972-01-19|
TRIAL STUDY 134XCP|QS|51B01BE3-230D-4AE0-A229-81EF519EA932|2|||||FACIT-DYSPNEA 33 ITEM BANK|||FT2|||10^9/G|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|N|2||58||SCREENING|1963-04-25||||1961-04-16||1968-10-16|1966-06-11|
TRIAL STUDY 134XCP|QS|51B01BE3-230D-4AE0-A229-81EF519EA932|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||UG/KG/MIN|||GBQ|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|NA|3||39||CONTINUATION TREATMENT|1966-10-22||||1962-04-13||1961-05-14|1964-09-08|
TRIAL STUDY 134XCP|QS|51B01BE3-230D-4AE0-A229-81EF519EA932|4|||||WHODAS 2.0 - 36-ITEM SELF|||ELISA UNIT|||ML/G/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|N|U|4||88||LONG-TERM FOLLOW-UP|1971-05-04||||1971-01-01||1963-08-12|1965-05-12|
TRIAL STUDY 134XCP|QS|51B01BE3-230D-4AE0-A229-81EF519EA932|5|||||FKSI-DRS V4|||U/KG/H|||G/G/DAY|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|U|5||7||SCREENING|1967-08-06||||1965-05-01||1963-05-19|1967-07-29|
TRIAL STUDY 134XCP|QS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1|||||YMRS|||MJOULE/CM2|||DNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|N|N|1||38||TREATMENT|1961-11-18||||1971-01-16||1968-09-21|1962-12-23|
TRIAL STUDY 134XCP|QS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2|||||ODI V2.1A|||FMOL/G|||EJACULATE U|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|2||58||OBSERVATION|1971-04-29||||1973-03-11||1967-11-19|1966-05-25|
TRIAL STUDY 134XCP|QS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|3|||||IPAQ-LF SELF-ADMINISTERED VERSION|||%|||NG/MOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|N|3||39||WASHOUT|1967-04-14||||1964-04-28||1970-08-09|1971-11-26|
TRIAL STUDY 134XCP|QS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||ML/DOSE|||V|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|U|4||88||INDUCTION TREATMENT|1965-01-22||||1971-05-31||1973-01-25|1965-07-12|
TRIAL STUDY 134XCP|QS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|5|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT|||MOL/L|||TSP EQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|5||7||LONG-TERM FOLLOW-UP|1965-09-11||||1962-12-18||1970-07-06|1971-09-22|
TRIAL STUDY 134XCP|QS|01FD66DA-C67B-48A7-9320-F29C6C226155|1|||||SOWS SUBJECTIVE|||MET*MIN|||LOG10 IU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|1||38||OBSERVATION|1968-03-25||||1964-07-14||1960-09-18|1960-04-08|
TRIAL STUDY 134XCP|QS|01FD66DA-C67B-48A7-9320-F29C6C226155|2|||||ASEX-FEMALE|||10^9/G|||MG|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|U|U|2||58||RUN-IN|1973-03-05||||1964-06-19||1965-05-14|1964-09-13|
TRIAL STUDY 134XCP|QS|01FD66DA-C67B-48A7-9320-F29C6C226155|3|||||PARTNER-DDS|||GENEQ|||10^6 CFU/G|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|Y|3||39||WASHOUT|1972-12-25||||1967-09-30||1961-10-21|1969-12-03|
TRIAL STUDY 134XCP|QS|01FD66DA-C67B-48A7-9320-F29C6C226155|4|||||ASEX-FEMALE|||10^6/L|||ML/G/H|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|N|U|4||88||WASHOUT|1964-01-11||||1968-06-28||1967-05-17|1965-12-18|
TRIAL STUDY 134XCP|QS|01FD66DA-C67B-48A7-9320-F29C6C226155|5|||||FACT/GOG-NTX V4|||BE/ML|||HOMEOPATHIC DILUTION|NOT DONE||LIKERT SCALE 3-POINT|Y|NA|U|5||7||TREATMENT|1960-09-21||||1964-10-28||1966-03-02|1970-05-11|
TRIAL STUDY 134XCP|QS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||IU/MG|||/10^5|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|N|1||38||WASHOUT|1970-05-07||||1966-11-28||1962-02-22|1963-07-29|
TRIAL STUDY 134XCP|QS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2|||||WHODAS 2.0 - 36-ITEM SELF|||CI/L|||HOURS|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|2||58||LONG-TERM FOLLOW-UP|1973-06-23||||1971-07-03||1968-05-18|1961-04-28|
TRIAL STUDY 134XCP|QS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|3|||||WPAI-SHP V2.0|||NMOL/ML/MIN|||/MM|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|3||39||INDUCTION TREATMENT|1964-05-21||||1962-03-21||1969-03-11|1972-08-18|
TRIAL STUDY 134XCP|QS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||10^5/HPF|||/DAY|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|NA|U|4||88||LONG-TERM FOLLOW-UP|1969-07-16||||1960-05-15||1966-07-10|1964-06-29|
TRIAL STUDY 134XCP|QS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|5|||||CCQ 24 HOUR VERSION|||COAT|||CD/M2|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|5||7||BASELINE|1965-12-06||||1961-04-14||1971-01-01|1964-12-01|
TRIAL STUDY 134XCP|QS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1|||||SOBDA|||MG/L|||%|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|Y|U|1||38||RUN-IN|1964-10-08||||1962-05-05||1969-04-21|1962-06-13|
TRIAL STUDY 134XCP|QS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2|||||NPS|||ML/MMHG/MIN/L|||ML/S/M2|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|U|2||58||WASHOUT|1966-02-01||||1966-11-26||1969-01-09|1967-04-08|
TRIAL STUDY 134XCP|QS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|3|||||IPAQ-SF PHONE VERSION|||ROENTGEN|||USP U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|Y|3||39||RUN-IN|1970-03-23||||1972-08-22||1960-08-12|1970-05-29|
TRIAL STUDY 134XCP|QS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|4|||||GCGI|||/10^4|||BAG|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|4||88||RUN-IN|1969-09-02||||1966-02-04||1961-09-13|1967-11-22|
TRIAL STUDY 134XCP|QS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|5|||||OAB-Q|||CYLINDER|||PFU|NOT DONE||LIKERT SCALE 7-POINT|U|N|Y|5||7||BASELINE|1961-11-04||||1973-05-22||1960-10-07|1972-05-04|
TRIAL STUDY 134XCP|QS|81E3641F-6145-4B3C-9E26-8DEC1200509D|1|||||FBRSI|||UOSM|||10^6 DNA COPIES/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|1||38||RUN-IN|1967-03-27||||1967-09-03||1960-01-16|1960-06-01|
TRIAL STUDY 134XCP|QS|81E3641F-6145-4B3C-9E26-8DEC1200509D|2|||||DAD|||PELLET|||LENS|NOT DONE||LIKERT SCALE 3-POINT|NA|N|U|2||58||OPEN LABEL TREATMENT|1964-03-13||||1961-02-04||1960-03-15|1971-11-23|
TRIAL STUDY 134XCP|QS|81E3641F-6145-4B3C-9E26-8DEC1200509D|3|||||FACT-BRM V4|||UMOL/MIN|||DEG/S|NOT DONE||LIKERT SCALE 5-POINT|NA|N|U|3||39||CONTINUATION TREATMENT|1969-05-14||||1968-11-25||1969-10-05|1960-04-02|
TRIAL STUDY 134XCP|QS|81E3641F-6145-4B3C-9E26-8DEC1200509D|4|||||TSCC|||MAMP|||AFU|NOT DONE||LIKERT SCALE 5-POINT|N|Y|N|4||88||OPEN LABEL TREATMENT|1971-03-01||||1970-04-20||1971-08-08|1964-01-31|
TRIAL STUDY 134XCP|QS|81E3641F-6145-4B3C-9E26-8DEC1200509D|5|||||AUDIT-C|||UG/MOL|||FMOL|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|N|5||7||TREATMENT|1962-05-19||||1960-11-15||1967-05-20|1968-04-03|
TRIAL STUDY 134XCP|QS|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1|||||FACT-L V4|||MG/M2/H|||AGU/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1971-11-03||||1967-05-11||1972-11-19|1967-09-25|
TRIAL STUDY 134XCP|QS|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2|||||SOWS SHORT|||MET*H|||EIA UNIT|NOT DONE||VERBAL RATING SCALE 5-POINT|N|U|U|2||58||FOLLOW-UP|1967-08-14||||1972-08-18||1966-08-26|1964-02-08|
TRIAL STUDY 134XCP|QS|8F3D0A71-FD09-4E43-BC54-0562AF99306E|3|||||C-SSRS BASELINE|||LB|||NMOL/ML/MIN|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|NA|N|3||39||SCREENING|1969-10-10||||1961-09-21||1971-06-25|1971-04-08|
TRIAL STUDY 134XCP|QS|8F3D0A71-FD09-4E43-BC54-0562AF99306E|4|||||PDDS|||%/S|||UG/H|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|4||88||RUN-IN|1972-12-08||||1964-08-02||1970-06-13|1966-11-10|
TRIAL STUDY 134XCP|QS|8F3D0A71-FD09-4E43-BC54-0562AF99306E|5|||||HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I|||LOG10 CCID 50/DOSE|||L/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|N|U|5||7||OBSERVATION|1963-11-25||||1961-02-06||1960-11-16|1963-02-17|
TRIAL STUDY 134XCP|QS|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1|||||GOSE|||MMOL/MIN/KPA|||TUBERCULIN UNIT|NOT DONE||LIKERT SCALE 7-POINT|NA|U|Y|1||38||INDUCTION TREATMENT|1968-09-07||||1972-01-12||1972-07-27|1973-08-01|
TRIAL STUDY 134XCP|QS|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2|||||MNSI|||MHZ|||LOG10 CFU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|Y|2||58||LONG-TERM FOLLOW-UP|1973-03-30||||1969-09-09||1963-08-14|1970-04-06|
TRIAL STUDY 134XCP|QS|BE750F04-5992-42B5-A084-A33D6FBBFD2E|3|||||FACT-BMT V4|||U/10^12 RBC|||DAGU/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|Y|Y|3||39||BLINDED TREATMENT|1971-12-09||||1961-05-01||1963-04-10|1968-11-10|
TRIAL STUDY 134XCP|QS|BE750F04-5992-42B5-A084-A33D6FBBFD2E|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD|||UKAT/L|||COPIES/UG|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|NA|4||88||INDUCTION TREATMENT|1967-03-30||||1972-02-13||1965-08-06|1961-09-29|
TRIAL STUDY 134XCP|QS|BE750F04-5992-42B5-A084-A33D6FBBFD2E|5|||||NSCLC-SAQ V1.0|||ELISA UNIT/ML|||CD/M2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|N|N|5||7||TREATMENT|1970-06-23||||1966-02-08||1969-10-24|1960-10-18|
TRIAL STUDY 134XCP|QS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1|||||TSQM V1.4|||MG/MOL|||USIEMENS|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|Y|1||38||TREATMENT|1972-10-21||||1961-06-03||1964-09-04|1972-06-01|
TRIAL STUDY 134XCP|QS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2|||||TSCYC|||MG/M2|||UG/ANIMAL|NOT DONE||LIKERT SCALE 5-POINT|N|U|Y|2||58||OPEN LABEL TREATMENT|1964-07-10||||1963-01-04||1968-09-05|1968-06-14|
TRIAL STUDY 134XCP|QS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|3|||||FACT-G V4|||RAD|||TABLET|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|3||39||BLINDED TREATMENT|1971-10-10||||1968-11-25||1967-04-07|1960-05-11|
TRIAL STUDY 134XCP|QS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|4|||||WOMAC NRS 3.1 INDEX|||CGY|||10^6 ORGANISMS/MG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|U|NA|4||88||FOLLOW-UP|1962-04-12||||1969-03-02||1973-01-06|1970-05-15|
TRIAL STUDY 134XCP|QS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|5|||||IBDQ|||ML|||10^7 TCID 50/DOSE|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|U|5||7||RUN-IN|1962-02-01||||1964-11-16||1969-04-18|1969-04-09|
TRIAL STUDY 134XCP|QS|8417B146-336C-4777-A566-C1D086F39430|1|||||DRRI-2|||10^6 ORGANISMS/MG|||USIEMENS|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|NA|1||38||SCREENING|1968-04-29||||1971-10-21||1967-03-01|1969-09-02|
TRIAL STUDY 134XCP|QS|8417B146-336C-4777-A566-C1D086F39430|2|||||PODCI - PEDIATRIC PARENT REPORTED|||UKAT|||MG/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|U|2||58||FOLLOW-UP|1963-03-12||||1972-01-15||1968-03-02|1966-04-20|
TRIAL STUDY 134XCP|QS|8417B146-336C-4777-A566-C1D086F39430|3|||||FLU-IIQ TWICE DAILY|||TRANSDUCING UNIT|||CMOL|NOT DONE||LIKERT SCALE 5-POINT|N|U|U|3||39||WASHOUT|1973-01-20||||1970-02-17||1972-07-15|1968-06-13|
TRIAL STUDY 134XCP|QS|8417B146-336C-4777-A566-C1D086F39430|4|||||MSIS-29 V2|||CONTAINER|||ANTIBODY UNIT|NOT DONE||LIKERT SCALE 7-POINT|N|U|U|4||88||OPEN LABEL TREATMENT|1968-04-27||||1962-11-19||1966-07-07|1967-02-18|
TRIAL STUDY 134XCP|QS|8417B146-336C-4777-A566-C1D086F39430|5|||||CCQ 1 WEEK VERSION|||GPS U|||PMOL/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|U|Y|5||7||OPEN LABEL TREATMENT|1964-02-19||||1960-12-04||1969-07-16|1965-04-30|
TRIAL STUDY 134XCP|QS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1|||||FAS-NACC UDS V3.0|||/2000 RBC|||RATIO|NOT DONE||LIKERT SCALE 5-POINT|NA|NA|NA|1||38||WASHOUT|1965-12-31||||1963-10-16||1962-10-28|1973-03-17|
TRIAL STUDY 134XCP|QS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2|||||SF12 V1.0 STANDARD|||PSEC|||PMOL/10^9 CELLS|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|2||58||OPEN LABEL TREATMENT|1964-05-08||||1964-11-30||1963-11-25|1964-04-21|
TRIAL STUDY 134XCP|QS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|3|||||AQ20|||CM/S|||PELLET|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|Y|U|3||39||FOLLOW-UP|1965-11-11||||1962-10-20||1964-06-06|1965-04-13|
TRIAL STUDY 134XCP|QS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|4|||||MSIS-29 V1|||DMOL|||1/(S*KPA)|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|NA|4||88||RUN-IN|1972-01-06||||1961-07-22||1968-09-13|1968-02-02|
TRIAL STUDY 134XCP|QS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|5|||||AQLQ|||10^4 CFU/ML|||G/DAY|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|5||7||FOLLOW-UP|1962-07-16||||1960-05-25||1972-03-28|1971-03-20|
TRIAL STUDY 134XCP|QS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT|||MESF|||JOULE|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|U|Y|1||38||OPEN LABEL TREATMENT|1967-06-10||||1961-08-30||1963-11-19|1962-07-26|
TRIAL STUDY 134XCP|QS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2|||||PCL-5|||PPTH|||GY/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|N|N|2||58||BLINDED TREATMENT|1972-03-19||||1960-05-19||1973-02-13|1970-07-10|
TRIAL STUDY 134XCP|QS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|3|||||RDQ|||10^10/L|||BAU/ML|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|Y|3||39||RUN-IN|1963-03-01||||1967-01-16||1964-09-24|1963-08-17|
TRIAL STUDY 134XCP|QS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|4|||||CHART-SF PAPER VERSION|||NG/DL|||BQ|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|NA|4||88||LONG-TERM FOLLOW-UP|1971-05-30||||1961-12-11||1972-04-10|1969-12-11|
TRIAL STUDY 134XCP|QS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|5|||||MSWS-12|||ML/M2/DAY|||10^3/L|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|Y|5||7||INDUCTION TREATMENT|1973-04-02||||1968-01-14||1973-08-02|1963-12-26|
TRIAL STUDY 134XCP|QS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1|||||EPIC-26|||BREATHS/30S|||BQ/L|NOT DONE||LIKERT SCALE 7-POINT|U|N|NA|1||38||OBSERVATION|1966-05-04||||1960-07-08||1963-02-26|1962-11-09|
TRIAL STUDY 134XCP|QS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2|||||FACT-LEU V4|||UM|||G/CM2|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|Y|N|2||58||FOLLOW-UP|1963-01-30||||1973-04-21||1965-09-21|1970-10-05|
TRIAL STUDY 134XCP|QS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|3|||||ADHD-RS-IV HOME VERSION|||RATIO|||MG/DL|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|3||39||CONTINUATION TREATMENT|1963-08-09||||1967-09-25||1960-10-05|1963-09-22|
TRIAL STUDY 134XCP|QS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|4|||||ODI V2.1A|||GTT|||10^6 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|Y|4||88||RUN-IN|1972-03-20||||1962-12-30||1972-10-09|1964-12-19|
TRIAL STUDY 134XCP|QS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|5|||||HAQ-DI WITH VAS|||G/ANIMAL/DAY|||/200 HPFS|NOT DONE||LIKERT SCALE 7-POINT|NA|U|N|5||7||FOLLOW-UP|1972-03-01||||1961-11-12||1966-07-04|1961-11-17|
TRIAL STUDY 134XCP|QS|2926D795-9C17-4440-8411-68525E93E78D|1|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II|||ANTI-XA IU|||/200 HPFS|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|N|1||38||TREATMENT|1969-07-19||||1966-11-20||1968-02-29|1970-06-23|
TRIAL STUDY 134XCP|QS|2926D795-9C17-4440-8411-68525E93E78D|2|||||BIS-11|||IU/L|||10^3 RNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|2||58||SCREENING|1969-07-11||||1973-07-26||1962-07-29|1962-07-22|
TRIAL STUDY 134XCP|QS|2926D795-9C17-4440-8411-68525E93E78D|3|||||PI|||PM|||UG/M2/H|NOT DONE||VERBAL RATING SCALE 5-POINT|U|U|N|3||39||BASELINE|1968-05-17||||1968-08-07||1972-01-30|1973-06-19|
TRIAL STUDY 134XCP|QS|2926D795-9C17-4440-8411-68525E93E78D|4|||||HAMD 6 SELF-REPORT VERSION|||G/G|||GAUSS|NOT DONE||LIKERT SCALE 7-POINT|U|Y|U|4||88||SCREENING|1960-04-15||||1965-03-12||1967-10-22|1965-05-24|
TRIAL STUDY 134XCP|QS|2926D795-9C17-4440-8411-68525E93E78D|5|||||HAEM-A-QOL|||/2000 RBC|||PPB|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|N|U|5||7||TREATMENT|1971-06-02||||1973-03-22||1972-09-17|1966-02-11|
TRIAL STUDY 134XCP|QS|BA3378F3-C308-469F-9818-9AD811086548|1|||||FACT-COG V3|||PIXELS/IN|||G/DAY|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|U|1||38||OBSERVATION|1967-09-29||||1973-01-15||1960-06-29|1970-02-10|
TRIAL STUDY 134XCP|QS|BA3378F3-C308-469F-9818-9AD811086548|2|||||MSIS-29 V1|||MG/G/MIN|||IU/MMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|U|2||58||LONG-TERM FOLLOW-UP|1961-03-31||||1965-10-11||1971-05-11|1963-04-02|
TRIAL STUDY 134XCP|QS|BA3378F3-C308-469F-9818-9AD811086548|3|||||T1-DDS|||LB|||NMOL/ML/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|Y|3||39||CONTINUATION TREATMENT|1969-06-15||||1968-05-24||1966-09-15|1963-12-30|
TRIAL STUDY 134XCP|QS|BA3378F3-C308-469F-9818-9AD811086548|4|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||10^4/HPF|||G/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|Y|N|4||88||OBSERVATION|1972-03-11||||1972-01-01||1963-07-08|1965-04-26|
TRIAL STUDY 134XCP|QS|BA3378F3-C308-469F-9818-9AD811086548|5|||||HAQ-DI WITH VAS|||KS|||JOULE|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|NA|NA|5||7||TREATMENT|1965-11-11||||1965-01-31||1971-08-21|1963-05-21|
TRIAL STUDY 134XCP|QS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1|||||OAB-Q|||MEQ/UG|||FMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|NA|NA|1||38||WASHOUT|1969-10-11||||1964-09-03||1960-11-19|1968-09-14|
TRIAL STUDY 134XCP|QS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2|||||BPI|||MANSON U/ML|||M/SEC|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|2||58||BASELINE|1968-04-01||||1965-08-13||1973-05-10|1972-04-07|
TRIAL STUDY 134XCP|QS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|3|||||C-SSRS BASELINE/SCREENING VERSION|||U/KG|||CI/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|U|N|3||39||TREATMENT|1971-10-28||||1962-12-23||1968-02-03|1968-02-20|
TRIAL STUDY 134XCP|QS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|4|||||CDR|||ML/MMHG/MIN/L|||G/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|NA|U|4||88||RUN-IN|1970-10-16||||1963-09-20||1961-09-20|1969-02-18|
TRIAL STUDY 134XCP|QS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|5|||||FACIT-DYSPNEA SF|||10^3 RNA COPIES/ML|||GRAVITATIONAL UNIT|NOT DONE||LIKERT SCALE 5-POINT|U|Y|NA|5||7||INDUCTION TREATMENT|1970-01-04||||1962-04-24||1971-10-22|1961-10-09|
TRIAL STUDY 134XCP|QS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1|||||EXACT|||MEQ/MMOL|||G/MOL|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|NA|1||38||WASHOUT|1962-07-12||||1968-05-04||1961-01-23|1972-11-07|
TRIAL STUDY 134XCP|QS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2|||||CCQ 24 HOUR VERSION|||PNU/ML|||SFC/10^6 PBMC|NOT DONE||LIKERT SCALE 7-POINT|NA|Y|Y|2||58||TREATMENT|1973-04-23||||1960-08-26||1969-04-24|1969-02-13|
TRIAL STUDY 134XCP|QS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN|||BQ|||VIRTUAL PIXEL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1971-11-16||||1969-05-23||1960-09-02|1965-07-24|
TRIAL STUDY 134XCP|QS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|4|||||WHODAS 2.0 - 36-ITEM SELF|||BEL|||10^6 DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|N|U|4||88||BLINDED TREATMENT|1961-12-03||||1967-02-27||1963-03-14|1964-01-27|
TRIAL STUDY 134XCP|QS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|5|||||FACIT-DYSPNEA SF|||TCID 50/DOSE|||UU/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|NA|5||7||LONG-TERM FOLLOW-UP|1967-09-08||||1960-05-24||1968-07-15|1965-02-19|
TRIAL STUDY 134XCP|QS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1|||||SIQ|||DEG2|||V/V|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|Y|NA|1||38||TREATMENT|1968-01-12||||1972-10-24||1969-12-03|1962-07-12|
TRIAL STUDY 134XCP|QS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2|||||EXPANDED DRS-PI SURVIVOR VERSION|||NKAT/L|||YEARS|NOT DONE||LIKERT SCALE 5-POINT|Y|NA|NA|2||58||WASHOUT|1972-03-21||||1965-03-08||1965-02-28|1973-08-02|
TRIAL STUDY 134XCP|QS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|3|||||ODI V2.1A|||NMOL/KG/DAY|||BAU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|N|3||39||RUN-IN|1964-02-06||||1967-01-06||1971-05-17|1963-11-16|
TRIAL STUDY 134XCP|QS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|4|||||SF12 V2.0 ACUTE|||OZ EQ|||CAN|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|NA|U|4||88||BASELINE|1960-09-03||||1968-09-01||1961-02-04|1961-10-15|
TRIAL STUDY 134XCP|QS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|5|||||BEBQ RETROSPECTIVE|||MG/KG|||HENRY|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|U|NA|5||7||SCREENING|1960-08-14||||1972-07-20||1973-08-09|1961-02-21|
TRIAL STUDY 134XCP|QS|15594D4E-1DAE-449F-AA52-9B0A926D9985|1|||||HAQ-DI WITH VAS|||%(W/V)|||FT3|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|N|1||38||SCREENING|1962-01-23||||1966-10-03||1968-06-19|1970-03-29|
TRIAL STUDY 134XCP|QS|15594D4E-1DAE-449F-AA52-9B0A926D9985|2|||||ESS|||NMOL BCE/NMOL|||FOZ_US|NOT DONE||VERBAL RATING SCALE 5-POINT|N|Y|U|2||58||CONTINUATION TREATMENT|1965-03-04||||1964-03-13||1973-05-02|1970-12-02|
TRIAL STUDY 134XCP|QS|15594D4E-1DAE-449F-AA52-9B0A926D9985|3|||||FLU-IIQ ONCE DAILY|||CI/L|||ML/M2/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|N|3||39||LONG-TERM FOLLOW-UP|1972-07-23||||1968-08-21||1967-11-07|1969-08-24|
TRIAL STUDY 134XCP|QS|15594D4E-1DAE-449F-AA52-9B0A926D9985|4|||||EPIC-CP|||/MM2|||FFU|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|Y|Y|4||88||OPEN LABEL TREATMENT|1968-10-23||||1966-03-02||1964-01-19|1973-08-05|
TRIAL STUDY 134XCP|QS|15594D4E-1DAE-449F-AA52-9B0A926D9985|5|||||VFQ-25 SELF ADMINISTERED|||MG/L FEU|||UMOL/H/MMOL|NOT DONE||VERBAL RATING SCALE 6-POINT|N|NA|U|5||7||LONG-TERM FOLLOW-UP|1962-01-01||||1970-12-17||1972-04-06|1970-06-05|
TRIAL STUDY 134XCP|QS|079DEA7B-A617-4787-9872-025F4248ABFF|1|||||FACT-C V4|||VOXEL|||UMOL/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|Y|1||38||OBSERVATION|1964-09-29||||1962-05-10||1969-11-24|1969-08-21|
TRIAL STUDY 134XCP|QS|079DEA7B-A617-4787-9872-025F4248ABFF|2|||||PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT|||KPA/L/SEC|||HOUNSFIELD UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|2||58||BLINDED TREATMENT|1961-07-22||||1964-08-29||1963-08-18|1971-11-15|
TRIAL STUDY 134XCP|QS|079DEA7B-A617-4787-9872-025F4248ABFF|3|||||BPI SHORT FORM|||CIGARETTE|||CI/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|U|3||39||LONG-TERM FOLLOW-UP|1973-06-14||||1960-07-11||1964-03-14|1972-10-14|
TRIAL STUDY 134XCP|QS|079DEA7B-A617-4787-9872-025F4248ABFF|4|||||PSQI|||VG/KG|||10^9 ORGANISMS/MG|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|NA|4||88||TREATMENT|1970-05-07||||1961-09-16||1968-09-19|1962-12-31|
TRIAL STUDY 134XCP|QS|079DEA7B-A617-4787-9872-025F4248ABFF|5|||||NCCN-FACT FKSI-19 V2|||/MM|||CAL|NOT DONE||LIKERT SCALE 3-POINT|N|Y|Y|5||7||WASHOUT|1973-01-13||||1973-06-13||1964-06-25|1960-09-24|
TRIAL STUDY 134XCP|QS|3178AE30-9653-4470-84E4-FB0E4587DF6B|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||DNA COPIES/ML|||UG/CM2|NOT DONE||LIKERT SCALE 5-POINT|U|Y|N|1||38||RUN-IN|1960-06-04||||1973-03-02||1971-03-06|1965-12-20|
TRIAL STUDY 134XCP|QS|3178AE30-9653-4470-84E4-FB0E4587DF6B|2|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||EID 50/DOSE|||MOL/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|NA|2||58||OPEN LABEL TREATMENT|1969-10-01||||1971-12-19||1963-10-29|1973-07-18|
TRIAL STUDY 134XCP|QS|3178AE30-9653-4470-84E4-FB0E4587DF6B|3|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||DPM/ML|||PELLET|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|Y|U|3||39||TREATMENT|1968-02-27||||1972-08-16||1966-08-09|1969-05-14|
TRIAL STUDY 134XCP|QS|3178AE30-9653-4470-84E4-FB0E4587DF6B|4|||||CDR|||10^9 ORGANISMS|||MG/M2/DAY|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|N|U|4||88||FOLLOW-UP|1967-12-16||||1962-04-19||1962-02-14|1971-03-08|
TRIAL STUDY 134XCP|QS|3178AE30-9653-4470-84E4-FB0E4587DF6B|5|||||SF12 V1.0 STANDARD|||MCI/KG|||FFU|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|N|5||7||BASELINE|1970-07-22||||1969-10-19||1960-06-04|1961-08-30|
TRIAL STUDY 134XCP|QS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1|||||FSS|||ML/DOSE|||UGEQ|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|Y|NA|1||38||TREATMENT|1964-10-08||||1966-06-27||1973-05-06|1971-03-04|
TRIAL STUDY 134XCP|QS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2|||||SF8 V1.0 ACUTE|||MET*MIN|||UL|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|U|Y|2||58||INDUCTION TREATMENT|1960-08-31||||1967-12-29||1963-01-26|1966-06-18|
TRIAL STUDY 134XCP|QS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|3|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||UM/DAY|||KBQ|NOT DONE||LIKERT SCALE 5-POINT|Y|N|Y|3||39||OBSERVATION|1960-03-02||||1963-09-10||1963-10-16|1965-01-23|
TRIAL STUDY 134XCP|QS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|4|||||SF36 V2.0 ACUTE|||GRAVITATIONAL UNIT|||UG/ANIMAL|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|NA|NA|4||88||BASELINE|1962-05-06||||1960-12-15||1960-09-09|1970-10-30|
TRIAL STUDY 134XCP|QS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT|||/MM|||L/H|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|5||7||FOLLOW-UP|1970-09-07||||1964-04-06||1972-04-21|1972-05-24|
TRIAL STUDY 134XCP|QS|D274C760-A607-4DA8-ACD3-346EF6E191D2|1|||||UPS|||CMHG|||BU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|U|Y|1||38||BLINDED TREATMENT|1964-12-08||||1962-01-06||1963-08-09|1960-10-24|
TRIAL STUDY 134XCP|QS|D274C760-A607-4DA8-ACD3-346EF6E191D2|2|||||EXPANDED DRS-PI CAREGIVER VERSION|||/KG|||AMP|NOT DONE||LIKERT SCALE 5-POINT|U|U|U|2||58||TREATMENT|1961-12-11||||1960-09-02||1970-01-21|1967-02-28|
TRIAL STUDY 134XCP|QS|D274C760-A607-4DA8-ACD3-346EF6E191D2|3|||||SF36 V2.0 ACUTE|||UG/M2|||F|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|U|3||39||CONTINUATION TREATMENT|1961-10-18||||1961-01-21||1967-06-17|1960-07-14|
TRIAL STUDY 134XCP|QS|D274C760-A607-4DA8-ACD3-346EF6E191D2|4|||||EORTC QLQ-LC13|||/5X10^4 WBC|||DAMOL/L|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|Y|4||88||BLINDED TREATMENT|1966-01-22||||1964-11-09||1963-06-22|1966-09-29|
TRIAL STUDY 134XCP|QS|D274C760-A607-4DA8-ACD3-346EF6E191D2|5|||||NPS|||%/MIN|||MV/SEC|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|Y|5||7||OBSERVATION|1972-06-27||||1968-07-10||1963-12-06|1961-07-03|
TRIAL STUDY 134XCP|QS|F5B7E82D-49AD-422E-9C38-5681105094AA|1|||||HAEM-A-QOL|||UG/DL|||CMH2O*S2/ML|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|NA|1||38||BLINDED TREATMENT|1971-12-06||||1962-05-24||1967-08-14|1973-05-19|
TRIAL STUDY 134XCP|QS|F5B7E82D-49AD-422E-9C38-5681105094AA|2|||||FACT-LEU V4|||DPM|||ML/DOSE|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|2||58||OPEN LABEL TREATMENT|1966-09-28||||1972-02-05||1960-10-17|1964-07-14|
TRIAL STUDY 134XCP|QS|F5B7E82D-49AD-422E-9C38-5681105094AA|3|||||PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT|||CM2|||CI/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|3||39||INDUCTION TREATMENT|1969-10-16||||1971-09-28||1960-03-03|1970-04-06|
TRIAL STUDY 134XCP|QS|F5B7E82D-49AD-422E-9C38-5681105094AA|4|||||FACT-TAXANE V4|||UM|||G/M2|NOT DONE||LIKERT SCALE 3-POINT|Y|U|Y|4||88||RUN-IN|1970-04-30||||1967-02-14||1972-12-04|1969-11-16|
TRIAL STUDY 134XCP|QS|F5B7E82D-49AD-422E-9C38-5681105094AA|5|||||UPS|||MM3/MM2/YEAR|||GY|NOT DONE||VISUAL ANALOG SCALE (100 MM)|Y|U|NA|5||7||SCREENING|1970-11-10||||1960-09-15||1972-10-11|1961-02-11|
TRIAL STUDY 134XCP|QS|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1|||||RAND-36 V1.0|||ML/M2/MIN|||10^9 CFU/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|U|1||38||CONTINUATION TREATMENT|1970-05-13||||1961-11-29||1961-05-17|1967-09-22|
TRIAL STUDY 134XCP|QS|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2|||||UPDRS|||UMOL/L/H|||NMOL/G|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|Y|2||58||LONG-TERM FOLLOW-UP|1972-04-06||||1971-09-03||1973-05-26|1972-10-27|
TRIAL STUDY 134XCP|QS|AF8D32B4-B2CC-4EE3-A612-179814C691B8|3|||||HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III|||C|||PSI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|N|3||39||RUN-IN|1968-10-12||||1972-07-11||1966-09-15|1969-11-07|
TRIAL STUDY 134XCP|QS|AF8D32B4-B2CC-4EE3-A612-179814C691B8|4|||||SF12 V2.0 ACUTE|||BU|||MEQ/G|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|NA|U|4||88||WASHOUT|1967-11-30||||1973-03-22||1973-05-23|1960-01-19|
TRIAL STUDY 134XCP|QS|AF8D32B4-B2CC-4EE3-A612-179814C691B8|5|||||EXPANDED DRS-PI SURVIVOR VERSION|||ML/BEAT|||K|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|NA|5||7||WASHOUT|1962-12-15||||1964-06-02||1973-08-28|1960-11-13|
TRIAL STUDY 134XCP|QS|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1|||||ADHD-RS-IV HOME VERSION|||MG/M2/MIN|||FT|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|N|N|1||38||SCREENING|1967-10-31||||1972-03-18||1971-02-18|1967-09-10|
TRIAL STUDY 134XCP|QS|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2|||||EXPANDED DRS-PI SURVIVOR VERSION|||ANTI-XA IU/ML|||MU/G|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|NA|2||58||CONTINUATION TREATMENT|1961-01-22||||1966-06-15||1962-05-06|1972-02-16|
TRIAL STUDY 134XCP|QS|64153B43-9DDC-473D-97E1-0E2E8C3E8116|3|||||NCCN-FACT FKSI-19 V2|||GY|||10^6 ORGANISMS/G|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|Y|3||39||TREATMENT|1972-09-04||||1968-11-19||1967-03-20|1961-07-02|
TRIAL STUDY 134XCP|QS|64153B43-9DDC-473D-97E1-0E2E8C3E8116|4|||||PDQUALIF|||GY/H|||UIU/DL|NOT DONE||LIKERT SCALE 3-POINT|U|Y|NA|4||88||RUN-IN|1966-11-20||||1971-03-08||1971-10-02|1966-08-04|
TRIAL STUDY 134XCP|QS|64153B43-9DDC-473D-97E1-0E2E8C3E8116|5|||||ODI V2.1A|||/2000 RBC|||DNA COPIES/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|Y|Y|5||7||WASHOUT|1965-04-13||||1973-06-05||1971-06-28|1962-08-28|
TRIAL STUDY 134XCP|QS|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1|||||WPAI-SHP V2.0|||GPS U|||CI/UG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|Y|NA|1||38||CONTINUATION TREATMENT|1960-01-16||||1960-05-13||1964-03-07|1963-11-20|
TRIAL STUDY 134XCP|QS|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2|||||FACT-C V4|||/100 WBC|||DAYS/WK|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|Y|NA|2||58||LONG-TERM FOLLOW-UP|1961-09-04||||1960-01-03||1973-03-24|1969-01-17|
TRIAL STUDY 134XCP|QS|0F5775AD-1D20-4B59-8558-8A41C12E03D0|3|||||WHODAS 2.0 - 36-ITEM INTERVIEWER|||PG/DL|||10^3 ORGANISMS/G|NOT DONE||LIKERT SCALE 3-POINT|NA|NA|NA|3||39||CONTINUATION TREATMENT|1963-10-19||||1961-09-21||1967-01-25|1967-04-05|
TRIAL STUDY 134XCP|QS|0F5775AD-1D20-4B59-8558-8A41C12E03D0|4|||||HAMD 6 SELF-REPORT VERSION|||NEWTON|||FINGERTIP UNIT|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|U|U|4||88||TREATMENT|1971-11-12||||1966-06-25||1966-12-21|1965-09-05|
TRIAL STUDY 134XCP|QS|0F5775AD-1D20-4B59-8558-8A41C12E03D0|5|||||BORG CR10|||KIU|||KG/CM|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|N|N|5||7||RUN-IN|1972-12-10||||1962-10-10||1970-02-18|1963-06-11|
TRIAL STUDY 134XCP|QS|DF533087-690C-489A-9163-9D4503B7BCC9|1|||||ADHD-RS-IV HOME VERSION|||PG/DL|||MET|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|1||38||CONTINUATION TREATMENT|1969-10-19||||1962-01-05||1973-02-25|1967-05-01|
TRIAL STUDY 134XCP|QS|DF533087-690C-489A-9163-9D4503B7BCC9|2|||||MSIS-29 V2|||UMOL/H/MMOL|||GPELISA UNIT/ML|NOT DONE||NUMERICAL RATING SCALE 11-POINT|Y|NA|Y|2||58||LONG-TERM FOLLOW-UP|1961-10-29||||1971-04-04||1973-01-26|1969-08-26|
TRIAL STUDY 134XCP|QS|DF533087-690C-489A-9163-9D4503B7BCC9|3|||||NCCN-FACT FBRSI-24 V2|||PIPE|||IU/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|U|3||39||FOLLOW-UP|1960-01-22||||1970-06-24||1972-12-24|1966-11-30|
TRIAL STUDY 134XCP|QS|DF533087-690C-489A-9163-9D4503B7BCC9|4|||||CHART-SF PAPER VERSION|||AU/ML|||LOG10 COPIES/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|U|Y|N|4||88||WASHOUT|1971-09-28||||1969-09-27||1961-04-09|1972-11-14|
TRIAL STUDY 134XCP|QS|DF533087-690C-489A-9163-9D4503B7BCC9|5|||||RDQ|||UM2|||BU/ML|NOT DONE||VERBAL RATING SCALE 6-POINT|U|N|Y|5||7||BLINDED TREATMENT|1961-05-25||||1961-11-06||1972-11-22|1972-03-03|
TRIAL STUDY 134XCP|QS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1|||||SMDDS V1.0|||HENRY|||1/(S*KPA)|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|N|1||38||TREATMENT|1962-12-08||||1960-03-07||1963-04-11|1964-02-15|
TRIAL STUDY 134XCP|QS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2|||||MADRS|||PACKAGE|||CMH2O/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|N|NA|U|2||58||SCREENING|1966-03-09||||1973-07-05||1969-10-12|1966-02-24|
TRIAL STUDY 134XCP|QS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|3|||||PARENT-DDS|||HENRY|||KALLIKREIN INHIBITOR UNIT|NOT DONE||VISUAL ANALOG SCALE (50 MM)|N|NA|Y|3||39||RUN-IN|1972-03-09||||1965-04-05||1967-04-26|1968-09-13|
TRIAL STUDY 134XCP|QS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|4|||||BIS-11|||/MIN|||MMOL/DAY|NOT DONE||LIKERT SCALE 5-POINT|Y|N|N|4||88||FOLLOW-UP|1962-09-08||||1969-11-07||1964-06-10|1968-12-31|
TRIAL STUDY 134XCP|QS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|5|||||EORTC QLQ-C15-PAL V1.0|||MG/KG/MIN|||UG/MIN|NOT DONE||VERBAL RATING SCALE 4-POINT|U|U|Y|5||7||OPEN LABEL TREATMENT|1963-10-25||||1964-05-18||1961-10-27|1965-03-16|
TRIAL STUDY 134XCP|QS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1|||||GDS SHORT FORM|||MMAL|||10^7 TCID 50/DOSE|NOT DONE||LIKERT SCALE 7-POINT|N|Y|N|1||38||LONG-TERM FOLLOW-UP|1970-10-15||||1969-03-15||1971-01-24|1971-06-16|
TRIAL STUDY 134XCP|QS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2|||||IBDQ|||MMHG/SEC|||GPELISA UNIT/ML|NOT DONE||VERBAL RATING SCALE 4-POINT|U|Y|Y|2||58||BASELINE|1960-07-26||||1966-04-02||1966-07-11|1972-08-23|
TRIAL STUDY 134XCP|QS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|3|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||10^6 ORGANISMS/MG|||SQU/ML|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|NA|U|3||39||FOLLOW-UP|1969-09-15||||1972-05-24||1961-04-24|1966-02-25|
TRIAL STUDY 134XCP|QS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|4|||||PODCI - PEDIATRIC PARENT REPORTED|||POINT|||PIXELS/IN|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|N|Y|4||88||OBSERVATION|1964-07-04||||1963-07-25||1973-04-11|1965-12-10|
TRIAL STUDY 134XCP|QS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|5|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT|||MSEC|||GBQ/MG|NOT DONE||LIKERT SCALE 3-POINT|Y|U|U|5||7||WASHOUT|1964-03-16||||1972-01-26||1966-09-09|1970-04-03|
TRIAL STUDY 134XCP|QS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1|||||ESS|||NMOL|||UMOL/L|NOT DONE||LIKERT SCALE 3-POINT|NA|Y|U|1||38||CONTINUATION TREATMENT|1962-01-22||||1966-02-15||1972-07-26|1965-12-24|
TRIAL STUDY 134XCP|QS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2|||||FKSI-DRS V4|||L/DAY|||MIU/L|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|N|2||58||OBSERVATION|1966-02-24||||1963-11-01||1964-05-28|1973-03-15|
TRIAL STUDY 134XCP|QS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|3|||||PCL-5|||IU/DAY|||VG/KG|NOT DONE||LIKERT SCALE 7-POINT|N|U|U|3||39||SCREENING|1971-01-04||||1965-09-10||1966-06-08|1969-09-24|
TRIAL STUDY 134XCP|QS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|4|||||WOMAC VA 3.1 INDEX|||ANTI-XA IU/ML|||BQ/L|NOT DONE||VERBAL RATING SCALE 6-POINT|U|U|U|4||88||RUN-IN|1966-10-22||||1968-04-14||1961-10-26|1965-03-11|
TRIAL STUDY 134XCP|QS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|5|||||FACT-P V4|||KEV|||APPLICATION|NOT DONE||VERBAL RATING SCALE 6-POINT|U|Y|NA|5||7||TREATMENT|1961-11-22||||1964-08-14||1966-07-02|1968-08-12|
TRIAL STUDY 134XCP|QS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1|||||IDS-SR|||DRAM|||S*KPA|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|NA|NA|1||38||FOLLOW-UP|1972-10-23||||1963-06-13||1962-02-27|1968-09-26|
TRIAL STUDY 134XCP|QS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2|||||GCGI|||MOL|||BAU/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|N|NA|U|2||58||OPEN LABEL TREATMENT|1971-10-30||||1972-11-02||1963-05-06|1965-04-17|
TRIAL STUDY 134XCP|QS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||NG|||TESLA|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|N|3||39||INDUCTION TREATMENT|1971-09-13||||1967-07-30||1962-07-09|1971-10-16|
TRIAL STUDY 134XCP|QS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|4|||||BEBQ RETROSPECTIVE|||G/G|||/2500 WBC|NOT DONE||LIKERT SCALE 5-POINT|U|N|N|4||88||OPEN LABEL TREATMENT|1969-10-09||||1971-01-05||1972-07-30|1964-09-24|
TRIAL STUDY 134XCP|QS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|5|||||FKSI-15|||MG/G/MIN|||MMOL/MIN/KPA/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|U|N|5||7||CONTINUATION TREATMENT|1973-01-21||||1973-02-28||1971-02-10|1964-01-23|
TRIAL STUDY 134XCP|QS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1|||||FACT/GOG-NTX V4|||KPA/L/SEC|||QUANTITY SUFFICIENT|NOT DONE||LIKERT SCALE 5-POINT|N|NA|Y|1||38||BLINDED TREATMENT|1961-11-24||||1962-08-21||1967-03-01|1963-02-07|
TRIAL STUDY 134XCP|QS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||G/L|||MIN/DAY|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|2||58||WASHOUT|1971-09-07||||1969-03-19||1969-08-25|1967-03-19|
TRIAL STUDY 134XCP|QS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|3|||||FSS|||UM/S|||DDU|NOT DONE||LIKERT SCALE 7-POINT|NA|N|U|3||39||WASHOUT|1961-01-06||||1960-03-17||1963-09-26|1965-09-29|
TRIAL STUDY 134XCP|QS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|4|||||PARENT-DDS|||MILE|||10^7/L|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|N|4||88||RUN-IN|1962-12-16||||1967-07-27||1965-02-11|1963-01-25|
TRIAL STUDY 134XCP|QS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|5|||||FACT-COG V3|||ML/H|||MM/H|NOT DONE||NUMERICAL RATING SCALE 21-POINT|Y|Y|U|5||7||RUN-IN|1963-02-16||||1965-07-04||1970-03-21|1971-08-18|
TRIAL STUDY 134XCP|QS|219A70B2-48A6-407C-B901-9847583DB5F4|1|||||EQ-5D-5L|||ML/G/H|||MM2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|N|1||38||OBSERVATION|1962-02-21||||1968-04-01||1972-08-24|1962-08-25|
TRIAL STUDY 134XCP|QS|219A70B2-48A6-407C-B901-9847583DB5F4|2|||||EQ-5D-3L|||10^6/L|||10^5/HPF|NOT DONE||LIKERT SCALE 3-POINT|Y|Y|N|2||58||BASELINE|1965-12-23||||1971-09-24||1968-06-08|1961-07-27|
TRIAL STUDY 134XCP|QS|219A70B2-48A6-407C-B901-9847583DB5F4|3|||||CCQ 24 HOUR VERSION|||L/MIN/M2|||U/MMOL|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|NA|NA|3||39||FOLLOW-UP|1965-01-05||||1970-10-09||1972-03-07|1964-02-17|
TRIAL STUDY 134XCP|QS|219A70B2-48A6-407C-B901-9847583DB5F4|4|||||SIQ-JR|||MIN|||PACKAGE|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|N|Y|4||88||WASHOUT|1963-07-04||||1962-10-28||1961-07-22|1962-05-09|
TRIAL STUDY 134XCP|QS|219A70B2-48A6-407C-B901-9847583DB5F4|5|||||ADCS-ADL|||CMHG|||MMOL/MIN/KPA|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|Y|U|5||7||INDUCTION TREATMENT|1965-04-02||||1960-01-27||1961-11-27|1972-04-05|
TRIAL STUDY 134XCP|QS|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1|||||WHODAS 2.0 - 12-ITEM PROXY|||BOLUS|||PL|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|N|NA|1||38||TREATMENT|1971-05-02||||1971-09-19||1971-06-21|1962-06-17|
TRIAL STUDY 134XCP|QS|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2|||||FACT-HEP V4|||AU/ML|||GPL U|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|NA|2||58||WASHOUT|1972-02-05||||1963-08-25||1962-12-27|1965-09-29|
TRIAL STUDY 134XCP|QS|CF3AC42D-DFBA-448E-A688-46A87D6264EB|3|||||C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL|||G/CAGE/WK|||10^7 PFU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|3||39||SCREENING|1966-08-02||||1961-08-20||1965-01-26|1967-07-07|
TRIAL STUDY 134XCP|QS|CF3AC42D-DFBA-448E-A688-46A87D6264EB|4|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT|||KM|||CM|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|4||88||BASELINE|1961-05-16||||1969-02-11||1971-04-29|1962-06-04|
TRIAL STUDY 134XCP|QS|CF3AC42D-DFBA-448E-A688-46A87D6264EB|5|||||HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II|||%(W/V)|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 21-POINT|NA|NA|Y|5||7||WASHOUT|1968-06-09||||1973-08-17||1960-03-18|1972-03-24|
TRIAL STUDY 134XCP|QS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1|||||VFQ-25 INTERVIEWER ADMINISTERED|||CMOL|||L/H|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|NA|N|1||38||SCREENING|1963-05-24||||1970-01-22||1963-04-20|1964-11-16|
TRIAL STUDY 134XCP|QS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2|||||SDS|||ELISA UNIT|||10^6 RNA COPIES/ML|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|U|Y|2||58||RUN-IN|1961-09-18||||1960-05-26||1966-05-11|1967-02-13|
TRIAL STUDY 134XCP|QS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|3|||||DAD|||10^3/HPF|||SHOCK WAVE|NOT DONE||LIKERT SCALE 7-POINT|Y|NA|NA|3||39||TREATMENT|1969-12-20||||1960-08-01||1961-01-06|1965-10-07|
TRIAL STUDY 134XCP|QS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|4|||||RAND SOCIAL SUPPORT SURVEY INSTRUMENT|||ML/MMHG/MIN/L|||MG/KG|NOT DONE||VERBAL RATING SCALE 5-POINT|Y|Y|Y|4||88||BASELINE|1963-12-18||||1972-07-05||1964-09-24|1972-12-25|
TRIAL STUDY 134XCP|QS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|5|||||CRQ-SAS FIRST ADMINISTRATION VERSION|||BAR|||10^6 ORGANISMS|NOT DONE||VISUAL ANALOG SCALE (50 MM)|Y|U|N|5||7||LONG-TERM FOLLOW-UP|1963-11-02||||1965-09-23||1962-03-06|1973-04-20|
TRIAL STUDY 134XCP|QS|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1|||||CCQ 24 HOUR VERSION|||FOZ_BR|||DL|NOT DONE||VERBAL RATING SCALE 6-POINT|U|NA|Y|1||38||TREATMENT|1971-02-03||||1964-05-11||1970-09-25|1960-04-11|
TRIAL STUDY 134XCP|QS|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2|||||GAD-7|||UMOL/H/MMOL|||CI/UL|NOT DONE||LIKERT SCALE 5-POINT|U|Y|N|2||58||FOLLOW-UP|1965-04-08||||1972-08-06||1971-12-05|1970-12-01|
TRIAL STUDY 134XCP|QS|D19D43A5-DFE6-415D-86B7-6A767A357BC9|3|||||BWCS|||/100 WBC|||MOL/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|U|U|3||39||TREATMENT|1970-06-27||||1961-11-10||1972-12-16|1972-07-26|
TRIAL STUDY 134XCP|QS|D19D43A5-DFE6-415D-86B7-6A767A357BC9|4|||||WOMAC VA 3.1 INDEX|||MV2/HZ|||ARBITRARY U|NOT DONE||LIKERT SCALE 3-POINT|U|NA|Y|4||88||BLINDED TREATMENT|1960-09-28||||1960-08-29||1969-06-17|1971-07-17|
TRIAL STUDY 134XCP|QS|D19D43A5-DFE6-415D-86B7-6A767A357BC9|5|||||SF12 V2.0 ACUTE|||MMOL|||NCI|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|NA|5||7||RUN-IN|1963-07-22||||1968-02-16||1972-05-27|1965-11-07|
TRIAL STUDY 134XCP|QS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1|||||AQ20|||UG/KG|||AMOL|NOT DONE||NUMERICAL RATING SCALE 6-POINT|NA|U|NA|1||38||CONTINUATION TREATMENT|1964-10-23||||1964-09-15||1972-11-08|1967-01-04|
TRIAL STUDY 134XCP|QS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2|||||PSQI|||G/CAGE|||PPTH|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|N|2||58||CONTINUATION TREATMENT|1972-07-25||||1967-03-29||1962-12-18|1965-05-01|
TRIAL STUDY 134XCP|QS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|3|||||BSFS|||DRAM|||UG/M2|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|U|3||39||BLINDED TREATMENT|1960-08-06||||1961-03-14||1963-07-24|1965-04-09|
TRIAL STUDY 134XCP|QS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|4|||||GMSS VERSION TYPE 1 DIABETES|||/10^3|||ELISA UNIT/ML|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|Y|NA|4||88||FOLLOW-UP|1967-06-04||||1970-01-31||1964-12-04|1972-11-04|
TRIAL STUDY 134XCP|QS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|5|||||PARTNER-DDS|||OHM|||S^-1(%O2)^-1|NOT DONE||LIKERT SCALE 3-POINT|U|N|U|5||7||TREATMENT|1970-02-20||||1965-08-05||1960-08-24|1965-05-16|
TRIAL STUDY 134XCP|QS|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1|||||ASEX-FEMALE|||KA_U/DL|||VP/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|U|NA|Y|1||38||LONG-TERM FOLLOW-UP|1961-09-03||||1971-10-29||1964-04-24|1970-12-21|
TRIAL STUDY 134XCP|QS|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2|||||TSQM V1.4|||MM|||EIA UNIT|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|Y|2||58||INDUCTION TREATMENT|1970-10-29||||1961-09-02||1961-10-17|1972-05-04|
TRIAL STUDY 134XCP|QS|7D307F63-4A25-4E7D-9980-16764AE5C4A4|3|||||SF36 V1.0 STANDARD|||MM/H|||BQ/KG|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|NA|3||39||BLINDED TREATMENT|1963-04-16||||1966-08-27||1969-04-07|1963-07-21|
TRIAL STUDY 134XCP|QS|7D307F63-4A25-4E7D-9980-16764AE5C4A4|4|||||MNSI|||/500 WBC|||MG/MOL|NOT DONE||LIKERT SCALE 7-POINT|Y|Y|Y|4||88||OBSERVATION|1972-03-28||||1960-07-02||1960-02-29|1972-09-14|
TRIAL STUDY 134XCP|QS|7D307F63-4A25-4E7D-9980-16764AE5C4A4|5|||||SF12 V1.0 ACUTE|||10^3 CFU|||P|NOT DONE||LIKERT SCALE 5-POINT|NA|Y|NA|5||7||OPEN LABEL TREATMENT|1960-09-23||||1963-02-25||1961-02-26|1970-09-16|
TRIAL STUDY 134XCP|QS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1|||||SGRQ PAST 3 MONTHS VERSION|||PATCH|||H*%|NOT DONE||NUMERICAL RATING SCALE 11-POINT|U|NA|N|1||38||OPEN LABEL TREATMENT|1965-10-21||||1968-03-08||1962-07-01|1960-04-30|
TRIAL STUDY 134XCP|QS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2|||||FACT-P V4|||MIN*MG/ML|||GBQ/UG|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|Y|NA|2||58||INDUCTION TREATMENT|1964-12-13||||1971-01-22||1971-06-14|1971-08-19|
TRIAL STUDY 134XCP|QS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|3|||||NPS|||MMHG|||NG|NOT DONE||VERBAL RATING SCALE 6-POINT|Y|U|NA|3||39||OPEN LABEL TREATMENT|1963-08-09||||1960-04-02||1963-05-24|1960-04-23|
TRIAL STUDY 134XCP|QS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|4|||||FSS|||MG/G/H|||U/G/DAY|NOT DONE||VISUAL ANALOG SCALE (10 CM)|Y|N|Y|4||88||TREATMENT|1973-01-06||||1960-05-13||1963-12-04|1971-10-02|
TRIAL STUDY 134XCP|QS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|5|||||CDLQ|||TSP EQ|||MM2|NOT DONE||VERBAL RATING SCALE 4-POINT|Y|U|N|5||7||TREATMENT|1972-04-30||||1966-06-10||1970-10-18|1962-08-15|
TRIAL STUDY 134XCP|QS|F4718E0D-4DD9-442E-8907-076551C83AEE|1|||||Q-LES-Q|||CS|||PG/L|NOT DONE||VISUAL ANALOG SCALE (50 MM)|U|Y|N|1||38||RUN-IN|1970-06-03||||1964-07-04||1967-11-17|1964-11-04|
TRIAL STUDY 134XCP|QS|F4718E0D-4DD9-442E-8907-076551C83AEE|2|||||PHQ-2|||U/M2|||DROP|NOT DONE||VISUAL ANALOG SCALE (10 CM)|N|U|N|2||58||BLINDED TREATMENT|1962-05-29||||1971-04-22||1964-11-03|1963-06-12|
TRIAL STUDY 134XCP|QS|F4718E0D-4DD9-442E-8907-076551C83AEE|3|||||FAQ-NACC VERSION|||MU/G|||DRINK|NOT DONE||LIKERT SCALE 7-POINT|U|Y|Y|3||39||RUN-IN|1966-06-02||||1967-07-04||1973-09-07|1966-12-24|
TRIAL STUDY 134XCP|QS|F4718E0D-4DD9-442E-8907-076551C83AEE|4|||||FACT-P V4|||LOG EID 50/DOSE|||MET*H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|U|NA|4||88||SCREENING|1960-12-02||||1966-08-28||1962-10-13|1972-08-03|
TRIAL STUDY 134XCP|QS|F4718E0D-4DD9-442E-8907-076551C83AEE|5|||||IDS-SR|||/DAY|||PG/DL|NOT DONE||VERBAL RATING SCALE 5-POINT|U|NA|NA|5||7||CONTINUATION TREATMENT|1968-09-23||||1963-01-03||1960-06-27|1963-10-27|
TRIAL STUDY 134XCP|QS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1|||||PCL-5|||KALLIKREIN INHIBITOR UNIT|||DDU|NOT DONE||LIKERT SCALE 7-POINT|NA|NA|U|1||38||LONG-TERM FOLLOW-UP|1967-05-06||||1966-05-08||1971-08-02|1972-03-08|
TRIAL STUDY 134XCP|QS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2|||||COPD ASSESSMENT TEST|||PACK YEAR|||KG/MOL|NOT DONE||LIKERT SCALE 7-POINT|Y|N|Y|2||58||OPEN LABEL TREATMENT|1973-06-17||||1969-11-28||1970-05-18|1963-03-31|
TRIAL STUDY 134XCP|QS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|3|||||WHODAS 2.0 - 12-ITEM PROXY|||H*%|||FT2|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|U|3||39||TREATMENT|1963-03-24||||1969-09-11||1964-11-16|1973-05-09|
TRIAL STUDY 134XCP|QS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|4|||||BPI SHORT FORM|||MV|||UG/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|U|4||88||FOLLOW-UP|1966-12-16||||1962-04-28||1962-07-20|1969-09-28|
TRIAL STUDY 134XCP|QS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|5|||||FACT-BMT V4|||HPA|||U.CARR|NOT DONE||LIKERT SCALE 3-POINT|U|Y|N|5||7||TREATMENT|1964-06-30||||1973-02-27||1961-12-05|1965-10-08|
TRIAL STUDY 134XCP|QS|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1|||||SGRQ PAST 3 MONTHS VERSION|||EQ|||UG/MIN|NOT DONE||LIKERT SCALE 5-POINT|Y|Y|U|1||38||RUN-IN|1966-11-15||||1961-08-02||1965-06-25|1966-06-15|
TRIAL STUDY 134XCP|QS|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2|||||DLQI|||CM H2O|||ABSORBANCE U/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|Y|N|Y|2||58||RUN-IN|1964-02-11||||1964-10-05||1972-10-24|1966-10-14|
TRIAL STUDY 134XCP|QS|E86F996D-3A96-4C36-82B2-1AC4B4906F49|3|||||UPDRS|||ANTIBODY UNIT|||OZ EQ|NOT DONE||VERBAL RATING SCALE 5-POINT|U|N|U|3||39||OBSERVATION|1966-03-01||||1971-01-25||1961-12-28|1968-08-15|
TRIAL STUDY 134XCP|QS|E86F996D-3A96-4C36-82B2-1AC4B4906F49|4|||||NCCN-FACT FOSI-18 V2|||KA_U/DL|||APS U|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|U|NA|4||88||OPEN LABEL TREATMENT|1960-08-31||||1969-07-20||1961-05-17|1961-06-18|
TRIAL STUDY 134XCP|QS|E86F996D-3A96-4C36-82B2-1AC4B4906F49|5|||||PARTNER-DDS|||10^3 ORGANISMS|||BAG|NOT DONE||VERBAL RATING SCALE 4-POINT|NA|NA|N|5||7||WASHOUT|1967-12-18||||1971-11-20||1971-03-22|1960-07-11|
TRIAL STUDY 134XCP|QS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1|||||FACT-BRM V4|||CAPSULE|||U/CL|NOT DONE||LIKERT SCALE 5-POINT|Y|N|Y|1||38||INDUCTION TREATMENT|1972-04-14||||1966-05-20||1963-04-18|1965-02-13|
TRIAL STUDY 134XCP|QS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2|||||BSI-18|||RAD|||CCID 50/DOSE|NOT DONE||VERBAL RATING SCALE 4-POINT|N|N|NA|2||58||SCREENING|1971-12-02||||1970-08-03||1969-03-05|1970-02-14|
TRIAL STUDY 134XCP|QS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|3|||||WOMAC VA 3.1 INDEX|||/MS|||MMAL|NOT DONE||VERBAL RATING SCALE 4-POINT|N|Y|U|3||39||WASHOUT|1972-03-31||||1960-02-27||1968-01-07|1960-10-31|
TRIAL STUDY 134XCP|QS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|4|||||SF10 V1.0 CHILDREN STANDARD|||10^4/L|||UG/ANIMAL|NOT DONE||VERBAL RATING SCALE 4-POINT|N|NA|N|4||88||LONG-TERM FOLLOW-UP|1960-10-18||||1968-01-07||1961-01-18|1965-07-16|
TRIAL STUDY 134XCP|QS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|5|||||C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY|||DRINK|||NG/L|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|NA|NA|5||7||INDUCTION TREATMENT|1963-05-09||||1965-11-19||1966-03-07|1972-03-14|
TRIAL STUDY 134XCP|QS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1|||||PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT|||HOURS|||UG/L|NOT DONE||LIKERT SCALE 3-POINT|N|U|U|1||38||TREATMENT|1960-11-18||||1962-08-08||1964-07-27|1969-03-23|
TRIAL STUDY 134XCP|QS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2|||||HAMD 6 SELF-REPORT VERSION|||ELISA UNIT|||MOL/MG|NOT DONE||VERBAL RATING SCALE 6-POINT|N|U|NA|2||58||BLINDED TREATMENT|1960-01-16||||1960-10-05||1968-01-04|1971-11-10|
TRIAL STUDY 134XCP|QS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|3|||||FAMS|||GMFI|||HOURS|NOT DONE||VERBAL RATING SCALE 6-POINT|N|Y|N|3||39||OBSERVATION|1967-03-22||||1961-10-12||1968-10-28|1963-07-14|
TRIAL STUDY 134XCP|QS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|4|||||TSQM V1.4|||MOSM/KG|||BQ|NOT DONE||LIKERT SCALE 7-POINT|U|NA|Y|4||88||SCREENING|1963-06-20||||1967-02-14||1963-02-26|1966-12-01|
TRIAL STUDY 134XCP|QS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|5|||||COWS|||MEQ/UG|||P|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|Y|Y|5||7||SCREENING|1973-01-09||||1963-10-17||1971-07-15|1971-08-25|
TRIAL STUDY 134XCP|QS|28E9B15E-4757-42F5-8AE7-2C868904F88B|1|||||RDQ|||MG2/DL2|||ML/100G/MIN|NOT DONE||VERBAL RATING SCALE 5-POINT|NA|NA|Y|1||38||WASHOUT|1968-02-04||||1970-10-01||1966-12-04|1964-07-14|
TRIAL STUDY 134XCP|QS|28E9B15E-4757-42F5-8AE7-2C868904F88B|2|||||PDQUALIF|||MG/M2/MIN|||DPM/0.5 ML|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|NA|U|2||58||TREATMENT|1965-11-26||||1972-08-10||1963-04-09|1964-10-23|
TRIAL STUDY 134XCP|QS|28E9B15E-4757-42F5-8AE7-2C868904F88B|3|||||GMSS VERSION TYPE 1 DIABETES|||NEBULE|||IU/DAY|NOT DONE||VERBAL RATING SCALE 6-POINT|NA|N|NA|3||39||BLINDED TREATMENT|1966-06-06||||1968-07-31||1968-05-14|1966-08-11|
TRIAL STUDY 134XCP|QS|28E9B15E-4757-42F5-8AE7-2C868904F88B|4|||||BARS|||CAPFUL|||PIPE|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|Y|4||88||SCREENING|1966-12-17||||1967-10-20||1970-04-26|1963-08-25|
TRIAL STUDY 134XCP|QS|28E9B15E-4757-42F5-8AE7-2C868904F88B|5|||||EORTC QLQ-C30 V3.0|||G/L|||MM2|NOT DONE||VISUAL ANALOG SCALE (10 CM)|U|NA|Y|5||7||TREATMENT|1962-09-21||||1967-05-30||1962-03-31|1968-08-27|
TRIAL STUDY 134XCP|QS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1|||||FAMS|||G/KG|||IU|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|Y|1||38||BLINDED TREATMENT|1971-12-12||||1963-01-25||1962-07-26|1961-03-31|
TRIAL STUDY 134XCP|QS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2|||||TSCYC|||10^6 ORGANISMS|||DPM/ML|NOT DONE||NUMERICAL RATING SCALE 5-POINT|NA|Y|NA|2||58||INDUCTION TREATMENT|1962-12-01||||1964-12-03||1963-05-26|1962-05-12|
TRIAL STUDY 134XCP|QS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|3|||||SF12 V2.0 ACUTE|||NEWTON|||MS/MMHG|NOT DONE||LIKERT SCALE 3-POINT|U|NA|Y|3||39||SCREENING|1971-05-22||||1964-03-25||1968-01-15|1969-08-08|
TRIAL STUDY 134XCP|QS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|4|||||CHART-SF PAPER VERSION|||MMHG|||SEC|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|NA|NA|4||88||TREATMENT|1960-02-07||||1962-05-19||1969-12-15|1967-07-26|
TRIAL STUDY 134XCP|QS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|5|||||OAB-Q SHORT FORM|||NGEQ/L|||APPLICATION|NOT DONE||NUMERICAL RATING SCALE 5-POINT|N|U|NA|5||7||TREATMENT|1971-05-10||||1965-05-02||1971-08-11|1971-09-07|
TRIAL STUDY 134XCP|QS|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1|||||YMRS|||UG/L DDU|||10^8 PFU|NOT DONE||LIKERT SCALE 5-POINT|U|U|NA|1||38||SCREENING|1966-08-19||||1963-02-22||1973-04-12|1966-07-14|
TRIAL STUDY 134XCP|QS|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2|||||CCQ 24 HOUR VERSION|||10^12/L|||G/KG|NOT DONE||VERBAL RATING SCALE 4-POINT|N|U|U|2||58||OPEN LABEL TREATMENT|1966-02-27||||1964-10-21||1973-02-27|1963-07-07|
TRIAL STUDY 134XCP|QS|2E1011F1-A091-4E7E-B661-477A1F6DD39A|3|||||NPI|||MNFI|||UMOL/L|NOT DONE||VISUAL ANALOG SCALE (100 MM)|NA|N|Y|3||39||WASHOUT|1961-11-13||||1967-05-27||1972-09-24|1971-04-01|
TRIAL STUDY 134XCP|QS|2E1011F1-A091-4E7E-B661-477A1F6DD39A|4|||||NPS|||PSEC|||UL/ML|NOT DONE||NUMERICAL RATING SCALE 6-POINT|N|Y|U|4||88||OPEN LABEL TREATMENT|1970-10-17||||1968-03-13||1967-12-08|1962-12-10|
TRIAL STUDY 134XCP|QS|2E1011F1-A091-4E7E-B661-477A1F6DD39A|5|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||STRIP|||GBQ|NOT DONE||LIKERT SCALE 7-POINT|N|U|N|5||7||OBSERVATION|1966-03-10||||1961-04-13||1960-03-07|1964-03-18|
TRIAL STUDY 134XCP|QS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1|||||SF36 V2.0 ACUTE|||LOG10 CFU/G|||ENZYME U/L|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|NA|NA|1||38||WASHOUT|1963-01-18||||1965-05-03||1964-02-19|1972-03-29|
TRIAL STUDY 134XCP|QS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2|||||C-SSRS CHILDREN'S BASELINE/SCREENING|||DDU|||NKAT/G HB|NOT DONE||NUMERICAL RATING SCALE 21-POINT|U|N|NA|2||58||FOLLOW-UP|1961-01-14||||1973-03-17||1971-04-27|1970-10-04|
TRIAL STUDY 134XCP|QS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|3|||||FLU-IIQ TWICE DAILY|||MV2/HZ|||UMOL|NOT DONE||NUMERICAL RATING SCALE 5-POINT|U|N|U|3||39||INDUCTION TREATMENT|1962-11-19||||1973-03-17||1961-04-21|1961-06-18|
TRIAL STUDY 134XCP|QS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|4|||||NCCN-FACT FPSI-17 V2|||MG/DOSE|||NMOL/MOL|NOT DONE||LIKERT SCALE 5-POINT|U|U|N|4||88||LONG-TERM FOLLOW-UP|1971-06-19||||1961-10-26||1961-02-22|1968-09-18|
TRIAL STUDY 134XCP|QS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|5|||||FLU-IIQ ONCE DAILY|||MOL/MG|||L/MIN/M2|NOT DONE||LIKERT SCALE 3-POINT|Y|U|NA|5||7||RUN-IN|1969-09-16||||1971-05-25||1967-12-30|1960-03-26|
TRIAL STUDY 134XCP|QS|176B6882-0C9E-435E-9842-FF8714BC9CAF|1|||||MRS|||PFU/ML|||BQ/G|NOT DONE||NUMERICAL RATING SCALE 6-POINT|Y|NA|U|1||38||TREATMENT|1964-09-05||||1969-05-03||1963-07-15|1960-02-10|
TRIAL STUDY 134XCP|QS|176B6882-0C9E-435E-9842-FF8714BC9CAF|2|||||MNSI|||%/S|||ANSON U|NOT DONE||NUMERICAL RATING SCALE 11-POINT|N|U|Y|2||58||OPEN LABEL TREATMENT|1970-09-07||||1971-10-01||1961-05-11|1964-08-08|
TRIAL STUDY 134XCP|QS|176B6882-0C9E-435E-9842-FF8714BC9CAF|3|||||SHORT-FORM MPQ-2|||EJACULATE U|||GTT|NOT DONE||VISUAL ANALOG SCALE (10 CM)|NA|U|U|3||39||INDUCTION TREATMENT|1969-09-22||||1972-06-20||1963-05-15|1963-07-12|
TRIAL STUDY 134XCP|QS|176B6882-0C9E-435E-9842-FF8714BC9CAF|4|||||PHQ-15|||CI/UG|||NMOL/L/H|NOT DONE||VISUAL ANALOG SCALE (100 MM)|U|U|NA|4||88||FOLLOW-UP|1962-11-23||||1972-07-31||1961-09-02|1960-06-26|
TRIAL STUDY 134XCP|QS|176B6882-0C9E-435E-9842-FF8714BC9CAF|5|||||AUDIT-SR|||G/ANIMAL|||MM/H|NOT DONE||NUMERICAL RATING SCALE 11-POINT|NA|N|U|5||7||OBSERVATION|1970-12-16||||1968-06-11||1968-09-27|1972-05-23|
